<SEC-DOCUMENT>0000849146-22-000027.txt : 20220503
<SEC-HEADER>0000849146-22-000027.hdr.sgml : 20220503
<ACCEPTANCE-DATETIME>20220503160550
ACCESSION NUMBER:		0000849146-22-000027
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		48
CONFORMED PERIOD OF REPORT:	20220331
FILED AS OF DATE:		20220503
DATE AS OF CHANGE:		20220503

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lifevantage Corp
		CENTRAL INDEX KEY:			0000849146
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				841097796
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35647
		FILM NUMBER:		22886806

	BUSINESS ADDRESS:	
		STREET 1:		3300 TRIUMPH BLVD
		STREET 2:		SUITE 700
		CITY:			LEHI
		STATE:			UT
		ZIP:			84043
		BUSINESS PHONE:		801-432-9000

	MAIL ADDRESS:	
		STREET 1:		3300 TRIUMPH BLVD
		STREET 2:		SUITE 700
		CITY:			LEHI
		STATE:			UT
		ZIP:			84043

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LIFELINE THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20041019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	YAAK RIVER RESOURCES INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANDRAPLEX CORP
		DATE OF NAME CHANGE:	19920406
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>lfvn-20220331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:638a0b91-4766-4439-9960-cd7043420117,g:40b96704-8fd2-45ed-83b9-f73156e5e4bc,d:41e77726867840e39498d8f5bb503840--><html xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:lfvn="http://www.lifevantage.com/20220331" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>lfvn-20220331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80L2ZyYWc6MWQyZTQyNTJkNDViNDg4ZTkwZmIwNjdhNmY2NmQ0NTAvdGFibGU6MjI2NTQyY2JjYjI3NDQ3MTgyYjZkZmQ4ZjIzMzQ5YjQvdGFibGVyYW5nZToyMjY1NDJjYmNiMjc0NDcxODJiNmRmZDhmMjMzNDliNF8yLTEtMS0xLTEzNTAz_e36ddfef-1ad7-41b4-96fe-9d8276bff48b">false</ix:nonNumeric><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80L2ZyYWc6MWQyZTQyNTJkNDViNDg4ZTkwZmIwNjdhNmY2NmQ0NTAvdGFibGU6MjI2NTQyY2JjYjI3NDQ3MTgyYjZkZmQ4ZjIzMzQ5YjQvdGFibGVyYW5nZToyMjY1NDJjYmNiMjc0NDcxODJiNmRmZDhmMjMzNDliNF8zLTEtMS0xLTEzNTAz_a68c8e8d-3a6e-4566-89db-4729679898c5">2022</ix:nonNumeric><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80L2ZyYWc6MWQyZTQyNTJkNDViNDg4ZTkwZmIwNjdhNmY2NmQ0NTAvdGFibGU6MjI2NTQyY2JjYjI3NDQ3MTgyYjZkZmQ4ZjIzMzQ5YjQvdGFibGVyYW5nZToyMjY1NDJjYmNiMjc0NDcxODJiNmRmZDhmMjMzNDliNF80LTEtMS0xLTEzNTAz_28998979-923c-4e63-8701-e428d4a2e93c">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80L2ZyYWc6MWQyZTQyNTJkNDViNDg4ZTkwZmIwNjdhNmY2NmQ0NTAvdGFibGU6MjI2NTQyY2JjYjI3NDQ3MTgyYjZkZmQ4ZjIzMzQ5YjQvdGFibGVyYW5nZToyMjY1NDJjYmNiMjc0NDcxODJiNmRmZDhmMjMzNDliNF81LTEtMS0xLTEzNTAz_1ae3f623-4c66-4a80-a426-87466f28120b">0000849146</ix:nonNumeric><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80L2ZyYWc6MWQyZTQyNTJkNDViNDg4ZTkwZmIwNjdhNmY2NmQ0NTAvdGFibGU6MjI2NTQyY2JjYjI3NDQ3MTgyYjZkZmQ4ZjIzMzQ5YjQvdGFibGVyYW5nZToyMjY1NDJjYmNiMjc0NDcxODJiNmRmZDhmMjMzNDliNF82LTEtMS0xLTEzNTAz_4abf1f46-cee0-45c7-a47e-0e723cf38f3a">--09-30</ix:nonNumeric><ix:nonFraction unitRef="segment" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="INF" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80My9mcmFnOjA4YTNjODhhMWM3ODQyYmVhZjA2OWQyZDg0ZjEyODA0L3RhYmxlOjQ0YTJhYmU0YzkzMTRhNWViNWFjZDc4YjJmZDY1MjFlL3RhYmxlcmFuZ2U6NDRhMmFiZTRjOTMxNGE1ZWI1YWNkNzhiMmZkNjUyMWVfMi0xLTEtMS0xMzUwMw_cca3375e-23c5-4f51-98cd-bf42533a2046">1</ix:nonFraction><ix:nonNumeric contextRef="ie705979a5a084ddc9bea319da91db13a_I20220331" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RleHRyZWdpb246ODcyNWU3ZDAxNDBkNDg4NTliNDdmZWNlYWI0Mjc3MGFfMTU4_911d9052-5493-440f-bc28-01448a771e79">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i643716d34b6a4245a763bf8bf4629aa8_D20100927-20100927" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMTE5OQ_88c1c3cf-56ec-4205-9f2f-deff51b9192d">P1Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="lfvn-20220331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i114f6d588eec41cca10eacf197741d76_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ib389c215613a45d48cba70a168c71912_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fc9c821fc9844eebd5eeda44da0b7b7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7c081c090f745529154ed6ce94b38f9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46af58f761da46259c37ec6f18a63af2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cbd37945df4470c99f8b2a0360dc403_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie272543a8f524dd6a6c9114d0b6cf545_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i357d0e28c2744a86a6382506b17c0264_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i591ebee999ed4b4cb8022ec6a31670f3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a9a7c2d6b1d487eaf86a59ab23c23ce_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6e22e23d13942a385a4a49560a7f544_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61547256e29c4919b4fe5ead6c816e24_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd0af93ed4f64a8c937539b4670c6e48_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba6a88e280384332a89b41a26f4cfab4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida700141a9ae4429b2b7a901f417f0bf_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48a61f3b86a440f692477c18672aa67f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbcabe3d4d654627b2330ec970846ddf_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd08c3f853324ff28662164585d1fce6_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bb6cf9ad217405a8247ca642e30509c_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3804241d822468b8c8a03364b2f4db0_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6cf8b23c28d42e593d1ae4e2d3c4019_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38ac3e0be007455d8666cf4e653aaa47_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fdcc53f50d94cfdbb432bb029d84ddd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb1ca35e5a104d6193f48d4b349fd675_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5263d30c26d9470b8de6e49fabce1c6f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida7724eff7a34d7e804bef8c3a260107_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a3861a962104cbaafc9ae69c1393aab_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34d7b9b3d06f458fa586f0f59243f9bd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d259b63592a4d5ca5fac8400bae6f58_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18b390fcfcd440aeb1bd8306b98b8360_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80e93762807c42728430aca71fb61c7d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i422faeaa855042ae85c18160145ee1aa_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8414ddffcc994aaca67582af5b64988d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87ee290661d3437bb9f238e5b3000de5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i962d85b9976d4fa6b5d9584e36bb2ab1_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c716aa1362243ccb5055e6e6b509ab8_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12c81306c48d435facd113371422e44d_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic551f8ef22194653996c3e7b7c2a4891_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68b782cee24b481ab1a20bb3a92aad68_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f6b95ce9ace4fcbbaf406066f26cb5d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i078343424c294ceca151c4f530b420fc_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36be45415d344673a4b1de8f2d0bf0fe_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i371a2ccf5aa04409abfd0f1176383ba2_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i272a3fb900ee42a0b17372fc51c0fd09_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68418c3e9e354ef68baafaaaad67d4db_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b04da3ccb2949e8a573db766889abb2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d971956fe1e405092f076fc100385f9_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1968b9f619f497180ce2af775046e41_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07e41a0a758d427ebab0f9e00cf68cfb_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99f28f304d1842658dac0719b5141740_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d8a258a91bd4059b27b728132af022c_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifeb352d0769a418ebda3b74b0acbf648_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1a17cb2d0ca4207a83089fb753965d7_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ab5b4c786a74727b650772bc5f9b6e0_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1fa511d00c840e68d4d9869eb7ddd2e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia281323b7eca4b0aac83a5aa68bb9dab_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3d79a145f79427694eee4afa398d9c7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id95d9cc8f1034f528cc66cff9ad5c9ef_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d0accfc67e54e8db1894b6929923ad1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8a85e0499a945de8e4808fe5e485e28_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb4a6be5906b4ce4a66d6061c62992dd_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4925e0ea7d9e481d96e9fa256be5a1bf_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib10cb8e7de8c4656ab658f3172b4c6c8_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fb5b0bffd7444c2babfc6c81537af68_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74275ea8913e4aabb9ae6b13024fbb68_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f571c6d0a364422a6f303b161efdd8a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba8aa560a2b64ef4b94817dac00694cb_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i486872c51e4640dab4cf26f789788bba_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02d0d983f156475da80d891080400c71_D20220331-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">lfvn:CashAccountsHeldPrimarilyAtFinancialInstitutionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-31</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8461345d4fc14a97aef4e829e0775dcc_D20220331-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">lfvn:CashAccountsHeldatOtherFinancialInstitutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-31</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i182b6ab241c640bfa92b9b402ecbe30b_D20210630-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">lfvn:CashAccountsHeldPrimarilyAtFinancialInstitutionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-30</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a84972552ec4e43882535e243362870_D20210630-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">lfvn:CashAccountsHeldatOtherFinancialInstitutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-30</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ic645b34a2785482d9664b71bdd91384e_I20200901"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:SandyUTMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id450c5bdf563442ca02fa3bd0de3267d_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:SandyUTMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i222bc716cf0a47dd8efde9c5d36eff58_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:SandyUTMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="region"><xbrli:measure>lfvn:region</xbrli:measure></xbrli:unit><xbrli:context id="id2939647eeae400482eba40fd37747e0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad789057464b445383e8e237ab794a70_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf9becab944541f9973e690359ee58d5_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e55f2a3f9c54683a2a69cee96783bac_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59577e105b574a07b1c8625a6eb9c7d1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:AsiaPacificAndEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieac81516c5ed43b983bf40a00b30e9c1_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:AsiaPacificAndEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i279ae95e5e154fd3ac7b3d02bbe2bba3_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:AsiaPacificAndEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic48a39651d07442f8d571c963b553e9f_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:AsiaPacificAndEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85f81a6375b645c98c3862ffe7700508_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09abcf3ac44849c49e3c780b175040a5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae8bb42b789646b4ba6f4b074eeffca3_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f44d883e0b2449897b56a1b34ccca8f_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f58b5474ebb4a5f830b29be3a2f7a7c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18167f341a8d41d5a9580b26693b5110_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia265df95ea7245d68fe8e38ba50df608_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93830f5b4c944ebf841a5318eff7e31d_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97c08f4a55f8470a9971ea339ea1c21d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53b30af5c47844f9b1a2b364a4dc51ec_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d74274057c84930a25d326155334bc0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic55ed5df77fa48efa92d5f7675cff1e4_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>lfvn:segment</xbrli:measure></xbrli:unit><xbrli:context id="i345de6f57ba548a6ba07b11d0d85bb30_I20191216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if676f17905b1439fb5721e767c883b01_D20191216-20191216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-16</xbrli:startDate><xbrli:endDate>2019-12-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7541c71e837e4987866f3c14bda4fcd9_D20191216-20191216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-16</xbrli:startDate><xbrli:endDate>2019-12-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie705979a5a084ddc9bea319da91db13a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c83ca889a7845a2a8fe7f12f6b7501f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91749ed981c5409a9273b2f8dbbe2722_I20160330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-03-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28ed7365c77c4b2db3b859a62be20d66_I20160330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-03-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e21e97ed1274414912f33d01244c913_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i712ce600357e432e9efd232d861ee1b2_I20180504"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-05-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6905908291e94757a8fba8a815f971d0_D20180504-20180504"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-04</xbrli:startDate><xbrli:endDate>2018-05-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4e41b786fa5480cbafaff2190125416_D20190201-20190201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-01</xbrli:startDate><xbrli:endDate>2019-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i138740ba50b5467d8eb135d8bfbf6674_I20190201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0c55b4954084c5aae5f41ea24e8318b_I20190201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2934f27e399b471b8b9dfd34e5e0ac1b_D20190201-20190201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-01</xbrli:startDate><xbrli:endDate>2019-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cbad6d70bc54ef6bae80ba6559acdcc_I20180504"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-05-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib44219a0ab0d49e6bc0c499248ce173b_D20210401-20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:UsTreasuryUstInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie90439fd1c8a43998c36b1c5528a888c_D20210401-20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44c9eefb9093469182cd44d1b4c1dd66_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifee0653b54af42bf80320efe99032f1d_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5c31a591c3c44ea943724f45a5bccda_D20200701-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied064917c4284ae1bbf8175e9b75f43b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia94b7a6d35ea49b3b94d253b14ae6d97_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfeffa2877114db7a47309a70bbb8f84_I20171127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-11-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15ef7d898c564726b93cc5e8c2ad2750_I20190201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b61f7ff2c2b4a908d35b37807707405_I20200827"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-08-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8365c04b98844bcea3d544bdda92cd4c_I20220217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-02-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfb9d06f4ea24bfb9da6d26bba64f59e_I20061121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndSevenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2006-11-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82db2efb56364be499fa24d948efc805_I20100927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2010-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i643716d34b6a4245a763bf8bf4629aa8_D20100927-20100927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2010-09-27</xbrli:startDate><xbrli:endDate>2010-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38dcb43eafd747fbbc7861d7bb8a2b03_D20100927-20100927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2010-09-27</xbrli:startDate><xbrli:endDate>2010-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4fb358160af4b1582deaf09e2b4bd56_D20100927-20100927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2010-09-27</xbrli:startDate><xbrli:endDate>2010-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1f4201b19a74fef8349a17facf7daa8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e2b576ca32a4d868584d602195e7c37_D20180202-20180202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-02-02</xbrli:startDate><xbrli:endDate>2018-02-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3eb364b1b32431298d5283303fb50c1_D20181115-20181115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-11-15</xbrli:startDate><xbrli:endDate>2018-11-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82320565cb5746a9a4deead3ae0f001d_D20201112-20201112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-12</xbrli:startDate><xbrli:endDate>2020-11-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cc2bb8a2f46410091908db5becaed25_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45d0f653093a43c1aa4ad8a6f44b65f5_I20180202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-02-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica0b13add21047009a5fb1a118222ecf_I20180202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-02-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1c7eca313734a9780d2949151a11055_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7df9f17944846a0ac9250ae7774a182_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandEighteenPerformancePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie920895e4f5f48ef81ce22593768c0b3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandEighteenPerformancePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="installment"><xbrli:measure>lfvn:installment</xbrli:measure></xbrli:unit><xbrli:context id="ibbe9559ba77040d5b39ea3519ff4b9b9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice3288151d3641c6b51df76356f2297c_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b7712dd2ecf4cc990ccba081959ed4a_D20191205-20191205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-05</xbrli:startDate><xbrli:endDate>2019-12-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>lfvn:claim</xbrli:measure></xbrli:unit><xbrli:context id="ic9473e77deb447f2b4bcc4e5432b8e7b_I20191205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="member"><xbrli:measure>lfvn:member</xbrli:measure></xbrli:unit><xbrli:context id="i8dd65cec87d94d2897061c2f0b29f444_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74cd73657787445193edd1ca4da3a419_D20210701-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i41e77726867840e39498d8f5bb503840_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"> UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________________________________________________________________________</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Form <ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGV4dHJlZ2lvbjo4Njc5M2NhODY2Mzg0YWYxYmYzM2RkOWU0ODE4MGZlNV8xNjQ_7207202d-a304-4dd2-ac9f-ef4cb8073383">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________________________________________________________________________</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGFibGU6YTUwZjViMzNjNDE1NDdlN2FiZDcyMzdhNGIyMjBlYTUvdGFibGVyYW5nZTphNTBmNWIzM2M0MTU0N2U3YWJkNzIzN2E0YjIyMGVhNV8wLTAtMS0xLTEzNTAz_f968b16c-8917-4203-b798-4bf6967705d5">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">QUARTERLY REPORT UNDER SECTION 13 OR 15 (d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE QUARTERLY PERIOD ENDED <ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGV4dHJlZ2lvbjo4Njc5M2NhODY2Mzg0YWYxYmYzM2RkOWU0ODE4MGZlNV8yODE_35a4f640-3544-4df7-ad1c-d85b50cd9201">MARCH 31, 2022</ix:nonNumeric></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGFibGU6MmJmZjIxZDdjMjY3NDA2YjgxZDQxN2I0YmMyYzNlZDEvdGFibGVyYW5nZToyYmZmMjFkN2MyNjc0MDZiODFkNDE3YjRiYzJjM2VkMV8wLTAtMS0xLTEzNTAz_f1a0fda8-801e-4e5c-8646-4cc94a42ae0c">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE TRANSITION PERIOD FROM </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> TO </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGV4dHJlZ2lvbjo4Njc5M2NhODY2Mzg0YWYxYmYzM2RkOWU0ODE4MGZlNV8zNjY_68e5b98c-2fff-49ad-9259-c684236f5e46">001-35647</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________________________________________________________________________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGV4dHJlZ2lvbjo4Njc5M2NhODY2Mzg0YWYxYmYzM2RkOWU0ODE4MGZlNV80NTE_4781f7fe-7e6b-4464-95e4-8e7dab6d3d7d">LIFEVANTAGE CORP</ix:nonNumeric>ORATION</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Exact name of Registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________________________________________________________________________</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGFibGU6M2E4NWVlZTBiOGIzNDc1YTg3NDk3NmEwOWVmMTEwYmUvdGFibGVyYW5nZTozYTg1ZWVlMGI4YjM0NzVhODc0OTc2YTA5ZWYxMTBiZV8wLTAtMS0xLTEzNTAz_0543b7fa-3489-4d17-949d-7a7be2a551fe">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGFibGU6M2E4NWVlZTBiOGIzNDc1YTg3NDk3NmEwOWVmMTEwYmUvdGFibGVyYW5nZTozYTg1ZWVlMGI4YjM0NzVhODc0OTc2YTA5ZWYxMTBiZV8wLTItMS0xLTEzNTAz_e69ccd94-7fa7-4f22-82d0-deb2a4e539ec">90-0224471</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(IRS Employer Identification No.)</span></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGV4dHJlZ2lvbjo4Njc5M2NhODY2Mzg0YWYxYmYzM2RkOWU0ODE4MGZlNV8yNDEy_898e4e7d-3724-4e23-9c40-93bde8864701">3300 Triumph Blvd</ix:nonNumeric>, <ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGV4dHJlZ2lvbjo4Njc5M2NhODY2Mzg0YWYxYmYzM2RkOWU0ODE4MGZlNV8yNDEz_7816679b-bb1c-4ecc-909d-f8278970ca47">Suite 700</ix:nonNumeric>, <ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGV4dHJlZ2lvbjo4Njc5M2NhODY2Mzg0YWYxYmYzM2RkOWU0ODE4MGZlNV8yNDE0_44652a3e-58b6-4b54-9ddb-15321b35736f">Lehi</ix:nonNumeric>, <ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGV4dHJlZ2lvbjo4Njc5M2NhODY2Mzg0YWYxYmYzM2RkOWU0ODE4MGZlNV82MzU_8f7c9696-b8db-481e-87b4-9c0a988a596c">UT</ix:nonNumeric> <ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGV4dHJlZ2lvbjo4Njc5M2NhODY2Mzg0YWYxYmYzM2RkOWU0ODE4MGZlNV82Mzg_b4b1a0ea-b2c7-4b0d-9be2-00ebe3c60de5">84043</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGV4dHJlZ2lvbjo4Njc5M2NhODY2Mzg0YWYxYmYzM2RkOWU0ODE4MGZlNV83MDM_4a6cf2b7-4f00-44cf-838a-b1a851967dea">801</ix:nonNumeric>) <ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGV4dHJlZ2lvbjo4Njc5M2NhODY2Mzg0YWYxYmYzM2RkOWU0ODE4MGZlNV83MDc_f32f59f7-4fda-49b9-968e-653e3fba6d85">432-9000</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:31.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.846%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGFibGU6OGQ4YTE2ZjViZGU2NDZjNjk1NTRiYWI5NjgxNTA3NTAvdGFibGVyYW5nZTo4ZDhhMTZmNWJkZTY0NmM2OTU1NGJhYjk2ODE1MDc1MF8wLTAtMS0xLTEzNTAz_0e2e4a80-a707-4fca-9fea-8268a5f8683d">Common Stock, par value $0.0001</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGFibGU6OGQ4YTE2ZjViZGU2NDZjNjk1NTRiYWI5NjgxNTA3NTAvdGFibGVyYW5nZTo4ZDhhMTZmNWJkZTY0NmM2OTU1NGJhYjk2ODE1MDc1MF8wLTItMS0xLTEzNTAz_a7053127-6c5a-43dd-84ba-49a255a5b8d8">LFVN</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGFibGU6OGQ4YTE2ZjViZGU2NDZjNjk1NTRiYWI5NjgxNTA3NTAvdGFibGVyYW5nZTo4ZDhhMTZmNWJkZTY0NmM2OTU1NGJhYjk2ODE1MDc1MF8wLTQtMS0xLTEzNTAz_180b33c5-1ed9-42b3-ac2a-f97ec8e1a121">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________________________________________________________________________</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15 (d)&#160;of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGV4dHJlZ2lvbjo4Njc5M2NhODY2Mzg0YWYxYmYzM2RkOWU0ODE4MGZlNV8xMjM0_752d3231-08e6-47f0-a835-1394c4eb2471">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGV4dHJlZ2lvbjo4Njc5M2NhODY2Mzg0YWYxYmYzM2RkOWU0ODE4MGZlNV8xNTU5_c3c55347-ceb2-4eda-be70-81e1ca88db12">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.849%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Large&#160;accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#168;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGFibGU6Nzg5NjA4MTAxNjJjNGQxMzhkNGYxM2U3NjE3YzMzZGQvdGFibGVyYW5nZTo3ODk2MDgxMDE2MmM0ZDEzOGQ0ZjEzZTc2MTdjMzNkZF8wLTItMS0xLTEzNTAz_08e01cb5-e9f4-41ba-a0a7-a0e808be2f76">Accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#168;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGFibGU6Nzg5NjA4MTAxNjJjNGQxMzhkNGYxM2U3NjE3YzMzZGQvdGFibGVyYW5nZTo3ODk2MDgxMDE2MmM0ZDEzOGQ0ZjEzZTc2MTdjMzNkZF8xLTMtMS0xLTEzNTAz_35eb261d-34e3-4cae-9692-d0deda74fcc3">&#9746;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Emerging Growth Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGFibGU6Nzg5NjA4MTAxNjJjNGQxMzhkNGYxM2U3NjE3YzMzZGQvdGFibGVyYW5nZTo3ODk2MDgxMDE2MmM0ZDEzOGQ0ZjEzZTc2MTdjMzNkZF8yLTEtMS0xLTEzNTAz_c258e79f-b5ed-4635-b3e8-fabcab44df36">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes&#160;&#160;<ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGV4dHJlZ2lvbjo4Njc5M2NhODY2Mzg0YWYxYmYzM2RkOWU0ODE4MGZlNV8yMjk1_66418443-38ff-471c-ae92-1b2aa590575a">&#9744;</ix:nonNumeric>&#160;&#160;No&#160;&#160;&#9746;</span></div><div style="margin-top:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The number of shares outstanding of the issuer&#8217;s common stock, par value $0.0001 per share, as of April&#160;29, 2022 was <ix:nonFraction unitRef="shares" contextRef="i114f6d588eec41cca10eacf197741d76_I20220429" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGV4dHJlZ2lvbjo4Njc5M2NhODY2Mzg0YWYxYmYzM2RkOWU0ODE4MGZlNV8yNDEw_178946fc-d18a-4af9-a82c-0454322349ce">12,590,098</ix:nonFraction>.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i41e77726867840e39498d8f5bb503840_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This quarterly report on Form 10-Q, in particular &#8220;Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; and the information incorporated by reference herein contains &#8220;forward-looking statements&#8221; (as such term is defined in Section&#160;27A of the Securities Act of 1933, as amended and Section&#160;21E of the Securities Exchange Act of 1934, as amended). These statements, which involve risks and uncertainties, reflect our current expectations, intentions, or strategies regarding our possible future results of operations, performance, and achievements. Forward-looking statements include, without limitation: statements regarding future products or product development; statements regarding future selling, general and administrative costs and research and development spending; statements regarding the future performance of our network marketing efforts; statements regarding our expectations regarding ongoing litigation; statements regarding international growth; and statements regarding future financial performance, results of operations, capital expenditures and sufficiency of capital resources to fund our operating requirements. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and applicable rules of the Securities and Exchange Commission and common law.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These forward-looking statements may be identified in this report and the information incorporated by reference by words such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should&#8221; and similar terms and expressions, including references to assumptions and strategies. These statements reflect our current beliefs and are based on information currently available to us. Accordingly, these statements are subject to certain risks, uncertainties, and contingencies, which could cause our actual results, performance, or achievements to differ materially from those expressed in, or implied by, such statements.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following factors are among those that may cause actual results to differ materially from our forward-looking statements:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inability to properly manage, motivate and retain our independent distributors or to attract new customers and independent distributors on an ongoing basis;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The COVID-19 pandemic or the widespread outbreak of any other illness or communicable disease or any other public health crisis, could adversely affect our business, results of operations and financial condition;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inability to protect against cyber security risks and to maintain the integrity of data;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inability to manage existing markets, open new international markets or expand our operations;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Non-compliance by our independent distributors with applicable legal requirements or our policies and procedures, including making improper and/or illegal claims about our products or earnings opportunity;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inability of new products and technological innovations to gain customer or independent distributor or market acceptance;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inability to execute our product launch process due to increased pressure on our supply chain, information systems and management;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inability to appropriately manage our inventory;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Potential adverse effects on our business and stock price due to ineffective internal controls;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Disruptions in our information technology systems;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inability to comply with financial covenants imposed by our credit facility and the impact of debt service obligations and restrictive debt covenants;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International trade or foreign exchange restrictions, increased tariffs, foreign currency exchange fluctuations;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inability to raise additional capital or complete desired acquisitions;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Dependence upon a few products for revenue;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">High quality materials for our products may become difficult to obtain or expensive;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Dependence on third parties to manufacture our products;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Disruptions to the transportation channels used to distribute our products;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be subject to a product recall;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Unfavorable publicity on our business or products;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our direct selling program could be found to not be in compliance with current or newly adopted laws or regulations in various markets;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Legal proceedings may be expensive and time consuming;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Strict government regulations on our business;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Regulations governing the production or marketing of our products;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk of investigatory and enforcement action;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Government authorities may question our tax positions or transfer pricing policies or change their laws in a manner that could increase our effective tax rate or otherwise harm our business;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Failure to comply with anti-corruption laws;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Loss of, or inability to attract, key personnel;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be held responsible for certain taxes or assessments and other obligations relating to the activity of our independent distributors;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Competition in the dietary supplement and personal care markets;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our inability to protect our intellectual property rights;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Third party claims that we infringe on their intellectual property;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Product liability claims against us;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Economic, political, foreign exchange and other risks associated with international operations;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Potential delisting of our common stock due to non-compliance with Nasdaq's continued listing requirements;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Volatility of the market price of our common stock;</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Substantial sales of shares may negatively impact the market price of our common stock; and</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Dilution of outstanding common shares may occur if holders of our existing options exercise their securities or upon future vesting of restricted stock units.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When considering these forward-looking statements, you should keep in mind the cautionary statements in this report and the documents incorporated by reference. Except as required by law, we have no obligation and do not undertake to update or revise any such forward-looking statements to reflect events or circumstances after the date of this report.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i41e77726867840e39498d8f5bb503840_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LIFEVANTAGE CORPORATION</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INDEX</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.686%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">PAGE</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_13">PART I. Financial Information</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_13">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_16">Financial Statements:</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_16">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_19">Condensed Consolidated Balance Sheets (unaudited) </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_19">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_22">Condensed Consolidated Statements of Operations and Comprehensive Income</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_22"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_22">(unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_22">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_25">Condensed Consolidated Statement of Stockholders&#8217; Equity (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_25">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_31">Condensed Consolidated Statements of Cash Flows (unaudited) </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_31">9</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_34">Notes to Condensed Consolidated Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_34">10</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_67">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_67">20</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_91">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_91">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_94">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_94">29</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_97">PART II. Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_97">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_100">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_100">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_103">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_103">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_106">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_106">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_109">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_109">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_112">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_112">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_115">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_115">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_118">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_118">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_121">Signatures</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i41e77726867840e39498d8f5bb503840_121">32</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i41e77726867840e39498d8f5bb503840_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I. Financial Information</span></div><div id="i41e77726867840e39498d8f5bb503840_16"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. Financial Statements</span></div><div id="i41e77726867840e39498d8f5bb503840_19"></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LIFEVANTAGE CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">(In thousands, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNC0xLTEtMS0xMzUwMw_8969148f-703c-4b32-b971-7d116d6eeffd">17,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNC0zLTEtMS0xMzUwMw_ca1c15e1-8b48-4872-9163-1470255e4c89">23,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNS0xLTEtMS0xMzUwMw_cb978c32-0071-4602-9f64-e2fab8cc73bb">2,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNS0zLTEtMS0xMzUwMw_9a7fa109-e038-4ae9-b266-b8ecbeedeef8">2,925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income tax receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:IncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNi0xLTEtMS0xMzUwMw_25b92956-6fcc-4a24-9bc0-170e5f80dd69">805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNi0zLTEtMS0xMzUwMw_a84592a5-0189-49dc-bebc-224f3a2c1c3f">1,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Inventory, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNy0xLTEtMS0xMzUwMw_74288c5d-44df-47db-bff6-1639c829c8ae">16,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNy0zLTEtMS0xMzUwMw_e6947323-5099-42d9-9bff-1d7c2ee8cc7e">16,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfOS0xLTEtMS0xMzUwMw_65ddb743-5c4b-4de8-89ca-51841c525626">7,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfOS0zLTEtMS0xMzUwMw_acd472cb-b3e6-43c3-b1dc-90c8c3508173">4,772</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTAtMS0xLTEtMTM1MDM_9515b7c3-b4ac-4abd-84dc-1cf4eae3311e">45,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTAtMy0xLTEtMTM1MDM_7cfe291d-e093-4764-a74e-2b6787c4e540">48,054</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTItMS0xLTEtMTM1MDM_72785baf-8cbc-4f75-8edd-913e9937ee1b">10,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTItMy0xLTEtMTM1MDM_7c742193-d9c2-4557-96bc-1576becef407">11,123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTMtMS0xLTEtMTM1MDM_595c1c0c-3833-4cff-b446-dc63cd23e3d7">11,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTMtMy0xLTEtMTM1MDM_1225c29b-9d2f-4b8f-920a-2b9ba374be83">13,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTQtMS0xLTEtMTM1MDM_9e09fc36-3674-46be-af7f-a4d2630c10ac">620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTQtMy0xLTEtMTM1MDM_234491ab-cb50-4254-8c34-f9aca0fc97f4">719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred income tax asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTUtMS0xLTEtMTM1MDM_c056d2f3-a9c1-4a71-9221-680be572355f">1,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTUtMy0xLTEtMTM1MDM_43220ba7-9e2c-4aff-a675-704b5af8623b">1,208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTYtMS0xLTEtMTM1MDM_96d6814f-631a-422a-a3d8-9425a31fb60c">2,205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTYtMy0xLTEtMTM1MDM_b7d4e9b0-0779-469d-b7fb-e213b8909b4b">2,205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTctMS0xLTEtMTM1MDM_f6309f86-c0e5-450e-bbcc-0c857e11d162">1,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTctMy0xLTEtMTM1MDM_9b404670-c32f-4542-b14e-c5381d148b7d">1,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">TOTAL ASSETS</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTgtMS0xLTEtMTM1MDM_0f9815ff-d1da-4884-8dad-457a1889ab77">72,215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTgtMy0xLTEtMTM1MDM_7fcdd690-24fc-4e0b-b9e7-c5b4daf069c1">78,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMjItMS0xLTEtMTM1MDM_685cfe8f-e073-4bf7-a2a2-436cf451d7c6">6,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMjItMy0xLTEtMTM1MDM_f7259664-c862-4da8-bf31-710880bbf2b9">6,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Commissions payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:AccruedSalesCommissionCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMjMtMS0xLTEtMTM1MDM_182962cc-3232-479a-9546-49896c4eda7e">7,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:AccruedSalesCommissionCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMjMtMy0xLTEtMTM1MDM_820ac842-b552-464a-8b38-a21b00fba7b6">8,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:TaxesPayableCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMjYtMS0xLTEtMTM1MDM_b85cd44c-b0ca-4d71-ad51-34f2d9bf5fb7">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:TaxesPayableCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMjYtMy0xLTEtMTM1MDM_db26b37c-ef70-4c49-b597-617d25bf342d">830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMjctMS0xLTEtMTM1MDM_aaa52cfa-066f-480c-ba49-c0aa985038be">2,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMjctMy0xLTEtMTM1MDM_da2098d6-1eb4-431b-9c5e-bdc621f4a5b7">2,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMjgtMS0xLTEtMTM1MDM_060ec134-b5ca-4c1a-8d08-dfbee5fd2308">7,054</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMjgtMy0xLTEtMTM1MDM_4d767b27-a7da-472e-a901-bdb44982d07c">7,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMzAtMS0xLTEtMTM1MDM_10295f0f-f3c1-48a7-95d4-73a2071a894d">23,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMzAtMy0xLTEtMTM1MDM_aba3434f-f859-41ab-b245-4ac5a03d4019">25,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-term lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMzYtMS0xLTEtMTM1MDM_f2af76e4-2616-4638-bdd0-6556530f61a1">13,876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMzYtMy0xLTEtMTM1MDM_e4696d1b-2429-4a15-9515-f648c4413c22">16,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMzctMS0xLTEtMTM1MDM_5a82a1a9-5b9c-4338-a1e5-cb07f37db146">700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMzctMy0xLTEtMTM1MDM_b097869b-b50a-471c-984c-026664e0d0ec">694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMzgtMS0xLTEtMTM1MDM_9133837d-d3cd-4ead-a4af-a2d37765b333">38,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMzgtMy0xLTEtMTM1MDM_c77340fd-4cc4-40f7-be48-ab1e6a22a7ee">41,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Commitments and contingencies - Note 8</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMzktMS0xLTEtMTM1MDM_f67a6213-f587-42e7-a786-d6f691b2c58d"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMzktMy0xLTEtMTM1MDM_2879dc7c-14d3-4a7e-8617-7e9f456c9497"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Preferred stock &#8212; par value $<ix:nonFraction unitRef="usdPerShare" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDEtMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpiYmQ3MmZkMmZmZDM0NjU0OTVlNmZmYTU3ZTUzYjY1NV8zMg_69b6e8a6-75b9-453c-8397-ac74df9bbe28"><ix:nonFraction unitRef="usdPerShare" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDEtMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpiYmQ3MmZkMmZmZDM0NjU0OTVlNmZmYTU3ZTUzYjY1NV8zMg_9206c46e-7c6a-4e99-b4fb-24577deb08bf">0.0001</ix:nonFraction></ix:nonFraction> per share, <ix:nonFraction unitRef="shares" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDEtMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpiYmQ3MmZkMmZmZDM0NjU0OTVlNmZmYTU3ZTUzYjY1NV80Ng_3a1dbe2d-ba16-4bfc-9b8b-f5fb4de15f1d"><ix:nonFraction unitRef="shares" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDEtMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpiYmQ3MmZkMmZmZDM0NjU0OTVlNmZmYTU3ZTUzYjY1NV80Ng_ff0402f7-2ee5-439f-b14c-f3dd0e5c1999">5,000</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDEtMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpiYmQ3MmZkMmZmZDM0NjU0OTVlNmZmYTU3ZTUzYjY1NV82OA_7d69cd42-fdaf-4f5a-b1fd-6810aaaa516f"><ix:nonFraction unitRef="shares" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDEtMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpiYmQ3MmZkMmZmZDM0NjU0OTVlNmZmYTU3ZTUzYjY1NV82OA_8809e1ee-6308-4609-bbd7-7339ab4aab79"><ix:nonFraction unitRef="shares" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDEtMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpiYmQ3MmZkMmZmZDM0NjU0OTVlNmZmYTU3ZTUzYjY1NV82OA_9fe476f1-e03d-401b-9fe2-dbd5112bb7d8"><ix:nonFraction unitRef="shares" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDEtMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpiYmQ3MmZkMmZmZDM0NjU0OTVlNmZmYTU3ZTUzYjY1NV82OA_cd264e2a-6115-4749-8893-0ad0ef03bded">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued or outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDEtMS0xLTEtMTM1MDM_6651bf8c-149a-4165-a3ed-5b6c2b34f6f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDEtMy0xLTEtMTM1MDM_31af3173-ffc7-4e93-8a3b-679760ef8d10">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Common stock &#8212; par value $<ix:nonFraction unitRef="usdPerShare" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDItMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpjOTQ4OGRlNDk5ZGM0ZjVjODJiZDVmNmE3MjQzMGJjNl8zMA_87618eba-60b0-4039-8cc5-5ef848390ea9"><ix:nonFraction unitRef="usdPerShare" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDItMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpjOTQ4OGRlNDk5ZGM0ZjVjODJiZDVmNmE3MjQzMGJjNl8zMA_ba6d19f9-f09a-403e-8cfd-1c33485beee6">0.0001</ix:nonFraction></ix:nonFraction> per share, <ix:nonFraction unitRef="shares" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDItMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpjOTQ4OGRlNDk5ZGM0ZjVjODJiZDVmNmE3MjQzMGJjNl80NA_21a37ccf-49f8-4dbf-b658-42d8b68d143e"><ix:nonFraction unitRef="shares" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDItMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpjOTQ4OGRlNDk5ZGM0ZjVjODJiZDVmNmE3MjQzMGJjNl80NA_9f2bca84-56fe-4dae-9458-1bf1dfa3127b">40,000</ix:nonFraction></ix:nonFraction> shares authorized and <ix:nonFraction unitRef="shares" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDItMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpjOTQ4OGRlNDk5ZGM0ZjVjODJiZDVmNmE3MjQzMGJjNl82OQ_21102eeb-344b-4475-8cef-98f30ef27e48"><ix:nonFraction unitRef="shares" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDItMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpjOTQ4OGRlNDk5ZGM0ZjVjODJiZDVmNmE3MjQzMGJjNl82OQ_9b372e4d-3730-45ed-81f0-d05925b2f8dd">12,577</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDItMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpjOTQ4OGRlNDk5ZGM0ZjVjODJiZDVmNmE3MjQzMGJjNl83Ng_83429067-d51a-4d25-9328-36c9d3fc8b1a"><ix:nonFraction unitRef="shares" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDItMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpjOTQ4OGRlNDk5ZGM0ZjVjODJiZDVmNmE3MjQzMGJjNl83Ng_8b010f36-ed42-493f-bca5-042794b752c1">13,609</ix:nonFraction></ix:nonFraction> issued and outstanding as of March&#160;31, 2022 and June&#160;30, 2021, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDItMS0xLTEtMTM1MDM_9332192d-549e-4967-b841-83aeebf26260">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDItMy0xLTEtMTM1MDM_9728bc53-e4e1-4092-a4fc-1eda836890bb">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDMtMS0xLTEtMTM1MDM_38437000-0f72-41dc-a052-8caff234e094">130,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDMtMy0xLTEtMTM1MDM_09fbbbca-6750-4d1f-8160-2ce3e97bf2b0">129,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDQtMS0xLTEtMTM1MDM_f3cdfb56-9275-429f-bb33-5befd2572fdc">96,184</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDQtMy0xLTEtMTM1MDM_4ab6f006-3ecb-4ca1-a173-557e946d33cf">92,346</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDUtMS0xLTEtMTM1MDM_02fd892d-6701-4d11-98c4-cbf6efb4bf1c">500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDUtMy0xLTEtMTM1MDM_be5bce33-7c9c-4748-a197-108d6edb45c1">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDYtMS0xLTEtMTM1MDM_0db87e5e-28e4-4932-8801-f046a0579110">34,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDYtMy0xLTEtMTM1MDM_2899c076-ecda-4d5e-9069-20be8ec13229">36,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDctMS0xLTEtMTM1MDM_8b3cb043-4c31-47a0-b294-8c7bf93539ee">72,215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDctMy0xLTEtMTM1MDM_1e7c9475-718a-4a6c-81e2-7fc2955ee3f3">78,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div id="i41e77726867840e39498d8f5bb503840_22"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LIFEVANTAGE CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMy0xLTEtMS0xMzUwMw_0297527c-0520-43e2-a14d-ba4d0f32f0e3">50,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMy0zLTEtMS0xMzUwMw_a16c8df2-2be5-471a-a925-bdb2ea8e48d4">51,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMy01LTEtMS0xMzUwMw_0791ec16-3d7e-480e-8b36-1e60ec0628ec">155,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMy03LTEtMS0xMzUwMw_fccc09ae-5b6a-40db-ab81-220031bd96b3">165,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfNC0xLTEtMS0xMzUwMw_8505a26d-384f-444e-8108-d4c095a29344">9,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfNC0zLTEtMS0xMzUwMw_3b4e7cfa-1c4d-4248-885a-d01a7e9cbf14">8,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfNC01LTEtMS0xMzUwMw_a95b58ba-d7a0-4386-8e67-e2687ff1a5af">28,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfNC03LTEtMS0xMzUwMw_3a4b3fd6-02dc-4ec6-9c9b-370a6490e802">28,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfNS0xLTEtMS0xMzUwMw_ab6fa699-590d-4846-8e9f-400df66d00ea">40,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfNS0zLTEtMS0xMzUwMw_e128d41f-a4ee-4f30-b033-ce9c81d2f0cd">42,752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfNS01LTEtMS0xMzUwMw_28aa2372-d360-4a76-8899-33096232dbda">126,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfNS03LTEtMS0xMzUwMw_1eaaeab2-0703-4662-be0e-2f3abc0b34dd">137,001</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commissions and incentives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" name="lfvn:CommissionAndIncentives" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfNy0xLTEtMS0xMzUwMw_bc373e99-6510-4e47-aced-9c248e4cf9b2">23,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" name="lfvn:CommissionAndIncentives" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfNy0zLTEtMS0xMzUwMw_f0535bf2-21ff-4673-9256-0aad74cdfc82">25,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="lfvn:CommissionAndIncentives" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfNy01LTEtMS0xMzUwMw_52b34ba4-3b28-4804-bb0a-2b2193cea60f">72,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="lfvn:CommissionAndIncentives" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfNy03LTEtMS0xMzUwMw_b5a41dce-6785-45cc-a2ad-458afe0006e7">77,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfOC0xLTEtMS0xMzUwMw_45355c7e-bdcc-47a1-a3b2-2b20b38b7557">15,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfOC0zLTEtMS0xMzUwMw_f14f7442-844f-4387-8704-4e0d2b8d25f0">15,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfOC01LTEtMS0xMzUwMw_b53a458c-0348-448d-9bdc-9d7d9778a3ce">47,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfOC03LTEtMS0xMzUwMw_5691e7ac-79ee-4eb2-9ef0-7ce1fbe6aa00">48,027</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTEtMS0xLTEtMTM1MDM_68e9f986-e632-4545-a235-c40493ade781">38,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTEtMy0xLTEtMTM1MDM_bd67306c-fe8b-44a9-b1b6-5413847846f7">40,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTEtNS0xLTEtMTM1MDM_cd81bb06-99dc-4412-a876-0815e0be932a">120,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTEtNy0xLTEtMTM1MDM_7ebddb77-7e47-4ddd-ba35-0d67aa5d6fdd">125,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTItMS0xLTEtMTM1MDM_6ad05966-1a81-46d9-8165-458c151036e9">1,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTItMy0xLTEtMTM1MDM_e817f101-73d7-48bf-8c7f-52ded3e24d74">2,088</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTItNS0xLTEtMTM1MDM_66ba5437-cd36-40d0-a1a2-9c1258ffd292">6,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTItNy0xLTEtMTM1MDM_c49f8c70-16ea-4a0d-93fa-303f9bc21207">11,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTQtMS0xLTEtMTM1MDM_3208d08c-9454-4dee-95c7-ee802d49c895">5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTQtMy0xLTEtMTM1MDM_69aa8c1d-22fc-46ce-a078-fbab0e5d7336">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTQtNS0xLTEtMTM1MDM_c53f8e4d-1898-4dc1-b10f-173322d89b09">10</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTQtNy0xLTEtMTM1MDM_8c489b48-3694-4eab-b82c-dd9d7b1bbeae">17</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTUtMS0xLTEtMTM1MDM_338d11dc-c5d5-435b-ab08-fa4ccbffc451">69</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTUtMy0xLTEtMTM1MDM_e681e8e6-60ec-4d77-8365-29d4b286b537">255</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTUtNS0xLTEtMTM1MDM_05a0cd7f-c471-4e74-b36b-027150058a03">385</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTUtNy0xLTEtMTM1MDM_e625ef65-6b73-4680-999d-1abee9d207ef">263</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTctMS0xLTEtMTM1MDM_5b4dc0fe-5383-46c1-97be-f696d6d8f993">74</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTctMy0xLTEtMTM1MDM_abf648a6-8421-4d59-bf44-4a3f48c8b08e">257</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTctNS0xLTEtMTM1MDM_ea7bd97d-c8b4-467a-baf3-08e69e00d6ec">395</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTctNy0xLTEtMTM1MDM_7f5fd66c-e029-4856-9dce-3e308b159514">280</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTgtMS0xLTEtMTM1MDM_727653fd-4a8f-48ca-ae3f-6b118b56b31a">1,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTgtMy0xLTEtMTM1MDM_9e3d198c-7042-4583-91a4-a94ea25ad523">1,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTgtNS0xLTEtMTM1MDM_c9eed362-0139-4b13-ae53-8b0a09fc0a8c">5,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTgtNy0xLTEtMTM1MDM_0a770968-b255-48bf-826f-62b7ea926286">10,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTktMS0xLTEtMTM1MDM_269c11db-ae13-4c8d-a032-1ac48bcbd7eb">610</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTktMy0xLTEtMTM1MDM_e836e719-7bda-40da-b4d5-da368520ae31">107</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTktNS0xLTEtMTM1MDM_c3fef7d4-80ca-4e30-b5d2-193521322b40">1,149</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTktNy0xLTEtMTM1MDM_9ff0af0c-4f7d-45e8-89b2-6f14a02b6787">2,768</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjAtMS0xLTEtMTM1MDM_2ca40150-544c-47cc-bc49-465bb588461e">1,141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjAtMy0xLTEtMTM1MDM_00e4a361-0b55-4097-ac66-dd1f1e2a3fb0">1,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjAtNS0xLTEtMTM1MDM_7203fa53-7790-45ce-b411-db50b76ff149">4,536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjAtNy0xLTEtMTM1MDM_db7e444b-7dd4-4f5c-9d13-478f14c3a899">7,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjItMS0xLTEtMTM1MDM_bb6e7db5-40ca-4001-96ec-6bdd002c68f0">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjItMy0xLTEtMTM1MDM_88a6ab93-8d87-476c-bad4-f8c8b506c8a3">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjItNS0xLTEtMTM1MDM_d4f7d752-72a7-45eb-a535-36d5ddc5f27c">0.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjItNy0xLTEtMTM1MDM_e99820a0-e77e-4ce2-be1d-bd759ae31006">0.56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjMtMS0xLTEtMTM1MDM_dca0693b-17e6-44cd-aae6-dcb2651fb791">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjMtMy0xLTEtMTM1MDM_107984ce-4848-46e3-a848-223aff0575f6">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjMtNS0xLTEtMTM1MDM_412d542f-eaf6-4cb1-9730-e94224d854f4">0.34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjMtNy0xLTEtMTM1MDM_68138447-c7bb-4f02-9637-7f94b69b63fc">0.55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjUtMS0xLTEtMTM1MDM_377d4389-6e0a-4922-8015-ba2e25d36e1b">13,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjUtMy0xLTEtMTM1MDM_9a51be5a-0769-47cf-b3a3-dd4314125bfb">14,071</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjUtNS0xLTEtMTM1MDM_3bed9b19-4192-4120-8e78-5d430ed8ba0c">13,261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjUtNy0xLTEtMTM1MDM_95e8015e-6a26-40d3-ba87-baf32f20496f">14,175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjYtMS0xLTEtMTM1MDM_c2a4a5df-1b4b-4b5e-9594-651e0c8e5714">13,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjYtMy0xLTEtMTM1MDM_21159732-197e-447d-9b33-497380cbbc13">14,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjYtNS0xLTEtMTM1MDM_aaa95c0b-ee71-46ce-8607-058ab21bef51">13,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjYtNy0xLTEtMTM1MDM_f749ffa8-21f6-4485-a191-64396ee3530f">14,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjgtMS0xLTEtMTM1MDM_61f3d956-87ce-4798-a2d2-c390e4c4bf13">290</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjgtMy0xLTEtMTM1MDM_60298538-c6e5-4c11-a109-a100a2c31804">443</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjgtNS0xLTEtMTM1MDM_f7906fc0-57df-4cb2-b2cd-e92477e91f10">604</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjgtNy0xLTEtMTM1MDM_62ecc61e-ccff-408c-a39f-ecb2c1f9fe46">39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMzAtMS0xLTEtMTM1MDM_8188bccc-7ba3-4152-b65e-6c9076ff19f7">290</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMzAtMy0xLTEtMTM1MDM_e3b86a1b-bbc6-4fef-a400-430657a367c3">443</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMzAtNS0xLTEtMTM1MDM_2d240306-138f-4582-9372-f470cf66f37f">604</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMzAtNy0xLTEtMTM1MDM_85bdef6e-e923-4c67-8a9c-4f61509d674d">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMzEtMS0xLTEtMTM1MDM_be2bdffe-8b0b-41a7-9077-bd7bbd760fcc">851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMzEtMy0xLTEtMTM1MDM_4d9b0718-ee8b-4deb-a829-280c57ed1a99">1,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMzEtNS0xLTEtMTM1MDM_915f0dcf-0251-435b-bef6-eea34ebf1766">3,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMzEtNy0xLTEtMTM1MDM_ccf59f7e-9b44-4530-8e05-7fae5bbbbc95">7,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i41e77726867840e39498d8f5bb503840_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LIFEVANTAGE CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:29.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.639%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive (Loss) Income</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances, June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9fc9c821fc9844eebd5eeda44da0b7b7_I20210630" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMy0xLTEtMS0xMzUwMw_339c12ac-4e10-4dd4-8dae-43570aff9635">13,609</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fc9c821fc9844eebd5eeda44da0b7b7_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMy0zLTEtMS0xMzUwMw_0a03f8d5-74b9-4180-8090-efe73b3fb484">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7c081c090f745529154ed6ce94b38f9_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMy01LTEtMS0xMzUwMw_c05f47e2-e377-4094-afd2-c607f2c67ba8">129,048</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46af58f761da46259c37ec6f18a63af2_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMy03LTEtMS0xMzUwMw_2a71549c-06a1-485a-b497-56e3895fb94e">92,346</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cbd37945df4470c99f8b2a0360dc403_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMy05LTEtMS0xMzUwMw_acd364ae-15a0-4b6c-90f1-2e8ad908715a">104</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMy0xMS0xLTEtMTM1MDM_e41d2fa0-9c62-41fa-9c7a-ab62d055edcd">36,807</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie272543a8f524dd6a6c9114d0b6cf545_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfNS01LTEtMS0xMzUwMw_ca90783c-eae9-4317-a654-84af7d26c0b5">645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i357d0e28c2744a86a6382506b17c0264_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfNS0xMS0xLTEtMTM1MDM_6c91f309-44ed-4ab4-ace0-0b5b8b6e241a">645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i591ebee999ed4b4cb8022ec6a31670f3_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfNi0xLTEtMS0xMzUwMw_1cb8b1b0-5fec-48b1-bf08-3aca228eabc4">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie272543a8f524dd6a6c9114d0b6cf545_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfNi01LTEtMS0xMzUwMw_f9e806cc-0387-43ae-83ba-a40200bcf81d">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i357d0e28c2744a86a6382506b17c0264_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfNi0xMS0xLTEtMTM1MDM_1180ea4d-cf01-4662-87ea-4b66238a8a5a">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under equity award plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i591ebee999ed4b4cb8022ec6a31670f3_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfNy0xLTEtMS0xMzUwMw_db62debb-2c10-49e6-a3cb-909a0fe3da52">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i357d0e28c2744a86a6382506b17c0264_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfNy0xMS0xLTEtMTM1MDM_272b7eee-a879-4fad-af36-becc0007b7d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares canceled or surrendered as payment of tax withholding and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i591ebee999ed4b4cb8022ec6a31670f3_D20210701-20210930" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfOC0xLTEtMS0xMzUwMw_b8291598-9f14-4abc-b662-a05f90fbab6f">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie272543a8f524dd6a6c9114d0b6cf545_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfOC01LTEtMS0xMzUwMw_10154c4a-c5e6-4595-98eb-1ece288f46c0">139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i357d0e28c2744a86a6382506b17c0264_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfOC0xMS0xLTEtMTM1MDM_430eefea-259c-42f0-91c0-5031e1e353fb">139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of company stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i591ebee999ed4b4cb8022ec6a31670f3_D20210701-20210930" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfOS0xLTEtMS0xMzUwMw_f77a67e1-aaf0-4228-9d2f-9a838338218f">460</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a9a7c2d6b1d487eaf86a59ab23c23ce_D20210701-20210930" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfOS03LTEtMS0xMzUwMw_33fff6f9-ba6a-4136-9eae-b4af0b286082">3,492</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i357d0e28c2744a86a6382506b17c0264_D20210701-20210930" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfOS0xMS0xLTEtMTM1MDM_08928cd6-503b-4354-aacb-1513ddf3dfb8">3,492</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i591ebee999ed4b4cb8022ec6a31670f3_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTAtMS0xLTEtMTM1MDM_65e15164-3af5-4657-b062-7d9a7297cb23">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie272543a8f524dd6a6c9114d0b6cf545_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTAtNS0xLTEtMTM1MDM_783d8975-2b70-453b-91ba-07437b59745d">175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i357d0e28c2744a86a6382506b17c0264_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTAtMTEtMS0xLTEzNTAz_ecb67824-ea48-4402-9b50-fec115e18829">175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6e22e23d13942a385a4a49560a7f544_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTEtOS0xLTEtMTM1MDM_120579ed-10bf-43f9-85cd-13e869fc1d0d">135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i357d0e28c2744a86a6382506b17c0264_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTEtMTEtMS0xLTEzNTAz_a4c8d26a-cea6-4ca6-8636-f22c06961fed">135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a9a7c2d6b1d487eaf86a59ab23c23ce_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTItNy0xLTEtMTM1MDM_0ffd6055-924a-414e-8c60-c23152b22921">3,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i357d0e28c2744a86a6382506b17c0264_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTItMTEtMS0xLTEzNTAz_d6240e71-23c6-4b5b-b8a1-680128e807a1">3,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances, September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61547256e29c4919b4fe5ead6c816e24_I20210930" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTMtMS0xLTEtMTM1MDM_a8a066d6-509f-489f-8a05-78588169f4bc">13,236</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61547256e29c4919b4fe5ead6c816e24_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTMtMy0xLTEtMTM1MDM_01dbb545-cb62-4e98-a0d1-4f7337c9d89e">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd0af93ed4f64a8c937539b4670c6e48_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTMtNS0xLTEtMTM1MDM_acbb20a4-b521-4146-a118-d59eb9fb120b">129,862</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba6a88e280384332a89b41a26f4cfab4_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTMtNy0xLTEtMTM1MDM_2ffd710e-a0ff-4111-be73-da603b3d94c1">92,522</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida700141a9ae4429b2b7a901f417f0bf_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTMtOS0xLTEtMTM1MDM_379c09f0-0e17-45c3-91ae-f64de5cd0e19">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48a61f3b86a440f692477c18672aa67f_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTMtMTEtMS0xLTEzNTAz_1d1d996f-e017-4d56-8c24-fb26726b5a09">37,310</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbcabe3d4d654627b2330ec970846ddf_D20211001-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTUtNS0xLTEtMTM1MDM_52eb7617-8e95-4119-8331-b90679623ec5">755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd08c3f853324ff28662164585d1fce6_D20211001-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTUtMTEtMS0xLTEzNTAz_1c71873d-516a-42ab-9922-d58c1a72e5e7">755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under equity award plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bb6cf9ad217405a8247ca642e30509c_D20211001-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTctMS0xLTEtMTM1MDM_1da3e8f0-21cb-4e85-8d53-730de464a28b">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd08c3f853324ff28662164585d1fce6_D20211001-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTctMTEtMS0xLTEzNTAz_5d06ea51-1554-49a2-91e4-4048517a6d98">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares canceled or surrendered as payment of tax withholding and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9bb6cf9ad217405a8247ca642e30509c_D20211001-20211231" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTgtMS0xLTEtMTM1MDM_f00f6bf3-63a6-4045-8a1a-ee9e5a66078d">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icbcabe3d4d654627b2330ec970846ddf_D20211001-20211231" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTgtNS0xLTEtMTM1MDM_9226ba57-185a-4770-8433-7c0f764bafe9">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icd08c3f853324ff28662164585d1fce6_D20211001-20211231" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTgtMTEtMS0xLTEzNTAz_74771cca-764a-4fc7-8304-f12a5e2730ab">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of company stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9bb6cf9ad217405a8247ca642e30509c_D20211001-20211231" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTktMS0xLTEtMTM1MDM_29d42da4-1bb2-4f73-a279-f8f16c0766b7">454</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3804241d822468b8c8a03364b2f4db0_D20211001-20211231" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTktNy0xLTEtMTM1MDM_69b1f531-ae97-47e4-aa02-08aa057eedb8">3,154</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icd08c3f853324ff28662164585d1fce6_D20211001-20211231" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTktMTEtMS0xLTEzNTAz_ee5cf57c-9b12-4530-91a4-9c5393d5c54d">3,154</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6cf8b23c28d42e593d1ae4e2d3c4019_D20211001-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjEtOS0xLTEtMTM1MDM_97b5c1d3-79e5-45a4-8041-b8e9482dea82">179</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icd08c3f853324ff28662164585d1fce6_D20211001-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjEtMTEtMS0xLTEzNTAz_7db456b3-5010-493b-be2a-bc6474eac933">179</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3804241d822468b8c8a03364b2f4db0_D20211001-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjItNy0xLTEtMTM1MDM_0fdb9a92-90f8-427d-9c75-23a6023076b1">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd08c3f853324ff28662164585d1fce6_D20211001-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjItMTEtMS0xLTEzNTAz_23bcde04-c4f8-40c8-a4f1-9286c4b3b963">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i38ac3e0be007455d8666cf4e653aaa47_I20211231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjMtMS0xLTEtMTM1MDM_d16e8953-49e0-4d18-8aa5-86a6cd9876b0">12,844</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38ac3e0be007455d8666cf4e653aaa47_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjMtMy0xLTEtMTM1MDM_a62648bf-c5d7-47df-a61c-f916a420c5cf">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fdcc53f50d94cfdbb432bb029d84ddd_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjMtNS0xLTEtMTM1MDM_08341f07-a445-4910-b08c-0af273ca10fd">130,586</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb1ca35e5a104d6193f48d4b349fd675_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjMtNy0xLTEtMTM1MDM_47a21142-7702-4a28-a62f-2cd5c3a7e7fa">95,597</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5263d30c26d9470b8de6e49fabce1c6f_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjMtOS0xLTEtMTM1MDM_ee391c4e-7e7e-4846-8ffe-db1f23cd4080">210</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida7724eff7a34d7e804bef8c3a260107_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjMtMTEtMS0xLTEzNTAz_f5544f28-2c4b-4015-a243-d0d8c9c0910e">34,780</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a3861a962104cbaafc9ae69c1393aab_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjUtNS0xLTEtMTM1MDM_f1b6ea4e-65c6-4f9d-a4b5-30092cadbdaf">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjUtMTEtMS0xLTEzNTAz_3352185b-a213-4952-abe6-1a71ddea9593">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i34d7b9b3d06f458fa586f0f59243f9bd_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjctMS0xLTEtMTM1MDM_a51161fc-4509-41bc-a723-6a6f944fc643">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a3861a962104cbaafc9ae69c1393aab_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjctNS0xLTEtMTM1MDM_84cd30f0-5212-48e3-a212-08b350ada609">197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjctMTEtMS0xLTEzNTAz_1e37823a-138b-4b88-b887-ea56c65b9fd9">197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under equity award plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i34d7b9b3d06f458fa586f0f59243f9bd_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjgtMS0xLTEtMTM1MDM_82c0cbef-11f8-4222-9009-ebbb6b9537b3">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjgtMTEtMS0xLTEzNTAz_abadb26a-b967-4219-b00d-bd22e1721444">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares canceled or surrendered as payment of tax withholding and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i34d7b9b3d06f458fa586f0f59243f9bd_D20220101-20220331" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjktMS0xLTEtMTM1MDM_326ea773-5fed-462d-a7f5-6c0d9cb32035">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a3861a962104cbaafc9ae69c1393aab_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjktNS0xLTEtMTM1MDM_756ef9a2-987a-46aa-9617-d2c03d6efa4f">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjktMTEtMS0xLTEzNTAz_012192aa-7a9a-4dfc-8ada-291019130dd7">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of company stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i34d7b9b3d06f458fa586f0f59243f9bd_D20220101-20220331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMzAtMS0xLTEtMTM1MDM_f94b3289-d5a7-4a91-8856-a17f296efe91">326</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d259b63592a4d5ca5fac8400bae6f58_D20220101-20220331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMzAtNy0xLTEtMTM1MDM_99823904-a9de-4842-8507-de8b08c0d1ca">1,728</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMzAtMTEtMS0xLTEzNTAz_0d9bbbb0-2872-4a79-af5f-33c15537b51d">1,728</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i18b390fcfcd440aeb1bd8306b98b8360_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMzItOS0xLTEtMTM1MDM_eecfe88c-e355-4667-a763-cb5260cf3159">290</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMzItMTEtMS0xLTEzNTAz_343994d5-8b4b-4398-8651-8f7511d2fa00">290</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d259b63592a4d5ca5fac8400bae6f58_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMzMtNy0xLTEtMTM1MDM_d3e132a1-62a8-475a-a98c-2e373ecafab1">1,141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMzMtMTEtMS0xLTEzNTAz_0bcbafbe-8ac2-4f59-8476-cd08f0c8a451">1,141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances, March 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i80e93762807c42728430aca71fb61c7d_I20220331" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMzQtMS0xLTEtMTM1MDM_32088d49-c97a-4602-9d44-b3c76bef59e3">12,577</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80e93762807c42728430aca71fb61c7d_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMzQtMy0xLTEtMTM1MDM_7e470417-42b1-465c-af6c-4fc7a7288fa2">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i422faeaa855042ae85c18160145ee1aa_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMzQtNS0xLTEtMTM1MDM_72978e2c-80b2-46fc-85f2-6d419906ebd6">130,714</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8414ddffcc994aaca67582af5b64988d_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMzQtNy0xLTEtMTM1MDM_6daf7ae5-fbc0-4808-876f-9453244b6207">96,184</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87ee290661d3437bb9f238e5b3000de5_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMzQtOS0xLTEtMTM1MDM_ff293166-ac4a-4b5a-b8aa-e9ac062d68d8">500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMzQtMTEtMS0xLTEzNTAz_6a7b8404-64b8-47d3-91d6-c7031c5bbe6b">34,031</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i41e77726867840e39498d8f5bb503840_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LIFEVANTAGE CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS&#8217; EQUITY (CONTINUED)</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:29.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.639%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive (Loss) Income</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances, June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i962d85b9976d4fa6b5d9584e36bb2ab1_I20200630" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMy0xLTEtMS0xMzUwMw_d2100390-554b-438a-9bbc-a73f233b4596">14,313</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i962d85b9976d4fa6b5d9584e36bb2ab1_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMy0zLTEtMS0xMzUwMw_aaf44061-8564-4a28-81ac-a41c7fae9fd8">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c716aa1362243ccb5055e6e6b509ab8_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMy01LTEtMS0xMzUwMw_8806be3c-326a-4c9f-a218-cf49148fc5d2">126,416</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12c81306c48d435facd113371422e44d_I20200630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMy03LTEtMS0xMzUwMw_855ec3b0-dc12-4db2-9d59-8bc75e8bea42">93,307</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic551f8ef22194653996c3e7b7c2a4891_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMy05LTEtMS0xMzUwMw_f83c9665-63d8-4148-bbab-0f8ea0acee42">144</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68b782cee24b481ab1a20bb3a92aad68_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMy0xMS0xLTEtMTM1MDM_c4a2a3c5-5536-41bf-a8ff-326c96f69352">33,254</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f6b95ce9ace4fcbbaf406066f26cb5d_D20200701-20200930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfNS01LTEtMS0xMzUwMw_0ac22dce-d42c-4756-964c-24dedbc93eee">520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i078343424c294ceca151c4f530b420fc_D20200701-20200930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfNS0xMS0xLTEtMTM1MDM_8c43037a-4724-4c64-8771-18171d7b634e">520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i36be45415d344673a4b1de8f2d0bf0fe_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfNi0xLTEtMS0xMzUwMw_e0460136-f124-414c-9532-5f8a195c3f98">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f6b95ce9ace4fcbbaf406066f26cb5d_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfNi01LTEtMS0xMzUwMw_ab9045db-6ec1-45f6-a8d6-667a7be8a256">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i078343424c294ceca151c4f530b420fc_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfNi0xMS0xLTEtMTM1MDM_6d9f1b16-67b7-46e5-b9c9-0c74cc559745">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under equity award plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i36be45415d344673a4b1de8f2d0bf0fe_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfNy0xLTEtMS0xMzUwMw_fc0a3143-a6f6-45b0-80ae-695d3122e442">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i078343424c294ceca151c4f530b420fc_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfNy0xMS0xLTEtMTM1MDM_fee1d670-3b1e-4910-894f-cad6aea3420f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares canceled or surrendered as payment of tax withholding and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i36be45415d344673a4b1de8f2d0bf0fe_D20200701-20200930" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfOC0xLTEtMS0xMzUwMw_6c6fe2e2-9296-40cf-a199-7f7c3dd7a503">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f6b95ce9ace4fcbbaf406066f26cb5d_D20200701-20200930" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfOC01LTEtMS0xMzUwMw_30d1bc7e-d1f0-4c02-8380-7490345806c4">506</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i078343424c294ceca151c4f530b420fc_D20200701-20200930" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfOC0xMS0xLTEtMTM1MDM_5bc8f65f-6653-4be3-8b7a-423a9f377748">506</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of company stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i36be45415d344673a4b1de8f2d0bf0fe_D20200701-20200930" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfOS0xLTEtMS0xMzUwMw_50b18c57-ea05-4b73-9b90-5476ac7e31b2">136</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i371a2ccf5aa04409abfd0f1176383ba2_D20200701-20200930" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfOS03LTEtMS0xMzUwMw_f5ed3419-62c6-4991-8078-ab35c535633d">2,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i078343424c294ceca151c4f530b420fc_D20200701-20200930" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfOS0xMS0xLTEtMTM1MDM_623d5487-5f20-4808-bfda-016c51f56860">2,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i36be45415d344673a4b1de8f2d0bf0fe_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTAtMS0xLTEtMTM1MDM_1786dd89-6e4a-4bd6-b25f-12a2e16fd3fc">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f6b95ce9ace4fcbbaf406066f26cb5d_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTAtNS0xLTEtMTM1MDM_f1f5554f-ecbb-432b-aa3d-1611e5a36ad6">246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i078343424c294ceca151c4f530b420fc_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTAtMTEtMS0xLTEzNTAz_e633c24e-1bae-471b-9cf3-df856afdcd12">246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i272a3fb900ee42a0b17372fc51c0fd09_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTEtOS0xLTEtMTM1MDM_3a450bd8-d0e1-42d0-ac5e-3d99d6325c9c">160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i078343424c294ceca151c4f530b420fc_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTEtMTEtMS0xLTEzNTAz_365f2dfa-3275-4cde-a40b-e789d57eaa43">160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371a2ccf5aa04409abfd0f1176383ba2_D20200701-20200930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTItNy0xLTEtMTM1MDM_4d3ce8b0-1bf5-4ca2-a2e7-c7fdb9815a36">2,451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i078343424c294ceca151c4f530b420fc_D20200701-20200930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTItMTEtMS0xLTEzNTAz_0f526d63-07ae-439f-a4d5-e0d0ed0768b6">2,451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances, September 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i68418c3e9e354ef68baafaaaad67d4db_I20200930" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTMtMS0xLTEtMTM1MDM_ea55ea9a-c85f-40fd-a726-ff940f866e12">14,238</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68418c3e9e354ef68baafaaaad67d4db_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTMtMy0xLTEtMTM1MDM_d76c259f-f8ba-4a7c-a8e3-06c194b1a5ce">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b04da3ccb2949e8a573db766889abb2_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTMtNS0xLTEtMTM1MDM_5a3ac3e3-a5ed-46a7-a669-4f45c7a76dad">126,687</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d971956fe1e405092f076fc100385f9_I20200930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTMtNy0xLTEtMTM1MDM_ba3c7bd4-b233-42b2-b0c7-220736b0ab35">92,856</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1968b9f619f497180ce2af775046e41_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTMtOS0xLTEtMTM1MDM_1dddb0a8-fe18-4e1a-ae28-7ac31df40d3a">304</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07e41a0a758d427ebab0f9e00cf68cfb_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTMtMTEtMS0xLTEzNTAz_d9e58bf6-6f8a-46c9-8774-b11465dbb87a">34,136</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99f28f304d1842658dac0719b5141740_D20201001-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTUtNS0xLTEtMTM1MDM_23d9da75-9c26-4282-a054-9a05cbd96509">999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d8a258a91bd4059b27b728132af022c_D20201001-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTUtMTEtMS0xLTEzNTAz_de3ee039-6415-40fc-902d-d1f704ac74d9">999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifeb352d0769a418ebda3b74b0acbf648_D20201001-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTYtMS0xLTEtMTM1MDM_f8cc5cd4-b170-4ad6-9bfb-a1dadbdb44a9">202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99f28f304d1842658dac0719b5141740_D20201001-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTYtNS0xLTEtMTM1MDM_d09c84a3-2d18-4906-9bc1-654474fbb7ee">991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d8a258a91bd4059b27b728132af022c_D20201001-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTYtMTEtMS0xLTEzNTAz_1c7fcf41-b2ba-44c6-8697-d259ce73b7fc">991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under equity award plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifeb352d0769a418ebda3b74b0acbf648_D20201001-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTctMS0xLTEtMTM1MDM_f483d9cd-463c-414c-a97e-859413b14338">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d8a258a91bd4059b27b728132af022c_D20201001-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTctMTEtMS0xLTEzNTAz_94ef285b-ff55-4f48-90e9-e7af72ce4e15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares canceled or surrendered as payment of tax withholding and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ifeb352d0769a418ebda3b74b0acbf648_D20201001-20201231" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTgtMS0xLTEtMTM1MDM_9376bc95-6056-4e1f-93d2-b85963621541">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99f28f304d1842658dac0719b5141740_D20201001-20201231" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTgtNS0xLTEtMTM1MDM_eaa6e912-9d69-4d66-adc9-d6828352f9f4">666</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d8a258a91bd4059b27b728132af022c_D20201001-20201231" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTgtMTEtMS0xLTEzNTAz_9fdbacff-d8df-4ff9-a186-c195caa236b1">666</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of company stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ifeb352d0769a418ebda3b74b0acbf648_D20201001-20201231" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTktMS0xLTEtMTM1MDM_e06be61a-6018-4d9b-ab8f-0c567b03d876">365</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1a17cb2d0ca4207a83089fb753965d7_D20201001-20201231" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTktNy0xLTEtMTM1MDM_8aa7a7a1-4132-4ef4-9959-aea9e9d8aba8">4,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d8a258a91bd4059b27b728132af022c_D20201001-20201231" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTktMTEtMS0xLTEzNTAz_ae600611-53a1-49a8-9628-2a3f2ff67944">4,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ab5b4c786a74727b650772bc5f9b6e0_D20201001-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjEtOS0xLTEtMTM1MDM_da85eed5-9cdd-4ba2-8261-4aec7d69506c">244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d8a258a91bd4059b27b728132af022c_D20201001-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjEtMTEtMS0xLTEzNTAz_23c63095-5ff0-4b67-a3ba-7414bb98c0dc">244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1a17cb2d0ca4207a83089fb753965d7_D20201001-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjItNy0xLTEtMTM1MDM_a95b6318-052f-4210-9e58-a4bd68db247a">3,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d8a258a91bd4059b27b728132af022c_D20201001-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjItMTEtMS0xLTEzNTAz_e3898539-7882-4883-902f-9a341f8d6f70">3,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances, December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if1fa511d00c840e68d4d9869eb7ddd2e_I20201231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjMtMS0xLTEtMTM1MDM_52d53aea-8893-4add-a7ee-a02edce518e4">14,151</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1fa511d00c840e68d4d9869eb7ddd2e_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjMtMy0xLTEtMTM1MDM_1be93740-16af-422d-b91b-ed9ac3ab6abc">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia281323b7eca4b0aac83a5aa68bb9dab_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjMtNS0xLTEtMTM1MDM_40c66ed9-d646-477a-96d8-6190beb936a7">128,011</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3d79a145f79427694eee4afa398d9c7_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjMtNy0xLTEtMTM1MDM_cdc04a89-d836-477f-ab48-b20176bf6374">93,044</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id95d9cc8f1034f528cc66cff9ad5c9ef_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjMtOS0xLTEtMTM1MDM_e0b6de02-9da2-408f-b5ff-d889ec0fbb56">548</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d0accfc67e54e8db1894b6929923ad1_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjMtMTEtMS0xLTEzNTAz_75922faf-ad9c-44d9-841e-6ed10bc797f5">35,516</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8a85e0499a945de8e4808fe5e485e28_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjUtNS0xLTEtMTM1MDM_bde8dd01-cfc8-4d71-8860-12df941ad73a">684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjUtMTEtMS0xLTEzNTAz_38b6cb96-289b-43f6-81b2-d5455ff1d3f1">684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieb4a6be5906b4ce4a66d6061c62992dd_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjYtMS0xLTEtMTM1MDM_9441d93d-eb6a-4604-b1b9-4d9d9df4b912">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8a85e0499a945de8e4808fe5e485e28_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjYtNS0xLTEtMTM1MDM_0171abdf-8e43-467e-9b7b-6e9d6211423c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjYtMTEtMS0xLTEzNTAz_d2991ffd-9cd4-4525-b847-b634418d1827">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjctMS0xLTEtMTM1MDM_7ee28e0d-22dc-4eff-944a-a7c0e606cb10">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8a85e0499a945de8e4808fe5e485e28_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjctNS0xLTEtMTM1MDM_b3a2425e-7bc8-4177-84fd-13cf15dd024d">271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjctMTEtMS0xLTEzNTAz_0a90a7e4-1699-496a-b4cf-d6976fb1bd28">271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under equity award plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieb4a6be5906b4ce4a66d6061c62992dd_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjgtMS0xLTEtMTM1MDM_bb6f265c-08bc-407d-a2a7-a41669c1a99e">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjgtMTEtMS0xLTEzNTAz_cd99f7f2-00bb-4a54-ad86-c045e2de62b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares canceled or surrendered as payment of tax withholding and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ieb4a6be5906b4ce4a66d6061c62992dd_D20210101-20210331" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjktMS0xLTEtMTM1MDM_f470c3f8-d944-4c55-8a6d-24c999734a34">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8a85e0499a945de8e4808fe5e485e28_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjktNS0xLTEtMTM1MDM_66734d4f-efeb-430f-9b8e-ab494514c1e2">126</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjktMTEtMS0xLTEzNTAz_31c53740-8490-4d1f-8d42-fc35a8ae451a">126</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of company stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ieb4a6be5906b4ce4a66d6061c62992dd_D20210101-20210331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMzAtMS0xLTEtMTM1MDM_95589f76-0145-4ef1-967e-b79ba425ae17">213</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4925e0ea7d9e481d96e9fa256be5a1bf_D20210101-20210331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMzAtNy0xLTEtMTM1MDM_45d19def-6598-4c7a-a405-d136eb231f15">2,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMzAtMTEtMS0xLTEzNTAz_aac51937-d828-42b9-aa8f-5a9f11dc2475">2,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib10cb8e7de8c4656ab658f3172b4c6c8_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMzItOS0xLTEtMTM1MDM_70409b54-0e0f-4d71-be68-2bbe69305424">443</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMzItMTEtMS0xLTEzNTAz_26867268-5b68-4464-83a8-a800ab3f0a87">443</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4925e0ea7d9e481d96e9fa256be5a1bf_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMzMtNy0xLTEtMTM1MDM_d804b355-7c55-42d1-a975-b9973b5ef59a">1,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMzMtMTEtMS0xLTEzNTAz_2bfbf7de-644b-4b6e-bcf7-36e625a7fcdb">1,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances, March 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9fb5b0bffd7444c2babfc6c81537af68_I20210331" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMzQtMS0xLTEtMTM1MDM_5ed3a8bb-4360-403c-b97d-3bc30538e736">13,989</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fb5b0bffd7444c2babfc6c81537af68_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMzQtMy0xLTEtMTM1MDM_7931196a-5145-452b-ad12-4477a3403ded">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74275ea8913e4aabb9ae6b13024fbb68_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMzQtNS0xLTEtMTM1MDM_5281b1d3-4977-472c-9388-2fd369140c3a">128,842</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f571c6d0a364422a6f303b161efdd8a_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMzQtNy0xLTEtMTM1MDM_b8f0d3a9-1a18-49bc-88f3-54973e08d732">93,320</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba8aa560a2b64ef4b94817dac00694cb_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMzQtOS0xLTEtMTM1MDM_656e1e42-402a-45cc-996a-abbcfe0f4293">105</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i486872c51e4640dab4cf26f789788bba_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMzQtMTEtMS0xLTEzNTAz_f06d237f-c04c-4f9f-9289-8f0464087135">35,628</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i41e77726867840e39498d8f5bb503840_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LIFEVANTAGE CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows from Operating Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNC0xLTEtMS0xMzUwMw_c874dab7-4d07-48bb-9019-62a4ac6e44bf">4,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNC0zLTEtMS0xMzUwMw_79e0ea68-fbfe-4b41-ad93-51b87e4315fb">7,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNi0xLTEtMS0xMzUwMw_ff4b5f26-7a6f-4965-8a91-0921c7b70a80">2,443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNi0zLTEtMS0xMzUwMw_0d0957f5-5557-4062-8b66-6074f4f93de5">2,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfOC0xLTEtMS0xMzUwMw_838dbfcc-fccd-400b-8898-42e337b46c01">1,362</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfOC0zLTEtMS0xMzUwMw_c1ca2bcc-41ae-4386-b05e-2cc612dc945c">2,115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfOS0xLTEtMS0xMzUwMw_16016652-bd52-441b-b0fd-59d68dacdce1">1,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfOS0zLTEtMS0xMzUwMw_8e530893-557b-4f05-ace8-1ecbe71116fd">2,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMTQtMS0xLTEtMTM1MDM_55883a90-3dbe-451b-84a6-e58d72869c72">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMTQtMy0xLTEtMTM1MDM_8b33f270-5716-4895-84df-d7c20978383d">341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMTYtMS0xLTEtMTM1MDM_4b8662a3-fac5-4de0-b026-13801da269a4">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMTYtMy0xLTEtMTM1MDM_7c7a90a5-f2c5-439b-851a-a3ca760e3e76">657</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInIncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMTctMS0xLTEtMTM1MDM_d76c9ee2-99b6-4275-883a-e9d4874f0456">234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInIncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMTctMy0xLTEtMTM1MDM_7c4fc61b-dcf4-47be-90c0-6d73417c6e2e">762</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMTgtMS0xLTEtMTM1MDM_91564866-402c-4108-adb1-d5e903266445">441</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMTgtMy0xLTEtMTM1MDM_777cd4b5-1970-40b2-a61e-0455528c8ee8">791</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMTktMS0xLTEtMTM1MDM_aea89416-9ba8-4b97-b6dc-9448202a7b6f">2,648</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMTktMy0xLTEtMTM1MDM_3069c9ec-ed4e-4b82-974e-a7a796552e77">518</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMjAtMS0xLTEtMTM1MDM_ff6336e0-6f2f-4c43-8fea-6790eefa4bfb">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMjAtMy0xLTEtMTM1MDM_2d282bc1-74ff-4df0-af53-7ba3b62fe1dd">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMjEtMS0xLTEtMTM1MDM_0dda037a-0fe8-4f5e-ae4d-812c59df3854">170</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMjEtMy0xLTEtMTM1MDM_f7b4ca6c-109a-45b6-b79e-26bc7c6ba470">1,636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMjItMS0xLTEtMTM1MDM_1b011e67-de86-410c-bba5-69a53eb70147">752</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMjItMy0xLTEtMTM1MDM_13f23f69-1772-496f-879b-c502dfa0716b">426</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMjMtMS0xLTEtMTM1MDM_df3fffa9-bd31-4350-931f-040134832083">874</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMjMtMy0xLTEtMTM1MDM_b82fdfbd-fb6d-4e55-88ac-6ea518bf6c4e">4,020</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" sign="-" name="lfvn:IncreaseDecreaseInLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMjQtMS0xLTEtMTM1MDM_a0759654-9f4a-4227-be03-716ab88b7f93">89</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" sign="-" name="lfvn:IncreaseDecreaseInLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMjQtMy0xLTEtMTM1MDM_d0157bc7-d51f-4e91-9458-16d07a602dcf">1,961</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMjUtMS0xLTEtMTM1MDM_524904ca-b128-49a1-b382-6ed463cb765b">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMjUtMy0xLTEtMTM1MDM_0099bef1-6161-47b6-9fe2-3c782fdc6fa8">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Cash Provided by Operating Activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMjYtMS0xLTEtMTM1MDM_637fc648-02b2-47f4-90d7-bd90ec4aad69">5,179</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMjYtMy0xLTEtMTM1MDM_fc1a52ba-1913-4ceb-9cda-1560f58c1042">7,899</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows from Investing Activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMzEtMS0xLTEtMTM1MDM_2d998907-b511-4780-990d-f78aef0eda13">1,264</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMzEtMy0xLTEtMTM1MDM_1e18c324-e163-4e12-ab01-90336c8622e6">3,261</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Cash Used in Investing Activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMzItMS0xLTEtMTM1MDM_77d4a1bd-98d8-4b26-b15e-a95ba15cb665">1,264</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMzItMy0xLTEtMTM1MDM_5cd314e9-94f5-424d-ba32-c6f1f389ec96">3,261</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows from Financing Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of company stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMzctMS0xLTEtMTM1MDM_3add35c3-fed0-423c-bf93-937818c3734c">8,374</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMzctMy0xLTEtMTM1MDM_d9150ee0-eb88-4f95-b851-f794f1b16557">8,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares canceled or surrendered as payment of tax withholding and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMzktMS0xLTEtMTM1MDM_8b6e7ead-b079-46ab-a887-fdf01b2227ec">201</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMzktMy0xLTEtMTM1MDM_a83fdb25-faea-448e-93d1-fff665bb5f0b">1,298</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from common stock issued under employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="lfvn:ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDAtMS0xLTEtMTM1MDM_b965fb93-ded3-4b43-9f51-8d0140660b48">372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="lfvn:ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDAtMy0xLTEtMTM1MDM_0fc67358-5c1e-4ef6-8331-d5e87f58356d">517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDEtMS0xLTEtMTM1MDM_ae8914b9-3fb5-450d-8df9-ff8aac4827f0">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDEtMy0xLTEtMTM1MDM_1526332c-7419-474a-8ec3-5164de09c229">1,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Cash Used in Financing Activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDItMS0xLTEtMTM1MDM_e41070c2-e031-4581-bbac-a8937b1501c8">8,070</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDItMy0xLTEtMTM1MDM_c6db5d2e-55e4-4064-8bf7-4e36291babd2">7,777</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Effect on Cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDMtMS0xLTEtMTM1MDM_a7c17858-e296-4fb9-a71e-4b130ef1b9c8">1,223</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDMtMy0xLTEtMTM1MDM_ce5d6e09-4ea3-4d3a-a97d-135549e0ef39">44</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Decrease in Cash and Cash Equivalents:</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDQtMS0xLTEtMTM1MDM_70cd3eaa-71fa-435d-a746-36a8fd2ddd30">5,378</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDQtMy0xLTEtMTM1MDM_e984eafc-01c8-43a8-b115-605fa2e5b2b0">3,183</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and Cash Equivalents &#8212; beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDUtMS0xLTEtMTM1MDM_699250ea-7ddc-459a-a216-0a977b3a9c02">23,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68b782cee24b481ab1a20bb3a92aad68_I20200630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDUtMy0xLTEtMTM1MDM_e8844eb0-2f44-42ae-a24e-2d443526fafa">22,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and Cash Equivalents &#8212; end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDYtMS0xLTEtMTM1MDM_1cbda9a7-ead5-4642-9fbb-9d150af56cb6">17,796</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i486872c51e4640dab4cf26f789788bba_I20210331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDYtMy0xLTEtMTM1MDM_b0a5e099-a98b-42fd-8afc-761090e21f7b">18,955</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non Cash Investing and Financing Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in property and equipment and lease liabilities from lease incentives</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="lfvn:IncreaseDecreaseInPropertyAndEquipmentAndLeaseLiabilitiesFromLeaseIncentives" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDgtMS0xLTEtMTM1MDM_bb4167cd-58ed-4fe7-837d-519fb0989ab4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="lfvn:IncreaseDecreaseInPropertyAndEquipmentAndLeaseLiabilitiesFromLeaseIncentives" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDgtMy0xLTEtMTM1MDM_74f02faa-98b5-480a-85f9-6116b5a621f6">3,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for interest </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNTEtMS0xLTEtMTM1MDM_13367f92-e5b6-4dec-b47c-488bfb927031">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNTEtMy0xLTEtMTM1MDM_446a093d-6758-416a-8fbf-ee5a326f3421">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNTItMS0xLTEtMTM1MDM_fd2ca928-6db6-4e71-b94f-0ee90b1e3ca3">2,554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNTItMy0xLTEtMTM1MDM_e8d9c4da-36e6-4ec3-859b-d53ee980f7bb">3,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="i41e77726867840e39498d8f5bb503840_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LIFEVANTAGE CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated financial statements and notes should be read in conjunction with the audited financial statements and notes of LifeVantage Corporation (the &#8220;Company&#8221;) as of and for the year ended June&#160;30, 2021 included in the annual report on Form 10-K filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) on August 19, 2021.</span></div><div id="i41e77726867840e39498d8f5bb503840_37"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1 &#8212; <ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zNy9mcmFnOmMzYmEwNGJiYTMwNDRjMWQ5YjBjMjAyODkxZjRmNzIwL3RleHRyZWdpb246YzNiYTA0YmJhMzA0NGMxZDliMGMyMDI4OTFmNGY3MjBfMjgwNQ_f6cbb63d-ac8b-460b-ab7d-71507418a0bf" continuedAt="ibfc5949807644c2681a723489af0f3ff" escape="true">Organization and Basis of Presentation</ix:nonNumeric></span></div><ix:continuation id="ibfc5949807644c2681a723489af0f3ff"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:23.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LifeVantage Corporation is a company focused on nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company is dedicated to helping people achieve their health, wellness and financial goals. The Company provides quality, scientifically-validated products to customers and independent distributors as well as a financially rewarding commission-based direct sales opportunity to its independent distributors. LifeVantage sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The Company also sells its products in a number of countries to customers for personal consumption only. In addition, the Company sells its products in China through a China approved cross-border e-commerce business model. </span></div><div style="text-indent:23.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath &amp; body, and targeted relief products. The Company&#8217;s line of scientifically-validated dietary supplements includes its flagship Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> family of products, LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Omega+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, ProBio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, IC Bright</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, and Daily Wellness</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> dietary supplements. TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> is the Company's line of skin, hair, bath &amp; body, and targeted relief products. The Company also markets and sells Petandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, its companion pet supplement formulated to combat oxidative stress in dogs, Axio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> its nootropic energy drink mixes, and PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, its smart weight management system.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements included herein have been prepared by the Company&#8217;s management, without audit, pursuant to the rules and regulations of the SEC. In the opinion of the Company&#8217;s management, these interim financial statements include all adjustments that are considered necessary for a fair presentation of its financial position as of March&#160;31, 2022, and the results of operations for the three and nine months ended March&#160;31, 2022 and 2021, and the cash flows for the nine months ended March&#160;31, 2022 and 2021. Interim results are not necessarily indicative of results for a full year or for any future period. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements and notes included herein are presented as required by Form 10-Q, and do not contain certain information included in the Company&#8217;s audited financial statements and notes for the fiscal year ended June&#160;30, 2021, pursuant to the rules and regulations of the SEC. For further information, refer to the financial statements and notes thereto as of and for the year ended June&#160;30, 2021, and included in the annual report on Form 10-K on file with the SEC.</span></div></ix:continuation><div id="i41e77726867840e39498d8f5bb503840_40"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2 &#8212; <ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTgwMTA_e014f797-276b-41e2-9cd2-8b012f997dc6" continuedAt="i6b0183aadff345dd9274629fadd37012" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i6b0183aadff345dd9274629fadd37012" continuedAt="ia4db2129c96442a2be2312ca0e08cdc4"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc5Njc_138ff20c-4a34-4593-a349-ac462f38a9d9" continuedAt="i72ff7e7e84c14c2db9be1775f2b66ba2" escape="true">Consolidation</ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i72ff7e7e84c14c2db9be1775f2b66ba2">The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.</ix:continuation> </span></div><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTgwMzE_785168c8-7711-4e80-865a-a2db1cf0d2dd" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company prepares the condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (GAAP). In preparing these statements, the Company is required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, the Company reviews its estimates, including, but not limited to, those related to inventory valuation and obsolescence, sales returns, income taxes and tax valuation reserves, transfer pricing methodology and positions, impairment of assets, share-based compensation, and loss contingencies.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTgwMzI_7651221e-60d2-422c-9681-445b24b70f02" continuedAt="i4498e52aaab64c28bda8043fb6b78023" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the Company&#8217;s business operations occurs outside the United States.&#160;The local currency of each of the Company&#8217;s subsidiaries is generally its functional currency.&#160;All assets and liabilities are translated into U.S. dollars at exchange rates existing at the balance sheet dates, revenue and expenses are translated at weighted-average exchange rates and stockholders&#8217; equity is recorded at historical exchange rates.&#160;The resulting foreign currency translation adjustments are recorded </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia4db2129c96442a2be2312ca0e08cdc4" continuedAt="i01000c01c72148f59fcc30040ea90235"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4498e52aaab64c28bda8043fb6b78023" continuedAt="i53fd34b24633424da2ffd620abc96357">as a separate component of stockholders&#8217; equity in the condensed consolidated balance sheets and as a component of com</ix:continuation></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i53fd34b24633424da2ffd620abc96357">prehensive income. Transaction gains and losses are included in other expense, net in the condensed consolidated statements of operations and comprehensive income.</ix:continuation> For the three months ended March 31, 2022 and 2021, net foreign currency losses of $<ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMjA1Ng_ec8b1ffa-d44b-434a-b79f-9e605c600ffe">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMjA3Mg_60da6b7a-1d94-44db-a28e-990b39880afc">0.3</ix:nonFraction> million, respectively, are recorded in other expense, net. For the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended March 31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2021, net foreign currency losses of $<ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMjE3Ng_0e1ba0dc-6c6c-4557-905d-ca67cc7e282e">0.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMjE5Mg_b76390cc-28ac-4081-873b-4eb131e730a5">0.2</ix:nonFraction> million, respectively, are recorded in other expense, net.</span></div><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc5MzI_79699ad5-debf-4654-811f-bdb2901f31f8" continuedAt="i00ab81df834544e5ac1c420423f8b028" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's subsidiaries enter into transactions with each other which may not be denominated in the respective subsidiaries' functional currencies. The Company seeks to reduce its exposure to fluctuations in foreign exchange rates through the use of derivatives. The Company does not use such derivative financial instruments for trading or speculative purposes.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i00ab81df834544e5ac1c420423f8b028">To hedge risks associated with the foreign-currency-denominated intercompany transactions, the Company entered into forward foreign exchange contracts which were all settled by the end of December 2021 and were not designated for hedge accounting.</ix:continuation> There were no realized gains or losses for three months ended March 31, 2022. For the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended March 31, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> realized losses of $<ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMjk0MA_53421447-4300-4e2d-ba6c-653c2505b374"><ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMjk0MA_b046d7c4-ec8f-4db7-b005-5e9982d11472">26,000</ix:nonFraction></ix:nonFraction> related to forward contracts, are recorded in other expense, net. For the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended March 31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2021, realized losses of $<ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMzA2Mg_690b7d63-80c4-4729-8059-2efabb29851b">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMzA2OQ_7e02f794-fa50-4a8a-9bfc-3d5d8fc6fd71">0.4</ix:nonFraction> million, respectively, related to forward contracts, are recorded in other expense, net. The Company did not hold any derivative instruments at March&#160;31, 2022.</span></div><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc5ODU_f46bb111-7e4c-4e4f-9f84-773358aa9471" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers only its monetary liquid assets with original maturities of three months or less as cash and cash equivalents.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTgwMDI_426827ac-3195-41e7-97e7-6b70a5274d7b" continuedAt="i0b252d67b781439c8283210ab951d91f" escape="true">Concentration of Credit Risk</ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0b252d67b781439c8283210ab951d91f" continuedAt="i9e9b91d2829c4158bbf486c1dd01482a">Accounting guidance for financial instruments requires disclosure of significant concentrations of credit risk regardless of the degree of </ix:continuation></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9e9b91d2829c4158bbf486c1dd01482a">such risk. Financial instruments with significant credit risk include cash and investments.</ix:continuation> At March&#160;31, 2022, the Company had $<ix:nonFraction unitRef="usd" contextRef="i02d0d983f156475da80d891080400c71_D20220331-20220331" decimals="-5" name="us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMzY1NA_a9cb04a8-2fdd-4a72-a0f0-a67ccfed461f">11.7</ix:nonFraction> million in cash accounts at one financial institution and $<ix:nonFraction unitRef="usd" contextRef="i8461345d4fc14a97aef4e829e0775dcc_D20220331-20220331" decimals="-5" name="us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMzcwNw_a326537c-61ac-4926-bce6-ccdf1e5c3a16">6.1</ix:nonFraction> million in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accounts at other financial institutions.  At June&#160;30, 2021, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company had $<ix:nonFraction unitRef="usd" contextRef="i182b6ab241c640bfa92b9b402ecbe30b_D20210630-20210630" decimals="-5" name="us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMzc3OQ_85cfccb9-b5aa-469d-81f0-42ab0b203552">17.2</ix:nonFraction>&#160;million in cash accounts at one financial institution and $<ix:nonFraction unitRef="usd" contextRef="i7a84972552ec4e43882535e243362870_D20210630-20210630" decimals="-5" name="us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMzgzMg_6a8826a4-1338-40b4-8fdd-1d206ec0b530">6.0</ix:nonFraction> million in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accounts at other financial institutions. As of March&#160;31, 2022 and June&#160;30, 2021, and during the periods then ended, the Company&#8217;s cash balances exceeded federally insured limits.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc5MzU_17157063-55c0-462f-bc37-7666ad73d046" continuedAt="i4d5bba7d72c34b4fb1c1a07a00229fa1" escape="true">Accounts Receivable</ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4d5bba7d72c34b4fb1c1a07a00229fa1">The Company&#8217;s accounts receivable as of March&#160;31, 2022 and June&#160;30, 2021 consist primarily of credit card receivables. Based on the Company&#8217;s verification process for customer credit cards and historical information available, management has determined that an allowance for doubtful accounts on credit card sales related to its customer sales as of March&#160;31, 2022 and June&#160;30, 2021 is not necessary.</ix:continuation> <ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="INF" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfNDM3MA_1c873658-3d49-48d1-b5db-105e9349aeef"><ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="INF" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfNDM3MA_1e83a9a4-5cf8-46c8-9a03-b7179d5de550"><ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="INF" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfNDM3MA_bda685cf-d39d-4df8-8f1b-ca3a685c71d3"><ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="INF" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfNDM3MA_fe56c8bb-30e5-4ecb-b55d-a80a7ef12ed5">No</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> bad debt expense was recorded during the three and nine months ended March&#160;31, 2022 and 2021.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTgwMjM_780477e8-de91-45b6-a28d-c1112d9929d0" continuedAt="i88b86a4965624464a7241084802954df" escape="true">As of March&#160;31, 2022 and June&#160;30, 2021, inventory consisted of (in thousands):</ix:nonNumeric></span><ix:continuation id="i88b86a4965624464a7241084802954df"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:31.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.115%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjAyYWRlYzUzODc0MTQxMzU4MmZkOGNiYTVmNTQ1NTY5L3RhYmxlcmFuZ2U6MDJhZGVjNTM4NzQxNDEzNTgyZmQ4Y2JhNWY1NDU1NjlfMS0xLTEtMS0xMzUwMw_71703a92-56d3-4c2a-b806-071d177d236c">12,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="3" name="lfvn:InventoryFinishedGoodsPercentOfTotalInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjAyYWRlYzUzODc0MTQxMzU4MmZkOGNiYTVmNTQ1NTY5L3RhYmxlcmFuZ2U6MDJhZGVjNTM4NzQxNDEzNTgyZmQ4Y2JhNWY1NDU1NjlfMS0zLTEtMS0xMzUwMw_36b016b8-aa54-4589-91a3-7171908a639c">75.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjAyYWRlYzUzODc0MTQxMzU4MmZkOGNiYTVmNTQ1NTY5L3RhYmxlcmFuZ2U6MDJhZGVjNTM4NzQxNDEzNTgyZmQ4Y2JhNWY1NDU1NjlfMS01LTEtMS0xMzUwMw_11d623a3-7d83-44d0-ad49-cc32f11e7118">12,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="3" name="lfvn:InventoryFinishedGoodsPercentOfTotalInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjAyYWRlYzUzODc0MTQxMzU4MmZkOGNiYTVmNTQ1NTY5L3RhYmxlcmFuZ2U6MDJhZGVjNTM4NzQxNDEzNTgyZmQ4Y2JhNWY1NDU1NjlfMS03LTEtMS0xMzUwMw_883a67db-9633-4ee8-99c5-f9cb913ef5a9">75.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjAyYWRlYzUzODc0MTQxMzU4MmZkOGNiYTVmNTQ1NTY5L3RhYmxlcmFuZ2U6MDJhZGVjNTM4NzQxNDEzNTgyZmQ4Y2JhNWY1NDU1NjlfMi0xLTEtMS0xMzUwMw_8cc204f4-90ed-49e9-a559-9d172dc3bd5a">3,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="3" name="lfvn:RawMaterialsPercentOfTotalInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjAyYWRlYzUzODc0MTQxMzU4MmZkOGNiYTVmNTQ1NTY5L3RhYmxlcmFuZ2U6MDJhZGVjNTM4NzQxNDEzNTgyZmQ4Y2JhNWY1NDU1NjlfMi0zLTEtMS0xMzUwMw_98e425e5-62d7-408c-b007-434c0235b39f">24.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjAyYWRlYzUzODc0MTQxMzU4MmZkOGNiYTVmNTQ1NTY5L3RhYmxlcmFuZ2U6MDJhZGVjNTM4NzQxNDEzNTgyZmQ4Y2JhNWY1NDU1NjlfMi01LTEtMS0xMzUwMw_83048141-fe22-4bcd-abab-f14c7f204684">3,920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="3" name="lfvn:RawMaterialsPercentOfTotalInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjAyYWRlYzUzODc0MTQxMzU4MmZkOGNiYTVmNTQ1NTY5L3RhYmxlcmFuZ2U6MDJhZGVjNTM4NzQxNDEzNTgyZmQ4Y2JhNWY1NDU1NjlfMi03LTEtMS0xMzUwMw_7d34bb02-384c-41aa-8b59-416cf374b77d">24.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjAyYWRlYzUzODc0MTQxMzU4MmZkOGNiYTVmNTQ1NTY5L3RhYmxlcmFuZ2U6MDJhZGVjNTM4NzQxNDEzNTgyZmQ4Y2JhNWY1NDU1NjlfMy0xLTEtMS0xMzUwMw_14efac3b-01d0-45af-a211-f146faff3834">16,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="INF" name="lfvn:InventoryPercentOfTotalInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjAyYWRlYzUzODc0MTQxMzU4MmZkOGNiYTVmNTQ1NTY5L3RhYmxlcmFuZ2U6MDJhZGVjNTM4NzQxNDEzNTgyZmQ4Y2JhNWY1NDU1NjlfMy0zLTEtMS0xMzUwMw_a52bbfd5-8a1b-4c25-84a1-219f5fa5e85f">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjAyYWRlYzUzODc0MTQxMzU4MmZkOGNiYTVmNTQ1NTY5L3RhYmxlcmFuZ2U6MDJhZGVjNTM4NzQxNDEzNTgyZmQ4Y2JhNWY1NDU1NjlfMy01LTEtMS0xMzUwMw_87b0d00a-00ac-4d7c-840c-894a2f67f273">16,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="INF" name="lfvn:InventoryPercentOfTotalInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjAyYWRlYzUzODc0MTQxMzU4MmZkOGNiYTVmNTQ1NTY5L3RhYmxlcmFuZ2U6MDJhZGVjNTM4NzQxNDEzNTgyZmQ4Y2JhNWY1NDU1NjlfMy03LTEtMS0xMzUwMw_c5ab0247-089c-4986-b56c-b3232211b137">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc5ODk_a81d50b3-61e4-42fb-adb1-edebfeaa1592" escape="true">Inventories are carried at the lower of cost or net realizable value, using the first-in, first-out method</ix:nonNumeric>, which includes a reduction in inventory values </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of $<ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-5" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfNDY1NA_cac95477-ee35-4b5d-ad86-1d5331ebcffb">1.0</ix:nonFraction> million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $<ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-5" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfNDY2MQ_35cf16a1-8100-468d-9c3e-68219ba9427d">0.5</ix:nonFraction> million at March 31, 2022 and June&#160;30, 2021, respectively, related to obsolete and slow-moving inventory.</span></div><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc5OTY_92e5a0a2-9735-4411-9ce1-2e87d6682774" continuedAt="if2a74eff8a704dd388236521ef777de9" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for assets and liabilities using a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company's market assumptions. These two types of inputs have created the fair-value hierarchy below. This hierarchy requires the Company to minimize the use of unobservable inputs and to use observable market data, if available, when determining fair value.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i01000c01c72148f59fcc30040ea90235" continuedAt="ifce5418908f446ada7c24c41478b8223"><ix:continuation id="if2a74eff8a704dd388236521ef777de9"><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1&#8212;Quoted prices for identical instruments in active markets; </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2&#8212;Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3&#8212;Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities held by the Company are measured at fair value on a nonrecurring basis; that is, the assets are not measured at fair value on an ongoing basis, but are subject to fair value adjustments using fair value measurements with unobservable inputs (level 3), in certain circumstances (e.g., when there is evidence of impairment).</span></div></ix:continuation><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc5Mzc_d5369263-b1d0-4f62-bf30-3c9b7d63a7d4" continuedAt="i36cc7b871aeb47699a9f1c3d6060b97b" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services are transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Sales, value-added, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates the majority of its revenue through product sales to customers. These products include the Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">line of dietary supplements, LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Omega+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ProBio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, IC Bright</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Daily Wellness</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> dietary supplements, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> skin, hair, bath &amp; body and targeted relief, Petandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Axio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;nootropic energy drink mixes, and the PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;smart weight management system. The Company ships most of its product directly to the consumer and receives substantially all payment for product sales in the form of credit card receipts. Revenue from direct product sales to customers is recognized upon shipment, which is when passage of title and risk of loss occurs. For items sold in packs and bundles, the Company determines the standalone selling price at contract inception for each distinct good, and then allocates the transaction price on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Shipping and handling revenue is recognized upon shipment when the performance obligation is completed.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also charges independent distributors to attend certain events that it holds. Tickets to events are sold as standalone items or included within packs. For event tickets sold in packs, the Company allocates a portion of the transaction price to the ticket on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Fee revenue associated with ticket sales is recorded in the month that the event is held, which is when the Company has performed its obligations under the contract.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i36cc7b871aeb47699a9f1c3d6060b97b" continuedAt="ibd49462b59fc4ed2a6d805f95f4d4da6">Estimated returns are recorded when product is shipped. Subject to some exceptions based on local regulations, the Company&#8217;s return policy is to provide a full refund for product returned within <ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="lfvn:MoneyBackGuaranteePeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfODM2NQ_050210a5-d41b-425a-9f24-3e3cb9849582">30</ix:nonNumeric> days. After 30 days of purchase, only unopened product that is in a resalable and restockable condition may be returned within twelve months of purchase and shall receive a 100% refund, less a <ix:nonFraction unitRef="number" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="INF" name="lfvn:HandlingAndRestockingFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfODU1NA_75a278ac-9710-4068-81ed-d732842319a0">10</ix:nonFraction>% handling and restocking fee and any shipping and handling costs. The Company establishes a refund liability reserve, and an asset reserve for its right to recover products, based on historical experience. The returns asset reserve and returns liability reserve are evaluated on a quarterly basis.</ix:continuation> As of&#160;March&#160;31, 2022 and June&#160;30, 2021, the returns liability reserve, net was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-5" name="lfvn:ReturnLiabilityReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfODkxMA_1ff1c518-a6d0-449c-9d3e-d97c0dc84c28">0.1</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $<ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-5" name="lfvn:ReturnLiabilityReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfODkxNw_95b9240c-3700-48cf-aba3-44a9f31ce571">0.2</ix:nonFraction> million, respectively.</span></div><ix:continuation id="ibd49462b59fc4ed2a6d805f95f4d4da6"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling costs associated with inbound freight and freight out to customers and independent distributors are included in cost of sales. Shipping and handling fees charged to customers and independent distributors are included in revenue.</span></div></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc5NDY_79835aa1-33ae-47e8-93d1-d87a83087113" continuedAt="i2ff9e3c7d99d4a15b3ef0efb10c89421" escape="true">Research and Development Costs</ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2ff9e3c7d99d4a15b3ef0efb10c89421">The Company expenses all costs related to research and development activities, as incurred.</ix:continuation> Research and development expens</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">es for the three months ended March 31, 2022 and 2021 were $<ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfOTM4OA_ff6791cc-87ad-4f51-af9d-70063784d0e6">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfOTM5NQ_db21c1bb-7a85-464a-a9b9-f92f28ea5aaa">0.2</ix:nonFraction> million, respectively. Research and development expenses for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended March 31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2021 were $<ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfOTQ3MA_59f66eeb-03e0-4896-8424-618762658f7d">0.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfOTQ3Nw_19fc8a7e-d9de-4758-8440-2244709093ae">0.6</ix:nonFraction> million, respectively.</span></div><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc5Mjk_b14fa87b-85dd-4bfe-9e26-a42ae48ffa4b" continuedAt="if8fbf2a206424635aef90168f6f1cc03" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for leases in accordance with Accounting Standards Codification ("ASC") 842. The Company reviews all contracts and determines if the arrangement is or contains a lease, at inception. Operating leases are included in right-of-use (&#8220;ROU&#8221;) assets, current lease liabilities and long-term lease liabilities on the condensed consolidated balance sheets. The Company does not have any finance leases.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ifce5418908f446ada7c24c41478b8223" continuedAt="i5d0c1770fe3d4fdaaffa1ae8c36e89ea"><ix:continuation id="if8fbf2a206424635aef90168f6f1cc03"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company uses its estimated incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. The operating lease ROU asset also includes any upfront lease payments made and excludes lease incentives and initial direct costs incurred. The Company&#8217;s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Leases with a term of 12 months or less are not recorded on the balance sheet. The Company&#8217;s lease agreements do not contain any residual value guarantees.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pandemic caused by coronavirus (&#8220;COVID-19&#8221;) has resulted in disruptions which had forced the Company's corporate workforce to a remote working environment.  On September 1, 2020, the Company abandoned the ROU asset related to the Corporate office lease in Sandy, Utah, as this lease terminated in February 2021.  A new Corporate office was opened in Lehi, Utah in January 2021.</span></div></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the abandonment of the Sandy, Utah office, operating lease expenses related to the ROU asset, along with the remaining leasehold assets in the office, have been reduced to their salvage values, which the Company has determined to be <ix:nonFraction unitRef="usd" contextRef="ic645b34a2785482d9664b71bdd91384e_I20200901" decimals="INF" name="lfvn:OperatingLeaseRightOfUseAssetSalvageValue" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTE2Mjk_90a027fd-17dd-46a8-844f-221b1644b444">zero</ix:nonFraction>.  The total expense related to the abandonment of the ROU asset for the nine months ended March 31, 2021 was $<ix:nonFraction unitRef="usd" contextRef="id450c5bdf563442ca02fa3bd0de3267d_D20200701-20210331" decimals="-5" name="lfvn:OperatingLeaseRightOfUseAssetAbandonmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTE3MTE_31d28bd2-acd0-46f4-be7b-bed72b336e57">0.8</ix:nonFraction>&#160;million and is included in selling, general, and administrative expenses.  There is <ix:nonFraction unitRef="usd" contextRef="i222bc716cf0a47dd8efde9c5d36eff58_I20220331" decimals="INF" name="us-gaap:OperatingLeaseLiability" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTE3OTA_a3a7ba68-17b1-4520-8f92-27f6e9f66bed">no</ix:nonFraction> remaining lease liability for the Sandy, Utah office at March&#160;31, 2022.</span></div><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc5NDc_f58a5b9d-980d-420b-8fe7-a8494e1ecfb4" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes stock-based compensation by measuring the cost of services to be rendered based on the grant date fair value of the equity award. The Company recognizes stock-based compensation, net of any estimated forfeitures, over the period an employee is required to provide service in exchange for the award, generally referred to as the requisite service period. For awards with market-based performance conditions, the cost of the awards is recognized as the requisite service is rendered by employees, regardless of when, if ever, the market-based performance conditions are satisfied.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model is used to estimate the fair value of stock options and options under the Company's 2019 Employee Stock Purchase Plan. The determination of the fair value of options is affected by the Company's stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends. The Company uses historical data for estimating the expected volatility and expected life of stock options required in the Black-Scholes model. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected terms of the stock options.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of restricted stock grants is based on the closing market price of the Company's stock on the date of grant less the Company's expected dividend yield. The fair value of performance restricted stock units that include market-based performance conditions is based on the closing market price of the Company's stock on the date of grant less the Company's expected dividend yield, with further adjustments made to reflect the market conditions that must be satisfied in order for the units to vest by using a Monte-Carlo simulation model. Key assumptions for the Monte-Carlo simulation model include the risk-free rate, expected volatility, expected dividends and the correlation coefficient. The fair value of cash-settled performance-based awards, accounted for as liabilities, is remeasured at the end of each reporting period and is based on the closing market price of the Company&#8217;s stock on the last day of the reporting period. The Company recognizes compensation costs for awards with performance conditions when it concludes it is probable that the performance conditions will be achieved. The Company reassesses the probability of vesting at each balance sheet date and adjusts compensation costs accordingly.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc5OTc_c61926df-0d39-480c-b485-1d7595bd3457" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled, updated as needed for changes in corporate tax rates. The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the effective date of the change. The Company recognizes tax liabilities or benefits from an uncertain position only if it is more likely than not that the position will be sust</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ained upon examination by taxing authorities based on the technical merits of the issue. The amount recognized would be the largest liability or benefit that the Company believes has greater than a 50% likelihood of being realized upon settlement.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended March 31, 2022 and 2021, the Company recognized income tax expense of $<ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTU1OTA_e4b3b2d1-fc62-4200-8beb-d26795fe0186">1.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTU1OTc_2eead5d4-2480-4005-b712-2aa9bf1e3d97">2.8</ix:nonFraction> million, respectively, which is reflective of the Company&#8217;s current estimated federal, state and foreign effective tax rate. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realization of deferred tax assets is dependent upon future earnings in specific tax jurisdictions, the timing and amount of which are uncertain.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5d0c1770fe3d4fdaaffa1ae8c36e89ea"><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTgwMTM_718beabd-6419-4fcc-bba2-173b4a4cc2cc" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Per Share</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic income per common share is computed by dividing the net income by the weighted-average number of common shares outstanding during the period, less unvested restricted stock awards. Diluted income per common share is computed by dividing net income by the weighted-average common shares and potentially dilutive common share equivalents using the treasury stock method.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2022 and 2021, the effects of approximately <ix:nonFraction unitRef="shares" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTYzMDM_c89b8b3b-8da7-46e0-89b8-43346fbea7ab">0.1</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTYzMTA_c41f4976-190f-467c-b6c3-2d61b4ee8087">0.1</ix:nonFraction> million common shares, respectively, issuable upon exercise of options and non-vested shares of restricted stock are not included in computations as their effect was anti-dilutive. For the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended March 31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2021, the effects of approximately <ix:nonFraction unitRef="shares" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTY1MzQ_555681a6-1ab5-4b27-9d7f-0664022baf79">0.2</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTY1NDE_9866519d-7eaa-4d58-a66f-5968665b6c82">0.1</ix:nonFraction> million common shares, respectively, issuable upon exercise of options and non-vested shares of restricted stock are not included in computations as their effect was anti-dilutive.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTgwMjk_62a43baf-6fee-4c5a-848f-385ef0dd708f" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of net income per share and the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share (in thousands, except per share amounts):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfMy0xLTEtMS0xMzUwMw_2ca40150-544c-47cc-bc49-465bb588461e">1,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfMy0zLTEtMS0xMzUwMw_ac1a95e6-8279-4543-b06d-d4307b87c98a">1,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfMy01LTEtMS0xMzUwMw_7203fa53-7790-45ce-b411-db50b76ff149">4,536</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfMy03LTEtMS0xMzUwMw_dcc25591-bd9d-40d3-840a-acffe05a9e76">7,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfNS0xLTEtMS0xMzUwMw_6efff37a-d7a6-4653-9338-a6e950971dfa">13,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfNS0zLTEtMS0xMzUwMw_c5c17a49-54fa-4c46-9120-2de1afd2fa5c">14,071</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfNS01LTEtMS0xMzUwMw_5a9fabed-0fe9-496f-b509-b826980e3bf1">13,261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfNS03LTEtMS0xMzUwMw_8a716704-9804-4acf-9ee5-4a241a25bda6">14,175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards and options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfNy0xLTEtMS0xMzUwMw_0c4ac8f8-037a-40bd-baa9-9a8806b82990">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfNy0zLTEtMS0xMzUwMw_8ae6f3ff-8c60-4c00-bd11-c0b0b6a09a86">141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfNy01LTEtMS0xMzUwMw_34af5b98-2a52-4453-974b-da8e9bd87e41">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfNy03LTEtMS0xMzUwMw_7bf12287-cd32-40ee-bfa6-9a8e44e8fdbd">245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfOS0xLTEtMS0xMzUwMw_2a82a57b-e1c3-468e-9a93-fd5d2a3790e4">13,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfOS0zLTEtMS0xMzUwMw_38db8e73-d17c-4eda-bd00-1a367e7b993c">14,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfOS01LTEtMS0xMzUwMw_d116d9fd-b2cd-4af2-87ba-7900221e52d4">13,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfOS03LTEtMS0xMzUwMw_d4fe8da8-592d-405d-b6e2-6dd7e9e59ba3">14,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share, basic</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfMTAtMS0xLTEtMTM1MDM_c5f4681d-5a16-49ac-9dc0-685c5e5a697c">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfMTAtMy0xLTEtMTM1MDM_326f7709-906a-45cb-b23a-0e732fb7d88d">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfMTAtNS0xLTEtMTM1MDM_5bb20d81-27ee-4987-a5d4-13db2d4c0eec">0.34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfMTAtNy0xLTEtMTM1MDM_8d9b18fb-5c92-48e5-a10e-06c4070f82fb">0.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share, diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfMTEtMS0xLTEtMTM1MDM_e4fd09b2-21b6-4528-84b1-51a6ba773601">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfMTEtMy0xLTEtMTM1MDM_db3e0932-42f3-4c4c-b46d-f9b297c8ba3f">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfMTEtNS0xLTEtMTM1MDM_f8117b38-74ed-45f5-91cd-c050d60e06ec">0.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfMTEtNy0xLTEtMTM1MDM_abe39d47-3320-4a36-8bea-8167cce63375">0.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc5OTg_d9f92867-93e5-4b1a-94ea-f41543ef115f" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in a single operating segment by selling products directly to customers and through an international network of independent distributors that operates in an integrated manner from market to market.&#160;Commissions and incentives expenses are the Company&#8217;s largest expense comprised of the commissions paid to its independent distributors.&#160;The Company manages its business primarily by managing its international network of independent distributors.&#160;The Company disaggregates revenue in <ix:nonFraction unitRef="region" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="INF" name="lfvn:NumberOfGeographicSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc0NTc_4fdfab17-6ed7-4c2d-9d64-7f93bce2bb87">two</ix:nonFraction>&#160;geographic regions: the Americas region and the Asia/Pacific &amp; Europe region.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc5Mzg_ab6a5317-8599-4e7d-9238-dcdc94f58ffc" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company's revenue disaggregated by these <ix:nonFraction unitRef="region" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="INF" name="lfvn:NumberOfGeographicSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc2MTI_4fdfab17-6ed7-4c2d-9d64-7f93bce2bb87">two</ix:nonFraction> geographic regions (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2939647eeae400482eba40fd37747e0_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjZjYTY1ZTVmNjQ4OTRmNGJiMmFiNGZlMWVhYWU0NDU0L3RhYmxlcmFuZ2U6NmNhNjVlNWY2NDg5NGY0YmIyYWI0ZmUxZWFhZTQ0NTRfMi0xLTEtMS0xMzUwMw_f0e8e87e-bf30-4f83-9bb5-374f0e4dec17">33,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad789057464b445383e8e237ab794a70_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjZjYTY1ZTVmNjQ4OTRmNGJiMmFiNGZlMWVhYWU0NDU0L3RhYmxlcmFuZ2U6NmNhNjVlNWY2NDg5NGY0YmIyYWI0ZmUxZWFhZTQ0NTRfMi0zLTEtMS0xMzUwMw_a61b459a-f0c5-4c70-af0c-7234a53897a7">36,421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf9becab944541f9973e690359ee58d5_D20210701-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjZjYTY1ZTVmNjQ4OTRmNGJiMmFiNGZlMWVhYWU0NDU0L3RhYmxlcmFuZ2U6NmNhNjVlNWY2NDg5NGY0YmIyYWI0ZmUxZWFhZTQ0NTRfMi01LTEtMS0xMzUwMw_802c7c80-3441-43d9-9e03-934d9146994e">104,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e55f2a3f9c54683a2a69cee96783bac_D20200701-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjZjYTY1ZTVmNjQ4OTRmNGJiMmFiNGZlMWVhYWU0NDU0L3RhYmxlcmFuZ2U6NmNhNjVlNWY2NDg5NGY0YmIyYWI0ZmUxZWFhZTQ0NTRfMi03LTEtMS0xMzUwMw_076cc76a-ee91-430d-9cd2-0149d53ccfa0">116,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia/Pacific &amp; Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59577e105b574a07b1c8625a6eb9c7d1_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjZjYTY1ZTVmNjQ4OTRmNGJiMmFiNGZlMWVhYWU0NDU0L3RhYmxlcmFuZ2U6NmNhNjVlNWY2NDg5NGY0YmIyYWI0ZmUxZWFhZTQ0NTRfMy0xLTEtMS0xMzUwMw_39e3c43e-c2db-48cb-86d0-c0e2b3d63fa9">16,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieac81516c5ed43b983bf40a00b30e9c1_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjZjYTY1ZTVmNjQ4OTRmNGJiMmFiNGZlMWVhYWU0NDU0L3RhYmxlcmFuZ2U6NmNhNjVlNWY2NDg5NGY0YmIyYWI0ZmUxZWFhZTQ0NTRfMy0zLTEtMS0xMzUwMw_0c766e40-76f9-4b7e-b7f7-6460f293baab">15,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i279ae95e5e154fd3ac7b3d02bbe2bba3_D20210701-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjZjYTY1ZTVmNjQ4OTRmNGJiMmFiNGZlMWVhYWU0NDU0L3RhYmxlcmFuZ2U6NmNhNjVlNWY2NDg5NGY0YmIyYWI0ZmUxZWFhZTQ0NTRfMy01LTEtMS0xMzUwMw_a9afc299-74f5-41d6-9b86-69da36f02181">50,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic48a39651d07442f8d571c963b553e9f_D20200701-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjZjYTY1ZTVmNjQ4OTRmNGJiMmFiNGZlMWVhYWU0NDU0L3RhYmxlcmFuZ2U6NmNhNjVlNWY2NDg5NGY0YmIyYWI0ZmUxZWFhZTQ0NTRfMy03LTEtMS0xMzUwMw_0af4ec31-574a-4760-8fe1-13ed2356c9ba">48,426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjZjYTY1ZTVmNjQ4OTRmNGJiMmFiNGZlMWVhYWU0NDU0L3RhYmxlcmFuZ2U6NmNhNjVlNWY2NDg5NGY0YmIyYWI0ZmUxZWFhZTQ0NTRfNC0xLTEtMS0xMzUwMw_61ceb578-cc68-453d-ba79-ee7b077897c8">50,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjZjYTY1ZTVmNjQ4OTRmNGJiMmFiNGZlMWVhYWU0NDU0L3RhYmxlcmFuZ2U6NmNhNjVlNWY2NDg5NGY0YmIyYWI0ZmUxZWFhZTQ0NTRfNC0zLTEtMS0xMzUwMw_4640b40d-e17b-4a03-897c-e17f968f3ae2">51,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjZjYTY1ZTVmNjQ4OTRmNGJiMmFiNGZlMWVhYWU0NDU0L3RhYmxlcmFuZ2U6NmNhNjVlNWY2NDg5NGY0YmIyYWI0ZmUxZWFhZTQ0NTRfNC01LTEtMS0xMzUwMw_8da4145d-174f-49c1-aaf1-0ab50e3f1ff3">155,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjZjYTY1ZTVmNjQ4OTRmNGJiMmFiNGZlMWVhYWU0NDU0L3RhYmxlcmFuZ2U6NmNhNjVlNWY2NDg5NGY0YmIyYWI0ZmUxZWFhZTQ0NTRfNC03LTEtMS0xMzUwMw_a364e8a7-8283-4606-9e7f-9dbf3e8ddd61">165,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information as to the Company&#8217;s revenue from operations in the most significant geographical areas is set forth below (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85f81a6375b645c98c3862ffe7700508_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmM2YTI3Yzk0NDI0MzQ4ZjBiYjExYjhlNzY2ZjQ4MjQ5L3RhYmxlcmFuZ2U6YzZhMjdjOTQ0MjQzNDhmMGJiMTFiOGU3NjZmNDgyNDlfMi0xLTEtMS0xMzUwMw_d1701787-e69c-4b32-9c8a-45e873e3a286">31,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09abcf3ac44849c49e3c780b175040a5_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmM2YTI3Yzk0NDI0MzQ4ZjBiYjExYjhlNzY2ZjQ4MjQ5L3RhYmxlcmFuZ2U6YzZhMjdjOTQ0MjQzNDhmMGJiMTFiOGU3NjZmNDgyNDlfMi0zLTEtMS0xMzUwMw_378fbc4f-3eb5-4266-a709-d219e94099dc">34,068</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae8bb42b789646b4ba6f4b074eeffca3_D20210701-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmM2YTI3Yzk0NDI0MzQ4ZjBiYjExYjhlNzY2ZjQ4MjQ5L3RhYmxlcmFuZ2U6YzZhMjdjOTQ0MjQzNDhmMGJiMTFiOGU3NjZmNDgyNDlfMi01LTEtMS0xMzUwMw_652ecbb0-1bef-4cd3-af87-9f1a578924eb">98,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f44d883e0b2449897b56a1b34ccca8f_D20200701-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmM2YTI3Yzk0NDI0MzQ4ZjBiYjExYjhlNzY2ZjQ4MjQ5L3RhYmxlcmFuZ2U6YzZhMjdjOTQ0MjQzNDhmMGJiMTFiOGU3NjZmNDgyNDlfMi03LTEtMS0xMzUwMw_a581d0a8-784c-4932-98e2-1324cd2617cf">109,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f58b5474ebb4a5f830b29be3a2f7a7c_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmM2YTI3Yzk0NDI0MzQ4ZjBiYjExYjhlNzY2ZjQ4MjQ5L3RhYmxlcmFuZ2U6YzZhMjdjOTQ0MjQzNDhmMGJiMTFiOGU3NjZmNDgyNDlfMy0xLTEtMS0xMzUwMw_e1452c50-babf-4677-abe3-d4d030527098">8,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18167f341a8d41d5a9580b26693b5110_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmM2YTI3Yzk0NDI0MzQ4ZjBiYjExYjhlNzY2ZjQ4MjQ5L3RhYmxlcmFuZ2U6YzZhMjdjOTQ0MjQzNDhmMGJiMTFiOGU3NjZmNDgyNDlfMy0zLTEtMS0xMzUwMw_d48be5d9-0f4b-4977-9e9d-bada6dbf2f6b">9,622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia265df95ea7245d68fe8e38ba50df608_D20210701-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmM2YTI3Yzk0NDI0MzQ4ZjBiYjExYjhlNzY2ZjQ4MjQ5L3RhYmxlcmFuZ2U6YzZhMjdjOTQ0MjQzNDhmMGJiMTFiOGU3NjZmNDgyNDlfMy01LTEtMS0xMzUwMw_f7145e20-e305-49b5-b0d4-f14d9f5b3a87">28,558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93830f5b4c944ebf841a5318eff7e31d_D20200701-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmM2YTI3Yzk0NDI0MzQ4ZjBiYjExYjhlNzY2ZjQ4MjQ5L3RhYmxlcmFuZ2U6YzZhMjdjOTQ0MjQzNDhmMGJiMTFiOGU3NjZmNDgyNDlfMy03LTEtMS0xMzUwMw_9c333841-f15a-40fe-b5a4-2763e8b30674">31,172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc5Mzk_d4a5999c-e6d2-4c10-b407-9dd97a006383" escape="true"><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc5NzE_e43400c4-d156-445b-a9fd-ca77af1c13df" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company's long-lived assets for its most significant geographic markets (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97c08f4a55f8470a9971ea339ea1c21d_I20220331" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjdkYjBhOTBhODUxNzRhYWY4MmY1ZjQ3NmI0YmM0NGU4L3RhYmxlcmFuZ2U6N2RiMGE5MGE4NTE3NGFhZjgyZjVmNDc2YjRiYzQ0ZThfMS0xLTEtMS0xMzUwMw_b16f286b-c680-469c-9f53-0ed5a7026d4b">20,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b30af5c47844f9b1a2b364a4dc51ec_I20210630" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjdkYjBhOTBhODUxNzRhYWY4MmY1ZjQ3NmI0YmM0NGU4L3RhYmxlcmFuZ2U6N2RiMGE5MGE4NTE3NGFhZjgyZjVmNDc2YjRiYzQ0ZThfMS0zLTEtMS0xMzUwMw_31d5c068-cca8-4db8-9c20-f8b68bafe36a">22,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d74274057c84930a25d326155334bc0_I20220331" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjdkYjBhOTBhODUxNzRhYWY4MmY1ZjQ3NmI0YmM0NGU4L3RhYmxlcmFuZ2U6N2RiMGE5MGE4NTE3NGFhZjgyZjVmNDc2YjRiYzQ0ZThfMi0xLTEtMS0xMzUwMw_e27fab1c-5afd-49c2-8063-e2b9840a7b41">2,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic55ed5df77fa48efa92d5f7675cff1e4_I20210630" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjdkYjBhOTBhODUxNzRhYWY4MmY1ZjQ3NmI0YmM0NGU4L3RhYmxlcmFuZ2U6N2RiMGE5MGE4NTE3NGFhZjgyZjVmNDc2YjRiYzQ0ZThfMi0zLTEtMS0xMzUwMw_e9f1d257-055f-434f-ad77-bbfabb221aa4">3,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:nonNumeric></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><div id="i41e77726867840e39498d8f5bb503840_46"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3 &#8212; <ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:InvestmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80Ni9mcmFnOmYzNWI5MmFmZTVmMTQyNDFiNmU0N2FhNWJkOGViYTJlL3RleHRyZWdpb246ZjM1YjkyYWZlNWYxNDI0MWI2ZTQ3YWE1YmQ4ZWJhMmVfMjk1OA_0f3236a6-b13e-4839-95e2-31294eceac24" continuedAt="i06d76df8daa44258b3dc146f9531aba8" escape="true">Gig Economy Group Investment</ix:nonNumeric></span></div><ix:continuation id="i06d76df8daa44258b3dc146f9531aba8"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Note Receivable</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into a convertible promissory note agreement with Gig Economy Group, Inc. ("GEG") pursuant to which the Company agreed to loan to GEG up to an aggregate of $<ix:nonFraction unitRef="usd" contextRef="i345de6f57ba548a6ba07b11d0d85bb30_I20191216" decimals="INF" name="lfvn:NotesReceivableRelatedPartyMaximumCommitment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80Ni9mcmFnOmYzNWI5MmFmZTVmMTQyNDFiNmU0N2FhNWJkOGViYTJlL3RleHRyZWdpb246ZjM1YjkyYWZlNWYxNDI0MWI2ZTQ3YWE1YmQ4ZWJhMmVfMjQ3_1dff4879-765c-40b1-9379-061efb0667fb">2.0</ix:nonFraction>&#160;million in a series of loan installments, evidenced by a convertible promissory note having a maturity date of May&#160;31, 2019 ("Convertible Note"). The Convertible Note accrued interest at a rate of <ix:nonFraction unitRef="number" contextRef="if676f17905b1439fb5721e767c883b01_D20191216-20191216" decimals="INF" name="us-gaap:DebtConversionOriginalDebtInterestRateOfDebt" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80Ni9mcmFnOmYzNWI5MmFmZTVmMTQyNDFiNmU0N2FhNWJkOGViYTJlL3RleHRyZWdpb246ZjM1YjkyYWZlNWYxNDI0MWI2ZTQ3YWE1YmQ4ZWJhMmVfNDI5_aa1d8cee-3da7-437f-b88a-8e00b9e1fe7d">8</ix:nonFraction>% per annum, compounded annually. On May&#160;17, 2019, the Company and GEG entered into an amendment agreement to extend the maturity date of the Convertible Note to December&#160;31, 2019. In all other aspects, the Convertible Note remained unchanged from the original agreement. Pursuant to a Common Stock Purchase Agreement between the Company and GEG dated December 16, 2019, GEG issued to the Company <ix:nonFraction unitRef="shares" contextRef="i7541c71e837e4987866f3c14bda4fcd9_D20191216-20191216" decimals="INF" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80Ni9mcmFnOmYzNWI5MmFmZTVmMTQyNDFiNmU0N2FhNWJkOGViYTJlL3RleHRyZWdpb246ZjM1YjkyYWZlNWYxNDI0MWI2ZTQ3YWE1YmQ4ZWJhMmVfODAy_cfb0de3e-26fb-43d2-a096-8b49c8b8112e">1,000,000</ix:nonFraction> shares of GEG&#8217;s common stock in consideration for conversion and cancellation of all principal, interest and other amounts due under the Convertible Note (representing $<ix:nonFraction unitRef="usd" contextRef="i7541c71e837e4987866f3c14bda4fcd9_D20191216-20191216" decimals="-5" name="us-gaap:DebtConversionConvertedInstrumentAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80Ni9mcmFnOmYzNWI5MmFmZTVmMTQyNDFiNmU0N2FhNWJkOGViYTJlL3RleHRyZWdpb246ZjM1YjkyYWZlNWYxNDI0MWI2ZTQ3YWE1YmQ4ZWJhMmVfOTcz_81086ae3-1ded-4d66-a928-1e1448dcb474">2.2</ix:nonFraction>&#160;million in aggregate consideration).</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Securities under ASC 321</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon conversion of the convertible promissory note receivable with GEG, the Company held a minority interest (less than 20%) in GEG, accounted for under ASC 321, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments - Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 321"), which is included in equity securities in the condensed consolidated balance sheets. Dividends received are reported in earnings if and when received. The Company reviews securities individually for impairment by evaluating if events or circumstances have occurred that may indicate the fair value of the investment is less than its carrying value. If such events or circumstances have occurred, the Company estimates the fair value of the investment and recognizes an impairment loss in other expense, net on the condensed consolidated statements of operations and comprehensive income equal to the difference between the fair value of the investment and its carrying value. In such cases, the estimated fair value of the investment is determined using unobservable inputs including assumptions by GEG's management and quantitative information such as lower valuations in recently completed or proposed financings. These inputs are classified as Level 3. Because GEG is in the early startup stage, GEG is subject to potential changes in cash flows and valuation, and may be unable to raise additional capital necessary to support its ongoing operations, which may result in future impairment.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities held by the Company lack readily determinable fair values and therefore the securities are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar equity securities of the same issuer. The carrying amount of equity securities held by the Company without readily determinable fair values was $<ix:nonFraction unitRef="usd" contextRef="ib389c215613a45d48cba70a168c71912_I20210630" decimals="-5" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80Ni9mcmFnOmYzNWI5MmFmZTVmMTQyNDFiNmU0N2FhNWJkOGViYTJlL3RleHRyZWdpb246ZjM1YjkyYWZlNWYxNDI0MWI2ZTQ3YWE1YmQ4ZWJhMmVfMjg0OQ_94dd8436-8a09-4063-86fc-afb6e1fbbdc5"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-5" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80Ni9mcmFnOmYzNWI5MmFmZTVmMTQyNDFiNmU0N2FhNWJkOGViYTJlL3RleHRyZWdpb246ZjM1YjkyYWZlNWYxNDI0MWI2ZTQ3YWE1YmQ4ZWJhMmVfMjg0OQ_c495923e-b156-4d76-bbab-2909389403cb">2.2</ix:nonFraction></ix:nonFraction>&#160;million at March&#160;31, 2022 and June&#160;30, 2021, respectively. During the three and nine months ended March&#160;31, 2022 and 2021, there were no price changes or impairments recognized.</span></div></ix:continuation><div id="i41e77726867840e39498d8f5bb503840_49"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4 &#8212; <ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RleHRyZWdpb246ODcyNWU3ZDAxNDBkNDg4NTliNDdmZWNlYWI0Mjc3MGFfNjEy_fc2e0448-75e1-445a-8130-c1172ee5c684" continuedAt="i3437141efec444eca3ae5fef48f923c7" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="i3437141efec444eca3ae5fef48f923c7" continuedAt="ie7081715cc684522a5093cb47c29cd61"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases for current corporate offices and certain equipment. These leases have remaining terms of appro</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ximately <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RleHRyZWdpb246ODcyNWU3ZDAxNDBkNDg4NTliNDdmZWNlYWI0Mjc3MGFfMTU4_911d9052-5493-440f-bc28-01448a771e79">one</span> to <ix:nonNumeric contextRef="i3c83ca889a7845a2a8fe7f12f6b7501f_I20220331" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RleHRyZWdpb246ODcyNWU3ZDAxNDBkNDg4NTliNDdmZWNlYWI0Mjc3MGFfMTY0_c137fa12-b6c3-409c-b239-f37e7b9ef5b9">ten years</ix:nonNumeric>. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the weighted average remaining lease term and weighted average discount rate for operating leases was <ix:nonNumeric contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RleHRyZWdpb246ODcyNWU3ZDAxNDBkNDg4NTliNDdmZWNlYWI0Mjc3MGFfMjgw_56643a27-4ce7-41a6-8350-bc9b9513a3f8">8.49</ix:nonNumeric> years and <ix:nonFraction unitRef="number" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RleHRyZWdpb246ODcyNWU3ZDAxNDBkNDg4NTliNDdmZWNlYWI0Mjc3MGFfMjg3_b2114ee0-e05d-4cae-9755-269d2ba32c4c">3.30</ix:nonFraction>%, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2022 and 2021, operating lease expense was $<ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RleHRyZWdpb246ODcyNWU3ZDAxNDBkNDg4NTliNDdmZWNlYWI0Mjc3MGFfMzUz_d4c1a01f-cfb7-4e71-bb98-c0b6abb278e2">0.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RleHRyZWdpb246ODcyNWU3ZDAxNDBkNDg4NTliNDdmZWNlYWI0Mjc3MGFfMzYw_15cb1b14-d37e-49e0-b969-da331be86459">0.8</ix:nonFraction> million, respectively. For the nine months ended March 31, 2022 and 2021, operating lease expense was $<ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RleHRyZWdpb246ODcyNWU3ZDAxNDBkNDg4NTliNDdmZWNlYWI0Mjc3MGFfNDI1_262a6030-bd26-48b9-8a73-b09d9be0a0bb">2.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RleHRyZWdpb246ODcyNWU3ZDAxNDBkNDg4NTliNDdmZWNlYWI0Mjc3MGFfNDMy_c41f5564-88d6-4b72-8cd5-9126dd10b92e">2.8</ix:nonFraction> million, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RleHRyZWdpb246ODcyNWU3ZDAxNDBkNDg4NTliNDdmZWNlYWI0Mjc3MGFfNjE0_895ba6e8-419f-4c59-a875-a1401fea15b6" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to operating leases was as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows from operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOjcyYjIxMDdlOGU4MjRjNDU4MWQ4YjZiYjRmYzlhZmViL3RhYmxlcmFuZ2U6NzJiMjEwN2U4ZTgyNGM0NTgxZDhiNmJiNGZjOWFmZWJfMi0xLTEtMS0xMzUwMw_c25cf623-5ab2-4784-be9e-585b912214ef">804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOjcyYjIxMDdlOGU4MjRjNDU4MWQ4YjZiYjRmYzlhZmViL3RhYmxlcmFuZ2U6NzJiMjEwN2U4ZTgyNGM0NTgxZDhiNmJiNGZjOWFmZWJfMi0zLTEtMS0xMzUwMw_5e5bfc75-4c83-456c-affc-9b58dbdd7a6b">645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOjcyYjIxMDdlOGU4MjRjNDU4MWQ4YjZiYjRmYzlhZmViL3RhYmxlcmFuZ2U6NzJiMjEwN2U4ZTgyNGM0NTgxZDhiNmJiNGZjOWFmZWJfMi01LTEtMS0xMzUwMw_b0a905bc-1e01-4ee6-8552-a02c2dca9500">1,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOjcyYjIxMDdlOGU4MjRjNDU4MWQ4YjZiYjRmYzlhZmViL3RhYmxlcmFuZ2U6NzJiMjEwN2U4ZTgyNGM0NTgxZDhiNmJiNGZjOWFmZWJfMi03LTEtMS0xMzUwMw_5500a442-68cf-47ff-8c64-21701ded3c9e">2,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOjcyYjIxMDdlOGU4MjRjNDU4MWQ4YjZiYjRmYzlhZmViL3RhYmxlcmFuZ2U6NzJiMjEwN2U4ZTgyNGM0NTgxZDhiNmJiNGZjOWFmZWJfMy0xLTEtMS0xMzUwMw_79c45020-77f4-4a5c-9b33-ee1002e63b63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOjcyYjIxMDdlOGU4MjRjNDU4MWQ4YjZiYjRmYzlhZmViL3RhYmxlcmFuZ2U6NzJiMjEwN2U4ZTgyNGM0NTgxZDhiNmJiNGZjOWFmZWJfMy0zLTEtMS0xMzUwMw_1bb34231-a797-434d-a87c-713d19601a7f">317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOjcyYjIxMDdlOGU4MjRjNDU4MWQ4YjZiYjRmYzlhZmViL3RhYmxlcmFuZ2U6NzJiMjEwN2U4ZTgyNGM0NTgxZDhiNmJiNGZjOWFmZWJfMy01LTEtMS0xMzUwMw_2c4e26db-d96d-4077-80ed-bb8ef20d8190">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOjcyYjIxMDdlOGU4MjRjNDU4MWQ4YjZiYjRmYzlhZmViL3RhYmxlcmFuZ2U6NzJiMjEwN2U4ZTgyNGM0NTgxZDhiNmJiNGZjOWFmZWJfMy03LTEtMS0xMzUwMw_99593d4e-7429-44b9-b5fc-52336934a875">15,013</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><ix:continuation id="ie7081715cc684522a5093cb47c29cd61"><ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RleHRyZWdpb246ODcyNWU3ZDAxNDBkNDg4NTliNDdmZWNlYWI0Mjc3MGFfNjE1_8ce092b1-a6bf-46d8-baba-6b860095dfac" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturity of lease liabilities at March&#160;31, 2022 are as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 (remaining three months ending June 30, 2022)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOmY2OTY4MDkxZWIzOTQwZmI4ODU4NWNkNDQ5MjRjN2UwL3RhYmxlcmFuZ2U6ZjY5NjgwOTFlYjM5NDBmYjg4NTg1Y2Q0NDkyNGM3ZTBfMS0yLTEtMS0xMzUwMw_3e961851-4900-436e-98ec-9214d55f4f34">791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOmY2OTY4MDkxZWIzOTQwZmI4ODU4NWNkNDQ5MjRjN2UwL3RhYmxlcmFuZ2U6ZjY5NjgwOTFlYjM5NDBmYjg4NTg1Y2Q0NDkyNGM3ZTBfMi0yLTEtMS0xMzUwMw_adc505bb-889e-4289-a1f1-bd7b74a137bd">3,197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOmY2OTY4MDkxZWIzOTQwZmI4ODU4NWNkNDQ5MjRjN2UwL3RhYmxlcmFuZ2U6ZjY5NjgwOTFlYjM5NDBmYjg4NTg1Y2Q0NDkyNGM3ZTBfMy0yLTEtMS0xMzUwMw_671238ad-60a4-45a3-97c9-4e06a57db38c">2,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOmY2OTY4MDkxZWIzOTQwZmI4ODU4NWNkNDQ5MjRjN2UwL3RhYmxlcmFuZ2U6ZjY5NjgwOTFlYjM5NDBmYjg4NTg1Y2Q0NDkyNGM3ZTBfNC0yLTEtMS0xMzUwMw_2f74f5ab-95f5-41ba-9bcd-2c3df100732a">1,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOmY2OTY4MDkxZWIzOTQwZmI4ODU4NWNkNDQ5MjRjN2UwL3RhYmxlcmFuZ2U6ZjY5NjgwOTFlYjM5NDBmYjg4NTg1Y2Q0NDkyNGM3ZTBfNS0yLTEtMS0xMzUwMw_5d167ce5-082d-4bef-9cc4-55c831ba4f9b">1,646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="lfvn:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOmY2OTY4MDkxZWIzOTQwZmI4ODU4NWNkNDQ5MjRjN2UwL3RhYmxlcmFuZ2U6ZjY5NjgwOTFlYjM5NDBmYjg4NTg1Y2Q0NDkyNGM3ZTBfNi0yLTEtMS0xMzUwMw_e3b21572-5133-4467-8ff9-99f9a3174aea">9,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOmY2OTY4MDkxZWIzOTQwZmI4ODU4NWNkNDQ5MjRjN2UwL3RhYmxlcmFuZ2U6ZjY5NjgwOTFlYjM5NDBmYjg4NTg1Y2Q0NDkyNGM3ZTBfNy0yLTEtMS0xMzUwMw_d552dbae-1abb-41f3-af21-6ff50b106886">19,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOmY2OTY4MDkxZWIzOTQwZmI4ODU4NWNkNDQ5MjRjN2UwL3RhYmxlcmFuZ2U6ZjY5NjgwOTFlYjM5NDBmYjg4NTg1Y2Q0NDkyNGM3ZTBfOC0yLTEtMS0xMzUwMw_d462c70f-9f41-46a8-a7ab-78fee7031399">2,496</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOmY2OTY4MDkxZWIzOTQwZmI4ODU4NWNkNDQ5MjRjN2UwL3RhYmxlcmFuZ2U6ZjY5NjgwOTFlYjM5NDBmYjg4NTg1Y2Q0NDkyNGM3ZTBfOS0yLTEtMS0xMzUwMw_5469859b-78c6-46ba-94ce-0f6fec56a465">16,564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div id="i41e77726867840e39498d8f5bb503840_52"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5 &#8212; <ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfNTMwOA_971b328d-da3c-4a19-b5c1-160ff84d5eb9" continuedAt="i1ee9dde059ee4cfca1483c86c2479cda" escape="true">Long-Term Debt</ix:nonNumeric></span></div><ix:continuation id="i1ee9dde059ee4cfca1483c86c2479cda" continuedAt="i23ce605bf96c42c898e57c97d7898860"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;30, 2016, the Company entered into a loan agreement (the &#8220;2016 Loan Agreement&#8221;) to refinance its outstanding debt. In connection with the 2016 Loan Agreement and on the same date, the Company entered into a security agreement (the &#8220;Security Agreement&#8221;). The 2016 Loan Agreement provides for a term loan in an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i91749ed981c5409a9273b2f8dbbe2722_I20160330" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMzY1_e51a24c2-862e-4493-a8a5-bf9903a602c5">10.0</ix:nonFraction> million (the &#8220;2016 Term Loan") and a revolving loan facility in an aggregate principal amount not to exceed $<ix:nonFraction unitRef="usd" contextRef="i28ed7365c77c4b2db3b859a62be20d66_I20160330" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfNDY4_02490ecc-5a11-418e-804d-cdedad7599ba">2.0</ix:nonFraction> million (the &#8220;2016 Revolving Loan,&#8221; and collectively with the 2016 Term Loan, the 2016 Loan Agreement and the Security Agreement, the &#8220;2016 Credit Facility&#8221;). </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal amount of the 2016 Term Loan is payable in consecutive quarterly installments in the amount of $<ix:nonFraction unitRef="usd" contextRef="i6e21e97ed1274414912f33d01244c913_D20210701-20220331" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfNzI1_5f4d04be-55d0-4229-813e-41ea05123cd8">0.5</ix:nonFraction> million plus accrued interest beginning with the fiscal quarter ended June&#160;30, 2016. If the Company borrows under the 2016 Revolving Loan, interest will be payable quarterly in arrears on the last day of each fiscal quarter.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;4, 2018, the Company entered into a loan modification agreement, which amended the 2016 Credit Facility (&#8220;Amendment No. 1&#8221;). Amendment No. 1 revised the maturity date from March&#160;30, 2019 to March&#160;31, 2021 and increased the fixed interest rate for the term loan from <ix:nonFraction unitRef="number" contextRef="i91749ed981c5409a9273b2f8dbbe2722_I20160330" decimals="INF" name="us-gaap:LongTermDebtPercentageBearingFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMTE3NA_f277ab3e-d11d-4c56-981f-9e79e329d912">4.93</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i712ce600357e432e9efd232d861ee1b2_I20180504" decimals="INF" name="us-gaap:LongTermDebtPercentageBearingFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMTE4MA_a9803646-32d0-41a8-ae34-bcd41f293d82">5.68</ix:nonFraction>%. Amendment No. 1 also revised certain financial covenants. The minimum fixed charge coverage ratio (as defined in Amendment No. 1) was revised from a minimum of <ix:nonFraction unitRef="number" contextRef="i91749ed981c5409a9273b2f8dbbe2722_I20160330" decimals="INF" name="lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMTM0NA_2feb8ba6-3f6b-46a4-b0dc-53770be6956b">1.50</ix:nonFraction> to 1.00 to <ix:nonFraction unitRef="number" contextRef="i712ce600357e432e9efd232d861ee1b2_I20180504" decimals="INF" name="lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMTM1Ng_6e667f24-32bf-4a38-a2eb-7e4d8dd9e446">1.25</ix:nonFraction> to 1.00, measured on a trailing <ix:nonNumeric contextRef="i6905908291e94757a8fba8a815f971d0_D20180504-20180504" name="lfvn:DebtInstrumentTrailingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfNTMwOQ_a89d292a-71c1-46ae-9b2a-5e3900d15dc7">twelve-month</ix:nonNumeric> basis, at the end of each fiscal quarter. The minimum working capital was increased from $<ix:nonFraction unitRef="usd" contextRef="i91749ed981c5409a9273b2f8dbbe2722_I20160330" decimals="INF" name="lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMTQ4Nw_a69e80cb-4e9c-4cab-88a4-4c33e899b553">5.0</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i712ce600357e432e9efd232d861ee1b2_I20180504" decimals="INF" name="lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMTQ5Mw_5ce05642-71af-49a9-a1d1-0cb859711e6e">8.0</ix:nonFraction> million. The funded debt to EBITDA ratio was replaced with the total liabilities to tangible net worth ratio (as defined in Amendment No. 1) of not greater than <ix:nonFraction unitRef="number" contextRef="i712ce600357e432e9efd232d861ee1b2_I20180504" decimals="INF" name="lfvn:DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMTY0OQ_5a05c76c-4dff-4533-80ab-3424482985f9">3.00</ix:nonFraction> to 1.00 at the end of each quarter. The minimum tangible net worth measure was removed from the financial covenants.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s obligations under the 2016 Credit Facility, as amended, are secured by a security interest in substantially all of the Company&#8217;s assets. Loans outstanding under the 2016 Credit Facility, as amended, may be prepaid in whole or in part at any time without premium or penalty. In addition, if, at any time, the aggregate principal amount outstanding under the 2016 Revolving Loan exceeds $<ix:nonFraction unitRef="usd" contextRef="i28ed7365c77c4b2db3b859a62be20d66_I20160330" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMjE2Ng_bb0c91e0-d201-4157-8ab2-39ab2203b014">2.0</ix:nonFraction> million, the Company must prepay an amount equal to such excess. Any principal amount of the 2016 Term Loan which is prepaid or repaid may not be re-borrowed.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;1, 2019, the Company entered into a loan modification agreement, which further amended the 2016 Credit Facility ("Amendment No. 2"). Under Amendment No. 2, the Company made a principal payment of $<ix:nonFraction unitRef="usd" contextRef="ia4e41b786fa5480cbafaff2190125416_D20190201-20190201" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMjUxNA_77501612-c4ba-4cdb-9f50-48abb4c6c8a3">2.0</ix:nonFraction> million and increased the revolving loan facility from $<ix:nonFraction unitRef="usd" contextRef="i28ed7365c77c4b2db3b859a62be20d66_I20160330" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMjU2NA_bb0c91e0-d201-4157-8ab2-39ab2203b014">2.0</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i138740ba50b5467d8eb135d8bfbf6674_I20190201" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMjU3MA_56fd6592-b684-433b-9fd3-50153205023c">5.0</ix:nonFraction> million. Amendment No. 2 also revised certain financial covenants. The minimum fixed charge coverage ratio (as defined in Amendment No. 2) was revised from a minimum of <ix:nonFraction unitRef="number" contextRef="i712ce600357e432e9efd232d861ee1b2_I20180504" decimals="INF" name="lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMjczNA_6e667f24-32bf-4a38-a2eb-7e4d8dd9e446">1.25</ix:nonFraction> to 1.00 to <ix:nonFraction unitRef="number" contextRef="ie0c55b4954084c5aae5f41ea24e8318b_I20190201" decimals="INF" name="lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMjc0Ng_ba4f43bf-bec6-463b-91d8-5ad5b84990ee">1.10</ix:nonFraction> to 1.00, measured on a trailing <ix:nonNumeric contextRef="i2934f27e399b471b8b9dfd34e5e0ac1b_D20190201-20190201" name="lfvn:DebtInstrumentTrailingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfNTMxMA_f5d9e27f-581f-4cce-ad73-649c016594e4">twelve-month</ix:nonNumeric> basis, at the end of each fiscal quarter. The minimum working capital was decreased from $<ix:nonFraction unitRef="usd" contextRef="i1cbad6d70bc54ef6bae80ba6559acdcc_I20180504" decimals="INF" name="lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMjg3Nw_5cbe4249-d7a6-41c9-9b8f-3801c69d8e45">8.0</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="ie0c55b4954084c5aae5f41ea24e8318b_I20190201" decimals="INF" name="lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMjg4Mw_f9e0bb53-32e3-4ddd-893f-5b5f43027094">6.0</ix:nonFraction> million.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;1, 2021, the Company entered into a loan modification agreement ("Amendment No. 3"), which amended the 2016 Credit Facility, as previously amended. Amendment No. 3 revised the maturity date from March&#160;31, 2021 to March&#160;31, 2024 and modified the variable interest rate based on the one-month United States Treasury Rate, plus a margin of <ix:nonFraction unitRef="number" contextRef="ib44219a0ab0d49e6bc0c499248ce173b_D20210401-20210401" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMzE5OA_b673f759-0ebb-476c-852b-e4b3eb4b25ef">3.00</ix:nonFraction>%, with an interest rate floor of <ix:nonFraction unitRef="number" contextRef="ie90439fd1c8a43998c36b1c5528a888c_D20210401-20210401" decimals="INF" name="lfvn:DebtInstrumentFloorInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMzIzMw_c4088ff7-4593-4a77-8332-878b0257c637">4.00</ix:nonFraction>%. Amendment No. 3 also revised the debt (total liabilities) to tangible net worth ratio (as defined in Amendment No. 3) covenant to require that the Company maintain this ratio not in excess of <ix:nonFraction unitRef="number" contextRef="i44c9eefb9093469182cd44d1b4c1dd66_I20210401" decimals="INF" name="lfvn:DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMzQyOQ_3528c171-ee50-40d9-8f67-cf0d03142d44">2.00</ix:nonFraction> to 1.00, measured as of the end of each fiscal quarter, and revised the definition and calculation of the minimum fixed charge coverage ratio (as defined in Amendment No. 3).  There were no other changes to the covenants or revolving loan facility as set forth in Amendment No. 2.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2016 Credit Facility, as amended, contains customary covenants, including affirmative and negative covenants that, among other things, restrict the Company&#8217;s ability to create certain types of liens, incur additional indebtedness, declare or pay dividends on or redeem capital stock, make other payments to holders of equity interests in the Company, make certain </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i23ce605bf96c42c898e57c97d7898860"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">investments, purchase or otherwise acquire all or substantially all the assets or equity interests of other companies, sell assets or enter into consolidations, mergers or transfers of all or any substantial part of the Company&#8217;s assets. The 2016 Credit Facility, as amended, also contains various financial covenants that require the Company to maintain certain consolidated working capital amounts, total liabilities to tangible net worth ratios and fixed charge coverage ratios. Additionally, the 2016 Credit Facility, as amended, contains cross-default provisions, whereby a default under the terms of certain indebtedness or an uncured default of a payment or other material obligation of the Company under a material contract of the Company will cause a default on the remaining indebtedness under the 2016 Credit Facility, as amended. As of March&#160;31, 2022, the Company was in compliance with all applicable covenants under the 2016 Credit Facility, as amended.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s book value for the 2016 Credit Facility, as amended, approximates the fair value. During the fiscal year ended June&#160;30, 2020, the Company repaid, in full, the remaining balance of the 2016 Term Loan in accordance with the terms of the 2016 Credit Facility, as amended.</span></div></ix:continuation><div id="i41e77726867840e39498d8f5bb503840_55"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6 &#8212; <ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMjUwMw_0c73af64-c03c-4f3c-9464-f6f0d015e669" continuedAt="i1d061d9e99194d6782639fde4e4f58b9" escape="true">Stockholders&#8217; Equity</ix:nonNumeric></span></div><ix:continuation id="i1d061d9e99194d6782639fde4e4f58b9"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended March 31, 2022 and 2021,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Company issued no shares of common stock upon the exercise of options. During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> March&#160;31, 2022 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the company issued <ix:nonFraction unitRef="shares" contextRef="ifee0653b54af42bf80320efe99032f1d_D20210701-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMjA1_297f6457-9021-4f1f-8f52-88a4456fe521">30,000</ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="id5c31a591c3c44ea943724f45a5bccda_D20200701-20210331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMjE5_e66d0f4a-df62-4af8-baa1-6c8a5b18fb72">0.2</ix:nonFraction> million shares, respectively, of common stock upon the exercise of options. During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended March 31, 2022 and 2021, approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ied064917c4284ae1bbf8175e9b75f43b_D20220101-20220331" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMzI2_874208f0-e029-4f94-8144-be1f06df6c80">5,000</ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="ia94b7a6d35ea49b3b94d253b14ae6d97_D20210101-20210331" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMzQw_af47471f-9186-4f7c-830a-1d18859e8a68">14,000</ix:nonFraction> shares, respectively, of restricted stock were canceled or surrendered as payment of tax withholding upon vesting. During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> March&#160;31, 2022 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, approximately <ix:nonFraction unitRef="shares" contextRef="ifee0653b54af42bf80320efe99032f1d_D20210701-20220331" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfNDk3_f27239b7-51d6-4579-b54a-0ceb8069303b">29,000</ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="id5c31a591c3c44ea943724f45a5bccda_D20200701-20210331" decimals="-5" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfNTEx_90b598b3-7846-43cf-8a3f-1ddc16e64a96">0.1</ix:nonFraction> million shares, respectively, of restricted stock were canceled or surrendered as payment of tax withholding upon vesting.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 27, 2017, the Company announced a share repurchase program authorizing it to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="idfeffa2877114db7a47309a70bbb8f84_I20171127" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfNzM1_bd865b30-c4f4-49fd-a22c-393c3482caef">5</ix:nonFraction> million in shares of the Company's common stock. The repurchase program permits the Company to purchase shares through a variety of methods, including in the open market, through privately negotiated transactions or other means as determined by the Company's management. As part of the repurchase program, the Company has entered into a pre-arranged stock repurchase plan which operates in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Accordingly, any transactions under such stock repurchase plan will be completed in accordance with the terms of the plan, including specified price, volume and timing conditions. The authorization may be suspended or discontinued at any time. On February 1, 2019, the Board of Directors approved an amendment to the share repurchase program to increase the authorized share repurchase amount from $<ix:nonFraction unitRef="usd" contextRef="idfeffa2877114db7a47309a70bbb8f84_I20171127" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMTYyNQ_e7ec9f9b-84fd-4293-8ec3-0e3eb47fa6eb">5</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i15ef7d898c564726b93cc5e8c2ad2750_I20190201" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMTYzMQ_81f88705-7633-4ad4-b05a-25621c9223b2">15</ix:nonFraction> million. On August 27, 2020, the Board of Directors approved an amendment to the share repurchase program to increase the authorized share repurchase amount from $<ix:nonFraction unitRef="usd" contextRef="i15ef7d898c564726b93cc5e8c2ad2750_I20190201" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMTc5Mg_6d02584c-0847-4741-9f8a-18191afcfa9f">15</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i2b61f7ff2c2b4a908d35b37807707405_I20200827" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMTc5OA_ca4ea23b-760d-47cf-b11c-ba937946bb41">35</ix:nonFraction> million and to extend the duration of the program through November 30, 20</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23 and, on February 17, 2022, the Board of Directors approved an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amendment to the share repurchase program to increase the authorized share repurchase amount from $<ix:nonFraction unitRef="usd" contextRef="i2b61f7ff2c2b4a908d35b37807707405_I20200827" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMTA5OTUxMTYzMDU1NQ_ca4ea23b-760d-47cf-b11c-ba937946bb41">35</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i8365c04b98844bcea3d544bdda92cd4c_I20220217" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMTA5OTUxMTYzMDYzMw_bf41aff3-1312-4251-90c4-40d1ecb0fb97">60</ix:nonFraction> million. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended March 31, 2022 and 2021, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company purchased <ix:nonFraction unitRef="shares" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMTkxNQ_1b16530c-3a97-44ad-9f0b-9f5b35053598">0.3</ix:nonFraction> million shares and <ix:nonFraction unitRef="shares" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMTkyOQ_6b6232ee-1add-48f1-828d-eef5307ec106">0.2</ix:nonFraction> million shares, respectively, of common stock at an aggregate price of $<ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMTk5NQ_fb27b73e-e5e6-40d3-a527-1646c4d94454">1.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMjAwMg_f1c4c80f-487e-4535-99f6-d088be79cfd8">2.0</ix:nonFraction> million under this repurchase program.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended&#160;March&#160;31, 2022 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company purchased <ix:nonFraction unitRef="shares" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMjA4Mw_ebb2f316-d3a0-4b69-8717-744854327fe3">1.2</ix:nonFraction> million shares and <ix:nonFraction unitRef="shares" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMjA5Nw_e42aa892-4c03-4318-ba21-e237bb826e77">0.7</ix:nonFraction> million shares, respectively, of common stock at an aggregate price of $<ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMjE2Mw_959774d0-bbc0-429f-a2ad-39b19bec223b">8.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMjE3MA_0a948bb3-a022-4572-86fd-2144ec28d6a4">8.0</ix:nonFraction> million under this repurchase program. At&#160;March&#160;31, 2022, there is $<ix:nonFraction unitRef="usd" contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331" decimals="-5" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMjIyMA_e71a90af-71b1-4ab8-96a3-145110a7c589">28.1</ix:nonFraction> million remaining under this repurchase program.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Certificate of Incorporation authorizes the issuance of preferred stock. However</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as of March&#160;31, 2022, none have been issued nor have any rights or preferences been assigned to the preferred stock by the Company&#8217;s board of directors.</span></div></ix:continuation><div id="i41e77726867840e39498d8f5bb503840_58"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7 &#8212; <ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNzA5Mg_182cea3f-ff83-472a-a2cd-354bd9f8fb8b" continuedAt="i281aefd091d8448d9aced11a55806009" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="i281aefd091d8448d9aced11a55806009" continuedAt="i484c5584d5704647bc8736ecc96c10dd"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long-Term Incentive Plans</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity-Settled Plans</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted, and the stockholders approved, the 2007 Long-Term Incentive Plan (the &#8220;2007 Plan&#8221;), effective November&#160;21, 2006, to provide incentives to eligible employees, directors and consultants. A maximum of <ix:nonFraction unitRef="shares" contextRef="icfb9d06f4ea24bfb9da6d26bba64f59e_I20061121" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMzA1_374b0b16-749d-4f4a-a9fb-975bd517f1d7">1.4</ix:nonFraction> million shares of the Company's common stock can be issued under the 2007 Plan in connection with the grant of awards. Effective November 21, 2016, no new awards can be granted under the 2007 Plan. As of March&#160;31, 2022, there were no stock option awards outstanding under the 2007 Plan.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted, and the stockholders approved, the 2010 Long-Term Incentive Plan (the &#8220;2010 Plan&#8221;), effective September 27, 2010, as amended on August&#160;21, 2014, to provide incentives to certain employees, directors and consultants. A maximum of <ix:nonFraction unitRef="shares" contextRef="i82db2efb56364be499fa24d948efc805_I20100927" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfODI1_795ef928-78c2-46cf-adbe-3bb6420bec4c">1.0</ix:nonFraction> million shares of the Company's common stock can be issued under the 2010 Plan in connection with the grant of awards. Awards to purchase common stock have been granted pursuant to the 2010 Plan and are outstanding to various employees, officers and directors. Outstanding stock options awarded under the 2010 Plan have exercise prices between $<ix:nonFraction unitRef="usdPerShare" contextRef="i643716d34b6a4245a763bf8bf4629aa8_D20100927-20100927" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMTE2NA_f283de0b-ea45-4870-b20c-d95290ae690d">9.31</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i38dcb43eafd747fbbc7861d7bb8a2b03_D20100927-20100927" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMTE3MQ_3a7f441c-ae1b-47d2-bc11-c2180d3b3e11">19.74</ix:nonFraction> per share, and vest over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMTE5OQ_88c1c3cf-56ec-4205-9f2f-deff51b9192d">one</span> to <ix:nonNumeric contextRef="i38dcb43eafd747fbbc7861d7bb8a2b03_D20100927-20100927" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNzA5Mw_bdd7a417-ebff-42f4-b023-6eba7bf1f582">four year</ix:nonNumeric> vesting periods. Awards expire in accordance with the terms of each award </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i484c5584d5704647bc8736ecc96c10dd" continuedAt="i3a8d8ac2a6f2457ebce84312a548706e"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and, upon expiration of the award, the shares subject to the award will be added to the 2017 Plan pool as described below. The contractual term of stock options granted is generally <ix:nonNumeric contextRef="ia4fb358160af4b1582deaf09e2b4bd56_D20100927-20100927" name="lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMTQ2OQ_c74b9bcd-9b5b-4178-adab-12d1c396507a">ten years</ix:nonNumeric>. No new awards will be granted under the 2010 Plan and forfeited or terminated shares may be added to the 2017 Plan pool as described below. As of March&#160;31, 2022, under the 2010 Plan, there were stock option awards outstanding, net of awards expired, for an aggregate of approximately <ix:nonFraction unitRef="shares" contextRef="ie1f4201b19a74fef8349a17facf7daa8_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMTc0NQ_82f1ffa1-c373-40f6-9ac0-c5dc9e33031c">20,000</ix:nonFraction> shares of the Company's common stock.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted, and the stockholders approved, the 2017 Long-Term Incentive Plan (the &#8220;2017 Plan&#8221;), effective February 16, 2017, to provide incentives to eligible employees, directors and consultants. On February 2, 2018, November 15, 2018, and November 12, 2020, the stockholders approved amendments to the 2017 Plan to increase by <ix:nonFraction unitRef="shares" contextRef="i6e2b576ca32a4d868584d602195e7c37_D20180202-20180202" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMjEyNA_2d1faa40-e35c-444b-a025-2c12c75d55f0">425,000</ix:nonFraction> shares, <ix:nonFraction unitRef="shares" contextRef="ic3eb364b1b32431298d5283303fb50c1_D20181115-20181115" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMjEzNQ_3567219f-d12f-441a-93b7-9b553a9f4e7a">715,000</ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="i82320565cb5746a9a4deead3ae0f001d_D20201112-20201112" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMjE0OQ_be500fd9-2fee-498a-871d-ece789bef755">650,000</ix:nonFraction> shares, respectively, the number of shares of the Company's common stock that are available for issuance under the 2017 Plan. As of&#160;March&#160;31, 2022, a maximum of <ix:nonFraction unitRef="shares" contextRef="i2cc2bb8a2f46410091908db5becaed25_I20220331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMjMwMQ_a48be340-81f0-4736-b39b-f662e5d3c057">2.9</ix:nonFraction> million&#160;shares of the Company's common stock can be issued under the 2017 Plan in connection with the grant of awards which is calculated as the sum of (i) <ix:nonFraction unitRef="shares" contextRef="i45d0f653093a43c1aa4ad8a6f44b65f5_I20180202" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMjQ1Mg_2a3a0d56-376e-40be-81b4-81ab04df0e41">2,440,000</ix:nonFraction> shares and (ii) up to <ix:nonFraction unitRef="shares" contextRef="ica0b13add21047009a5fb1a118222ecf_I20180202" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMjQ3Nw_69c42bed-16bc-4b2b-a151-4e8b53f6b39b">475,000</ix:nonFraction> shares previously reserved for issuance under the 2010 Plan, including shares returned upon cancellation, termination or forfeiture of awards that were previously granted under that plan. O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">utstanding stock options awarded under the 2017 Plan have exercise prices of $<ix:nonFraction unitRef="usdPerShare" contextRef="i2cc2bb8a2f46410091908db5becaed25_I20220331" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMjc0Ng_21f30f6f-deeb-4bad-af4e-1c55c85c6b12">4.44</ix:nonFraction> per share, and vest over a <ix:nonNumeric contextRef="ib1c7eca313734a9780d2949151a11055_D20210701-20220331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNzA4OA_3e3e5146-aeed-4e69-8286-d74ee9b64aac">three year</ix:nonNumeric> vesting period. Awards expire in accordance with the terms of each award and, upon expiration of the award, the shares subject to the award are added back to the 2017 Plan. The contractual term of stock options granted are substantially the same as described above for the 2010 Plan. As of March&#160;31, 2022, under the 2017 Plan, there were stock option awards outstanding, net of awards expired, for an aggregate of <ix:nonFraction unitRef="shares" contextRef="i2cc2bb8a2f46410091908db5becaed25_I20220331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMzE4Ng_856b949c-5973-40d9-897d-00f6c0021e52">0.1</ix:nonFraction> million shares of the Company's common stock.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash-Settled Plans</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted a performance incentive plan effective July 1, 2017 (the "Fiscal 2018 Performance Plan"). The Fiscal 2018 Performance Plan is intended to provide selected employees an opportunity to earn performance-based cash bonuses whose value is based upon the Company&#8217;s stock value and to encourage such employees to provide services to the Company and to attract new individuals with outstanding qualifications. The Fiscal 2018 Performance Plan seeks to achieve this purpose by providing for awards in the form of performance share units (the &#8220;Units&#8221;).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonFraction unitRef="shares" contextRef="ia7df9f17944846a0ac9250ae7774a182_D20210701-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMzgwOQ_18b86544-7aa8-48e9-9614-ad1f188ff24b">No</ix:nonFraction> shares will be issued under the Fiscal 2018 Performance Plan. Awards may be settled only with cash and will be paid subsequent to award vesting. The fair value of share-based compensation awards, that include performance shares, are accounted for as liabilities. Vesting for the Units is subject to achievement of both service-based and performance-based vesting requirements. Performance-based vesting occurs in <ix:nonFraction unitRef="installment" contextRef="ie920895e4f5f48ef81ce22593768c0b3_I20220331" decimals="INF" name="lfvn:SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofVestingInstallments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNDIyNQ_22a81a28-c01d-487c-aabc-851b32ed8939">three</ix:nonFraction> installments if the Company meets certain performance criteria generally set for each year of a <ix:nonNumeric contextRef="ia7df9f17944846a0ac9250ae7774a182_D20210701-20220331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNzA5NA_072801cf-7357-451c-8f15-7fde55820f1a">three-year</ix:nonNumeric> performance period. The service-based vesting criteria occurs in a single installment at the end of the third fiscal year after the awards are granted if the participant has continuously remained in service from the date of award through the end of the third fiscal year. The fair value of these awards is based on the trading price of the Company's common stock and is remeasured at each reporting period date until settlement.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The Company's 2019 Employee Stock Purchase Plan ("ESPP") was adopted by the board of directors in September 2018 and the Company's stockholders approved it in November 2018. The ESPP is intended to qualify under Section 423 of the Internal Revenue Code.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Reserve.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The Company has reserved <ix:nonFraction unitRef="shares" contextRef="ibbe9559ba77040d5b39ea3519ff4b9b9_I20220331" decimals="-5" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNTA5NQ_e69d4247-17d0-49e7-bc90-362407ef51da">0.4</ix:nonFraction> million shares of its common stock for issuance under the ESPP. As of March&#160;31, 2022, <ix:nonFraction unitRef="shares" contextRef="ibbe9559ba77040d5b39ea3519ff4b9b9_I20220331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNTE2NA_2403c139-3ee0-44ea-aabf-aa8b87952ce9">0.2</ix:nonFraction> million shares were available for issuance. The number of shares reserved under the ESPP will automatically be adjusted in the event of a stock split, stock dividend or a reverse stock split (including an adjustment to the per-purchase period share limit).</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Employees may purchase each share of common stock under the ESPP at a price equal to <ix:nonFraction unitRef="number" contextRef="ice3288151d3641c6b51df76356f2297c_D20210701-20220331" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNTUxOA_30ae0feb-eb66-468d-90ca-847666900c9b">85</ix:nonFraction>% of the lower of the fair market values of the stock as of the beginning or the end of the six-month offering periods. An employee's contributions to the ESPP are limited to <ix:nonFraction unitRef="number" contextRef="ibbe9559ba77040d5b39ea3519ff4b9b9_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNTY5NA_91e69813-2337-4781-a45d-93052203796f">15</ix:nonFraction>% of their regular hourly or salary compensation, and up to a maximum of <ix:nonFraction unitRef="shares" contextRef="ice3288151d3641c6b51df76356f2297c_D20210701-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNTc2OA_4d9c629a-08f5-40cf-aa55-932adaaf577f">3,000</ix:nonFraction> shares may be purchased during any offering period. A participant shall not be granted an option under the ESPP if such option would permit the participant's rights to purchase stock to accrue at a rate exceeding $<ix:nonFraction unitRef="usd" contextRef="ibbe9559ba77040d5b39ea3519ff4b9b9_I20220331" decimals="INF" name="lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNTk4NA_28400f44-bc76-4eb4-aac3-11d19d88c8ca">25,000</ix:nonFraction> grant date fair market value of stock for each calendar year in which such option is outstanding at any time.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Offering Periods.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Unless otherwise determined by the compensation committee, the ESPP will be operated through a series of successive <ix:nonNumeric contextRef="ice3288151d3641c6b51df76356f2297c_D20210701-20220331" name="lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNzA4OQ_f4842eb2-9525-4feb-830e-20b2fa8c5a9a">six-month</ix:nonNumeric> offering periods, which will begin each year on March 1 and September 1.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Duri</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ng the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and nine months ended</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2022,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> approximately <ix:nonFraction unitRef="shares" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMTA5OTUxMTYzNDkyMg_1b6eae56-6cb0-4140-9f72-c64629b393d9">41,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMTA5OTUxMTYzNDg4NQ_cc989e93-399a-4f2a-a496-0e04fea15626">0.1</ix:nonFraction> million shares of common stock were issued under the ESPP, respectively. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Duri</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ng the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and nine months ended</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2021,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> approximately <ix:nonFraction unitRef="shares" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMTA5OTUxMTYzNDkzMA_233b33f3-6d31-44ea-8792-b64da50c9ea6">36,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMTA5OTUxMTYzNDkxNQ_50604929-061f-4b1e-b0aa-e5a5ad4e7c46">0.1</ix:nonFraction> million shares of common stock were issued under the ESPP. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i3a8d8ac2a6f2457ebce84312a548706e"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock-Based Compensation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with accounting guidance for stock-based compensation, payments in equity instruments for goods or services are accounted for by the fair value method. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2022, a decrease to additional paid-in capital of $<ix:nonFraction unitRef="usd" contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMTA5OTUxMTYzNTE2Mg_0024e0c8-0e43-484f-ac4b-5ae6c26c732f">38,000</ix:nonFraction>, all of which was employee related, was recognized due to changes in estimates in performance stock unit performance measures and reductions in headcount. For the nine months ended March 31, 2022, compensation of $<ix:nonFraction unitRef="usd" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNjcyOA_24041aac-46c8-4b6f-97f1-b8c30f50ff07">1.4</ix:nonFraction> million was reflected as an increase to additional</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> paid-in capital, all of which was employee related. Fo</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r the three and nine months ended March&#160;31, 2021, stock-based compensation of $<ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNjg4NA_6c2d701a-d793-4f0e-aaaa-9292b581d85d">0.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNjg5MQ_3ccb9228-182e-4bdd-be10-7cc435579d70">2.2</ix:nonFraction> million, respectively, was reflected as an increase to additional paid-in capital and a decrease of <ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="-3" sign="-" name="lfvn:SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNjk4Ng_069bf980-264d-4a1a-9510-10f9164a9efb">17,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="-5" sign="-" name="lfvn:SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNjk5Mw_dd57f65a-20a9-41da-8024-2fb6626dd671">0.1</ix:nonFraction> million, respectively, was included in other accrued expenses, all of which was employee related.</span></div></ix:continuation><div id="i41e77726867840e39498d8f5bb503840_61"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8 &#8212; <ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:LossContingencyDisclosures" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF82MS9mcmFnOmQzNTY0YTg1Yzk5NTQyNTc5OWUxNWZmNDdmMzFlMWQxL3RleHRyZWdpb246ZDM1NjRhODVjOTk1NDI1Nzk5ZTE1ZmY0N2YzMWUxZDFfODQxOA_7d7362c1-92ff-4934-af0f-c0c0dd8fb953" continuedAt="i590a9ddc19914d549422c11b07a2e09b" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="i590a9ddc19914d549422c11b07a2e09b" continuedAt="ibae6ced4c780477f958e9e571610b9fd"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company accounts for contingent liabilities in accordance with ASC 450, Contingencies. This guidance requires management to assess potential contingent liabilities that may exist as of the date of the financial statements to determine the probability and amount of loss that may have occurred, which inherently involves an exercise of judgment. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company&#8217;s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. For loss contingencies considered remote, no accrual or disclosures are generally made. Management has assessed potential contingent liabilities as of  March&#160;31, 2022, and based on the assessment, there are no probable loss contingencies requiring accrual or disclosures within its financial statements.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Accruals</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations in the ordinary course of business, from time to time, the Company is subject to various claims, pending and potential legal actions, investigations relating to governmental laws and regulations and other matters arising out of the normal conduct of its business. Management assesses contingencies to determine the degree of probability and range of possible loss for potential accrual in the consolidated financial statements. An estimated loss contingency is accrued in the consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because evaluating legal claims and litigation results are inherently unpredictable and unfavorable results could occur, assessing contingencies is highly subjective and requires judgments about future events. When evaluating contingencies, management may be unable to provide a meaningful estimate due to a number of factors, including the procedural status of the matter in question, the presence of complex or novel legal theories, and/or the ongoing discovery and development of information important to the matters. In addition, damage amounts claimed or asserted against the Company may be unsupported, exaggerated or unrelated to possible outcomes, and as such are not meaningful indicators of a potential liability. Management regularly reviews contingencies to determine the adequacy of financial statement accruals and related disclosures. The amount of ultimate loss may differ from these estimates. It is possible that cash flows or results of operations could be materially affected in any particular period by the unfavorable publicity or resolution of one or more of these contingencies. Whether any losses finally determined in any claim, action, investigation or proceeding or publicity related to such could reasonably have a material effect on the Company's business, financial condition, results of operations or cash flows will depend on a number of variables, including: the timing and amount of such losses; the structure and type of any remedies; the significance of the impact of any such losses, damages or remedies may have on the consolidated financial statements; and the unique facts and circumstances of the particular matter that may give rise to additional factors.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Class Action Lawsuit (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Smith v. LifeVantage Corp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On January 24, 2018, a purported class action was filed in the United States District Court for the District of Connecticut, entitled Smith v. LifeVantage Corp., Case No. 3:18-cv-a35 (D. Connecticut filed Jan. 24, 2018). In this action, Plaintiffs alleged that the Company, its Chief Executive Officer, Chief Sales Officer and Chief Marketing Officer operated a pyramid scheme in violation of a variety of federal and state statutes, including RICO and the Connecticut Unfair Trade Practices Act. On April 16, 2018, the Company filed motions with the court to dismiss the complaint against LifeVantage, dismiss the complaint against the Company's executives, transfer the venue of the case from the State of Connecticut to the State of Utah, and contest class certification. On July 23, 2018, the parties filed a stipulation with the Court agreeing to transfer the case to the Federal District Court for Utah. On September 20, 2018, Plaintiffs filed an amended complaint in Utah. As per the parties stipulated agreement, Plaintiffs' amended complaint dropped the RICO and Connecticut state law claims and removed the Company's Chief Sales Officer and Chief Marketing Officer as individual defendants (the former Chief Executive Officer remains a defendant in the case). The Plaintiffs' amended complaint added an antitrust claim, alleging that the Company fraudulently obtained patents for its products and is attempting to use those patents in an anti-competitive manner. The Company filed a Motion to Dismiss the amended complaint on November 5, 2018, Plaintiffs filed a response to the Company&#8217;s Motion to Dismiss on December 17, 2018, and the Company filed a reply brief on January </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibae6ced4c780477f958e9e571610b9fd" continuedAt="i1060ab4446b74f56832e79ce9e2af891">10, 2019. The Court ruled on the motion on December 5, 2019, dismissing <ix:nonFraction unitRef="claim" contextRef="i7b7712dd2ecf4cc990ccba081959ed4a_D20191205-20191205" decimals="INF" name="us-gaap:LossContingencyClaimsDismissedNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF82MS9mcmFnOmQzNTY0YTg1Yzk5NTQyNTc5OWUxNWZmNDdmMzFlMWQxL3RleHRyZWdpb246ZDM1NjRhODVjOTk1NDI1Nzk5ZTE1ZmY0N2YzMWUxZDFfMzg0ODI5MDcwNTYzOA_4f4f2f9b-f6f7-4dc8-be89-b764d6240d50">three</ix:nonFraction> of the Plaintiff's <ix:nonFraction unitRef="claim" contextRef="ic9473e77deb447f2b4bcc4e5432b8e7b_I20191205" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF82MS9mcmFnOmQzNTY0YTg1Yzk5NTQyNTc5OWUxNWZmNDdmMzFlMWQxL3RleHRyZWdpb246ZDM1NjRhODVjOTk1NDI1Nzk5ZTE1ZmY0N2YzMWUxZDFfMzg0ODI5MDcwNTYzOQ_d3493b3a-8c28-407e-bdaa-4ea0aa3daaf9">four</ix:nonFraction> claims, including the antitrust claim, unjust enrichment claim, and the securities claim for the sale of unregistered securities. On December 19, 2019, Plaintiffs filed a second amended complaint which included three causes of action, including a 10(b)(5) securities fraud claim, and renewed claims relating to the sale of unregistered securities and unjust enrichment. LifeVantage filed a Motion to Dismiss the Second Amended Complaint on January 28, 2020, and with the Motion fully briefed by the parties as of March 17, 2020, the Court decided the matter on the parties&#8217; briefs only on November 25, 2020. In its decision, the Court dismissed with prejudice the Plaintiffs&#8217; Section 12(1) claim (sale of an unregistered security), because the Court concluded the claim is time barred. The Court also dismissed the Plaintiffs&#8217; claim for unjust enrichment against LifeVantage without prejudice, and the Plaintiffs did not amend their complaint following the Court&#8217;s order to re-plead unjust enrichment. The court found that the Plaintiffs had sufficiently pled their claim under Section 12(2) (offer to sell a security that misstates or omits a material fact by means of a prospectus or oral communication). LifeVantage filed its Answer to the Second Amended Complaint on December 23, 2020, responding to the Plaintiffs&#8217; remaining securities claims. On February 2, 2021, the Court issued an amended scheduling order that reflects the parties&#8217; agreement on a schedule for discovery and other litigation matters. On June 15, 2021, the plaintiffs filed their motion for class certification, and on July 13, 2021, the defendants, including LifeVantage Corporation, filed their opposition brief that opposed class certification. On July 27, 2021, the Plaintiffs filed their reply to LifeVantage&#8217;s opposition brief. The court held a hearing for the motion for class certification on March 28, 2022. On April 19, 2022, the court issued an order denying the Plaintiff&#8217;s motion for class certification. The Company has not established a loss contingency accrual for this lawsuit as it believes liability is not probable or estimable, and the Company plans to vigorously defend against this lawsuit. Nonetheless, an unfavorable resolution of this matter could have a material adverse effect on the Company's business, results of operations or financial condition.</ix:continuation></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><ix:continuation id="i1060ab4446b74f56832e79ce9e2af891" continuedAt="i2d41d44a6667417fb5f9721b799bcf64"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Matters.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">    </span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2d41d44a6667417fb5f9721b799bcf64">In addition to the matters described above, the Company also may become involved in other litigation and regulatory matters incidental to its business and the matters disclosed in this quarterly report on Form 10-Q, including, but not limited to, product liability claims, regulatory actions, employment matters and commercial disputes. The Company intends to defend itself in any such matters and does not currently believe that the outcome of any such matters will have a material adverse effect on the Company's business, financial condition, results of operations and cash flows.</ix:continuation> </span></div><div id="i41e77726867840e39498d8f5bb503840_64"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9 &#8212; <ix:nonNumeric contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF82NC9mcmFnOmE1ZmU3MWFlNmExMjQ4NGI4M2I3MDQ0MWQ2Zjk0OTJhL3RleHRyZWdpb246YTVmZTcxYWU2YTEyNDg0YjgzYjcwNDQxZDZmOTQ5MmFfNDk5_333a0167-cc36-482f-8ec5-59dfad2dc270" continuedAt="i1e0de8197d6340a68d28c72f787f5aa1" escape="true">Related Party Transactions</ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><ix:continuation id="i1e0de8197d6340a68d28c72f787f5aa1"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into a series of agreements with GEG for outsourced software application development services. The Company and GEG have also entered into a common stock purchase agreement. For discussion related to the common stock purchase agreement, see Note 3. <ix:nonFraction unitRef="member" contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331" decimals="INF" name="lfvn:MembersOfBoardOfDirectorsServingOnRelatedPartyBoardOfDirectors" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF82NC9mcmFnOmE1ZmU3MWFlNmExMjQ4NGI4M2I3MDQ0MWQ2Zjk0OTJhL3RleHRyZWdpb246YTVmZTcxYWU2YTEyNDg0YjgzYjcwNDQxZDZmOTQ5MmFfMzEz_f086584c-2d00-43b3-904a-d9f156902bb5">Two</ix:nonFraction> members of the Company's board of directors serve on the GEG board of directors.  <ix:nonFraction unitRef="usd" contextRef="i8dd65cec87d94d2897061c2f0b29f444_D20220101-20220331" decimals="INF" name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF82NC9mcmFnOmE1ZmU3MWFlNmExMjQ4NGI4M2I3MDQ0MWQ2Zjk0OTJhL3RleHRyZWdpb246YTVmZTcxYWU2YTEyNDg0YjgzYjcwNDQxZDZmOTQ5MmFfMzk4_3ec35094-856e-46c0-8499-90ffce56f060"><ix:nonFraction unitRef="usd" contextRef="i74cd73657787445193edd1ca4da3a419_D20210701-20220331" decimals="INF" name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF82NC9mcmFnOmE1ZmU3MWFlNmExMjQ4NGI4M2I3MDQ0MWQ2Zjk0OTJhL3RleHRyZWdpb246YTVmZTcxYWU2YTEyNDg0YjgzYjcwNDQxZDZmOTQ5MmFfMzk4_515b9581-c2b1-4d88-800e-2a82060ad41f"><ix:nonFraction unitRef="usd" contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331" decimals="INF" name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF82NC9mcmFnOmE1ZmU3MWFlNmExMjQ4NGI4M2I3MDQ0MWQ2Zjk0OTJhL3RleHRyZWdpb246YTVmZTcxYWU2YTEyNDg0YjgzYjcwNDQxZDZmOTQ5MmFfMzk4_85ff9ab9-b16b-4f5a-b787-f654bdb79415"><ix:nonFraction unitRef="usd" contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331" decimals="INF" name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF82NC9mcmFnOmE1ZmU3MWFlNmExMjQ4NGI4M2I3MDQ0MWQ2Zjk0OTJhL3RleHRyZWdpb246YTVmZTcxYWU2YTEyNDg0YjgzYjcwNDQxZDZmOTQ5MmFfMzk4_86580868-814e-4b5a-851d-9d7ec5aff3ff">No</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> payments were made to GEG for software and application development service during the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and nine months ended March&#160;31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></ix:continuation></div><div id="i41e77726867840e39498d8f5bb503840_67"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div id="i41e77726867840e39498d8f5bb503840_70"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a company focused on nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. We are dedicated to helping people achieve their health, wellness and financial goals. We provide quality, scientifically-validated products to customers an</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d independent distributors as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">well as a financially rewarding commission-based direct sales opportunity to our independent distributors. We engage in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath &amp; body, and targeted relief products. We currently sell our products to customers and independent distributors in two geographic regions that we have classified as the Americas region and the Asia/Pacific &amp; Europe region.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:23.04pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success and growth of our business is primarily based on the effectiveness of our independent distributors to attract and retain customers in order to sell our products and our ability to attract and retain independent distributors. When we are successful in attracting and retaining independent distributors and customers, it is largely because of:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Our products, including our flagship Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> family of scientifically-validated dietary supplements, LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Omega+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ProBio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, IC Bright</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Daily Wellness</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> dietary supplements, our line of Nrf2 enhanced TrueScience&#174; skin, hair, bath &amp; body, and targeted relief products, Petandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our companion pet supplement formulated to combat oxidative stress in dogs, Axio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our nootropic energy drink mixes, and PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our smart weight management system.;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Our sales compensation plan and other sales initiatives and incentives; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Our delivery of superior customer service.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, it is vital to our success that we leverage our product development resources to develop and introduce compelling and innovative products and provide opportunities for our independent distributors to sell these products in a variety of markets. We sell our products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. In addition, we sell our products in a number of countries to customers for personal consumption only and in China through a China approved cross-border e-commerce business model. Entering a new market requires a considerable amount of time, resources and continued support. If we are unable to properly support an existing or new market, our revenue growth may be negatively impacted.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of COVID-19 on Our Business</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pandemic caused by an outbreak of a new strain of coronavirus (&#8220;COVID-19&#8221;) has resulted, and is likely to continue to result, in significant national and global economic disruption and may adversely affect our business. Uncertainty exists concerning the magnitude of the impact and duration of the COVID-19 pandemic. As of the date of this filing, we have experienced moderate disruptions at the corporate level as we have transitioned our corporate workforce to a hybrid working environment, temporarily closed some of our showrooms and will call locations in international markets and cancelled multiple planned events in order to comply with group meeting restrictions. Our independent distributors have also experienced disruptions. Specifically, in Japan, independent distributors are required to provide a hard-copy introductory packet (gaiyoshomen) in person to each person they approach to sponsor as an independent distributor before presenting our products and business opportunity. This requirement inhibits independent distributors from connecting with potential new independent distributors virtually or through social media. Accordingly, quarantines, avoidance of public places and general concerns about physical distancing related to COVID-19 or otherwise can significantly reduce the ability for independent distributors to meet people in person and commence the enrollment process. Elsewhere, our independent distributors have begun to adapt their approach for customer outreach and enrollment, including transitioning to a stronger social media presence, in an effort to sustain their sales volume. Our business may, in the future, experience additional disruptions and be negatively impacted by the COVID-19 pandemic, including as a result of limitations on the ability of our suppliers to manufacture, or procure from manufacturers, the products we sell or any of the raw materials or components required in the production process, or to meet delivery requirements and commitments; limitations on the ability of our employees to perform their work due to illness caused by the pandemic or local, state, or federal orders requiring employees to remain at home; limitations on the ability of carriers to deliver our products to customers; limitations on the ability of our independent distributors to conduct their businesses and purchase our products; and limitations on the ability of our independent distributors or customers to continue to purchase our products due to decreased disposable income.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made modifications, and are evaluating additional potential modifications that may be needed, to protect our supply chain and preserve adequate liquidity to ensure that our business can continue to operate during this uncertain time. Some states have issued executive orders requiring all workers to remain at home, unless their work is critical, essential, or life-sustaining. Near the end of fiscal 2020 we transitioned all of our corporate employees to a work from home model and beginning July 2021 we transitioned our workforce to a hybrid model whereby employees work certain days of the week in the office and other days have the option to work from home or in the office. To date, our employees are performing and adapting well with the evolving environment. With respect to liquidity, we are evaluating and taking actions to ensure that we continue to responsibly manage expenses across our organization.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we are unable to determine or predict the nature, duration or scope of the overall impact that the COVID-19 pandemic will have on our business, results of operations, liquidity or capital resources, we will continue to actively monitor the situation and may take further actions that alter our business operations as may be required by federal, state or local authorities or that we determine are in the best interests of our employees, independent distributors, customers, and stockholders.</span></div><div id="i41e77726867840e39498d8f5bb503840_73"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Products</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products include the Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> line of scientifically-validated dietary supplements, LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Omega+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ProBio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, IC Bright</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Daily Wellness</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> dietary supplements, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our line of skin, bath &amp; body, target relief, and hair care products, Petandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our companion pet supplement formulated to combat oxidative stress in dogs, Axio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our nootropic energy drink mixes, and PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our smart weight management system. The Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> product line includes Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> NRF1 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NAD Synergizer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Protandim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> NRF1 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is formulated to increase cellular energy and performance by boosting mitochondria production to improve cellular repair and slow cellular aging. The Protandim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> contains a proprietary blend of ingredients and has been shown to combat oxidative stress and enhance energy production by increasing the body&#8217;s natural antioxidant protection at the genetic level, inducing the production of naturally-occurring protective antioxidant enzymes, including superoxide dismutase, catalase, and glutathione synthase. The Protandim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> NAD Synergizer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was specifically formulated to target cell signaling pathways involved in the synthesis and recycling of a specific molecule c</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">alled NAD (nicotinamide adenine dinucleotide), and has been shown to double sirtuin activity, supporting increased health, focus, energy, mental clarity and mood. Use of the three </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products together has been shown to produce synergistic benefits greater than using the single products on their own. LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Omega+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and Vitamin D3 to support cognitive health, cardiovascular health, skin health, and the i</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mmune system. LifeVantage</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ProBio is a dietary supplement designed to support optimal digestion and immune system function. LifeVantage</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> IC Bright</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> combines macular carotenoids with vitamins and key ingredients that effectively support eye and brain health. LifeVa</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ntage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Daily Wellness</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a dietary supplement designed to support and strengthen immune health. Our TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> line of anti-aging skin and hair care, and CBD Nrf2 enhanced, bath &amp; body, targeted relief products includes TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Facial Cleanser, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Perfecting Lotion, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Eye Serum, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Anti-Aging Cream, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Beauty Serum, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Hand Cream, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Invigorating Shampoo, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Nourishing Conditioner, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Scalp Serum, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Body Lotion, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Body Wash, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Body Butter, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Deodorant, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Soothing Balm, and TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Body Rub. Petandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a supplement specially formulated to combat oxidative stress in dogs through Nrf2 activation. Axio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is our line of our nootropic energy drink mixes formulated to promote alertness and support mental performance. PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is our smart weight management system, which includes PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fat Burn, PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Prebiotic and PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Whey Protein, all formulated to aid in weight management.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell our products both individually and in stacks. A stack consists of multiple products bundled together that are designed to achieve a specific result. By studying the effects of nutrients and natural compounds, we have developed scientifically-backed nutrigenomics products that promote healthy aging on the cellular level. By stacking these products together, we have created a foundation for synergy from nutrigenomic products to promote a healthier life. The Vitality Stack</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> includes four of our nutrigenomics products &#8212; Protandim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> NRF1 Synergizer</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Protandim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nrf2 Synergizer</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, LifeVantage</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Omega+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and LifeVantage</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ProBio. This product stack was designed to provide a foundation for wellness, supporting healthy organs, including the brain, heart, eyes, and other vitals. With the Ultimate Stack</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we added Protandim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> NAD Synergizer</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and PhysIQ</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Prebiotic to our Vitality Stack</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to support gut health and increase sirtuin activity, supporting increased health, focus, energy, mental clarity and mood. The Protandim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Tri-Synergizer</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consists of our Protandim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> NRF1 Synergizer</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Protandim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Protandim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> NAD Synergizer</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and was designed to effectively and synergistically reduce oxidative stress, support mitochondria function, increase sirtuin activity, and target cell signaling pathways to fight the effects of aging. We also offer stacks that directly support the following consumer needs: immune support, heart health, energy, well-being, eye health, cognition and memory, metabolism, gut health, skin care, and hair care.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently have additional products in development. Any delays or difficulties in intr</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">oducing compelling products or attractive initiatives or tools into our markets may have a negative impact on our revenue and our ability to attract new independent distributors and customers. </span></div><div id="i41e77726867840e39498d8f5bb503840_76"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we utilize a direct selling model for the distribution of a majority of our products, the success and growth of our business is primarily based on the effectiveness of our independent distributors to attract customers and sell our products and our ability to attract new and retain existing independent distributors. Changes in our product sales typically are the result of variations in product sales volume relating to fluctuations in the number of active independent distributors and customers purchasing our products. The number of active independent distributors and customers is, therefore, used by management as a key non-financial measure.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the changes in our active accounts base by geographic region. These numbers have been rounded to the nearest thousand as of the dates indicated. For purposes of this report, we define &#8220;Active Accounts&#8221; as only those independent distributors and customers who have purchased from us at any time during the most recent three-month period, either for personal use or for resale.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:30.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.654%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change from Prior Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Active Independent Distributors</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Americas</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Asia/Pacific &amp; Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total Active Independent Distributors</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Active Customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Americas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Asia/Pacific &amp; Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total Active Customers</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,000)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Active Accounts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Americas</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Asia/Pacific &amp; Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total Active Accounts</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,000)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div id="i41e77726867840e39498d8f5bb503840_79"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three and Nine Months ended March&#160;31, 2022 and 2021</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We generated net revenue of $50.0 million and $51.6 million during the three months ended March 31, 2022 and 2021, respectively. We generated net revenue of $155.4 million and $165.4 million during the nine months ended March 31, 2022 and 2021, respectively.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Foreign currency fluctuations negatively impacted our revenue $1.2 million or 2.4%  and $2.4 million or 1.4% during the three and nine months ended March&#160;31, 2022, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Americas</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The following table sets forth revenue for the three and nine months ended March&#160;31, 2022 and 2021 for the Americas region (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.209%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.581%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,068&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,868&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,593&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,444&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,421&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,600&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,979&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Re</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">venue in the Americas region for the three and nine months ended March&#160;31, 2022 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">decreased $3.0 million or 8.2% and $12.4 million or 10.6%, respectively, from the prior year periods. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Active Accounts decreased by 10.7% in the region compared to the prior year period which drove the decrease in revenue</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our Independent Distributors have been forced to continually adapt to the changing business and social environments due to the COVID-19 pandemic. We remain committed to providing digital tools and support to our distributors to help them grow their businesses despite difficulties with in person meetings and events and are rolling out new hybrid in person and virtual meeting opportunities to provide better training and business support to our distributors.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Asia/Pacific &amp; Europe</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The following table sets forth revenue for the three and nine months ended March&#160;31, 2022 and 2021 for the Asia/Pacific &amp; Europe region and its principal markets (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.209%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.581%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,724&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,622&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,558&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,172&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia &amp; New Zealand</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,840&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,099&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia/Pacific &amp; Europe Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,560&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,149&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,818&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,426&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue in the Asia/Pacific &amp; Europe region increased $1.4 million or 9.3% and $2.4 million or 4.9% for the three and nine months ended March&#160;31, 2022 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively, as com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pared to the prior year periods. Active Accounts in the region increased 4.3% compared to the prior year</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> period.  We continue to be encouraged by the results we are seeing in our Australia and New Zealand region due to continued distributor leadership development and advancement within the region. The launch of Philippines has also shown encouraging results. Japan revenues continue to be down as compared to the prior year period due to continued restrictions in place for in person meetings and recruiting due to the COVID-19 pandemic and impacts from foreign currency exchange rate fluctuations.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overall, revenue in the Asia/Pacific &amp; Europe region was negatively impacted by foreign currency exchange rate fluctuations in the amount of approximately $1.2 million or 8.1% and $2.5 million or 5.3% during the three and nine months ended March&#160;31, 2022, respectively, as compared to the prior year periods, mainly due to currency fluctuations in Japan, partially offset by currency benefits in other markets within the region. Revenue in Japan was negatively impacted by foreign exchange rate fluctuations in the amount of approximately $0.8 million or 8.8% and $2.1 million or 6.8%, during the three and nine months ended March&#160;31, 2022, respectively, as compared to the prior year periods. On a constant currency basis, revenue in Japan increased 0.1% and decreased 0.3% for the three and nine months ended March&#160;31, 2022 and 2021, respectively, as compared to the prior year periods. </span></div><div style="text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Globally, our sales and marketing efforts continue to be directed toward strengthening our core business through our fiscal year initiatives and building our worldwide revenue. In October 2021, we held our first major event with both in person and virtual attendance options since the start of the COVID-19 global pandemic and we plan to hold additional in person meetings throughout the year as we are able. During our October 2021 global convention, we launched our new LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> IC Bright</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> eye health product and have plans for both continued product expansion and future market expansion during the remaining fiscal 2022. We expect this launch and other continued expansion will drive revenue growth globally through increased average order size and increased ability to attract and retain new independent distributors and customers with a compelling product lineup.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gross Margin. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our gross profit percentage for the three months ended March 31, 2022 and 2021 was 80.7% and 82.9%, respectively. Our gross profit percentage for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended March 31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2021 was 81.5% and 82.8%, respectively. The decrease in gross margins, as compared to the prior year periods, is primarily due to increased inventory obsolescence expenses and increased shipping to customer expenses during the current year period as well as shifts in geographic and product sales mix. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commissions and Incentives.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Commissions and incentives expenses during the three months ended March 31, 2022 were $23.2 million or 46.4% of revenue as compared to $25.2 million or 48.8% of revenue for the three months ended March 31, 2021. Commissions and incentives expenses during the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended March 31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> were $72.8 million or 46.8% of revenue as compared to $77.9 million or 47.1% of revenue for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended March 31, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The decrease in commissions and incentives expenses as a percentage of revenue as compared to the prior periods is due mainly to the timing and magnitude of our various promotional and incentive programs. Commissions and incentives expenses, as a percentage of revenue, may fluctuate in future periods based on ability to hold incentive trips and events and the timing and magnitude of compensation, incentive and promotional programs.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Selling, general and administrative expenses during the three months ended March 31, 2022 were $15.3 million or 30.6% of revenue as compared to $15.5 million or 30.1% of revenue for the three months ended March 31, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Selling, general and administrative expenses during the nine months ended March 31, 2022 were $47.8 million or 30.8% of revenue as compared to $48.0 million or 29.0% of revenue for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended March 31, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The increase in selling, general and administrative expenses as a percentage of revenue during the three and nine months ended March&#160;31, 2022 compared to the prior year periods is primarily due to increased event and travel expenses as restrictions related </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the COVID-19 pandemic have begun to ease as well as increased legal expenses. These increases were offset slightly by decreases in salaries and wages and other employee related expenses. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect selling, general and administrative expenses, as a percent of revenue, to remain steady during the remainder of the fiscal year.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Total Other Expens</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended March 31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> we recognized total net other expense of $0.1 million as compared to $0.3 million for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended March 31, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended March 31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we recognized total net other expense of $0.4 million as compared to $0.3 million for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended March 31, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net other expense for the three and nine months ended March&#160;31, 2022 and 2021 consisted primarily of foreign currency losses and interest expense. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Tax Expense</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We recognized income tax expense of $0.6 million and $1.1 million, respectively, for the three and nine months ended March&#160;31, 2022, as compared to income tax expense of $0.1 million and $2.8 million, respectively, for the three and nine months ended March&#160;31, 2021.</span></div><div style="text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The effective tax rate was 20.2% of pre-tax income during the nine months ended March 31, 2022, compared to 25.7% for the prior year period. The change in the tax rate for the nine months ended March 31, 2022 was mainly due to a change in estimate in our calculations of foreign-derived intangible income (&#8220;FDII&#8221;) and foreign tax credits (&#8220;FTC&#8221;).  The specific allocation of costs attributable foreign and domestic income led to an increase in the FDII deduction as well as the FTC limitation.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that our effective tax rate will fluctuate slightly during the remainder of fiscal 2022 as the impact of discrete items and other permanent differences are recognized during the year; however, our tax rate can be impacted by various book to tax differences and fluctuations in our stock price that occur during the year which are difficult to forecast.</span></div><div id="i41e77726867840e39498d8f5bb503840_82"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Liquidity</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary liquidity and capital resource requirements are to finance the cost of our planned operating expenses and working capital (principally inventory purchases), fund capital expenditures, and service our debt, which includes any outstanding balances under the 2016 Credit Facility. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have generally relied on cash flow from operations to fund operating activities and we have, at times, incurred long-term debt in order to fund stock repurchases and strategic transactions.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, our available liquidity was $17.8 million, which consisted of available cash and cash equivalents. This represents a decrease of $5.4 million from the $23.2 million in cash and cash equivalents as of June&#160;30, 2021. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended March&#160;31, 2022, our net cash provided by operating activities was $5.2 million as compared to our net cash provided by operating activities of $7.9 million during the nine months ended March&#160;31, 2021.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended March&#160;31, 2022, our net cash used in investing activities was $1.3 million, as a result of the purchase of fixed assets. During the nine months ended March&#160;31, 2021, our net cash used in investing activities was $3.3 million, as a result of the purchase of fixed assets.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in financing activities during the nine months ended March&#160;31, 2022 was $8.1 million as a result of our repurchase of common stock and shares purchased as payment of tax withholding upon vesting of equity awards, partially offset by proceeds from stock issued under our employee stock purchase plan and stock option exercises. Cash used in financing activities during the nine months ended March&#160;31, 2021 was $7.8 million as a result of our repurchas</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e of common stock, and shares purchased as payment of tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">withholding upon vesting of equity awards, partially offset by proceeds from stock issued under our employee stock purchase plan and stock option exercises.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022 and June&#160;30, 2021, the total amount of our foreign subsidiary cash </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was $8.9 million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $8.8 million, respectively. The federal tax reform legislation that was passed into law during December 2017 enacted a 100% dividend deduction for &gt; 10% owned foreign corporations. Therefore, in the future, if needed, we expect to be able to repatriate cash from foreign subsidiaries without paying additional U.S. taxes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022, we had working capital (current assets minus current liabilities) of $21.5 million, compared to working capital of $22.9 million at June&#160;30, 2021. We believe that our cash and cash equivalents balances and our ongoing cash flow from operations will be sufficient to satisfy our cash requirements for at least the next 12 months. The majority of our historical expenses have been variable in nature and as such, a potential reduction in the level of revenue would reduce our cash flow needs. In the event that our current cash balances and future cash flow from operations are not sufficient to meet our obligations or strategic needs, we would consider raising additional funds, which may not be available on terms that are acceptable to us, or at all. Our credit facility, however, contains covenants that restrict our ability to raise additional funds in the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">debt markets and repurchase our equity securities without prior approval from the lender. Additionally, our credit facility, as amended, provides for a revolving loan facility in an aggregate principal amount up to $5.0 million. We would also consider realigning our strategic plans including a reduction in capital spending and expenses.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Capital Resources</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shelf Registration Statement</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 24, 2020, we filed a shelf registration statement (the "Shelf Registration") on Form S-3 with the SEC that was declared effective April 3, 2020, which permits us to offer up to $75 million of common stock, preferred stock, debt securities and warrants in one or more offerings and in any combination, including in units from time to time. Our Shelf Registration is intended to provide us with additional flexibility to access capital markets for general corporate purposes, which may include, among other purposes, working capital, capital expenditures, other corporate expenses and acquisitions of assets, licenses, products, technologies or businesses.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2016 Credit Facility</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;30, 2016, we entered into a loan agreement (the &#8220;2016 Loan Agreement&#8221;) to refinance our outstanding debt. In connection with the 2016 Loan Agreement and on the same date, we entered into a security agreement (the &#8220;Security Agreement&#8221;). The 2016 Loan Agreement provides for a term loan in an aggregate principal amount of $10.0 million (the &#8220;2016 Term Loan") and a revolving loan facility in an aggregate principal amount not to exceed $2.0 million (the &#8220;2016 Revolving Loan,&#8221; and collectively with the 2016 Term Loan, the 2016 Loan Agreement and the Security Agreement, the &#8220;2016 Credit Facility&#8221;). </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal amount of the 2016 Term Loan was payable in consecutive quarterly installments in the amount of $0.5 million plus accrued interest beginning with the fiscal quarter ended June&#160;30, 2016. If we borrow under the 2016 Revolving Loan, interest will be payable quarterly in arrears on the last day of each fiscal quarter.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;4, 2018, we entered into a loan modification agreement, which amended the 2016 Credit Facility (&#8220;Amendment No. 1&#8221;). Amendment No. 1 revised the maturity date from March&#160;30, 2019 to March&#160;31, 2021 and increased the fixed interest rate for the term loan from 4.93% to 5.68%. Amendment No. 1 also revised certain financial covenants. The minimum fixed charge coverage ratio (as defined in Amendment No. 1) was revised from a minimum of 1.50 to 1.00 to 1.25 to 1.00, measured on a trailing twelve-month basis, at the end of each fiscal quarter. The minimum working capital was increased from $5.0 million to $8.0 million. The funded debt to EBITDA ratio was replaced with the total liabilities to tangible net worth ratio (as defined in Amendment No. 1) of not greater than 3.00 to 1.00 at the end of each quarter. The minimum tangible net worth measure was removed from the financial covenants.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2019, we entered into a loan modification agreement, which further amended the 2016 Credit Facility ("Amendment No. 2"). Under Amendment No. 2, we made a principal payment of $2.0 million and increased the revolving loan facility from $2.0 million to $5.0 million. Amendment No. 2 also revised certain financial covenants. The minimum fixed charge coverage ratio (as defined in Amendment No. 2) was revised from a minimum of 1.25 to 1.00 to 1.10 to 1.00, measured on a trailing twelve-month basis, at the end of each fiscal quarter. The minimum working capital was decreased from $8.0 million to $6.0 million.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;1, 2021, we entered into a loan modification agreement ("Amendment No. 3"), which amended the 2016 Credit Facility, as previously amended. Amendment No. 3 revised the maturity date from March&#160;31, 2021 to March&#160;31, 2024 and modified the variable interest rate based on the one-month United States Treasury Rate, plus a margin of 3.00%, with an interest rate floor of 4.00%. Amendment No. 3 also revised the debt (total liabilities) to tangible net worth ratio (as defined in Amendment No. 3) covenant to require that we maintain this ratio not in excess of 2.00 to 1.00, measured as of the end of each fiscal quarter, and revised the definition and calculation of the minimum fixed charge coverage ratio (as defined in Amendment No. 3).  There were no other changes to the covenants or revolving loan facility amount as set forth in Amendment No. 2.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2016 Credit Facility, as amended, contains customary covenants, including affirmative and negative covenants that, among other things, restrict our ability to create certain types of liens, incur additional indebtedness, declare or pay dividends on or redeem capital stock, make other payments to holders of our equity interests, make certain investments, purchase or otherwise acquire all or substantially all the assets or equity interests of other companies, sell assets or enter into consolidations, mergers or transfers of all or any substantial part of our assets. As of March&#160;31, 2022, we were in compliance with all applicable non-financial and restrictive covenants under the 2016 Credit Facility, as amended. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2016 Credit Facility, as amended, also contains various financial covenants that require us to maintain certain consolidated working capital amounts, total liabilities to tangible net worth ratios and fixed charge coverage ratios. Specifically, we must:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Maintain a minimum fixed charge coverage ratio (as defined in the 2016 Loan Agreement, as amended) of at least 1.10 to 1.00 at the end of each fiscal quarter, measured on a trailing twelve month basis;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Maintain minimum consolidated working capital (as defined in the 2016 Loan Agreement, as amended) at the end of each fiscal quarter of at least $6.0&#160;million; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Maintain a ratio of debt (total liabilities) to tangible net worth (as defined in the 2016 Loan Agreement, as amended) of not greater than 2.00 to 1.00 at the end of each quarter, measured on a trailing twelve month basis.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, we were in compliance with all applicable financial covenants under the 2016 Credit Facility, as amended. Additionally, management anticipates that in the normal course of operations we will be in compliance with the financial covenants during the ensuing year.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal year ended June 30, 2020, we repaid, in full, the remaining balance of the 2016 Term Loan in accordance with the terms of the 2016 Credit Facility, as amended.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Commitments and Obligations</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our contractual payment obligations and commitments as of&#160;March&#160;31, 2022&#160;(in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:41.462%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.654%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payments due by period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contractual Obligations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less&#160;than<br/>1 year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1-3&#160;years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3-5&#160;years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Thereafter</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligations </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,293&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,354&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,077&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,312&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,550&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating obligations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,663&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,724&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,077&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,312&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,550&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Other operating obligations represent contractual obligations primarily related to marketing and sponsorship commitments and purchases of inventory.</span></div><div id="i41e77726867840e39498d8f5bb503840_85"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, we did not have any off-balance sheet arrangements.</span></div><div id="i41e77726867840e39498d8f5bb503840_88"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We prepare our financial statements in conformity with accounting principles generally accepted in the United States of America. As such, we are required to make certain estimates, judgments, and assumptions that we believe are reasonable based upon the information available. These estimates and assumptions affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the periods presented. Actual results could differ from these estimates. Our significant accounting policies are described in Note 2 to our unaudited condensed consolidated financial statements. Certain of these significant accounting policies require us to make difficult, subjective, or complex judgments or estimates. We consider an accounting estimate to be critical if (1)&#160;the accounting estimate requires us to make assumptions about matters that were highly uncertain at the time the accounting estimate was made, and (2)&#160;changes in the estimate that are reasonably likely to occur from period to period, or use of different estimates that we reasonably could have used in the current period, would have a material impact on our financial condition or results of operations.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are other items within our financial statements that require estimation, but are not deemed critical as defined above. Changes in estimates used in these and other items could have a material impact on our financial statements. Management has discussed the development and selection of these critical accounting estimates with our board of directors, and the audit committee has reviewed the disclosures noted below.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Allowances for Product Returns</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record allowances for product returns at the time we ship the product based on estimated return rates. Subject to some exceptions based on local regulations, our return policy is to provide a full refund for product returned within 30 days. After 30 days of purchase, only unopened product that is in a resalable and restockable condition may be returned within twelve months of purchase and shall receive a 100% refund, less a 10% handling and restocking fee and any shipping and handling costs. As of March&#160;31, 2022, our shipments of products sold totaling approxi</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mately $17.6 million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">were subject to the return policy. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We monitor our product returns estimate on an ongoing basis and revise the allowances to reflect our experience. Our allowance for product returns was $0.1 million at March&#160;31, 2022, compared with $0.2 million at June&#160;30, 2021. To date, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">product expiration dates have not played any role in product returns, and we do not expect that they will in the future as it is unlikely that we will ship product with an expiration date earlier than the latest allowable product return date. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inventory Valuation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We value our inventory at the lower of cost or net realizable value on a first-in first-out basis. Accordingly, we reduce our inventories for the diminution of value resulting from product obsolescence, damage or other issues affecting marketability equal to the difference between the cost of the inventory and its net realizable value. Factors utilized in the determination of net realizable value include: (i)&#160;current sales data and historical return rates, (ii)&#160;estimates of future demand, (iii)&#160;competitive pricing pressures, (iv)&#160;new production introductions, (v)&#160;product expiration dates, and (vi)&#160;component and packaging obsolescence.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022 and 2021, we recognized expenses of approximately $0.5 million and $0.2 million, respectively, related to obsolete and slow-moving inventory. During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> March&#160;31, 2022 and 2021, we recognized expenses of approximately $1.0 million and $0.3 million, respectively, related to obsolete and slow-moving inventory. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revenue Recognition</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services are transferred to the customer, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. Sales, value-added, and other taxes that we collect concurrent with revenue-producing activities are excluded from revenue.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock-Based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the fair value approach to account for stock-based compensation in accordance with current accounting guidance. We recognize compensation costs for awards with performance conditions when we conclude it is probable that the performance conditions will be achieved. We reassess the probability of vesting at each balance sheet date and adjust compensation costs based on our probability assessment. For awards with market-based performance conditions, the cost of the awards is recognized as the requisite service is rendered by the employees, regardless of when, if ever, the market-based performance conditions are satisfied.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Research and Development Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expense all of our costs related to research and development activities as incurred.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Legal Accruals</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are occasionally involved in lawsuits and disputes arising in the normal course of business. Management regularly reviews all pending litigation matters in which we are involved and establishes accruals as we deem appropriate for these litigation matters when a probable loss estimate can be made. Estimated accruals require management judgment about future events. The results of lawsuits are inherently unpredictable and unfavorable resolutions could occur. As such, the amount of loss may differ from management estimates.</span></div><div id="i41e77726867840e39498d8f5bb503840_91"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3. Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct business in several countries and intend to continue to grow our international operations. Net revenue, operating income and net income are affected by fluctuations in currency exchange rates and other uncertainties in doing business and selling products in more than one currency. In addition, our operations are exposed to risks associated with changes in social, political and economic conditions inherent in international operations, including changes in the laws and policies that govern international investment in countries where we have operations, as well as, to a lesser extent, changes in U.S. laws and regulations relating to international trade and investment.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Exchange Risk</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended March&#160;31, 2022, approximately 36% of our net revenue was realized outside of the United States. The local currency of each international subsidiary is generally the functional currency. All revenue and expenses are translated at weighted-average exchange rates for the periods reported. Therefore, our reported revenue and earnings will be positively impacted by a weakening of the U.S. dollar and will be negatively impacted by a strengthening of the U.S. dollar. Currency fluctuations, however, have the opposite effect on our expenses incurred outside the United States. Given the large portion of our business derived from Japan, any weakening of the Japanese yen will negatively impact our reported revenue and profits, whereas a strengthening of the Japanese yen will positively impact our reported revenue and profits. Because of the uncertainty of exchange rate fluctuations, it is difficult to predict the effect of these fluctuations on our future business, product pricing and results of operations or financial condition. Changes in various currency exchange rates affect the relative prices at </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which we sell our products. We regularly monitor our foreign currency risks and periodically take measures to reduce the risk of foreign exchange rate fluctuations on our operating results. Additionally, we may seek to reduce our exposure to fluctuations in foreign currency exchange rates through the use of foreign currency exchange contracts. We do not use derivative financial instruments for trading or speculative purposes. At March&#160;31, 2022, we did not have any deriva</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tive instruments. A 10% strengthening of the U.S. dollar compared to all of the foreign currencies in which we transact business would have resulted in a 3.3% decrease of our nine months ended March&#160;31, 2022 revenue, in the amount of $5.1 million.</span></div><div id="i41e77726867840e39498d8f5bb503840_94"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4. Controls and Procedures</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disclosure Controls and Procedures </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act of 1934, as amended) that are designed to ensure that the information required to be disclosed in the reports we file or submit under the Exchange Act of 1934, as amended, is (a)&#160;recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC and (b)&#160;accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. As of the end of the period covered by this quarterly report on Form 10-Q, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness and design and operation of such disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act of 1934, as amended. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were designed and operating effectively as of March&#160;31, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal controls over financial reporting during the quarter ended March&#160;31, 2022 that have materially affected or are reasonably likely to materially affect our internal controls over financial reporting.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An evaluation required by paragraph (d)&#160;of Rules 13a-15 and 15d-15 of the Exchange Act of 1934, as amended, was also performed under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of any change in our internal control over financial reporting that occurred during our last fiscal quarter. That evaluation did not identify any changes in our internal control over financial reporting during the three months ended March&#160;31, 2022&#160;that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inherent Limitations of Internal Control Over Financial Reporting</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the inherent limitations of internal control over financial reporting, including the possibility of collusion or improper management override of controls, material misstatements due to error or fraud may not be prevented or detected on a timely basis. Also, projections of any evaluation of the effectiveness of the internal control over financial reporting to future periods are subject to the risk that the controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div id="i41e77726867840e39498d8f5bb503840_97"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II. Other Information</span></div><div id="i41e77726867840e39498d8f5bb503840_100"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. Legal Proceedings</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 8 to our unaudited condensed consolidated financial statements contained within this quarterly report on Form 10-Q for a discussion of our legal proceedings.</span></div><div id="i41e77726867840e39498d8f5bb503840_103"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A. Risk Factors</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the other information set forth in this report, you should carefully consider the risk factors discussed in &#8220;Part I. Item 1A &#8212; Risk Factors&#8221; in our annual report on Form 10-K for the fiscal year ended June 30, 2021, filed on August 19, 2021. The risks and uncertainties described in such risk factors and elsewhere in this report have the potential to materially affect our business, financial condition, results of operations, cash flows, projected results and future prospects. We do not believe that there have been any material changes to the risk factors previously disclosed in our recent SEC filings, including our most recently filed Form 10-K, as referenced above.</span></div><div id="i41e77726867840e39498d8f5bb503840_106"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 27, 2017, our Board of Directors approved a stock repurchase plan, as amended on February 1, 2019, August 27, 2020, and February 17, 2022. Under the plan, we are authorized to repurchase up to $60.0 million of our outstanding shares through November 30, 2023. The repurchase program permits us to purchase shares from time to time through a variety of methods, including in the open market, through privately negotiated transactions or other means as </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">determined by our management, in accordance with applicable securities laws. As part of the repurchase program, we have entered into a pre-arranged stock repurchase plan which operates in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Accordingly, any transactions under such stock repurchase plan will be completed in accordance with the terms of the plan, including specified price, volume and timing conditions. The authorization may be suspended or discontinued at any time. During the three months ended March 31, 2022, we repurchased 0.3 million shares of our common stock on the open market at an aggregate purchase price of $1.7 million under this repurchase program.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information with respect to all purchases&#160;made by the Company during the three months ended March 31, 2022. All purchases listed below were made in the&#160;open market at prevailing market prices.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:23.053%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.162%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.014%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.162%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.165%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of Shares Purchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price Paid Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maximum Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1 - January 31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,861,972&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1 - February 28</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,314,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1 - March 31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,133,664&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326,288&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326,288&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1) Adjusted to account for the increase in the authorized share repurchase amount approved by our Board of Directors on February 17, 2022.</span></div><div id="i41e77726867840e39498d8f5bb503840_109"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3. Defaults Upon Senior Securities</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i41e77726867840e39498d8f5bb503840_112"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4. Mine Safety Disclosures</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i41e77726867840e39498d8f5bb503840_115"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;5. Other Information</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">None.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="i41e77726867840e39498d8f5bb503840_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6. Exhibits</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.029%"><tr><td style="width:1.0%"></td><td style="width:8.130%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.594%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Document Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filed Herewith or Incorporate by Reference From</span></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/849146/000084914618000046/ex31-certificateofincorpor.htm">Certificate of Incorporation, as filed with the Delaware Secretary of State on March 9, 2018</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 3.1 to the Current Report on Form 8-K filed on March 13, 2018.</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/849146/000084914619000066/lifevantage-amendedandrest.htm">Amended and Restated Bylaws, August 9, 2019</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 3.1 to the Current Report on Form 8-K filed on August 15, 2019</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="lfvn_033122xex311.htm">Certification of principal executive officer pursuant to Rule 13a-14(a)/15d-14(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="lfvn_033122xex312.htm">Certification of principal financial officer pursuant to Rule 13a-14(a)/15d-14(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="lfvn_033122xex321.htm">Certification of principal executive officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furnished herewith</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="lfvn_033122xex322.htm">Certification of principal financial officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furnished herewith</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following financial information from the Company&#8217;s quarterly report on Form 10-Q for the quarter ended March 31, 2022 formatted in Inline XBRL (extensible Business Reporting Language): (i) Unaudited Condensed Consolidated Balance Sheets at March 31, 2022 and June&#160;30, 2021; (ii) Unaudited Condensed Consolidated Statements of Operations and Other Comprehensive Income for the three and nine months ended March 31, 2022 and 2021; (iii) Unaudited Condensed Consolidated Statement of Stockholders&#8217; Equity for the three and nine months ended March 31, 2022 and 2022; (iv) Unaudited Condensed Consolidated Statements of Cash Flows for the nine months ended March 31, 2022 and 2021; and (v) Notes to Unaudited Condensed Consolidated Financial Statements, tagged as blocks of text</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr></table></div><div style="margin-bottom:8pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.181%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This certification is being furnished solely to accompany this report pursuant to 18 U.S.C. 1350, and is not being filed for purposes of Section&#160;18 of the Exchange Act and is not to be incorporated by reference into any filing of the registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;text-align:center;text-indent:24.75pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="i41e77726867840e39498d8f5bb503840_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.174%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIFEVANTAGE CORPORATION</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 3, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Steven R. Fife</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Steven R. Fife<br/>President and Chief Executive Officer<br/>(Principal Executive Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 3, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Carl A. Aure</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carl A. Aure<br/>Chief Financial Officer<br/>(Principal Financial Officer and Principal Accounting Officer)</span></td></tr></table></div><div style="margin-bottom:8pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>lfvn_033122xex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ieede5dae58454d1fa4083688a5ccc608_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="margin-bottom:8pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Steven R. Fife, certify that&#58;</font></div><div style="margin-bottom:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">I have reviewed this quarterly report on Form 10-Q of LifeVantage Corporation&#59;</font></div><div style="margin-bottom:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;3, 2022</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.666%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Steven R. Fife</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Steven R. Fife</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>lfvn_033122xex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i28f37bac828347b2b300dc2cc546f97c_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="margin-bottom:8pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Carl A. Aure, certify that&#58;</font></div><div style="margin-bottom:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">I have reviewed this quarterly report on Form 10-Q of LifeVantage Corporation&#59;</font></div><div style="margin-bottom:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;3, 2022</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.666%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Carl A. Aure</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carl A. Aure</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>lfvn_033122xex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ifdc7cce6d41c4d2e854aecf3f387bd46_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:8pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the filing of this quarterly report on Form 10-Q of LifeVantage Corporation (the &#8220;Company&#8221;) for the period ended March&#160;31, 2022, with the Securities and Exchange Commission on the date hereof (the &#8220;report&#8221;), I, Steven R. Fife, Principal Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.17pt">The report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.17pt">The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:8pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing certification is being furnished solely pursuant to 18 U.S.C. &#167; 1350 and is not being filed as part of the report or as a separate disclosure document.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;3, 2022</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.666%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Steven R. Fife</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Steven R. Fife</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>lfvn_033122xex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i92f7bb5dc3524dac9be03e305e4ddcf9_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:8pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the filing of this quarterly report on Form 10-Q of LifeVantage Corporation (the &#8220;Company&#8221;) for the period ended March&#160;31, 2022, with the Securities and Exchange Commission on the date hereof (the &#8220;report&#8221;), I, Carl A. Aure, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.17pt">The report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.17pt">The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:8pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing certification is being furnished solely pursuant to 18 U.S.C. &#167; 1350 and is not being filed as part of the report or as a separate disclosure document.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;3, 2022</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.666%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Carl A. Aure</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carl A. Aure</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>lfvn-20220331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:638a0b91-4766-4439-9960-cd7043420117,g:40b96704-8fd2-45ed-83b9-f73156e5e4bc-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lfvn="http://www.lifevantage.com/20220331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.lifevantage.com/20220331">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lfvn-20220331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lfvn-20220331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lfvn-20220331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lfvn-20220331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.lifevantage.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited" roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited">
        <link:definition>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited" roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS&#8217; EQUITY (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited">
        <link:definition>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandBasisofPresentation" roleURI="http://www.lifevantage.com/role/OrganizationandBasisofPresentation">
        <link:definition>2101101 - Disclosure - Organization and Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>2102102 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>2203201 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>2304301 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2405401 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails" roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails">
        <link:definition>2406402 - Disclosure - Summary of Significant Accounting Policies - Components of Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails" roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails">
        <link:definition>2407403 - Disclosure - Summary of Significant Accounting Policies - Summary of Computation of Net Income Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesSegmentInformationDetails" roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails">
        <link:definition>2408404 - Disclosure - Summary of Significant Accounting Policies - Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GigEconomyGroupInvestment" roleURI="http://www.lifevantage.com/role/GigEconomyGroupInvestment">
        <link:definition>2109103 - Disclosure - Gig Economy Group Investment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GigEconomyGroupInvestmentDetails" roleURI="http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails">
        <link:definition>2410405 - Disclosure - Gig Economy Group Investment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.lifevantage.com/role/Leases">
        <link:definition>2111104 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.lifevantage.com/role/LeasesTables">
        <link:definition>2312302 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.lifevantage.com/role/LeasesNarrativeDetails">
        <link:definition>2413406 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofLeaseCostDetails" roleURI="http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails">
        <link:definition>2414407 - Disclosure - Leases - Schedule of Lease, Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofMaturityofLeaseLiabilitiesDetails" roleURI="http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails">
        <link:definition>2415408 - Disclosure - Leases - Schedule of Maturity of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1" roleURI="http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1">
        <link:definition>2415408 - Disclosure - Leases - Schedule of Maturity of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://www.lifevantage.com/role/LongTermDebt">
        <link:definition>2116105 - Disclosure - Long-Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtNarrativeDetails" roleURI="http://www.lifevantage.com/role/LongTermDebtNarrativeDetails">
        <link:definition>2417409 - Disclosure - Long-Term Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.lifevantage.com/role/StockholdersEquity">
        <link:definition>2118106 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDetails" roleURI="http://www.lifevantage.com/role/StockholdersEquityDetails">
        <link:definition>2419410 - Disclosure - Stockholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.lifevantage.com/role/StockBasedCompensation">
        <link:definition>2120107 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationDetails" roleURI="http://www.lifevantage.com/role/StockBasedCompensationDetails">
        <link:definition>2421411 - Disclosure - Stock-Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.lifevantage.com/role/CommitmentsandContingencies">
        <link:definition>2122108 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesDetails" roleURI="http://www.lifevantage.com/role/CommitmentandContingenciesDetails">
        <link:definition>2423412 - Disclosure - Commitment and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions" roleURI="http://www.lifevantage.com/role/RelatedPartyTransactions">
        <link:definition>2124109 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsDetails" roleURI="http://www.lifevantage.com/role/RelatedPartyTransactionsDetails">
        <link:definition>2425413 - Disclosure - Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="lfvn_IncreaseDecreaseInLeaseLiabilities" abstract="false" name="IncreaseDecreaseInLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember" abstract="true" name="CashAccountsHeldPrimarilyAtFinancialInstitutionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofVestingInstallments" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofVestingInstallments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio" abstract="false" name="DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="lfvn_InventoryPercentOfTotalInventory" abstract="false" name="InventoryPercentOfTotalInventory" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lfvn_RawMaterialsPercentOfTotalInventory" abstract="false" name="RawMaterialsPercentOfTotalInventory" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lfvn_TwoThousandAndTenLongTermIncentivePlanMember" abstract="true" name="TwoThousandAndTenLongTermIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_SandyUTMember" abstract="true" name="SandyUTMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_EmployeeStockPurchasePlanMember" abstract="true" name="EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital" abstract="false" name="DebtInstrumentCovenantRequiredMinimumWorkingCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_TwoThousandAndSevenLongTermIncentivePlanMember" abstract="true" name="TwoThousandAndSevenLongTermIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_MembersOfBoardOfDirectorsServingOnRelatedPartyBoardOfDirectors" abstract="false" name="MembersOfBoardOfDirectorsServingOnRelatedPartyBoardOfDirectors" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lfvn_DebtInstrumentTrailingPeriod" abstract="false" name="DebtInstrumentTrailingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio" abstract="false" name="DebtInstrumentCovenantFixedChargeCoverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="lfvn_MoneyBackGuaranteePeriod" abstract="false" name="MoneyBackGuaranteePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" abstract="false" name="ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_OperatingLeaseRightOfUseAssetAbandonmentExpense" abstract="false" name="OperatingLeaseRightOfUseAssetAbandonmentExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_March2016TermLoanMember" abstract="true" name="March2016TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_NotesReceivableRelatedPartyMaximumCommitment" abstract="false" name="NotesReceivableRelatedPartyMaximumCommitment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_IncreaseDecreaseInPropertyAndEquipmentAndLeaseLiabilitiesFromLeaseIncentives" abstract="false" name="IncreaseDecreaseInPropertyAndEquipmentAndLeaseLiabilitiesFromLeaseIncentives" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_InventoryFinishedGoodsPercentOfTotalInventory" abstract="false" name="InventoryFinishedGoodsPercentOfTotalInventory" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lfvn_TwoThousandEighteenPerformancePlanMember" abstract="true" name="TwoThousandEighteenPerformancePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_OperatingLeaseRightOfUseAssetSalvageValue" abstract="false" name="OperatingLeaseRightOfUseAssetSalvageValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_ReturnLiabilityReserve" abstract="false" name="ReturnLiabilityReserve" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_March2016RevolvingLoanMember" abstract="true" name="March2016RevolvingLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_HandlingAndRestockingFeePercentage" abstract="false" name="HandlingAndRestockingFeePercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" abstract="true" name="TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_AsiaPacificAndEuropeMember" abstract="true" name="AsiaPacificAndEuropeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_TwoThousandSeventeenLongTermIncentivePlanMember" abstract="true" name="TwoThousandSeventeenLongTermIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_NumberOfGeographicSegments" abstract="false" name="NumberOfGeographicSegments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember" abstract="true" name="CashAccountsHeldatOtherFinancialInstitutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_CommissionAndIncentives" abstract="false" name="CommissionAndIncentives" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lfvn_DebtInstrumentFloorInterestRate" abstract="false" name="DebtInstrumentFloorInterestRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>lfvn-20220331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:638a0b91-4766-4439-9960-cd7043420117,g:40b96704-8fd2-45ed-83b9-f73156e5e4bc-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="simple" xlink:href="lfvn-20220331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_0f6c96f7-b756-45c7-a6a0-41c478e75fc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0c23ad98-1ac9-408d-9e92-2f31b2412ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0f6c96f7-b756-45c7-a6a0-41c478e75fc0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0c23ad98-1ac9-408d-9e92-2f31b2412ae4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_6e00a2b6-b1f0-412e-bcd7-ac5d4ac36ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0f6c96f7-b756-45c7-a6a0-41c478e75fc0" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_6e00a2b6-b1f0-412e-bcd7-ac5d4ac36ae8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_2847db62-d02a-4b8a-929a-9d3d2ef2f23f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0f6c96f7-b756-45c7-a6a0-41c478e75fc0" xlink:to="loc_us-gaap_IncomeTaxesReceivable_2847db62-d02a-4b8a-929a-9d3d2ef2f23f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_b4b85c1e-a009-4629-a16b-e046c0dd3918" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0f6c96f7-b756-45c7-a6a0-41c478e75fc0" xlink:to="loc_us-gaap_InventoryNet_b4b85c1e-a009-4629-a16b-e046c0dd3918" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ed8e0671-379c-46bd-8426-2a8789f150d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0f6c96f7-b756-45c7-a6a0-41c478e75fc0" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ed8e0671-379c-46bd-8426-2a8789f150d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_7658b8b5-cff5-4284-ab22-537d29c33bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_372b4890-9e0f-4841-bff7-ab56f9cceaa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7658b8b5-cff5-4284-ab22-537d29c33bdf" xlink:to="loc_us-gaap_Liabilities_372b4890-9e0f-4841-bff7-ab56f9cceaa7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_75061e90-08a1-4ed2-8d25-986815e49e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7658b8b5-cff5-4284-ab22-537d29c33bdf" xlink:to="loc_us-gaap_CommitmentsAndContingencies_75061e90-08a1-4ed2-8d25-986815e49e9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_03a397d8-d67f-41c0-a822-2fd6ec79ae03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7658b8b5-cff5-4284-ab22-537d29c33bdf" xlink:to="loc_us-gaap_StockholdersEquity_03a397d8-d67f-41c0-a822-2fd6ec79ae03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_a0913b3b-ca53-45f9-a564-00c682d2e778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_47a4424e-660f-472c-84fd-538e6cb93995" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a0913b3b-ca53-45f9-a564-00c682d2e778" xlink:to="loc_us-gaap_AssetsCurrent_47a4424e-660f-472c-84fd-538e6cb93995" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_aecdbf29-5b9c-448f-bf75-e6377daba9cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a0913b3b-ca53-45f9-a564-00c682d2e778" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_aecdbf29-5b9c-448f-bf75-e6377daba9cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7880b674-73f6-4209-b1eb-5929639c58f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a0913b3b-ca53-45f9-a564-00c682d2e778" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_7880b674-73f6-4209-b1eb-5929639c58f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d70d499f-fe61-4991-9898-9d65f07068ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a0913b3b-ca53-45f9-a564-00c682d2e778" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d70d499f-fe61-4991-9898-9d65f07068ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_137d23c1-f328-4ec1-8f10-8a84b65f6730" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a0913b3b-ca53-45f9-a564-00c682d2e778" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_137d23c1-f328-4ec1-8f10-8a84b65f6730" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_6aad9247-71d4-4f1b-a37f-eff9ebd67cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a0913b3b-ca53-45f9-a564-00c682d2e778" xlink:to="loc_us-gaap_LongTermInvestments_6aad9247-71d4-4f1b-a37f-eff9ebd67cd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_165b2549-cca6-43e5-a4d6-51e629c4ed63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a0913b3b-ca53-45f9-a564-00c682d2e778" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_165b2549-cca6-43e5-a4d6-51e629c4ed63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_dd1e56e9-a7a0-4b31-8f9c-52371889529b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_0bb67c1e-358e-4f77-ba58-d36f8c0f4f24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_dd1e56e9-a7a0-4b31-8f9c-52371889529b" xlink:to="loc_us-gaap_AccountsPayableCurrent_0bb67c1e-358e-4f77-ba58-d36f8c0f4f24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent_106d65db-bdb5-42d7-a3bf-45501588b590" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_dd1e56e9-a7a0-4b31-8f9c-52371889529b" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrent_106d65db-bdb5-42d7-a3bf-45501588b590" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_7fd09a87-1131-4a3f-864b-c9e981d17637" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_dd1e56e9-a7a0-4b31-8f9c-52371889529b" xlink:to="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_7fd09a87-1131-4a3f-864b-c9e981d17637" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_26f338bc-5708-4ccd-8d0a-e5fdcb681fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_dd1e56e9-a7a0-4b31-8f9c-52371889529b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_26f338bc-5708-4ccd-8d0a-e5fdcb681fb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_e3c4ec94-28ad-43f1-a8f9-af06e9b894aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_dd1e56e9-a7a0-4b31-8f9c-52371889529b" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_e3c4ec94-28ad-43f1-a8f9-af06e9b894aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_0558b863-1953-4111-8f32-df735f9abe7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_483be160-566d-4267-944f-c3122f3d3b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0558b863-1953-4111-8f32-df735f9abe7f" xlink:to="loc_us-gaap_LiabilitiesCurrent_483be160-566d-4267-944f-c3122f3d3b7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_01857d1a-9fcf-41a9-9aa0-0629e393e6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0558b863-1953-4111-8f32-df735f9abe7f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_01857d1a-9fcf-41a9-9aa0-0629e393e6bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_841862a8-4fbd-4019-a961-784c52a8d6c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0558b863-1953-4111-8f32-df735f9abe7f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_841862a8-4fbd-4019-a961-784c52a8d6c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b1e33ce3-489e-42ad-b19b-e5bf5fe7eb8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_854eb94f-47a5-4488-9689-bf48d4e72733" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b1e33ce3-489e-42ad-b19b-e5bf5fe7eb8d" xlink:to="loc_us-gaap_PreferredStockValue_854eb94f-47a5-4488-9689-bf48d4e72733" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_ac617a20-17cf-47ea-b511-f8c632aaed3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b1e33ce3-489e-42ad-b19b-e5bf5fe7eb8d" xlink:to="loc_us-gaap_CommonStockValue_ac617a20-17cf-47ea-b511-f8c632aaed3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_48d5c05c-b2e9-46a7-b0df-79181442b01e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b1e33ce3-489e-42ad-b19b-e5bf5fe7eb8d" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_48d5c05c-b2e9-46a7-b0df-79181442b01e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_eaa16eb1-c970-4887-94e1-3e92165b22eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b1e33ce3-489e-42ad-b19b-e5bf5fe7eb8d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_eaa16eb1-c970-4887-94e1-3e92165b22eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_229477c5-ea01-4943-888c-b2340c4f4095" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b1e33ce3-489e-42ad-b19b-e5bf5fe7eb8d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_229477c5-ea01-4943-888c-b2340c4f4095" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited" xlink:type="simple" xlink:href="lfvn-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_41c13cb5-872d-4ad7-8b2d-50c5c26c194a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_869777b2-b9bb-418f-8b68-f1d46c70e4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_41c13cb5-872d-4ad7-8b2d-50c5c26c194a" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_869777b2-b9bb-418f-8b68-f1d46c70e4e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5fd9ca0b-7ce3-463f-a861-56184eca318f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_41c13cb5-872d-4ad7-8b2d-50c5c26c194a" xlink:to="loc_us-gaap_OperatingIncomeLoss_5fd9ca0b-7ce3-463f-a861-56184eca318f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c07c3401-4a7e-44fc-bb41-7e76be54b1e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_8e3b19cf-fbab-4a6a-a8a2-327bec48c261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c07c3401-4a7e-44fc-bb41-7e76be54b1e5" xlink:to="loc_us-gaap_GrossProfit_8e3b19cf-fbab-4a6a-a8a2-327bec48c261" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_5f67142a-389c-4a98-ba14-797fdfca44f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c07c3401-4a7e-44fc-bb41-7e76be54b1e5" xlink:to="loc_us-gaap_OperatingExpenses_5f67142a-389c-4a98-ba14-797fdfca44f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_b902f150-7139-490a-b499-1da7714d3992" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_dd7b734f-e057-4e92-871c-f88248b6ed89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_b902f150-7139-490a-b499-1da7714d3992" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_dd7b734f-e057-4e92-871c-f88248b6ed89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_33ca1b45-313f-45cf-a618-56ffe0675c42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_8697918f-3fd3-41dd-b73f-41825c5b53c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_33ca1b45-313f-45cf-a618-56ffe0675c42" xlink:to="loc_us-gaap_InterestExpense_8697918f-3fd3-41dd-b73f-41825c5b53c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_9ff8ebfc-25a2-4bdd-a6fc-3ff5d43c9800" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_33ca1b45-313f-45cf-a618-56ffe0675c42" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_9ff8ebfc-25a2-4bdd-a6fc-3ff5d43c9800" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_03ed9b60-7eaa-4595-9245-1e8040246c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_cfaf5b75-4b43-48e0-8fc9-8574e6040684" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_03ed9b60-7eaa-4595-9245-1e8040246c7c" xlink:to="loc_us-gaap_NetIncomeLoss_cfaf5b75-4b43-48e0-8fc9-8574e6040684" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_138e518c-f79b-47ba-8aa6-f8a3d6b9da35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_03ed9b60-7eaa-4595-9245-1e8040246c7c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_138e518c-f79b-47ba-8aa6-f8a3d6b9da35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_870aa983-e903-4c7a-bde4-9fd3acd83a46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e01a3d0c-cd3a-4b11-a08a-ba67e0264b87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_870aa983-e903-4c7a-bde4-9fd3acd83a46" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e01a3d0c-cd3a-4b11-a08a-ba67e0264b87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_c9c1c0a7-e80c-49c6-b450-dbfa4ff52043" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_870aa983-e903-4c7a-bde4-9fd3acd83a46" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_c9c1c0a7-e80c-49c6-b450-dbfa4ff52043" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_0878189e-123a-43cc-9812-ae22795355d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CommissionAndIncentives_6724e80c-32a2-48f4-b163-a70af52bb1b0" xlink:href="lfvn-20220331.xsd#lfvn_CommissionAndIncentives"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0878189e-123a-43cc-9812-ae22795355d9" xlink:to="loc_lfvn_CommissionAndIncentives_6724e80c-32a2-48f4-b163-a70af52bb1b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_89f3ca14-41d4-4976-8010-ae3c56202034" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0878189e-123a-43cc-9812-ae22795355d9" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_89f3ca14-41d4-4976-8010-ae3c56202034" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fceb893a-3080-4b85-b6c9-830c179ad70e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f1639154-47e6-4715-8828-7f2eb24cb535" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_fceb893a-3080-4b85-b6c9-830c179ad70e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f1639154-47e6-4715-8828-7f2eb24cb535" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e9bc2fa9-5cd0-480d-901c-8d19bf8afc36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_fceb893a-3080-4b85-b6c9-830c179ad70e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e9bc2fa9-5cd0-480d-901c-8d19bf8afc36" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="lfvn-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e60060c1-3a6e-4c4c-b372-b4022411cc4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1a9f1324-950c-48c4-ac27-7dc59c4927a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e60060c1-3a6e-4c4c-b372-b4022411cc4c" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1a9f1324-950c-48c4-ac27-7dc59c4927a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd636ae4-c57a-4d36-b4f0-288b51d7810d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_54fede34-df98-47c8-b636-da254866a124" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd636ae4-c57a-4d36-b4f0-288b51d7810d" xlink:to="loc_us-gaap_NetIncomeLoss_54fede34-df98-47c8-b636-da254866a124" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b41e0271-1933-4b97-a83e-c85ce6d902f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd636ae4-c57a-4d36-b4f0-288b51d7810d" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b41e0271-1933-4b97-a83e-c85ce6d902f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e6fafec0-e7c1-4516-9485-8494f2e4146b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd636ae4-c57a-4d36-b4f0-288b51d7810d" xlink:to="loc_us-gaap_ShareBasedCompensation_e6fafec0-e7c1-4516-9485-8494f2e4146b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_c961a74b-4b24-4772-914b-bdd4ccb1f1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd636ae4-c57a-4d36-b4f0-288b51d7810d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_c961a74b-4b24-4772-914b-bdd4ccb1f1c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e41164d0-fd9f-440c-84aa-57659ad26eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd636ae4-c57a-4d36-b4f0-288b51d7810d" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e41164d0-fd9f-440c-84aa-57659ad26eb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_efaf7447-40c9-42cc-852f-0b965aab80b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd636ae4-c57a-4d36-b4f0-288b51d7810d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_efaf7447-40c9-42cc-852f-0b965aab80b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_6ea9eb1b-eabd-490a-945b-b450266fe2fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd636ae4-c57a-4d36-b4f0-288b51d7810d" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_6ea9eb1b-eabd-490a-945b-b450266fe2fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_8e2f1919-5513-49c6-9165-bcb834a3319e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd636ae4-c57a-4d36-b4f0-288b51d7810d" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_8e2f1919-5513-49c6-9165-bcb834a3319e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_2e159292-70d9-492f-af95-3f7072c73c45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd636ae4-c57a-4d36-b4f0-288b51d7810d" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_2e159292-70d9-492f-af95-3f7072c73c45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_a09887aa-797e-4600-9535-f3fa310e9795" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd636ae4-c57a-4d36-b4f0-288b51d7810d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_a09887aa-797e-4600-9535-f3fa310e9795" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3e0c27df-111d-4fbc-9c11-e7f1f7649d19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd636ae4-c57a-4d36-b4f0-288b51d7810d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3e0c27df-111d-4fbc-9c11-e7f1f7649d19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_d5daad52-a905-4d25-b53f-de8c5fff61e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd636ae4-c57a-4d36-b4f0-288b51d7810d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_d5daad52-a905-4d25-b53f-de8c5fff61e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_45d4c5d8-ab70-4289-bf7b-ab063e94a6cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd636ae4-c57a-4d36-b4f0-288b51d7810d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_45d4c5d8-ab70-4289-bf7b-ab063e94a6cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_IncreaseDecreaseInLeaseLiabilities_3e5abdb9-76f7-426e-889b-7ac22ee203b8" xlink:href="lfvn-20220331.xsd#lfvn_IncreaseDecreaseInLeaseLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd636ae4-c57a-4d36-b4f0-288b51d7810d" xlink:to="loc_lfvn_IncreaseDecreaseInLeaseLiabilities_3e5abdb9-76f7-426e-889b-7ac22ee203b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_bc64c6b0-9493-47bb-92f1-414787df0c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd636ae4-c57a-4d36-b4f0-288b51d7810d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_bc64c6b0-9493-47bb-92f1-414787df0c0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5912f03d-d977-463c-9ca4-47c9e9a07c01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_270cc207-6f10-4111-979d-9d0d9e06ec09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5912f03d-d977-463c-9ca4-47c9e9a07c01" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_270cc207-6f10-4111-979d-9d0d9e06ec09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_83ea6b6f-7751-4afa-9c67-d33d40cc25fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5912f03d-d977-463c-9ca4-47c9e9a07c01" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_83ea6b6f-7751-4afa-9c67-d33d40cc25fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_50a9b224-2d15-484d-bf94-627f2d935d15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5912f03d-d977-463c-9ca4-47c9e9a07c01" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_50a9b224-2d15-484d-bf94-627f2d935d15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_591996f7-46dd-494b-9639-31f9a453e95c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5912f03d-d977-463c-9ca4-47c9e9a07c01" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_591996f7-46dd-494b-9639-31f9a453e95c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_33d4667f-2693-4ac9-bfca-609c8ba19cb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_f1760396-d795-4b84-ac48-cf3d583a8eec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_33d4667f-2693-4ac9-bfca-609c8ba19cb1" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_f1760396-d795-4b84-ac48-cf3d583a8eec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_77b3ad93-9165-4bf8-ab5b-10bfa64218ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_33d4667f-2693-4ac9-bfca-609c8ba19cb1" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_77b3ad93-9165-4bf8-ab5b-10bfa64218ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_16d588e5-0251-4bd6-a7e7-6f9cd279f683" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_33d4667f-2693-4ac9-bfca-609c8ba19cb1" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_16d588e5-0251-4bd6-a7e7-6f9cd279f683" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan_8168c18f-f804-4cab-8eab-22458325232e" xlink:href="lfvn-20220331.xsd#lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_33d4667f-2693-4ac9-bfca-609c8ba19cb1" xlink:to="loc_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan_8168c18f-f804-4cab-8eab-22458325232e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails" xlink:type="simple" xlink:href="lfvn-20220331.xsd#SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_a7e2479e-5089-4da9-8cf8-be48425efab8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_203a99e8-ce4c-4fe1-94e6-713da1a148c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_a7e2479e-5089-4da9-8cf8-be48425efab8" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_203a99e8-ce4c-4fe1-94e6-713da1a148c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_5448743d-0b46-40c4-a7d6-44d185e69640" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_a7e2479e-5089-4da9-8cf8-be48425efab8" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_5448743d-0b46-40c4-a7d6-44d185e69640" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_InventoryPercentOfTotalInventory_44f7fb73-c72d-41e7-a65f-23a428bbe2e5" xlink:href="lfvn-20220331.xsd#lfvn_InventoryPercentOfTotalInventory"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_InventoryFinishedGoodsPercentOfTotalInventory_243cd9f0-3e5a-483a-935f-9fd2bb2acc26" xlink:href="lfvn-20220331.xsd#lfvn_InventoryFinishedGoodsPercentOfTotalInventory"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lfvn_InventoryPercentOfTotalInventory_44f7fb73-c72d-41e7-a65f-23a428bbe2e5" xlink:to="loc_lfvn_InventoryFinishedGoodsPercentOfTotalInventory_243cd9f0-3e5a-483a-935f-9fd2bb2acc26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_RawMaterialsPercentOfTotalInventory_ccf5f898-b16e-4846-af57-7717b549e488" xlink:href="lfvn-20220331.xsd#lfvn_RawMaterialsPercentOfTotalInventory"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lfvn_InventoryPercentOfTotalInventory_44f7fb73-c72d-41e7-a65f-23a428bbe2e5" xlink:to="loc_lfvn_RawMaterialsPercentOfTotalInventory_ccf5f898-b16e-4846-af57-7717b549e488" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails" xlink:type="simple" xlink:href="lfvn-20220331.xsd#SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3f1bc863-79f0-470d-9c8c-24f72f192933" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7311560d-0da5-496d-9fa0-ad8867240987" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3f1bc863-79f0-470d-9c8c-24f72f192933" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7311560d-0da5-496d-9fa0-ad8867240987" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_b293a73b-9303-49ff-b61a-f546fb683862" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3f1bc863-79f0-470d-9c8c-24f72f192933" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_b293a73b-9303-49ff-b61a-f546fb683862" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="lfvn-20220331.xsd#LeasesScheduleofMaturityofLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6311166b-22e4-4888-bb2b-643de3a652d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_e0157c6d-be5b-4ab6-aef8-9092b765c2a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6311166b-22e4-4888-bb2b-643de3a652d4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_e0157c6d-be5b-4ab6-aef8-9092b765c2a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_55fe6225-b09a-4961-b399-6d085f63573a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6311166b-22e4-4888-bb2b-643de3a652d4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_55fe6225-b09a-4961-b399-6d085f63573a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b1b63f15-abe9-462c-aa61-bb779b481fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6311166b-22e4-4888-bb2b-643de3a652d4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b1b63f15-abe9-462c-aa61-bb779b481fa3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_4f34e603-f711-4266-9367-543b1814cc1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6311166b-22e4-4888-bb2b-643de3a652d4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_4f34e603-f711-4266-9367-543b1814cc1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_1b38465c-1975-4648-b80f-a38d9bcde194" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6311166b-22e4-4888-bb2b-643de3a652d4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_1b38465c-1975-4648-b80f-a38d9bcde194" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_831102ff-fe07-4b17-986d-5566e8affa10" xlink:href="lfvn-20220331.xsd#lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6311166b-22e4-4888-bb2b-643de3a652d4" xlink:to="loc_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_831102ff-fe07-4b17-986d-5566e8affa10" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="lfvn-20220331.xsd#LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fe83c2c6-f15e-463a-a29f-e8baf26ecc82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_e02dad12-39b6-4b8a-b6d0-21480d5531d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fe83c2c6-f15e-463a-a29f-e8baf26ecc82" xlink:to="loc_us-gaap_OperatingLeaseLiability_e02dad12-39b6-4b8a-b6d0-21480d5531d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_25ce7fe2-08d9-4d22-bc91-5dfd5800231d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fe83c2c6-f15e-463a-a29f-e8baf26ecc82" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_25ce7fe2-08d9-4d22-bc91-5dfd5800231d" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>lfvn-20220331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:638a0b91-4766-4439-9960-cd7043420117,g:40b96704-8fd2-45ed-83b9-f73156e5e4bc-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="simple" xlink:href="lfvn-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="extended" id="i06e9c2a511bc48ce9b2817d8f314ec26_CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_06ba5dd4-e376-4444-b5be-30e1c4c40cfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_06ba5dd4-e376-4444-b5be-30e1c4c40cfd" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_25667fad-8e1f-450c-93ff-df7dd2e77083" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_SharesOutstanding_25667fad-8e1f-450c-93ff-df7dd2e77083" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_355dcd0f-6afa-4b03-9751-160014fdd89b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_StockholdersEquity_355dcd0f-6afa-4b03-9751-160014fdd89b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_85b4069d-0fe2-400d-845a-560f9a973e36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_85b4069d-0fe2-400d-845a-560f9a973e36" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_7099fa80-485d-4463-93b3-21beccd160d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_7099fa80-485d-4463-93b3-21beccd160d5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_5f9e834d-8e5d-4270-894f-579b6ccab93c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_5f9e834d-8e5d-4270-894f-579b6ccab93c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_1409ed25-b49a-4d13-9de6-4b5c9ecf9f44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_1409ed25-b49a-4d13-9de6-4b5c9ecf9f44" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_960fcf25-2618-4226-92c5-b58bd97a62c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_960fcf25-2618-4226-92c5-b58bd97a62c3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_9b5bd472-eb11-4044-be74-d86878c1d460" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_9b5bd472-eb11-4044-be74-d86878c1d460" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_9dca98a7-ae32-4cf8-b739-2e90787aac28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_9dca98a7-ae32-4cf8-b739-2e90787aac28" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_31839ea2-6ccf-4e95-bdc1-dfdf8da2c900" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_31839ea2-6ccf-4e95-bdc1-dfdf8da2c900" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_e0b0f271-6f6d-42f6-ae0c-4837a5557107" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_e0b0f271-6f6d-42f6-ae0c-4837a5557107" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_b2688d11-9515-4587-9c05-aa887cec63f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_b2688d11-9515-4587-9c05-aa887cec63f1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_23891e71-366b-428f-9024-6742228b33ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_23891e71-366b-428f-9024-6742228b33ff" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_92c6020d-b729-40e8-a894-011f6279fc99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_92c6020d-b729-40e8-a894-011f6279fc99" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9b6dc3dc-f931-4852-9ecf-641e870add90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_NetIncomeLoss_9b6dc3dc-f931-4852-9ecf-641e870add90" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_926820a2-f1fe-41e5-b7af-e76edb7d0b27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_86ffa894-b096-4d25-9aa5-5a1060b0127c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_677e18bf-fcb3-41a9-ae4e-47a7de81fd3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_06ba5dd4-e376-4444-b5be-30e1c4c40cfd" xlink:to="loc_us-gaap_StatementTable_677e18bf-fcb3-41a9-ae4e-47a7de81fd3b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2221b96b-ce72-47d8-a69f-52a0c661b498" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_677e18bf-fcb3-41a9-ae4e-47a7de81fd3b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2221b96b-ce72-47d8-a69f-52a0c661b498" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2221b96b-ce72-47d8-a69f-52a0c661b498_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2221b96b-ce72-47d8-a69f-52a0c661b498" xlink:to="loc_us-gaap_EquityComponentDomain_2221b96b-ce72-47d8-a69f-52a0c661b498_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_20e8ea72-3ea4-4e29-a51d-a598d28e6da2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2221b96b-ce72-47d8-a69f-52a0c661b498" xlink:to="loc_us-gaap_EquityComponentDomain_20e8ea72-3ea4-4e29-a51d-a598d28e6da2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c68a0a2d-f094-44c1-8e4c-efd6b12ea1ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_20e8ea72-3ea4-4e29-a51d-a598d28e6da2" xlink:to="loc_us-gaap_CommonStockMember_c68a0a2d-f094-44c1-8e4c-efd6b12ea1ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_7637e2a0-9ab2-4372-bec7-f8e4c31023c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_20e8ea72-3ea4-4e29-a51d-a598d28e6da2" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_7637e2a0-9ab2-4372-bec7-f8e4c31023c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_f95e6571-7e18-4095-ae9a-bf1fd38ef8af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_20e8ea72-3ea4-4e29-a51d-a598d28e6da2" xlink:to="loc_us-gaap_RetainedEarningsMember_f95e6571-7e18-4095-ae9a-bf1fd38ef8af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8bbda635-fc73-4fc1-be1b-b9217562d040" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_20e8ea72-3ea4-4e29-a51d-a598d28e6da2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8bbda635-fc73-4fc1-be1b-b9217562d040" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20220331.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="ie0694ca952894b0fbed9c52cbb7d6df6_SummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_ac422b7c-3bc3-46b7-93a4-542edf385814" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_ac422b7c-3bc3-46b7-93a4-542edf385814" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_90696fe6-1a13-476b-a3f2-3b756f414f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_90696fe6-1a13-476b-a3f2-3b756f414f5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_dea7d0b2-c607-4f1c-bd73-d72c7e9c1eea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_dea7d0b2-c607-4f1c-bd73-d72c7e9c1eea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_83495ffb-619c-46e2-8d7b-a29d356e3de4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_83495ffb-619c-46e2-8d7b-a29d356e3de4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_d070aa93-8de1-4a60-a3ec-6d3040fd4be6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_us-gaap_InventoryValuationReserves_d070aa93-8de1-4a60-a3ec-6d3040fd4be6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_MoneyBackGuaranteePeriod_a56096bb-46cc-4a14-b876-52965b3ced79" xlink:href="lfvn-20220331.xsd#lfvn_MoneyBackGuaranteePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_lfvn_MoneyBackGuaranteePeriod_a56096bb-46cc-4a14-b876-52965b3ced79" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_HandlingAndRestockingFeePercentage_f74f39c9-0979-4362-a95b-cc45e3f78841" xlink:href="lfvn-20220331.xsd#lfvn_HandlingAndRestockingFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_lfvn_HandlingAndRestockingFeePercentage_f74f39c9-0979-4362-a95b-cc45e3f78841" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ReturnLiabilityReserve_90170fb0-0718-42a5-b011-1300f7971abe" xlink:href="lfvn-20220331.xsd#lfvn_ReturnLiabilityReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_lfvn_ReturnLiabilityReserve_90170fb0-0718-42a5-b011-1300f7971abe" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_612472a7-a777-4592-8c67-082ec2af6a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_612472a7-a777-4592-8c67-082ec2af6a1a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_OperatingLeaseRightOfUseAssetSalvageValue_dd04361a-9806-4584-b86b-8922042c4f16" xlink:href="lfvn-20220331.xsd#lfvn_OperatingLeaseRightOfUseAssetSalvageValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_lfvn_OperatingLeaseRightOfUseAssetSalvageValue_dd04361a-9806-4584-b86b-8922042c4f16" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_OperatingLeaseRightOfUseAssetAbandonmentExpense_84039c19-4084-4bbd-bac6-c8ec87799283" xlink:href="lfvn-20220331.xsd#lfvn_OperatingLeaseRightOfUseAssetAbandonmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_lfvn_OperatingLeaseRightOfUseAssetAbandonmentExpense_84039c19-4084-4bbd-bac6-c8ec87799283" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_ba6d4f44-fe58-4660-adef-37d5f397817d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_us-gaap_OperatingLeaseLiability_ba6d4f44-fe58-4660-adef-37d5f397817d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_32a476db-c325-4b75-a7d7-b9ec9b0fef51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_32a476db-c325-4b75-a7d7-b9ec9b0fef51" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c263fa16-81f1-4b8a-87ea-cbf7523a0e11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c263fa16-81f1-4b8a-87ea-cbf7523a0e11" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NumberOfGeographicSegments_b777618c-0e39-4173-84a8-3774348e32b4" xlink:href="lfvn-20220331.xsd#lfvn_NumberOfGeographicSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_lfvn_NumberOfGeographicSegments_b777618c-0e39-4173-84a8-3774348e32b4" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_f1dcc075-8190-454c-8400-6eed5624a75d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_us-gaap_NumberOfOperatingSegments_f1dcc075-8190-454c-8400-6eed5624a75d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_94a76546-6659-4742-b0a8-8b5cfca96261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_us-gaap_ConcentrationRiskTable_94a76546-6659-4742-b0a8-8b5cfca96261" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_6914fa9e-07ea-430d-b7ec-7604344deb57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_94a76546-6659-4742-b0a8-8b5cfca96261" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_6914fa9e-07ea-430d-b7ec-7604344deb57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_6914fa9e-07ea-430d-b7ec-7604344deb57_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_6914fa9e-07ea-430d-b7ec-7604344deb57" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_6914fa9e-07ea-430d-b7ec-7604344deb57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_47eb5462-2609-4dfd-9a0c-139e72006028" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_6914fa9e-07ea-430d-b7ec-7604344deb57" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_47eb5462-2609-4dfd-9a0c-139e72006028" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember_90869a4d-83ad-477e-af89-6128b2c5b26c" xlink:href="lfvn-20220331.xsd#lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_47eb5462-2609-4dfd-9a0c-139e72006028" xlink:to="loc_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember_90869a4d-83ad-477e-af89-6128b2c5b26c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember_0169a497-ba24-4e74-bc6b-14d6865d6dcd" xlink:href="lfvn-20220331.xsd#lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_47eb5462-2609-4dfd-9a0c-139e72006028" xlink:to="loc_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember_0169a497-ba24-4e74-bc6b-14d6865d6dcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_325ea726-3c94-4d7b-a611-280424a8049c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_94a76546-6659-4742-b0a8-8b5cfca96261" xlink:to="loc_srt_StatementGeographicalAxis_325ea726-3c94-4d7b-a611-280424a8049c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_325ea726-3c94-4d7b-a611-280424a8049c_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_325ea726-3c94-4d7b-a611-280424a8049c" xlink:to="loc_srt_SegmentGeographicalDomain_325ea726-3c94-4d7b-a611-280424a8049c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_82e5835a-cf95-4510-a4b0-991aa1efb425" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_325ea726-3c94-4d7b-a611-280424a8049c" xlink:to="loc_srt_SegmentGeographicalDomain_82e5835a-cf95-4510-a4b0-991aa1efb425" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_SandyUTMember_4eb98e11-2470-4b99-9b05-82857699ddd0" xlink:href="lfvn-20220331.xsd#lfvn_SandyUTMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_82e5835a-cf95-4510-a4b0-991aa1efb425" xlink:to="loc_lfvn_SandyUTMember_4eb98e11-2470-4b99-9b05-82857699ddd0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails" xlink:type="simple" xlink:href="lfvn-20220331.xsd#SummaryofSignificantAccountingPoliciesSegmentInformationDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails" xlink:type="extended" id="i023ded3985a04daf9ef7b39bfcf0cfe4_SummaryofSignificantAccountingPoliciesSegmentInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_0cdff6a5-7087-4891-ac6b-f5a80e99f30f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a64f6e96-52b6-4051-afdf-0d830afd3181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_0cdff6a5-7087-4891-ac6b-f5a80e99f30f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a64f6e96-52b6-4051-afdf-0d830afd3181" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_143c6944-2f72-4a04-90bf-003b46752dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_0cdff6a5-7087-4891-ac6b-f5a80e99f30f" xlink:to="loc_us-gaap_NoncurrentAssets_143c6944-2f72-4a04-90bf-003b46752dcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_6ecf4f87-9582-4fa3-8e5f-508614fe3f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_0cdff6a5-7087-4891-ac6b-f5a80e99f30f" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_6ecf4f87-9582-4fa3-8e5f-508614fe3f9b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e4f2def4-b503-4021-9f35-b4faa0840daa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_6ecf4f87-9582-4fa3-8e5f-508614fe3f9b" xlink:to="loc_srt_StatementGeographicalAxis_e4f2def4-b503-4021-9f35-b4faa0840daa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e4f2def4-b503-4021-9f35-b4faa0840daa_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_e4f2def4-b503-4021-9f35-b4faa0840daa" xlink:to="loc_srt_SegmentGeographicalDomain_e4f2def4-b503-4021-9f35-b4faa0840daa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_49aefde6-330e-4080-b595-e3f93b863b30" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_e4f2def4-b503-4021-9f35-b4faa0840daa" xlink:to="loc_srt_SegmentGeographicalDomain_49aefde6-330e-4080-b595-e3f93b863b30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_37b5c102-d4f0-4e16-911d-5bdfdfcb1617" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_49aefde6-330e-4080-b595-e3f93b863b30" xlink:to="loc_srt_AmericasMember_37b5c102-d4f0-4e16-911d-5bdfdfcb1617" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_AsiaPacificAndEuropeMember_eea0aa6e-ae38-4ceb-a14d-e6ff7871893f" xlink:href="lfvn-20220331.xsd#lfvn_AsiaPacificAndEuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_49aefde6-330e-4080-b595-e3f93b863b30" xlink:to="loc_lfvn_AsiaPacificAndEuropeMember_eea0aa6e-ae38-4ceb-a14d-e6ff7871893f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_26dd2293-7739-40d3-9ab7-299c54af0fe0" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_49aefde6-330e-4080-b595-e3f93b863b30" xlink:to="loc_country_US_26dd2293-7739-40d3-9ab7-299c54af0fe0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_eb8fb65a-362e-41fd-983f-36070ef6043c" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_JP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_49aefde6-330e-4080-b595-e3f93b863b30" xlink:to="loc_country_JP_eb8fb65a-362e-41fd-983f-36070ef6043c" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails" xlink:type="simple" xlink:href="lfvn-20220331.xsd#GigEconomyGroupInvestmentDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails" xlink:type="extended" id="i5ac0716953804d789026990a2b2b22a9_GigEconomyGroupInvestmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_2fc71e84-c2d4-4f42-98bc-3567e3a09b59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NotesReceivableRelatedPartyMaximumCommitment_464cf1de-a021-4e67-b054-1ba582200ec6" xlink:href="lfvn-20220331.xsd#lfvn_NotesReceivableRelatedPartyMaximumCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2fc71e84-c2d4-4f42-98bc-3567e3a09b59" xlink:to="loc_lfvn_NotesReceivableRelatedPartyMaximumCommitment_464cf1de-a021-4e67-b054-1ba582200ec6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt_613608ff-7667-48a4-8d7c-cd42eb795892" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionOriginalDebtInterestRateOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2fc71e84-c2d4-4f42-98bc-3567e3a09b59" xlink:to="loc_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt_613608ff-7667-48a4-8d7c-cd42eb795892" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_0796b0e6-9815-4d7e-9769-e4431fa48343" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2fc71e84-c2d4-4f42-98bc-3567e3a09b59" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_0796b0e6-9815-4d7e-9769-e4431fa48343" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_a0283b48-901c-4620-a0da-f02b1254a6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2fc71e84-c2d4-4f42-98bc-3567e3a09b59" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_a0283b48-901c-4620-a0da-f02b1254a6d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_da9ac533-c424-48ff-bfbf-41ef0cbf1efc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2fc71e84-c2d4-4f42-98bc-3567e3a09b59" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_da9ac533-c424-48ff-bfbf-41ef0cbf1efc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_2c9961ca-ec7e-4f05-a02a-0a95a2d10e66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2fc71e84-c2d4-4f42-98bc-3567e3a09b59" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_2c9961ca-ec7e-4f05-a02a-0a95a2d10e66" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_459acb4d-948d-47f5-943d-cbfa4ef0e98c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_2c9961ca-ec7e-4f05-a02a-0a95a2d10e66" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_459acb4d-948d-47f5-943d-cbfa4ef0e98c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_459acb4d-948d-47f5-943d-cbfa4ef0e98c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_459acb4d-948d-47f5-943d-cbfa4ef0e98c" xlink:to="loc_us-gaap_RelatedPartyDomain_459acb4d-948d-47f5-943d-cbfa4ef0e98c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_34e7e5a8-24f7-4a14-bb0e-6d7fee80dd71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_459acb4d-948d-47f5-943d-cbfa4ef0e98c" xlink:to="loc_us-gaap_RelatedPartyDomain_34e7e5a8-24f7-4a14-bb0e-6d7fee80dd71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_9557370a-af39-4e21-a1f9-45410274b4ab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_34e7e5a8-24f7-4a14-bb0e-6d7fee80dd71" xlink:to="loc_srt_AffiliatedEntityMember_9557370a-af39-4e21-a1f9-45410274b4ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_a60737eb-b408-497b-8969-7de26f1ab655" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_2c9961ca-ec7e-4f05-a02a-0a95a2d10e66" xlink:to="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_a60737eb-b408-497b-8969-7de26f1ab655" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_a60737eb-b408-497b-8969-7de26f1ab655_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_a60737eb-b408-497b-8969-7de26f1ab655" xlink:to="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_a60737eb-b408-497b-8969-7de26f1ab655_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_74008dc5-7d00-4399-9839-43e643b17501" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_a60737eb-b408-497b-8969-7de26f1ab655" xlink:to="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_74008dc5-7d00-4399-9839-43e643b17501" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_aa2670d4-80f8-4bc5-8df9-85bd85c7b005" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_74008dc5-7d00-4399-9839-43e643b17501" xlink:to="loc_us-gaap_CommonStockMember_aa2670d4-80f8-4bc5-8df9-85bd85c7b005" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20220331.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/LeasesNarrativeDetails" xlink:type="extended" id="i5fcef2f080334edd94c7adccf61bf5a4_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_75379962-e89d-42ac-8e3a-ffe396f8d77b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_985a6497-9fee-44ae-8701-9f2db7c50c30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75379962-e89d-42ac-8e3a-ffe396f8d77b" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_985a6497-9fee-44ae-8701-9f2db7c50c30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_8b15e8d6-9a71-4390-9973-a49eddd52436" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75379962-e89d-42ac-8e3a-ffe396f8d77b" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_8b15e8d6-9a71-4390-9973-a49eddd52436" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_0fe4543c-2e14-4095-b074-902531dd27ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75379962-e89d-42ac-8e3a-ffe396f8d77b" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_0fe4543c-2e14-4095-b074-902531dd27ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_e0fc3eb3-049b-4f8e-98c1-47b7346634c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75379962-e89d-42ac-8e3a-ffe396f8d77b" xlink:to="loc_us-gaap_OperatingLeaseExpense_e0fc3eb3-049b-4f8e-98c1-47b7346634c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_0e981841-861f-4dd4-b084-d117370029e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75379962-e89d-42ac-8e3a-ffe396f8d77b" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_0e981841-861f-4dd4-b084-d117370029e3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a28e8a42-41c8-42b5-9171-eb6a1b3a0205" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_0e981841-861f-4dd4-b084-d117370029e3" xlink:to="loc_srt_RangeAxis_a28e8a42-41c8-42b5-9171-eb6a1b3a0205" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a28e8a42-41c8-42b5-9171-eb6a1b3a0205_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a28e8a42-41c8-42b5-9171-eb6a1b3a0205" xlink:to="loc_srt_RangeMember_a28e8a42-41c8-42b5-9171-eb6a1b3a0205_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_411a333f-4ae9-4932-a149-5efc977c20ea" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a28e8a42-41c8-42b5-9171-eb6a1b3a0205" xlink:to="loc_srt_RangeMember_411a333f-4ae9-4932-a149-5efc977c20ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3767c261-7cba-4fc2-8088-e5cbb3679821" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_411a333f-4ae9-4932-a149-5efc977c20ea" xlink:to="loc_srt_MinimumMember_3767c261-7cba-4fc2-8088-e5cbb3679821" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_530aeca0-631b-4a19-98ed-f8e4326dff33" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_411a333f-4ae9-4932-a149-5efc977c20ea" xlink:to="loc_srt_MaximumMember_530aeca0-631b-4a19-98ed-f8e4326dff33" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20220331.xsd#LongTermDebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/LongTermDebtNarrativeDetails" xlink:type="extended" id="ic99a99702a1c440f84827b15ba11c4f1_LongTermDebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_e701697c-4973-49e7-8404-f952fe3b53e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e134a45f-499e-4b3b-9805-53598ff127fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e701697c-4973-49e7-8404-f952fe3b53e3" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e134a45f-499e-4b3b-9805-53598ff127fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_2b98dbfd-cbe9-424c-a5fc-a9816af66381" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e701697c-4973-49e7-8404-f952fe3b53e3" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_2b98dbfd-cbe9-424c-a5fc-a9816af66381" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_2eb34b35-36fe-40ce-94d2-14b1919c6149" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e701697c-4973-49e7-8404-f952fe3b53e3" xlink:to="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_2eb34b35-36fe-40ce-94d2-14b1919c6149" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio_e52aacab-4943-4667-b6c7-5540ba48bf17" xlink:href="lfvn-20220331.xsd#lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e701697c-4973-49e7-8404-f952fe3b53e3" xlink:to="loc_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio_e52aacab-4943-4667-b6c7-5540ba48bf17" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentTrailingPeriod_7184d625-e5a3-4187-bf19-e62881aebc72" xlink:href="lfvn-20220331.xsd#lfvn_DebtInstrumentTrailingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e701697c-4973-49e7-8404-f952fe3b53e3" xlink:to="loc_lfvn_DebtInstrumentTrailingPeriod_7184d625-e5a3-4187-bf19-e62881aebc72" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital_44be36cc-d474-43de-a840-13bb55c614a1" xlink:href="lfvn-20220331.xsd#lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e701697c-4973-49e7-8404-f952fe3b53e3" xlink:to="loc_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital_44be36cc-d474-43de-a840-13bb55c614a1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio_b655b01e-1832-45a7-96f8-4a54fed6743d" xlink:href="lfvn-20220331.xsd#lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e701697c-4973-49e7-8404-f952fe3b53e3" xlink:to="loc_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio_b655b01e-1832-45a7-96f8-4a54fed6743d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_48b4c298-2862-443b-ae04-30540c41754a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e701697c-4973-49e7-8404-f952fe3b53e3" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_48b4c298-2862-443b-ae04-30540c41754a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8ba8bd99-5fc7-4a11-8641-f521314b5466" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e701697c-4973-49e7-8404-f952fe3b53e3" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8ba8bd99-5fc7-4a11-8641-f521314b5466" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentFloorInterestRate_3fea8f7f-836d-4d18-9406-ab4f88c39c20" xlink:href="lfvn-20220331.xsd#lfvn_DebtInstrumentFloorInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e701697c-4973-49e7-8404-f952fe3b53e3" xlink:to="loc_lfvn_DebtInstrumentFloorInterestRate_3fea8f7f-836d-4d18-9406-ab4f88c39c20" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_3a3ad21e-194b-4738-bf6f-4d326217a121" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e701697c-4973-49e7-8404-f952fe3b53e3" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_3a3ad21e-194b-4738-bf6f-4d326217a121" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_20d7717f-b717-4c90-84ee-3fca6f385121" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3a3ad21e-194b-4738-bf6f-4d326217a121" xlink:to="loc_us-gaap_DebtInstrumentAxis_20d7717f-b717-4c90-84ee-3fca6f385121" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_20d7717f-b717-4c90-84ee-3fca6f385121_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_20d7717f-b717-4c90-84ee-3fca6f385121" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_20d7717f-b717-4c90-84ee-3fca6f385121_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2078c2f4-f60d-4b9d-807f-f501d508371f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_20d7717f-b717-4c90-84ee-3fca6f385121" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2078c2f4-f60d-4b9d-807f-f501d508371f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_March2016TermLoanMember_c90ae13a-e9ef-483f-b7ca-72235e5883ff" xlink:href="lfvn-20220331.xsd#lfvn_March2016TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2078c2f4-f60d-4b9d-807f-f501d508371f" xlink:to="loc_lfvn_March2016TermLoanMember_c90ae13a-e9ef-483f-b7ca-72235e5883ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_March2016RevolvingLoanMember_b599a5ee-db6c-4262-a143-65e6179558a1" xlink:href="lfvn-20220331.xsd#lfvn_March2016RevolvingLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2078c2f4-f60d-4b9d-807f-f501d508371f" xlink:to="loc_lfvn_March2016RevolvingLoanMember_b599a5ee-db6c-4262-a143-65e6179558a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_44cf6cb7-1a6f-46a4-bd66-d90945a3b526" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3a3ad21e-194b-4738-bf6f-4d326217a121" xlink:to="loc_us-gaap_CreditFacilityAxis_44cf6cb7-1a6f-46a4-bd66-d90945a3b526" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_44cf6cb7-1a6f-46a4-bd66-d90945a3b526_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_44cf6cb7-1a6f-46a4-bd66-d90945a3b526" xlink:to="loc_us-gaap_CreditFacilityDomain_44cf6cb7-1a6f-46a4-bd66-d90945a3b526_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_1c875643-7c17-4c13-82c9-d7e8fe862944" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_44cf6cb7-1a6f-46a4-bd66-d90945a3b526" xlink:to="loc_us-gaap_CreditFacilityDomain_1c875643-7c17-4c13-82c9-d7e8fe862944" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_27d0e7fb-9dff-4f1f-a8f3-f9c21cb7e8fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_1c875643-7c17-4c13-82c9-d7e8fe862944" xlink:to="loc_us-gaap_SecuredDebtMember_27d0e7fb-9dff-4f1f-a8f3-f9c21cb7e8fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_1ef6f443-6080-4a0f-9ed3-53ffa8870ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_1c875643-7c17-4c13-82c9-d7e8fe862944" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_1ef6f443-6080-4a0f-9ed3-53ffa8870ad5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_27c5c5da-a356-4f2e-b076-72eddf00c19d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3a3ad21e-194b-4738-bf6f-4d326217a121" xlink:to="loc_us-gaap_VariableRateAxis_27c5c5da-a356-4f2e-b076-72eddf00c19d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_27c5c5da-a356-4f2e-b076-72eddf00c19d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_27c5c5da-a356-4f2e-b076-72eddf00c19d" xlink:to="loc_us-gaap_VariableRateDomain_27c5c5da-a356-4f2e-b076-72eddf00c19d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_4d660f68-0736-4dac-b624-26b2a55c9685" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_27c5c5da-a356-4f2e-b076-72eddf00c19d" xlink:to="loc_us-gaap_VariableRateDomain_4d660f68-0736-4dac-b624-26b2a55c9685" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UsTreasuryUstInterestRateMember_ed51a2db-99c8-4c7a-b157-7929405e61d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UsTreasuryUstInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_4d660f68-0736-4dac-b624-26b2a55c9685" xlink:to="loc_us-gaap_UsTreasuryUstInterestRateMember_ed51a2db-99c8-4c7a-b157-7929405e61d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_cf6d684f-af1c-4fa8-95e8-d2ac7531c5c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3a3ad21e-194b-4738-bf6f-4d326217a121" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_cf6d684f-af1c-4fa8-95e8-d2ac7531c5c8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_cf6d684f-af1c-4fa8-95e8-d2ac7531c5c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cf6d684f-af1c-4fa8-95e8-d2ac7531c5c8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_cf6d684f-af1c-4fa8-95e8-d2ac7531c5c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_44c058c1-a4f9-4a2e-b492-04a900191331" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cf6d684f-af1c-4fa8-95e8-d2ac7531c5c8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_44c058c1-a4f9-4a2e-b492-04a900191331" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_d6d277b2-ebeb-40e4-9df7-0c232252f543" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_44c058c1-a4f9-4a2e-b492-04a900191331" xlink:to="loc_us-gaap_LineOfCreditMember_d6d277b2-ebeb-40e4-9df7-0c232252f543" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/StockholdersEquityDetails" xlink:type="simple" xlink:href="lfvn-20220331.xsd#StockholdersEquityDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/StockholdersEquityDetails" xlink:type="extended" id="ied60bd6c860c425d9b4e6403190cb9f0_StockholdersEquityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_689bd165-99e0-4f4f-8f2f-76bf318031b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8bd09984-6fe1-433a-97d9-c98814852a57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_689bd165-99e0-4f4f-8f2f-76bf318031b7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8bd09984-6fe1-433a-97d9-c98814852a57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_3d05360c-3088-4d0e-9bab-1a4a67399475" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_689bd165-99e0-4f4f-8f2f-76bf318031b7" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_3d05360c-3088-4d0e-9bab-1a4a67399475" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_e0f42aee-d8be-4231-a3cd-8c1877a648ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_689bd165-99e0-4f4f-8f2f-76bf318031b7" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_e0f42aee-d8be-4231-a3cd-8c1877a648ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_0d49af5f-c8ab-4831-8140-74b71f6a4bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_689bd165-99e0-4f4f-8f2f-76bf318031b7" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_0d49af5f-c8ab-4831-8140-74b71f6a4bb2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_cb2731c9-1bd9-4507-8b19-28e6fb130136" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_689bd165-99e0-4f4f-8f2f-76bf318031b7" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_cb2731c9-1bd9-4507-8b19-28e6fb130136" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_9a757eac-189e-43f4-b6f8-f74a50d07d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_689bd165-99e0-4f4f-8f2f-76bf318031b7" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_9a757eac-189e-43f4-b6f8-f74a50d07d1e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_af9070be-d500-4822-b0ac-366db77cb269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_689bd165-99e0-4f4f-8f2f-76bf318031b7" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_af9070be-d500-4822-b0ac-366db77cb269" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_7d44bcc8-6586-4817-a247-ae10b5191bd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_af9070be-d500-4822-b0ac-366db77cb269" xlink:to="loc_us-gaap_StatementClassOfStockAxis_7d44bcc8-6586-4817-a247-ae10b5191bd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_7d44bcc8-6586-4817-a247-ae10b5191bd3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7d44bcc8-6586-4817-a247-ae10b5191bd3" xlink:to="loc_us-gaap_ClassOfStockDomain_7d44bcc8-6586-4817-a247-ae10b5191bd3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_1850cd0e-15a8-455f-83b2-772e26f30b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7d44bcc8-6586-4817-a247-ae10b5191bd3" xlink:to="loc_us-gaap_ClassOfStockDomain_1850cd0e-15a8-455f-83b2-772e26f30b7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_cd8a6aca-fd14-4b12-9e61-1b0256ae0362" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1850cd0e-15a8-455f-83b2-772e26f30b7a" xlink:to="loc_us-gaap_CommonStockMember_cd8a6aca-fd14-4b12-9e61-1b0256ae0362" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/StockBasedCompensationDetails" xlink:type="simple" xlink:href="lfvn-20220331.xsd#StockBasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/StockBasedCompensationDetails" xlink:type="extended" id="i929c9fed7d8a4acca484a7c6824c1f33_StockBasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_558a586a-8dbe-4949-9cfe-cec54119d233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_558a586a-8dbe-4949-9cfe-cec54119d233" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_5814d8a7-29e7-4377-9109-5b1b3d1b8035" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_5814d8a7-29e7-4377-9109-5b1b3d1b8035" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_60872ab0-1abe-41de-8340-8845e8b705fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_60872ab0-1abe-41de-8340-8845e8b705fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm_3f7e612c-f99a-48f3-a073-4f0028784aa7" xlink:href="lfvn-20220331.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm_3f7e612c-f99a-48f3-a073-4f0028784aa7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1a49e445-448b-42c5-aae2-398b62667a54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1a49e445-448b-42c5-aae2-398b62667a54" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_2483b9ca-1222-44f1-a903-b54d603bd462" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_2483b9ca-1222-44f1-a903-b54d603bd462" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_01bd8e95-2d68-4a0c-84ec-cebdc5f4630e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_01bd8e95-2d68-4a0c-84ec-cebdc5f4630e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_18450693-d1f2-4382-ab29-b6cdf035b136" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_18450693-d1f2-4382-ab29-b6cdf035b136" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofVestingInstallments_a2189959-1e06-43cd-9e33-194f7f911dc3" xlink:href="lfvn-20220331.xsd#lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofVestingInstallments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofVestingInstallments_a2189959-1e06-43cd-9e33-194f7f911dc3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_d4a92eca-6a5b-4a8e-a53a-971b1d09cad7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_d4a92eca-6a5b-4a8e-a53a-971b1d09cad7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_ac56b2c4-078d-4af7-b9e4-32aeff5cca3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_ac56b2c4-078d-4af7-b9e4-32aeff5cca3e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_4ff7867c-6246-4395-aa46-364d329e34a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_4ff7867c-6246-4395-aa46-364d329e34a2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_9040fefe-2492-47b0-bd1d-00b0d8d760a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_9040fefe-2492-47b0-bd1d-00b0d8d760a4" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_839ba496-759c-4928-8208-dbd6a6261142" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_839ba496-759c-4928-8208-dbd6a6261142" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted_9b218ae4-f8cc-4e96-b3dc-77d4d2c2b0d4" xlink:href="lfvn-20220331.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted_9b218ae4-f8cc-4e96-b3dc-77d4d2c2b0d4" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_8785edb7-6ac2-48d7-927f-b61bc6169130" xlink:href="lfvn-20220331.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_8785edb7-6ac2-48d7-927f-b61bc6169130" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_88e44d17-2b8f-4bd7-ae88-54b5c7ca435b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_88e44d17-2b8f-4bd7-ae88-54b5c7ca435b" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_0f760d15-4c27-426c-b0ed-f230963deb09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_0f760d15-4c27-426c-b0ed-f230963deb09" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities_7eff2720-475f-4af0-8153-ac1b7afddcb0" xlink:href="lfvn-20220331.xsd#lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities_7eff2720-475f-4af0-8153-ac1b7afddcb0" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_66449899-d019-4e60-b88e-923fea7cfd19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_66449899-d019-4e60-b88e-923fea7cfd19" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_fdac4250-9784-405d-a80b-c672e292a8a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_66449899-d019-4e60-b88e-923fea7cfd19" xlink:to="loc_us-gaap_PlanNameAxis_fdac4250-9784-405d-a80b-c672e292a8a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_fdac4250-9784-405d-a80b-c672e292a8a6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_fdac4250-9784-405d-a80b-c672e292a8a6" xlink:to="loc_us-gaap_PlanNameDomain_fdac4250-9784-405d-a80b-c672e292a8a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_a53f414b-b9b3-48a1-af27-27509c62cec9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_fdac4250-9784-405d-a80b-c672e292a8a6" xlink:to="loc_us-gaap_PlanNameDomain_a53f414b-b9b3-48a1-af27-27509c62cec9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember_5db4ad0b-8a22-4e27-8b33-b5c67b45f80c" xlink:href="lfvn-20220331.xsd#lfvn_TwoThousandAndSevenLongTermIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_a53f414b-b9b3-48a1-af27-27509c62cec9" xlink:to="loc_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember_5db4ad0b-8a22-4e27-8b33-b5c67b45f80c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandAndTenLongTermIncentivePlanMember_7f3c51c8-84a7-4618-918f-9bc83cd39e5e" xlink:href="lfvn-20220331.xsd#lfvn_TwoThousandAndTenLongTermIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_a53f414b-b9b3-48a1-af27-27509c62cec9" xlink:to="loc_lfvn_TwoThousandAndTenLongTermIncentivePlanMember_7f3c51c8-84a7-4618-918f-9bc83cd39e5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember_bcdebc1a-9e38-4f10-876f-2014ea50aff7" xlink:href="lfvn-20220331.xsd#lfvn_TwoThousandSeventeenLongTermIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_a53f414b-b9b3-48a1-af27-27509c62cec9" xlink:to="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember_bcdebc1a-9e38-4f10-876f-2014ea50aff7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember_c0b9e10d-e3bc-4106-8191-57dde2f81680" xlink:href="lfvn-20220331.xsd#lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_a53f414b-b9b3-48a1-af27-27509c62cec9" xlink:to="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember_c0b9e10d-e3bc-4106-8191-57dde2f81680" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandEighteenPerformancePlanMember_859e451a-9286-435c-b0b7-46ad45a68d2f" xlink:href="lfvn-20220331.xsd#lfvn_TwoThousandEighteenPerformancePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_a53f414b-b9b3-48a1-af27-27509c62cec9" xlink:to="loc_lfvn_TwoThousandEighteenPerformancePlanMember_859e451a-9286-435c-b0b7-46ad45a68d2f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EmployeeStockPurchasePlanMember_b029f641-b2a6-493a-a242-20b4bed33083" xlink:href="lfvn-20220331.xsd#lfvn_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_a53f414b-b9b3-48a1-af27-27509c62cec9" xlink:to="loc_lfvn_EmployeeStockPurchasePlanMember_b029f641-b2a6-493a-a242-20b4bed33083" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_445b10fd-baba-4e19-8507-d7f866b83921" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_66449899-d019-4e60-b88e-923fea7cfd19" xlink:to="loc_srt_RangeAxis_445b10fd-baba-4e19-8507-d7f866b83921" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_445b10fd-baba-4e19-8507-d7f866b83921_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_445b10fd-baba-4e19-8507-d7f866b83921" xlink:to="loc_srt_RangeMember_445b10fd-baba-4e19-8507-d7f866b83921_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fb181578-dadc-44b1-9e54-cde352fb0ee5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_445b10fd-baba-4e19-8507-d7f866b83921" xlink:to="loc_srt_RangeMember_fb181578-dadc-44b1-9e54-cde352fb0ee5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3a732bfa-7a10-43aa-b6e8-ab2d2630d7e5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fb181578-dadc-44b1-9e54-cde352fb0ee5" xlink:to="loc_srt_MinimumMember_3a732bfa-7a10-43aa-b6e8-ab2d2630d7e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c285a58a-6dbc-420d-b2d8-808989e284e6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fb181578-dadc-44b1-9e54-cde352fb0ee5" xlink:to="loc_srt_MaximumMember_c285a58a-6dbc-420d-b2d8-808989e284e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6360ba25-e65f-4528-b122-081f41d53ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_66449899-d019-4e60-b88e-923fea7cfd19" xlink:to="loc_us-gaap_AwardTypeAxis_6360ba25-e65f-4528-b122-081f41d53ef2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6360ba25-e65f-4528-b122-081f41d53ef2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6360ba25-e65f-4528-b122-081f41d53ef2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6360ba25-e65f-4528-b122-081f41d53ef2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3aaeea05-23cd-48ba-a999-551a0680fbbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6360ba25-e65f-4528-b122-081f41d53ef2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3aaeea05-23cd-48ba-a999-551a0680fbbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_5ebff6dc-c930-4889-8717-6344fed88df4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3aaeea05-23cd-48ba-a999-551a0680fbbe" xlink:to="loc_us-gaap_PerformanceSharesMember_5ebff6dc-c930-4889-8717-6344fed88df4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="lfvn-20220331.xsd#RelatedPartyTransactionsDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/RelatedPartyTransactionsDetails" xlink:type="extended" id="i7c630db8c9f443bc82f22421e6d12b4a_RelatedPartyTransactionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_a74700aa-5932-447b-935e-c661af9dab7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_MembersOfBoardOfDirectorsServingOnRelatedPartyBoardOfDirectors_035f0d5a-1b57-48ec-b45f-f1a045ef9f30" xlink:href="lfvn-20220331.xsd#lfvn_MembersOfBoardOfDirectorsServingOnRelatedPartyBoardOfDirectors"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_a74700aa-5932-447b-935e-c661af9dab7a" xlink:to="loc_lfvn_MembersOfBoardOfDirectorsServingOnRelatedPartyBoardOfDirectors_035f0d5a-1b57-48ec-b45f-f1a045ef9f30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_cef6c45f-15c1-4901-b05e-023124e93009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_a74700aa-5932-447b-935e-c661af9dab7a" xlink:to="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_cef6c45f-15c1-4901-b05e-023124e93009" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_bfb4980e-08b2-4d41-890b-791b164f3eac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_a74700aa-5932-447b-935e-c661af9dab7a" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_bfb4980e-08b2-4d41-890b-791b164f3eac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b8756bae-b1cf-4808-8ef8-1c76d9813279" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_bfb4980e-08b2-4d41-890b-791b164f3eac" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b8756bae-b1cf-4808-8ef8-1c76d9813279" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_b8756bae-b1cf-4808-8ef8-1c76d9813279_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b8756bae-b1cf-4808-8ef8-1c76d9813279" xlink:to="loc_us-gaap_RelatedPartyDomain_b8756bae-b1cf-4808-8ef8-1c76d9813279_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_8eb3ad64-f7b6-416c-a24f-ab8790568b16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b8756bae-b1cf-4808-8ef8-1c76d9813279" xlink:to="loc_us-gaap_RelatedPartyDomain_8eb3ad64-f7b6-416c-a24f-ab8790568b16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_258da812-1673-48a2-a2fe-6ec551e938b2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_8eb3ad64-f7b6-416c-a24f-ab8790568b16" xlink:to="loc_srt_AffiliatedEntityMember_258da812-1673-48a2-a2fe-6ec551e938b2" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>lfvn-20220331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:638a0b91-4766-4439-9960-cd7043420117,g:40b96704-8fd2-45ed-83b9-f73156e5e4bc-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_f1510421-5763-42f8-95de-53f68170cada_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ac3b38b0-345e-4c5c-9390-a0cd2b7a2ccd_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase common stock amount authorized (up to)</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_3b788633-a130-485a-b845-2c882c37ffeb_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_9add7096-2994-417c-9df4-16b7217bab07_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized_ea2c8d3d-8e06-4cfa-b8e3-b5009d5a2a05_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency transaction loss, realized</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), Realized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_91ac365c-b2ab-4c13-a710-af5da6da4ea8_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_a60911f7-b4af-4c43-8b30-b3db3b174f34_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_2f32ecd7-bfec-47cd-8f2a-9d11ecf28816_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term assets</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract" xlink:to="lab_us-gaap_AssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_7d97fb63-6031-42ae-90b7-f604a96420d7_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_11da1533-a902-4801-8fcb-49934bb23459_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_3de277a1-0f73-479c-9ede-24a459ce5bcf_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_1d0d1ced-0683-4a0b-82ee-df1bb76c3d05_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_6ba51c7f-35d1-48ec-9bb8-3888a6c2939f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_eebea3e0-380e-484b-9b3b-b8ee631e9b17_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_e105f919-21e7-4fb6-92cc-9bd6f9dc67cf_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_548564a7-2378-43e2-aabe-0cf93b167139_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_2bd960ed-5c0c-4bee-aca9-260d8eace3a5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio_57276051-f223-458f-b1c6-cf92c01502cb_terseLabel_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant, total liabilities to tangible net worth ratio (not greater than)</link:label>
    <link:label id="lab_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio_label_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Total Liabilities To Tangible Net Worth Ratio</link:label>
    <link:label id="lab_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio_documentation_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Total Liabilities To Tangible Net Worth Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio" xlink:href="lfvn-20220331.xsd#lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio" xlink:to="lab_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_4598cb78-ba07-41b2-9945-5531d31a700e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_5ab72526-6158-4b93-8e32-f40763264385_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_b3635f1a-e584-41b0-bbab-129a1838f4b4_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_5cacd9d1-539d-4987-b0a0-22968209d00e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_b52fa21b-bd88-475c-8de3-7052b6234127_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_b31ea08f-e030-428f-abd5-4ea4b48a99f2_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_4b0e2de3-6c75-43d5-ab6f-55877ed7fda5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum number of shares per employee (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_bd1a4538-481d-4aef-b7d0-1f7921811922_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_7f3a86af-9baa-4615-b07e-558c41778ec0_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_8abfaf42-6abc-4f2f-a6f7-8c6178110c64_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_dd6b9744-8b12-4f39-9df5-20df9e459ecd_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_b9ea6acc-8b2f-4fce-b12c-3025ff034709_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_7b6c941a-3965-4011-9413-795223d4aeac_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_bd6763e3-7f48-4b33-82b4-fa704d288279_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_d5d7d2c1-b7d3-49fd-8d62-4427be3b6d56_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0f0b0c8f-7880-4bf1-b62d-5995f9ca3d9e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_90a2f23b-3ff9-43fb-87a2-b2ce781e67dc_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_eadffa76-45b4-4d7a-bef8-10d5ff9fe00c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_caa73cd2-1b53-4e1b-8800-32633b3b4369_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for issuance under the ESPP (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3b1fa7f8-c807-44bc-9126-95b513f59fbc_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Cash and Cash Equivalents:</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_ce3c7c61-8078-4a22-8636-29c117fd1250_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials and Supplies, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_398f2575-c030-45c6-b787-4c12bcbf5853_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_896a7ed4-405f-4e32-9b90-2d96b9843b08_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_c92bbff5-ff70-4405-81d8-d1ae22be3555_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e9530ec5-7272-4c79-ba5f-f6a581c82fa5_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_002b49b0-771f-4dcf-9006-9e29443b8c83_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_639dc81f-aed6-470e-a286-211ee0d16714_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_4ed32d34-3954-4d3b-a967-9bb8df6daecd_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyClaimsDismissedNumber_809f8ce9-6e70-4526-a16f-14fb1e966dce_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsDismissedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims dismissed</link:label>
    <link:label id="lab_us-gaap_LossContingencyClaimsDismissedNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsDismissedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Dismissed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsDismissedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyClaimsDismissedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyClaimsDismissedNumber" xlink:to="lab_us-gaap_LossContingencyClaimsDismissedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_7511fd2b-86ab-4f5b-bccf-cb60d748a71d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_d67cc5e0-da21-49c8-bcec-e1b7a7d3ddec_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_d30a0cdd-50aa-46f2-9ca5-af24f68f63e9_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_415c96ba-4487-4285-9bb0-a45be66b3d5e_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_3a6eab3d-1404-4b2b-a354-79d0257cf75d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right to purchase common stock, minimum price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_065b8152-d7dd-41a8-b68c-4d1f70f7bae1_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_edf97d53-e9df-4b70-85eb-dd876190fc4f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_b54dfb02-c1f5-46d3-82c7-eba82920a601_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_5b6111e6-d95f-434a-982b-e37a689d66c7_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_fd581273-394e-4972-84de-65ac6c5a2983_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_8d09bfc3-5d16-43bf-ad47-8a9b37d1240c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_91524f0a-3947-49a3-bf87-2ceb2d81175a_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_6edd25e2-4dbd-421d-948d-fe59581a132b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_438e4bbc-ea55-47e5-9396-e1fa1908781e_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of company stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_df521bf2-9dba-4df0-8ef6-d28f2e0e0964_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_3bd7a619-b1e9-4b7b-91a3-586be7b08cf2_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining authorized repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio_c48b75a1-e0ee-459f-b1e0-96815e471479_terseLabel_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant, fixed charge coverage ratio</link:label>
    <link:label id="lab_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio_label_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Fixed Charge Coverage Ratio</link:label>
    <link:label id="lab_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio_documentation_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Fixed Charge Coverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio" xlink:href="lfvn-20220331.xsd#lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio" xlink:to="lab_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_d940e789-4763-4304-a2e8-1a899f1818a8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_793b3036-6fd6-452e-9d18-793141467d2e_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from EPS calculation (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_736a7638-bc79-4daf-b2cc-4c42baa68e31_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital_6944fd43-d59b-46ea-98ca-242cb5257b3e_terseLabel_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant, required minimum working capital</link:label>
    <link:label id="lab_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital_label_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Required Minimum Working Capital</link:label>
    <link:label id="lab_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital_documentation_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Required Minimum Working Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital" xlink:href="lfvn-20220331.xsd#lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital" xlink:to="lab_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan_79445a6b-7309-4aba-8d34-e6f5681a5e22_terseLabel_en-US" xlink:label="lab_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from common stock issued under employee stock purchase plan</link:label>
    <link:label id="lab_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan</link:label>
    <link:label id="lab_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan_documentation_en-US" xlink:label="lab_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" xlink:href="lfvn-20220331.xsd#lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" xlink:to="lab_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_c29685a4-a767-44c7-b7f1-da5a28ae62e4_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities held without readily determinable value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_ed8770c7-3502-4fbd-895f-8ec2f5ed3f18_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember_348ef76a-f0ac-4f1d-99ad-88c659c88245_terseLabel_en-US" xlink:label="lab_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2007 Long-Term Incentive Plan</link:label>
    <link:label id="lab_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember_label_en-US" xlink:label="lab_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Seven Long Term Incentive Plan [Member]</link:label>
    <link:label id="lab_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember_documentation_en-US" xlink:label="lab_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand and seven long term incentive plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember" xlink:href="lfvn-20220331.xsd#lfvn_TwoThousandAndSevenLongTermIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember" xlink:to="lab_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_0bef3c6a-443c-4ab1-8c2a-fb2ffcce0657_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_384e3286-afd5-4036-9a8e-b0cd21b7405d_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right to purchase common stock, non-vested and outstanding, exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_f109909f-abe5-411b-8dff-be21fcf4d562_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt conversion, converted instrument, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1f8fac25-491a-42cc-80eb-204c7bfacd03_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_0eb29c61-60ed-4d0c-b52f-1777f796f4da_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments, realized loss</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_e0753d23-dbf3-4ab4-9753-6470a35f742e_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_acd807f6-3c35-46fd-80d4-a0ec1a4fa89b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of company stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_7160edbc-8282-4893-9870-68406c0fb2bd_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program shares repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd60422f-5caf-4a11-b2b5-376e856b86eb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_ddfb4df0-3727-47d2-8a47-0cf1f07dcc48_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_abd5da54-2709-476d-b1c9-75fbe167ab06_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_CommissionAndIncentives_949846a8-7f8c-44ed-b452-c70648e9a852_terseLabel_en-US" xlink:label="lab_lfvn_CommissionAndIncentives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commissions and incentives</link:label>
    <link:label id="lab_lfvn_CommissionAndIncentives_label_en-US" xlink:label="lab_lfvn_CommissionAndIncentives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission And Incentives</link:label>
    <link:label id="lab_lfvn_CommissionAndIncentives_documentation_en-US" xlink:label="lab_lfvn_CommissionAndIncentives" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses related to commissions and other incentives earned by independent distributors. Commission and incentive expenses include sales commissions paid to our independent distributors, special incentives, costs for incentive trip and other rewards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CommissionAndIncentives" xlink:href="lfvn-20220331.xsd#lfvn_CommissionAndIncentives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_CommissionAndIncentives" xlink:to="lab_lfvn_CommissionAndIncentives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_0d4653c9-c58a-4f31-915f-3abf61ff16a5_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_TwoThousandEighteenPerformancePlanMember_7989cd49-9c55-4ba4-8dfe-f02cbc5dfa18_terseLabel_en-US" xlink:label="lab_lfvn_TwoThousandEighteenPerformancePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Performance Plan</link:label>
    <link:label id="lab_lfvn_TwoThousandEighteenPerformancePlanMember_label_en-US" xlink:label="lab_lfvn_TwoThousandEighteenPerformancePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Eighteen Performance Plan [Member]</link:label>
    <link:label id="lab_lfvn_TwoThousandEighteenPerformancePlanMember_documentation_en-US" xlink:label="lab_lfvn_TwoThousandEighteenPerformancePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Eighteen Performance Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandEighteenPerformancePlanMember" xlink:href="lfvn-20220331.xsd#lfvn_TwoThousandEighteenPerformancePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_TwoThousandEighteenPerformancePlanMember" xlink:to="lab_lfvn_TwoThousandEighteenPerformancePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_1775c7c8-e9c8-4bdf-8ed9-70e28ab9eafd_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_7e925a83-9311-4af4-9992-5e68c77002de_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_3320353a-ddb6-4a64-9406-d3a65c9b4c2e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_4a897541-a531-4a26-ba8f-324c3e885681_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt_a9c4b420-4ab7-4c46-bd54-08725dc870a4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt conversion, original debt, interest rate of debt (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt_label_en-US" xlink:label="lab_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Original Debt, Interest Rate of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionOriginalDebtInterestRateOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt" xlink:to="lab_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_64c30681-04ea-4305-b1e8-838921a1b17e_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock &#8212; par value $0.0001 per share, 5,000 shares authorized, no shares issued or outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_428290de-7223-48f8-a737-adb697d21a91_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party purchase</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Purchases from Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b619863c-b308-4a1c-ae5d-f2b23f94bddb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, net of awards expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_12467cbe-727c-4dca-9500-cc0d28668286_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under equity award plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_4afe50c4-a4cf-46a1-a216-c87e05e6dd87_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_257b5446-0c24-4ae3-804e-893c3a880464_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_DebtInstrumentFloorInterestRate_1cec82fd-eab5-46af-87e6-b2171a10aa47_terseLabel_en-US" xlink:label="lab_lfvn_DebtInstrumentFloorInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floor interest rate (as a percent)</link:label>
    <link:label id="lab_lfvn_DebtInstrumentFloorInterestRate_label_en-US" xlink:label="lab_lfvn_DebtInstrumentFloorInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Floor Interest Rate</link:label>
    <link:label id="lab_lfvn_DebtInstrumentFloorInterestRate_documentation_en-US" xlink:label="lab_lfvn_DebtInstrumentFloorInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Floor Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentFloorInterestRate" xlink:href="lfvn-20220331.xsd#lfvn_DebtInstrumentFloorInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_DebtInstrumentFloorInterestRate" xlink:to="lab_lfvn_DebtInstrumentFloorInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_65916fe5-4cd0-46c3-8433-4f88ffe9ac0e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_f0ddf432-bd6a-41da-884f-14b05df8b7e7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted_e0cd90b7-8410-490c-90e9-6d0421e970c4_terseLabel_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount in excess of fair market value of stock for option not to be granted</link:label>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted_label_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Amount In Excess Of Fair Market Value Of Stock For Option Not To Be Granted</link:label>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted_documentation_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Amount In Excess Of Fair Market Value Of Stock For Option Not To Be Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" xlink:href="lfvn-20220331.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" xlink:to="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_1f920af5-03ce-48bc-82f6-1697c7a7851e_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price of common stock (as a percent)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember_3b44a498-7233-4541-a357-3d158004b92e_terseLabel_en-US" xlink:label="lab_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash accounts held primarily at One Financial Institution</link:label>
    <link:label id="lab_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember_label_en-US" xlink:label="lab_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Accounts Held Primarily At Financial Institution [Member]</link:label>
    <link:label id="lab_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember_documentation_en-US" xlink:label="lab_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Accounts Held Primarily At Financial Institution [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember" xlink:href="lfvn-20220331.xsd#lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember" xlink:to="lab_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ede3b4a0-0e44-44d5-b6e1-a9ad6970e9d2_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_fda13ec6-b8b1-46f5-bf85-3161c55715f7_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_6ca3ed03-0d07-4b78-b49e-d53fbf2a07ef_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, All Other Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_3765e9d5-55e4-4cbc-a528-68916217382d_terseLabel_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-lived Assets by Geographic Areas</link:label>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived Assets by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_7e496307-9a2a-45d4-80a9-63f9433315b3_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2c621a5c-01f9-4887-8880-d066a551cb38_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for lease obligations</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_fa81f966-d1f5-420e-849b-444b0bbb3e51_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_e8debc77-eed9-4979-90e5-a74271632ab1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Computation of Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_373f7a68-8b42-49c7-bdef-c83aebde2558_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum employee subscription rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1c00c81e-be0e-4c3b-9331-7297fee2ac8b_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_d509a893-e7b2-424a-b246-cb4288b94251_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares canceled or surrendered as payment of tax withholding and other (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_b721c526-ae5b-4898-beab-a3072b024aae_terseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares canceled or surrendered as payment of tax withholding (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDisclosures_61af1a7d-75b5-45b5-9b17-1f733393130d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDisclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_LossContingencyDisclosures_label_en-US" xlink:label="lab_us-gaap_LossContingencyDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDisclosures" xlink:to="lab_us-gaap_LossContingencyDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5e2a3e70-3028-4dcc-a0e4-edec750431f2_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_92cf0fb0-4107-40be-b93e-d3aa75b7d2a7_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_8bcbb82b-fe10-41de-922c-4e81e799093e_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL ASSETS</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_4e717f07-b05a-433a-8418-0d72ad1544ba_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_0598f074-66ff-4930-93e9-5c0e4915962c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_827782aa-4b20-41ed-a8e5-e0de6ecd18c3_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_44e2a241-65a5-4154-8342-46b14ee816a6_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_aa7b1ef8-67b5-4527-ad0a-ac98d53af08a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share, basic (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_1fc39914-e270-43b2-b96c-bccab987a5d2_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_793cb25c-087e-4f60-9f85-406e0753ac90_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending claims</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_a06f719e-f143-43f8-b55c-c2ffdb8c678f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_ec41796c-a4a0-4a37-aeb1-8bca356b7d81_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities_49cb10ad-f58c-4735-a05c-ddad01d75802_negatedLabel_en-US" xlink:label="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in share-based compensation included in other accrued expenses</link:label>
    <link:label id="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities_label_en-US" xlink:label="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Increase (Decrease) of Share-based Liabilities</link:label>
    <link:label id="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities_documentation_en-US" xlink:label="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Increase (Decrease) of Share-based Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities" xlink:href="lfvn-20220331.xsd#lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities" xlink:to="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_40975e63-ffb4-4a64-90e1-7398c6b40603_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_58165bc2-e0f2-4514-a301-d7ea91853669_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_b5a0b26f-4b24-4860-aa80-6c47d7e25728_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5aa07af-291d-4129-90cc-951dd7db414d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_df9ebdbf-f433-46f6-a3f4-a007ff107f93_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_bcd71fe7-b0a0-408f-8895-9a1310bf45b5_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_9b363c33-4e5e-44a7-bdc0-d693736f80bd_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UsTreasuryUstInterestRateMember_50a4b890-a349-4eb6-9814-e56935410354_terseLabel_en-US" xlink:label="lab_us-gaap_UsTreasuryUstInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury (UST) Interest Rate</link:label>
    <link:label id="lab_us-gaap_UsTreasuryUstInterestRateMember_label_en-US" xlink:label="lab_us-gaap_UsTreasuryUstInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury (UST) Interest Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UsTreasuryUstInterestRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UsTreasuryUstInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UsTreasuryUstInterestRateMember" xlink:to="lab_us-gaap_UsTreasuryUstInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_f7ceefe8-8068-4f82-91e4-550700e2464f_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_ce833bed-fb64-4dbb-96f1-b8b0eeb385f2_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares canceled or surrendered as payment of tax withholding and other</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_f9e83b5b-63bd-4af2-938b-02e003ad7281_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_ec68baef-7578-40d7-8a3e-b5a5ef7f840c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash outflows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_NumberOfGeographicSegments_cd5e5acf-8049-41fa-9f08-6b8725fe9e5f_terseLabel_en-US" xlink:label="lab_lfvn_NumberOfGeographicSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of geographic segments</link:label>
    <link:label id="lab_lfvn_NumberOfGeographicSegments_label_en-US" xlink:label="lab_lfvn_NumberOfGeographicSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Geographic Segments</link:label>
    <link:label id="lab_lfvn_NumberOfGeographicSegments_documentation_en-US" xlink:label="lab_lfvn_NumberOfGeographicSegments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of geographic segments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NumberOfGeographicSegments" xlink:href="lfvn-20220331.xsd#lfvn_NumberOfGeographicSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_NumberOfGeographicSegments" xlink:to="lab_lfvn_NumberOfGeographicSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_6943243b-de13-419f-b578-d7d456b6667d_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_4a0d8d89-c4e6-4f6b-8d96-9025da748ee7_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Costs</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a3115019-4529-4a3d-9f1b-2b40970fbb06_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_17d069a1-e237-4abc-8dc2-ebc06bd9a074_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted-average common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_47f905c6-fed9-4010-9218-e291bfca6c64_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_83ce6ed5-46f7-4313-9309-7bf5e8047ef1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share, diluted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_4a457158-b217-40a1-b29e-85427e73fc7e_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_693b2cde-e68f-4c6e-96ca-9e243a1257bb_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_42b2f5d1-bcb9-4fc1-ab58-2f90dc2ba976_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bad debt expenses</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_HandlingAndRestockingFeePercentage_ec867514-2610-4086-9325-3c9a142202a8_terseLabel_en-US" xlink:label="lab_lfvn_HandlingAndRestockingFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Handling and restocking fee, percentage (as a percent)</link:label>
    <link:label id="lab_lfvn_HandlingAndRestockingFeePercentage_label_en-US" xlink:label="lab_lfvn_HandlingAndRestockingFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Handling and Restocking Fee, Percentage</link:label>
    <link:label id="lab_lfvn_HandlingAndRestockingFeePercentage_documentation_en-US" xlink:label="lab_lfvn_HandlingAndRestockingFeePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Handling and Restocking Fee, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_HandlingAndRestockingFeePercentage" xlink:href="lfvn-20220331.xsd#lfvn_HandlingAndRestockingFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_HandlingAndRestockingFeePercentage" xlink:to="lab_lfvn_HandlingAndRestockingFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_db59b492-bd48-4193-9d8f-ec3b4e4b9a84_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_8d777b6e-6abd-4a16-8801-0bbde8802abd_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_71efac9d-57b6-44fe-9ba8-44521fe0a50c_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_66ba73af-81f0-490e-808d-10d58cff6d25_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows from Investing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_3227647f-8cda-4dd3-a29a-6b4e340e897e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Used in Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a5101db4-69c6-4bf1-9f70-45de76b645c2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember_79f39de5-3b1a-467a-8301-b194dbc6a946_terseLabel_en-US" xlink:label="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Long-Term Incentive Plan Excluding 2010 Long-Term Incentive Plan</link:label>
    <link:label id="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember_label_en-US" xlink:label="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Seventeen Long Term Incentive Plan, Excluding Two Thousand And Ten Long Term Incentive Plan [Member]</link:label>
    <link:label id="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember_documentation_en-US" xlink:label="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Seventeen Long Term Incentive Plan, Excluding Two Thousand And Ten Long Term Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" xlink:href="lfvn-20220331.xsd#lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" xlink:to="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_484368a0-dcff-4f52-a33c-1e20e5d0e416_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_229b3e6c-d16c-46e7-9061-6b2e97fe229a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based payment award, vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_ba213e9b-dd8e-40f6-85e1-4a6b60a48411_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_3af956de-4150-4cbd-8937-9c156bccaef9_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_38618e20-d1f6-4e55-82a3-16b944501aab_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued expenses</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AmericasMember_8eb74968-7b9b-45b2-953e-d90ef6d349fa_terseLabel_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas</link:label>
    <link:label id="lab_srt_AmericasMember_label_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AmericasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AmericasMember" xlink:to="lab_srt_AmericasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_d9bc756c-2218-44d5-8b6d-af6fc2595753_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_RawMaterialsPercentOfTotalInventory_f564867f-7dfa-4693-b45c-72aaa3657e61_terseLabel_en-US" xlink:label="lab_lfvn_RawMaterialsPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials, percent of inventory (in percentage)</link:label>
    <link:label id="lab_lfvn_RawMaterialsPercentOfTotalInventory_label_en-US" xlink:label="lab_lfvn_RawMaterialsPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw Materials, Percent Of Total Inventory</link:label>
    <link:label id="lab_lfvn_RawMaterialsPercentOfTotalInventory_documentation_en-US" xlink:label="lab_lfvn_RawMaterialsPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw Materials, Percent Of Total Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_RawMaterialsPercentOfTotalInventory" xlink:href="lfvn-20220331.xsd#lfvn_RawMaterialsPercentOfTotalInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_RawMaterialsPercentOfTotalInventory" xlink:to="lab_lfvn_RawMaterialsPercentOfTotalInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_3d3c6358-cc48-4c55-baa1-fb4e7a7276c4_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_e2210422-73ea-45cc-9672-bb50a955f6dd_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_80c0691a-63de-4f5e-be77-a4afa8af9240_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_a54392b8-f777-4a56-8230-aebc64d5a921_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_76b24aa8-a518-4e2d-84ee-f6058e5a23c9_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_cdb0c0dc-617a-4700-9d66-e5de78e854a7_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_098478aa-d428-4cd9-990f-0c9b953d0b14_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Loss) Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_8d9b5c52-58dd-422b-80ba-975b36e19386_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_6eee9f1e-4312-445a-80ee-cb02e768b87d_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermInvestments_d96604d0-6ec1-4af9-a6ba-6d56df6779ad_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_label_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermInvestments" xlink:to="lab_us-gaap_LongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_75381d38-d1d0-403c-ab97-87afbe7d0d21_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_InventoryFinishedGoodsPercentOfTotalInventory_6a4c2c8a-7501-45ee-9b43-8b53e397b71c_terseLabel_en-US" xlink:label="lab_lfvn_InventoryFinishedGoodsPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods, percent of inventory (in percentage)</link:label>
    <link:label id="lab_lfvn_InventoryFinishedGoodsPercentOfTotalInventory_label_en-US" xlink:label="lab_lfvn_InventoryFinishedGoodsPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Percent Of Total Inventory</link:label>
    <link:label id="lab_lfvn_InventoryFinishedGoodsPercentOfTotalInventory_documentation_en-US" xlink:label="lab_lfvn_InventoryFinishedGoodsPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Percent Of Total Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_InventoryFinishedGoodsPercentOfTotalInventory" xlink:href="lfvn-20220331.xsd#lfvn_InventoryFinishedGoodsPercentOfTotalInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_InventoryFinishedGoodsPercentOfTotalInventory" xlink:to="lab_lfvn_InventoryFinishedGoodsPercentOfTotalInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_5bf9ec8e-b25f-4b06-bc75-4770d0a44ce4_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_0c2eaa25-7296-4b49-9c85-b4ccfb89c4ab_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3f8627c4-1163-497b-9cf4-65bb922f4ba2_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_5cc7db66-752d-44ba-958f-7119e288d7e7_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_c426f147-5e68-48d8-a0af-8176e1b55eb9_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_2106402d-1a6a-49f7-bff2-8b5ad645fb65_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under equity award plans (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_c6fbe22f-794c-4df3-9df1-5dc09bf99ff0_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization and Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_bde784d9-ee0b-4410-a504-19ea691b37c4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_3bc1bce0-af42-454f-9f38-657b7c424fc4_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AffiliatedEntityMember_e751654b-10de-4075-8bf5-723f06d65e33_terseLabel_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GEG</link:label>
    <link:label id="lab_srt_AffiliatedEntityMember_label_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Entity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AffiliatedEntityMember" xlink:to="lab_srt_AffiliatedEntityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_7707f208-4f93-4212-a48a-6785f2c8de92_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_27de2f9d-9d36-4154-af71-c330e6531ff2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_MoneyBackGuaranteePeriod_231bba5d-d5e4-49d9-84e2-f5c8d902b50b_terseLabel_en-US" xlink:label="lab_lfvn_MoneyBackGuaranteePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money back guarantee period</link:label>
    <link:label id="lab_lfvn_MoneyBackGuaranteePeriod_label_en-US" xlink:label="lab_lfvn_MoneyBackGuaranteePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Back Guarantee Period</link:label>
    <link:label id="lab_lfvn_MoneyBackGuaranteePeriod_documentation_en-US" xlink:label="lab_lfvn_MoneyBackGuaranteePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money back guarantee period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_MoneyBackGuaranteePeriod" xlink:href="lfvn-20220331.xsd#lfvn_MoneyBackGuaranteePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_MoneyBackGuaranteePeriod" xlink:to="lab_lfvn_MoneyBackGuaranteePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7d0dbf04-d861-4c20-a7e8-cf845b3594b4_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Effect on Cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_3b558bc2-509b-466a-ac0e-0a4efa11cddf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_90d3c6a4-0e5e-4a24-bf68-3451a47f047d_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTextBlock_23911799-1ee7-4763-bb1e-1cabc954c7ac_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gig Economy Group Investment</link:label>
    <link:label id="lab_us-gaap_InvestmentTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTextBlock" xlink:to="lab_us-gaap_InvestmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_be89eeca-6f37-41a5-a265-3141b2655366_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_OperatingLeaseRightOfUseAssetAbandonmentExpense_708c85eb-4a6c-4189-a31b-0c56cd71b57e_terseLabel_en-US" xlink:label="lab_lfvn_OperatingLeaseRightOfUseAssetAbandonmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abandonment expense</link:label>
    <link:label id="lab_lfvn_OperatingLeaseRightOfUseAssetAbandonmentExpense_label_en-US" xlink:label="lab_lfvn_OperatingLeaseRightOfUseAssetAbandonmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right of Use Asset, Abandonment Expense</link:label>
    <link:label id="lab_lfvn_OperatingLeaseRightOfUseAssetAbandonmentExpense_documentation_en-US" xlink:label="lab_lfvn_OperatingLeaseRightOfUseAssetAbandonmentExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right of Use Asset, Abandonment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_OperatingLeaseRightOfUseAssetAbandonmentExpense" xlink:href="lfvn-20220331.xsd#lfvn_OperatingLeaseRightOfUseAssetAbandonmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_OperatingLeaseRightOfUseAssetAbandonmentExpense" xlink:to="lab_lfvn_OperatingLeaseRightOfUseAssetAbandonmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_3118f2c5-9955-445a-867d-7ca189776e91_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_13aa83f3-8deb-4fa2-8ec6-d47e776d5523_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Cash Investing and Financing Activities:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_b933d220-5884-4816-8784-ddd10eca295c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of additional shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember_032b5ecf-1ef0-4b44-9281-3137cc047e12_terseLabel_en-US" xlink:label="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Long-Term Incentive Plan</link:label>
    <link:label id="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember_label_en-US" xlink:label="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Seventeen Long Term Incentive Plan [Member]</link:label>
    <link:label id="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember_documentation_en-US" xlink:label="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Seventeen Long Term Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember" xlink:href="lfvn-20220331.xsd#lfvn_TwoThousandSeventeenLongTermIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember" xlink:to="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_36f28b06-f8f3-44f6-a9c6-b29d9445a19d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_979823f6-f77e-4dc1-8b8d-8a3cbdf0e631_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_f7a44b4c-df71-408d-86a1-ea58bc004993_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_MembersOfBoardOfDirectorsServingOnRelatedPartyBoardOfDirectors_9af55067-7d77-4e2a-b116-97ff9cd0600d_terseLabel_en-US" xlink:label="lab_lfvn_MembersOfBoardOfDirectorsServingOnRelatedPartyBoardOfDirectors" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Members of company board of directors serving on GEG board of directors</link:label>
    <link:label id="lab_lfvn_MembersOfBoardOfDirectorsServingOnRelatedPartyBoardOfDirectors_label_en-US" xlink:label="lab_lfvn_MembersOfBoardOfDirectorsServingOnRelatedPartyBoardOfDirectors" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Members of Board of Directors Serving on Related Party Board of Directors</link:label>
    <link:label id="lab_lfvn_MembersOfBoardOfDirectorsServingOnRelatedPartyBoardOfDirectors_documentation_en-US" xlink:label="lab_lfvn_MembersOfBoardOfDirectorsServingOnRelatedPartyBoardOfDirectors" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Members of Board of Directors Serving on Related Party Board of Directors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_MembersOfBoardOfDirectorsServingOnRelatedPartyBoardOfDirectors" xlink:href="lfvn-20220331.xsd#lfvn_MembersOfBoardOfDirectorsServingOnRelatedPartyBoardOfDirectors"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_MembersOfBoardOfDirectorsServingOnRelatedPartyBoardOfDirectors" xlink:to="lab_lfvn_MembersOfBoardOfDirectorsServingOnRelatedPartyBoardOfDirectors" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_19854821-42f2-4df5-a5ad-5185da61a667_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_4a5c94be-29e3-40fa-bc7a-1bb4ef4a73b0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax asset</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm_e8c46fb7-3b3e-4a63-a127-ab6983973e42_terseLabel_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual term of stock options granted</link:label>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm_label_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Contractual Term</link:label>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm_documentation_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm" xlink:href="lfvn-20220331.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm" xlink:to="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_c8ac3a8c-f19b-4d41-aa64-55a4b6b15840_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_be58a1ba-8499-4f39-bb3a-429c06bd9cdc_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of term loan</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_5e078c79-84fa-4e2f-9776-63cd29904750_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_f4a24385-debd-4098-a42d-a21003ad04c3_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_16e7dcf9-7cee-4869-a247-ce9c377033e8_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_9b4b9fa3-67d0-4340-9a6b-039fbc9275fc_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_04955c30-6838-42e7-bb0d-44b0c10062e1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_NotesReceivableRelatedPartyMaximumCommitment_4d56a77e-3968-4582-b983-65afcff38cf0_terseLabel_en-US" xlink:label="lab_lfvn_NotesReceivableRelatedPartyMaximumCommitment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes receivable, related party, maximum commitment</link:label>
    <link:label id="lab_lfvn_NotesReceivableRelatedPartyMaximumCommitment_label_en-US" xlink:label="lab_lfvn_NotesReceivableRelatedPartyMaximumCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Related Party, Maximum Commitment</link:label>
    <link:label id="lab_lfvn_NotesReceivableRelatedPartyMaximumCommitment_documentation_en-US" xlink:label="lab_lfvn_NotesReceivableRelatedPartyMaximumCommitment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Related Party, Maximum Commitment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NotesReceivableRelatedPartyMaximumCommitment" xlink:href="lfvn-20220331.xsd#lfvn_NotesReceivableRelatedPartyMaximumCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_NotesReceivableRelatedPartyMaximumCommitment" xlink:to="lab_lfvn_NotesReceivableRelatedPartyMaximumCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_da5996a3-9a65-4df1-b048-f7b832cece9f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_fbed8aee-5ef5-4206-a906-812a38b2a123_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_c2120772-edb2-41b9-96a0-dc50fc8b67d6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_37b72752-235e-4f32-93c1-9eb6ab46fb59_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofVestingInstallments_9735d2ed-b0ea-4656-b365-f4eff76ca505_terseLabel_en-US" xlink:label="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofVestingInstallments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of vesting installments</link:label>
    <link:label id="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofVestingInstallments_label_en-US" xlink:label="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofVestingInstallments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Vesting Installments</link:label>
    <link:label id="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofVestingInstallments_documentation_en-US" xlink:label="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofVestingInstallments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Vesting Installments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofVestingInstallments" xlink:href="lfvn-20220331.xsd#lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofVestingInstallments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofVestingInstallments" xlink:to="lab_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofVestingInstallments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_3a682d83-1269-4798-969e-a459735941f6_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_198ee768-404a-4e95-953b-59437b3b6024_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_a7f51e07-59f5-437b-b788-540c13bd45d6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_8346c26e-3225-4c65-98f8-b92c270d5df3_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_IncreaseDecreaseInPropertyAndEquipmentAndLeaseLiabilitiesFromLeaseIncentives_3d3e78c5-3849-4242-96e3-7beab820523f_terseLabel_en-US" xlink:label="lab_lfvn_IncreaseDecreaseInPropertyAndEquipmentAndLeaseLiabilitiesFromLeaseIncentives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in property and equipment and lease liabilities from lease incentives</link:label>
    <link:label id="lab_lfvn_IncreaseDecreaseInPropertyAndEquipmentAndLeaseLiabilitiesFromLeaseIncentives_label_en-US" xlink:label="lab_lfvn_IncreaseDecreaseInPropertyAndEquipmentAndLeaseLiabilitiesFromLeaseIncentives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Property and Equipment and Lease Liabilities From Lease Incentives</link:label>
    <link:label id="lab_lfvn_IncreaseDecreaseInPropertyAndEquipmentAndLeaseLiabilitiesFromLeaseIncentives_documentation_en-US" xlink:label="lab_lfvn_IncreaseDecreaseInPropertyAndEquipmentAndLeaseLiabilitiesFromLeaseIncentives" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Property, Equipment and Lease Liabilities From Lease Incentives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_IncreaseDecreaseInPropertyAndEquipmentAndLeaseLiabilitiesFromLeaseIncentives" xlink:href="lfvn-20220331.xsd#lfvn_IncreaseDecreaseInPropertyAndEquipmentAndLeaseLiabilitiesFromLeaseIncentives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_IncreaseDecreaseInPropertyAndEquipmentAndLeaseLiabilitiesFromLeaseIncentives" xlink:to="lab_lfvn_IncreaseDecreaseInPropertyAndEquipmentAndLeaseLiabilitiesFromLeaseIncentives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_1e0ba727-a5be-4203-9d63-c713c5128218_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock &#8212; par value $0.0001 per share, 40,000 shares authorized and 12,577 and 13,609 issued and outstanding as of March&#160;31, 2022 and June&#160;30, 2021, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_b509f8c9-ca8d-4bb0-b6be-bc33131e599c_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other expense</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_fb6821ba-b9d3-4192-95ce-404466072b68_terseLabel_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering period</link:label>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_label_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Period</link:label>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_documentation_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:href="lfvn-20220331.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:to="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_b41a13b6-5c43-47bc-8b1e-5f39a00f0499_terseLabel_en-US" xlink:label="lab_us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Interest Issued or Issuable, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_label_en-US" xlink:label="lab_us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Interest Issued or Issuable, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="lab_us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_868872fc-30fb-4a48-8ac9-47444e71a119_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_c76656e9-5a4f-4e93-a222-16c7806b5d18_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies - Note 8</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9435e2df-bee4-4b9a-b1d6-09dc581d5833_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_16ae8e22-f520-4c51-932b-6a636752dda1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_64309ae5-f35e-40cf-b45a-1dca62fe6107_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_0fc2d3ed-bde8-4a9f-b29b-1c63e7ea197a_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_f8d60009-035f-46ad-ba65-d1ef896064dd_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_263d2bf7-2691-42fd-ba83-4162e25e1868_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of credit risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:to="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_March2016RevolvingLoanMember_103dba7e-b22f-4e1f-be72-313a3b0bb867_terseLabel_en-US" xlink:label="lab_lfvn_March2016RevolvingLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2016 Revolving Loan</link:label>
    <link:label id="lab_lfvn_March2016RevolvingLoanMember_label_en-US" xlink:label="lab_lfvn_March2016RevolvingLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2016 Revolving Loan [Member]</link:label>
    <link:label id="lab_lfvn_March2016RevolvingLoanMember_documentation_en-US" xlink:label="lab_lfvn_March2016RevolvingLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2016 Revolving Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_March2016RevolvingLoanMember" xlink:href="lfvn-20220331.xsd#lfvn_March2016RevolvingLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_March2016RevolvingLoanMember" xlink:to="lab_lfvn_March2016RevolvingLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_27d295a6-6dce-4d9c-9e7e-0b5f8bde0e47_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 (remaining three months ending June 30, 2022)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember_5a44e5e4-47d0-4d94-a9c9-780a0986bf13_terseLabel_en-US" xlink:label="lab_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash held primarily at Other Financial Institutions</link:label>
    <link:label id="lab_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember_label_en-US" xlink:label="lab_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Accounts Held at Other Financial Institutions [Member]</link:label>
    <link:label id="lab_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember_documentation_en-US" xlink:label="lab_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Accounts Held At Other Financial Institutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember" xlink:href="lfvn-20220331.xsd#lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember" xlink:to="lab_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_EmployeeStockPurchasePlanMember_b23a024e-d765-4abd-aa2b-a405c613c726_terseLabel_en-US" xlink:label="lab_lfvn_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_lfvn_EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_lfvn_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_lfvn_EmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_lfvn_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EmployeeStockPurchasePlanMember" xlink:href="lfvn-20220331.xsd#lfvn_EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_EmployeeStockPurchasePlanMember" xlink:to="lab_lfvn_EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryValuationReserves_6fa29fea-8508-4922-ae58-201948be207a_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory valuation reserves</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserves_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves" xlink:to="lab_us-gaap_InventoryValuationReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_97601551-cf05-44c2-afb9-0f7a886bb3c3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly installments</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e203c25b-1bbc-4bc0-8d82-883561d1c319_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock awards and options (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_46a87b12-979c-4b28-a317-3faff3231f35_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d1c3a7b1-3d87-4956-9902-f6d3d03d4ae1_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents &#8212; beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_559df4b0-afeb-4af9-8b77-0a1dd1c95b95_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents &#8212; end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_962c6946-bb78-4ead-8616-60c7fd280fee_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_0a5c3b6a-449c-490e-860b-41bc9a228ee8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_ecf4ee11-86ec-428f-abb4-f86709627fbc_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue Disaggregated by Geographic Regions</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_027e07fa-b815-4ee7-a89e-d3f5979522bf_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_dc37e5ff-2955-46d9-8e48-37776d2a8545_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_1e3e717d-a450-4780-a547-84dc4ef2e761_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_55b5e751-5e8e-4aac-8d71-218f90d3e1b2_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_31189d53-4447-4f66-b931-2ebbee26eda4_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ReturnLiabilityReserve_3649dd87-e30d-48f9-844c-38f44e319cf9_terseLabel_en-US" xlink:label="lab_lfvn_ReturnLiabilityReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return liability reserve</link:label>
    <link:label id="lab_lfvn_ReturnLiabilityReserve_label_en-US" xlink:label="lab_lfvn_ReturnLiabilityReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return Liability Reserve</link:label>
    <link:label id="lab_lfvn_ReturnLiabilityReserve_documentation_en-US" xlink:label="lab_lfvn_ReturnLiabilityReserve" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return Liability Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ReturnLiabilityReserve" xlink:href="lfvn-20220331.xsd#lfvn_ReturnLiabilityReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ReturnLiabilityReserve" xlink:to="lab_lfvn_ReturnLiabilityReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_20a04859-cc67-47aa-b167-a6f2043c635b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, capital shares reserved for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_1212ac0b-8fee-4a11-8eaa-64602749d00e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_f9db413a-90fb-4f37-b8ef-82bba2e71549_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_5667bac8-c976-493d-9ca5-41ce3b90c53d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Interest Type [Axis]</link:label>
    <link:label id="lab_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_label_en-US" xlink:label="lab_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Interest Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="lab_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_5d3b9240-f710-49f8-8680-c7bc2dfcb4ae_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed rate interest on debt (as a percent)</link:label>
    <link:label id="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_label_en-US" xlink:label="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:to="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_4d6b3af9-adfc-4133-b19e-fd3b2639a35e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition And Shipping and Handling</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_32491f1e-8f8f-4598-9f92-88a7fbc78e97_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1efb994f-4846-48fa-a5ad-fdf40abe66e4_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1eb3d631-dfa0-4b22-8e52-c78ef154323f_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9e15c231-7f16-4f9d-97d2-7414071ac49b_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted-average common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ad7d471a-f73c-45f2-96ae-498e15a2ba2f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, net</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_66adb7cb-e1d1-4c32-af08-225dfbaaa1b2_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_211eff5c-b84b-4d61-a674-a9259f6ee907_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_342db386-c1b1-4bfb-afed-0ef5d95c2a34_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_d8220293-c234-485e-9405-df178236a89e_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_556564b9-6821-4cb1-b955-7f11011eb1ee_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_5c9ae457-a86a-43e4-956a-e7d993d98612_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_2b9bd2fe-d9ea-4445-94b1-969ecd44714a_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_ac055b13-3f44-4884-9701-370cb7e4f530_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_90a39ea3-951f-4e11-8134-12743508e252_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_448156a1-9f1a-4f5e-9430-05c83dd57055_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_5ee01208-acb0-494b-b1bd-1e2c5c43b499_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_e6616778-4224-4314-9cc5-a08cf5572e8c_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_a9cff71e-306b-4680-8d7b-273e04b3b369_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_9a0473f6-f0f2-4d55-8a48-24604f7412cf_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense:</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_19e8400f-c9e3-4520-ab09-ec11dc4f0ae8_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_c5efcae7-69b0-40e8-a928-d379a70eab5a_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_c0af7b74-4bef-41b2-a1fd-37cdc908216a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_b1256a78-7346-4102-92af-1259ba6ff932_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_8d65ab79-cdb3-4932-84fe-2bad3b1093cb_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_d0410199-2c09-4e72-966d-9813e9ce7f25_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Used in Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_305f8082-56f3-4ed0-8b97-a07a56c09bd2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1f674d2f-47e1-4e52-b1ec-b0c4ad2e0791_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_8089dbe3-21fc-4a23-b6ef-82a039546854_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_9aa0f80c-6101-416c-bade-1038c3762baf_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_42aba9ec-af1f-4465-a011-3786fa313e09_terseLabel_en-US" xlink:label="lab_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_label_en-US" xlink:label="lab_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments Due, After Year Four</link:label>
    <link:label id="lab_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_documentation_en-US" xlink:label="lab_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments Due, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:href="lfvn-20220331.xsd#lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:to="lab_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2ed575ad-6fd7-4977-a85e-80478bc3b672_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows from Operating Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_47f90f96-e5c3-4345-96c1-a0a37c6d3e6e_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_0b89491d-23e0-4752-b02d-4b6934dd51c7_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_da41a87a-b56f-43f0-b304-42f0fc0cba02_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_50dbb126-5758-413d-991a-113337a219bc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_288a4d68-884e-472f-903d-c51216308efe_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_ce04ea62-ff5c-4b3a-a858-0ebc3934110c_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_ec496200-a035-409d-9009-d8f0d4c3d8da_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares canceled or surrendered as payment of tax withholding and other</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b572c049-b2b9-4d18-879b-64d37abef594_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_568a7cf0-05da-4b4d-a901-4afc1853b0de_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_8ae4e972-3a78-43fb-bd3a-24968b2229af_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_a82d799e-cc12-4960-a9c7-0ccb0fb66aab_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock based compensation reflected in additional paid in capital</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_da566dc1-e370-4a6a-a40d-a9d4f4fe8162_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_e9f0afad-9e41-4bd2-9caf-22f37253a480_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_IncreaseDecreaseInLeaseLiabilities_f8d7beef-70f9-4a89-b998-5ed225225a26_terseLabel_en-US" xlink:label="lab_lfvn_IncreaseDecreaseInLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_lfvn_IncreaseDecreaseInLeaseLiabilities_label_en-US" xlink:label="lab_lfvn_IncreaseDecreaseInLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Lease Liabilities</link:label>
    <link:label id="lab_lfvn_IncreaseDecreaseInLeaseLiabilities_documentation_en-US" xlink:label="lab_lfvn_IncreaseDecreaseInLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_IncreaseDecreaseInLeaseLiabilities" xlink:href="lfvn-20220331.xsd#lfvn_IncreaseDecreaseInLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_IncreaseDecreaseInLeaseLiabilities" xlink:to="lab_lfvn_IncreaseDecreaseInLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_OperatingLeaseRightOfUseAssetSalvageValue_01da184c-9e82-47b7-b84d-dcf99de51d34_terseLabel_en-US" xlink:label="lab_lfvn_OperatingLeaseRightOfUseAssetSalvageValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Salvage value</link:label>
    <link:label id="lab_lfvn_OperatingLeaseRightOfUseAssetSalvageValue_label_en-US" xlink:label="lab_lfvn_OperatingLeaseRightOfUseAssetSalvageValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right of Use Asset, Salvage Value</link:label>
    <link:label id="lab_lfvn_OperatingLeaseRightOfUseAssetSalvageValue_documentation_en-US" xlink:label="lab_lfvn_OperatingLeaseRightOfUseAssetSalvageValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right of Use Asset, Salvage Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_OperatingLeaseRightOfUseAssetSalvageValue" xlink:href="lfvn-20220331.xsd#lfvn_OperatingLeaseRightOfUseAssetSalvageValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_OperatingLeaseRightOfUseAssetSalvageValue" xlink:to="lab_lfvn_OperatingLeaseRightOfUseAssetSalvageValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_017a7c7e-306e-4fb5-ac41-603aba397879_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum capacity on draw</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_57bbba17-8187-4260-bada-dd0d0488ce00_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_TwoThousandAndTenLongTermIncentivePlanMember_d9da8743-96cd-4923-9d69-2af43adfc5c9_terseLabel_en-US" xlink:label="lab_lfvn_TwoThousandAndTenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2010 Long-Term Incentive Plan</link:label>
    <link:label id="lab_lfvn_TwoThousandAndTenLongTermIncentivePlanMember_label_en-US" xlink:label="lab_lfvn_TwoThousandAndTenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Ten Long Term Incentive Plan [Member]</link:label>
    <link:label id="lab_lfvn_TwoThousandAndTenLongTermIncentivePlanMember_documentation_en-US" xlink:label="lab_lfvn_TwoThousandAndTenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand and ten long term incentive plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandAndTenLongTermIncentivePlanMember" xlink:href="lfvn-20220331.xsd#lfvn_TwoThousandAndTenLongTermIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_TwoThousandAndTenLongTermIncentivePlanMember" xlink:to="lab_lfvn_TwoThousandAndTenLongTermIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_ba22c9f2-1885-4dcf-8572-93ce734f134a_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_c66bd67c-0598-4573-9e8b-7a02ebf494b8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrent_1b2a9eed-e777-4da2-9a42-6771bc98ee0f_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commissions payable</link:label>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Commission, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalesCommissionCurrent" xlink:to="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_InventoryPercentOfTotalInventory_c244d442-e64d-4996-931a-0e9aff26582f_totalLabel_en-US" xlink:label="lab_lfvn_InventoryPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of total inventory (in percentage)</link:label>
    <link:label id="lab_lfvn_InventoryPercentOfTotalInventory_label_en-US" xlink:label="lab_lfvn_InventoryPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Percent Of Total Inventory</link:label>
    <link:label id="lab_lfvn_InventoryPercentOfTotalInventory_documentation_en-US" xlink:label="lab_lfvn_InventoryPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Percent Of Total Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_InventoryPercentOfTotalInventory" xlink:href="lfvn-20220331.xsd#lfvn_InventoryPercentOfTotalInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_InventoryPercentOfTotalInventory" xlink:to="lab_lfvn_InventoryPercentOfTotalInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_722338e2-df59-45a8-baba-a75f7f51bd45_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_89067543-b584-4747-a0c6-c386ee2a1f2c_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_AsiaPacificAndEuropeMember_cbf4068b-0b98-4165-9a78-c43e7d3a1b0b_terseLabel_en-US" xlink:label="lab_lfvn_AsiaPacificAndEuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia/Pacific &amp; Europe</link:label>
    <link:label id="lab_lfvn_AsiaPacificAndEuropeMember_label_en-US" xlink:label="lab_lfvn_AsiaPacificAndEuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific And Europe [Member]</link:label>
    <link:label id="lab_lfvn_AsiaPacificAndEuropeMember_documentation_en-US" xlink:label="lab_lfvn_AsiaPacificAndEuropeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific And Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_AsiaPacificAndEuropeMember" xlink:href="lfvn-20220331.xsd#lfvn_AsiaPacificAndEuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_AsiaPacificAndEuropeMember" xlink:to="lab_lfvn_AsiaPacificAndEuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_23d77cb4-b40d-47a5-a962-a34267e30a65_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_March2016TermLoanMember_a5adebd6-a2f8-4e78-9c52-f455b26acfc8_terseLabel_en-US" xlink:label="lab_lfvn_March2016TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2016 Term Loan</link:label>
    <link:label id="lab_lfvn_March2016TermLoanMember_label_en-US" xlink:label="lab_lfvn_March2016TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2016 Term Loan [Member]</link:label>
    <link:label id="lab_lfvn_March2016TermLoanMember_documentation_en-US" xlink:label="lab_lfvn_March2016TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2016 Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_March2016TermLoanMember" xlink:href="lfvn-20220331.xsd#lfvn_March2016TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_March2016TermLoanMember" xlink:to="lab_lfvn_March2016TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncurrentAssets_3579f3c6-19e2-4ae3-97f0-5e9025d93c78_terseLabel_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived assets</link:label>
    <link:label id="lab_us-gaap_NoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets" xlink:to="lab_us-gaap_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_36fec5aa-3f8d-4915-b97a-4ff21eba7c0e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_38b78b77-f1d1-431f-a9d5-139dafd5c221_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_59623380-8be2-4fa4-8db8-8a203d287ee3_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_9ce0c22e-13ef-443c-9c7d-0c95b013a591_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_104999e6-c160-4f30-9082-a7edce97c8ec_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0df30574-d17f-41d5-ae16-374575fee071_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_d850178b-2f69-433a-8552-d17d0b04c470_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_b764c1af-8d58-457a-971a-ee8ea1c792da_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_DebtInstrumentTrailingPeriod_04a1cd66-047f-46b4-babe-7989e4c41e9a_terseLabel_en-US" xlink:label="lab_lfvn_DebtInstrumentTrailingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trailing period</link:label>
    <link:label id="lab_lfvn_DebtInstrumentTrailingPeriod_label_en-US" xlink:label="lab_lfvn_DebtInstrumentTrailingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Trailing Period</link:label>
    <link:label id="lab_lfvn_DebtInstrumentTrailingPeriod_documentation_en-US" xlink:label="lab_lfvn_DebtInstrumentTrailingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Trailing Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentTrailingPeriod" xlink:href="lfvn-20220331.xsd#lfvn_DebtInstrumentTrailingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_DebtInstrumentTrailingPeriod" xlink:to="lab_lfvn_DebtInstrumentTrailingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_country_JP_b3cdcc81-6c62-4f97-a574-5d7be4af643d_terseLabel_en-US" xlink:label="lab_country_JP" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan</link:label>
    <link:label id="lab_country_JP_label_en-US" xlink:label="lab_country_JP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JAPAN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_JP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_JP" xlink:to="lab_country_JP" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_29525e8f-520a-4c1b-88b7-c89b2bd25bfb_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_61e066f8-6692-42b2-84f4-64cc5cbf8a31_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows from Financing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_3dc8d9b5-bd8a-4269-bc8a-efeed8e3495a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturity of Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_2b73d0f6-e99a-4b46-a58a-9ae3ba422a3b_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_7ce90762-1042-4012-ad75-33c3b3e09717_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_139b5d6a-a594-459a-81b7-5774dcb69926_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_adcb3c82-4754-4c81-b568-f6ce2cb5379c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_29d94124-114e-4c93-84c5-e85daadf7749_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_c5bc5514-f569-4016-869e-91d64f141c38_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_054a839c-4fed-476e-8b31-452b4fcb26f0_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_SandyUTMember_c3308c3c-f139-4df9-a5e2-69555a0986e0_terseLabel_en-US" xlink:label="lab_lfvn_SandyUTMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sandy, UT</link:label>
    <link:label id="lab_lfvn_SandyUTMember_label_en-US" xlink:label="lab_lfvn_SandyUTMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sandy, UT [Member]</link:label>
    <link:label id="lab_lfvn_SandyUTMember_documentation_en-US" xlink:label="lab_lfvn_SandyUTMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sandy, UT</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_SandyUTMember" xlink:href="lfvn-20220331.xsd#lfvn_SandyUTMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_SandyUTMember" xlink:to="lab_lfvn_SandyUTMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_18ae9048-664e-4260-98bd-9ee668e80cc2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_e6a333d2-f828-4aa9-83a0-31d3e496cbb7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt conversion, converted instrument, amount</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_f2ecc166-ee15-4041-8c34-9e4d2c191e1b_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrentAndNoncurrent_2bec9e82-8fcb-4e13-9aa1-f1f3cddf2645_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax payable</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_1e289864-d7db-40b9-bb49-c0085e6457d6_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of company stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_cacae24a-68eb-4c2b-9fa3-2b92936ef071_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of company stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_dcb99c81-ee6c-44ab-92f6-ba148e29a9a7_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_fcbd8f56-c752-4965-8058-f070374803c4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_deb4d612-71cc-49b8-baf9-df391d0c1024_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>lfvn-20220331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:638a0b91-4766-4439-9960-cd7043420117,g:40b96704-8fd2-45ed-83b9-f73156e5e4bc-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.lifevantage.com/role/CoverPage" xlink:type="simple" xlink:href="lfvn-20220331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_37f27da3-57e2-4573-81ca-8b4543b7c86e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_9b6c444e-1b20-4f01-8076-59201b79e242" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37f27da3-57e2-4573-81ca-8b4543b7c86e" xlink:to="loc_dei_DocumentType_9b6c444e-1b20-4f01-8076-59201b79e242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_c3eb6eb4-f3b1-4475-9e3f-b660e68b2285" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37f27da3-57e2-4573-81ca-8b4543b7c86e" xlink:to="loc_dei_DocumentQuarterlyReport_c3eb6eb4-f3b1-4475-9e3f-b660e68b2285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_d25d6bf5-28a7-411b-8f06-f06c952bf248" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37f27da3-57e2-4573-81ca-8b4543b7c86e" xlink:to="loc_dei_DocumentPeriodEndDate_d25d6bf5-28a7-411b-8f06-f06c952bf248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_49842bb9-f91c-4cf7-bf62-e439fc057292" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37f27da3-57e2-4573-81ca-8b4543b7c86e" xlink:to="loc_dei_DocumentTransitionReport_49842bb9-f91c-4cf7-bf62-e439fc057292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_8fa7ab1d-1b39-4176-8de7-84159d1a1481" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37f27da3-57e2-4573-81ca-8b4543b7c86e" xlink:to="loc_dei_EntityFileNumber_8fa7ab1d-1b39-4176-8de7-84159d1a1481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_81c5ceec-cf70-4610-b53d-950bf6814b77" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37f27da3-57e2-4573-81ca-8b4543b7c86e" xlink:to="loc_dei_EntityRegistrantName_81c5ceec-cf70-4610-b53d-950bf6814b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_f610b5d9-4135-42ea-8e8c-7e31ed12ae85" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37f27da3-57e2-4573-81ca-8b4543b7c86e" xlink:to="loc_dei_EntityIncorporationStateCountryCode_f610b5d9-4135-42ea-8e8c-7e31ed12ae85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_13646f32-9542-4b06-80ff-03fba4ea6232" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37f27da3-57e2-4573-81ca-8b4543b7c86e" xlink:to="loc_dei_EntityTaxIdentificationNumber_13646f32-9542-4b06-80ff-03fba4ea6232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_eec26b72-67a0-40e1-a0aa-ac10ab17a776" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37f27da3-57e2-4573-81ca-8b4543b7c86e" xlink:to="loc_dei_EntityAddressAddressLine1_eec26b72-67a0-40e1-a0aa-ac10ab17a776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_8bb38714-3329-4386-a8c3-4548a6011559" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37f27da3-57e2-4573-81ca-8b4543b7c86e" xlink:to="loc_dei_EntityAddressAddressLine2_8bb38714-3329-4386-a8c3-4548a6011559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_55ac4248-40de-48b1-81e1-e9058ab28c52" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37f27da3-57e2-4573-81ca-8b4543b7c86e" xlink:to="loc_dei_EntityAddressCityOrTown_55ac4248-40de-48b1-81e1-e9058ab28c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_24074936-288f-4583-923d-748193bc7adb" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37f27da3-57e2-4573-81ca-8b4543b7c86e" xlink:to="loc_dei_EntityAddressStateOrProvince_24074936-288f-4583-923d-748193bc7adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_a5051646-7467-4e46-a7af-0b037e27f7af" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37f27da3-57e2-4573-81ca-8b4543b7c86e" xlink:to="loc_dei_EntityAddressPostalZipCode_a5051646-7467-4e46-a7af-0b037e27f7af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_5a6f548f-1cd3-4e4c-b235-462fb22bd522" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37f27da3-57e2-4573-81ca-8b4543b7c86e" xlink:to="loc_dei_CityAreaCode_5a6f548f-1cd3-4e4c-b235-462fb22bd522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_64a2e7ac-6302-47c0-a905-15dd90fa73fe" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37f27da3-57e2-4573-81ca-8b4543b7c86e" xlink:to="loc_dei_LocalPhoneNumber_64a2e7ac-6302-47c0-a905-15dd90fa73fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_74cf9f9d-1bd6-4985-9c4e-efcefd3d5b20" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37f27da3-57e2-4573-81ca-8b4543b7c86e" xlink:to="loc_dei_Security12bTitle_74cf9f9d-1bd6-4985-9c4e-efcefd3d5b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_c1f35ff0-fe5f-41dd-8d7f-d9e1924482cb" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37f27da3-57e2-4573-81ca-8b4543b7c86e" xlink:to="loc_dei_TradingSymbol_c1f35ff0-fe5f-41dd-8d7f-d9e1924482cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_c025fc65-fa70-4c78-97a8-b26e9988d8d8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37f27da3-57e2-4573-81ca-8b4543b7c86e" xlink:to="loc_dei_SecurityExchangeName_c025fc65-fa70-4c78-97a8-b26e9988d8d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_193fb5af-9364-45cb-bb36-e6069aa26c75" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37f27da3-57e2-4573-81ca-8b4543b7c86e" xlink:to="loc_dei_EntityCurrentReportingStatus_193fb5af-9364-45cb-bb36-e6069aa26c75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_73d37f88-4a7e-44f1-8505-ca7038171c9c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37f27da3-57e2-4573-81ca-8b4543b7c86e" xlink:to="loc_dei_EntityInteractiveDataCurrent_73d37f88-4a7e-44f1-8505-ca7038171c9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_b0583fc7-b6a9-4b5f-8fd0-162077ddb822" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37f27da3-57e2-4573-81ca-8b4543b7c86e" xlink:to="loc_dei_EntityFilerCategory_b0583fc7-b6a9-4b5f-8fd0-162077ddb822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_2bfe218a-aedf-4d49-83fd-22a667540bc7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37f27da3-57e2-4573-81ca-8b4543b7c86e" xlink:to="loc_dei_EntitySmallBusiness_2bfe218a-aedf-4d49-83fd-22a667540bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_c2816165-a8e6-4251-9c67-56fd380d1ee2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37f27da3-57e2-4573-81ca-8b4543b7c86e" xlink:to="loc_dei_EntityEmergingGrowthCompany_c2816165-a8e6-4251-9c67-56fd380d1ee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_8f4023c4-6893-4ae3-ad8c-91651ee8dfea" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37f27da3-57e2-4573-81ca-8b4543b7c86e" xlink:to="loc_dei_EntityShellCompany_8f4023c4-6893-4ae3-ad8c-91651ee8dfea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_24af7519-8d5c-4521-8271-b7bd5fa2566d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37f27da3-57e2-4573-81ca-8b4543b7c86e" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_24af7519-8d5c-4521-8271-b7bd5fa2566d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_e45e1e89-ba01-43d3-bba4-7b64d907c2cb" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37f27da3-57e2-4573-81ca-8b4543b7c86e" xlink:to="loc_dei_AmendmentFlag_e45e1e89-ba01-43d3-bba4-7b64d907c2cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_7632bc26-35ac-47e7-aa53-caf2e0f87b70" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37f27da3-57e2-4573-81ca-8b4543b7c86e" xlink:to="loc_dei_DocumentFiscalYearFocus_7632bc26-35ac-47e7-aa53-caf2e0f87b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_07264a0f-984d-4fa0-a63b-9d13cbb79ceb" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37f27da3-57e2-4573-81ca-8b4543b7c86e" xlink:to="loc_dei_DocumentFiscalPeriodFocus_07264a0f-984d-4fa0-a63b-9d13cbb79ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_9d124790-7f1a-4081-9b40-989549542141" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37f27da3-57e2-4573-81ca-8b4543b7c86e" xlink:to="loc_dei_EntityCentralIndexKey_9d124790-7f1a-4081-9b40-989549542141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_27723ab0-336e-4628-9c33-d6f132201a60" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_37f27da3-57e2-4573-81ca-8b4543b7c86e" xlink:to="loc_dei_CurrentFiscalYearEndDate_27723ab0-336e-4628-9c33-d6f132201a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="simple" xlink:href="lfvn-20220331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_a22ae5a3-a060-44ce-8187-c07548b05cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_ae9a2abb-363c-46cf-9e99-65bce13c9bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a22ae5a3-a060-44ce-8187-c07548b05cd4" xlink:to="loc_us-gaap_AssetsAbstract_ae9a2abb-363c-46cf-9e99-65bce13c9bd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_f7a84ec3-9910-41bc-beef-9f982b0339f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ae9a2abb-363c-46cf-9e99-65bce13c9bd9" xlink:to="loc_us-gaap_AssetsCurrentAbstract_f7a84ec3-9910-41bc-beef-9f982b0339f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ba8c52b5-4250-48ee-a3c7-1a180caf75ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f7a84ec3-9910-41bc-beef-9f982b0339f3" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ba8c52b5-4250-48ee-a3c7-1a180caf75ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_2973dde8-e489-4bba-853c-bc96bf5e1c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f7a84ec3-9910-41bc-beef-9f982b0339f3" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_2973dde8-e489-4bba-853c-bc96bf5e1c9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_623fd2ad-5bfc-4b8b-a3d2-7ee1bd6c5666" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f7a84ec3-9910-41bc-beef-9f982b0339f3" xlink:to="loc_us-gaap_IncomeTaxesReceivable_623fd2ad-5bfc-4b8b-a3d2-7ee1bd6c5666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_d5a3b958-5477-4ad5-8fe3-6d20a1cc5b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f7a84ec3-9910-41bc-beef-9f982b0339f3" xlink:to="loc_us-gaap_InventoryNet_d5a3b958-5477-4ad5-8fe3-6d20a1cc5b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_db248468-7985-440e-bc88-d7804253a156" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f7a84ec3-9910-41bc-beef-9f982b0339f3" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_db248468-7985-440e-bc88-d7804253a156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b6f58d1d-ceb7-4bfb-8c92-af0ef1701967" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f7a84ec3-9910-41bc-beef-9f982b0339f3" xlink:to="loc_us-gaap_AssetsCurrent_b6f58d1d-ceb7-4bfb-8c92-af0ef1701967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_d3e01613-4456-437b-9118-0031624388bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ae9a2abb-363c-46cf-9e99-65bce13c9bd9" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_d3e01613-4456-437b-9118-0031624388bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_fb050f92-be24-47a6-8488-df5e6f125565" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_d3e01613-4456-437b-9118-0031624388bb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_fb050f92-be24-47a6-8488-df5e6f125565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_797867b4-6530-47d1-b260-164bce83faaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_d3e01613-4456-437b-9118-0031624388bb" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_797867b4-6530-47d1-b260-164bce83faaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a7211630-b5c7-4461-8e13-065a50386b18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_d3e01613-4456-437b-9118-0031624388bb" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a7211630-b5c7-4461-8e13-065a50386b18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_13b1618a-8745-40f7-84ef-3dfb37b504d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_d3e01613-4456-437b-9118-0031624388bb" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_13b1618a-8745-40f7-84ef-3dfb37b504d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_cb0dcf5e-6f21-46a5-9ce8-325ea72465ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_d3e01613-4456-437b-9118-0031624388bb" xlink:to="loc_us-gaap_LongTermInvestments_cb0dcf5e-6f21-46a5-9ce8-325ea72465ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_730d8743-4ca0-4594-ac68-4615465790e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_d3e01613-4456-437b-9118-0031624388bb" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_730d8743-4ca0-4594-ac68-4615465790e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_175d6c97-604f-448b-8e8c-308c85aa7bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ae9a2abb-363c-46cf-9e99-65bce13c9bd9" xlink:to="loc_us-gaap_Assets_175d6c97-604f-448b-8e8c-308c85aa7bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1654dbbb-3c4a-4bcb-ad3e-e3fd41f20fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a22ae5a3-a060-44ce-8187-c07548b05cd4" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1654dbbb-3c4a-4bcb-ad3e-e3fd41f20fa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_1929d457-166f-4e9c-aa58-25a3638639d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1654dbbb-3c4a-4bcb-ad3e-e3fd41f20fa5" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_1929d457-166f-4e9c-aa58-25a3638639d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_727203de-2b61-4b0d-9bcd-1dabdc812c79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1929d457-166f-4e9c-aa58-25a3638639d6" xlink:to="loc_us-gaap_AccountsPayableCurrent_727203de-2b61-4b0d-9bcd-1dabdc812c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent_fbd7d8d2-fa32-40f4-b39d-22430217681a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1929d457-166f-4e9c-aa58-25a3638639d6" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrent_fbd7d8d2-fa32-40f4-b39d-22430217681a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_ec0dce0b-7cf4-4283-9501-40969c56b7a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1929d457-166f-4e9c-aa58-25a3638639d6" xlink:to="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_ec0dce0b-7cf4-4283-9501-40969c56b7a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_32af4759-5694-4648-89b8-4190be97bb43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1929d457-166f-4e9c-aa58-25a3638639d6" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_32af4759-5694-4648-89b8-4190be97bb43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_3135d127-a999-4780-a914-b5309678a9ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1929d457-166f-4e9c-aa58-25a3638639d6" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_3135d127-a999-4780-a914-b5309678a9ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_82432c20-604a-494f-b16c-aea06d1fbb3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1929d457-166f-4e9c-aa58-25a3638639d6" xlink:to="loc_us-gaap_LiabilitiesCurrent_82432c20-604a-494f-b16c-aea06d1fbb3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_eaf8f2e6-81e0-4b9f-9c58-2626a8b8edbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1654dbbb-3c4a-4bcb-ad3e-e3fd41f20fa5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_eaf8f2e6-81e0-4b9f-9c58-2626a8b8edbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_3d8e2043-4c50-4040-a325-7c3402c0c2a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1654dbbb-3c4a-4bcb-ad3e-e3fd41f20fa5" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_3d8e2043-4c50-4040-a325-7c3402c0c2a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_d011e1f0-9c96-461e-aca9-5ee4047153b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1654dbbb-3c4a-4bcb-ad3e-e3fd41f20fa5" xlink:to="loc_us-gaap_Liabilities_d011e1f0-9c96-461e-aca9-5ee4047153b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_409f91ae-001f-4ade-84b7-6d9af958002f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1654dbbb-3c4a-4bcb-ad3e-e3fd41f20fa5" xlink:to="loc_us-gaap_CommitmentsAndContingencies_409f91ae-001f-4ade-84b7-6d9af958002f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_cbeb89b3-4ddc-4766-96e0-50f1e472ca56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1654dbbb-3c4a-4bcb-ad3e-e3fd41f20fa5" xlink:to="loc_us-gaap_StockholdersEquityAbstract_cbeb89b3-4ddc-4766-96e0-50f1e472ca56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_27c5ac95-7017-45cd-9d7c-372f63fb33ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_cbeb89b3-4ddc-4766-96e0-50f1e472ca56" xlink:to="loc_us-gaap_PreferredStockValue_27c5ac95-7017-45cd-9d7c-372f63fb33ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_1bb37afa-a8a2-44ca-af9d-1839ae8c4bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_cbeb89b3-4ddc-4766-96e0-50f1e472ca56" xlink:to="loc_us-gaap_CommonStockValue_1bb37afa-a8a2-44ca-af9d-1839ae8c4bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_6b84b269-d3a6-4f3d-b22f-1ea92a430ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_cbeb89b3-4ddc-4766-96e0-50f1e472ca56" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_6b84b269-d3a6-4f3d-b22f-1ea92a430ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a746eefe-59bb-4a11-9ab4-13d80fa2f39d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_cbeb89b3-4ddc-4766-96e0-50f1e472ca56" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a746eefe-59bb-4a11-9ab4-13d80fa2f39d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d6151856-e1f3-4d05-878f-454dbb007ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_cbeb89b3-4ddc-4766-96e0-50f1e472ca56" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d6151856-e1f3-4d05-878f-454dbb007ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e7b09115-f816-4fd5-8716-dd43217cfc95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_cbeb89b3-4ddc-4766-96e0-50f1e472ca56" xlink:to="loc_us-gaap_StockholdersEquity_e7b09115-f816-4fd5-8716-dd43217cfc95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_69edf956-5e9a-4236-afb3-0c855f099636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1654dbbb-3c4a-4bcb-ad3e-e3fd41f20fa5" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_69edf956-5e9a-4236-afb3-0c855f099636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" xlink:type="simple" xlink:href="lfvn-20220331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_e2e199bb-b648-4626-84f8-b41bdd039f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_454c8c0f-89d3-49bd-9e3a-67a488c4d579" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e2e199bb-b648-4626-84f8-b41bdd039f0a" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_454c8c0f-89d3-49bd-9e3a-67a488c4d579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_460c4d3c-016c-4f39-9359-ef53a37100eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e2e199bb-b648-4626-84f8-b41bdd039f0a" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_460c4d3c-016c-4f39-9359-ef53a37100eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_3c3bc392-14b8-4c38-90c9-54cf5b52d30a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e2e199bb-b648-4626-84f8-b41bdd039f0a" xlink:to="loc_us-gaap_PreferredStockSharesIssued_3c3bc392-14b8-4c38-90c9-54cf5b52d30a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_0f729507-404d-444c-abc0-6738b285846d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e2e199bb-b648-4626-84f8-b41bdd039f0a" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_0f729507-404d-444c-abc0-6738b285846d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_5eca5368-c899-4251-ab06-191297fe2280" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e2e199bb-b648-4626-84f8-b41bdd039f0a" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_5eca5368-c899-4251-ab06-191297fe2280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_84d8b29f-2a28-4943-915e-171ccf7e7b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e2e199bb-b648-4626-84f8-b41bdd039f0a" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_84d8b29f-2a28-4943-915e-171ccf7e7b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_49184f86-bedc-4c2a-ac2e-946baceee29c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e2e199bb-b648-4626-84f8-b41bdd039f0a" xlink:to="loc_us-gaap_CommonStockSharesIssued_49184f86-bedc-4c2a-ac2e-946baceee29c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_5da012e6-5464-4b4a-b9c6-0e7b2bd08b07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e2e199bb-b648-4626-84f8-b41bdd039f0a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_5da012e6-5464-4b4a-b9c6-0e7b2bd08b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited" xlink:type="simple" xlink:href="lfvn-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_3f790905-94e0-45aa-a42c-5d860eaf5cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5785d6c4-5598-473c-a6f4-a404f93188d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3f790905-94e0-45aa-a42c-5d860eaf5cbf" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5785d6c4-5598-473c-a6f4-a404f93188d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_ecf28a0f-94d2-4d73-8399-bf000aaffaa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3f790905-94e0-45aa-a42c-5d860eaf5cbf" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_ecf28a0f-94d2-4d73-8399-bf000aaffaa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_bbaf4f43-5486-44c6-b22d-54c09f542db8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3f790905-94e0-45aa-a42c-5d860eaf5cbf" xlink:to="loc_us-gaap_GrossProfit_bbaf4f43-5486-44c6-b22d-54c09f542db8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_b217daed-0371-47a1-ab61-41481f76a815" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3f790905-94e0-45aa-a42c-5d860eaf5cbf" xlink:to="loc_us-gaap_OperatingExpensesAbstract_b217daed-0371-47a1-ab61-41481f76a815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CommissionAndIncentives_7598d221-3818-456c-8a3f-84dca96014cf" xlink:href="lfvn-20220331.xsd#lfvn_CommissionAndIncentives"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b217daed-0371-47a1-ab61-41481f76a815" xlink:to="loc_lfvn_CommissionAndIncentives_7598d221-3818-456c-8a3f-84dca96014cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b9ba6599-d0e5-454f-986d-b4f72b26e222" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b217daed-0371-47a1-ab61-41481f76a815" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b9ba6599-d0e5-454f-986d-b4f72b26e222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_640bd617-a238-4d62-9925-c5a1f2f1a946" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_b217daed-0371-47a1-ab61-41481f76a815" xlink:to="loc_us-gaap_OperatingExpenses_640bd617-a238-4d62-9925-c5a1f2f1a946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_591a4f27-1980-4ff1-8ff4-37608258f7a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3f790905-94e0-45aa-a42c-5d860eaf5cbf" xlink:to="loc_us-gaap_OperatingIncomeLoss_591a4f27-1980-4ff1-8ff4-37608258f7a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9ba8e622-b6f9-40d3-8392-9fd5ef40ed61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3f790905-94e0-45aa-a42c-5d860eaf5cbf" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9ba8e622-b6f9-40d3-8392-9fd5ef40ed61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_c1c6502f-93d5-4705-acae-4c6b5aba789f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9ba8e622-b6f9-40d3-8392-9fd5ef40ed61" xlink:to="loc_us-gaap_InterestExpense_c1c6502f-93d5-4705-acae-4c6b5aba789f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_7be271b5-71ae-4c3f-9e58-7276a6f5676e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9ba8e622-b6f9-40d3-8392-9fd5ef40ed61" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_7be271b5-71ae-4c3f-9e58-7276a6f5676e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_cb5eb8c4-0df2-4c74-a5ea-c278852c9157" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9ba8e622-b6f9-40d3-8392-9fd5ef40ed61" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_cb5eb8c4-0df2-4c74-a5ea-c278852c9157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_caac420e-0978-433a-9970-2bb9888214eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3f790905-94e0-45aa-a42c-5d860eaf5cbf" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_caac420e-0978-433a-9970-2bb9888214eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_00048404-cf55-4624-ba1d-1a99dcf8e8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3f790905-94e0-45aa-a42c-5d860eaf5cbf" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_00048404-cf55-4624-ba1d-1a99dcf8e8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_28edf0aa-5d4e-4250-a27c-f8db3e4ec41b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3f790905-94e0-45aa-a42c-5d860eaf5cbf" xlink:to="loc_us-gaap_NetIncomeLoss_28edf0aa-5d4e-4250-a27c-f8db3e4ec41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0520efff-5b6e-4719-a233-eaf7a648d964" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3f790905-94e0-45aa-a42c-5d860eaf5cbf" xlink:to="loc_us-gaap_EarningsPerShareAbstract_0520efff-5b6e-4719-a233-eaf7a648d964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_0d6f6529-5dfb-4379-b369-a1474622d7eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0520efff-5b6e-4719-a233-eaf7a648d964" xlink:to="loc_us-gaap_EarningsPerShareBasic_0d6f6529-5dfb-4379-b369-a1474622d7eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_e56be2d5-a31a-4433-b337-78c486c8cd15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0520efff-5b6e-4719-a233-eaf7a648d964" xlink:to="loc_us-gaap_EarningsPerShareDiluted_e56be2d5-a31a-4433-b337-78c486c8cd15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_9941abf8-a82f-4bea-82c3-6174f591d724" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3f790905-94e0-45aa-a42c-5d860eaf5cbf" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_9941abf8-a82f-4bea-82c3-6174f591d724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e8748dba-98d0-4290-b834-54519cf3c001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_9941abf8-a82f-4bea-82c3-6174f591d724" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e8748dba-98d0-4290-b834-54519cf3c001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f2a1f6b8-5612-4c4f-ba3c-ea5f21e93e40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_9941abf8-a82f-4bea-82c3-6174f591d724" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f2a1f6b8-5612-4c4f-ba3c-ea5f21e93e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_dc830678-38ce-4878-a15c-ebf2a1ceaf17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3f790905-94e0-45aa-a42c-5d860eaf5cbf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_dc830678-38ce-4878-a15c-ebf2a1ceaf17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_607fe635-403d-4de0-b6b3-69f4c4c0a4bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_dc830678-38ce-4878-a15c-ebf2a1ceaf17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_607fe635-403d-4de0-b6b3-69f4c4c0a4bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_55915362-d96f-4e92-bb50-f9457820262c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_dc830678-38ce-4878-a15c-ebf2a1ceaf17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_55915362-d96f-4e92-bb50-f9457820262c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_8a1ba353-0911-40de-a42c-187f16a2cbf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3f790905-94e0-45aa-a42c-5d860eaf5cbf" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_8a1ba353-0911-40de-a42c-187f16a2cbf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="simple" xlink:href="lfvn-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_7ef6084b-86c5-4cb1-939e-338cec9ec771" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_677e18bf-fcb3-41a9-ae4e-47a7de81fd3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_7ef6084b-86c5-4cb1-939e-338cec9ec771" xlink:to="loc_us-gaap_StatementTable_677e18bf-fcb3-41a9-ae4e-47a7de81fd3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2221b96b-ce72-47d8-a69f-52a0c661b498" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_677e18bf-fcb3-41a9-ae4e-47a7de81fd3b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2221b96b-ce72-47d8-a69f-52a0c661b498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_20e8ea72-3ea4-4e29-a51d-a598d28e6da2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2221b96b-ce72-47d8-a69f-52a0c661b498" xlink:to="loc_us-gaap_EquityComponentDomain_20e8ea72-3ea4-4e29-a51d-a598d28e6da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c68a0a2d-f094-44c1-8e4c-efd6b12ea1ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_20e8ea72-3ea4-4e29-a51d-a598d28e6da2" xlink:to="loc_us-gaap_CommonStockMember_c68a0a2d-f094-44c1-8e4c-efd6b12ea1ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_7637e2a0-9ab2-4372-bec7-f8e4c31023c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_20e8ea72-3ea4-4e29-a51d-a598d28e6da2" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_7637e2a0-9ab2-4372-bec7-f8e4c31023c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_f95e6571-7e18-4095-ae9a-bf1fd38ef8af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_20e8ea72-3ea4-4e29-a51d-a598d28e6da2" xlink:to="loc_us-gaap_RetainedEarningsMember_f95e6571-7e18-4095-ae9a-bf1fd38ef8af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8bbda635-fc73-4fc1-be1b-b9217562d040" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_20e8ea72-3ea4-4e29-a51d-a598d28e6da2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8bbda635-fc73-4fc1-be1b-b9217562d040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_06ba5dd4-e376-4444-b5be-30e1c4c40cfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_677e18bf-fcb3-41a9-ae4e-47a7de81fd3b" xlink:to="loc_us-gaap_StatementLineItems_06ba5dd4-e376-4444-b5be-30e1c4c40cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_06ba5dd4-e376-4444-b5be-30e1c4c40cfd" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_25667fad-8e1f-450c-93ff-df7dd2e77083" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_SharesOutstanding_25667fad-8e1f-450c-93ff-df7dd2e77083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_355dcd0f-6afa-4b03-9751-160014fdd89b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_StockholdersEquity_355dcd0f-6afa-4b03-9751-160014fdd89b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_85b4069d-0fe2-400d-845a-560f9a973e36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_85b4069d-0fe2-400d-845a-560f9a973e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_7099fa80-485d-4463-93b3-21beccd160d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_7099fa80-485d-4463-93b3-21beccd160d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_5f9e834d-8e5d-4270-894f-579b6ccab93c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_5f9e834d-8e5d-4270-894f-579b6ccab93c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_1409ed25-b49a-4d13-9de6-4b5c9ecf9f44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_1409ed25-b49a-4d13-9de6-4b5c9ecf9f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_960fcf25-2618-4226-92c5-b58bd97a62c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_960fcf25-2618-4226-92c5-b58bd97a62c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_9b5bd472-eb11-4044-be74-d86878c1d460" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_9b5bd472-eb11-4044-be74-d86878c1d460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_9dca98a7-ae32-4cf8-b739-2e90787aac28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_9dca98a7-ae32-4cf8-b739-2e90787aac28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_31839ea2-6ccf-4e95-bdc1-dfdf8da2c900" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_31839ea2-6ccf-4e95-bdc1-dfdf8da2c900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_e0b0f271-6f6d-42f6-ae0c-4837a5557107" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_e0b0f271-6f6d-42f6-ae0c-4837a5557107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_b2688d11-9515-4587-9c05-aa887cec63f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_b2688d11-9515-4587-9c05-aa887cec63f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_23891e71-366b-428f-9024-6742228b33ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_23891e71-366b-428f-9024-6742228b33ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_92c6020d-b729-40e8-a894-011f6279fc99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_92c6020d-b729-40e8-a894-011f6279fc99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9b6dc3dc-f931-4852-9ecf-641e870add90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_NetIncomeLoss_9b6dc3dc-f931-4852-9ecf-641e870add90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_926820a2-f1fe-41e5-b7af-e76edb7d0b27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_SharesOutstanding_926820a2-f1fe-41e5-b7af-e76edb7d0b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_86ffa894-b096-4d25-9aa5-5a1060b0127c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ff032b7-4e5f-429d-8d54-de9cf682bf9b" xlink:to="loc_us-gaap_StockholdersEquity_86ffa894-b096-4d25-9aa5-5a1060b0127c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="lfvn-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_8249b916-3788-4b7d-a880-9488a0f23097" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3b442aa3-51c8-448d-8ef9-2c861140d82b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8249b916-3788-4b7d-a880-9488a0f23097" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3b442aa3-51c8-448d-8ef9-2c861140d82b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_66dc5a28-8710-4c90-a0c4-e771d1a852d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3b442aa3-51c8-448d-8ef9-2c861140d82b" xlink:to="loc_us-gaap_NetIncomeLoss_66dc5a28-8710-4c90-a0c4-e771d1a852d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_77f15cd5-2f1b-4235-ba8d-df2430764f04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3b442aa3-51c8-448d-8ef9-2c861140d82b" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_77f15cd5-2f1b-4235-ba8d-df2430764f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_2bb65533-0217-4524-9fd0-eaba95e683be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_77f15cd5-2f1b-4235-ba8d-df2430764f04" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_2bb65533-0217-4524-9fd0-eaba95e683be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_a0c9c247-95e7-4214-94e2-4e6e6738c3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_77f15cd5-2f1b-4235-ba8d-df2430764f04" xlink:to="loc_us-gaap_ShareBasedCompensation_a0c9c247-95e7-4214-94e2-4e6e6738c3c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_6876ddce-21a2-452a-90e1-3d062e39c925" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_77f15cd5-2f1b-4235-ba8d-df2430764f04" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_6876ddce-21a2-452a-90e1-3d062e39c925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4a786c85-9930-41be-a616-7e390484d52c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_77f15cd5-2f1b-4235-ba8d-df2430764f04" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4a786c85-9930-41be-a616-7e390484d52c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_72b4e2cc-d970-4686-965f-bcea5e2f05f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_77f15cd5-2f1b-4235-ba8d-df2430764f04" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_72b4e2cc-d970-4686-965f-bcea5e2f05f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b70ce284-688f-4c35-a63e-2c89ed80fa04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_72b4e2cc-d970-4686-965f-bcea5e2f05f4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b70ce284-688f-4c35-a63e-2c89ed80fa04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_7831617f-77cf-4238-9b14-1ecd0056215a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_72b4e2cc-d970-4686-965f-bcea5e2f05f4" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_7831617f-77cf-4238-9b14-1ecd0056215a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_d60247b1-1e09-4d55-b9c0-a88a041e2a44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_72b4e2cc-d970-4686-965f-bcea5e2f05f4" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_d60247b1-1e09-4d55-b9c0-a88a041e2a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_4e2eed45-ad16-4e68-a6f0-8d8b3a8d3d6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_72b4e2cc-d970-4686-965f-bcea5e2f05f4" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_4e2eed45-ad16-4e68-a6f0-8d8b3a8d3d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_c1d6b672-3eab-4496-b9bd-09fffb69d667" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_72b4e2cc-d970-4686-965f-bcea5e2f05f4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_c1d6b672-3eab-4496-b9bd-09fffb69d667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_86b80029-abab-4951-83d6-7d047e9a2b82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_72b4e2cc-d970-4686-965f-bcea5e2f05f4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_86b80029-abab-4951-83d6-7d047e9a2b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_18f004ad-99fe-4da2-a056-ef4f23cb6a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_72b4e2cc-d970-4686-965f-bcea5e2f05f4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_18f004ad-99fe-4da2-a056-ef4f23cb6a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_35185d0d-fbb3-477f-aaba-79cd1db5428b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_72b4e2cc-d970-4686-965f-bcea5e2f05f4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_35185d0d-fbb3-477f-aaba-79cd1db5428b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_IncreaseDecreaseInLeaseLiabilities_d74f29e8-793d-40a9-b0b2-056039b746a1" xlink:href="lfvn-20220331.xsd#lfvn_IncreaseDecreaseInLeaseLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_72b4e2cc-d970-4686-965f-bcea5e2f05f4" xlink:to="loc_lfvn_IncreaseDecreaseInLeaseLiabilities_d74f29e8-793d-40a9-b0b2-056039b746a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_ac858747-43bb-49b7-a315-4562f184f87d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_72b4e2cc-d970-4686-965f-bcea5e2f05f4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_ac858747-43bb-49b7-a315-4562f184f87d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a82106f0-b5fc-493a-81b7-462553b869d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3b442aa3-51c8-448d-8ef9-2c861140d82b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a82106f0-b5fc-493a-81b7-462553b869d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_888b20dd-3c5a-487d-8149-03482b6f3c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8249b916-3788-4b7d-a880-9488a0f23097" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_888b20dd-3c5a-487d-8149-03482b6f3c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2e29bbc5-c28e-4c75-92ea-dd082ec0a8f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_888b20dd-3c5a-487d-8149-03482b6f3c4d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2e29bbc5-c28e-4c75-92ea-dd082ec0a8f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_08f8a0ed-fdea-4589-ae04-6dc20be8f6e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_888b20dd-3c5a-487d-8149-03482b6f3c4d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_08f8a0ed-fdea-4589-ae04-6dc20be8f6e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_def6463a-3a2b-481f-85c3-5457fa7db6c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8249b916-3788-4b7d-a880-9488a0f23097" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_def6463a-3a2b-481f-85c3-5457fa7db6c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_a2919abf-8df5-48e3-bf65-bf07469bb6d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_def6463a-3a2b-481f-85c3-5457fa7db6c4" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_a2919abf-8df5-48e3-bf65-bf07469bb6d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_99f8c994-3f7f-471f-a67f-6e3cf6be93bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_def6463a-3a2b-481f-85c3-5457fa7db6c4" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_99f8c994-3f7f-471f-a67f-6e3cf6be93bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan_1c6c1b57-8092-48d0-aa1b-c180c5306793" xlink:href="lfvn-20220331.xsd#lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_def6463a-3a2b-481f-85c3-5457fa7db6c4" xlink:to="loc_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan_1c6c1b57-8092-48d0-aa1b-c180c5306793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_6fed16fa-7e4e-4c65-826a-9f3d38b69792" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_def6463a-3a2b-481f-85c3-5457fa7db6c4" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_6fed16fa-7e4e-4c65-826a-9f3d38b69792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_84e57bfe-837f-476e-a238-ef06fc526643" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_def6463a-3a2b-481f-85c3-5457fa7db6c4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_84e57bfe-837f-476e-a238-ef06fc526643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ba252682-591e-4687-b48a-da9a79c6f628" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8249b916-3788-4b7d-a880-9488a0f23097" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ba252682-591e-4687-b48a-da9a79c6f628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_abb7e766-0214-469e-80e6-924e8aeccaf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8249b916-3788-4b7d-a880-9488a0f23097" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_abb7e766-0214-469e-80e6-924e8aeccaf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3d9d2643-2973-46f9-b49a-15e277c210e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8249b916-3788-4b7d-a880-9488a0f23097" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3d9d2643-2973-46f9-b49a-15e277c210e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c1dd1207-f31a-4fc2-8be7-ee3b43017c28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8249b916-3788-4b7d-a880-9488a0f23097" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c1dd1207-f31a-4fc2-8be7-ee3b43017c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_9a6b0937-cb5b-463d-afc7-ec8470c2e15c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8249b916-3788-4b7d-a880-9488a0f23097" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_9a6b0937-cb5b-463d-afc7-ec8470c2e15c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_IncreaseDecreaseInPropertyAndEquipmentAndLeaseLiabilitiesFromLeaseIncentives_60ef9d08-1e33-43d1-9b66-c692ce1e7423" xlink:href="lfvn-20220331.xsd#lfvn_IncreaseDecreaseInPropertyAndEquipmentAndLeaseLiabilitiesFromLeaseIncentives"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_9a6b0937-cb5b-463d-afc7-ec8470c2e15c" xlink:to="loc_lfvn_IncreaseDecreaseInPropertyAndEquipmentAndLeaseLiabilitiesFromLeaseIncentives_60ef9d08-1e33-43d1-9b66-c692ce1e7423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_963d887a-c34e-402b-9b34-b0d6abd0bc71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8249b916-3788-4b7d-a880-9488a0f23097" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_963d887a-c34e-402b-9b34-b0d6abd0bc71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_950d5f53-e853-4b84-acd9-a55d752aa5a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_963d887a-c34e-402b-9b34-b0d6abd0bc71" xlink:to="loc_us-gaap_InterestPaidNet_950d5f53-e853-4b84-acd9-a55d752aa5a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_b5875621-b0a2-40b0-a9a2-9efd2faabe3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_963d887a-c34e-402b-9b34-b0d6abd0bc71" xlink:to="loc_us-gaap_IncomeTaxesPaid_b5875621-b0a2-40b0-a9a2-9efd2faabe3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/OrganizationandBasisofPresentation" xlink:type="simple" xlink:href="lfvn-20220331.xsd#OrganizationandBasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/OrganizationandBasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7eb7c493-07fa-4662-9808-83b8ed3d0fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_c41aa317-dcd1-4b89-86ba-46340ffcab3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7eb7c493-07fa-4662-9808-83b8ed3d0fdb" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_c41aa317-dcd1-4b89-86ba-46340ffcab3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="lfvn-20220331.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_689acf99-9b83-433b-bb07-a76070136c64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_2e3a1ea0-2dde-46f1-a1f4-552cba11dec7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_689acf99-9b83-433b-bb07-a76070136c64" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_2e3a1ea0-2dde-46f1-a1f4-552cba11dec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="lfvn-20220331.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_88ed5aa9-eb63-4aa7-8c60-5b67db24e724" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_a3178174-089d-40bc-823e-7b614347a39e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88ed5aa9-eb63-4aa7-8c60-5b67db24e724" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_a3178174-089d-40bc-823e-7b614347a39e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_a14de915-aa65-463d-a549-2572ec316d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88ed5aa9-eb63-4aa7-8c60-5b67db24e724" xlink:to="loc_us-gaap_UseOfEstimates_a14de915-aa65-463d-a549-2572ec316d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_d63853d5-ec02-4525-b1ff-5e7aa2000aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88ed5aa9-eb63-4aa7-8c60-5b67db24e724" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_d63853d5-ec02-4525-b1ff-5e7aa2000aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_7079e207-b4b1-4f87-b01a-34a76d2c3022" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88ed5aa9-eb63-4aa7-8c60-5b67db24e724" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_7079e207-b4b1-4f87-b01a-34a76d2c3022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_b16a1969-4575-478e-bd17-7a1698fe18c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88ed5aa9-eb63-4aa7-8c60-5b67db24e724" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_b16a1969-4575-478e-bd17-7a1698fe18c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_533de868-96d6-456e-9d71-457944a1cf7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88ed5aa9-eb63-4aa7-8c60-5b67db24e724" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_533de868-96d6-456e-9d71-457944a1cf7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_f3429397-cb03-4726-9757-bfb6c8584958" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88ed5aa9-eb63-4aa7-8c60-5b67db24e724" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_f3429397-cb03-4726-9757-bfb6c8584958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_02482345-3fb7-401b-99a4-cad868fdd7d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88ed5aa9-eb63-4aa7-8c60-5b67db24e724" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_02482345-3fb7-401b-99a4-cad868fdd7d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_b8cb2d3d-d34f-48bc-a017-077709d71011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88ed5aa9-eb63-4aa7-8c60-5b67db24e724" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_b8cb2d3d-d34f-48bc-a017-077709d71011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_c5e9e68b-3896-4300-afef-c789f8d4340a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88ed5aa9-eb63-4aa7-8c60-5b67db24e724" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_c5e9e68b-3896-4300-afef-c789f8d4340a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_9b671877-b51e-48db-b1de-7127ef11a284" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88ed5aa9-eb63-4aa7-8c60-5b67db24e724" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_9b671877-b51e-48db-b1de-7127ef11a284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_a1b0aad6-7c08-46aa-a830-9f6407f4223c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88ed5aa9-eb63-4aa7-8c60-5b67db24e724" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_a1b0aad6-7c08-46aa-a830-9f6407f4223c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_fa63c98b-e110-4494-a486-3fa1c6349060" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88ed5aa9-eb63-4aa7-8c60-5b67db24e724" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_fa63c98b-e110-4494-a486-3fa1c6349060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_3a01cd2f-e48d-4f98-911b-3ea22f379cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88ed5aa9-eb63-4aa7-8c60-5b67db24e724" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_3a01cd2f-e48d-4f98-911b-3ea22f379cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_bd4fc396-3e27-4912-8899-60b1c1a9f3ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88ed5aa9-eb63-4aa7-8c60-5b67db24e724" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_bd4fc396-3e27-4912-8899-60b1c1a9f3ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_4ddbf628-ed2e-4c76-9001-dc41848cc5df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88ed5aa9-eb63-4aa7-8c60-5b67db24e724" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_4ddbf628-ed2e-4c76-9001-dc41848cc5df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="lfvn-20220331.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_92490efc-6b9b-4dd5-8650-0fc1708a1d60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_af2f0cee-7550-424e-8dcf-9a2bbb7c6f73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_92490efc-6b9b-4dd5-8650-0fc1708a1d60" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_af2f0cee-7550-424e-8dcf-9a2bbb7c6f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_271fd7a8-01d0-49d5-b3b4-9abb1b366416" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_92490efc-6b9b-4dd5-8650-0fc1708a1d60" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_271fd7a8-01d0-49d5-b3b4-9abb1b366416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_af488ac7-6bae-4526-aa88-080eaf848f42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_92490efc-6b9b-4dd5-8650-0fc1708a1d60" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_af488ac7-6bae-4526-aa88-080eaf848f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_8b1a5d22-2e74-45bc-b752-1301c185fb60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_92490efc-6b9b-4dd5-8650-0fc1708a1d60" xlink:to="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_8b1a5d22-2e74-45bc-b752-1301c185fb60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20220331.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e2da5296-ba87-4548-a71a-50404ea2dc7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_94a76546-6659-4742-b0a8-8b5cfca96261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2da5296-ba87-4548-a71a-50404ea2dc7f" xlink:to="loc_us-gaap_ConcentrationRiskTable_94a76546-6659-4742-b0a8-8b5cfca96261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_6914fa9e-07ea-430d-b7ec-7604344deb57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_94a76546-6659-4742-b0a8-8b5cfca96261" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_6914fa9e-07ea-430d-b7ec-7604344deb57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_47eb5462-2609-4dfd-9a0c-139e72006028" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_6914fa9e-07ea-430d-b7ec-7604344deb57" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_47eb5462-2609-4dfd-9a0c-139e72006028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember_90869a4d-83ad-477e-af89-6128b2c5b26c" xlink:href="lfvn-20220331.xsd#lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_47eb5462-2609-4dfd-9a0c-139e72006028" xlink:to="loc_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember_90869a4d-83ad-477e-af89-6128b2c5b26c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember_0169a497-ba24-4e74-bc6b-14d6865d6dcd" xlink:href="lfvn-20220331.xsd#lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_47eb5462-2609-4dfd-9a0c-139e72006028" xlink:to="loc_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember_0169a497-ba24-4e74-bc6b-14d6865d6dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_325ea726-3c94-4d7b-a611-280424a8049c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_94a76546-6659-4742-b0a8-8b5cfca96261" xlink:to="loc_srt_StatementGeographicalAxis_325ea726-3c94-4d7b-a611-280424a8049c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_82e5835a-cf95-4510-a4b0-991aa1efb425" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_325ea726-3c94-4d7b-a611-280424a8049c" xlink:to="loc_srt_SegmentGeographicalDomain_82e5835a-cf95-4510-a4b0-991aa1efb425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_SandyUTMember_4eb98e11-2470-4b99-9b05-82857699ddd0" xlink:href="lfvn-20220331.xsd#lfvn_SandyUTMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_82e5835a-cf95-4510-a4b0-991aa1efb425" xlink:to="loc_lfvn_SandyUTMember_4eb98e11-2470-4b99-9b05-82857699ddd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_94a76546-6659-4742-b0a8-8b5cfca96261" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_ac422b7c-3bc3-46b7-93a4-542edf385814" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_ac422b7c-3bc3-46b7-93a4-542edf385814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_90696fe6-1a13-476b-a3f2-3b756f414f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_90696fe6-1a13-476b-a3f2-3b756f414f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_dea7d0b2-c607-4f1c-bd73-d72c7e9c1eea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_dea7d0b2-c607-4f1c-bd73-d72c7e9c1eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_83495ffb-619c-46e2-8d7b-a29d356e3de4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_83495ffb-619c-46e2-8d7b-a29d356e3de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_d070aa93-8de1-4a60-a3ec-6d3040fd4be6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_us-gaap_InventoryValuationReserves_d070aa93-8de1-4a60-a3ec-6d3040fd4be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_MoneyBackGuaranteePeriod_a56096bb-46cc-4a14-b876-52965b3ced79" xlink:href="lfvn-20220331.xsd#lfvn_MoneyBackGuaranteePeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_lfvn_MoneyBackGuaranteePeriod_a56096bb-46cc-4a14-b876-52965b3ced79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_HandlingAndRestockingFeePercentage_f74f39c9-0979-4362-a95b-cc45e3f78841" xlink:href="lfvn-20220331.xsd#lfvn_HandlingAndRestockingFeePercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_lfvn_HandlingAndRestockingFeePercentage_f74f39c9-0979-4362-a95b-cc45e3f78841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ReturnLiabilityReserve_90170fb0-0718-42a5-b011-1300f7971abe" xlink:href="lfvn-20220331.xsd#lfvn_ReturnLiabilityReserve"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_lfvn_ReturnLiabilityReserve_90170fb0-0718-42a5-b011-1300f7971abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_612472a7-a777-4592-8c67-082ec2af6a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_612472a7-a777-4592-8c67-082ec2af6a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_OperatingLeaseRightOfUseAssetSalvageValue_dd04361a-9806-4584-b86b-8922042c4f16" xlink:href="lfvn-20220331.xsd#lfvn_OperatingLeaseRightOfUseAssetSalvageValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_lfvn_OperatingLeaseRightOfUseAssetSalvageValue_dd04361a-9806-4584-b86b-8922042c4f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_OperatingLeaseRightOfUseAssetAbandonmentExpense_84039c19-4084-4bbd-bac6-c8ec87799283" xlink:href="lfvn-20220331.xsd#lfvn_OperatingLeaseRightOfUseAssetAbandonmentExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_lfvn_OperatingLeaseRightOfUseAssetAbandonmentExpense_84039c19-4084-4bbd-bac6-c8ec87799283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_ba6d4f44-fe58-4660-adef-37d5f397817d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_us-gaap_OperatingLeaseLiability_ba6d4f44-fe58-4660-adef-37d5f397817d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_32a476db-c325-4b75-a7d7-b9ec9b0fef51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_32a476db-c325-4b75-a7d7-b9ec9b0fef51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c263fa16-81f1-4b8a-87ea-cbf7523a0e11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c263fa16-81f1-4b8a-87ea-cbf7523a0e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NumberOfGeographicSegments_b777618c-0e39-4173-84a8-3774348e32b4" xlink:href="lfvn-20220331.xsd#lfvn_NumberOfGeographicSegments"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_lfvn_NumberOfGeographicSegments_b777618c-0e39-4173-84a8-3774348e32b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_f1dcc075-8190-454c-8400-6eed5624a75d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_9a9f0972-51d7-4393-9478-7d79f442a497" xlink:to="loc_us-gaap_NumberOfOperatingSegments_f1dcc075-8190-454c-8400-6eed5624a75d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails" xlink:type="simple" xlink:href="lfvn-20220331.xsd#SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8d83338d-6373-474c-ae51-f061b9ff9236" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_785484d5-6ed1-4c24-87a7-2f69734b935e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8d83338d-6373-474c-ae51-f061b9ff9236" xlink:to="loc_us-gaap_InventoryDisclosureAbstract_785484d5-6ed1-4c24-87a7-2f69734b935e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_f52fcbe8-a2e2-48b3-9dea-063bdcebcbf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_785484d5-6ed1-4c24-87a7-2f69734b935e" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_f52fcbe8-a2e2-48b3-9dea-063bdcebcbf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_336e0204-f077-4ea8-a188-3e29f12a6ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_785484d5-6ed1-4c24-87a7-2f69734b935e" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_336e0204-f077-4ea8-a188-3e29f12a6ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c2e83ec5-b3bb-4a0b-abac-c1acaf754eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_785484d5-6ed1-4c24-87a7-2f69734b935e" xlink:to="loc_us-gaap_InventoryNet_c2e83ec5-b3bb-4a0b-abac-c1acaf754eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_InventoryFinishedGoodsPercentOfTotalInventory_fb85dcff-10af-408c-a5e4-cdbbe40c564f" xlink:href="lfvn-20220331.xsd#lfvn_InventoryFinishedGoodsPercentOfTotalInventory"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_785484d5-6ed1-4c24-87a7-2f69734b935e" xlink:to="loc_lfvn_InventoryFinishedGoodsPercentOfTotalInventory_fb85dcff-10af-408c-a5e4-cdbbe40c564f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_RawMaterialsPercentOfTotalInventory_b5fdf429-4c0c-4d05-99fd-498e2807086c" xlink:href="lfvn-20220331.xsd#lfvn_RawMaterialsPercentOfTotalInventory"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_785484d5-6ed1-4c24-87a7-2f69734b935e" xlink:to="loc_lfvn_RawMaterialsPercentOfTotalInventory_b5fdf429-4c0c-4d05-99fd-498e2807086c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_InventoryPercentOfTotalInventory_8cac0405-8e75-4117-b08e-6744ceba027c" xlink:href="lfvn-20220331.xsd#lfvn_InventoryPercentOfTotalInventory"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_785484d5-6ed1-4c24-87a7-2f69734b935e" xlink:to="loc_lfvn_InventoryPercentOfTotalInventory_8cac0405-8e75-4117-b08e-6744ceba027c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails" xlink:type="simple" xlink:href="lfvn-20220331.xsd#SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ee1336a0-3c44-48eb-a79d-d9f32053c597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_1e747e04-ff04-4122-a633-c9f605b99e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ee1336a0-3c44-48eb-a79d-d9f32053c597" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_1e747e04-ff04-4122-a633-c9f605b99e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d7c469de-7a96-450c-8baf-a0c719e1ef3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_1e747e04-ff04-4122-a633-c9f605b99e5b" xlink:to="loc_us-gaap_NetIncomeLoss_d7c469de-7a96-450c-8baf-a0c719e1ef3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_d007c25b-d51a-41b0-ace4-491c05f2c71f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ee1336a0-3c44-48eb-a79d-d9f32053c597" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_d007c25b-d51a-41b0-ace4-491c05f2c71f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e18f708b-103d-4d89-86a6-3351b3296787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_d007c25b-d51a-41b0-ace4-491c05f2c71f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e18f708b-103d-4d89-86a6-3351b3296787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_98b6a962-81f6-423c-86f2-3f146c142fd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ee1336a0-3c44-48eb-a79d-d9f32053c597" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_98b6a962-81f6-423c-86f2-3f146c142fd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_f4f62384-9dac-4977-9ac5-22229a989773" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_98b6a962-81f6-423c-86f2-3f146c142fd7" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_f4f62384-9dac-4977-9ac5-22229a989773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ac48dd7b-81d8-44ac-a876-88695707b437" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ee1336a0-3c44-48eb-a79d-d9f32053c597" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ac48dd7b-81d8-44ac-a876-88695707b437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_792d348e-4b23-4b56-9ca2-2a251da8d461" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ee1336a0-3c44-48eb-a79d-d9f32053c597" xlink:to="loc_us-gaap_EarningsPerShareBasic_792d348e-4b23-4b56-9ca2-2a251da8d461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_43c402f4-4eba-4d1a-968f-51a2c8e33140" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ee1336a0-3c44-48eb-a79d-d9f32053c597" xlink:to="loc_us-gaap_EarningsPerShareDiluted_43c402f4-4eba-4d1a-968f-51a2c8e33140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails" xlink:type="simple" xlink:href="lfvn-20220331.xsd#SummaryofSignificantAccountingPoliciesSegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_08d0be5a-0a62-4f91-b14f-2810bc4da1af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_6ecf4f87-9582-4fa3-8e5f-508614fe3f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_08d0be5a-0a62-4f91-b14f-2810bc4da1af" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_6ecf4f87-9582-4fa3-8e5f-508614fe3f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e4f2def4-b503-4021-9f35-b4faa0840daa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_6ecf4f87-9582-4fa3-8e5f-508614fe3f9b" xlink:to="loc_srt_StatementGeographicalAxis_e4f2def4-b503-4021-9f35-b4faa0840daa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_49aefde6-330e-4080-b595-e3f93b863b30" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_e4f2def4-b503-4021-9f35-b4faa0840daa" xlink:to="loc_srt_SegmentGeographicalDomain_49aefde6-330e-4080-b595-e3f93b863b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_37b5c102-d4f0-4e16-911d-5bdfdfcb1617" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_49aefde6-330e-4080-b595-e3f93b863b30" xlink:to="loc_srt_AmericasMember_37b5c102-d4f0-4e16-911d-5bdfdfcb1617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_AsiaPacificAndEuropeMember_eea0aa6e-ae38-4ceb-a14d-e6ff7871893f" xlink:href="lfvn-20220331.xsd#lfvn_AsiaPacificAndEuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_49aefde6-330e-4080-b595-e3f93b863b30" xlink:to="loc_lfvn_AsiaPacificAndEuropeMember_eea0aa6e-ae38-4ceb-a14d-e6ff7871893f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_26dd2293-7739-40d3-9ab7-299c54af0fe0" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_49aefde6-330e-4080-b595-e3f93b863b30" xlink:to="loc_country_US_26dd2293-7739-40d3-9ab7-299c54af0fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_eb8fb65a-362e-41fd-983f-36070ef6043c" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_JP"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_49aefde6-330e-4080-b595-e3f93b863b30" xlink:to="loc_country_JP_eb8fb65a-362e-41fd-983f-36070ef6043c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_0cdff6a5-7087-4891-ac6b-f5a80e99f30f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_6ecf4f87-9582-4fa3-8e5f-508614fe3f9b" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_0cdff6a5-7087-4891-ac6b-f5a80e99f30f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a64f6e96-52b6-4051-afdf-0d830afd3181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_0cdff6a5-7087-4891-ac6b-f5a80e99f30f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a64f6e96-52b6-4051-afdf-0d830afd3181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_143c6944-2f72-4a04-90bf-003b46752dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_0cdff6a5-7087-4891-ac6b-f5a80e99f30f" xlink:to="loc_us-gaap_NoncurrentAssets_143c6944-2f72-4a04-90bf-003b46752dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/GigEconomyGroupInvestment" xlink:type="simple" xlink:href="lfvn-20220331.xsd#GigEconomyGroupInvestment"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/GigEconomyGroupInvestment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_d1dece65-2ec4-4ba5-a65b-b3b68a0355eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTextBlock_d9bf49f4-0d4a-47ef-9e8e-35fe99e30128" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_d1dece65-2ec4-4ba5-a65b-b3b68a0355eb" xlink:to="loc_us-gaap_InvestmentTextBlock_d9bf49f4-0d4a-47ef-9e8e-35fe99e30128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails" xlink:type="simple" xlink:href="lfvn-20220331.xsd#GigEconomyGroupInvestmentDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_48765cd6-789b-4df9-bb83-309cef677e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_2c9961ca-ec7e-4f05-a02a-0a95a2d10e66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_48765cd6-789b-4df9-bb83-309cef677e9d" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_2c9961ca-ec7e-4f05-a02a-0a95a2d10e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_459acb4d-948d-47f5-943d-cbfa4ef0e98c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_2c9961ca-ec7e-4f05-a02a-0a95a2d10e66" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_459acb4d-948d-47f5-943d-cbfa4ef0e98c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_34e7e5a8-24f7-4a14-bb0e-6d7fee80dd71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_459acb4d-948d-47f5-943d-cbfa4ef0e98c" xlink:to="loc_us-gaap_RelatedPartyDomain_34e7e5a8-24f7-4a14-bb0e-6d7fee80dd71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_9557370a-af39-4e21-a1f9-45410274b4ab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_34e7e5a8-24f7-4a14-bb0e-6d7fee80dd71" xlink:to="loc_srt_AffiliatedEntityMember_9557370a-af39-4e21-a1f9-45410274b4ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_a60737eb-b408-497b-8969-7de26f1ab655" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_2c9961ca-ec7e-4f05-a02a-0a95a2d10e66" xlink:to="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_a60737eb-b408-497b-8969-7de26f1ab655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_74008dc5-7d00-4399-9839-43e643b17501" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_a60737eb-b408-497b-8969-7de26f1ab655" xlink:to="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_74008dc5-7d00-4399-9839-43e643b17501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_aa2670d4-80f8-4bc5-8df9-85bd85c7b005" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_74008dc5-7d00-4399-9839-43e643b17501" xlink:to="loc_us-gaap_CommonStockMember_aa2670d4-80f8-4bc5-8df9-85bd85c7b005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_2fc71e84-c2d4-4f42-98bc-3567e3a09b59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_2c9961ca-ec7e-4f05-a02a-0a95a2d10e66" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_2fc71e84-c2d4-4f42-98bc-3567e3a09b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NotesReceivableRelatedPartyMaximumCommitment_464cf1de-a021-4e67-b054-1ba582200ec6" xlink:href="lfvn-20220331.xsd#lfvn_NotesReceivableRelatedPartyMaximumCommitment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2fc71e84-c2d4-4f42-98bc-3567e3a09b59" xlink:to="loc_lfvn_NotesReceivableRelatedPartyMaximumCommitment_464cf1de-a021-4e67-b054-1ba582200ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt_613608ff-7667-48a4-8d7c-cd42eb795892" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionOriginalDebtInterestRateOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2fc71e84-c2d4-4f42-98bc-3567e3a09b59" xlink:to="loc_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt_613608ff-7667-48a4-8d7c-cd42eb795892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_0796b0e6-9815-4d7e-9769-e4431fa48343" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2fc71e84-c2d4-4f42-98bc-3567e3a09b59" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_0796b0e6-9815-4d7e-9769-e4431fa48343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_a0283b48-901c-4620-a0da-f02b1254a6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2fc71e84-c2d4-4f42-98bc-3567e3a09b59" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_a0283b48-901c-4620-a0da-f02b1254a6d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_da9ac533-c424-48ff-bfbf-41ef0cbf1efc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2fc71e84-c2d4-4f42-98bc-3567e3a09b59" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_da9ac533-c424-48ff-bfbf-41ef0cbf1efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/Leases" xlink:type="simple" xlink:href="lfvn-20220331.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_a078dc03-1a67-4860-bc06-c6dda5a8a55f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_20cb866a-fa0b-4a9a-b4b7-8b256d6c29df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a078dc03-1a67-4860-bc06-c6dda5a8a55f" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_20cb866a-fa0b-4a9a-b4b7-8b256d6c29df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesTables" xlink:type="simple" xlink:href="lfvn-20220331.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_cf5854f7-0ed7-45db-9c87-ad7ffe11cbfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_4ba52c76-6947-4a21-a466-e851aed885e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cf5854f7-0ed7-45db-9c87-ad7ffe11cbfa" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_4ba52c76-6947-4a21-a466-e851aed885e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_74a7f4b5-e5c3-476f-930b-f2d88a5798b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cf5854f7-0ed7-45db-9c87-ad7ffe11cbfa" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_74a7f4b5-e5c3-476f-930b-f2d88a5798b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20220331.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_2b11cb64-30b8-4e67-8a0d-529c5c0800e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_0e981841-861f-4dd4-b084-d117370029e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2b11cb64-30b8-4e67-8a0d-529c5c0800e4" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_0e981841-861f-4dd4-b084-d117370029e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a28e8a42-41c8-42b5-9171-eb6a1b3a0205" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_0e981841-861f-4dd4-b084-d117370029e3" xlink:to="loc_srt_RangeAxis_a28e8a42-41c8-42b5-9171-eb6a1b3a0205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_411a333f-4ae9-4932-a149-5efc977c20ea" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a28e8a42-41c8-42b5-9171-eb6a1b3a0205" xlink:to="loc_srt_RangeMember_411a333f-4ae9-4932-a149-5efc977c20ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3767c261-7cba-4fc2-8088-e5cbb3679821" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_411a333f-4ae9-4932-a149-5efc977c20ea" xlink:to="loc_srt_MinimumMember_3767c261-7cba-4fc2-8088-e5cbb3679821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_530aeca0-631b-4a19-98ed-f8e4326dff33" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_411a333f-4ae9-4932-a149-5efc977c20ea" xlink:to="loc_srt_MaximumMember_530aeca0-631b-4a19-98ed-f8e4326dff33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_75379962-e89d-42ac-8e3a-ffe396f8d77b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_0e981841-861f-4dd4-b084-d117370029e3" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_75379962-e89d-42ac-8e3a-ffe396f8d77b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_985a6497-9fee-44ae-8701-9f2db7c50c30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75379962-e89d-42ac-8e3a-ffe396f8d77b" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_985a6497-9fee-44ae-8701-9f2db7c50c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_8b15e8d6-9a71-4390-9973-a49eddd52436" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75379962-e89d-42ac-8e3a-ffe396f8d77b" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_8b15e8d6-9a71-4390-9973-a49eddd52436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_0fe4543c-2e14-4095-b074-902531dd27ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75379962-e89d-42ac-8e3a-ffe396f8d77b" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_0fe4543c-2e14-4095-b074-902531dd27ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_e0fc3eb3-049b-4f8e-98c1-47b7346634c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75379962-e89d-42ac-8e3a-ffe396f8d77b" xlink:to="loc_us-gaap_OperatingLeaseExpense_e0fc3eb3-049b-4f8e-98c1-47b7346634c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails" xlink:type="simple" xlink:href="lfvn-20220331.xsd#LeasesScheduleofLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_0d696c59-13f4-4d3c-9640-c14631d392d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_a50cff86-0163-4a9c-97bb-c1b84be970e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0d696c59-13f4-4d3c-9640-c14631d392d5" xlink:to="loc_us-gaap_OperatingLeasePayments_a50cff86-0163-4a9c-97bb-c1b84be970e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_9c475ac6-ab1f-4783-989b-f8da121df4cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0d696c59-13f4-4d3c-9640-c14631d392d5" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_9c475ac6-ab1f-4783-989b-f8da121df4cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="lfvn-20220331.xsd#LeasesScheduleofMaturityofLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d340ae88-a6c6-4fca-a948-9d33241a615a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_9255d5cf-2456-4f4b-9bcc-f725840a7cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d340ae88-a6c6-4fca-a948-9d33241a615a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_9255d5cf-2456-4f4b-9bcc-f725840a7cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_06921f3f-e085-49dc-be93-9122a7701684" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d340ae88-a6c6-4fca-a948-9d33241a615a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_06921f3f-e085-49dc-be93-9122a7701684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6923e611-d2a7-46b0-94b0-df5f141fbb27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d340ae88-a6c6-4fca-a948-9d33241a615a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6923e611-d2a7-46b0-94b0-df5f141fbb27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_f421ce04-7570-495d-bb6e-ac7e21c8a284" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d340ae88-a6c6-4fca-a948-9d33241a615a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_f421ce04-7570-495d-bb6e-ac7e21c8a284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_376388f3-49d4-411b-9ef7-0921583cdf02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d340ae88-a6c6-4fca-a948-9d33241a615a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_376388f3-49d4-411b-9ef7-0921583cdf02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_206c1038-3fe5-4bc8-864a-e660e0bbb536" xlink:href="lfvn-20220331.xsd#lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d340ae88-a6c6-4fca-a948-9d33241a615a" xlink:to="loc_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_206c1038-3fe5-4bc8-864a-e660e0bbb536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_90e1fcd1-ea8f-4658-aa07-24eb35d311aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d340ae88-a6c6-4fca-a948-9d33241a615a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_90e1fcd1-ea8f-4658-aa07-24eb35d311aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_10b0b56a-de33-4d85-a6d4-80df419c353d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d340ae88-a6c6-4fca-a948-9d33241a615a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_10b0b56a-de33-4d85-a6d4-80df419c353d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_76add0cb-a713-4dc3-9438-bd0d97884b91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d340ae88-a6c6-4fca-a948-9d33241a615a" xlink:to="loc_us-gaap_OperatingLeaseLiability_76add0cb-a713-4dc3-9438-bd0d97884b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="lfvn-20220331.xsd#LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LongTermDebt" xlink:type="simple" xlink:href="lfvn-20220331.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_057cbd84-0448-47ff-80c0-f812650ea8fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_2748dbb7-086f-4163-a677-f21871dee039" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_057cbd84-0448-47ff-80c0-f812650ea8fb" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_2748dbb7-086f-4163-a677-f21871dee039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20220331.xsd#LongTermDebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/LongTermDebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_209a7126-b7a6-432b-be39-76f663e7d78b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_3a3ad21e-194b-4738-bf6f-4d326217a121" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_209a7126-b7a6-432b-be39-76f663e7d78b" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_3a3ad21e-194b-4738-bf6f-4d326217a121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_20d7717f-b717-4c90-84ee-3fca6f385121" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3a3ad21e-194b-4738-bf6f-4d326217a121" xlink:to="loc_us-gaap_DebtInstrumentAxis_20d7717f-b717-4c90-84ee-3fca6f385121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2078c2f4-f60d-4b9d-807f-f501d508371f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_20d7717f-b717-4c90-84ee-3fca6f385121" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2078c2f4-f60d-4b9d-807f-f501d508371f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_March2016TermLoanMember_c90ae13a-e9ef-483f-b7ca-72235e5883ff" xlink:href="lfvn-20220331.xsd#lfvn_March2016TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2078c2f4-f60d-4b9d-807f-f501d508371f" xlink:to="loc_lfvn_March2016TermLoanMember_c90ae13a-e9ef-483f-b7ca-72235e5883ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_March2016RevolvingLoanMember_b599a5ee-db6c-4262-a143-65e6179558a1" xlink:href="lfvn-20220331.xsd#lfvn_March2016RevolvingLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2078c2f4-f60d-4b9d-807f-f501d508371f" xlink:to="loc_lfvn_March2016RevolvingLoanMember_b599a5ee-db6c-4262-a143-65e6179558a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_44cf6cb7-1a6f-46a4-bd66-d90945a3b526" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3a3ad21e-194b-4738-bf6f-4d326217a121" xlink:to="loc_us-gaap_CreditFacilityAxis_44cf6cb7-1a6f-46a4-bd66-d90945a3b526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_1c875643-7c17-4c13-82c9-d7e8fe862944" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_44cf6cb7-1a6f-46a4-bd66-d90945a3b526" xlink:to="loc_us-gaap_CreditFacilityDomain_1c875643-7c17-4c13-82c9-d7e8fe862944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_27d0e7fb-9dff-4f1f-a8f3-f9c21cb7e8fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_1c875643-7c17-4c13-82c9-d7e8fe862944" xlink:to="loc_us-gaap_SecuredDebtMember_27d0e7fb-9dff-4f1f-a8f3-f9c21cb7e8fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_1ef6f443-6080-4a0f-9ed3-53ffa8870ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_1c875643-7c17-4c13-82c9-d7e8fe862944" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_1ef6f443-6080-4a0f-9ed3-53ffa8870ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_27c5c5da-a356-4f2e-b076-72eddf00c19d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3a3ad21e-194b-4738-bf6f-4d326217a121" xlink:to="loc_us-gaap_VariableRateAxis_27c5c5da-a356-4f2e-b076-72eddf00c19d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_4d660f68-0736-4dac-b624-26b2a55c9685" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_27c5c5da-a356-4f2e-b076-72eddf00c19d" xlink:to="loc_us-gaap_VariableRateDomain_4d660f68-0736-4dac-b624-26b2a55c9685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UsTreasuryUstInterestRateMember_ed51a2db-99c8-4c7a-b157-7929405e61d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UsTreasuryUstInterestRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_4d660f68-0736-4dac-b624-26b2a55c9685" xlink:to="loc_us-gaap_UsTreasuryUstInterestRateMember_ed51a2db-99c8-4c7a-b157-7929405e61d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_cf6d684f-af1c-4fa8-95e8-d2ac7531c5c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3a3ad21e-194b-4738-bf6f-4d326217a121" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_cf6d684f-af1c-4fa8-95e8-d2ac7531c5c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_44c058c1-a4f9-4a2e-b492-04a900191331" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cf6d684f-af1c-4fa8-95e8-d2ac7531c5c8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_44c058c1-a4f9-4a2e-b492-04a900191331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_d6d277b2-ebeb-40e4-9df7-0c232252f543" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_44c058c1-a4f9-4a2e-b492-04a900191331" xlink:to="loc_us-gaap_LineOfCreditMember_d6d277b2-ebeb-40e4-9df7-0c232252f543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_e701697c-4973-49e7-8404-f952fe3b53e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3a3ad21e-194b-4738-bf6f-4d326217a121" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_e701697c-4973-49e7-8404-f952fe3b53e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e134a45f-499e-4b3b-9805-53598ff127fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e701697c-4973-49e7-8404-f952fe3b53e3" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e134a45f-499e-4b3b-9805-53598ff127fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_2b98dbfd-cbe9-424c-a5fc-a9816af66381" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e701697c-4973-49e7-8404-f952fe3b53e3" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_2b98dbfd-cbe9-424c-a5fc-a9816af66381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_2eb34b35-36fe-40ce-94d2-14b1919c6149" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e701697c-4973-49e7-8404-f952fe3b53e3" xlink:to="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_2eb34b35-36fe-40ce-94d2-14b1919c6149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio_e52aacab-4943-4667-b6c7-5540ba48bf17" xlink:href="lfvn-20220331.xsd#lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e701697c-4973-49e7-8404-f952fe3b53e3" xlink:to="loc_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio_e52aacab-4943-4667-b6c7-5540ba48bf17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentTrailingPeriod_7184d625-e5a3-4187-bf19-e62881aebc72" xlink:href="lfvn-20220331.xsd#lfvn_DebtInstrumentTrailingPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e701697c-4973-49e7-8404-f952fe3b53e3" xlink:to="loc_lfvn_DebtInstrumentTrailingPeriod_7184d625-e5a3-4187-bf19-e62881aebc72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital_44be36cc-d474-43de-a840-13bb55c614a1" xlink:href="lfvn-20220331.xsd#lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e701697c-4973-49e7-8404-f952fe3b53e3" xlink:to="loc_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital_44be36cc-d474-43de-a840-13bb55c614a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio_b655b01e-1832-45a7-96f8-4a54fed6743d" xlink:href="lfvn-20220331.xsd#lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e701697c-4973-49e7-8404-f952fe3b53e3" xlink:to="loc_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio_b655b01e-1832-45a7-96f8-4a54fed6743d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_48b4c298-2862-443b-ae04-30540c41754a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e701697c-4973-49e7-8404-f952fe3b53e3" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_48b4c298-2862-443b-ae04-30540c41754a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8ba8bd99-5fc7-4a11-8641-f521314b5466" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e701697c-4973-49e7-8404-f952fe3b53e3" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8ba8bd99-5fc7-4a11-8641-f521314b5466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentFloorInterestRate_3fea8f7f-836d-4d18-9406-ab4f88c39c20" xlink:href="lfvn-20220331.xsd#lfvn_DebtInstrumentFloorInterestRate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e701697c-4973-49e7-8404-f952fe3b53e3" xlink:to="loc_lfvn_DebtInstrumentFloorInterestRate_3fea8f7f-836d-4d18-9406-ab4f88c39c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/StockholdersEquity" xlink:type="simple" xlink:href="lfvn-20220331.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f3744905-15e8-450b-b6ac-10e9f41b9fe3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_49e4bbde-26ea-4f37-8324-881243b65819" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f3744905-15e8-450b-b6ac-10e9f41b9fe3" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_49e4bbde-26ea-4f37-8324-881243b65819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/StockholdersEquityDetails" xlink:type="simple" xlink:href="lfvn-20220331.xsd#StockholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/StockholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_828611db-b4de-4f5b-a3df-5962992c5584" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_af9070be-d500-4822-b0ac-366db77cb269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_828611db-b4de-4f5b-a3df-5962992c5584" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_af9070be-d500-4822-b0ac-366db77cb269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_7d44bcc8-6586-4817-a247-ae10b5191bd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_af9070be-d500-4822-b0ac-366db77cb269" xlink:to="loc_us-gaap_StatementClassOfStockAxis_7d44bcc8-6586-4817-a247-ae10b5191bd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_1850cd0e-15a8-455f-83b2-772e26f30b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7d44bcc8-6586-4817-a247-ae10b5191bd3" xlink:to="loc_us-gaap_ClassOfStockDomain_1850cd0e-15a8-455f-83b2-772e26f30b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_cd8a6aca-fd14-4b12-9e61-1b0256ae0362" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1850cd0e-15a8-455f-83b2-772e26f30b7a" xlink:to="loc_us-gaap_CommonStockMember_cd8a6aca-fd14-4b12-9e61-1b0256ae0362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_689bd165-99e0-4f4f-8f2f-76bf318031b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_af9070be-d500-4822-b0ac-366db77cb269" xlink:to="loc_us-gaap_ClassOfStockLineItems_689bd165-99e0-4f4f-8f2f-76bf318031b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8bd09984-6fe1-433a-97d9-c98814852a57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_689bd165-99e0-4f4f-8f2f-76bf318031b7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8bd09984-6fe1-433a-97d9-c98814852a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_3d05360c-3088-4d0e-9bab-1a4a67399475" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_689bd165-99e0-4f4f-8f2f-76bf318031b7" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_3d05360c-3088-4d0e-9bab-1a4a67399475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_e0f42aee-d8be-4231-a3cd-8c1877a648ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_689bd165-99e0-4f4f-8f2f-76bf318031b7" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_e0f42aee-d8be-4231-a3cd-8c1877a648ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_0d49af5f-c8ab-4831-8140-74b71f6a4bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_689bd165-99e0-4f4f-8f2f-76bf318031b7" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_0d49af5f-c8ab-4831-8140-74b71f6a4bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_cb2731c9-1bd9-4507-8b19-28e6fb130136" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_689bd165-99e0-4f4f-8f2f-76bf318031b7" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_cb2731c9-1bd9-4507-8b19-28e6fb130136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_9a757eac-189e-43f4-b6f8-f74a50d07d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_689bd165-99e0-4f4f-8f2f-76bf318031b7" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_9a757eac-189e-43f4-b6f8-f74a50d07d1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="lfvn-20220331.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ca010fa7-24ef-41ec-bdec-09f4a3a41ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_0811accf-97ac-4c3c-b4fb-63e62ab15338" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ca010fa7-24ef-41ec-bdec-09f4a3a41ae8" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_0811accf-97ac-4c3c-b4fb-63e62ab15338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/StockBasedCompensationDetails" xlink:type="simple" xlink:href="lfvn-20220331.xsd#StockBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/StockBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f9f71a99-2022-4507-b946-dd45841d4b16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_66449899-d019-4e60-b88e-923fea7cfd19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f9f71a99-2022-4507-b946-dd45841d4b16" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_66449899-d019-4e60-b88e-923fea7cfd19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_fdac4250-9784-405d-a80b-c672e292a8a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_66449899-d019-4e60-b88e-923fea7cfd19" xlink:to="loc_us-gaap_PlanNameAxis_fdac4250-9784-405d-a80b-c672e292a8a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_a53f414b-b9b3-48a1-af27-27509c62cec9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_fdac4250-9784-405d-a80b-c672e292a8a6" xlink:to="loc_us-gaap_PlanNameDomain_a53f414b-b9b3-48a1-af27-27509c62cec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember_5db4ad0b-8a22-4e27-8b33-b5c67b45f80c" xlink:href="lfvn-20220331.xsd#lfvn_TwoThousandAndSevenLongTermIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_a53f414b-b9b3-48a1-af27-27509c62cec9" xlink:to="loc_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember_5db4ad0b-8a22-4e27-8b33-b5c67b45f80c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandAndTenLongTermIncentivePlanMember_7f3c51c8-84a7-4618-918f-9bc83cd39e5e" xlink:href="lfvn-20220331.xsd#lfvn_TwoThousandAndTenLongTermIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_a53f414b-b9b3-48a1-af27-27509c62cec9" xlink:to="loc_lfvn_TwoThousandAndTenLongTermIncentivePlanMember_7f3c51c8-84a7-4618-918f-9bc83cd39e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember_bcdebc1a-9e38-4f10-876f-2014ea50aff7" xlink:href="lfvn-20220331.xsd#lfvn_TwoThousandSeventeenLongTermIncentivePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_a53f414b-b9b3-48a1-af27-27509c62cec9" xlink:to="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember_bcdebc1a-9e38-4f10-876f-2014ea50aff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember_c0b9e10d-e3bc-4106-8191-57dde2f81680" xlink:href="lfvn-20220331.xsd#lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_a53f414b-b9b3-48a1-af27-27509c62cec9" xlink:to="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember_c0b9e10d-e3bc-4106-8191-57dde2f81680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandEighteenPerformancePlanMember_859e451a-9286-435c-b0b7-46ad45a68d2f" xlink:href="lfvn-20220331.xsd#lfvn_TwoThousandEighteenPerformancePlanMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_a53f414b-b9b3-48a1-af27-27509c62cec9" xlink:to="loc_lfvn_TwoThousandEighteenPerformancePlanMember_859e451a-9286-435c-b0b7-46ad45a68d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EmployeeStockPurchasePlanMember_b029f641-b2a6-493a-a242-20b4bed33083" xlink:href="lfvn-20220331.xsd#lfvn_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_a53f414b-b9b3-48a1-af27-27509c62cec9" xlink:to="loc_lfvn_EmployeeStockPurchasePlanMember_b029f641-b2a6-493a-a242-20b4bed33083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_445b10fd-baba-4e19-8507-d7f866b83921" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_66449899-d019-4e60-b88e-923fea7cfd19" xlink:to="loc_srt_RangeAxis_445b10fd-baba-4e19-8507-d7f866b83921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fb181578-dadc-44b1-9e54-cde352fb0ee5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_445b10fd-baba-4e19-8507-d7f866b83921" xlink:to="loc_srt_RangeMember_fb181578-dadc-44b1-9e54-cde352fb0ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3a732bfa-7a10-43aa-b6e8-ab2d2630d7e5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fb181578-dadc-44b1-9e54-cde352fb0ee5" xlink:to="loc_srt_MinimumMember_3a732bfa-7a10-43aa-b6e8-ab2d2630d7e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c285a58a-6dbc-420d-b2d8-808989e284e6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fb181578-dadc-44b1-9e54-cde352fb0ee5" xlink:to="loc_srt_MaximumMember_c285a58a-6dbc-420d-b2d8-808989e284e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6360ba25-e65f-4528-b122-081f41d53ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_66449899-d019-4e60-b88e-923fea7cfd19" xlink:to="loc_us-gaap_AwardTypeAxis_6360ba25-e65f-4528-b122-081f41d53ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3aaeea05-23cd-48ba-a999-551a0680fbbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6360ba25-e65f-4528-b122-081f41d53ef2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3aaeea05-23cd-48ba-a999-551a0680fbbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_5ebff6dc-c930-4889-8717-6344fed88df4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3aaeea05-23cd-48ba-a999-551a0680fbbe" xlink:to="loc_us-gaap_PerformanceSharesMember_5ebff6dc-c930-4889-8717-6344fed88df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_66449899-d019-4e60-b88e-923fea7cfd19" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_558a586a-8dbe-4949-9cfe-cec54119d233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_558a586a-8dbe-4949-9cfe-cec54119d233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_5814d8a7-29e7-4377-9109-5b1b3d1b8035" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_5814d8a7-29e7-4377-9109-5b1b3d1b8035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_60872ab0-1abe-41de-8340-8845e8b705fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_60872ab0-1abe-41de-8340-8845e8b705fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm_3f7e612c-f99a-48f3-a073-4f0028784aa7" xlink:href="lfvn-20220331.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm_3f7e612c-f99a-48f3-a073-4f0028784aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1a49e445-448b-42c5-aae2-398b62667a54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1a49e445-448b-42c5-aae2-398b62667a54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_2483b9ca-1222-44f1-a903-b54d603bd462" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_2483b9ca-1222-44f1-a903-b54d603bd462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_01bd8e95-2d68-4a0c-84ec-cebdc5f4630e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_01bd8e95-2d68-4a0c-84ec-cebdc5f4630e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_18450693-d1f2-4382-ab29-b6cdf035b136" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_18450693-d1f2-4382-ab29-b6cdf035b136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofVestingInstallments_a2189959-1e06-43cd-9e33-194f7f911dc3" xlink:href="lfvn-20220331.xsd#lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofVestingInstallments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofVestingInstallments_a2189959-1e06-43cd-9e33-194f7f911dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_d4a92eca-6a5b-4a8e-a53a-971b1d09cad7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_d4a92eca-6a5b-4a8e-a53a-971b1d09cad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_ac56b2c4-078d-4af7-b9e4-32aeff5cca3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_ac56b2c4-078d-4af7-b9e4-32aeff5cca3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_4ff7867c-6246-4395-aa46-364d329e34a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_4ff7867c-6246-4395-aa46-364d329e34a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_9040fefe-2492-47b0-bd1d-00b0d8d760a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_9040fefe-2492-47b0-bd1d-00b0d8d760a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_839ba496-759c-4928-8208-dbd6a6261142" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_839ba496-759c-4928-8208-dbd6a6261142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted_9b218ae4-f8cc-4e96-b3dc-77d4d2c2b0d4" xlink:href="lfvn-20220331.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted_9b218ae4-f8cc-4e96-b3dc-77d4d2c2b0d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_8785edb7-6ac2-48d7-927f-b61bc6169130" xlink:href="lfvn-20220331.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_8785edb7-6ac2-48d7-927f-b61bc6169130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_88e44d17-2b8f-4bd7-ae88-54b5c7ca435b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_88e44d17-2b8f-4bd7-ae88-54b5c7ca435b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_0f760d15-4c27-426c-b0ed-f230963deb09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_0f760d15-4c27-426c-b0ed-f230963deb09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities_7eff2720-475f-4af0-8153-ac1b7afddcb0" xlink:href="lfvn-20220331.xsd#lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ada1350f-398b-4a42-a6be-b586b6ba4901" xlink:to="loc_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities_7eff2720-475f-4af0-8153-ac1b7afddcb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="lfvn-20220331.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9c8cdfd8-839d-459a-a81e-bc4e1c35a0bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDisclosures_73f14f55-22f6-4e43-a021-ebb6367c51f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDisclosures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9c8cdfd8-839d-459a-a81e-bc4e1c35a0bc" xlink:to="loc_us-gaap_LossContingencyDisclosures_73f14f55-22f6-4e43-a021-ebb6367c51f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CommitmentandContingenciesDetails" xlink:type="simple" xlink:href="lfvn-20220331.xsd#CommitmentandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CommitmentandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_370b315f-6b27-484e-af9a-aa013db3e2de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsDismissedNumber_98e081d8-975a-416d-bbec-c74a7ec38e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyClaimsDismissedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_370b315f-6b27-484e-af9a-aa013db3e2de" xlink:to="loc_us-gaap_LossContingencyClaimsDismissedNumber_98e081d8-975a-416d-bbec-c74a7ec38e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_4fc6ea13-b08d-412d-92b4-e973fdf83cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_370b315f-6b27-484e-af9a-aa013db3e2de" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_4fc6ea13-b08d-412d-92b4-e973fdf83cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="lfvn-20220331.xsd#RelatedPartyTransactions"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/RelatedPartyTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_ef0de64a-e57d-495b-873d-442de49cbf74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_cb7bfcef-81ab-4e9a-9d41-2932f1379495" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_ef0de64a-e57d-495b-873d-442de49cbf74" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_cb7bfcef-81ab-4e9a-9d41-2932f1379495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="lfvn-20220331.xsd#RelatedPartyTransactionsDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_d6b10c28-1022-4c14-8103-9e012212f0c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_bfb4980e-08b2-4d41-890b-791b164f3eac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_d6b10c28-1022-4c14-8103-9e012212f0c2" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_bfb4980e-08b2-4d41-890b-791b164f3eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b8756bae-b1cf-4808-8ef8-1c76d9813279" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_bfb4980e-08b2-4d41-890b-791b164f3eac" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b8756bae-b1cf-4808-8ef8-1c76d9813279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_8eb3ad64-f7b6-416c-a24f-ab8790568b16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b8756bae-b1cf-4808-8ef8-1c76d9813279" xlink:to="loc_us-gaap_RelatedPartyDomain_8eb3ad64-f7b6-416c-a24f-ab8790568b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_258da812-1673-48a2-a2fe-6ec551e938b2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_8eb3ad64-f7b6-416c-a24f-ab8790568b16" xlink:to="loc_srt_AffiliatedEntityMember_258da812-1673-48a2-a2fe-6ec551e938b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_a74700aa-5932-447b-935e-c661af9dab7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_bfb4980e-08b2-4d41-890b-791b164f3eac" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_a74700aa-5932-447b-935e-c661af9dab7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_MembersOfBoardOfDirectorsServingOnRelatedPartyBoardOfDirectors_035f0d5a-1b57-48ec-b45f-f1a045ef9f30" xlink:href="lfvn-20220331.xsd#lfvn_MembersOfBoardOfDirectorsServingOnRelatedPartyBoardOfDirectors"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_a74700aa-5932-447b-935e-c661af9dab7a" xlink:to="loc_lfvn_MembersOfBoardOfDirectorsServingOnRelatedPartyBoardOfDirectors_035f0d5a-1b57-48ec-b45f-f1a045ef9f30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_cef6c45f-15c1-4901-b05e-023124e93009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_a74700aa-5932-447b-935e-c661af9dab7a" xlink:to="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_cef6c45f-15c1-4901-b05e-023124e93009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140218912656728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Apr. 29, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LIFEVANTAGE CORP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">90-0224471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3300 Triumph Blvd<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Lehi<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">432-9000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LFVN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,590,098<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000849146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--09-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140218913329032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 17,796<span></span>
</td>
<td class="nump">$ 23,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">2,798<span></span>
</td>
<td class="nump">2,925<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income tax receivable</a></td>
<td class="nump">805<span></span>
</td>
<td class="nump">1,038<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">16,276<span></span>
</td>
<td class="nump">16,145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">7,383<span></span>
</td>
<td class="nump">4,772<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">45,058<span></span>
</td>
<td class="nump">48,054<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Long-term assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">10,035<span></span>
</td>
<td class="nump">11,123<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">11,760<span></span>
</td>
<td class="nump">13,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">620<span></span>
</td>
<td class="nump">719<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income tax asset</a></td>
<td class="nump">1,077<span></span>
</td>
<td class="nump">1,208<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Equity securities</a></td>
<td class="nump">2,205<span></span>
</td>
<td class="nump">2,205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">1,460<span></span>
</td>
<td class="nump">1,723<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">72,215<span></span>
</td>
<td class="nump">78,732<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">6,533<span></span>
</td>
<td class="nump">6,744<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalesCommissionCurrent', window );">Commissions payable</a></td>
<td class="nump">7,255<span></span>
</td>
<td class="nump">8,138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrentAndNoncurrent', window );">Income tax payable</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">830<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liabilities</a></td>
<td class="nump">2,688<span></span>
</td>
<td class="nump">2,151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued expenses</a></td>
<td class="nump">7,054<span></span>
</td>
<td class="nump">7,336<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">23,608<span></span>
</td>
<td class="nump">25,199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term lease liabilities</a></td>
<td class="nump">13,876<span></span>
</td>
<td class="nump">16,032<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">700<span></span>
</td>
<td class="nump">694<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">38,184<span></span>
</td>
<td class="nump">41,925<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies - Note 8</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock &#8212; par value $0.0001 per share, 5,000 shares authorized, no shares issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock &#8212; par value $0.0001 per share, 40,000 shares authorized and 12,577 and 13,609 issued and outstanding as of March&#160;31, 2022 and June&#160;30, 2021, respectively</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">130,714<span></span>
</td>
<td class="nump">129,048<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(96,184)<span></span>
</td>
<td class="num">(92,346)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive (loss) income</a></td>
<td class="num">(500)<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">34,031<span></span>
</td>
<td class="nump">36,807<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</a></td>
<td class="nump">$ 72,215<span></span>
</td>
<td class="nump">$ 78,732<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalesCommissionCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalesCommissionCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140218913465704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">40,000,000<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">12,577,000<span></span>
</td>
<td class="nump">13,609,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">12,577,000<span></span>
</td>
<td class="nump">13,609,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140218909286008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Unaudited) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">$ 50,004<span></span>
</td>
<td class="nump">$ 51,570<span></span>
</td>
<td class="nump">$ 155,418<span></span>
</td>
<td class="nump">$ 165,405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">9,657<span></span>
</td>
<td class="nump">8,818<span></span>
</td>
<td class="nump">28,765<span></span>
</td>
<td class="nump">28,404<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">40,347<span></span>
</td>
<td class="nump">42,752<span></span>
</td>
<td class="nump">126,653<span></span>
</td>
<td class="nump">137,001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lfvn_CommissionAndIncentives', window );">Commissions and incentives</a></td>
<td class="nump">23,206<span></span>
</td>
<td class="nump">25,154<span></span>
</td>
<td class="nump">72,760<span></span>
</td>
<td class="nump">77,939<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">15,316<span></span>
</td>
<td class="nump">15,510<span></span>
</td>
<td class="nump">47,813<span></span>
</td>
<td class="nump">48,027<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">38,522<span></span>
</td>
<td class="nump">40,664<span></span>
</td>
<td class="nump">120,573<span></span>
</td>
<td class="nump">125,966<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">1,825<span></span>
</td>
<td class="nump">2,088<span></span>
</td>
<td class="nump">6,080<span></span>
</td>
<td class="nump">11,035<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense, net</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(69)<span></span>
</td>
<td class="num">(255)<span></span>
</td>
<td class="num">(385)<span></span>
</td>
<td class="num">(263)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense</a></td>
<td class="num">(74)<span></span>
</td>
<td class="num">(257)<span></span>
</td>
<td class="num">(395)<span></span>
</td>
<td class="num">(280)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">1,751<span></span>
</td>
<td class="nump">1,831<span></span>
</td>
<td class="nump">5,685<span></span>
</td>
<td class="nump">10,755<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(610)<span></span>
</td>
<td class="num">(107)<span></span>
</td>
<td class="num">(1,149)<span></span>
</td>
<td class="num">(2,768)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 1,141<span></span>
</td>
<td class="nump">$ 1,724<span></span>
</td>
<td class="nump">$ 4,536<span></span>
</td>
<td class="nump">$ 7,987<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in USD per share)</a></td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="nump">$ 0.34<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in USD per share)</a></td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="nump">$ 0.34<span></span>
</td>
<td class="nump">$ 0.55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Weighted-average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">13,195<span></span>
</td>
<td class="nump">14,071<span></span>
</td>
<td class="nump">13,261<span></span>
</td>
<td class="nump">14,175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">13,257<span></span>
</td>
<td class="nump">14,212<span></span>
</td>
<td class="nump">13,312<span></span>
</td>
<td class="nump">14,420<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive loss, net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="num">$ (290)<span></span>
</td>
<td class="num">$ (443)<span></span>
</td>
<td class="num">$ (604)<span></span>
</td>
<td class="num">$ (39)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">(290)<span></span>
</td>
<td class="num">(443)<span></span>
</td>
<td class="num">(604)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 851<span></span>
</td>
<td class="nump">$ 1,281<span></span>
</td>
<td class="nump">$ 3,932<span></span>
</td>
<td class="nump">$ 7,948<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_CommissionAndIncentives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses related to commissions and other incentives earned by independent distributors. Commission and incentive expenses include sales commissions paid to our independent distributors, special incentives, costs for incentive trip and other rewards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_CommissionAndIncentives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140218837259256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS&#8217; EQUITY (Unaudited) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Accumulated Other Comprehensive (Loss) Income</div></th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Jun. 30, 2020</a></td>
<td class="nump">$ 33,254<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 126,416<span></span>
</td>
<td class="num">$ (93,307)<span></span>
</td>
<td class="nump">$ 144<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Common stock issued under equity award plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Common stock issued under equity award plans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other</a></td>
<td class="num">(506)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(506)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of company stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(136)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of company stock</a></td>
<td class="num">(2,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under employee stock purchase plan</a></td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustment</a></td>
<td class="nump">160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">2,451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="nump">34,136<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">126,687<span></span>
</td>
<td class="num">(92,856)<span></span>
</td>
<td class="nump">304<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Jun. 30, 2020</a></td>
<td class="nump">$ 33,254<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">126,416<span></span>
</td>
<td class="num">(93,307)<span></span>
</td>
<td class="nump">144<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of company stock (in shares)</a></td>
<td class="num">(700)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 7,987<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2021</a></td>
<td class="nump">35,628<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">128,842<span></span>
</td>
<td class="num">(93,320)<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Sep. 30, 2020</a></td>
<td class="nump">34,136<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">126,687<span></span>
</td>
<td class="num">(92,856)<span></span>
</td>
<td class="nump">304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options</a></td>
<td class="nump">991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Common stock issued under equity award plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Common stock issued under equity award plans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other</a></td>
<td class="num">(666)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(666)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of company stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(365)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of company stock</a></td>
<td class="num">(4,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustment</a></td>
<td class="nump">244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">3,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="nump">35,516<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">128,011<span></span>
</td>
<td class="num">(93,044)<span></span>
</td>
<td class="nump">548<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">684<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">684<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Common stock issued under equity award plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Common stock issued under equity award plans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other</a></td>
<td class="num">$ (126)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(126)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of company stock (in shares)</a></td>
<td class="num">(200)<span></span>
</td>
<td class="num">(213)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of company stock</a></td>
<td class="num">$ (2,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under employee stock purchase plan</a></td>
<td class="nump">$ 271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustment</a></td>
<td class="num">(443)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(443)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">1,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2021</a></td>
<td class="nump">35,628<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">128,842<span></span>
</td>
<td class="num">(93,320)<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Jun. 30, 2021</a></td>
<td class="nump">36,807<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">129,048<span></span>
</td>
<td class="num">(92,346)<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options</a></td>
<td class="nump">133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Common stock issued under equity award plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Common stock issued under equity award plans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other</a></td>
<td class="num">(139)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(139)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of company stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(460)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of company stock</a></td>
<td class="num">(3,492)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,492)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under employee stock purchase plan</a></td>
<td class="nump">175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustment</a></td>
<td class="num">(135)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(135)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">3,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="nump">37,310<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">129,862<span></span>
</td>
<td class="num">(92,522)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Jun. 30, 2021</a></td>
<td class="nump">$ 36,807<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">129,048<span></span>
</td>
<td class="num">(92,346)<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of company stock (in shares)</a></td>
<td class="num">(1,200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 4,536<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="nump">34,031<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">130,714<span></span>
</td>
<td class="num">(96,184)<span></span>
</td>
<td class="num">(500)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Sep. 30, 2021</a></td>
<td class="nump">37,310<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">129,862<span></span>
</td>
<td class="num">(92,522)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Common stock issued under equity award plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Common stock issued under equity award plans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other</a></td>
<td class="num">(31)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of company stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(454)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of company stock</a></td>
<td class="num">(3,154)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,154)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustment</a></td>
<td class="num">(179)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(179)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="nump">34,780<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">130,586<span></span>
</td>
<td class="num">(95,597)<span></span>
</td>
<td class="num">(210)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Common stock issued under equity award plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Common stock issued under equity award plans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other</a></td>
<td class="num">$ (31)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of company stock (in shares)</a></td>
<td class="num">(300)<span></span>
</td>
<td class="num">(326)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of company stock</a></td>
<td class="num">$ (1,728)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,728)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under employee stock purchase plan</a></td>
<td class="nump">$ 197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustment</a></td>
<td class="num">(290)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(290)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">1,141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="nump">$ 34,031<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 130,714<span></span>
</td>
<td class="num">$ (96,184)<span></span>
</td>
<td class="num">$ (500)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140218916951976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 4,536<span></span>
</td>
<td class="nump">$ 7,987<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2,443<span></span>
</td>
<td class="nump">2,643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">1,362<span></span>
</td>
<td class="nump">2,115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of right-of-use assets</a></td>
<td class="nump">1,228<span></span>
</td>
<td class="nump">2,216<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax</a></td>
<td class="nump">131<span></span>
</td>
<td class="nump">341<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">53<span></span>
</td>
<td class="num">(657)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable', window );">Income tax receivable</a></td>
<td class="nump">234<span></span>
</td>
<td class="num">(762)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory, net</a></td>
<td class="num">(441)<span></span>
</td>
<td class="num">(791)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses and other</a></td>
<td class="num">(2,648)<span></span>
</td>
<td class="num">(518)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other long-term assets</a></td>
<td class="nump">141<span></span>
</td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(170)<span></span>
</td>
<td class="nump">1,636<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income tax payable</a></td>
<td class="num">(752)<span></span>
</td>
<td class="num">(426)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Other accrued expenses</a></td>
<td class="num">(874)<span></span>
</td>
<td class="num">(4,020)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lfvn_IncreaseDecreaseInLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="num">(89)<span></span>
</td>
<td class="num">(1,961)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other long-term liabilities</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash Provided by Operating Activities</a></td>
<td class="nump">5,179<span></span>
</td>
<td class="nump">7,899<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(1,264)<span></span>
</td>
<td class="num">(3,261)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net Cash Used in Investing Activities</a></td>
<td class="num">(1,264)<span></span>
</td>
<td class="num">(3,261)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of company stock</a></td>
<td class="num">(8,374)<span></span>
</td>
<td class="num">(8,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other</a></td>
<td class="num">(201)<span></span>
</td>
<td class="num">(1,298)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan', window );">Proceeds from common stock issued under employee stock purchase plan</a></td>
<td class="nump">372<span></span>
</td>
<td class="nump">517<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Exercise of options</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">1,004<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net Cash Used in Financing Activities</a></td>
<td class="num">(8,070)<span></span>
</td>
<td class="num">(7,777)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Foreign Currency Effect on Cash</a></td>
<td class="num">(1,223)<span></span>
</td>
<td class="num">(44)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Decrease in Cash and Cash Equivalents:</a></td>
<td class="num">(5,378)<span></span>
</td>
<td class="num">(3,183)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and Cash Equivalents &#8212; beginning of period</a></td>
<td class="nump">23,174<span></span>
</td>
<td class="nump">22,138<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and Cash Equivalents &#8212; end of period</a></td>
<td class="nump">17,796<span></span>
</td>
<td class="nump">18,955<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non Cash Investing and Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lfvn_IncreaseDecreaseInPropertyAndEquipmentAndLeaseLiabilitiesFromLeaseIncentives', window );">Increase in property and equipment and lease liabilities from lease incentives</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,543<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid for income taxes</a></td>
<td class="nump">$ 2,554<span></span>
</td>
<td class="nump">$ 3,331<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_IncreaseDecreaseInLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_IncreaseDecreaseInLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_IncreaseDecreaseInPropertyAndEquipmentAndLeaseLiabilitiesFromLeaseIncentives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Property, Equipment and Lease Liabilities From Lease Incentives</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_IncreaseDecreaseInPropertyAndEquipmentAndLeaseLiabilitiesFromLeaseIncentives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInIncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140218916172888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization and Basis of Presentation</a></td>
<td class="text">Organization and Basis of Presentation<div style="margin-bottom:8pt;margin-top:8pt;text-indent:23.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LifeVantage Corporation is a company focused on nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company is dedicated to helping people achieve their health, wellness and financial goals. The Company provides quality, scientifically-validated products to customers and independent distributors as well as a financially rewarding commission-based direct sales opportunity to its independent distributors. LifeVantage sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The Company also sells its products in a number of countries to customers for personal consumption only. In addition, the Company sells its products in China through a China approved cross-border e-commerce business model. </span></div><div style="text-indent:23.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath &amp; body, and targeted relief products. The Company&#8217;s line of scientifically-validated dietary supplements includes its flagship Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> family of products, LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Omega+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, ProBio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, IC Bright</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, and Daily Wellness</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> dietary supplements. TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> is the Company's line of skin, hair, bath &amp; body, and targeted relief products. The Company also markets and sells Petandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, its companion pet supplement formulated to combat oxidative stress in dogs, Axio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> its nootropic energy drink mixes, and PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, its smart weight management system.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements included herein have been prepared by the Company&#8217;s management, without audit, pursuant to the rules and regulations of the SEC. In the opinion of the Company&#8217;s management, these interim financial statements include all adjustments that are considered necessary for a fair presentation of its financial position as of March&#160;31, 2022, and the results of operations for the three and nine months ended March&#160;31, 2022 and 2021, and the cash flows for the nine months ended March&#160;31, 2022 and 2021. Interim results are not necessarily indicative of results for a full year or for any future period. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements and notes included herein are presented as required by Form 10-Q, and do not contain certain information included in the Company&#8217;s audited financial statements and notes for the fiscal year ended June&#160;30, 2021, pursuant to the rules and regulations of the SEC. For further information, refer to the financial statements and notes thereto as of and for the year ended June&#160;30, 2021, and included in the annual report on Form 10-K on file with the SEC.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140218916118504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company prepares the condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (GAAP). In preparing these statements, the Company is required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, the Company reviews its estimates, including, but not limited to, those related to inventory valuation and obsolescence, sales returns, income taxes and tax valuation reserves, transfer pricing methodology and positions, impairment of assets, share-based compensation, and loss contingencies.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the Company&#8217;s business operations occurs outside the United States.&#160;The local currency of each of the Company&#8217;s subsidiaries is generally its functional currency.&#160;All assets and liabilities are translated into U.S. dollars at exchange rates existing at the balance sheet dates, revenue and expenses are translated at weighted-average exchange rates and stockholders&#8217; equity is recorded at historical exchange rates.&#160;The resulting foreign currency translation adjustments are recorded </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as a separate component of stockholders&#8217; equity in the condensed consolidated balance sheets and as a component of com</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prehensive income. Transaction gains and losses are included in other expense, net in the condensed consolidated statements of operations and comprehensive income. For the three months ended March 31, 2022 and 2021, net foreign currency losses of $0.1 million and $0.3 million, respectively, are recorded in other expense, net. For the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended March 31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2021, net foreign currency losses of $0.4 million and $0.2 million, respectively, are recorded in other expense, net.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's subsidiaries enter into transactions with each other which may not be denominated in the respective subsidiaries' functional currencies. The Company seeks to reduce its exposure to fluctuations in foreign exchange rates through the use of derivatives. The Company does not use such derivative financial instruments for trading or speculative purposes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To hedge risks associated with the foreign-currency-denominated intercompany transactions, the Company entered into forward foreign exchange contracts which were all settled by the end of December 2021 and were not designated for hedge accounting. There were no realized gains or losses for three months ended March 31, 2022. For the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended March 31, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> realized losses of $26,000 related to forward contracts, are recorded in other expense, net. For the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended March 31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2021, realized losses of $0.1 million and $0.4 million, respectively, related to forward contracts, are recorded in other expense, net. The Company did not hold any derivative instruments at March&#160;31, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers only its monetary liquid assets with original maturities of three months or less as cash and cash equivalents.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting guidance for financial instruments requires disclosure of significant concentrations of credit risk regardless of the degree of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">such risk. Financial instruments with significant credit risk include cash and investments. At March&#160;31, 2022, the Company had $11.7 million in cash accounts at one financial institution and $6.1 million in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accounts at other financial institutions.  At June&#160;30, 2021, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company had $17.2&#160;million in cash accounts at one financial institution and $6.0 million in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accounts at other financial institutions. As of March&#160;31, 2022 and June&#160;30, 2021, and during the periods then ended, the Company&#8217;s cash balances exceeded federally insured limits.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s accounts receivable as of March&#160;31, 2022 and June&#160;30, 2021 consist primarily of credit card receivables. Based on the Company&#8217;s verification process for customer credit cards and historical information available, management has determined that an allowance for doubtful accounts on credit card sales related to its customer sales as of March&#160;31, 2022 and June&#160;30, 2021 is not necessary. No bad debt expense was recorded during the three and nine months ended March&#160;31, 2022 and 2021.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of March&#160;31, 2022 and June&#160;30, 2021, inventory consisted of (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:31.778%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.115%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,276&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,145&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are carried at the lower of cost or net realizable value, using the first-in, first-out method, which includes a reduction in inventory values </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of $1.0 million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $0.5 million at March 31, 2022 and June&#160;30, 2021, respectively, related to obsolete and slow-moving inventory.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for assets and liabilities using a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company's market assumptions. These two types of inputs have created the fair-value hierarchy below. This hierarchy requires the Company to minimize the use of unobservable inputs and to use observable market data, if available, when determining fair value.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1&#8212;Quoted prices for identical instruments in active markets; </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2&#8212;Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3&#8212;Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities held by the Company are measured at fair value on a nonrecurring basis; that is, the assets are not measured at fair value on an ongoing basis, but are subject to fair value adjustments using fair value measurements with unobservable inputs (level 3), in certain circumstances (e.g., when there is evidence of impairment).</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services are transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Sales, value-added, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates the majority of its revenue through product sales to customers. These products include the Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">line of dietary supplements, LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Omega+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ProBio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, IC Bright</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Daily Wellness</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> dietary supplements, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> skin, hair, bath &amp; body and targeted relief, Petandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Axio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;nootropic energy drink mixes, and the PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;smart weight management system. The Company ships most of its product directly to the consumer and receives substantially all payment for product sales in the form of credit card receipts. Revenue from direct product sales to customers is recognized upon shipment, which is when passage of title and risk of loss occurs. For items sold in packs and bundles, the Company determines the standalone selling price at contract inception for each distinct good, and then allocates the transaction price on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Shipping and handling revenue is recognized upon shipment when the performance obligation is completed.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also charges independent distributors to attend certain events that it holds. Tickets to events are sold as standalone items or included within packs. For event tickets sold in packs, the Company allocates a portion of the transaction price to the ticket on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Fee revenue associated with ticket sales is recorded in the month that the event is held, which is when the Company has performed its obligations under the contract.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated returns are recorded when product is shipped. Subject to some exceptions based on local regulations, the Company&#8217;s return policy is to provide a full refund for product returned within 30 days. After 30 days of purchase, only unopened product that is in a resalable and restockable condition may be returned within twelve months of purchase and shall receive a 100% refund, less a 10% handling and restocking fee and any shipping and handling costs. The Company establishes a refund liability reserve, and an asset reserve for its right to recover products, based on historical experience. The returns asset reserve and returns liability reserve are evaluated on a quarterly basis. As of&#160;March&#160;31, 2022 and June&#160;30, 2021, the returns liability reserve, net was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$0.1 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $0.2 million, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling costs associated with inbound freight and freight out to customers and independent distributors are included in cost of sales. Shipping and handling fees charged to customers and independent distributors are included in revenue.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Costs</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expenses all costs related to research and development activities, as incurred. Research and development expens</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">es for the three months ended March 31, 2022 and 2021 were $0.1 million and $0.2 million, respectively. Research and development expenses for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended March 31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2021 were $0.6 million and $0.6 million, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for leases in accordance with Accounting Standards Codification ("ASC") 842. The Company reviews all contracts and determines if the arrangement is or contains a lease, at inception. Operating leases are included in right-of-use (&#8220;ROU&#8221;) assets, current lease liabilities and long-term lease liabilities on the condensed consolidated balance sheets. The Company does not have any finance leases.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company uses its estimated incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. The operating lease ROU asset also includes any upfront lease payments made and excludes lease incentives and initial direct costs incurred. The Company&#8217;s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Leases with a term of 12 months or less are not recorded on the balance sheet. The Company&#8217;s lease agreements do not contain any residual value guarantees.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pandemic caused by coronavirus (&#8220;COVID-19&#8221;) has resulted in disruptions which had forced the Company's corporate workforce to a remote working environment.  On September 1, 2020, the Company abandoned the ROU asset related to the Corporate office lease in Sandy, Utah, as this lease terminated in February 2021.  A new Corporate office was opened in Lehi, Utah in January 2021.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the abandonment of the Sandy, Utah office, operating lease expenses related to the ROU asset, along with the remaining leasehold assets in the office, have been reduced to their salvage values, which the Company has determined to be zero.  The total expense related to the abandonment of the ROU asset for the nine months ended March 31, 2021 was $0.8&#160;million and is included in selling, general, and administrative expenses.  There is no remaining lease liability for the Sandy, Utah office at March&#160;31, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes stock-based compensation by measuring the cost of services to be rendered based on the grant date fair value of the equity award. The Company recognizes stock-based compensation, net of any estimated forfeitures, over the period an employee is required to provide service in exchange for the award, generally referred to as the requisite service period. For awards with market-based performance conditions, the cost of the awards is recognized as the requisite service is rendered by employees, regardless of when, if ever, the market-based performance conditions are satisfied.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model is used to estimate the fair value of stock options and options under the Company's 2019 Employee Stock Purchase Plan. The determination of the fair value of options is affected by the Company's stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends. The Company uses historical data for estimating the expected volatility and expected life of stock options required in the Black-Scholes model. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected terms of the stock options.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of restricted stock grants is based on the closing market price of the Company's stock on the date of grant less the Company's expected dividend yield. The fair value of performance restricted stock units that include market-based performance conditions is based on the closing market price of the Company's stock on the date of grant less the Company's expected dividend yield, with further adjustments made to reflect the market conditions that must be satisfied in order for the units to vest by using a Monte-Carlo simulation model. Key assumptions for the Monte-Carlo simulation model include the risk-free rate, expected volatility, expected dividends and the correlation coefficient. The fair value of cash-settled performance-based awards, accounted for as liabilities, is remeasured at the end of each reporting period and is based on the closing market price of the Company&#8217;s stock on the last day of the reporting period. The Company recognizes compensation costs for awards with performance conditions when it concludes it is probable that the performance conditions will be achieved. The Company reassesses the probability of vesting at each balance sheet date and adjusts compensation costs accordingly.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled, updated as needed for changes in corporate tax rates. The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the effective date of the change. The Company recognizes tax liabilities or benefits from an uncertain position only if it is more likely than not that the position will be sust</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ained upon examination by taxing authorities based on the technical merits of the issue. The amount recognized would be the largest liability or benefit that the Company believes has greater than a 50% likelihood of being realized upon settlement.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended March 31, 2022 and 2021, the Company recognized income tax expense of $1.1 million and $2.8 million, respectively, which is reflective of the Company&#8217;s current estimated federal, state and foreign effective tax rate. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realization of deferred tax assets is dependent upon future earnings in specific tax jurisdictions, the timing and amount of which are uncertain.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Per Share</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic income per common share is computed by dividing the net income by the weighted-average number of common shares outstanding during the period, less unvested restricted stock awards. Diluted income per common share is computed by dividing net income by the weighted-average common shares and potentially dilutive common share equivalents using the treasury stock method.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2022 and 2021, the effects of approximately 0.1 million and 0.1 million common shares, respectively, issuable upon exercise of options and non-vested shares of restricted stock are not included in computations as their effect was anti-dilutive. For the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended March 31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2021, the effects of approximately 0.2 million and 0.1 million common shares, respectively, issuable upon exercise of options and non-vested shares of restricted stock are not included in computations as their effect was anti-dilutive.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of net income per share and the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share (in thousands, except per share amounts):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,536&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards and options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,257&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,212&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,312&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share, basic</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.34&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.56&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share, diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.34&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.55&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in a single operating segment by selling products directly to customers and through an international network of independent distributors that operates in an integrated manner from market to market.&#160;Commissions and incentives expenses are the Company&#8217;s largest expense comprised of the commissions paid to its independent distributors.&#160;The Company manages its business primarily by managing its international network of independent distributors.&#160;The Company disaggregates revenue in two&#160;geographic regions: the Americas region and the Asia/Pacific &amp; Europe region.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company's revenue disaggregated by these two geographic regions (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,444&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,421&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,979&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia/Pacific &amp; Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,004&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,570&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,418&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,405&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information as to the Company&#8217;s revenue from operations in the most significant geographical areas is set forth below (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,068&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,868&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,593&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company's long-lived assets for its most significant geographic markets (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:66.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,391&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140218916126648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Gig Economy Group Investment<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract', window );"><strong>Investments, All Other Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTextBlock', window );">Gig Economy Group Investment</a></td>
<td class="text">Gig Economy Group Investment<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Note Receivable</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into a convertible promissory note agreement with Gig Economy Group, Inc. ("GEG") pursuant to which the Company agreed to loan to GEG up to an aggregate of $2.0&#160;million in a series of loan installments, evidenced by a convertible promissory note having a maturity date of May&#160;31, 2019 ("Convertible Note"). The Convertible Note accrued interest at a rate of 8% per annum, compounded annually. On May&#160;17, 2019, the Company and GEG entered into an amendment agreement to extend the maturity date of the Convertible Note to December&#160;31, 2019. In all other aspects, the Convertible Note remained unchanged from the original agreement. Pursuant to a Common Stock Purchase Agreement between the Company and GEG dated December 16, 2019, GEG issued to the Company 1,000,000 shares of GEG&#8217;s common stock in consideration for conversion and cancellation of all principal, interest and other amounts due under the Convertible Note (representing $2.2&#160;million in aggregate consideration).</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Securities under ASC 321</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon conversion of the convertible promissory note receivable with GEG, the Company held a minority interest (less than 20%) in GEG, accounted for under ASC 321, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments - Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 321"), which is included in equity securities in the condensed consolidated balance sheets. Dividends received are reported in earnings if and when received. The Company reviews securities individually for impairment by evaluating if events or circumstances have occurred that may indicate the fair value of the investment is less than its carrying value. If such events or circumstances have occurred, the Company estimates the fair value of the investment and recognizes an impairment loss in other expense, net on the condensed consolidated statements of operations and comprehensive income equal to the difference between the fair value of the investment and its carrying value. In such cases, the estimated fair value of the investment is determined using unobservable inputs including assumptions by GEG's management and quantitative information such as lower valuations in recently completed or proposed financings. These inputs are classified as Level 3. Because GEG is in the early startup stage, GEG is subject to potential changes in cash flows and valuation, and may be unable to raise additional capital necessary to support its ongoing operations, which may result in future impairment.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities held by the Company lack readily determinable fair values and therefore the securities are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar equity securities of the same issuer. The carrying amount of equity securities held by the Company without readily determinable fair values was $2.2&#160;million at March&#160;31, 2022 and June&#160;30, 2021, respectively. During the three and nine months ended March&#160;31, 2022 and 2021, there were no price changes or impairments recognized.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -URI http://asc.fasb.org/topic&amp;trid=75115024<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 325<br> -URI http://asc.fasb.org/topic&amp;trid=2197064<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI http://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAllOtherInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140218916137480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases for current corporate offices and certain equipment. These leases have remaining terms of appro</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ximately <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RleHRyZWdpb246ODcyNWU3ZDAxNDBkNDg4NTliNDdmZWNlYWI0Mjc3MGFfMTU4_911d9052-5493-440f-bc28-01448a771e79">one</span> to ten years. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the weighted average remaining lease term and weighted average discount rate for operating leases was 8.49 years and 3.30%, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2022 and 2021, operating lease expense was $0.8 million and $0.8 million, respectively. For the nine months ended March 31, 2022 and 2021, operating lease expense was $2.5 million and $2.8 million, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to operating leases was as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows from operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">645&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,037&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,013&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturity of lease liabilities at March&#160;31, 2022 are as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 (remaining three months ending June 30, 2022)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">791&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,010&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,646&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,060&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,496)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,564&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140218913412632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Long-Term Debt</a></td>
<td class="text">Long-Term Debt<div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;30, 2016, the Company entered into a loan agreement (the &#8220;2016 Loan Agreement&#8221;) to refinance its outstanding debt. In connection with the 2016 Loan Agreement and on the same date, the Company entered into a security agreement (the &#8220;Security Agreement&#8221;). The 2016 Loan Agreement provides for a term loan in an aggregate principal amount of $10.0 million (the &#8220;2016 Term Loan") and a revolving loan facility in an aggregate principal amount not to exceed $2.0 million (the &#8220;2016 Revolving Loan,&#8221; and collectively with the 2016 Term Loan, the 2016 Loan Agreement and the Security Agreement, the &#8220;2016 Credit Facility&#8221;). </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal amount of the 2016 Term Loan is payable in consecutive quarterly installments in the amount of $0.5 million plus accrued interest beginning with the fiscal quarter ended June&#160;30, 2016. If the Company borrows under the 2016 Revolving Loan, interest will be payable quarterly in arrears on the last day of each fiscal quarter.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;4, 2018, the Company entered into a loan modification agreement, which amended the 2016 Credit Facility (&#8220;Amendment No. 1&#8221;). Amendment No. 1 revised the maturity date from March&#160;30, 2019 to March&#160;31, 2021 and increased the fixed interest rate for the term loan from 4.93% to 5.68%. Amendment No. 1 also revised certain financial covenants. The minimum fixed charge coverage ratio (as defined in Amendment No. 1) was revised from a minimum of 1.50 to 1.00 to 1.25 to 1.00, measured on a trailing twelve-month basis, at the end of each fiscal quarter. The minimum working capital was increased from $5.0 million to $8.0 million. The funded debt to EBITDA ratio was replaced with the total liabilities to tangible net worth ratio (as defined in Amendment No. 1) of not greater than 3.00 to 1.00 at the end of each quarter. The minimum tangible net worth measure was removed from the financial covenants.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s obligations under the 2016 Credit Facility, as amended, are secured by a security interest in substantially all of the Company&#8217;s assets. Loans outstanding under the 2016 Credit Facility, as amended, may be prepaid in whole or in part at any time without premium or penalty. In addition, if, at any time, the aggregate principal amount outstanding under the 2016 Revolving Loan exceeds $2.0 million, the Company must prepay an amount equal to such excess. Any principal amount of the 2016 Term Loan which is prepaid or repaid may not be re-borrowed.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;1, 2019, the Company entered into a loan modification agreement, which further amended the 2016 Credit Facility ("Amendment No. 2"). Under Amendment No. 2, the Company made a principal payment of $2.0 million and increased the revolving loan facility from $2.0 million to $5.0 million. Amendment No. 2 also revised certain financial covenants. The minimum fixed charge coverage ratio (as defined in Amendment No. 2) was revised from a minimum of 1.25 to 1.00 to 1.10 to 1.00, measured on a trailing twelve-month basis, at the end of each fiscal quarter. The minimum working capital was decreased from $8.0 million to $6.0 million.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;1, 2021, the Company entered into a loan modification agreement ("Amendment No. 3"), which amended the 2016 Credit Facility, as previously amended. Amendment No. 3 revised the maturity date from March&#160;31, 2021 to March&#160;31, 2024 and modified the variable interest rate based on the one-month United States Treasury Rate, plus a margin of 3.00%, with an interest rate floor of 4.00%. Amendment No. 3 also revised the debt (total liabilities) to tangible net worth ratio (as defined in Amendment No. 3) covenant to require that the Company maintain this ratio not in excess of 2.00 to 1.00, measured as of the end of each fiscal quarter, and revised the definition and calculation of the minimum fixed charge coverage ratio (as defined in Amendment No. 3).  There were no other changes to the covenants or revolving loan facility as set forth in Amendment No. 2.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2016 Credit Facility, as amended, contains customary covenants, including affirmative and negative covenants that, among other things, restrict the Company&#8217;s ability to create certain types of liens, incur additional indebtedness, declare or pay dividends on or redeem capital stock, make other payments to holders of equity interests in the Company, make certain </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">investments, purchase or otherwise acquire all or substantially all the assets or equity interests of other companies, sell assets or enter into consolidations, mergers or transfers of all or any substantial part of the Company&#8217;s assets. The 2016 Credit Facility, as amended, also contains various financial covenants that require the Company to maintain certain consolidated working capital amounts, total liabilities to tangible net worth ratios and fixed charge coverage ratios. Additionally, the 2016 Credit Facility, as amended, contains cross-default provisions, whereby a default under the terms of certain indebtedness or an uncured default of a payment or other material obligation of the Company under a material contract of the Company will cause a default on the remaining indebtedness under the 2016 Credit Facility, as amended. As of March&#160;31, 2022, the Company was in compliance with all applicable covenants under the 2016 Credit Facility, as amended.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s book value for the 2016 Credit Facility, as amended, approximates the fair value. During the fiscal year ended June&#160;30, 2020, the Company repaid, in full, the remaining balance of the 2016 Term Loan in accordance with the terms of the 2016 Credit Facility, as amended.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140218916100200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders&#8217; Equity<div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended March 31, 2022 and 2021,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Company issued no shares of common stock upon the exercise of options. During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> March&#160;31, 2022 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the company issued 30,000 shares and 0.2 million shares, respectively, of common stock upon the exercise of options. During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended March 31, 2022 and 2021, approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,000 shares and 14,000 shares, respectively, of restricted stock were canceled or surrendered as payment of tax withholding upon vesting. During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> March&#160;31, 2022 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, approximately 29,000 shares and 0.1 million shares, respectively, of restricted stock were canceled or surrendered as payment of tax withholding upon vesting.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 27, 2017, the Company announced a share repurchase program authorizing it to repurchase up to $5 million in shares of the Company's common stock. The repurchase program permits the Company to purchase shares through a variety of methods, including in the open market, through privately negotiated transactions or other means as determined by the Company's management. As part of the repurchase program, the Company has entered into a pre-arranged stock repurchase plan which operates in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Accordingly, any transactions under such stock repurchase plan will be completed in accordance with the terms of the plan, including specified price, volume and timing conditions. The authorization may be suspended or discontinued at any time. On February 1, 2019, the Board of Directors approved an amendment to the share repurchase program to increase the authorized share repurchase amount from $5 million to $15 million. On August 27, 2020, the Board of Directors approved an amendment to the share repurchase program to increase the authorized share repurchase amount from $15 million to $35 million and to extend the duration of the program through November 30, 20</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23 and, on February 17, 2022, the Board of Directors approved an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amendment to the share repurchase program to increase the authorized share repurchase amount from $35 million to $60 million. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended March 31, 2022 and 2021, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company purchased 0.3 million shares and 0.2 million shares, respectively, of common stock at an aggregate price of $1.7 million and $2.0 million under this repurchase program.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended&#160;March&#160;31, 2022 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company purchased 1.2 million shares and 0.7 million shares, respectively, of common stock at an aggregate price of $8.4 million and $8.0 million under this repurchase program. At&#160;March&#160;31, 2022, there is $28.1 million remaining under this repurchase program.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Certificate of Incorporation authorizes the issuance of preferred stock. However</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as of March&#160;31, 2022, none have been issued nor have any rights or preferences been assigned to the preferred stock by the Company&#8217;s board of directors.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140218917030984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation<div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long-Term Incentive Plans</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity-Settled Plans</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted, and the stockholders approved, the 2007 Long-Term Incentive Plan (the &#8220;2007 Plan&#8221;), effective November&#160;21, 2006, to provide incentives to eligible employees, directors and consultants. A maximum of 1.4 million shares of the Company's common stock can be issued under the 2007 Plan in connection with the grant of awards. Effective November 21, 2016, no new awards can be granted under the 2007 Plan. As of March&#160;31, 2022, there were no stock option awards outstanding under the 2007 Plan.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted, and the stockholders approved, the 2010 Long-Term Incentive Plan (the &#8220;2010 Plan&#8221;), effective September 27, 2010, as amended on August&#160;21, 2014, to provide incentives to certain employees, directors and consultants. A maximum of 1.0 million shares of the Company's common stock can be issued under the 2010 Plan in connection with the grant of awards. Awards to purchase common stock have been granted pursuant to the 2010 Plan and are outstanding to various employees, officers and directors. Outstanding stock options awarded under the 2010 Plan have exercise prices between $9.31 and $19.74 per share, and vest over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMTE5OQ_88c1c3cf-56ec-4205-9f2f-deff51b9192d">one</span> to four year vesting periods. Awards expire in accordance with the terms of each award </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and, upon expiration of the award, the shares subject to the award will be added to the 2017 Plan pool as described below. The contractual term of stock options granted is generally ten years. No new awards will be granted under the 2010 Plan and forfeited or terminated shares may be added to the 2017 Plan pool as described below. As of March&#160;31, 2022, under the 2010 Plan, there were stock option awards outstanding, net of awards expired, for an aggregate of approximately 20,000 shares of the Company's common stock.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted, and the stockholders approved, the 2017 Long-Term Incentive Plan (the &#8220;2017 Plan&#8221;), effective February 16, 2017, to provide incentives to eligible employees, directors and consultants. On February 2, 2018, November 15, 2018, and November 12, 2020, the stockholders approved amendments to the 2017 Plan to increase by 425,000 shares, 715,000 shares and 650,000 shares, respectively, the number of shares of the Company's common stock that are available for issuance under the 2017 Plan. As of&#160;March&#160;31, 2022, a maximum of 2.9 million&#160;shares of the Company's common stock can be issued under the 2017 Plan in connection with the grant of awards which is calculated as the sum of (i) 2,440,000 shares and (ii) up to 475,000 shares previously reserved for issuance under the 2010 Plan, including shares returned upon cancellation, termination or forfeiture of awards that were previously granted under that plan. O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">utstanding stock options awarded under the 2017 Plan have exercise prices of $4.44 per share, and vest over a three year vesting period. Awards expire in accordance with the terms of each award and, upon expiration of the award, the shares subject to the award are added back to the 2017 Plan. The contractual term of stock options granted are substantially the same as described above for the 2010 Plan. As of March&#160;31, 2022, under the 2017 Plan, there were stock option awards outstanding, net of awards expired, for an aggregate of 0.1 million shares of the Company's common stock.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash-Settled Plans</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted a performance incentive plan effective July 1, 2017 (the "Fiscal 2018 Performance Plan"). The Fiscal 2018 Performance Plan is intended to provide selected employees an opportunity to earn performance-based cash bonuses whose value is based upon the Company&#8217;s stock value and to encourage such employees to provide services to the Company and to attract new individuals with outstanding qualifications. The Fiscal 2018 Performance Plan seeks to achieve this purpose by providing for awards in the form of performance share units (the &#8220;Units&#8221;).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No shares will be issued under the Fiscal 2018 Performance Plan. Awards may be settled only with cash and will be paid subsequent to award vesting. The fair value of share-based compensation awards, that include performance shares, are accounted for as liabilities. Vesting for the Units is subject to achievement of both service-based and performance-based vesting requirements. Performance-based vesting occurs in three installments if the Company meets certain performance criteria generally set for each year of a three-year performance period. The service-based vesting criteria occurs in a single installment at the end of the third fiscal year after the awards are granted if the participant has continuously remained in service from the date of award through the end of the third fiscal year. The fair value of these awards is based on the trading price of the Company's common stock and is remeasured at each reporting period date until settlement.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The Company's 2019 Employee Stock Purchase Plan ("ESPP") was adopted by the board of directors in September 2018 and the Company's stockholders approved it in November 2018. The ESPP is intended to qualify under Section 423 of the Internal Revenue Code.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Reserve.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The Company has reserved 0.4 million shares of its common stock for issuance under the ESPP. As of March&#160;31, 2022, 0.2 million shares were available for issuance. The number of shares reserved under the ESPP will automatically be adjusted in the event of a stock split, stock dividend or a reverse stock split (including an adjustment to the per-purchase period share limit).</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Employees may purchase each share of common stock under the ESPP at a price equal to 85% of the lower of the fair market values of the stock as of the beginning or the end of the six-month offering periods. An employee's contributions to the ESPP are limited to 15% of their regular hourly or salary compensation, and up to a maximum of 3,000 shares may be purchased during any offering period. A participant shall not be granted an option under the ESPP if such option would permit the participant's rights to purchase stock to accrue at a rate exceeding $25,000 grant date fair market value of stock for each calendar year in which such option is outstanding at any time.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Offering Periods.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Unless otherwise determined by the compensation committee, the ESPP will be operated through a series of successive six-month offering periods, which will begin each year on March 1 and September 1.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Duri</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ng the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and nine months ended</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2022,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> approximately 41,000 and 0.1 million shares of common stock were issued under the ESPP, respectively. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Duri</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ng the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and nine months ended</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2021,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> approximately 36,000 and 0.1 million shares of common stock were issued under the ESPP. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock-Based Compensation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with accounting guidance for stock-based compensation, payments in equity instruments for goods or services are accounted for by the fair value method. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2022, a decrease to additional paid-in capital of $38,000, all of which was employee related, was recognized due to changes in estimates in performance stock unit performance measures and reductions in headcount. For the nine months ended March 31, 2022, compensation of $1.4 million was reflected as an increase to additional</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> paid-in capital, all of which was employee related. Fo</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r the three and nine months ended March&#160;31, 2021, stock-based compensation of $0.7 million and $2.2 million, respectively, was reflected as an increase to additional paid-in capital and a decrease of 17,000 and $0.1 million, respectively, was included in other accrued expenses, all of which was employee related.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140218916160904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDisclosures', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company accounts for contingent liabilities in accordance with ASC 450, Contingencies. This guidance requires management to assess potential contingent liabilities that may exist as of the date of the financial statements to determine the probability and amount of loss that may have occurred, which inherently involves an exercise of judgment. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company&#8217;s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. For loss contingencies considered remote, no accrual or disclosures are generally made. Management has assessed potential contingent liabilities as of  March&#160;31, 2022, and based on the assessment, there are no probable loss contingencies requiring accrual or disclosures within its financial statements.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Accruals</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations in the ordinary course of business, from time to time, the Company is subject to various claims, pending and potential legal actions, investigations relating to governmental laws and regulations and other matters arising out of the normal conduct of its business. Management assesses contingencies to determine the degree of probability and range of possible loss for potential accrual in the consolidated financial statements. An estimated loss contingency is accrued in the consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because evaluating legal claims and litigation results are inherently unpredictable and unfavorable results could occur, assessing contingencies is highly subjective and requires judgments about future events. When evaluating contingencies, management may be unable to provide a meaningful estimate due to a number of factors, including the procedural status of the matter in question, the presence of complex or novel legal theories, and/or the ongoing discovery and development of information important to the matters. In addition, damage amounts claimed or asserted against the Company may be unsupported, exaggerated or unrelated to possible outcomes, and as such are not meaningful indicators of a potential liability. Management regularly reviews contingencies to determine the adequacy of financial statement accruals and related disclosures. The amount of ultimate loss may differ from these estimates. It is possible that cash flows or results of operations could be materially affected in any particular period by the unfavorable publicity or resolution of one or more of these contingencies. Whether any losses finally determined in any claim, action, investigation or proceeding or publicity related to such could reasonably have a material effect on the Company's business, financial condition, results of operations or cash flows will depend on a number of variables, including: the timing and amount of such losses; the structure and type of any remedies; the significance of the impact of any such losses, damages or remedies may have on the consolidated financial statements; and the unique facts and circumstances of the particular matter that may give rise to additional factors.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Class Action Lawsuit (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Smith v. LifeVantage Corp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On January 24, 2018, a purported class action was filed in the United States District Court for the District of Connecticut, entitled Smith v. LifeVantage Corp., Case No. 3:18-cv-a35 (D. Connecticut filed Jan. 24, 2018). In this action, Plaintiffs alleged that the Company, its Chief Executive Officer, Chief Sales Officer and Chief Marketing Officer operated a pyramid scheme in violation of a variety of federal and state statutes, including RICO and the Connecticut Unfair Trade Practices Act. On April 16, 2018, the Company filed motions with the court to dismiss the complaint against LifeVantage, dismiss the complaint against the Company's executives, transfer the venue of the case from the State of Connecticut to the State of Utah, and contest class certification. On July 23, 2018, the parties filed a stipulation with the Court agreeing to transfer the case to the Federal District Court for Utah. On September 20, 2018, Plaintiffs filed an amended complaint in Utah. As per the parties stipulated agreement, Plaintiffs' amended complaint dropped the RICO and Connecticut state law claims and removed the Company's Chief Sales Officer and Chief Marketing Officer as individual defendants (the former Chief Executive Officer remains a defendant in the case). The Plaintiffs' amended complaint added an antitrust claim, alleging that the Company fraudulently obtained patents for its products and is attempting to use those patents in an anti-competitive manner. The Company filed a Motion to Dismiss the amended complaint on November 5, 2018, Plaintiffs filed a response to the Company&#8217;s Motion to Dismiss on December 17, 2018, and the Company filed a reply brief on January </span></div>10, 2019. The Court ruled on the motion on December 5, 2019, dismissing three of the Plaintiff's four claims, including the antitrust claim, unjust enrichment claim, and the securities claim for the sale of unregistered securities. On December 19, 2019, Plaintiffs filed a second amended complaint which included three causes of action, including a 10(b)(5) securities fraud claim, and renewed claims relating to the sale of unregistered securities and unjust enrichment. LifeVantage filed a Motion to Dismiss the Second Amended Complaint on January 28, 2020, and with the Motion fully briefed by the parties as of March 17, 2020, the Court decided the matter on the parties&#8217; briefs only on November 25, 2020. In its decision, the Court dismissed with prejudice the Plaintiffs&#8217; Section 12(1) claim (sale of an unregistered security), because the Court concluded the claim is time barred. The Court also dismissed the Plaintiffs&#8217; claim for unjust enrichment against LifeVantage without prejudice, and the Plaintiffs did not amend their complaint following the Court&#8217;s order to re-plead unjust enrichment. The court found that the Plaintiffs had sufficiently pled their claim under Section 12(2) (offer to sell a security that misstates or omits a material fact by means of a prospectus or oral communication). LifeVantage filed its Answer to the Second Amended Complaint on December 23, 2020, responding to the Plaintiffs&#8217; remaining securities claims. On February 2, 2021, the Court issued an amended scheduling order that reflects the parties&#8217; agreement on a schedule for discovery and other litigation matters. On June 15, 2021, the plaintiffs filed their motion for class certification, and on July 13, 2021, the defendants, including LifeVantage Corporation, filed their opposition brief that opposed class certification. On July 27, 2021, the Plaintiffs filed their reply to LifeVantage&#8217;s opposition brief. The court held a hearing for the motion for class certification on March 28, 2022. On April 19, 2022, the court issued an order denying the Plaintiff&#8217;s motion for class certification. The Company has not established a loss contingency accrual for this lawsuit as it believes liability is not probable or estimable, and the Company plans to vigorously defend against this lawsuit. Nonetheless, an unfavorable resolution of this matter could have a material adverse effect on the Company's business, results of operations or financial condition.<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Matters.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">    </span>In addition to the matters described above, the Company also may become involved in other litigation and regulatory matters incidental to its business and the matters disclosed in this quarterly report on Form 10-Q, including, but not limited to, product liability claims, regulatory actions, employment matters and commercial disputes. The Company intends to defend itself in any such matters and does not currently believe that the outcome of any such matters will have a material adverse effect on the Company's business, financial condition, results of operations and cash flows.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=2127197<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2127163<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140218918896600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text">Related Party Transactions<span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into a series of agreements with GEG for outsourced software application development services. The Company and GEG have also entered into a common stock purchase agreement. For discussion related to the common stock purchase agreement, see Note 3. Two members of the Company's board of directors serve on the GEG board of directors.  No payments were made to GEG for software and application development service during the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and nine months ended March&#160;31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140218909146808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation</a></td>
<td class="text">ConsolidationThe condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company prepares the condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (GAAP). In preparing these statements, the Company is required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, the Company reviews its estimates, including, but not limited to, those related to inventory valuation and obsolescence, sales returns, income taxes and tax valuation reserves, transfer pricing methodology and positions, impairment of assets, share-based compensation, and loss contingencies.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the Company&#8217;s business operations occurs outside the United States.&#160;The local currency of each of the Company&#8217;s subsidiaries is generally its functional currency.&#160;All assets and liabilities are translated into U.S. dollars at exchange rates existing at the balance sheet dates, revenue and expenses are translated at weighted-average exchange rates and stockholders&#8217; equity is recorded at historical exchange rates.&#160;The resulting foreign currency translation adjustments are recorded </span></div>as a separate component of stockholders&#8217; equity in the condensed consolidated balance sheets and as a component of comprehensive income. Transaction gains and losses are included in other expense, net in the condensed consolidated statements of operations and comprehensive income.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Instruments and Hedging Activities</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's subsidiaries enter into transactions with each other which may not be denominated in the respective subsidiaries' functional currencies. The Company seeks to reduce its exposure to fluctuations in foreign exchange rates through the use of derivatives. The Company does not use such derivative financial instruments for trading or speculative purposes.</span></div>To hedge risks associated with the foreign-currency-denominated intercompany transactions, the Company entered into forward foreign exchange contracts which were all settled by the end of December 2021 and were not designated for hedge accounting.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers only its monetary liquid assets with original maturities of three months or less as cash and cash equivalents.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text">Concentration of Credit RiskAccounting guidance for financial instruments requires disclosure of significant concentrations of credit risk regardless of the degree of such risk. Financial instruments with significant credit risk include cash and investments.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text">Accounts ReceivableThe Company&#8217;s accounts receivable as of March&#160;31, 2022 and June&#160;30, 2021 consist primarily of credit card receivables. Based on the Company&#8217;s verification process for customer credit cards and historical information available, management has determined that an allowance for doubtful accounts on credit card sales related to its customer sales as of March&#160;31, 2022 and June&#160;30, 2021 is not necessary.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text">Inventories are carried at the lower of cost or net realizable value, using the first-in, first-out method<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for assets and liabilities using a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company's market assumptions. These two types of inputs have created the fair-value hierarchy below. This hierarchy requires the Company to minimize the use of unobservable inputs and to use observable market data, if available, when determining fair value.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1&#8212;Quoted prices for identical instruments in active markets; </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2&#8212;Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3&#8212;Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities held by the Company are measured at fair value on a nonrecurring basis; that is, the assets are not measured at fair value on an ongoing basis, but are subject to fair value adjustments using fair value measurements with unobservable inputs (level 3), in certain circumstances (e.g., when there is evidence of impairment).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition And Shipping and Handling</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services are transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Sales, value-added, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates the majority of its revenue through product sales to customers. These products include the Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">line of dietary supplements, LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Omega+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ProBio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, IC Bright</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Daily Wellness</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> dietary supplements, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> skin, hair, bath &amp; body and targeted relief, Petandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Axio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;nootropic energy drink mixes, and the PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;smart weight management system. The Company ships most of its product directly to the consumer and receives substantially all payment for product sales in the form of credit card receipts. Revenue from direct product sales to customers is recognized upon shipment, which is when passage of title and risk of loss occurs. For items sold in packs and bundles, the Company determines the standalone selling price at contract inception for each distinct good, and then allocates the transaction price on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Shipping and handling revenue is recognized upon shipment when the performance obligation is completed.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also charges independent distributors to attend certain events that it holds. Tickets to events are sold as standalone items or included within packs. For event tickets sold in packs, the Company allocates a portion of the transaction price to the ticket on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Fee revenue associated with ticket sales is recorded in the month that the event is held, which is when the Company has performed its obligations under the contract.</span></div>Estimated returns are recorded when product is shipped. Subject to some exceptions based on local regulations, the Company&#8217;s return policy is to provide a full refund for product returned within 30 days. After 30 days of purchase, only unopened product that is in a resalable and restockable condition may be returned within twelve months of purchase and shall receive a 100% refund, less a 10% handling and restocking fee and any shipping and handling costs. The Company establishes a refund liability reserve, and an asset reserve for its right to recover products, based on historical experience. The returns asset reserve and returns liability reserve are evaluated on a quarterly basis.<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling costs associated with inbound freight and freight out to customers and independent distributors are included in cost of sales. Shipping and handling fees charged to customers and independent distributors are included in revenue.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Costs</a></td>
<td class="text">Research and Development CostsThe Company expenses all costs related to research and development activities, as incurred.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for leases in accordance with Accounting Standards Codification ("ASC") 842. The Company reviews all contracts and determines if the arrangement is or contains a lease, at inception. Operating leases are included in right-of-use (&#8220;ROU&#8221;) assets, current lease liabilities and long-term lease liabilities on the condensed consolidated balance sheets. The Company does not have any finance leases.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company uses its estimated incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. The operating lease ROU asset also includes any upfront lease payments made and excludes lease incentives and initial direct costs incurred. The Company&#8217;s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Leases with a term of 12 months or less are not recorded on the balance sheet. The Company&#8217;s lease agreements do not contain any residual value guarantees.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pandemic caused by coronavirus (&#8220;COVID-19&#8221;) has resulted in disruptions which had forced the Company's corporate workforce to a remote working environment.  On September 1, 2020, the Company abandoned the ROU asset related to the Corporate office lease in Sandy, Utah, as this lease terminated in February 2021.  A new Corporate office was opened in Lehi, Utah in January 2021.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes stock-based compensation by measuring the cost of services to be rendered based on the grant date fair value of the equity award. The Company recognizes stock-based compensation, net of any estimated forfeitures, over the period an employee is required to provide service in exchange for the award, generally referred to as the requisite service period. For awards with market-based performance conditions, the cost of the awards is recognized as the requisite service is rendered by employees, regardless of when, if ever, the market-based performance conditions are satisfied.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model is used to estimate the fair value of stock options and options under the Company's 2019 Employee Stock Purchase Plan. The determination of the fair value of options is affected by the Company's stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends. The Company uses historical data for estimating the expected volatility and expected life of stock options required in the Black-Scholes model. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected terms of the stock options.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of restricted stock grants is based on the closing market price of the Company's stock on the date of grant less the Company's expected dividend yield. The fair value of performance restricted stock units that include market-based performance conditions is based on the closing market price of the Company's stock on the date of grant less the Company's expected dividend yield, with further adjustments made to reflect the market conditions that must be satisfied in order for the units to vest by using a Monte-Carlo simulation model. Key assumptions for the Monte-Carlo simulation model include the risk-free rate, expected volatility, expected dividends and the correlation coefficient. The fair value of cash-settled performance-based awards, accounted for as liabilities, is remeasured at the end of each reporting period and is based on the closing market price of the Company&#8217;s stock on the last day of the reporting period. The Company recognizes compensation costs for awards with performance conditions when it concludes it is probable that the performance conditions will be achieved. The Company reassesses the probability of vesting at each balance sheet date and adjusts compensation costs accordingly.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled, updated as needed for changes in corporate tax rates. The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the effective date of the change. The Company recognizes tax liabilities or benefits from an uncertain position only if it is more likely than not that the position will be sust</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ained upon examination by taxing authorities based on the technical merits of the issue. The amount recognized would be the largest liability or benefit that the Company believes has greater than a 50% likelihood of being realized upon settlement.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Income Per Share</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Per Share</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic income per common share is computed by dividing the net income by the weighted-average number of common shares outstanding during the period, less unvested restricted stock awards. Diluted income per common share is computed by dividing net income by the weighted-average common shares and potentially dilutive common share equivalents using the treasury stock method.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in a single operating segment by selling products directly to customers and through an international network of independent distributors that operates in an integrated manner from market to market.&#160;Commissions and incentives expenses are the Company&#8217;s largest expense comprised of the commissions paid to its independent distributors.&#160;The Company manages its business primarily by managing its international network of independent distributors.&#160;The Company disaggregates revenue in two&#160;geographic regions: the Americas region and the Asia/Pacific &amp; Europe region.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140218909093384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Components of Inventory</a></td>
<td class="text">As of March&#160;31, 2022 and June&#160;30, 2021, inventory consisted of (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:31.778%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.115%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,276&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,145&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Net Income Per Share</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of net income per share and the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share (in thousands, except per share amounts):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,536&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards and options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,257&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,212&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,312&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share, basic</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.34&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.56&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share, diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.34&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.55&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Schedule of Revenue Disaggregated by Geographic Regions</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company's revenue disaggregated by these two geographic regions (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,444&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,421&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,979&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia/Pacific &amp; Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,004&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,570&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,418&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,405&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information as to the Company&#8217;s revenue from operations in the most significant geographical areas is set forth below (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,068&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,868&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,593&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock', window );">Schedule of Long-lived Assets by Geographic Areas</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company's long-lived assets for its most significant geographic markets (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:66.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,391&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140218916036424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease, Cost</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to operating leases was as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows from operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">645&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,037&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,013&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturity of Lease Liabilities</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturity of lease liabilities at March&#160;31, 2022 are as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 (remaining three months ending June 30, 2022)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">791&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,010&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,646&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,060&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,496)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,564&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140218909572104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Narrative (Details)<br> shares in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>region </div>
<div>segment </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 01, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossRealized', window );">Foreign currency transaction loss, realized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Derivative instruments, realized loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,000<span></span>
</td>
<td class="nump">26,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad debt expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Inventory valuation reserves</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lfvn_MoneyBackGuaranteePeriod', window );">Money back guarantee period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lfvn_HandlingAndRestockingFeePercentage', window );">Handling and restocking fee, percentage (as a percent)</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lfvn_ReturnLiabilityReserve', window );">Return liability reserve</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">16,564,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,564,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,564,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 610,000<span></span>
</td>
<td class="nump">$ 107,000<span></span>
</td>
<td class="nump">$ 1,149,000<span></span>
</td>
<td class="nump">$ 2,768,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from EPS calculation (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lfvn_NumberOfGeographicSegments', window );">Number of geographic segments | region</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=lfvn_SandyUTMember', window );">Sandy, UT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lfvn_OperatingLeaseRightOfUseAssetSalvageValue', window );">Salvage value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lfvn_OperatingLeaseRightOfUseAssetAbandonmentExpense', window );">Abandonment expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember', window );">Cash accounts held primarily at One Financial Institution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure', window );">Concentration of credit risk</a></td>
<td class="nump">11,700,000<span></span>
</td>
<td class="nump">17,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember', window );">Cash held primarily at Other Financial Institutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure', window );">Concentration of credit risk</a></td>
<td class="nump">$ 6,100,000<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_HandlingAndRestockingFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Handling and Restocking Fee, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_HandlingAndRestockingFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_MoneyBackGuaranteePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Money back guarantee period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_MoneyBackGuaranteePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_NumberOfGeographicSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of geographic segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_NumberOfGeographicSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_OperatingLeaseRightOfUseAssetAbandonmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Right of Use Asset, Abandonment Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_OperatingLeaseRightOfUseAssetAbandonmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_OperatingLeaseRightOfUseAssetSalvageValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Right of Use Asset, Salvage Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_OperatingLeaseRightOfUseAssetSalvageValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_ReturnLiabilityReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Return Liability Reserve</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_ReturnLiabilityReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum amount of loss due to credit risk that, based on the gross fair value of the financial instrument, the entity would incur if parties to the financial instruments that make up the concentration failed completely to perform according to the terms of the contracts and the collateral or other security, if any, for the amount due proved to be of no value to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossRealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossRealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=lfvn_SandyUTMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=lfvn_SandyUTMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140218913430904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Components of Inventory (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">$ 12,348<span></span>
</td>
<td class="nump">$ 12,225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves', window );">Raw materials</a></td>
<td class="nump">3,928<span></span>
</td>
<td class="nump">3,920<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventory</a></td>
<td class="nump">$ 16,276<span></span>
</td>
<td class="nump">$ 16,145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lfvn_InventoryFinishedGoodsPercentOfTotalInventory', window );">Finished goods, percent of inventory (in percentage)</a></td>
<td class="nump">75.90%<span></span>
</td>
<td class="nump">75.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lfvn_RawMaterialsPercentOfTotalInventory', window );">Raw materials, percent of inventory (in percentage)</a></td>
<td class="nump">24.10%<span></span>
</td>
<td class="nump">24.30%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lfvn_InventoryPercentOfTotalInventory', window );">Percent of total inventory (in percentage)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_InventoryFinishedGoodsPercentOfTotalInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Inventory, Finished Goods, Percent Of Total Inventory</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_InventoryFinishedGoodsPercentOfTotalInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_InventoryPercentOfTotalInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Inventory, Percent Of Total Inventory</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_InventoryPercentOfTotalInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_RawMaterialsPercentOfTotalInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Raw Materials, Percent Of Total Inventory</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_RawMaterialsPercentOfTotalInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140218909254200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Summary of Computation of Net Income Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 1,141<span></span>
</td>
<td class="nump">$ 79<span></span>
</td>
<td class="nump">$ 3,316<span></span>
</td>
<td class="nump">$ 1,724<span></span>
</td>
<td class="nump">$ 3,812<span></span>
</td>
<td class="nump">$ 2,451<span></span>
</td>
<td class="nump">$ 4,536<span></span>
</td>
<td class="nump">$ 7,987<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted-average common shares outstanding (in shares)</a></td>
<td class="nump">13,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,261<span></span>
</td>
<td class="nump">14,175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Stock awards and options (in shares)</a></td>
<td class="nump">62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="nump">245<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted-average common shares outstanding (in shares)</a></td>
<td class="nump">13,257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,312<span></span>
</td>
<td class="nump">14,420<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income per share, basic (in USD per share)</a></td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.34<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income per share, diluted (in USD per share)</a></td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.34<span></span>
</td>
<td class="nump">$ 0.55<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140218837138168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Segment Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">$ 50,004<span></span>
</td>
<td class="nump">$ 51,570<span></span>
</td>
<td class="nump">$ 155,418<span></span>
</td>
<td class="nump">$ 165,405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AmericasMember', window );">Americas</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">33,444<span></span>
</td>
<td class="nump">36,421<span></span>
</td>
<td class="nump">104,600<span></span>
</td>
<td class="nump">116,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=lfvn_AsiaPacificAndEuropeMember', window );">Asia/Pacific &amp; Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">16,560<span></span>
</td>
<td class="nump">15,149<span></span>
</td>
<td class="nump">50,818<span></span>
</td>
<td class="nump">48,426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">31,674<span></span>
</td>
<td class="nump">34,068<span></span>
</td>
<td class="nump">98,868<span></span>
</td>
<td class="nump">109,593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">20,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,696<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_JP', window );">Japan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">8,724<span></span>
</td>
<td class="nump">$ 9,622<span></span>
</td>
<td class="nump">28,558<span></span>
</td>
<td class="nump">$ 31,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 2,337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,363<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=lfvn_AsiaPacificAndEuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=lfvn_AsiaPacificAndEuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_JP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_JP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140218913287608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Gig Economy Group Investment (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 16, 2019</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity securities held without readily determinable value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="nump">$ 2,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">GEG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lfvn_NotesReceivableRelatedPartyMaximumCommitment', window );">Notes receivable, related party, maximum commitment</a></td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt', window );">Debt conversion, original debt, interest rate of debt (as a percent)</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">GEG | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt conversion, converted instrument, shares issued (in shares)</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt conversion, converted instrument, amount</a></td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_NotesReceivableRelatedPartyMaximumCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Notes Receivable, Related Party, Maximum Commitment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_NotesReceivableRelatedPartyMaximumCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The rate of interest that was being paid on the original debt issue that is being converted in the noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionOriginalDebtInterestRateOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140218913286264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">8 years 5 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 5 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate (as a percent)</a></td>
<td class="nump">3.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expense</a></td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="nump">$ 2.5<span></span>
</td>
<td class="nump">$ 2.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140218917199592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Lease, Cost (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash outflows from operating leases</a></td>
<td class="nump">$ 804<span></span>
</td>
<td class="nump">$ 645<span></span>
</td>
<td class="nump">$ 1,858<span></span>
</td>
<td class="nump">$ 2,037<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for lease obligations</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 317<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 15,013<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140218909112952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Maturity of Lease Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2022 (remaining three months ending June 30, 2022)</a></td>
<td class="nump">$ 791<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">3,197<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">2,010<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">1,606<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">1,646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour', window );">Thereafter</a></td>
<td class="nump">9,810<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total</a></td>
<td class="nump">19,060<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(2,496)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 16,564<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, Payments Due, After Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140218912916488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2021</div></th>
<th class="th">
<div>Feb. 01, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 04, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 30, 2016 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio', window );">Debt instrument, covenant, total liabilities to tangible net worth ratio (not greater than)</a></td>
<td class="nump">2.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lfvn_DebtInstrumentFloorInterestRate', window );">Floor interest rate (as a percent)</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | US Treasury (UST) Interest Rate | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=lfvn_March2016TermLoanMember', window );">March 2016 Term Loan | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum capacity on draw</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Quarterly installments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtPercentageBearingFixedInterestRate', window );">Fixed rate interest on debt (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.68%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.93%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio', window );">Debt instrument, covenant, fixed charge coverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lfvn_DebtInstrumentTrailingPeriod', window );">Trailing period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital', window );">Debt instrument, covenant, required minimum working capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio', window );">Debt instrument, covenant, total liabilities to tangible net worth ratio (not greater than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=lfvn_March2016RevolvingLoanMember', window );">March 2016 Revolving Loan | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio', window );">Debt instrument, covenant, fixed charge coverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital', window );">Debt instrument, covenant, required minimum working capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of term loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=lfvn_March2016RevolvingLoanMember', window );">March 2016 Revolving Loan | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum capacity on draw</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Fixed Charge Coverage Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Required Minimum Working Capital</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Total Liabilities To Tangible Net Worth Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_DebtInstrumentFloorInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Floor Interest Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_DebtInstrumentFloorInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_DebtInstrumentTrailingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Trailing Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_DebtInstrumentTrailingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtPercentageBearingFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtPercentageBearingFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_UsTreasuryUstInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_UsTreasuryUstInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=lfvn_March2016TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=lfvn_March2016TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=lfvn_March2016RevolvingLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=lfvn_March2016RevolvingLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140218909158824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Details) - USD ($)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Feb. 17, 2022</div></th>
<th class="th"><div>Aug. 27, 2020</div></th>
<th class="th"><div>Feb. 01, 2019</div></th>
<th class="th"><div>Nov. 27, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Repurchase common stock amount authorized (up to)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000,000<span></span>
</td>
<td class="nump">$ 35,000,000<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock repurchase program shares repurchased (in shares)</a></td>
<td class="nump">300<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of company stock</a></td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="nump">$ 8,374,000<span></span>
</td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining authorized repurchase amount</a></td>
<td class="nump">$ 28,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding (in shares)</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140218914939768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 12, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 15, 2018 </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 02, 2018 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 27, 2010 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>installment </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>installment </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 21, 2006 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,000<span></span>
</td>
<td class="nump">36,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock based compensation reflected in additional paid in capital | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (38,000)<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities', window );">Decrease in share-based compensation included in other accrued expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lfvn_TwoThousandAndSevenLongTermIncentivePlanMember', window );">2007 Long-Term Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lfvn_TwoThousandAndTenLongTermIncentivePlanMember', window );">2010 Long-Term Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">475,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm', window );">Contractual term of stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, net of awards expired (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lfvn_TwoThousandAndTenLongTermIncentivePlanMember', window );">2010 Long-Term Incentive Plan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Right to purchase common stock, minimum price (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share based payment award, vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lfvn_TwoThousandAndTenLongTermIncentivePlanMember', window );">2010 Long-Term Incentive Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Right to purchase common stock, minimum price (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share based payment award, vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lfvn_TwoThousandSeventeenLongTermIncentivePlanMember', window );">2017 Long-Term Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share based payment award, vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, net of awards expired (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Number of additional shares authorized (in shares)</a></td>
<td class="nump">650,000<span></span>
</td>
<td class="nump">715,000<span></span>
</td>
<td class="nump">425,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Right to purchase common stock, non-vested and outstanding, exercise price (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember', window );">2017 Long-Term Incentive Plan Excluding 2010 Long-Term Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,440,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lfvn_TwoThousandEighteenPerformancePlanMember', window );">2018 Performance Plan | Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share based payment award, vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofVestingInstallments', window );">Number of vesting installments | installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lfvn_EmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common Stock, capital shares reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for issuance under the ESPP (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price of common stock (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate', window );">Maximum employee subscription rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee', window );">Maximum number of shares per employee (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted', window );">Amount in excess of fair market value of stock for option not to be granted | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod', window );">Offering period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Amount In Excess Of Fair Market Value Of Stock For Option Not To Be Granted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Contractual Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Increase (Decrease) of Share-based Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofVestingInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Number of Vesting Installments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofVestingInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The highest quantity of shares an employee can purchase under the plan per period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lfvn_TwoThousandAndSevenLongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lfvn_TwoThousandAndSevenLongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lfvn_TwoThousandAndTenLongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lfvn_TwoThousandAndTenLongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lfvn_TwoThousandSeventeenLongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lfvn_TwoThousandSeventeenLongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lfvn_TwoThousandEighteenPerformancePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lfvn_TwoThousandEighteenPerformancePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lfvn_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lfvn_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140218916013176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitment and Contingencies (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 05, 2019 </div>
<div>claim</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyClaimsDismissedNumber', window );">Claims dismissed</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Pending claims</a></td>
<td class="nump">4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyClaimsDismissedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of claims dismissed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyClaimsDismissedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140218909156392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>member</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lfvn_MembersOfBoardOfDirectorsServingOnRelatedPartyBoardOfDirectors', window );">Members of company board of directors serving on GEG board of directors | member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty', window );">Related party purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">GEG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty', window );">Related party purchase</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_MembersOfBoardOfDirectorsServingOnRelatedPartyBoardOfDirectors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Members of Board of Directors Serving on Related Party Board of Directors</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_MembersOfBoardOfDirectorsServingOnRelatedPartyBoardOfDirectors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>lfvn-20220331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:lfvn="http://www.lifevantage.com/20220331"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="lfvn-20220331.xsd" xlink:type="simple"/>
    <context id="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i114f6d588eec41cca10eacf197741d76_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i48bc8c6f35e243a6b2a9a8d306274583_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib389c215613a45d48cba70a168c71912_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia7987d4236804621a4361835b057e0ce_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9fc9c821fc9844eebd5eeda44da0b7b7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie7c081c090f745529154ed6ce94b38f9_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i46af58f761da46259c37ec6f18a63af2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7cbd37945df4470c99f8b2a0360dc403_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie272543a8f524dd6a6c9114d0b6cf545_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i357d0e28c2744a86a6382506b17c0264_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i591ebee999ed4b4cb8022ec6a31670f3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6a9a7c2d6b1d487eaf86a59ab23c23ce_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic6e22e23d13942a385a4a49560a7f544_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i61547256e29c4919b4fe5ead6c816e24_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibd0af93ed4f64a8c937539b4670c6e48_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iba6a88e280384332a89b41a26f4cfab4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ida700141a9ae4429b2b7a901f417f0bf_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i48a61f3b86a440f692477c18672aa67f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="icbcabe3d4d654627b2330ec970846ddf_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icd08c3f853324ff28662164585d1fce6_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9bb6cf9ad217405a8247ca642e30509c_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if3804241d822468b8c8a03364b2f4db0_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if6cf8b23c28d42e593d1ae4e2d3c4019_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i38ac3e0be007455d8666cf4e653aaa47_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5fdcc53f50d94cfdbb432bb029d84ddd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ieb1ca35e5a104d6193f48d4b349fd675_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5263d30c26d9470b8de6e49fabce1c6f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ida7724eff7a34d7e804bef8c3a260107_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8a3861a962104cbaafc9ae69c1393aab_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i34d7b9b3d06f458fa586f0f59243f9bd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9d259b63592a4d5ca5fac8400bae6f58_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i18b390fcfcd440aeb1bd8306b98b8360_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i80e93762807c42728430aca71fb61c7d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i422faeaa855042ae85c18160145ee1aa_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8414ddffcc994aaca67582af5b64988d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i87ee290661d3437bb9f238e5b3000de5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i962d85b9976d4fa6b5d9584e36bb2ab1_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i4c716aa1362243ccb5055e6e6b509ab8_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i12c81306c48d435facd113371422e44d_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ic551f8ef22194653996c3e7b7c2a4891_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i68b782cee24b481ab1a20bb3a92aad68_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6f6b95ce9ace4fcbbaf406066f26cb5d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i078343424c294ceca151c4f530b420fc_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i36be45415d344673a4b1de8f2d0bf0fe_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i371a2ccf5aa04409abfd0f1176383ba2_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i272a3fb900ee42a0b17372fc51c0fd09_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i68418c3e9e354ef68baafaaaad67d4db_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7b04da3ccb2949e8a573db766889abb2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0d971956fe1e405092f076fc100385f9_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic1968b9f619f497180ce2af775046e41_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i07e41a0a758d427ebab0f9e00cf68cfb_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i99f28f304d1842658dac0719b5141740_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5d8a258a91bd4059b27b728132af022c_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifeb352d0769a418ebda3b74b0acbf648_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if1a17cb2d0ca4207a83089fb753965d7_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2ab5b4c786a74727b650772bc5f9b6e0_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if1fa511d00c840e68d4d9869eb7ddd2e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia281323b7eca4b0aac83a5aa68bb9dab_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if3d79a145f79427694eee4afa398d9c7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id95d9cc8f1034f528cc66cff9ad5c9ef_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7d0accfc67e54e8db1894b6929923ad1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib8a85e0499a945de8e4808fe5e485e28_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ieb4a6be5906b4ce4a66d6061c62992dd_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4925e0ea7d9e481d96e9fa256be5a1bf_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib10cb8e7de8c4656ab658f3172b4c6c8_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9fb5b0bffd7444c2babfc6c81537af68_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i74275ea8913e4aabb9ae6b13024fbb68_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6f571c6d0a364422a6f303b161efdd8a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iba8aa560a2b64ef4b94817dac00694cb_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i486872c51e4640dab4cf26f789788bba_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i02d0d983f156475da80d891080400c71_D20220331-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">lfvn:CashAccountsHeldPrimarilyAtFinancialInstitutionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-31</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8461345d4fc14a97aef4e829e0775dcc_D20220331-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">lfvn:CashAccountsHeldatOtherFinancialInstitutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-31</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i182b6ab241c640bfa92b9b402ecbe30b_D20210630-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">lfvn:CashAccountsHeldPrimarilyAtFinancialInstitutionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-30</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7a84972552ec4e43882535e243362870_D20210630-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">lfvn:CashAccountsHeldatOtherFinancialInstitutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-30</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic645b34a2785482d9664b71bdd91384e_I20200901">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:SandyUTMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-01</instant>
        </period>
    </context>
    <context id="id450c5bdf563442ca02fa3bd0de3267d_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:SandyUTMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i222bc716cf0a47dd8efde9c5d36eff58_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:SandyUTMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id2939647eeae400482eba40fd37747e0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iad789057464b445383e8e237ab794a70_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="icf9becab944541f9973e690359ee58d5_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1e55f2a3f9c54683a2a69cee96783bac_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i59577e105b574a07b1c8625a6eb9c7d1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:AsiaPacificAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ieac81516c5ed43b983bf40a00b30e9c1_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:AsiaPacificAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i279ae95e5e154fd3ac7b3d02bbe2bba3_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:AsiaPacificAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic48a39651d07442f8d571c963b553e9f_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:AsiaPacificAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i85f81a6375b645c98c3862ffe7700508_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i09abcf3ac44849c49e3c780b175040a5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iae8bb42b789646b4ba6f4b074eeffca3_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0f44d883e0b2449897b56a1b34ccca8f_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6f58b5474ebb4a5f830b29be3a2f7a7c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i18167f341a8d41d5a9580b26693b5110_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia265df95ea7245d68fe8e38ba50df608_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i93830f5b4c944ebf841a5318eff7e31d_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i97c08f4a55f8470a9971ea339ea1c21d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i53b30af5c47844f9b1a2b364a4dc51ec_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7d74274057c84930a25d326155334bc0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic55ed5df77fa48efa92d5f7675cff1e4_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i345de6f57ba548a6ba07b11d0d85bb30_I20191216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-16</instant>
        </period>
    </context>
    <context id="if676f17905b1439fb5721e767c883b01_D20191216-20191216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-16</startDate>
            <endDate>2019-12-16</endDate>
        </period>
    </context>
    <context id="i7541c71e837e4987866f3c14bda4fcd9_D20191216-20191216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-16</startDate>
            <endDate>2019-12-16</endDate>
        </period>
    </context>
    <context id="ie705979a5a084ddc9bea319da91db13a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3c83ca889a7845a2a8fe7f12f6b7501f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i91749ed981c5409a9273b2f8dbbe2722_I20160330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-03-30</instant>
        </period>
    </context>
    <context id="i28ed7365c77c4b2db3b859a62be20d66_I20160330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-03-30</instant>
        </period>
    </context>
    <context id="i6e21e97ed1274414912f33d01244c913_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i712ce600357e432e9efd232d861ee1b2_I20180504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-04</instant>
        </period>
    </context>
    <context id="i6905908291e94757a8fba8a815f971d0_D20180504-20180504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-04</startDate>
            <endDate>2018-05-04</endDate>
        </period>
    </context>
    <context id="ia4e41b786fa5480cbafaff2190125416_D20190201-20190201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-02-01</endDate>
        </period>
    </context>
    <context id="i138740ba50b5467d8eb135d8bfbf6674_I20190201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-01</instant>
        </period>
    </context>
    <context id="ie0c55b4954084c5aae5f41ea24e8318b_I20190201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-01</instant>
        </period>
    </context>
    <context id="i2934f27e399b471b8b9dfd34e5e0ac1b_D20190201-20190201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-02-01</endDate>
        </period>
    </context>
    <context id="i1cbad6d70bc54ef6bae80ba6559acdcc_I20180504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-04</instant>
        </period>
    </context>
    <context id="ib44219a0ab0d49e6bc0c499248ce173b_D20210401-20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:UsTreasuryUstInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-01</endDate>
        </period>
    </context>
    <context id="ie90439fd1c8a43998c36b1c5528a888c_D20210401-20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-01</endDate>
        </period>
    </context>
    <context id="i44c9eefb9093469182cd44d1b4c1dd66_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="ifee0653b54af42bf80320efe99032f1d_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id5c31a591c3c44ea943724f45a5bccda_D20200701-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ied064917c4284ae1bbf8175e9b75f43b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia94b7a6d35ea49b3b94d253b14ae6d97_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="idfeffa2877114db7a47309a70bbb8f84_I20171127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2017-11-27</instant>
        </period>
    </context>
    <context id="i15ef7d898c564726b93cc5e8c2ad2750_I20190201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2019-02-01</instant>
        </period>
    </context>
    <context id="i2b61f7ff2c2b4a908d35b37807707405_I20200827">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2020-08-27</instant>
        </period>
    </context>
    <context id="i8365c04b98844bcea3d544bdda92cd4c_I20220217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2022-02-17</instant>
        </period>
    </context>
    <context id="icfb9d06f4ea24bfb9da6d26bba64f59e_I20061121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndSevenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2006-11-21</instant>
        </period>
    </context>
    <context id="i82db2efb56364be499fa24d948efc805_I20100927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2010-09-27</instant>
        </period>
    </context>
    <context id="i643716d34b6a4245a763bf8bf4629aa8_D20100927-20100927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-09-27</startDate>
            <endDate>2010-09-27</endDate>
        </period>
    </context>
    <context id="i38dcb43eafd747fbbc7861d7bb8a2b03_D20100927-20100927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-09-27</startDate>
            <endDate>2010-09-27</endDate>
        </period>
    </context>
    <context id="ia4fb358160af4b1582deaf09e2b4bd56_D20100927-20100927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-09-27</startDate>
            <endDate>2010-09-27</endDate>
        </period>
    </context>
    <context id="ie1f4201b19a74fef8349a17facf7daa8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6e2b576ca32a4d868584d602195e7c37_D20180202-20180202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-02</startDate>
            <endDate>2018-02-02</endDate>
        </period>
    </context>
    <context id="ic3eb364b1b32431298d5283303fb50c1_D20181115-20181115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-15</startDate>
            <endDate>2018-11-15</endDate>
        </period>
    </context>
    <context id="i82320565cb5746a9a4deead3ae0f001d_D20201112-20201112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-12</startDate>
            <endDate>2020-11-12</endDate>
        </period>
    </context>
    <context id="i2cc2bb8a2f46410091908db5becaed25_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i45d0f653093a43c1aa4ad8a6f44b65f5_I20180202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-02-02</instant>
        </period>
    </context>
    <context id="ica0b13add21047009a5fb1a118222ecf_I20180202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-02-02</instant>
        </period>
    </context>
    <context id="ib1c7eca313734a9780d2949151a11055_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia7df9f17944846a0ac9250ae7774a182_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandEighteenPerformancePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie920895e4f5f48ef81ce22593768c0b3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandEighteenPerformancePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibbe9559ba77040d5b39ea3519ff4b9b9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ice3288151d3641c6b51df76356f2297c_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7b7712dd2ecf4cc990ccba081959ed4a_D20191205-20191205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2019-12-05</startDate>
            <endDate>2019-12-05</endDate>
        </period>
    </context>
    <context id="ic9473e77deb447f2b4bcc4e5432b8e7b_I20191205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2019-12-05</instant>
        </period>
    </context>
    <context id="i8dd65cec87d94d2897061c2f0b29f444_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i74cd73657787445193edd1ca4da3a419_D20210701-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="region">
        <measure>lfvn:region</measure>
    </unit>
    <unit id="segment">
        <measure>lfvn:segment</measure>
    </unit>
    <unit id="installment">
        <measure>lfvn:installment</measure>
    </unit>
    <unit id="claim">
        <measure>lfvn:claim</measure>
    </unit>
    <unit id="member">
        <measure>lfvn:member</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80L2ZyYWc6MWQyZTQyNTJkNDViNDg4ZTkwZmIwNjdhNmY2NmQ0NTAvdGFibGU6MjI2NTQyY2JjYjI3NDQ3MTgyYjZkZmQ4ZjIzMzQ5YjQvdGFibGVyYW5nZToyMjY1NDJjYmNiMjc0NDcxODJiNmRmZDhmMjMzNDliNF8yLTEtMS0xLTEzNTAz_e36ddfef-1ad7-41b4-96fe-9d8276bff48b">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80L2ZyYWc6MWQyZTQyNTJkNDViNDg4ZTkwZmIwNjdhNmY2NmQ0NTAvdGFibGU6MjI2NTQyY2JjYjI3NDQ3MTgyYjZkZmQ4ZjIzMzQ5YjQvdGFibGVyYW5nZToyMjY1NDJjYmNiMjc0NDcxODJiNmRmZDhmMjMzNDliNF8zLTEtMS0xLTEzNTAz_a68c8e8d-3a6e-4566-89db-4729679898c5">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80L2ZyYWc6MWQyZTQyNTJkNDViNDg4ZTkwZmIwNjdhNmY2NmQ0NTAvdGFibGU6MjI2NTQyY2JjYjI3NDQ3MTgyYjZkZmQ4ZjIzMzQ5YjQvdGFibGVyYW5nZToyMjY1NDJjYmNiMjc0NDcxODJiNmRmZDhmMjMzNDliNF80LTEtMS0xLTEzNTAz_28998979-923c-4e63-8701-e428d4a2e93c">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80L2ZyYWc6MWQyZTQyNTJkNDViNDg4ZTkwZmIwNjdhNmY2NmQ0NTAvdGFibGU6MjI2NTQyY2JjYjI3NDQ3MTgyYjZkZmQ4ZjIzMzQ5YjQvdGFibGVyYW5nZToyMjY1NDJjYmNiMjc0NDcxODJiNmRmZDhmMjMzNDliNF81LTEtMS0xLTEzNTAz_1ae3f623-4c66-4a80-a426-87466f28120b">0000849146</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80L2ZyYWc6MWQyZTQyNTJkNDViNDg4ZTkwZmIwNjdhNmY2NmQ0NTAvdGFibGU6MjI2NTQyY2JjYjI3NDQ3MTgyYjZkZmQ4ZjIzMzQ5YjQvdGFibGVyYW5nZToyMjY1NDJjYmNiMjc0NDcxODJiNmRmZDhmMjMzNDliNF82LTEtMS0xLTEzNTAz_4abf1f46-cee0-45c7-a47e-0e723cf38f3a">--09-30</dei:CurrentFiscalYearEndDate>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80My9mcmFnOjA4YTNjODhhMWM3ODQyYmVhZjA2OWQyZDg0ZjEyODA0L3RhYmxlOjQ0YTJhYmU0YzkzMTRhNWViNWFjZDc4YjJmZDY1MjFlL3RhYmxlcmFuZ2U6NDRhMmFiZTRjOTMxNGE1ZWI1YWNkNzhiMmZkNjUyMWVfMi0xLTEtMS0xMzUwMw_cca3375e-23c5-4f51-98cd-bf42533a2046"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="ie705979a5a084ddc9bea319da91db13a_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RleHRyZWdpb246ODcyNWU3ZDAxNDBkNDg4NTliNDdmZWNlYWI0Mjc3MGFfMTU4_911d9052-5493-440f-bc28-01448a771e79">P1Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i643716d34b6a4245a763bf8bf4629aa8_D20100927-20100927"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMTE5OQ_88c1c3cf-56ec-4205-9f2f-deff51b9192d">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <dei:DocumentType
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGV4dHJlZ2lvbjo4Njc5M2NhODY2Mzg0YWYxYmYzM2RkOWU0ODE4MGZlNV8xNjQ_7207202d-a304-4dd2-ac9f-ef4cb8073383">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGFibGU6YTUwZjViMzNjNDE1NDdlN2FiZDcyMzdhNGIyMjBlYTUvdGFibGVyYW5nZTphNTBmNWIzM2M0MTU0N2U3YWJkNzIzN2E0YjIyMGVhNV8wLTAtMS0xLTEzNTAz_f968b16c-8917-4203-b798-4bf6967705d5">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGV4dHJlZ2lvbjo4Njc5M2NhODY2Mzg0YWYxYmYzM2RkOWU0ODE4MGZlNV8yODE_35a4f640-3544-4df7-ad1c-d85b50cd9201">2022-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGFibGU6MmJmZjIxZDdjMjY3NDA2YjgxZDQxN2I0YmMyYzNlZDEvdGFibGVyYW5nZToyYmZmMjFkN2MyNjc0MDZiODFkNDE3YjRiYzJjM2VkMV8wLTAtMS0xLTEzNTAz_f1a0fda8-801e-4e5c-8646-4cc94a42ae0c">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGV4dHJlZ2lvbjo4Njc5M2NhODY2Mzg0YWYxYmYzM2RkOWU0ODE4MGZlNV8zNjY_68e5b98c-2fff-49ad-9259-c684236f5e46">001-35647</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGV4dHJlZ2lvbjo4Njc5M2NhODY2Mzg0YWYxYmYzM2RkOWU0ODE4MGZlNV80NTE_4781f7fe-7e6b-4464-95e4-8e7dab6d3d7d">LIFEVANTAGE CORP</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGFibGU6M2E4NWVlZTBiOGIzNDc1YTg3NDk3NmEwOWVmMTEwYmUvdGFibGVyYW5nZTozYTg1ZWVlMGI4YjM0NzVhODc0OTc2YTA5ZWYxMTBiZV8wLTAtMS0xLTEzNTAz_0543b7fa-3489-4d17-949d-7a7be2a551fe">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGFibGU6M2E4NWVlZTBiOGIzNDc1YTg3NDk3NmEwOWVmMTEwYmUvdGFibGVyYW5nZTozYTg1ZWVlMGI4YjM0NzVhODc0OTc2YTA5ZWYxMTBiZV8wLTItMS0xLTEzNTAz_e69ccd94-7fa7-4f22-82d0-deb2a4e539ec">90-0224471</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGV4dHJlZ2lvbjo4Njc5M2NhODY2Mzg0YWYxYmYzM2RkOWU0ODE4MGZlNV8yNDEy_898e4e7d-3724-4e23-9c40-93bde8864701">3300 Triumph Blvd</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGV4dHJlZ2lvbjo4Njc5M2NhODY2Mzg0YWYxYmYzM2RkOWU0ODE4MGZlNV8yNDEz_7816679b-bb1c-4ecc-909d-f8278970ca47">Suite 700</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGV4dHJlZ2lvbjo4Njc5M2NhODY2Mzg0YWYxYmYzM2RkOWU0ODE4MGZlNV8yNDE0_44652a3e-58b6-4b54-9ddb-15321b35736f">Lehi</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGV4dHJlZ2lvbjo4Njc5M2NhODY2Mzg0YWYxYmYzM2RkOWU0ODE4MGZlNV82MzU_8f7c9696-b8db-481e-87b4-9c0a988a596c">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGV4dHJlZ2lvbjo4Njc5M2NhODY2Mzg0YWYxYmYzM2RkOWU0ODE4MGZlNV82Mzg_b4b1a0ea-b2c7-4b0d-9be2-00ebe3c60de5">84043</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGV4dHJlZ2lvbjo4Njc5M2NhODY2Mzg0YWYxYmYzM2RkOWU0ODE4MGZlNV83MDM_4a6cf2b7-4f00-44cf-838a-b1a851967dea">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGV4dHJlZ2lvbjo4Njc5M2NhODY2Mzg0YWYxYmYzM2RkOWU0ODE4MGZlNV83MDc_f32f59f7-4fda-49b9-968e-653e3fba6d85">432-9000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGFibGU6OGQ4YTE2ZjViZGU2NDZjNjk1NTRiYWI5NjgxNTA3NTAvdGFibGVyYW5nZTo4ZDhhMTZmNWJkZTY0NmM2OTU1NGJhYjk2ODE1MDc1MF8wLTAtMS0xLTEzNTAz_0e2e4a80-a707-4fca-9fea-8268a5f8683d">Common Stock, par value $0.0001</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGFibGU6OGQ4YTE2ZjViZGU2NDZjNjk1NTRiYWI5NjgxNTA3NTAvdGFibGVyYW5nZTo4ZDhhMTZmNWJkZTY0NmM2OTU1NGJhYjk2ODE1MDc1MF8wLTItMS0xLTEzNTAz_a7053127-6c5a-43dd-84ba-49a255a5b8d8">LFVN</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGFibGU6OGQ4YTE2ZjViZGU2NDZjNjk1NTRiYWI5NjgxNTA3NTAvdGFibGVyYW5nZTo4ZDhhMTZmNWJkZTY0NmM2OTU1NGJhYjk2ODE1MDc1MF8wLTQtMS0xLTEzNTAz_180b33c5-1ed9-42b3-ac2a-f97ec8e1a121">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGV4dHJlZ2lvbjo4Njc5M2NhODY2Mzg0YWYxYmYzM2RkOWU0ODE4MGZlNV8xMjM0_752d3231-08e6-47f0-a835-1394c4eb2471">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGV4dHJlZ2lvbjo4Njc5M2NhODY2Mzg0YWYxYmYzM2RkOWU0ODE4MGZlNV8xNTU5_c3c55347-ceb2-4eda-be70-81e1ca88db12">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGFibGU6Nzg5NjA4MTAxNjJjNGQxMzhkNGYxM2U3NjE3YzMzZGQvdGFibGVyYW5nZTo3ODk2MDgxMDE2MmM0ZDEzOGQ0ZjEzZTc2MTdjMzNkZF8wLTItMS0xLTEzNTAz_08e01cb5-e9f4-41ba-a0a7-a0e808be2f76">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGFibGU6Nzg5NjA4MTAxNjJjNGQxMzhkNGYxM2U3NjE3YzMzZGQvdGFibGVyYW5nZTo3ODk2MDgxMDE2MmM0ZDEzOGQ0ZjEzZTc2MTdjMzNkZF8xLTMtMS0xLTEzNTAz_35eb261d-34e3-4cae-9692-d0deda74fcc3">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGFibGU6Nzg5NjA4MTAxNjJjNGQxMzhkNGYxM2U3NjE3YzMzZGQvdGFibGVyYW5nZTo3ODk2MDgxMDE2MmM0ZDEzOGQ0ZjEzZTc2MTdjMzNkZF8yLTEtMS0xLTEzNTAz_c258e79f-b5ed-4635-b3e8-fabcab44df36">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGV4dHJlZ2lvbjo4Njc5M2NhODY2Mzg0YWYxYmYzM2RkOWU0ODE4MGZlNV8yMjk1_66418443-38ff-471c-ae92-1b2aa590575a">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i114f6d588eec41cca10eacf197741d76_I20220429"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xL2ZyYWc6ODY3OTNjYTg2NjM4NGFmMWJmMzNkZDllNDgxODBmZTUvdGV4dHJlZ2lvbjo4Njc5M2NhODY2Mzg0YWYxYmYzM2RkOWU0ODE4MGZlNV8yNDEw_178946fc-d18a-4af9-a82c-0454322349ce"
      unitRef="shares">12590098</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNC0xLTEtMS0xMzUwMw_8969148f-703c-4b32-b971-7d116d6eeffd"
      unitRef="usd">17796000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNC0zLTEtMS0xMzUwMw_ca1c15e1-8b48-4872-9163-1470255e4c89"
      unitRef="usd">23174000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNS0xLTEtMS0xMzUwMw_cb978c32-0071-4602-9f64-e2fab8cc73bb"
      unitRef="usd">2798000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNS0zLTEtMS0xMzUwMw_9a7fa109-e038-4ae9-b266-b8ecbeedeef8"
      unitRef="usd">2925000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNi0xLTEtMS0xMzUwMw_25b92956-6fcc-4a24-9bc0-170e5f80dd69"
      unitRef="usd">805000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNi0zLTEtMS0xMzUwMw_a84592a5-0189-49dc-bebc-224f3a2c1c3f"
      unitRef="usd">1038000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:InventoryNet
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNy0xLTEtMS0xMzUwMw_74288c5d-44df-47db-bff6-1639c829c8ae"
      unitRef="usd">16276000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNy0zLTEtMS0xMzUwMw_e6947323-5099-42d9-9bff-1d7c2ee8cc7e"
      unitRef="usd">16145000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfOS0xLTEtMS0xMzUwMw_65ddb743-5c4b-4de8-89ca-51841c525626"
      unitRef="usd">7383000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfOS0zLTEtMS0xMzUwMw_acd472cb-b3e6-43c3-b1dc-90c8c3508173"
      unitRef="usd">4772000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTAtMS0xLTEtMTM1MDM_9515b7c3-b4ac-4abd-84dc-1cf4eae3311e"
      unitRef="usd">45058000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTAtMy0xLTEtMTM1MDM_7cfe291d-e093-4764-a74e-2b6787c4e540"
      unitRef="usd">48054000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTItMS0xLTEtMTM1MDM_72785baf-8cbc-4f75-8edd-913e9937ee1b"
      unitRef="usd">10035000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTItMy0xLTEtMTM1MDM_7c742193-d9c2-4557-96bc-1576becef407"
      unitRef="usd">11123000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTMtMS0xLTEtMTM1MDM_595c1c0c-3833-4cff-b446-dc63cd23e3d7"
      unitRef="usd">11760000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTMtMy0xLTEtMTM1MDM_1225c29b-9d2f-4b8f-920a-2b9ba374be83"
      unitRef="usd">13700000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTQtMS0xLTEtMTM1MDM_9e09fc36-3674-46be-af7f-a4d2630c10ac"
      unitRef="usd">620000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTQtMy0xLTEtMTM1MDM_234491ab-cb50-4254-8c34-f9aca0fc97f4"
      unitRef="usd">719000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTUtMS0xLTEtMTM1MDM_c056d2f3-a9c1-4a71-9221-680be572355f"
      unitRef="usd">1077000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTUtMy0xLTEtMTM1MDM_43220ba7-9e2c-4aff-a675-704b5af8623b"
      unitRef="usd">1208000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:LongTermInvestments
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTYtMS0xLTEtMTM1MDM_96d6814f-631a-422a-a3d8-9425a31fb60c"
      unitRef="usd">2205000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTYtMy0xLTEtMTM1MDM_b7d4e9b0-0779-469d-b7fb-e213b8909b4b"
      unitRef="usd">2205000</us-gaap:LongTermInvestments>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTctMS0xLTEtMTM1MDM_f6309f86-c0e5-450e-bbcc-0c857e11d162"
      unitRef="usd">1460000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTctMy0xLTEtMTM1MDM_9b404670-c32f-4542-b14e-c5381d148b7d"
      unitRef="usd">1723000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTgtMS0xLTEtMTM1MDM_0f9815ff-d1da-4884-8dad-457a1889ab77"
      unitRef="usd">72215000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMTgtMy0xLTEtMTM1MDM_7fcdd690-24fc-4e0b-b9e7-c5b4daf069c1"
      unitRef="usd">78732000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMjItMS0xLTEtMTM1MDM_685cfe8f-e073-4bf7-a2a2-436cf451d7c6"
      unitRef="usd">6533000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMjItMy0xLTEtMTM1MDM_f7259664-c862-4da8-bf31-710880bbf2b9"
      unitRef="usd">6744000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedSalesCommissionCurrent
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMjMtMS0xLTEtMTM1MDM_182962cc-3232-479a-9546-49896c4eda7e"
      unitRef="usd">7255000</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:AccruedSalesCommissionCurrent
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMjMtMy0xLTEtMTM1MDM_820ac842-b552-464a-8b38-a21b00fba7b6"
      unitRef="usd">8138000</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:TaxesPayableCurrentAndNoncurrent
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMjYtMS0xLTEtMTM1MDM_b85cd44c-b0ca-4d71-ad51-34f2d9bf5fb7"
      unitRef="usd">78000</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <us-gaap:TaxesPayableCurrentAndNoncurrent
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMjYtMy0xLTEtMTM1MDM_db26b37c-ef70-4c49-b597-617d25bf342d"
      unitRef="usd">830000</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMjctMS0xLTEtMTM1MDM_aaa52cfa-066f-480c-ba49-c0aa985038be"
      unitRef="usd">2688000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMjctMy0xLTEtMTM1MDM_da2098d6-1eb4-431b-9c5e-bdc621f4a5b7"
      unitRef="usd">2151000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMjgtMS0xLTEtMTM1MDM_060ec134-b5ca-4c1a-8d08-dfbee5fd2308"
      unitRef="usd">7054000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMjgtMy0xLTEtMTM1MDM_4d767b27-a7da-472e-a901-bdb44982d07c"
      unitRef="usd">7336000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMzAtMS0xLTEtMTM1MDM_10295f0f-f3c1-48a7-95d4-73a2071a894d"
      unitRef="usd">23608000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMzAtMy0xLTEtMTM1MDM_aba3434f-f859-41ab-b245-4ac5a03d4019"
      unitRef="usd">25199000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMzYtMS0xLTEtMTM1MDM_f2af76e4-2616-4638-bdd0-6556530f61a1"
      unitRef="usd">13876000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMzYtMy0xLTEtMTM1MDM_e4696d1b-2429-4a15-9515-f648c4413c22"
      unitRef="usd">16032000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMzctMS0xLTEtMTM1MDM_5a82a1a9-5b9c-4338-a1e5-cb07f37db146"
      unitRef="usd">700000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMzctMy0xLTEtMTM1MDM_b097869b-b50a-471c-984c-026664e0d0ec"
      unitRef="usd">694000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMzgtMS0xLTEtMTM1MDM_9133837d-d3cd-4ead-a4af-a2d37765b333"
      unitRef="usd">38184000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMzgtMy0xLTEtMTM1MDM_c77340fd-4cc4-40f7-be48-ab1e6a22a7ee"
      unitRef="usd">41925000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMzktMS0xLTEtMTM1MDM_f67a6213-f587-42e7-a786-d6f691b2c58d"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfMzktMy0xLTEtMTM1MDM_2879dc7c-14d3-4a7e-8617-7e9f456c9497"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDEtMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpiYmQ3MmZkMmZmZDM0NjU0OTVlNmZmYTU3ZTUzYjY1NV8zMg_69b6e8a6-75b9-453c-8397-ac74df9bbe28"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDEtMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpiYmQ3MmZkMmZmZDM0NjU0OTVlNmZmYTU3ZTUzYjY1NV8zMg_9206c46e-7c6a-4e99-b4fb-24577deb08bf"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDEtMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpiYmQ3MmZkMmZmZDM0NjU0OTVlNmZmYTU3ZTUzYjY1NV80Ng_3a1dbe2d-ba16-4bfc-9b8b-f5fb4de15f1d"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDEtMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpiYmQ3MmZkMmZmZDM0NjU0OTVlNmZmYTU3ZTUzYjY1NV80Ng_ff0402f7-2ee5-439f-b14c-f3dd0e5c1999"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDEtMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpiYmQ3MmZkMmZmZDM0NjU0OTVlNmZmYTU3ZTUzYjY1NV82OA_7d69cd42-fdaf-4f5a-b1fd-6810aaaa516f"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDEtMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpiYmQ3MmZkMmZmZDM0NjU0OTVlNmZmYTU3ZTUzYjY1NV82OA_8809e1ee-6308-4609-bbd7-7339ab4aab79"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDEtMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpiYmQ3MmZkMmZmZDM0NjU0OTVlNmZmYTU3ZTUzYjY1NV82OA_9fe476f1-e03d-401b-9fe2-dbd5112bb7d8"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDEtMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpiYmQ3MmZkMmZmZDM0NjU0OTVlNmZmYTU3ZTUzYjY1NV82OA_cd264e2a-6115-4749-8893-0ad0ef03bded"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDEtMS0xLTEtMTM1MDM_6651bf8c-149a-4165-a3ed-5b6c2b34f6f4"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDEtMy0xLTEtMTM1MDM_31af3173-ffc7-4e93-8a3b-679760ef8d10"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDItMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpjOTQ4OGRlNDk5ZGM0ZjVjODJiZDVmNmE3MjQzMGJjNl8zMA_87618eba-60b0-4039-8cc5-5ef848390ea9"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDItMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpjOTQ4OGRlNDk5ZGM0ZjVjODJiZDVmNmE3MjQzMGJjNl8zMA_ba6d19f9-f09a-403e-8cfd-1c33485beee6"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDItMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpjOTQ4OGRlNDk5ZGM0ZjVjODJiZDVmNmE3MjQzMGJjNl80NA_21a37ccf-49f8-4dbf-b658-42d8b68d143e"
      unitRef="shares">40000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDItMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpjOTQ4OGRlNDk5ZGM0ZjVjODJiZDVmNmE3MjQzMGJjNl80NA_9f2bca84-56fe-4dae-9458-1bf1dfa3127b"
      unitRef="shares">40000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDItMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpjOTQ4OGRlNDk5ZGM0ZjVjODJiZDVmNmE3MjQzMGJjNl82OQ_21102eeb-344b-4475-8cef-98f30ef27e48"
      unitRef="shares">12577000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDItMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpjOTQ4OGRlNDk5ZGM0ZjVjODJiZDVmNmE3MjQzMGJjNl82OQ_9b372e4d-3730-45ed-81f0-d05925b2f8dd"
      unitRef="shares">12577000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDItMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpjOTQ4OGRlNDk5ZGM0ZjVjODJiZDVmNmE3MjQzMGJjNl83Ng_83429067-d51a-4d25-9328-36c9d3fc8b1a"
      unitRef="shares">13609000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDItMC0xLTEtMTM1MDMvdGV4dHJlZ2lvbjpjOTQ4OGRlNDk5ZGM0ZjVjODJiZDVmNmE3MjQzMGJjNl83Ng_8b010f36-ed42-493f-bca5-042794b752c1"
      unitRef="shares">13609000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDItMS0xLTEtMTM1MDM_9332192d-549e-4967-b841-83aeebf26260"
      unitRef="usd">1000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDItMy0xLTEtMTM1MDM_9728bc53-e4e1-4092-a4fc-1eda836890bb"
      unitRef="usd">1000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDMtMS0xLTEtMTM1MDM_38437000-0f72-41dc-a052-8caff234e094"
      unitRef="usd">130714000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDMtMy0xLTEtMTM1MDM_09fbbbca-6750-4d1f-8160-2ce3e97bf2b0"
      unitRef="usd">129048000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDQtMS0xLTEtMTM1MDM_f3cdfb56-9275-429f-bb33-5befd2572fdc"
      unitRef="usd">-96184000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDQtMy0xLTEtMTM1MDM_4ab6f006-3ecb-4ca1-a173-557e946d33cf"
      unitRef="usd">-92346000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDUtMS0xLTEtMTM1MDM_02fd892d-6701-4d11-98c4-cbf6efb4bf1c"
      unitRef="usd">-500000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDUtMy0xLTEtMTM1MDM_be5bce33-7c9c-4748-a197-108d6edb45c1"
      unitRef="usd">104000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDYtMS0xLTEtMTM1MDM_0db87e5e-28e4-4932-8801-f046a0579110"
      unitRef="usd">34031000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDYtMy0xLTEtMTM1MDM_2899c076-ecda-4d5e-9069-20be8ec13229"
      unitRef="usd">36807000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDctMS0xLTEtMTM1MDM_8b3cb043-4c31-47a0-b294-8c7bf93539ee"
      unitRef="usd">72215000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8xOS9mcmFnOjY1YzNmYWIwZTQ5YzQ1MThhOWU4ZjQ5OWM5ZTFkNjEzL3RhYmxlOjczZDcxOWU2NjJmZDQ5ZWNiNTU4ZTAwZmJlYWRjNDMzL3RhYmxlcmFuZ2U6NzNkNzE5ZTY2MmZkNDllY2I1NThlMDBmYmVhZGM0MzNfNDctMy0xLTEtMTM1MDM_1e7c9475-718a-4a6c-81e2-7fc2955ee3f3"
      unitRef="usd">78732000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMy0xLTEtMS0xMzUwMw_0297527c-0520-43e2-a14d-ba4d0f32f0e3"
      unitRef="usd">50004000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMy0zLTEtMS0xMzUwMw_a16c8df2-2be5-471a-a925-bdb2ea8e48d4"
      unitRef="usd">51570000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMy01LTEtMS0xMzUwMw_0791ec16-3d7e-480e-8b36-1e60ec0628ec"
      unitRef="usd">155418000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMy03LTEtMS0xMzUwMw_fccc09ae-5b6a-40db-ab81-220031bd96b3"
      unitRef="usd">165405000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfNC0xLTEtMS0xMzUwMw_8505a26d-384f-444e-8108-d4c095a29344"
      unitRef="usd">9657000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfNC0zLTEtMS0xMzUwMw_3b4e7cfa-1c4d-4248-885a-d01a7e9cbf14"
      unitRef="usd">8818000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfNC01LTEtMS0xMzUwMw_a95b58ba-d7a0-4386-8e67-e2687ff1a5af"
      unitRef="usd">28765000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfNC03LTEtMS0xMzUwMw_3a4b3fd6-02dc-4ec6-9c9b-370a6490e802"
      unitRef="usd">28404000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfNS0xLTEtMS0xMzUwMw_ab6fa699-590d-4846-8e9f-400df66d00ea"
      unitRef="usd">40347000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfNS0zLTEtMS0xMzUwMw_e128d41f-a4ee-4f30-b033-ce9c81d2f0cd"
      unitRef="usd">42752000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfNS01LTEtMS0xMzUwMw_28aa2372-d360-4a76-8899-33096232dbda"
      unitRef="usd">126653000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfNS03LTEtMS0xMzUwMw_1eaaeab2-0703-4662-be0e-2f3abc0b34dd"
      unitRef="usd">137001000</us-gaap:GrossProfit>
    <lfvn:CommissionAndIncentives
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfNy0xLTEtMS0xMzUwMw_bc373e99-6510-4e47-aced-9c248e4cf9b2"
      unitRef="usd">23206000</lfvn:CommissionAndIncentives>
    <lfvn:CommissionAndIncentives
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfNy0zLTEtMS0xMzUwMw_f0535bf2-21ff-4673-9256-0aad74cdfc82"
      unitRef="usd">25154000</lfvn:CommissionAndIncentives>
    <lfvn:CommissionAndIncentives
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfNy01LTEtMS0xMzUwMw_52b34ba4-3b28-4804-bb0a-2b2193cea60f"
      unitRef="usd">72760000</lfvn:CommissionAndIncentives>
    <lfvn:CommissionAndIncentives
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfNy03LTEtMS0xMzUwMw_b5a41dce-6785-45cc-a2ad-458afe0006e7"
      unitRef="usd">77939000</lfvn:CommissionAndIncentives>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfOC0xLTEtMS0xMzUwMw_45355c7e-bdcc-47a1-a3b2-2b20b38b7557"
      unitRef="usd">15316000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfOC0zLTEtMS0xMzUwMw_f14f7442-844f-4387-8704-4e0d2b8d25f0"
      unitRef="usd">15510000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfOC01LTEtMS0xMzUwMw_b53a458c-0348-448d-9bdc-9d7d9778a3ce"
      unitRef="usd">47813000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfOC03LTEtMS0xMzUwMw_5691e7ac-79ee-4eb2-9ef0-7ce1fbe6aa00"
      unitRef="usd">48027000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTEtMS0xLTEtMTM1MDM_68e9f986-e632-4545-a235-c40493ade781"
      unitRef="usd">38522000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTEtMy0xLTEtMTM1MDM_bd67306c-fe8b-44a9-b1b6-5413847846f7"
      unitRef="usd">40664000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTEtNS0xLTEtMTM1MDM_cd81bb06-99dc-4412-a876-0815e0be932a"
      unitRef="usd">120573000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTEtNy0xLTEtMTM1MDM_7ebddb77-7e47-4ddd-ba35-0d67aa5d6fdd"
      unitRef="usd">125966000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTItMS0xLTEtMTM1MDM_6ad05966-1a81-46d9-8165-458c151036e9"
      unitRef="usd">1825000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTItMy0xLTEtMTM1MDM_e817f101-73d7-48bf-8c7f-52ded3e24d74"
      unitRef="usd">2088000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTItNS0xLTEtMTM1MDM_66ba5437-cd36-40d0-a1a2-9c1258ffd292"
      unitRef="usd">6080000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTItNy0xLTEtMTM1MDM_c49f8c70-16ea-4a0d-93fa-303f9bc21207"
      unitRef="usd">11035000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTQtMS0xLTEtMTM1MDM_3208d08c-9454-4dee-95c7-ee802d49c895"
      unitRef="usd">5000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTQtMy0xLTEtMTM1MDM_69aa8c1d-22fc-46ce-a078-fbab0e5d7336"
      unitRef="usd">2000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTQtNS0xLTEtMTM1MDM_c53f8e4d-1898-4dc1-b10f-173322d89b09"
      unitRef="usd">10000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTQtNy0xLTEtMTM1MDM_8c489b48-3694-4eab-b82c-dd9d7b1bbeae"
      unitRef="usd">17000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTUtMS0xLTEtMTM1MDM_338d11dc-c5d5-435b-ab08-fa4ccbffc451"
      unitRef="usd">-69000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTUtMy0xLTEtMTM1MDM_e681e8e6-60ec-4d77-8365-29d4b286b537"
      unitRef="usd">-255000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTUtNS0xLTEtMTM1MDM_05a0cd7f-c471-4e74-b36b-027150058a03"
      unitRef="usd">-385000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTUtNy0xLTEtMTM1MDM_e625ef65-6b73-4680-999d-1abee9d207ef"
      unitRef="usd">-263000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTctMS0xLTEtMTM1MDM_5b4dc0fe-5383-46c1-97be-f696d6d8f993"
      unitRef="usd">-74000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTctMy0xLTEtMTM1MDM_abf648a6-8421-4d59-bf44-4a3f48c8b08e"
      unitRef="usd">-257000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTctNS0xLTEtMTM1MDM_ea7bd97d-c8b4-467a-baf3-08e69e00d6ec"
      unitRef="usd">-395000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTctNy0xLTEtMTM1MDM_7f5fd66c-e029-4856-9dce-3e308b159514"
      unitRef="usd">-280000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTgtMS0xLTEtMTM1MDM_727653fd-4a8f-48ca-ae3f-6b118b56b31a"
      unitRef="usd">1751000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTgtMy0xLTEtMTM1MDM_9e3d198c-7042-4583-91a4-a94ea25ad523"
      unitRef="usd">1831000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTgtNS0xLTEtMTM1MDM_c9eed362-0139-4b13-ae53-8b0a09fc0a8c"
      unitRef="usd">5685000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTgtNy0xLTEtMTM1MDM_0a770968-b255-48bf-826f-62b7ea926286"
      unitRef="usd">10755000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTktMS0xLTEtMTM1MDM_269c11db-ae13-4c8d-a032-1ac48bcbd7eb"
      unitRef="usd">610000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTktMy0xLTEtMTM1MDM_e836e719-7bda-40da-b4d5-da368520ae31"
      unitRef="usd">107000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTktNS0xLTEtMTM1MDM_c3fef7d4-80ca-4e30-b5d2-193521322b40"
      unitRef="usd">1149000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMTktNy0xLTEtMTM1MDM_9ff0af0c-4f7d-45e8-89b2-6f14a02b6787"
      unitRef="usd">2768000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjAtMS0xLTEtMTM1MDM_2ca40150-544c-47cc-bc49-465bb588461e"
      unitRef="usd">1141000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjAtMy0xLTEtMTM1MDM_00e4a361-0b55-4097-ac66-dd1f1e2a3fb0"
      unitRef="usd">1724000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjAtNS0xLTEtMTM1MDM_7203fa53-7790-45ce-b411-db50b76ff149"
      unitRef="usd">4536000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjAtNy0xLTEtMTM1MDM_db7e444b-7dd4-4f5c-9d13-478f14c3a899"
      unitRef="usd">7987000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjItMS0xLTEtMTM1MDM_bb6e7db5-40ca-4001-96ec-6bdd002c68f0"
      unitRef="usdPerShare">0.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjItMy0xLTEtMTM1MDM_88a6ab93-8d87-476c-bad4-f8c8b506c8a3"
      unitRef="usdPerShare">0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjItNS0xLTEtMTM1MDM_d4f7d752-72a7-45eb-a535-36d5ddc5f27c"
      unitRef="usdPerShare">0.34</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjItNy0xLTEtMTM1MDM_e99820a0-e77e-4ce2-be1d-bd759ae31006"
      unitRef="usdPerShare">0.56</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjMtMS0xLTEtMTM1MDM_dca0693b-17e6-44cd-aae6-dcb2651fb791"
      unitRef="usdPerShare">0.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjMtMy0xLTEtMTM1MDM_107984ce-4848-46e3-a848-223aff0575f6"
      unitRef="usdPerShare">0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjMtNS0xLTEtMTM1MDM_412d542f-eaf6-4cb1-9730-e94224d854f4"
      unitRef="usdPerShare">0.34</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjMtNy0xLTEtMTM1MDM_68138447-c7bb-4f02-9637-7f94b69b63fc"
      unitRef="usdPerShare">0.55</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjUtMS0xLTEtMTM1MDM_377d4389-6e0a-4922-8015-ba2e25d36e1b"
      unitRef="shares">13195000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjUtMy0xLTEtMTM1MDM_9a51be5a-0769-47cf-b3a3-dd4314125bfb"
      unitRef="shares">14071000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjUtNS0xLTEtMTM1MDM_3bed9b19-4192-4120-8e78-5d430ed8ba0c"
      unitRef="shares">13261000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjUtNy0xLTEtMTM1MDM_95e8015e-6a26-40d3-ba87-baf32f20496f"
      unitRef="shares">14175000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjYtMS0xLTEtMTM1MDM_c2a4a5df-1b4b-4b5e-9594-651e0c8e5714"
      unitRef="shares">13257000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjYtMy0xLTEtMTM1MDM_21159732-197e-447d-9b33-497380cbbc13"
      unitRef="shares">14212000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjYtNS0xLTEtMTM1MDM_aaa95c0b-ee71-46ce-8607-058ab21bef51"
      unitRef="shares">13312000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjYtNy0xLTEtMTM1MDM_f749ffa8-21f6-4485-a191-64396ee3530f"
      unitRef="shares">14420000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjgtMS0xLTEtMTM1MDM_61f3d956-87ce-4798-a2d2-c390e4c4bf13"
      unitRef="usd">-290000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjgtMy0xLTEtMTM1MDM_60298538-c6e5-4c11-a109-a100a2c31804"
      unitRef="usd">-443000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjgtNS0xLTEtMTM1MDM_f7906fc0-57df-4cb2-b2cd-e92477e91f10"
      unitRef="usd">-604000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMjgtNy0xLTEtMTM1MDM_62ecc61e-ccff-408c-a39f-ecb2c1f9fe46"
      unitRef="usd">-39000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMzAtMS0xLTEtMTM1MDM_8188bccc-7ba3-4152-b65e-6c9076ff19f7"
      unitRef="usd">-290000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMzAtMy0xLTEtMTM1MDM_e3b86a1b-bbc6-4fef-a400-430657a367c3"
      unitRef="usd">-443000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMzAtNS0xLTEtMTM1MDM_2d240306-138f-4582-9372-f470cf66f37f"
      unitRef="usd">-604000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMzAtNy0xLTEtMTM1MDM_85bdef6e-e923-4c67-8a9c-4f61509d674d"
      unitRef="usd">-39000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMzEtMS0xLTEtMTM1MDM_be2bdffe-8b0b-41a7-9077-bd7bbd760fcc"
      unitRef="usd">851000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMzEtMy0xLTEtMTM1MDM_4d9b0718-ee8b-4deb-a829-280c57ed1a99"
      unitRef="usd">1281000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMzEtNS0xLTEtMTM1MDM_915f0dcf-0251-435b-bef6-eea34ebf1766"
      unitRef="usd">3932000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yMi9mcmFnOmQzMjM5ZjI2NjFmMTQ4YWQ4NTg2MzM1NTE4ZjIxY2E5L3RhYmxlOjkzYTI2ZWRjYWI1ODRmZDk4ZTJkMDlkNzUxN2Q3NTdmL3RhYmxlcmFuZ2U6OTNhMjZlZGNhYjU4NGZkOThlMmQwOWQ3NTE3ZDc1N2ZfMzEtNy0xLTEtMTM1MDM_ccf59f7e-9b44-4530-8e05-7fae5bbbbc95"
      unitRef="usd">7948000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="i9fc9c821fc9844eebd5eeda44da0b7b7_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMy0xLTEtMS0xMzUwMw_339c12ac-4e10-4dd4-8dae-43570aff9635"
      unitRef="shares">13609000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i9fc9c821fc9844eebd5eeda44da0b7b7_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMy0zLTEtMS0xMzUwMw_0a03f8d5-74b9-4180-8090-efe73b3fb484"
      unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie7c081c090f745529154ed6ce94b38f9_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMy01LTEtMS0xMzUwMw_c05f47e2-e377-4094-afd2-c607f2c67ba8"
      unitRef="usd">129048000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i46af58f761da46259c37ec6f18a63af2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMy03LTEtMS0xMzUwMw_2a71549c-06a1-485a-b497-56e3895fb94e"
      unitRef="usd">-92346000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7cbd37945df4470c99f8b2a0360dc403_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMy05LTEtMS0xMzUwMw_acd364ae-15a0-4b6c-90f1-2e8ad908715a"
      unitRef="usd">104000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMy0xMS0xLTEtMTM1MDM_e41d2fa0-9c62-41fa-9c7a-ab62d055edcd"
      unitRef="usd">36807000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie272543a8f524dd6a6c9114d0b6cf545_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfNS01LTEtMS0xMzUwMw_ca90783c-eae9-4317-a654-84af7d26c0b5"
      unitRef="usd">645000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i357d0e28c2744a86a6382506b17c0264_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfNS0xMS0xLTEtMTM1MDM_6c91f309-44ed-4ab4-ace0-0b5b8b6e241a"
      unitRef="usd">645000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i591ebee999ed4b4cb8022ec6a31670f3_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfNi0xLTEtMS0xMzUwMw_1cb8b1b0-5fec-48b1-bf08-3aca228eabc4"
      unitRef="shares">30000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ie272543a8f524dd6a6c9114d0b6cf545_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfNi01LTEtMS0xMzUwMw_f9e806cc-0387-43ae-83ba-a40200bcf81d"
      unitRef="usd">133000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i357d0e28c2744a86a6382506b17c0264_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfNi0xMS0xLTEtMTM1MDM_1180ea4d-cf01-4662-87ea-4b66238a8a5a"
      unitRef="usd">133000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i591ebee999ed4b4cb8022ec6a31670f3_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfNy0xLTEtMS0xMzUwMw_db62debb-2c10-49e6-a3cb-909a0fe3da52"
      unitRef="shares">49000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i357d0e28c2744a86a6382506b17c0264_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfNy0xMS0xLTEtMTM1MDM_272b7eee-a879-4fad-af36-becc0007b7d5"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i591ebee999ed4b4cb8022ec6a31670f3_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfOC0xLTEtMS0xMzUwMw_b8291598-9f14-4abc-b662-a05f90fbab6f"
      unitRef="shares">19000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ie272543a8f524dd6a6c9114d0b6cf545_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfOC01LTEtMS0xMzUwMw_10154c4a-c5e6-4595-98eb-1ece288f46c0"
      unitRef="usd">139000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i357d0e28c2744a86a6382506b17c0264_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfOC0xMS0xLTEtMTM1MDM_430eefea-259c-42f0-91c0-5031e1e353fb"
      unitRef="usd">139000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i591ebee999ed4b4cb8022ec6a31670f3_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfOS0xLTEtMS0xMzUwMw_f77a67e1-aaf0-4228-9d2f-9a838338218f"
      unitRef="shares">460000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i6a9a7c2d6b1d487eaf86a59ab23c23ce_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfOS03LTEtMS0xMzUwMw_33fff6f9-ba6a-4136-9eae-b4af0b286082"
      unitRef="usd">3492000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i357d0e28c2744a86a6382506b17c0264_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfOS0xMS0xLTEtMTM1MDM_08928cd6-503b-4354-aacb-1513ddf3dfb8"
      unitRef="usd">3492000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i591ebee999ed4b4cb8022ec6a31670f3_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTAtMS0xLTEtMTM1MDM_65e15164-3af5-4657-b062-7d9a7297cb23"
      unitRef="shares">27000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ie272543a8f524dd6a6c9114d0b6cf545_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTAtNS0xLTEtMTM1MDM_783d8975-2b70-453b-91ba-07437b59745d"
      unitRef="usd">175000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i357d0e28c2744a86a6382506b17c0264_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTAtMTEtMS0xLTEzNTAz_ecb67824-ea48-4402-9b50-fec115e18829"
      unitRef="usd">175000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ic6e22e23d13942a385a4a49560a7f544_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTEtOS0xLTEtMTM1MDM_120579ed-10bf-43f9-85cd-13e869fc1d0d"
      unitRef="usd">-135000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i357d0e28c2744a86a6382506b17c0264_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTEtMTEtMS0xLTEzNTAz_a4c8d26a-cea6-4ca6-8636-f22c06961fed"
      unitRef="usd">-135000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i6a9a7c2d6b1d487eaf86a59ab23c23ce_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTItNy0xLTEtMTM1MDM_0ffd6055-924a-414e-8c60-c23152b22921"
      unitRef="usd">3316000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i357d0e28c2744a86a6382506b17c0264_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTItMTEtMS0xLTEzNTAz_d6240e71-23c6-4b5b-b8a1-680128e807a1"
      unitRef="usd">3316000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i61547256e29c4919b4fe5ead6c816e24_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTMtMS0xLTEtMTM1MDM_a8a066d6-509f-489f-8a05-78588169f4bc"
      unitRef="shares">13236000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i61547256e29c4919b4fe5ead6c816e24_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTMtMy0xLTEtMTM1MDM_01dbb545-cb62-4e98-a0d1-4f7337c9d89e"
      unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibd0af93ed4f64a8c937539b4670c6e48_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTMtNS0xLTEtMTM1MDM_acbb20a4-b521-4146-a118-d59eb9fb120b"
      unitRef="usd">129862000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iba6a88e280384332a89b41a26f4cfab4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTMtNy0xLTEtMTM1MDM_2ffd710e-a0ff-4111-be73-da603b3d94c1"
      unitRef="usd">-92522000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ida700141a9ae4429b2b7a901f417f0bf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTMtOS0xLTEtMTM1MDM_379c09f0-0e17-45c3-91ae-f64de5cd0e19"
      unitRef="usd">-31000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i48a61f3b86a440f692477c18672aa67f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTMtMTEtMS0xLTEzNTAz_1d1d996f-e017-4d56-8c24-fb26726b5a09"
      unitRef="usd">37310000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="icbcabe3d4d654627b2330ec970846ddf_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTUtNS0xLTEtMTM1MDM_52eb7617-8e95-4119-8331-b90679623ec5"
      unitRef="usd">755000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="icd08c3f853324ff28662164585d1fce6_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTUtMTEtMS0xLTEzNTAz_1c71873d-516a-42ab-9922-d58c1a72e5e7"
      unitRef="usd">755000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i9bb6cf9ad217405a8247ca642e30509c_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTctMS0xLTEtMTM1MDM_1da3e8f0-21cb-4e85-8d53-730de464a28b"
      unitRef="shares">67000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="icd08c3f853324ff28662164585d1fce6_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTctMTEtMS0xLTEzNTAz_5d06ea51-1554-49a2-91e4-4048517a6d98"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i9bb6cf9ad217405a8247ca642e30509c_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTgtMS0xLTEtMTM1MDM_f00f6bf3-63a6-4045-8a1a-ee9e5a66078d"
      unitRef="shares">5000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="icbcabe3d4d654627b2330ec970846ddf_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTgtNS0xLTEtMTM1MDM_9226ba57-185a-4770-8433-7c0f764bafe9"
      unitRef="usd">31000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="icd08c3f853324ff28662164585d1fce6_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTgtMTEtMS0xLTEzNTAz_74771cca-764a-4fc7-8304-f12a5e2730ab"
      unitRef="usd">31000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i9bb6cf9ad217405a8247ca642e30509c_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTktMS0xLTEtMTM1MDM_29d42da4-1bb2-4f73-a279-f8f16c0766b7"
      unitRef="shares">454000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="if3804241d822468b8c8a03364b2f4db0_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTktNy0xLTEtMTM1MDM_69b1f531-ae97-47e4-aa02-08aa057eedb8"
      unitRef="usd">3154000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="icd08c3f853324ff28662164585d1fce6_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMTktMTEtMS0xLTEzNTAz_ee5cf57c-9b12-4530-91a4-9c5393d5c54d"
      unitRef="usd">3154000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="if6cf8b23c28d42e593d1ae4e2d3c4019_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjEtOS0xLTEtMTM1MDM_97b5c1d3-79e5-45a4-8041-b8e9482dea82"
      unitRef="usd">-179000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="icd08c3f853324ff28662164585d1fce6_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjEtMTEtMS0xLTEzNTAz_7db456b3-5010-493b-be2a-bc6474eac933"
      unitRef="usd">-179000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="if3804241d822468b8c8a03364b2f4db0_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjItNy0xLTEtMTM1MDM_0fdb9a92-90f8-427d-9c75-23a6023076b1"
      unitRef="usd">79000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="icd08c3f853324ff28662164585d1fce6_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjItMTEtMS0xLTEzNTAz_23bcde04-c4f8-40c8-a4f1-9286c4b3b963"
      unitRef="usd">79000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i38ac3e0be007455d8666cf4e653aaa47_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjMtMS0xLTEtMTM1MDM_d16e8953-49e0-4d18-8aa5-86a6cd9876b0"
      unitRef="shares">12844000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i38ac3e0be007455d8666cf4e653aaa47_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjMtMy0xLTEtMTM1MDM_a62648bf-c5d7-47df-a61c-f916a420c5cf"
      unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5fdcc53f50d94cfdbb432bb029d84ddd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjMtNS0xLTEtMTM1MDM_08341f07-a445-4910-b08c-0af273ca10fd"
      unitRef="usd">130586000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ieb1ca35e5a104d6193f48d4b349fd675_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjMtNy0xLTEtMTM1MDM_47a21142-7702-4a28-a62f-2cd5c3a7e7fa"
      unitRef="usd">-95597000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5263d30c26d9470b8de6e49fabce1c6f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjMtOS0xLTEtMTM1MDM_ee391c4e-7e7e-4846-8ffe-db1f23cd4080"
      unitRef="usd">-210000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ida7724eff7a34d7e804bef8c3a260107_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjMtMTEtMS0xLTEzNTAz_f5544f28-2c4b-4015-a243-d0d8c9c0910e"
      unitRef="usd">34780000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8a3861a962104cbaafc9ae69c1393aab_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjUtNS0xLTEtMTM1MDM_f1b6ea4e-65c6-4f9d-a4b5-30092cadbdaf"
      unitRef="usd">-38000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjUtMTEtMS0xLTEzNTAz_3352185b-a213-4952-abe6-1a71ddea9593"
      unitRef="usd">-38000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i34d7b9b3d06f458fa586f0f59243f9bd_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjctMS0xLTEtMTM1MDM_a51161fc-4509-41bc-a723-6a6f944fc643"
      unitRef="shares">41000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i8a3861a962104cbaafc9ae69c1393aab_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjctNS0xLTEtMTM1MDM_84cd30f0-5212-48e3-a212-08b350ada609"
      unitRef="usd">197000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjctMTEtMS0xLTEzNTAz_1e37823a-138b-4b88-b887-ea56c65b9fd9"
      unitRef="usd">197000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i34d7b9b3d06f458fa586f0f59243f9bd_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjgtMS0xLTEtMTM1MDM_82c0cbef-11f8-4222-9009-ebbb6b9537b3"
      unitRef="shares">23000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjgtMTEtMS0xLTEzNTAz_abadb26a-b967-4219-b00d-bd22e1721444"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i34d7b9b3d06f458fa586f0f59243f9bd_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjktMS0xLTEtMTM1MDM_326ea773-5fed-462d-a7f5-6c0d9cb32035"
      unitRef="shares">5000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i8a3861a962104cbaafc9ae69c1393aab_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjktNS0xLTEtMTM1MDM_756ef9a2-987a-46aa-9617-d2c03d6efa4f"
      unitRef="usd">31000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMjktMTEtMS0xLTEzNTAz_012192aa-7a9a-4dfc-8ada-291019130dd7"
      unitRef="usd">31000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i34d7b9b3d06f458fa586f0f59243f9bd_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMzAtMS0xLTEtMTM1MDM_f94b3289-d5a7-4a91-8856-a17f296efe91"
      unitRef="shares">326000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i9d259b63592a4d5ca5fac8400bae6f58_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMzAtNy0xLTEtMTM1MDM_99823904-a9de-4842-8507-de8b08c0d1ca"
      unitRef="usd">1728000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMzAtMTEtMS0xLTEzNTAz_0d9bbbb0-2872-4a79-af5f-33c15537b51d"
      unitRef="usd">1728000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i18b390fcfcd440aeb1bd8306b98b8360_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMzItOS0xLTEtMTM1MDM_eecfe88c-e355-4667-a763-cb5260cf3159"
      unitRef="usd">-290000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMzItMTEtMS0xLTEzNTAz_343994d5-8b4b-4398-8651-8f7511d2fa00"
      unitRef="usd">-290000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i9d259b63592a4d5ca5fac8400bae6f58_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMzMtNy0xLTEtMTM1MDM_d3e132a1-62a8-475a-a98c-2e373ecafab1"
      unitRef="usd">1141000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMzMtMTEtMS0xLTEzNTAz_0bcbafbe-8ac2-4f59-8476-cd08f0c8a451"
      unitRef="usd">1141000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i80e93762807c42728430aca71fb61c7d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMzQtMS0xLTEtMTM1MDM_32088d49-c97a-4602-9d44-b3c76bef59e3"
      unitRef="shares">12577000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i80e93762807c42728430aca71fb61c7d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMzQtMy0xLTEtMTM1MDM_7e470417-42b1-465c-af6c-4fc7a7288fa2"
      unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i422faeaa855042ae85c18160145ee1aa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMzQtNS0xLTEtMTM1MDM_72978e2c-80b2-46fc-85f2-6d419906ebd6"
      unitRef="usd">130714000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8414ddffcc994aaca67582af5b64988d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMzQtNy0xLTEtMTM1MDM_6daf7ae5-fbc0-4808-876f-9453244b6207"
      unitRef="usd">-96184000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i87ee290661d3437bb9f238e5b3000de5_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMzQtOS0xLTEtMTM1MDM_ff293166-ac4a-4b5a-b8aa-e9ac062d68d8"
      unitRef="usd">-500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yNS9mcmFnOjZmNDBhNDU1N2FiYjQ2ZDg5ZjkwYWMzMWFjN2U0Yjk4L3RhYmxlOjZjMDA2ZWRhY2Q5NTQ4NDNiMGIyMjljOTEyNDM3NjIwL3RhYmxlcmFuZ2U6NmMwMDZlZGFjZDk1NDg0M2IwYjIyOWM5MTI0Mzc2MjBfMzQtMTEtMS0xLTEzNTAz_6a7b8404-64b8-47d3-91d6-c7031c5bbe6b"
      unitRef="usd">34031000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i962d85b9976d4fa6b5d9584e36bb2ab1_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMy0xLTEtMS0xMzUwMw_d2100390-554b-438a-9bbc-a73f233b4596"
      unitRef="shares">14313000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i962d85b9976d4fa6b5d9584e36bb2ab1_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMy0zLTEtMS0xMzUwMw_aaf44061-8564-4a28-81ac-a41c7fae9fd8"
      unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4c716aa1362243ccb5055e6e6b509ab8_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMy01LTEtMS0xMzUwMw_8806be3c-326a-4c9f-a218-cf49148fc5d2"
      unitRef="usd">126416000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i12c81306c48d435facd113371422e44d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMy03LTEtMS0xMzUwMw_855ec3b0-dc12-4db2-9d59-8bc75e8bea42"
      unitRef="usd">-93307000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic551f8ef22194653996c3e7b7c2a4891_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMy05LTEtMS0xMzUwMw_f83c9665-63d8-4148-bbab-0f8ea0acee42"
      unitRef="usd">144000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i68b782cee24b481ab1a20bb3a92aad68_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMy0xMS0xLTEtMTM1MDM_c4a2a3c5-5536-41bf-a8ff-326c96f69352"
      unitRef="usd">33254000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6f6b95ce9ace4fcbbaf406066f26cb5d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfNS01LTEtMS0xMzUwMw_0ac22dce-d42c-4756-964c-24dedbc93eee"
      unitRef="usd">520000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i078343424c294ceca151c4f530b420fc_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfNS0xMS0xLTEtMTM1MDM_8c43037a-4724-4c64-8771-18171d7b634e"
      unitRef="usd">520000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i36be45415d344673a4b1de8f2d0bf0fe_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfNi0xLTEtMS0xMzUwMw_e0460136-f124-414c-9532-5f8a195c3f98"
      unitRef="shares">2000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i6f6b95ce9ace4fcbbaf406066f26cb5d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfNi01LTEtMS0xMzUwMw_ab9045db-6ec1-45f6-a8d6-667a7be8a256"
      unitRef="usd">11000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i078343424c294ceca151c4f530b420fc_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfNi0xMS0xLTEtMTM1MDM_6d9f1b16-67b7-46e5-b9c9-0c74cc559745"
      unitRef="usd">11000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i36be45415d344673a4b1de8f2d0bf0fe_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfNy0xLTEtMS0xMzUwMw_fc0a3143-a6f6-45b0-80ae-695d3122e442"
      unitRef="shares">74000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i078343424c294ceca151c4f530b420fc_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfNy0xMS0xLTEtMTM1MDM_fee1d670-3b1e-4910-894f-cad6aea3420f"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i36be45415d344673a4b1de8f2d0bf0fe_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfOC0xLTEtMS0xMzUwMw_6c6fe2e2-9296-40cf-a199-7f7c3dd7a503"
      unitRef="shares">38000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i6f6b95ce9ace4fcbbaf406066f26cb5d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfOC01LTEtMS0xMzUwMw_30d1bc7e-d1f0-4c02-8380-7490345806c4"
      unitRef="usd">506000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i078343424c294ceca151c4f530b420fc_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfOC0xMS0xLTEtMTM1MDM_5bc8f65f-6653-4be3-8b7a-423a9f377748"
      unitRef="usd">506000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i36be45415d344673a4b1de8f2d0bf0fe_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfOS0xLTEtMS0xMzUwMw_50b18c57-ea05-4b73-9b90-5476ac7e31b2"
      unitRef="shares">136000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i371a2ccf5aa04409abfd0f1176383ba2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfOS03LTEtMS0xMzUwMw_f5ed3419-62c6-4991-8078-ab35c535633d"
      unitRef="usd">2000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i078343424c294ceca151c4f530b420fc_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfOS0xMS0xLTEtMTM1MDM_623d5487-5f20-4808-bfda-016c51f56860"
      unitRef="usd">2000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i36be45415d344673a4b1de8f2d0bf0fe_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTAtMS0xLTEtMTM1MDM_1786dd89-6e4a-4bd6-b25f-12a2e16fd3fc"
      unitRef="shares">23000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i6f6b95ce9ace4fcbbaf406066f26cb5d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTAtNS0xLTEtMTM1MDM_f1f5554f-ecbb-432b-aa3d-1611e5a36ad6"
      unitRef="usd">246000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i078343424c294ceca151c4f530b420fc_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTAtMTEtMS0xLTEzNTAz_e633c24e-1bae-471b-9cf3-df856afdcd12"
      unitRef="usd">246000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i272a3fb900ee42a0b17372fc51c0fd09_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTEtOS0xLTEtMTM1MDM_3a450bd8-d0e1-42d0-ac5e-3d99d6325c9c"
      unitRef="usd">160000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i078343424c294ceca151c4f530b420fc_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTEtMTEtMS0xLTEzNTAz_365f2dfa-3275-4cde-a40b-e789d57eaa43"
      unitRef="usd">160000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i371a2ccf5aa04409abfd0f1176383ba2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTItNy0xLTEtMTM1MDM_4d3ce8b0-1bf5-4ca2-a2e7-c7fdb9815a36"
      unitRef="usd">2451000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i078343424c294ceca151c4f530b420fc_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTItMTEtMS0xLTEzNTAz_0f526d63-07ae-439f-a4d5-e0d0ed0768b6"
      unitRef="usd">2451000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i68418c3e9e354ef68baafaaaad67d4db_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTMtMS0xLTEtMTM1MDM_ea55ea9a-c85f-40fd-a726-ff940f866e12"
      unitRef="shares">14238000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i68418c3e9e354ef68baafaaaad67d4db_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTMtMy0xLTEtMTM1MDM_d76c259f-f8ba-4a7c-a8e3-06c194b1a5ce"
      unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7b04da3ccb2949e8a573db766889abb2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTMtNS0xLTEtMTM1MDM_5a3ac3e3-a5ed-46a7-a669-4f45c7a76dad"
      unitRef="usd">126687000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0d971956fe1e405092f076fc100385f9_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTMtNy0xLTEtMTM1MDM_ba3c7bd4-b233-42b2-b0c7-220736b0ab35"
      unitRef="usd">-92856000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic1968b9f619f497180ce2af775046e41_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTMtOS0xLTEtMTM1MDM_1dddb0a8-fe18-4e1a-ae28-7ac31df40d3a"
      unitRef="usd">304000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i07e41a0a758d427ebab0f9e00cf68cfb_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTMtMTEtMS0xLTEzNTAz_d9e58bf6-6f8a-46c9-8774-b11465dbb87a"
      unitRef="usd">34136000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i99f28f304d1842658dac0719b5141740_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTUtNS0xLTEtMTM1MDM_23d9da75-9c26-4282-a054-9a05cbd96509"
      unitRef="usd">999000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5d8a258a91bd4059b27b728132af022c_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTUtMTEtMS0xLTEzNTAz_de3ee039-6415-40fc-902d-d1f704ac74d9"
      unitRef="usd">999000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ifeb352d0769a418ebda3b74b0acbf648_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTYtMS0xLTEtMTM1MDM_f8cc5cd4-b170-4ad6-9bfb-a1dadbdb44a9"
      unitRef="shares">202000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i99f28f304d1842658dac0719b5141740_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTYtNS0xLTEtMTM1MDM_d09c84a3-2d18-4906-9bc1-654474fbb7ee"
      unitRef="usd">991000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i5d8a258a91bd4059b27b728132af022c_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTYtMTEtMS0xLTEzNTAz_1c7fcf41-b2ba-44c6-8697-d259ce73b7fc"
      unitRef="usd">991000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="ifeb352d0769a418ebda3b74b0acbf648_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTctMS0xLTEtMTM1MDM_f483d9cd-463c-414c-a97e-859413b14338"
      unitRef="shares">101000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i5d8a258a91bd4059b27b728132af022c_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTctMTEtMS0xLTEzNTAz_94ef285b-ff55-4f48-90e9-e7af72ce4e15"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ifeb352d0769a418ebda3b74b0acbf648_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTgtMS0xLTEtMTM1MDM_9376bc95-6056-4e1f-93d2-b85963621541"
      unitRef="shares">25000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i99f28f304d1842658dac0719b5141740_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTgtNS0xLTEtMTM1MDM_eaa6e912-9d69-4d66-adc9-d6828352f9f4"
      unitRef="usd">666000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i5d8a258a91bd4059b27b728132af022c_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTgtMTEtMS0xLTEzNTAz_9fdbacff-d8df-4ff9-a186-c195caa236b1"
      unitRef="usd">666000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ifeb352d0769a418ebda3b74b0acbf648_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTktMS0xLTEtMTM1MDM_e06be61a-6018-4d9b-ab8f-0c567b03d876"
      unitRef="shares">365000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="if1a17cb2d0ca4207a83089fb753965d7_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTktNy0xLTEtMTM1MDM_8aa7a7a1-4132-4ef4-9959-aea9e9d8aba8"
      unitRef="usd">4000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i5d8a258a91bd4059b27b728132af022c_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMTktMTEtMS0xLTEzNTAz_ae600611-53a1-49a8-9628-2a3f2ff67944"
      unitRef="usd">4000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i2ab5b4c786a74727b650772bc5f9b6e0_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjEtOS0xLTEtMTM1MDM_da85eed5-9cdd-4ba2-8261-4aec7d69506c"
      unitRef="usd">244000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i5d8a258a91bd4059b27b728132af022c_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjEtMTEtMS0xLTEzNTAz_23c63095-5ff0-4b67-a3ba-7414bb98c0dc"
      unitRef="usd">244000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="if1a17cb2d0ca4207a83089fb753965d7_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjItNy0xLTEtMTM1MDM_a95b6318-052f-4210-9e58-a4bd68db247a"
      unitRef="usd">3812000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5d8a258a91bd4059b27b728132af022c_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjItMTEtMS0xLTEzNTAz_e3898539-7882-4883-902f-9a341f8d6f70"
      unitRef="usd">3812000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="if1fa511d00c840e68d4d9869eb7ddd2e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjMtMS0xLTEtMTM1MDM_52d53aea-8893-4add-a7ee-a02edce518e4"
      unitRef="shares">14151000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="if1fa511d00c840e68d4d9869eb7ddd2e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjMtMy0xLTEtMTM1MDM_1be93740-16af-422d-b91b-ed9ac3ab6abc"
      unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia281323b7eca4b0aac83a5aa68bb9dab_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjMtNS0xLTEtMTM1MDM_40c66ed9-d646-477a-96d8-6190beb936a7"
      unitRef="usd">128011000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if3d79a145f79427694eee4afa398d9c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjMtNy0xLTEtMTM1MDM_cdc04a89-d836-477f-ab48-b20176bf6374"
      unitRef="usd">-93044000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id95d9cc8f1034f528cc66cff9ad5c9ef_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjMtOS0xLTEtMTM1MDM_e0b6de02-9da2-408f-b5ff-d889ec0fbb56"
      unitRef="usd">548000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7d0accfc67e54e8db1894b6929923ad1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjMtMTEtMS0xLTEzNTAz_75922faf-ad9c-44d9-841e-6ed10bc797f5"
      unitRef="usd">35516000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib8a85e0499a945de8e4808fe5e485e28_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjUtNS0xLTEtMTM1MDM_bde8dd01-cfc8-4d71-8860-12df941ad73a"
      unitRef="usd">684000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjUtMTEtMS0xLTEzNTAz_38b6cb96-289b-43f6-81b2-d5455ff1d3f1"
      unitRef="usd">684000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ieb4a6be5906b4ce4a66d6061c62992dd_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjYtMS0xLTEtMTM1MDM_9441d93d-eb6a-4604-b1b9-4d9d9df4b912"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ib8a85e0499a945de8e4808fe5e485e28_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjYtNS0xLTEtMTM1MDM_0171abdf-8e43-467e-9b7b-6e9d6211423c"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjYtMTEtMS0xLTEzNTAz_d2991ffd-9cd4-4525-b847-b634418d1827"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjctMS0xLTEtMTM1MDM_7ee28e0d-22dc-4eff-944a-a7c0e606cb10"
      unitRef="shares">36000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ib8a85e0499a945de8e4808fe5e485e28_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjctNS0xLTEtMTM1MDM_b3a2425e-7bc8-4177-84fd-13cf15dd024d"
      unitRef="usd">271000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjctMTEtMS0xLTEzNTAz_0a90a7e4-1699-496a-b4cf-d6976fb1bd28"
      unitRef="usd">271000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="ieb4a6be5906b4ce4a66d6061c62992dd_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjgtMS0xLTEtMTM1MDM_bb6f265c-08bc-407d-a2a7-a41669c1a99e"
      unitRef="shares">29000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjgtMTEtMS0xLTEzNTAz_cd99f7f2-00bb-4a54-ad86-c045e2de62b9"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ieb4a6be5906b4ce4a66d6061c62992dd_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjktMS0xLTEtMTM1MDM_f470c3f8-d944-4c55-8a6d-24c999734a34"
      unitRef="shares">14000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ib8a85e0499a945de8e4808fe5e485e28_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjktNS0xLTEtMTM1MDM_66734d4f-efeb-430f-9b8e-ab494514c1e2"
      unitRef="usd">126000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMjktMTEtMS0xLTEzNTAz_31c53740-8490-4d1f-8d42-fc35a8ae451a"
      unitRef="usd">126000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ieb4a6be5906b4ce4a66d6061c62992dd_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMzAtMS0xLTEtMTM1MDM_95589f76-0145-4ef1-967e-b79ba425ae17"
      unitRef="shares">213000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i4925e0ea7d9e481d96e9fa256be5a1bf_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMzAtNy0xLTEtMTM1MDM_45d19def-6598-4c7a-a405-d136eb231f15"
      unitRef="usd">2000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMzAtMTEtMS0xLTEzNTAz_aac51937-d828-42b9-aa8f-5a9f11dc2475"
      unitRef="usd">2000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ib10cb8e7de8c4656ab658f3172b4c6c8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMzItOS0xLTEtMTM1MDM_70409b54-0e0f-4d71-be68-2bbe69305424"
      unitRef="usd">-443000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMzItMTEtMS0xLTEzNTAz_26867268-5b68-4464-83a8-a800ab3f0a87"
      unitRef="usd">-443000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i4925e0ea7d9e481d96e9fa256be5a1bf_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMzMtNy0xLTEtMTM1MDM_d804b355-7c55-42d1-a975-b9973b5ef59a"
      unitRef="usd">1724000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMzMtMTEtMS0xLTEzNTAz_2bfbf7de-644b-4b6e-bcf7-36e625a7fcdb"
      unitRef="usd">1724000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i9fb5b0bffd7444c2babfc6c81537af68_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMzQtMS0xLTEtMTM1MDM_5ed3a8bb-4360-403c-b97d-3bc30538e736"
      unitRef="shares">13989000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i9fb5b0bffd7444c2babfc6c81537af68_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMzQtMy0xLTEtMTM1MDM_7931196a-5145-452b-ad12-4477a3403ded"
      unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i74275ea8913e4aabb9ae6b13024fbb68_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMzQtNS0xLTEtMTM1MDM_5281b1d3-4977-472c-9388-2fd369140c3a"
      unitRef="usd">128842000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6f571c6d0a364422a6f303b161efdd8a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMzQtNy0xLTEtMTM1MDM_b8f0d3a9-1a18-49bc-88f3-54973e08d732"
      unitRef="usd">-93320000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iba8aa560a2b64ef4b94817dac00694cb_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMzQtOS0xLTEtMTM1MDM_656e1e42-402a-45cc-996a-abbcfe0f4293"
      unitRef="usd">105000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i486872c51e4640dab4cf26f789788bba_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8yOC9mcmFnOjk2MDU5MDAzNTI0MTQxZjM5ZjQ0ZTkxNzA0OGM3MTRjL3RhYmxlOmQ5MGU5ODI1NGI2NjQ0OGFiYzdkYjQ3NzI4YTNmZWEyL3RhYmxlcmFuZ2U6ZDkwZTk4MjU0YjY2NDQ4YWJjN2RiNDc3MjhhM2ZlYTJfMzQtMTEtMS0xLTEzNTAz_f06d237f-c04c-4f9f-9289-8f0464087135"
      unitRef="usd">35628000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNC0xLTEtMS0xMzUwMw_c874dab7-4d07-48bb-9019-62a4ac6e44bf"
      unitRef="usd">4536000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNC0zLTEtMS0xMzUwMw_79e0ea68-fbfe-4b41-ad93-51b87e4315fb"
      unitRef="usd">7987000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNi0xLTEtMS0xMzUwMw_ff4b5f26-7a6f-4965-8a91-0921c7b70a80"
      unitRef="usd">2443000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNi0zLTEtMS0xMzUwMw_0d0957f5-5557-4062-8b66-6074f4f93de5"
      unitRef="usd">2643000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfOC0xLTEtMS0xMzUwMw_838dbfcc-fccd-400b-8898-42e337b46c01"
      unitRef="usd">1362000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfOC0zLTEtMS0xMzUwMw_c1ca2bcc-41ae-4386-b05e-2cc612dc945c"
      unitRef="usd">2115000</us-gaap:ShareBasedCompensation>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfOS0xLTEtMS0xMzUwMw_16016652-bd52-441b-b0fd-59d68dacdce1"
      unitRef="usd">1228000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfOS0zLTEtMS0xMzUwMw_8e530893-557b-4f05-ace8-1ecbe71116fd"
      unitRef="usd">2216000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMTQtMS0xLTEtMTM1MDM_55883a90-3dbe-451b-84a6-e58d72869c72"
      unitRef="usd">131000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMTQtMy0xLTEtMTM1MDM_8b33f270-5716-4895-84df-d7c20978383d"
      unitRef="usd">341000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMTYtMS0xLTEtMTM1MDM_4b8662a3-fac5-4de0-b026-13801da269a4"
      unitRef="usd">-53000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMTYtMy0xLTEtMTM1MDM_7c7a90a5-f2c5-439b-851a-a3ca760e3e76"
      unitRef="usd">657000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMTctMS0xLTEtMTM1MDM_d76c9ee2-99b6-4275-883a-e9d4874f0456"
      unitRef="usd">-234000</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMTctMy0xLTEtMTM1MDM_7c4fc61b-dcf4-47be-90c0-6d73417c6e2e"
      unitRef="usd">762000</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMTgtMS0xLTEtMTM1MDM_91564866-402c-4108-adb1-d5e903266445"
      unitRef="usd">441000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMTgtMy0xLTEtMTM1MDM_777cd4b5-1970-40b2-a61e-0455528c8ee8"
      unitRef="usd">791000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMTktMS0xLTEtMTM1MDM_aea89416-9ba8-4b97-b6dc-9448202a7b6f"
      unitRef="usd">2648000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMTktMy0xLTEtMTM1MDM_3069c9ec-ed4e-4b82-974e-a7a796552e77"
      unitRef="usd">518000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMjAtMS0xLTEtMTM1MDM_ff6336e0-6f2f-4c43-8fea-6790eefa4bfb"
      unitRef="usd">-141000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMjAtMy0xLTEtMTM1MDM_2d282bc1-74ff-4df0-af53-7ba3b62fe1dd"
      unitRef="usd">-71000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMjEtMS0xLTEtMTM1MDM_0dda037a-0fe8-4f5e-ae4d-812c59df3854"
      unitRef="usd">-170000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMjEtMy0xLTEtMTM1MDM_f7b4ca6c-109a-45b6-b79e-26bc7c6ba470"
      unitRef="usd">1636000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMjItMS0xLTEtMTM1MDM_1b011e67-de86-410c-bba5-69a53eb70147"
      unitRef="usd">-752000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMjItMy0xLTEtMTM1MDM_13f23f69-1772-496f-879b-c502dfa0716b"
      unitRef="usd">-426000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMjMtMS0xLTEtMTM1MDM_df3fffa9-bd31-4350-931f-040134832083"
      unitRef="usd">-874000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMjMtMy0xLTEtMTM1MDM_b82fdfbd-fb6d-4e55-88ac-6ea518bf6c4e"
      unitRef="usd">-4020000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <lfvn:IncreaseDecreaseInLeaseLiabilities
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMjQtMS0xLTEtMTM1MDM_a0759654-9f4a-4227-be03-716ab88b7f93"
      unitRef="usd">-89000</lfvn:IncreaseDecreaseInLeaseLiabilities>
    <lfvn:IncreaseDecreaseInLeaseLiabilities
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMjQtMy0xLTEtMTM1MDM_d0157bc7-d51f-4e91-9458-16d07a602dcf"
      unitRef="usd">-1961000</lfvn:IncreaseDecreaseInLeaseLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMjUtMS0xLTEtMTM1MDM_524904ca-b128-49a1-b382-6ed463cb765b"
      unitRef="usd">25000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMjUtMy0xLTEtMTM1MDM_0099bef1-6161-47b6-9fe2-3c782fdc6fa8"
      unitRef="usd">25000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMjYtMS0xLTEtMTM1MDM_637fc648-02b2-47f4-90d7-bd90ec4aad69"
      unitRef="usd">5179000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMjYtMy0xLTEtMTM1MDM_fc1a52ba-1913-4ceb-9cda-1560f58c1042"
      unitRef="usd">7899000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMzEtMS0xLTEtMTM1MDM_2d998907-b511-4780-990d-f78aef0eda13"
      unitRef="usd">1264000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMzEtMy0xLTEtMTM1MDM_1e18c324-e163-4e12-ab01-90336c8622e6"
      unitRef="usd">3261000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMzItMS0xLTEtMTM1MDM_77d4a1bd-98d8-4b26-b15e-a95ba15cb665"
      unitRef="usd">-1264000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMzItMy0xLTEtMTM1MDM_5cd314e9-94f5-424d-ba32-c6f1f389ec96"
      unitRef="usd">-3261000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMzctMS0xLTEtMTM1MDM_3add35c3-fed0-423c-bf93-937818c3734c"
      unitRef="usd">8374000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMzctMy0xLTEtMTM1MDM_d9150ee0-eb88-4f95-b851-f794f1b16557"
      unitRef="usd">8000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMzktMS0xLTEtMTM1MDM_8b6e7ead-b079-46ab-a887-fdf01b2227ec"
      unitRef="usd">201000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfMzktMy0xLTEtMTM1MDM_a83fdb25-faea-448e-93d1-fff665bb5f0b"
      unitRef="usd">1298000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <lfvn:ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDAtMS0xLTEtMTM1MDM_b965fb93-ded3-4b43-9f51-8d0140660b48"
      unitRef="usd">372000</lfvn:ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan>
    <lfvn:ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDAtMy0xLTEtMTM1MDM_0fc67358-5c1e-4ef6-8331-d5e87f58356d"
      unitRef="usd">517000</lfvn:ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDEtMS0xLTEtMTM1MDM_ae8914b9-3fb5-450d-8df9-ff8aac4827f0"
      unitRef="usd">133000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDEtMy0xLTEtMTM1MDM_1526332c-7419-474a-8ec3-5164de09c229"
      unitRef="usd">1004000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDItMS0xLTEtMTM1MDM_e41070c2-e031-4581-bbac-a8937b1501c8"
      unitRef="usd">-8070000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDItMy0xLTEtMTM1MDM_c6db5d2e-55e4-4064-8bf7-4e36291babd2"
      unitRef="usd">-7777000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDMtMS0xLTEtMTM1MDM_a7c17858-e296-4fb9-a71e-4b130ef1b9c8"
      unitRef="usd">-1223000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDMtMy0xLTEtMTM1MDM_ce5d6e09-4ea3-4d3a-a97d-135549e0ef39"
      unitRef="usd">-44000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDQtMS0xLTEtMTM1MDM_70cd3eaa-71fa-435d-a746-36a8fd2ddd30"
      unitRef="usd">-5378000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDQtMy0xLTEtMTM1MDM_e984eafc-01c8-43a8-b115-605fa2e5b2b0"
      unitRef="usd">-3183000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDUtMS0xLTEtMTM1MDM_699250ea-7ddc-459a-a216-0a977b3a9c02"
      unitRef="usd">23174000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i68b782cee24b481ab1a20bb3a92aad68_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDUtMy0xLTEtMTM1MDM_e8844eb0-2f44-42ae-a24e-2d443526fafa"
      unitRef="usd">22138000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDYtMS0xLTEtMTM1MDM_1cbda9a7-ead5-4642-9fbb-9d150af56cb6"
      unitRef="usd">17796000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i486872c51e4640dab4cf26f789788bba_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDYtMy0xLTEtMTM1MDM_b0a5e099-a98b-42fd-8afc-761090e21f7b"
      unitRef="usd">18955000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <lfvn:IncreaseDecreaseInPropertyAndEquipmentAndLeaseLiabilitiesFromLeaseIncentives
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDgtMS0xLTEtMTM1MDM_bb4167cd-58ed-4fe7-837d-519fb0989ab4"
      unitRef="usd">0</lfvn:IncreaseDecreaseInPropertyAndEquipmentAndLeaseLiabilitiesFromLeaseIncentives>
    <lfvn:IncreaseDecreaseInPropertyAndEquipmentAndLeaseLiabilitiesFromLeaseIncentives
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNDgtMy0xLTEtMTM1MDM_74f02faa-98b5-480a-85f9-6116b5a621f6"
      unitRef="usd">3543000</lfvn:IncreaseDecreaseInPropertyAndEquipmentAndLeaseLiabilitiesFromLeaseIncentives>
    <us-gaap:InterestPaidNet
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNTEtMS0xLTEtMTM1MDM_13367f92-e5b6-4dec-b47c-488bfb927031"
      unitRef="usd">10000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNTEtMy0xLTEtMTM1MDM_446a093d-6758-416a-8fbf-ee5a326f3421"
      unitRef="usd">17000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNTItMS0xLTEtMTM1MDM_fd2ca928-6db6-4e71-b94f-0ee90b1e3ca3"
      unitRef="usd">2554000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zMS9mcmFnOmVmZWVkNWI3MmI4ZTRmYzk4ODFmMzVmZWNmN2RkNDQzL3RhYmxlOjZlOTA2OTc0NDcxNzRiOWZiYzc4ZDkwNmY4OTI5YmIzL3RhYmxlcmFuZ2U6NmU5MDY5NzQ0NzE3NGI5ZmJjNzhkOTA2Zjg5MjliYjNfNTItMy0xLTEtMTM1MDM_e8d9c4da-36e6-4ec3-859b-d53ee980f7bb"
      unitRef="usd">3331000</us-gaap:IncomeTaxesPaid>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF8zNy9mcmFnOmMzYmEwNGJiYTMwNDRjMWQ5YjBjMjAyODkxZjRmNzIwL3RleHRyZWdpb246YzNiYTA0YmJhMzA0NGMxZDliMGMyMDI4OTFmNGY3MjBfMjgwNQ_f6cbb63d-ac8b-460b-ab7d-71507418a0bf">Organization and Basis of Presentation&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:23.4pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;LifeVantage Corporation is a company focused on nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company is dedicated to helping people achieve their health, wellness and financial goals. The Company provides quality, scientifically-validated products to customers and independent distributors as well as a financially rewarding commission-based direct sales opportunity to its independent distributors. LifeVantage sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The Company also sells its products in a number of countries to customers for personal consumption only. In addition, the Company sells its products in China through a China approved cross-border e-commerce business model. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:23.4pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath &amp;amp; body, and targeted relief products. The Company&#x2019;s line of scientifically-validated dietary supplements includes its flagship Protandim&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; family of products, LifeVantage&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Omega+&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, ProBio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, IC Bright&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, and Daily Wellness&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; dietary supplements. TrueScience&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; is the Company's line of skin, hair, bath &amp;amp; body, and targeted relief products. The Company also markets and sells Petandim&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, its companion pet supplement formulated to combat oxidative stress in dogs, Axio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; its nootropic energy drink mixes, and PhysIQ&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, its smart weight management system.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements included herein have been prepared by the Company&#x2019;s management, without audit, pursuant to the rules and regulations of the SEC. In the opinion of the Company&#x2019;s management, these interim financial statements include all adjustments that are considered necessary for a fair presentation of its financial position as of March&#160;31, 2022, and the results of operations for the three and nine months ended March&#160;31, 2022 and 2021, and the cash flows for the nine months ended March&#160;31, 2022 and 2021. Interim results are not necessarily indicative of results for a full year or for any future period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements and notes included herein are presented as required by Form 10-Q, and do not contain certain information included in the Company&#x2019;s audited financial statements and notes for the fiscal year ended June&#160;30, 2021, pursuant to the rules and regulations of the SEC. For further information, refer to the financial statements and notes thereto as of and for the year ended June&#160;30, 2021, and included in the annual report on Form 10-K on file with the SEC.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTgwMTA_e014f797-276b-41e2-9cd2-8b012f997dc6">Summary of Significant Accounting Policies&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company prepares the condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (GAAP). In preparing these statements, the Company is required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, the Company reviews its estimates, including, but not limited to, those related to inventory valuation and obsolescence, sales returns, income taxes and tax valuation reserves, transfer pricing methodology and positions, impairment of assets, share-based compensation, and loss contingencies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A portion of the Company&#x2019;s business operations occurs outside the United States.&#160;The local currency of each of the Company&#x2019;s subsidiaries is generally its functional currency.&#160;All assets and liabilities are translated into U.S. dollars at exchange rates existing at the balance sheet dates, revenue and expenses are translated at weighted-average exchange rates and stockholders&#x2019; equity is recorded at historical exchange rates.&#160;The resulting foreign currency translation adjustments are recorded &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;as a separate component of stockholders&#x2019; equity in the condensed consolidated balance sheets and as a component of com&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;prehensive income. Transaction gains and losses are included in other expense, net in the condensed consolidated statements of operations and comprehensive income. For the three months ended March 31, 2022 and 2021, net foreign currency losses of $0.1 million and $0.3 million, respectively, are recorded in other expense, net. For the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nine months ended March 31, 2022&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and 2021, net foreign currency losses of $0.4 million and $0.2 million, respectively, are recorded in other expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Derivative Instruments and Hedging Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's subsidiaries enter into transactions with each other which may not be denominated in the respective subsidiaries' functional currencies. The Company seeks to reduce its exposure to fluctuations in foreign exchange rates through the use of derivatives. The Company does not use such derivative financial instruments for trading or speculative purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To hedge risks associated with the foreign-currency-denominated intercompany transactions, the Company entered into forward foreign exchange contracts which were all settled by the end of December 2021 and were not designated for hedge accounting. There were no realized gains or losses for three months ended March 31, 2022. For the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three months ended March 31, 2021&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; realized losses of $26,000 related to forward contracts, are recorded in other expense, net. For the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nine months ended March 31, 2022&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and 2021, realized losses of $0.1 million and $0.4 million, respectively, related to forward contracts, are recorded in other expense, net. The Company did not hold any derivative instruments at March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers only its monetary liquid assets with original maturities of three months or less as cash and cash equivalents.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounting guidance for financial instruments requires disclosure of significant concentrations of credit risk regardless of the degree of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;such risk. Financial instruments with significant credit risk include cash and investments. At March&#160;31, 2022, the Company had $11.7 million in cash accounts at one financial institution and $6.1 million in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;accounts at other financial institutions.  At June&#160;30, 2021, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Company had $17.2&#160;million in cash accounts at one financial institution and $6.0 million in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;accounts at other financial institutions. As of March&#160;31, 2022 and June&#160;30, 2021, and during the periods then ended, the Company&#x2019;s cash balances exceeded federally insured limits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s accounts receivable as of March&#160;31, 2022 and June&#160;30, 2021 consist primarily of credit card receivables. Based on the Company&#x2019;s verification process for customer credit cards and historical information available, management has determined that an allowance for doubtful accounts on credit card sales related to its customer sales as of March&#160;31, 2022 and June&#160;30, 2021 is not necessary. No bad debt expense was recorded during the three and nine months ended March&#160;31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; As of March&#160;31, 2022 and June&#160;30, 2021, inventory consisted of (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.778%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are carried at the lower of cost or net realizable value, using the first-in, first-out method, which includes a reduction in inventory values &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of $1.0 million &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and $0.5 million at March 31, 2022 and June&#160;30, 2021, respectively, related to obsolete and slow-moving inventory.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for assets and liabilities using a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company's market assumptions. These two types of inputs have created the fair-value hierarchy below. This hierarchy requires the Company to minimize the use of unobservable inputs and to use observable market data, if available, when determining fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1&#x2014;Quoted prices for identical instruments in active markets; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2&#x2014;Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3&#x2014;Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity securities held by the Company are measured at fair value on a nonrecurring basis; that is, the assets are not measured at fair value on an ongoing basis, but are subject to fair value adjustments using fair value measurements with unobservable inputs (level 3), in certain circumstances (e.g., when there is evidence of impairment).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized when control of the promised goods or services are transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Sales, value-added, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generates the majority of its revenue through product sales to customers. These products include the Protandim&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;line of dietary supplements, LifeVantage&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Omega+&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, ProBio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, IC Bright&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and Daily Wellness&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; dietary supplements, TrueScience&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; skin, hair, bath &amp;amp; body and targeted relief, Petandim&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Axio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;nootropic energy drink mixes, and the PhysIQ&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;smart weight management system. The Company ships most of its product directly to the consumer and receives substantially all payment for product sales in the form of credit card receipts. Revenue from direct product sales to customers is recognized upon shipment, which is when passage of title and risk of loss occurs. For items sold in packs and bundles, the Company determines the standalone selling price at contract inception for each distinct good, and then allocates the transaction price on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Shipping and handling revenue is recognized upon shipment when the performance obligation is completed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also charges independent distributors to attend certain events that it holds. Tickets to events are sold as standalone items or included within packs. For event tickets sold in packs, the Company allocates a portion of the transaction price to the ticket on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Fee revenue associated with ticket sales is recorded in the month that the event is held, which is when the Company has performed its obligations under the contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated returns are recorded when product is shipped. Subject to some exceptions based on local regulations, the Company&#x2019;s return policy is to provide a full refund for product returned within 30 days. After 30 days of purchase, only unopened product that is in a resalable and restockable condition may be returned within twelve months of purchase and shall receive a 100% refund, less a 10% handling and restocking fee and any shipping and handling costs. The Company establishes a refund liability reserve, and an asset reserve for its right to recover products, based on historical experience. The returns asset reserve and returns liability reserve are evaluated on a quarterly basis. As of&#160;March&#160;31, 2022 and June&#160;30, 2021, the returns liability reserve, net was &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$0.1 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and $0.2 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Shipping and Handling&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shipping and handling costs associated with inbound freight and freight out to customers and independent distributors are included in cost of sales. Shipping and handling fees charged to customers and independent distributors are included in revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Research and Development Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company expenses all costs related to research and development activities, as incurred. Research and development expens&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;es for the three months ended March 31, 2022 and 2021 were $0.1 million and $0.2 million, respectively. Research and development expenses for the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nine months ended March 31, 2022&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and 2021 were $0.6 million and $0.6 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for leases in accordance with Accounting Standards Codification ("ASC") 842. The Company reviews all contracts and determines if the arrangement is or contains a lease, at inception. Operating leases are included in right-of-use (&#x201c;ROU&#x201d;) assets, current lease liabilities and long-term lease liabilities on the condensed consolidated balance sheets. The Company does not have any finance leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease ROU assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Company uses its estimated incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. The operating lease ROU asset also includes any upfront lease payments made and excludes lease incentives and initial direct costs incurred. The Company&#x2019;s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Leases with a term of 12 months or less are not recorded on the balance sheet. The Company&#x2019;s lease agreements do not contain any residual value guarantees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The pandemic caused by coronavirus (&#x201c;COVID-19&#x201d;) has resulted in disruptions which had forced the Company's corporate workforce to a remote working environment.  On September 1, 2020, the Company abandoned the ROU asset related to the Corporate office lease in Sandy, Utah, as this lease terminated in February 2021.  A new Corporate office was opened in Lehi, Utah in January 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the abandonment of the Sandy, Utah office, operating lease expenses related to the ROU asset, along with the remaining leasehold assets in the office, have been reduced to their salvage values, which the Company has determined to be zero.  The total expense related to the abandonment of the ROU asset for the nine months ended March 31, 2021 was $0.8&#160;million and is included in selling, general, and administrative expenses.  There is no remaining lease liability for the Sandy, Utah office at March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes stock-based compensation by measuring the cost of services to be rendered based on the grant date fair value of the equity award. The Company recognizes stock-based compensation, net of any estimated forfeitures, over the period an employee is required to provide service in exchange for the award, generally referred to as the requisite service period. For awards with market-based performance conditions, the cost of the awards is recognized as the requisite service is rendered by employees, regardless of when, if ever, the market-based performance conditions are satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Black-Scholes option pricing model is used to estimate the fair value of stock options and options under the Company's 2019 Employee Stock Purchase Plan. The determination of the fair value of options is affected by the Company's stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends. The Company uses historical data for estimating the expected volatility and expected life of stock options required in the Black-Scholes model. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected terms of the stock options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of restricted stock grants is based on the closing market price of the Company's stock on the date of grant less the Company's expected dividend yield. The fair value of performance restricted stock units that include market-based performance conditions is based on the closing market price of the Company's stock on the date of grant less the Company's expected dividend yield, with further adjustments made to reflect the market conditions that must be satisfied in order for the units to vest by using a Monte-Carlo simulation model. Key assumptions for the Monte-Carlo simulation model include the risk-free rate, expected volatility, expected dividends and the correlation coefficient. The fair value of cash-settled performance-based awards, accounted for as liabilities, is remeasured at the end of each reporting period and is based on the closing market price of the Company&#x2019;s stock on the last day of the reporting period. The Company recognizes compensation costs for awards with performance conditions when it concludes it is probable that the performance conditions will be achieved. The Company reassesses the probability of vesting at each balance sheet date and adjusts compensation costs accordingly.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled, updated as needed for changes in corporate tax rates. The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the effective date of the change. The Company recognizes tax liabilities or benefits from an uncertain position only if it is more likely than not that the position will be sust&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ained upon examination by taxing authorities based on the technical merits of the issue. The amount recognized would be the largest liability or benefit that the Company believes has greater than a 50% likelihood of being realized upon settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the nine months ended March 31, 2022 and 2021, the Company recognized income tax expense of $1.1 million and $2.8 million, respectively, which is reflective of the Company&#x2019;s current estimated federal, state and foreign effective tax rate. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Realization of deferred tax assets is dependent upon future earnings in specific tax jurisdictions, the timing and amount of which are uncertain.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic income per common share is computed by dividing the net income by the weighted-average number of common shares outstanding during the period, less unvested restricted stock awards. Diluted income per common share is computed by dividing net income by the weighted-average common shares and potentially dilutive common share equivalents using the treasury stock method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March 31, 2022 and 2021, the effects of approximately 0.1 million and 0.1 million common shares, respectively, issuable upon exercise of options and non-vested shares of restricted stock are not included in computations as their effect was anti-dilutive. For the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nine months ended March 31, 2022&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and 2021, the effects of approximately 0.2 million and 0.1 million common shares, respectively, issuable upon exercise of options and non-vested shares of restricted stock are not included in computations as their effect was anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of net income per share and the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share (in thousands, except per share amounts):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards and options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share, basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share, diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Segment Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in a single operating segment by selling products directly to customers and through an international network of independent distributors that operates in an integrated manner from market to market.&#160;Commissions and incentives expenses are the Company&#x2019;s largest expense comprised of the commissions paid to its independent distributors.&#160;The Company manages its business primarily by managing its international network of independent distributors.&#160;The Company disaggregates revenue in two&#160;geographic regions: the Americas region and the Asia/Pacific &amp;amp; Europe region.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company's revenue disaggregated by these two geographic regions (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia/Pacific &amp;amp; Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additional information as to the Company&#x2019;s revenue from operations in the most significant geographical areas is set forth below (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company's long-lived assets for its most significant geographic markets (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc5Njc_138ff20c-4a34-4593-a349-ac462f38a9d9">ConsolidationThe condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTgwMzE_785168c8-7711-4e80-865a-a2db1cf0d2dd">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company prepares the condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (GAAP). In preparing these statements, the Company is required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, the Company reviews its estimates, including, but not limited to, those related to inventory valuation and obsolescence, sales returns, income taxes and tax valuation reserves, transfer pricing methodology and positions, impairment of assets, share-based compensation, and loss contingencies.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTgwMzI_7651221e-60d2-422c-9681-445b24b70f02">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A portion of the Company&#x2019;s business operations occurs outside the United States.&#160;The local currency of each of the Company&#x2019;s subsidiaries is generally its functional currency.&#160;All assets and liabilities are translated into U.S. dollars at exchange rates existing at the balance sheet dates, revenue and expenses are translated at weighted-average exchange rates and stockholders&#x2019; equity is recorded at historical exchange rates.&#160;The resulting foreign currency translation adjustments are recorded &lt;/span&gt;&lt;/div&gt;as a separate component of stockholders&#x2019; equity in the condensed consolidated balance sheets and as a component of comprehensive income. Transaction gains and losses are included in other expense, net in the condensed consolidated statements of operations and comprehensive income.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMjA1Ng_ec8b1ffa-d44b-434a-b79f-9e605c600ffe"
      unitRef="usd">-100000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMjA3Mg_60da6b7a-1d94-44db-a28e-990b39880afc"
      unitRef="usd">-300000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMjE3Ng_0e1ba0dc-6c6c-4557-905d-ca67cc7e282e"
      unitRef="usd">-400000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMjE5Mg_b76390cc-28ac-4081-873b-4eb131e730a5"
      unitRef="usd">-200000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc5MzI_79699ad5-debf-4654-811f-bdb2901f31f8">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Derivative Instruments and Hedging Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's subsidiaries enter into transactions with each other which may not be denominated in the respective subsidiaries' functional currencies. The Company seeks to reduce its exposure to fluctuations in foreign exchange rates through the use of derivatives. The Company does not use such derivative financial instruments for trading or speculative purposes.&lt;/span&gt;&lt;/div&gt;To hedge risks associated with the foreign-currency-denominated intercompany transactions, the Company entered into forward foreign exchange contracts which were all settled by the end of December 2021 and were not designated for hedge accounting.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMjk0MA_53421447-4300-4e2d-ba6c-653c2505b374"
      unitRef="usd">-26000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMjk0MA_b046d7c4-ec8f-4db7-b005-5e9982d11472"
      unitRef="usd">-26000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMzA2Mg_690b7d63-80c4-4729-8059-2efabb29851b"
      unitRef="usd">-100000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMzA2OQ_7e02f794-fa50-4a8a-9bfc-3d5d8fc6fd71"
      unitRef="usd">-400000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc5ODU_f46bb111-7e4c-4e4f-9f84-773358aa9471">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers only its monetary liquid assets with original maturities of three months or less as cash and cash equivalents.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTgwMDI_426827ac-3195-41e7-97e7-6b70a5274d7b">Concentration of Credit RiskAccounting guidance for financial instruments requires disclosure of significant concentrations of credit risk regardless of the degree of such risk. Financial instruments with significant credit risk include cash and investments.</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure
      contextRef="i02d0d983f156475da80d891080400c71_D20220331-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMzY1NA_a9cb04a8-2fdd-4a72-a0f0-a67ccfed461f"
      unitRef="usd">11700000</us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure>
    <us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure
      contextRef="i8461345d4fc14a97aef4e829e0775dcc_D20220331-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMzcwNw_a326537c-61ac-4926-bce6-ccdf1e5c3a16"
      unitRef="usd">6100000</us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure>
    <us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure
      contextRef="i182b6ab241c640bfa92b9b402ecbe30b_D20210630-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMzc3OQ_85cfccb9-b5aa-469d-81f0-42ab0b203552"
      unitRef="usd">17200000</us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure>
    <us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure
      contextRef="i7a84972552ec4e43882535e243362870_D20210630-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMzgzMg_6a8826a4-1338-40b4-8fdd-1d206ec0b530"
      unitRef="usd">6000000</us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc5MzU_17157063-55c0-462f-bc37-7666ad73d046">Accounts ReceivableThe Company&#x2019;s accounts receivable as of March&#160;31, 2022 and June&#160;30, 2021 consist primarily of credit card receivables. Based on the Company&#x2019;s verification process for customer credit cards and historical information available, management has determined that an allowance for doubtful accounts on credit card sales related to its customer sales as of March&#160;31, 2022 and June&#160;30, 2021 is not necessary.</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfNDM3MA_1c873658-3d49-48d1-b5db-105e9349aeef"
      unitRef="usd">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfNDM3MA_1e83a9a4-5cf8-46c8-9a03-b7179d5de550"
      unitRef="usd">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfNDM3MA_bda685cf-d39d-4df8-8f1b-ca3a685c71d3"
      unitRef="usd">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfNDM3MA_fe56c8bb-30e5-4ecb-b55d-a80a7ef12ed5"
      unitRef="usd">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTgwMjM_780477e8-de91-45b6-a28d-c1112d9929d0">As of March&#160;31, 2022 and June&#160;30, 2021, inventory consisted of (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.778%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjAyYWRlYzUzODc0MTQxMzU4MmZkOGNiYTVmNTQ1NTY5L3RhYmxlcmFuZ2U6MDJhZGVjNTM4NzQxNDEzNTgyZmQ4Y2JhNWY1NDU1NjlfMS0xLTEtMS0xMzUwMw_71703a92-56d3-4c2a-b806-071d177d236c"
      unitRef="usd">12348000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <lfvn:InventoryFinishedGoodsPercentOfTotalInventory
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjAyYWRlYzUzODc0MTQxMzU4MmZkOGNiYTVmNTQ1NTY5L3RhYmxlcmFuZ2U6MDJhZGVjNTM4NzQxNDEzNTgyZmQ4Y2JhNWY1NDU1NjlfMS0zLTEtMS0xMzUwMw_36b016b8-aa54-4589-91a3-7171908a639c"
      unitRef="number">0.759</lfvn:InventoryFinishedGoodsPercentOfTotalInventory>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjAyYWRlYzUzODc0MTQxMzU4MmZkOGNiYTVmNTQ1NTY5L3RhYmxlcmFuZ2U6MDJhZGVjNTM4NzQxNDEzNTgyZmQ4Y2JhNWY1NDU1NjlfMS01LTEtMS0xMzUwMw_11d623a3-7d83-44d0-ad49-cc32f11e7118"
      unitRef="usd">12225000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <lfvn:InventoryFinishedGoodsPercentOfTotalInventory
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjAyYWRlYzUzODc0MTQxMzU4MmZkOGNiYTVmNTQ1NTY5L3RhYmxlcmFuZ2U6MDJhZGVjNTM4NzQxNDEzNTgyZmQ4Y2JhNWY1NDU1NjlfMS03LTEtMS0xMzUwMw_883a67db-9633-4ee8-99c5-f9cb913ef5a9"
      unitRef="number">0.757</lfvn:InventoryFinishedGoodsPercentOfTotalInventory>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjAyYWRlYzUzODc0MTQxMzU4MmZkOGNiYTVmNTQ1NTY5L3RhYmxlcmFuZ2U6MDJhZGVjNTM4NzQxNDEzNTgyZmQ4Y2JhNWY1NDU1NjlfMi0xLTEtMS0xMzUwMw_8cc204f4-90ed-49e9-a559-9d172dc3bd5a"
      unitRef="usd">3928000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <lfvn:RawMaterialsPercentOfTotalInventory
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjAyYWRlYzUzODc0MTQxMzU4MmZkOGNiYTVmNTQ1NTY5L3RhYmxlcmFuZ2U6MDJhZGVjNTM4NzQxNDEzNTgyZmQ4Y2JhNWY1NDU1NjlfMi0zLTEtMS0xMzUwMw_98e425e5-62d7-408c-b007-434c0235b39f"
      unitRef="number">0.241</lfvn:RawMaterialsPercentOfTotalInventory>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjAyYWRlYzUzODc0MTQxMzU4MmZkOGNiYTVmNTQ1NTY5L3RhYmxlcmFuZ2U6MDJhZGVjNTM4NzQxNDEzNTgyZmQ4Y2JhNWY1NDU1NjlfMi01LTEtMS0xMzUwMw_83048141-fe22-4bcd-abab-f14c7f204684"
      unitRef="usd">3920000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <lfvn:RawMaterialsPercentOfTotalInventory
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjAyYWRlYzUzODc0MTQxMzU4MmZkOGNiYTVmNTQ1NTY5L3RhYmxlcmFuZ2U6MDJhZGVjNTM4NzQxNDEzNTgyZmQ4Y2JhNWY1NDU1NjlfMi03LTEtMS0xMzUwMw_7d34bb02-384c-41aa-8b59-416cf374b77d"
      unitRef="number">0.243</lfvn:RawMaterialsPercentOfTotalInventory>
    <us-gaap:InventoryNet
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjAyYWRlYzUzODc0MTQxMzU4MmZkOGNiYTVmNTQ1NTY5L3RhYmxlcmFuZ2U6MDJhZGVjNTM4NzQxNDEzNTgyZmQ4Y2JhNWY1NDU1NjlfMy0xLTEtMS0xMzUwMw_14efac3b-01d0-45af-a211-f146faff3834"
      unitRef="usd">16276000</us-gaap:InventoryNet>
    <lfvn:InventoryPercentOfTotalInventory
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjAyYWRlYzUzODc0MTQxMzU4MmZkOGNiYTVmNTQ1NTY5L3RhYmxlcmFuZ2U6MDJhZGVjNTM4NzQxNDEzNTgyZmQ4Y2JhNWY1NDU1NjlfMy0zLTEtMS0xMzUwMw_a52bbfd5-8a1b-4c25-84a1-219f5fa5e85f"
      unitRef="number">1.000</lfvn:InventoryPercentOfTotalInventory>
    <us-gaap:InventoryNet
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjAyYWRlYzUzODc0MTQxMzU4MmZkOGNiYTVmNTQ1NTY5L3RhYmxlcmFuZ2U6MDJhZGVjNTM4NzQxNDEzNTgyZmQ4Y2JhNWY1NDU1NjlfMy01LTEtMS0xMzUwMw_87b0d00a-00ac-4d7c-840c-894a2f67f273"
      unitRef="usd">16145000</us-gaap:InventoryNet>
    <lfvn:InventoryPercentOfTotalInventory
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjAyYWRlYzUzODc0MTQxMzU4MmZkOGNiYTVmNTQ1NTY5L3RhYmxlcmFuZ2U6MDJhZGVjNTM4NzQxNDEzNTgyZmQ4Y2JhNWY1NDU1NjlfMy03LTEtMS0xMzUwMw_c5ab0247-089c-4986-b56c-b3232211b137"
      unitRef="number">1.000</lfvn:InventoryPercentOfTotalInventory>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc5ODk_a81d50b3-61e4-42fb-adb1-edebfeaa1592">Inventories are carried at the lower of cost or net realizable value, using the first-in, first-out method</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:InventoryValuationReserves
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfNDY1NA_cac95477-ee35-4b5d-ad86-1d5331ebcffb"
      unitRef="usd">1000000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfNDY2MQ_35cf16a1-8100-468d-9c3e-68219ba9427d"
      unitRef="usd">500000</us-gaap:InventoryValuationReserves>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc5OTY_92e5a0a2-9735-4411-9ce1-2e87d6682774">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for assets and liabilities using a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company's market assumptions. These two types of inputs have created the fair-value hierarchy below. This hierarchy requires the Company to minimize the use of unobservable inputs and to use observable market data, if available, when determining fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1&#x2014;Quoted prices for identical instruments in active markets; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2&#x2014;Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3&#x2014;Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity securities held by the Company are measured at fair value on a nonrecurring basis; that is, the assets are not measured at fair value on an ongoing basis, but are subject to fair value adjustments using fair value measurements with unobservable inputs (level 3), in certain circumstances (e.g., when there is evidence of impairment).&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc5Mzc_d5369263-b1d0-4f62-bf30-3c9b7d63a7d4">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized when control of the promised goods or services are transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Sales, value-added, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generates the majority of its revenue through product sales to customers. These products include the Protandim&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;line of dietary supplements, LifeVantage&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Omega+&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, ProBio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, IC Bright&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and Daily Wellness&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; dietary supplements, TrueScience&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; skin, hair, bath &amp;amp; body and targeted relief, Petandim&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Axio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;nootropic energy drink mixes, and the PhysIQ&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;smart weight management system. The Company ships most of its product directly to the consumer and receives substantially all payment for product sales in the form of credit card receipts. Revenue from direct product sales to customers is recognized upon shipment, which is when passage of title and risk of loss occurs. For items sold in packs and bundles, the Company determines the standalone selling price at contract inception for each distinct good, and then allocates the transaction price on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Shipping and handling revenue is recognized upon shipment when the performance obligation is completed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also charges independent distributors to attend certain events that it holds. Tickets to events are sold as standalone items or included within packs. For event tickets sold in packs, the Company allocates a portion of the transaction price to the ticket on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Fee revenue associated with ticket sales is recorded in the month that the event is held, which is when the Company has performed its obligations under the contract.&lt;/span&gt;&lt;/div&gt;Estimated returns are recorded when product is shipped. Subject to some exceptions based on local regulations, the Company&#x2019;s return policy is to provide a full refund for product returned within 30 days. After 30 days of purchase, only unopened product that is in a resalable and restockable condition may be returned within twelve months of purchase and shall receive a 100% refund, less a 10% handling and restocking fee and any shipping and handling costs. The Company establishes a refund liability reserve, and an asset reserve for its right to recover products, based on historical experience. The returns asset reserve and returns liability reserve are evaluated on a quarterly basis.&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Shipping and Handling&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shipping and handling costs associated with inbound freight and freight out to customers and independent distributors are included in cost of sales. Shipping and handling fees charged to customers and independent distributors are included in revenue.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <lfvn:MoneyBackGuaranteePeriod
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfODM2NQ_050210a5-d41b-425a-9f24-3e3cb9849582">P30D</lfvn:MoneyBackGuaranteePeriod>
    <lfvn:HandlingAndRestockingFeePercentage
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfODU1NA_75a278ac-9710-4068-81ed-d732842319a0"
      unitRef="number">0.10</lfvn:HandlingAndRestockingFeePercentage>
    <lfvn:ReturnLiabilityReserve
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfODkxMA_1ff1c518-a6d0-449c-9d3e-d97c0dc84c28"
      unitRef="usd">100000</lfvn:ReturnLiabilityReserve>
    <lfvn:ReturnLiabilityReserve
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfODkxNw_95b9240c-3700-48cf-aba3-44a9f31ce571"
      unitRef="usd">200000</lfvn:ReturnLiabilityReserve>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc5NDY_79835aa1-33ae-47e8-93d1-d87a83087113">Research and Development CostsThe Company expenses all costs related to research and development activities, as incurred.</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfOTM4OA_ff6791cc-87ad-4f51-af9d-70063784d0e6"
      unitRef="usd">100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfOTM5NQ_db21c1bb-7a85-464a-a9b9-f92f28ea5aaa"
      unitRef="usd">200000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfOTQ3MA_59f66eeb-03e0-4896-8424-618762658f7d"
      unitRef="usd">600000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfOTQ3Nw_19fc8a7e-d9de-4758-8440-2244709093ae"
      unitRef="usd">600000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc5Mjk_b14fa87b-85dd-4bfe-9e26-a42ae48ffa4b">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for leases in accordance with Accounting Standards Codification ("ASC") 842. The Company reviews all contracts and determines if the arrangement is or contains a lease, at inception. Operating leases are included in right-of-use (&#x201c;ROU&#x201d;) assets, current lease liabilities and long-term lease liabilities on the condensed consolidated balance sheets. The Company does not have any finance leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease ROU assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Company uses its estimated incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. The operating lease ROU asset also includes any upfront lease payments made and excludes lease incentives and initial direct costs incurred. The Company&#x2019;s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Leases with a term of 12 months or less are not recorded on the balance sheet. The Company&#x2019;s lease agreements do not contain any residual value guarantees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The pandemic caused by coronavirus (&#x201c;COVID-19&#x201d;) has resulted in disruptions which had forced the Company's corporate workforce to a remote working environment.  On September 1, 2020, the Company abandoned the ROU asset related to the Corporate office lease in Sandy, Utah, as this lease terminated in February 2021.  A new Corporate office was opened in Lehi, Utah in January 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <lfvn:OperatingLeaseRightOfUseAssetSalvageValue
      contextRef="ic645b34a2785482d9664b71bdd91384e_I20200901"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTE2Mjk_90a027fd-17dd-46a8-844f-221b1644b444"
      unitRef="usd">0</lfvn:OperatingLeaseRightOfUseAssetSalvageValue>
    <lfvn:OperatingLeaseRightOfUseAssetAbandonmentExpense
      contextRef="id450c5bdf563442ca02fa3bd0de3267d_D20200701-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTE3MTE_31d28bd2-acd0-46f4-be7b-bed72b336e57"
      unitRef="usd">800000</lfvn:OperatingLeaseRightOfUseAssetAbandonmentExpense>
    <us-gaap:OperatingLeaseLiability
      contextRef="i222bc716cf0a47dd8efde9c5d36eff58_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTE3OTA_a3a7ba68-17b1-4520-8f92-27f6e9f66bed"
      unitRef="usd">0</us-gaap:OperatingLeaseLiability>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc5NDc_f58a5b9d-980d-420b-8fe7-a8494e1ecfb4">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes stock-based compensation by measuring the cost of services to be rendered based on the grant date fair value of the equity award. The Company recognizes stock-based compensation, net of any estimated forfeitures, over the period an employee is required to provide service in exchange for the award, generally referred to as the requisite service period. For awards with market-based performance conditions, the cost of the awards is recognized as the requisite service is rendered by employees, regardless of when, if ever, the market-based performance conditions are satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Black-Scholes option pricing model is used to estimate the fair value of stock options and options under the Company's 2019 Employee Stock Purchase Plan. The determination of the fair value of options is affected by the Company's stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends. The Company uses historical data for estimating the expected volatility and expected life of stock options required in the Black-Scholes model. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected terms of the stock options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of restricted stock grants is based on the closing market price of the Company's stock on the date of grant less the Company's expected dividend yield. The fair value of performance restricted stock units that include market-based performance conditions is based on the closing market price of the Company's stock on the date of grant less the Company's expected dividend yield, with further adjustments made to reflect the market conditions that must be satisfied in order for the units to vest by using a Monte-Carlo simulation model. Key assumptions for the Monte-Carlo simulation model include the risk-free rate, expected volatility, expected dividends and the correlation coefficient. The fair value of cash-settled performance-based awards, accounted for as liabilities, is remeasured at the end of each reporting period and is based on the closing market price of the Company&#x2019;s stock on the last day of the reporting period. The Company recognizes compensation costs for awards with performance conditions when it concludes it is probable that the performance conditions will be achieved. The Company reassesses the probability of vesting at each balance sheet date and adjusts compensation costs accordingly.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc5OTc_c61926df-0d39-480c-b485-1d7595bd3457">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled, updated as needed for changes in corporate tax rates. The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the effective date of the change. The Company recognizes tax liabilities or benefits from an uncertain position only if it is more likely than not that the position will be sust&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ained upon examination by taxing authorities based on the technical merits of the issue. The amount recognized would be the largest liability or benefit that the Company believes has greater than a 50% likelihood of being realized upon settlement.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTU1OTA_e4b3b2d1-fc62-4200-8beb-d26795fe0186"
      unitRef="usd">1100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTU1OTc_2eead5d4-2480-4005-b712-2aa9bf1e3d97"
      unitRef="usd">2800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTgwMTM_718beabd-6419-4fcc-bba2-173b4a4cc2cc">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic income per common share is computed by dividing the net income by the weighted-average number of common shares outstanding during the period, less unvested restricted stock awards. Diluted income per common share is computed by dividing net income by the weighted-average common shares and potentially dilutive common share equivalents using the treasury stock method.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTYzMDM_c89b8b3b-8da7-46e0-89b8-43346fbea7ab"
      unitRef="shares">100000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTYzMTA_c41f4976-190f-467c-b6c3-2d61b4ee8087"
      unitRef="shares">100000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTY1MzQ_555681a6-1ab5-4b27-9d7f-0664022baf79"
      unitRef="shares">200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTY1NDE_9866519d-7eaa-4d58-a66f-5968665b6c82"
      unitRef="shares">100000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTgwMjk_62a43baf-6fee-4c5a-848f-385ef0dd708f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of net income per share and the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share (in thousands, except per share amounts):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards and options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share, basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share, diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfMy0xLTEtMS0xMzUwMw_2ca40150-544c-47cc-bc49-465bb588461e"
      unitRef="usd">1141000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfMy0zLTEtMS0xMzUwMw_ac1a95e6-8279-4543-b06d-d4307b87c98a"
      unitRef="usd">1724000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfMy01LTEtMS0xMzUwMw_7203fa53-7790-45ce-b411-db50b76ff149"
      unitRef="usd">4536000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfMy03LTEtMS0xMzUwMw_dcc25591-bd9d-40d3-840a-acffe05a9e76"
      unitRef="usd">7987000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfNS0xLTEtMS0xMzUwMw_6efff37a-d7a6-4653-9338-a6e950971dfa"
      unitRef="shares">13195000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfNS0zLTEtMS0xMzUwMw_c5c17a49-54fa-4c46-9120-2de1afd2fa5c"
      unitRef="shares">14071000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfNS01LTEtMS0xMzUwMw_5a9fabed-0fe9-496f-b509-b826980e3bf1"
      unitRef="shares">13261000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfNS03LTEtMS0xMzUwMw_8a716704-9804-4acf-9ee5-4a241a25bda6"
      unitRef="shares">14175000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfNy0xLTEtMS0xMzUwMw_0c4ac8f8-037a-40bd-baa9-9a8806b82990"
      unitRef="shares">62000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfNy0zLTEtMS0xMzUwMw_8ae6f3ff-8c60-4c00-bd11-c0b0b6a09a86"
      unitRef="shares">141000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfNy01LTEtMS0xMzUwMw_34af5b98-2a52-4453-974b-da8e9bd87e41"
      unitRef="shares">51000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfNy03LTEtMS0xMzUwMw_7bf12287-cd32-40ee-bfa6-9a8e44e8fdbd"
      unitRef="shares">245000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfOS0xLTEtMS0xMzUwMw_2a82a57b-e1c3-468e-9a93-fd5d2a3790e4"
      unitRef="shares">13257000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfOS0zLTEtMS0xMzUwMw_38db8e73-d17c-4eda-bd00-1a367e7b993c"
      unitRef="shares">14212000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfOS01LTEtMS0xMzUwMw_d116d9fd-b2cd-4af2-87ba-7900221e52d4"
      unitRef="shares">13312000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfOS03LTEtMS0xMzUwMw_d4fe8da8-592d-405d-b6e2-6dd7e9e59ba3"
      unitRef="shares">14420000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfMTAtMS0xLTEtMTM1MDM_c5f4681d-5a16-49ac-9dc0-685c5e5a697c"
      unitRef="usdPerShare">0.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfMTAtMy0xLTEtMTM1MDM_326f7709-906a-45cb-b23a-0e732fb7d88d"
      unitRef="usdPerShare">0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfMTAtNS0xLTEtMTM1MDM_5bb20d81-27ee-4987-a5d4-13db2d4c0eec"
      unitRef="usdPerShare">0.34</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfMTAtNy0xLTEtMTM1MDM_8d9b18fb-5c92-48e5-a10e-06c4070f82fb"
      unitRef="usdPerShare">0.56</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfMTEtMS0xLTEtMTM1MDM_e4fd09b2-21b6-4528-84b1-51a6ba773601"
      unitRef="usdPerShare">0.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfMTEtMy0xLTEtMTM1MDM_db3e0932-42f3-4c4c-b46d-f9b297c8ba3f"
      unitRef="usdPerShare">0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfMTEtNS0xLTEtMTM1MDM_f8117b38-74ed-45f5-91cd-c050d60e06ec"
      unitRef="usdPerShare">0.34</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmU4N2ExYzAzZjFlZTRjMGRhZDFiMDM3ZWFkY2UyZGE4L3RhYmxlcmFuZ2U6ZTg3YTFjMDNmMWVlNGMwZGFkMWIwMzdlYWRjZTJkYThfMTEtNy0xLTEtMTM1MDM_abe39d47-3320-4a36-8bea-8167cce63375"
      unitRef="usdPerShare">0.55</us-gaap:EarningsPerShareDiluted>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc5OTg_d9f92867-93e5-4b1a-94ea-f41543ef115f">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Segment Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in a single operating segment by selling products directly to customers and through an international network of independent distributors that operates in an integrated manner from market to market.&#160;Commissions and incentives expenses are the Company&#x2019;s largest expense comprised of the commissions paid to its independent distributors.&#160;The Company manages its business primarily by managing its international network of independent distributors.&#160;The Company disaggregates revenue in two&#160;geographic regions: the Americas region and the Asia/Pacific &amp;amp; Europe region.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <lfvn:NumberOfGeographicSegments
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc0NTc_4fdfab17-6ed7-4c2d-9d64-7f93bce2bb87"
      unitRef="region">2</lfvn:NumberOfGeographicSegments>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc5Mzg_ab6a5317-8599-4e7d-9238-dcdc94f58ffc">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company's revenue disaggregated by these two geographic regions (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia/Pacific &amp;amp; Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additional information as to the Company&#x2019;s revenue from operations in the most significant geographical areas is set forth below (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <lfvn:NumberOfGeographicSegments
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc2MTI_4fdfab17-6ed7-4c2d-9d64-7f93bce2bb87"
      unitRef="region">2</lfvn:NumberOfGeographicSegments>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id2939647eeae400482eba40fd37747e0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjZjYTY1ZTVmNjQ4OTRmNGJiMmFiNGZlMWVhYWU0NDU0L3RhYmxlcmFuZ2U6NmNhNjVlNWY2NDg5NGY0YmIyYWI0ZmUxZWFhZTQ0NTRfMi0xLTEtMS0xMzUwMw_f0e8e87e-bf30-4f83-9bb5-374f0e4dec17"
      unitRef="usd">33444000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iad789057464b445383e8e237ab794a70_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjZjYTY1ZTVmNjQ4OTRmNGJiMmFiNGZlMWVhYWU0NDU0L3RhYmxlcmFuZ2U6NmNhNjVlNWY2NDg5NGY0YmIyYWI0ZmUxZWFhZTQ0NTRfMi0zLTEtMS0xMzUwMw_a61b459a-f0c5-4c70-af0c-7234a53897a7"
      unitRef="usd">36421000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icf9becab944541f9973e690359ee58d5_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjZjYTY1ZTVmNjQ4OTRmNGJiMmFiNGZlMWVhYWU0NDU0L3RhYmxlcmFuZ2U6NmNhNjVlNWY2NDg5NGY0YmIyYWI0ZmUxZWFhZTQ0NTRfMi01LTEtMS0xMzUwMw_802c7c80-3441-43d9-9e03-934d9146994e"
      unitRef="usd">104600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1e55f2a3f9c54683a2a69cee96783bac_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjZjYTY1ZTVmNjQ4OTRmNGJiMmFiNGZlMWVhYWU0NDU0L3RhYmxlcmFuZ2U6NmNhNjVlNWY2NDg5NGY0YmIyYWI0ZmUxZWFhZTQ0NTRfMi03LTEtMS0xMzUwMw_076cc76a-ee91-430d-9cd2-0149d53ccfa0"
      unitRef="usd">116979000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i59577e105b574a07b1c8625a6eb9c7d1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjZjYTY1ZTVmNjQ4OTRmNGJiMmFiNGZlMWVhYWU0NDU0L3RhYmxlcmFuZ2U6NmNhNjVlNWY2NDg5NGY0YmIyYWI0ZmUxZWFhZTQ0NTRfMy0xLTEtMS0xMzUwMw_39e3c43e-c2db-48cb-86d0-c0e2b3d63fa9"
      unitRef="usd">16560000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieac81516c5ed43b983bf40a00b30e9c1_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjZjYTY1ZTVmNjQ4OTRmNGJiMmFiNGZlMWVhYWU0NDU0L3RhYmxlcmFuZ2U6NmNhNjVlNWY2NDg5NGY0YmIyYWI0ZmUxZWFhZTQ0NTRfMy0zLTEtMS0xMzUwMw_0c766e40-76f9-4b7e-b7f7-6460f293baab"
      unitRef="usd">15149000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i279ae95e5e154fd3ac7b3d02bbe2bba3_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjZjYTY1ZTVmNjQ4OTRmNGJiMmFiNGZlMWVhYWU0NDU0L3RhYmxlcmFuZ2U6NmNhNjVlNWY2NDg5NGY0YmIyYWI0ZmUxZWFhZTQ0NTRfMy01LTEtMS0xMzUwMw_a9afc299-74f5-41d6-9b86-69da36f02181"
      unitRef="usd">50818000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic48a39651d07442f8d571c963b553e9f_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjZjYTY1ZTVmNjQ4OTRmNGJiMmFiNGZlMWVhYWU0NDU0L3RhYmxlcmFuZ2U6NmNhNjVlNWY2NDg5NGY0YmIyYWI0ZmUxZWFhZTQ0NTRfMy03LTEtMS0xMzUwMw_0af4ec31-574a-4760-8fe1-13ed2356c9ba"
      unitRef="usd">48426000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjZjYTY1ZTVmNjQ4OTRmNGJiMmFiNGZlMWVhYWU0NDU0L3RhYmxlcmFuZ2U6NmNhNjVlNWY2NDg5NGY0YmIyYWI0ZmUxZWFhZTQ0NTRfNC0xLTEtMS0xMzUwMw_61ceb578-cc68-453d-ba79-ee7b077897c8"
      unitRef="usd">50004000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjZjYTY1ZTVmNjQ4OTRmNGJiMmFiNGZlMWVhYWU0NDU0L3RhYmxlcmFuZ2U6NmNhNjVlNWY2NDg5NGY0YmIyYWI0ZmUxZWFhZTQ0NTRfNC0zLTEtMS0xMzUwMw_4640b40d-e17b-4a03-897c-e17f968f3ae2"
      unitRef="usd">51570000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjZjYTY1ZTVmNjQ4OTRmNGJiMmFiNGZlMWVhYWU0NDU0L3RhYmxlcmFuZ2U6NmNhNjVlNWY2NDg5NGY0YmIyYWI0ZmUxZWFhZTQ0NTRfNC01LTEtMS0xMzUwMw_8da4145d-174f-49c1-aaf1-0ab50e3f1ff3"
      unitRef="usd">155418000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjZjYTY1ZTVmNjQ4OTRmNGJiMmFiNGZlMWVhYWU0NDU0L3RhYmxlcmFuZ2U6NmNhNjVlNWY2NDg5NGY0YmIyYWI0ZmUxZWFhZTQ0NTRfNC03LTEtMS0xMzUwMw_a364e8a7-8283-4606-9e7f-9dbf3e8ddd61"
      unitRef="usd">165405000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i85f81a6375b645c98c3862ffe7700508_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmM2YTI3Yzk0NDI0MzQ4ZjBiYjExYjhlNzY2ZjQ4MjQ5L3RhYmxlcmFuZ2U6YzZhMjdjOTQ0MjQzNDhmMGJiMTFiOGU3NjZmNDgyNDlfMi0xLTEtMS0xMzUwMw_d1701787-e69c-4b32-9c8a-45e873e3a286"
      unitRef="usd">31674000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i09abcf3ac44849c49e3c780b175040a5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmM2YTI3Yzk0NDI0MzQ4ZjBiYjExYjhlNzY2ZjQ4MjQ5L3RhYmxlcmFuZ2U6YzZhMjdjOTQ0MjQzNDhmMGJiMTFiOGU3NjZmNDgyNDlfMi0zLTEtMS0xMzUwMw_378fbc4f-3eb5-4266-a709-d219e94099dc"
      unitRef="usd">34068000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iae8bb42b789646b4ba6f4b074eeffca3_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmM2YTI3Yzk0NDI0MzQ4ZjBiYjExYjhlNzY2ZjQ4MjQ5L3RhYmxlcmFuZ2U6YzZhMjdjOTQ0MjQzNDhmMGJiMTFiOGU3NjZmNDgyNDlfMi01LTEtMS0xMzUwMw_652ecbb0-1bef-4cd3-af87-9f1a578924eb"
      unitRef="usd">98868000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0f44d883e0b2449897b56a1b34ccca8f_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmM2YTI3Yzk0NDI0MzQ4ZjBiYjExYjhlNzY2ZjQ4MjQ5L3RhYmxlcmFuZ2U6YzZhMjdjOTQ0MjQzNDhmMGJiMTFiOGU3NjZmNDgyNDlfMi03LTEtMS0xMzUwMw_a581d0a8-784c-4932-98e2-1324cd2617cf"
      unitRef="usd">109593000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f58b5474ebb4a5f830b29be3a2f7a7c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmM2YTI3Yzk0NDI0MzQ4ZjBiYjExYjhlNzY2ZjQ4MjQ5L3RhYmxlcmFuZ2U6YzZhMjdjOTQ0MjQzNDhmMGJiMTFiOGU3NjZmNDgyNDlfMy0xLTEtMS0xMzUwMw_e1452c50-babf-4677-abe3-d4d030527098"
      unitRef="usd">8724000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i18167f341a8d41d5a9580b26693b5110_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmM2YTI3Yzk0NDI0MzQ4ZjBiYjExYjhlNzY2ZjQ4MjQ5L3RhYmxlcmFuZ2U6YzZhMjdjOTQ0MjQzNDhmMGJiMTFiOGU3NjZmNDgyNDlfMy0zLTEtMS0xMzUwMw_d48be5d9-0f4b-4977-9e9d-bada6dbf2f6b"
      unitRef="usd">9622000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia265df95ea7245d68fe8e38ba50df608_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmM2YTI3Yzk0NDI0MzQ4ZjBiYjExYjhlNzY2ZjQ4MjQ5L3RhYmxlcmFuZ2U6YzZhMjdjOTQ0MjQzNDhmMGJiMTFiOGU3NjZmNDgyNDlfMy01LTEtMS0xMzUwMw_f7145e20-e305-49b5-b0d4-f14d9f5b3a87"
      unitRef="usd">28558000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i93830f5b4c944ebf841a5318eff7e31d_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOmM2YTI3Yzk0NDI0MzQ4ZjBiYjExYjhlNzY2ZjQ4MjQ5L3RhYmxlcmFuZ2U6YzZhMjdjOTQ0MjQzNDhmMGJiMTFiOGU3NjZmNDgyNDlfMy03LTEtMS0xMzUwMw_9c333841-f15a-40fe-b5a4-2763e8b30674"
      unitRef="usd">31172000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc5Mzk_d4a5999c-e6d2-4c10-b407-9dd97a006383">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company's long-lived assets for its most significant geographic markets (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock>
    <us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RleHRyZWdpb246YzUzM2FmZmFiNGRmNDNhYzg2NTQ5NmM0N2IyNzc2ZWFfMTc5NzE_e43400c4-d156-445b-a9fd-ca77af1c13df">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company's long-lived assets for its most significant geographic markets (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock>
    <us-gaap:NoncurrentAssets
      contextRef="i97c08f4a55f8470a9971ea339ea1c21d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjdkYjBhOTBhODUxNzRhYWY4MmY1ZjQ3NmI0YmM0NGU4L3RhYmxlcmFuZ2U6N2RiMGE5MGE4NTE3NGFhZjgyZjVmNDc2YjRiYzQ0ZThfMS0xLTEtMS0xMzUwMw_b16f286b-c680-469c-9f53-0ed5a7026d4b"
      unitRef="usd">20391000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i53b30af5c47844f9b1a2b364a4dc51ec_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjdkYjBhOTBhODUxNzRhYWY4MmY1ZjQ3NmI0YmM0NGU4L3RhYmxlcmFuZ2U6N2RiMGE5MGE4NTE3NGFhZjgyZjVmNDc2YjRiYzQ0ZThfMS0zLTEtMS0xMzUwMw_31d5c068-cca8-4db8-9c20-f8b68bafe36a"
      unitRef="usd">22696000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i7d74274057c84930a25d326155334bc0_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjdkYjBhOTBhODUxNzRhYWY4MmY1ZjQ3NmI0YmM0NGU4L3RhYmxlcmFuZ2U6N2RiMGE5MGE4NTE3NGFhZjgyZjVmNDc2YjRiYzQ0ZThfMi0xLTEtMS0xMzUwMw_e27fab1c-5afd-49c2-8063-e2b9840a7b41"
      unitRef="usd">2337000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ic55ed5df77fa48efa92d5f7675cff1e4_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80MC9mcmFnOmM1MzNhZmZhYjRkZjQzYWM4NjU0OTZjNDdiMjc3NmVhL3RhYmxlOjdkYjBhOTBhODUxNzRhYWY4MmY1ZjQ3NmI0YmM0NGU4L3RhYmxlcmFuZ2U6N2RiMGE5MGE4NTE3NGFhZjgyZjVmNDc2YjRiYzQ0ZThfMi0zLTEtMS0xMzUwMw_e9f1d257-055f-434f-ad77-bbfabb221aa4"
      unitRef="usd">3363000</us-gaap:NoncurrentAssets>
    <us-gaap:InvestmentTextBlock
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80Ni9mcmFnOmYzNWI5MmFmZTVmMTQyNDFiNmU0N2FhNWJkOGViYTJlL3RleHRyZWdpb246ZjM1YjkyYWZlNWYxNDI0MWI2ZTQ3YWE1YmQ4ZWJhMmVfMjk1OA_0f3236a6-b13e-4839-95e2-31294eceac24">Gig Economy Group Investment&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Convertible Note Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company entered into a convertible promissory note agreement with Gig Economy Group, Inc. ("GEG") pursuant to which the Company agreed to loan to GEG up to an aggregate of $2.0&#160;million in a series of loan installments, evidenced by a convertible promissory note having a maturity date of May&#160;31, 2019 ("Convertible Note"). The Convertible Note accrued interest at a rate of 8% per annum, compounded annually. On May&#160;17, 2019, the Company and GEG entered into an amendment agreement to extend the maturity date of the Convertible Note to December&#160;31, 2019. In all other aspects, the Convertible Note remained unchanged from the original agreement. Pursuant to a Common Stock Purchase Agreement between the Company and GEG dated December 16, 2019, GEG issued to the Company 1,000,000 shares of GEG&#x2019;s common stock in consideration for conversion and cancellation of all principal, interest and other amounts due under the Convertible Note (representing $2.2&#160;million in aggregate consideration).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Securities under ASC 321&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon conversion of the convertible promissory note receivable with GEG, the Company held a minority interest (less than 20%) in GEG, accounted for under ASC 321, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments - Equity Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; ("ASC 321"), which is included in equity securities in the condensed consolidated balance sheets. Dividends received are reported in earnings if and when received. The Company reviews securities individually for impairment by evaluating if events or circumstances have occurred that may indicate the fair value of the investment is less than its carrying value. If such events or circumstances have occurred, the Company estimates the fair value of the investment and recognizes an impairment loss in other expense, net on the condensed consolidated statements of operations and comprehensive income equal to the difference between the fair value of the investment and its carrying value. In such cases, the estimated fair value of the investment is determined using unobservable inputs including assumptions by GEG's management and quantitative information such as lower valuations in recently completed or proposed financings. These inputs are classified as Level 3. Because GEG is in the early startup stage, GEG is subject to potential changes in cash flows and valuation, and may be unable to raise additional capital necessary to support its ongoing operations, which may result in future impairment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity securities held by the Company lack readily determinable fair values and therefore the securities are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar equity securities of the same issuer. The carrying amount of equity securities held by the Company without readily determinable fair values was $2.2&#160;million at March&#160;31, 2022 and June&#160;30, 2021, respectively. During the three and nine months ended March&#160;31, 2022 and 2021, there were no price changes or impairments recognized.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentTextBlock>
    <lfvn:NotesReceivableRelatedPartyMaximumCommitment
      contextRef="i345de6f57ba548a6ba07b11d0d85bb30_I20191216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80Ni9mcmFnOmYzNWI5MmFmZTVmMTQyNDFiNmU0N2FhNWJkOGViYTJlL3RleHRyZWdpb246ZjM1YjkyYWZlNWYxNDI0MWI2ZTQ3YWE1YmQ4ZWJhMmVfMjQ3_1dff4879-765c-40b1-9379-061efb0667fb"
      unitRef="usd">2000000</lfvn:NotesReceivableRelatedPartyMaximumCommitment>
    <us-gaap:DebtConversionOriginalDebtInterestRateOfDebt
      contextRef="if676f17905b1439fb5721e767c883b01_D20191216-20191216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80Ni9mcmFnOmYzNWI5MmFmZTVmMTQyNDFiNmU0N2FhNWJkOGViYTJlL3RleHRyZWdpb246ZjM1YjkyYWZlNWYxNDI0MWI2ZTQ3YWE1YmQ4ZWJhMmVfNDI5_aa1d8cee-3da7-437f-b88a-8e00b9e1fe7d"
      unitRef="number">0.08</us-gaap:DebtConversionOriginalDebtInterestRateOfDebt>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="i7541c71e837e4987866f3c14bda4fcd9_D20191216-20191216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80Ni9mcmFnOmYzNWI5MmFmZTVmMTQyNDFiNmU0N2FhNWJkOGViYTJlL3RleHRyZWdpb246ZjM1YjkyYWZlNWYxNDI0MWI2ZTQ3YWE1YmQ4ZWJhMmVfODAy_cfb0de3e-26fb-43d2-a096-8b49c8b8112e"
      unitRef="shares">1000000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="i7541c71e837e4987866f3c14bda4fcd9_D20191216-20191216"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80Ni9mcmFnOmYzNWI5MmFmZTVmMTQyNDFiNmU0N2FhNWJkOGViYTJlL3RleHRyZWdpb246ZjM1YjkyYWZlNWYxNDI0MWI2ZTQ3YWE1YmQ4ZWJhMmVfOTcz_81086ae3-1ded-4d66-a928-1e1448dcb474"
      unitRef="usd">2200000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="ib389c215613a45d48cba70a168c71912_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80Ni9mcmFnOmYzNWI5MmFmZTVmMTQyNDFiNmU0N2FhNWJkOGViYTJlL3RleHRyZWdpb246ZjM1YjkyYWZlNWYxNDI0MWI2ZTQ3YWE1YmQ4ZWJhMmVfMjg0OQ_94dd8436-8a09-4063-86fc-afb6e1fbbdc5"
      unitRef="usd">2200000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80Ni9mcmFnOmYzNWI5MmFmZTVmMTQyNDFiNmU0N2FhNWJkOGViYTJlL3RleHRyZWdpb246ZjM1YjkyYWZlNWYxNDI0MWI2ZTQ3YWE1YmQ4ZWJhMmVfMjg0OQ_c495923e-b156-4d76-bbab-2909389403cb"
      unitRef="usd">2200000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RleHRyZWdpb246ODcyNWU3ZDAxNDBkNDg4NTliNDdmZWNlYWI0Mjc3MGFfNjEy_fc2e0448-75e1-445a-8130-c1172ee5c684">Leases&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has operating leases for current corporate offices and certain equipment. These leases have remaining terms of appro&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ximately &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RleHRyZWdpb246ODcyNWU3ZDAxNDBkNDg4NTliNDdmZWNlYWI0Mjc3MGFfMTU4_911d9052-5493-440f-bc28-01448a771e79"&gt;one&lt;/span&gt; to ten years. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, the weighted average remaining lease term and weighted average discount rate for operating leases was 8.49 years and 3.30%, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March 31, 2022 and 2021, operating lease expense was $0.8 million and $0.8 million, respectively. For the nine months ended March 31, 2022 and 2021, operating lease expense was $2.5 million and $2.8 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to operating leases was as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash outflows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturity of lease liabilities at March&#160;31, 2022 are as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 (remaining three months ending June 30, 2022)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,496)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i3c83ca889a7845a2a8fe7f12f6b7501f_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RleHRyZWdpb246ODcyNWU3ZDAxNDBkNDg4NTliNDdmZWNlYWI0Mjc3MGFfMTY0_c137fa12-b6c3-409c-b239-f37e7b9ef5b9">P10Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RleHRyZWdpb246ODcyNWU3ZDAxNDBkNDg4NTliNDdmZWNlYWI0Mjc3MGFfMjgw_56643a27-4ce7-41a6-8350-bc9b9513a3f8">P8Y5M26D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RleHRyZWdpb246ODcyNWU3ZDAxNDBkNDg4NTliNDdmZWNlYWI0Mjc3MGFfMjg3_b2114ee0-e05d-4cae-9755-269d2ba32c4c"
      unitRef="number">0.0330</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseExpense
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RleHRyZWdpb246ODcyNWU3ZDAxNDBkNDg4NTliNDdmZWNlYWI0Mjc3MGFfMzUz_d4c1a01f-cfb7-4e71-bb98-c0b6abb278e2"
      unitRef="usd">800000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RleHRyZWdpb246ODcyNWU3ZDAxNDBkNDg4NTliNDdmZWNlYWI0Mjc3MGFfMzYw_15cb1b14-d37e-49e0-b969-da331be86459"
      unitRef="usd">800000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RleHRyZWdpb246ODcyNWU3ZDAxNDBkNDg4NTliNDdmZWNlYWI0Mjc3MGFfNDI1_262a6030-bd26-48b9-8a73-b09d9be0a0bb"
      unitRef="usd">2500000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RleHRyZWdpb246ODcyNWU3ZDAxNDBkNDg4NTliNDdmZWNlYWI0Mjc3MGFfNDMy_c41f5564-88d6-4b72-8cd5-9126dd10b92e"
      unitRef="usd">2800000</us-gaap:OperatingLeaseExpense>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RleHRyZWdpb246ODcyNWU3ZDAxNDBkNDg4NTliNDdmZWNlYWI0Mjc3MGFfNjE0_895ba6e8-419f-4c59-a875-a1401fea15b6">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to operating leases was as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash outflows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOjcyYjIxMDdlOGU4MjRjNDU4MWQ4YjZiYjRmYzlhZmViL3RhYmxlcmFuZ2U6NzJiMjEwN2U4ZTgyNGM0NTgxZDhiNmJiNGZjOWFmZWJfMi0xLTEtMS0xMzUwMw_c25cf623-5ab2-4784-be9e-585b912214ef"
      unitRef="usd">804000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOjcyYjIxMDdlOGU4MjRjNDU4MWQ4YjZiYjRmYzlhZmViL3RhYmxlcmFuZ2U6NzJiMjEwN2U4ZTgyNGM0NTgxZDhiNmJiNGZjOWFmZWJfMi0zLTEtMS0xMzUwMw_5e5bfc75-4c83-456c-affc-9b58dbdd7a6b"
      unitRef="usd">645000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOjcyYjIxMDdlOGU4MjRjNDU4MWQ4YjZiYjRmYzlhZmViL3RhYmxlcmFuZ2U6NzJiMjEwN2U4ZTgyNGM0NTgxZDhiNmJiNGZjOWFmZWJfMi01LTEtMS0xMzUwMw_b0a905bc-1e01-4ee6-8552-a02c2dca9500"
      unitRef="usd">1858000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOjcyYjIxMDdlOGU4MjRjNDU4MWQ4YjZiYjRmYzlhZmViL3RhYmxlcmFuZ2U6NzJiMjEwN2U4ZTgyNGM0NTgxZDhiNmJiNGZjOWFmZWJfMi03LTEtMS0xMzUwMw_5500a442-68cf-47ff-8c64-21701ded3c9e"
      unitRef="usd">2037000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOjcyYjIxMDdlOGU4MjRjNDU4MWQ4YjZiYjRmYzlhZmViL3RhYmxlcmFuZ2U6NzJiMjEwN2U4ZTgyNGM0NTgxZDhiNmJiNGZjOWFmZWJfMy0xLTEtMS0xMzUwMw_79c45020-77f4-4a5c-9b33-ee1002e63b63"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOjcyYjIxMDdlOGU4MjRjNDU4MWQ4YjZiYjRmYzlhZmViL3RhYmxlcmFuZ2U6NzJiMjEwN2U4ZTgyNGM0NTgxZDhiNmJiNGZjOWFmZWJfMy0zLTEtMS0xMzUwMw_1bb34231-a797-434d-a87c-713d19601a7f"
      unitRef="usd">317000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOjcyYjIxMDdlOGU4MjRjNDU4MWQ4YjZiYjRmYzlhZmViL3RhYmxlcmFuZ2U6NzJiMjEwN2U4ZTgyNGM0NTgxZDhiNmJiNGZjOWFmZWJfMy01LTEtMS0xMzUwMw_2c4e26db-d96d-4077-80ed-bb8ef20d8190"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOjcyYjIxMDdlOGU4MjRjNDU4MWQ4YjZiYjRmYzlhZmViL3RhYmxlcmFuZ2U6NzJiMjEwN2U4ZTgyNGM0NTgxZDhiNmJiNGZjOWFmZWJfMy03LTEtMS0xMzUwMw_99593d4e-7429-44b9-b5fc-52336934a875"
      unitRef="usd">15013000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RleHRyZWdpb246ODcyNWU3ZDAxNDBkNDg4NTliNDdmZWNlYWI0Mjc3MGFfNjE1_8ce092b1-a6bf-46d8-baba-6b860095dfac">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturity of lease liabilities at March&#160;31, 2022 are as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 (remaining three months ending June 30, 2022)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,496)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOmY2OTY4MDkxZWIzOTQwZmI4ODU4NWNkNDQ5MjRjN2UwL3RhYmxlcmFuZ2U6ZjY5NjgwOTFlYjM5NDBmYjg4NTg1Y2Q0NDkyNGM3ZTBfMS0yLTEtMS0xMzUwMw_3e961851-4900-436e-98ec-9214d55f4f34"
      unitRef="usd">791000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOmY2OTY4MDkxZWIzOTQwZmI4ODU4NWNkNDQ5MjRjN2UwL3RhYmxlcmFuZ2U6ZjY5NjgwOTFlYjM5NDBmYjg4NTg1Y2Q0NDkyNGM3ZTBfMi0yLTEtMS0xMzUwMw_adc505bb-889e-4289-a1f1-bd7b74a137bd"
      unitRef="usd">3197000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOmY2OTY4MDkxZWIzOTQwZmI4ODU4NWNkNDQ5MjRjN2UwL3RhYmxlcmFuZ2U6ZjY5NjgwOTFlYjM5NDBmYjg4NTg1Y2Q0NDkyNGM3ZTBfMy0yLTEtMS0xMzUwMw_671238ad-60a4-45a3-97c9-4e06a57db38c"
      unitRef="usd">2010000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOmY2OTY4MDkxZWIzOTQwZmI4ODU4NWNkNDQ5MjRjN2UwL3RhYmxlcmFuZ2U6ZjY5NjgwOTFlYjM5NDBmYjg4NTg1Y2Q0NDkyNGM3ZTBfNC0yLTEtMS0xMzUwMw_2f74f5ab-95f5-41ba-9bcd-2c3df100732a"
      unitRef="usd">1606000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOmY2OTY4MDkxZWIzOTQwZmI4ODU4NWNkNDQ5MjRjN2UwL3RhYmxlcmFuZ2U6ZjY5NjgwOTFlYjM5NDBmYjg4NTg1Y2Q0NDkyNGM3ZTBfNS0yLTEtMS0xMzUwMw_5d167ce5-082d-4bef-9cc4-55c831ba4f9b"
      unitRef="usd">1646000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <lfvn:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOmY2OTY4MDkxZWIzOTQwZmI4ODU4NWNkNDQ5MjRjN2UwL3RhYmxlcmFuZ2U6ZjY5NjgwOTFlYjM5NDBmYjg4NTg1Y2Q0NDkyNGM3ZTBfNi0yLTEtMS0xMzUwMw_e3b21572-5133-4467-8ff9-99f9a3174aea"
      unitRef="usd">9810000</lfvn:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOmY2OTY4MDkxZWIzOTQwZmI4ODU4NWNkNDQ5MjRjN2UwL3RhYmxlcmFuZ2U6ZjY5NjgwOTFlYjM5NDBmYjg4NTg1Y2Q0NDkyNGM3ZTBfNy0yLTEtMS0xMzUwMw_d552dbae-1abb-41f3-af21-6ff50b106886"
      unitRef="usd">19060000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOmY2OTY4MDkxZWIzOTQwZmI4ODU4NWNkNDQ5MjRjN2UwL3RhYmxlcmFuZ2U6ZjY5NjgwOTFlYjM5NDBmYjg4NTg1Y2Q0NDkyNGM3ZTBfOC0yLTEtMS0xMzUwMw_d462c70f-9f41-46a8-a7ab-78fee7031399"
      unitRef="usd">2496000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF80OS9mcmFnOjg3MjVlN2QwMTQwZDQ4ODU5YjQ3ZmVjZWFiNDI3NzBhL3RhYmxlOmY2OTY4MDkxZWIzOTQwZmI4ODU4NWNkNDQ5MjRjN2UwL3RhYmxlcmFuZ2U6ZjY5NjgwOTFlYjM5NDBmYjg4NTg1Y2Q0NDkyNGM3ZTBfOS0yLTEtMS0xMzUwMw_5469859b-78c6-46ba-94ce-0f6fec56a465"
      unitRef="usd">16564000</us-gaap:OperatingLeaseLiability>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfNTMwOA_971b328d-da3c-4a19-b5c1-160ff84d5eb9">Long-Term Debt&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March&#160;30, 2016, the Company entered into a loan agreement (the &#x201c;2016 Loan Agreement&#x201d;) to refinance its outstanding debt. In connection with the 2016 Loan Agreement and on the same date, the Company entered into a security agreement (the &#x201c;Security Agreement&#x201d;). The 2016 Loan Agreement provides for a term loan in an aggregate principal amount of $10.0 million (the &#x201c;2016 Term Loan") and a revolving loan facility in an aggregate principal amount not to exceed $2.0 million (the &#x201c;2016 Revolving Loan,&#x201d; and collectively with the 2016 Term Loan, the 2016 Loan Agreement and the Security Agreement, the &#x201c;2016 Credit Facility&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The principal amount of the 2016 Term Loan is payable in consecutive quarterly installments in the amount of $0.5 million plus accrued interest beginning with the fiscal quarter ended June&#160;30, 2016. If the Company borrows under the 2016 Revolving Loan, interest will be payable quarterly in arrears on the last day of each fiscal quarter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May&#160;4, 2018, the Company entered into a loan modification agreement, which amended the 2016 Credit Facility (&#x201c;Amendment No. 1&#x201d;). Amendment No. 1 revised the maturity date from March&#160;30, 2019 to March&#160;31, 2021 and increased the fixed interest rate for the term loan from 4.93% to 5.68%. Amendment No. 1 also revised certain financial covenants. The minimum fixed charge coverage ratio (as defined in Amendment No. 1) was revised from a minimum of 1.50 to 1.00 to 1.25 to 1.00, measured on a trailing twelve-month basis, at the end of each fiscal quarter. The minimum working capital was increased from $5.0 million to $8.0 million. The funded debt to EBITDA ratio was replaced with the total liabilities to tangible net worth ratio (as defined in Amendment No. 1) of not greater than 3.00 to 1.00 at the end of each quarter. The minimum tangible net worth measure was removed from the financial covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s obligations under the 2016 Credit Facility, as amended, are secured by a security interest in substantially all of the Company&#x2019;s assets. Loans outstanding under the 2016 Credit Facility, as amended, may be prepaid in whole or in part at any time without premium or penalty. In addition, if, at any time, the aggregate principal amount outstanding under the 2016 Revolving Loan exceeds $2.0 million, the Company must prepay an amount equal to such excess. Any principal amount of the 2016 Term Loan which is prepaid or repaid may not be re-borrowed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February&#160;1, 2019, the Company entered into a loan modification agreement, which further amended the 2016 Credit Facility ("Amendment No. 2"). Under Amendment No. 2, the Company made a principal payment of $2.0 million and increased the revolving loan facility from $2.0 million to $5.0 million. Amendment No. 2 also revised certain financial covenants. The minimum fixed charge coverage ratio (as defined in Amendment No. 2) was revised from a minimum of 1.25 to 1.00 to 1.10 to 1.00, measured on a trailing twelve-month basis, at the end of each fiscal quarter. The minimum working capital was decreased from $8.0 million to $6.0 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April&#160;1, 2021, the Company entered into a loan modification agreement ("Amendment No. 3"), which amended the 2016 Credit Facility, as previously amended. Amendment No. 3 revised the maturity date from March&#160;31, 2021 to March&#160;31, 2024 and modified the variable interest rate based on the one-month United States Treasury Rate, plus a margin of 3.00%, with an interest rate floor of 4.00%. Amendment No. 3 also revised the debt (total liabilities) to tangible net worth ratio (as defined in Amendment No. 3) covenant to require that the Company maintain this ratio not in excess of 2.00 to 1.00, measured as of the end of each fiscal quarter, and revised the definition and calculation of the minimum fixed charge coverage ratio (as defined in Amendment No. 3).  There were no other changes to the covenants or revolving loan facility as set forth in Amendment No. 2.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2016 Credit Facility, as amended, contains customary covenants, including affirmative and negative covenants that, among other things, restrict the Company&#x2019;s ability to create certain types of liens, incur additional indebtedness, declare or pay dividends on or redeem capital stock, make other payments to holders of equity interests in the Company, make certain &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;investments, purchase or otherwise acquire all or substantially all the assets or equity interests of other companies, sell assets or enter into consolidations, mergers or transfers of all or any substantial part of the Company&#x2019;s assets. The 2016 Credit Facility, as amended, also contains various financial covenants that require the Company to maintain certain consolidated working capital amounts, total liabilities to tangible net worth ratios and fixed charge coverage ratios. Additionally, the 2016 Credit Facility, as amended, contains cross-default provisions, whereby a default under the terms of certain indebtedness or an uncured default of a payment or other material obligation of the Company under a material contract of the Company will cause a default on the remaining indebtedness under the 2016 Credit Facility, as amended. As of March&#160;31, 2022, the Company was in compliance with all applicable covenants under the 2016 Credit Facility, as amended.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s book value for the 2016 Credit Facility, as amended, approximates the fair value. During the fiscal year ended June&#160;30, 2020, the Company repaid, in full, the remaining balance of the 2016 Term Loan in accordance with the terms of the 2016 Credit Facility, as amended.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i91749ed981c5409a9273b2f8dbbe2722_I20160330"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMzY1_e51a24c2-862e-4493-a8a5-bf9903a602c5"
      unitRef="usd">10000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i28ed7365c77c4b2db3b859a62be20d66_I20160330"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfNDY4_02490ecc-5a11-418e-804d-cdedad7599ba"
      unitRef="usd">2000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i6e21e97ed1274414912f33d01244c913_D20210701-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfNzI1_5f4d04be-55d0-4229-813e-41ea05123cd8"
      unitRef="usd">500000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:LongTermDebtPercentageBearingFixedInterestRate
      contextRef="i91749ed981c5409a9273b2f8dbbe2722_I20160330"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMTE3NA_f277ab3e-d11d-4c56-981f-9e79e329d912"
      unitRef="number">0.0493</us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:LongTermDebtPercentageBearingFixedInterestRate
      contextRef="i712ce600357e432e9efd232d861ee1b2_I20180504"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMTE4MA_a9803646-32d0-41a8-ae34-bcd41f293d82"
      unitRef="number">0.0568</us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
    <lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio
      contextRef="i91749ed981c5409a9273b2f8dbbe2722_I20160330"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMTM0NA_2feb8ba6-3f6b-46a4-b0dc-53770be6956b"
      unitRef="number">1.50</lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio>
    <lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio
      contextRef="i712ce600357e432e9efd232d861ee1b2_I20180504"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMTM1Ng_6e667f24-32bf-4a38-a2eb-7e4d8dd9e446"
      unitRef="number">1.25</lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio>
    <lfvn:DebtInstrumentTrailingPeriod
      contextRef="i6905908291e94757a8fba8a815f971d0_D20180504-20180504"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfNTMwOQ_a89d292a-71c1-46ae-9b2a-5e3900d15dc7">P12M</lfvn:DebtInstrumentTrailingPeriod>
    <lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital
      contextRef="i91749ed981c5409a9273b2f8dbbe2722_I20160330"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMTQ4Nw_a69e80cb-4e9c-4cab-88a4-4c33e899b553"
      unitRef="usd">5000000</lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital>
    <lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital
      contextRef="i712ce600357e432e9efd232d861ee1b2_I20180504"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMTQ5Mw_5ce05642-71af-49a9-a1d1-0cb859711e6e"
      unitRef="usd">8000000</lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital>
    <lfvn:DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio
      contextRef="i712ce600357e432e9efd232d861ee1b2_I20180504"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMTY0OQ_5a05c76c-4dff-4533-80ab-3424482985f9"
      unitRef="number">3.00</lfvn:DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i28ed7365c77c4b2db3b859a62be20d66_I20160330"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMjE2Ng_bb0c91e0-d201-4157-8ab2-39ab2203b014"
      unitRef="usd">2000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ia4e41b786fa5480cbafaff2190125416_D20190201-20190201"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMjUxNA_77501612-c4ba-4cdb-9f50-48abb4c6c8a3"
      unitRef="usd">2000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i28ed7365c77c4b2db3b859a62be20d66_I20160330"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMjU2NA_bb0c91e0-d201-4157-8ab2-39ab2203b014"
      unitRef="usd">2000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i138740ba50b5467d8eb135d8bfbf6674_I20190201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMjU3MA_56fd6592-b684-433b-9fd3-50153205023c"
      unitRef="usd">5000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio
      contextRef="i712ce600357e432e9efd232d861ee1b2_I20180504"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMjczNA_6e667f24-32bf-4a38-a2eb-7e4d8dd9e446"
      unitRef="number">1.25</lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio>
    <lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio
      contextRef="ie0c55b4954084c5aae5f41ea24e8318b_I20190201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMjc0Ng_ba4f43bf-bec6-463b-91d8-5ad5b84990ee"
      unitRef="number">1.10</lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio>
    <lfvn:DebtInstrumentTrailingPeriod
      contextRef="i2934f27e399b471b8b9dfd34e5e0ac1b_D20190201-20190201"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfNTMxMA_f5d9e27f-581f-4cce-ad73-649c016594e4">P12M</lfvn:DebtInstrumentTrailingPeriod>
    <lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital
      contextRef="i1cbad6d70bc54ef6bae80ba6559acdcc_I20180504"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMjg3Nw_5cbe4249-d7a6-41c9-9b8f-3801c69d8e45"
      unitRef="usd">8000000</lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital>
    <lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital
      contextRef="ie0c55b4954084c5aae5f41ea24e8318b_I20190201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMjg4Mw_f9e0bb53-32e3-4ddd-893f-5b5f43027094"
      unitRef="usd">6000000</lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ib44219a0ab0d49e6bc0c499248ce173b_D20210401-20210401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMzE5OA_b673f759-0ebb-476c-852b-e4b3eb4b25ef"
      unitRef="number">0.0300</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <lfvn:DebtInstrumentFloorInterestRate
      contextRef="ie90439fd1c8a43998c36b1c5528a888c_D20210401-20210401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMzIzMw_c4088ff7-4593-4a77-8332-878b0257c637"
      unitRef="number">0.0400</lfvn:DebtInstrumentFloorInterestRate>
    <lfvn:DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio
      contextRef="i44c9eefb9093469182cd44d1b4c1dd66_I20210401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81Mi9mcmFnOjBiMjc4NTZmZTQzMTRlMWY5NmFiYWJhYzdlNTQ5YjU1L3RleHRyZWdpb246MGIyNzg1NmZlNDMxNGUxZjk2YWJhYmFjN2U1NDliNTVfMzQyOQ_3528c171-ee50-40d9-8f67-cf0d03142d44"
      unitRef="number">2.00</lfvn:DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMjUwMw_0c73af64-c03c-4f3c-9464-f6f0d015e669">Stockholders&#x2019; Equity&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three months ended March 31, 2022 and 2021,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the Company issued no shares of common stock upon the exercise of options. During the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nine months ended&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; March&#160;31, 2022 and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the company issued 30,000 shares and 0.2 million shares, respectively, of common stock upon the exercise of options. During the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three months ended March 31, 2022 and 2021, approximately &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,000 shares and 14,000 shares, respectively, of restricted stock were canceled or surrendered as payment of tax withholding upon vesting. During the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nine months ended&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; March&#160;31, 2022 and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, approximately 29,000 shares and 0.1 million shares, respectively, of restricted stock were canceled or surrendered as payment of tax withholding upon vesting.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 27, 2017, the Company announced a share repurchase program authorizing it to repurchase up to $5 million in shares of the Company's common stock. The repurchase program permits the Company to purchase shares through a variety of methods, including in the open market, through privately negotiated transactions or other means as determined by the Company's management. As part of the repurchase program, the Company has entered into a pre-arranged stock repurchase plan which operates in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Accordingly, any transactions under such stock repurchase plan will be completed in accordance with the terms of the plan, including specified price, volume and timing conditions. The authorization may be suspended or discontinued at any time. On February 1, 2019, the Board of Directors approved an amendment to the share repurchase program to increase the authorized share repurchase amount from $5 million to $15 million. On August 27, 2020, the Board of Directors approved an amendment to the share repurchase program to increase the authorized share repurchase amount from $15 million to $35 million and to extend the duration of the program through November 30, 20&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23 and, on February 17, 2022, the Board of Directors approved an &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;amendment to the share repurchase program to increase the authorized share repurchase amount from $35 million to $60 million. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three months ended March 31, 2022 and 2021, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Company purchased 0.3 million shares and 0.2 million shares, respectively, of common stock at an aggregate price of $1.7 million and $2.0 million under this repurchase program.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended&#160;March&#160;31, 2022 and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company purchased 1.2 million shares and 0.7 million shares, respectively, of common stock at an aggregate price of $8.4 million and $8.0 million under this repurchase program. At&#160;March&#160;31, 2022, there is $28.1 million remaining under this repurchase program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Certificate of Incorporation authorizes the issuance of preferred stock. However&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as of March&#160;31, 2022, none have been issued nor have any rights or preferences been assigned to the preferred stock by the Company&#x2019;s board of directors.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ifee0653b54af42bf80320efe99032f1d_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMjA1_297f6457-9021-4f1f-8f52-88a4456fe521"
      unitRef="shares">30000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="id5c31a591c3c44ea943724f45a5bccda_D20200701-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMjE5_e66d0f4a-df62-4af8-baa1-6c8a5b18fb72"
      unitRef="shares">200000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ied064917c4284ae1bbf8175e9b75f43b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMzI2_874208f0-e029-4f94-8144-be1f06df6c80"
      unitRef="shares">5000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ia94b7a6d35ea49b3b94d253b14ae6d97_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMzQw_af47471f-9186-4f7c-830a-1d18859e8a68"
      unitRef="shares">14000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ifee0653b54af42bf80320efe99032f1d_D20210701-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfNDk3_f27239b7-51d6-4579-b54a-0ceb8069303b"
      unitRef="shares">29000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="id5c31a591c3c44ea943724f45a5bccda_D20200701-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfNTEx_90b598b3-7846-43cf-8a3f-1ddc16e64a96"
      unitRef="shares">100000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="idfeffa2877114db7a47309a70bbb8f84_I20171127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfNzM1_bd865b30-c4f4-49fd-a22c-393c3482caef"
      unitRef="usd">5000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="idfeffa2877114db7a47309a70bbb8f84_I20171127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMTYyNQ_e7ec9f9b-84fd-4293-8ec3-0e3eb47fa6eb"
      unitRef="usd">5000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i15ef7d898c564726b93cc5e8c2ad2750_I20190201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMTYzMQ_81f88705-7633-4ad4-b05a-25621c9223b2"
      unitRef="usd">15000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i15ef7d898c564726b93cc5e8c2ad2750_I20190201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMTc5Mg_6d02584c-0847-4741-9f8a-18191afcfa9f"
      unitRef="usd">15000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i2b61f7ff2c2b4a908d35b37807707405_I20200827"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMTc5OA_ca4ea23b-760d-47cf-b11c-ba937946bb41"
      unitRef="usd">35000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i2b61f7ff2c2b4a908d35b37807707405_I20200827"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMTA5OTUxMTYzMDU1NQ_ca4ea23b-760d-47cf-b11c-ba937946bb41"
      unitRef="usd">35000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i8365c04b98844bcea3d544bdda92cd4c_I20220217"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMTA5OTUxMTYzMDYzMw_bf41aff3-1312-4251-90c4-40d1ecb0fb97"
      unitRef="usd">60000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMTkxNQ_1b16530c-3a97-44ad-9f0b-9f5b35053598"
      unitRef="shares">300000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMTkyOQ_6b6232ee-1add-48f1-828d-eef5307ec106"
      unitRef="shares">200000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMTk5NQ_fb27b73e-e5e6-40d3-a527-1646c4d94454"
      unitRef="usd">1700000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMjAwMg_f1c4c80f-487e-4535-99f6-d088be79cfd8"
      unitRef="usd">2000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMjA4Mw_ebb2f316-d3a0-4b69-8717-744854327fe3"
      unitRef="shares">1200000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMjA5Nw_e42aa892-4c03-4318-ba21-e237bb826e77"
      unitRef="shares">700000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMjE2Mw_959774d0-bbc0-429f-a2ad-39b19bec223b"
      unitRef="usd">8400000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMjE3MA_0a948bb3-a022-4572-86fd-2144ec28d6a4"
      unitRef="usd">8000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i48bc8c6f35e243a6b2a9a8d306274583_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81NS9mcmFnOmNhMDNmYWJmMjdmMDRhZTBiN2RlNWQ2YzU1ZGYwYjdmL3RleHRyZWdpb246Y2EwM2ZhYmYyN2YwNGFlMGI3ZGU1ZDZjNTVkZjBiN2ZfMjIyMA_e71a90af-71b1-4ab8-96a3-145110a7c589"
      unitRef="usd">28100000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNzA5Mg_182cea3f-ff83-472a-a2cd-354bd9f8fb8b">Stock-Based Compensation&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Long-Term Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Equity-Settled Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company adopted, and the stockholders approved, the 2007 Long-Term Incentive Plan (the &#x201c;2007 Plan&#x201d;), effective November&#160;21, 2006, to provide incentives to eligible employees, directors and consultants. A maximum of 1.4 million shares of the Company's common stock can be issued under the 2007 Plan in connection with the grant of awards. Effective November 21, 2016, no new awards can be granted under the 2007 Plan. As of March&#160;31, 2022, there were no stock option awards outstanding under the 2007 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company adopted, and the stockholders approved, the 2010 Long-Term Incentive Plan (the &#x201c;2010 Plan&#x201d;), effective September 27, 2010, as amended on August&#160;21, 2014, to provide incentives to certain employees, directors and consultants. A maximum of 1.0 million shares of the Company's common stock can be issued under the 2010 Plan in connection with the grant of awards. Awards to purchase common stock have been granted pursuant to the 2010 Plan and are outstanding to various employees, officers and directors. Outstanding stock options awarded under the 2010 Plan have exercise prices between $9.31 and $19.74 per share, and vest over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMTE5OQ_88c1c3cf-56ec-4205-9f2f-deff51b9192d"&gt;one&lt;/span&gt; to four year vesting periods. Awards expire in accordance with the terms of each award &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and, upon expiration of the award, the shares subject to the award will be added to the 2017 Plan pool as described below. The contractual term of stock options granted is generally ten years. No new awards will be granted under the 2010 Plan and forfeited or terminated shares may be added to the 2017 Plan pool as described below. As of March&#160;31, 2022, under the 2010 Plan, there were stock option awards outstanding, net of awards expired, for an aggregate of approximately 20,000 shares of the Company's common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company adopted, and the stockholders approved, the 2017 Long-Term Incentive Plan (the &#x201c;2017 Plan&#x201d;), effective February 16, 2017, to provide incentives to eligible employees, directors and consultants. On February 2, 2018, November 15, 2018, and November 12, 2020, the stockholders approved amendments to the 2017 Plan to increase by 425,000 shares, 715,000 shares and 650,000 shares, respectively, the number of shares of the Company's common stock that are available for issuance under the 2017 Plan. As of&#160;March&#160;31, 2022, a maximum of 2.9 million&#160;shares of the Company's common stock can be issued under the 2017 Plan in connection with the grant of awards which is calculated as the sum of (i) 2,440,000 shares and (ii) up to 475,000 shares previously reserved for issuance under the 2010 Plan, including shares returned upon cancellation, termination or forfeiture of awards that were previously granted under that plan. O&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;utstanding stock options awarded under the 2017 Plan have exercise prices of $4.44 per share, and vest over a three year vesting period. Awards expire in accordance with the terms of each award and, upon expiration of the award, the shares subject to the award are added back to the 2017 Plan. The contractual term of stock options granted are substantially the same as described above for the 2010 Plan. As of March&#160;31, 2022, under the 2017 Plan, there were stock option awards outstanding, net of awards expired, for an aggregate of 0.1 million shares of the Company's common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash-Settled Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company adopted a performance incentive plan effective July 1, 2017 (the "Fiscal 2018 Performance Plan"). The Fiscal 2018 Performance Plan is intended to provide selected employees an opportunity to earn performance-based cash bonuses whose value is based upon the Company&#x2019;s stock value and to encourage such employees to provide services to the Company and to attract new individuals with outstanding qualifications. The Fiscal 2018 Performance Plan seeks to achieve this purpose by providing for awards in the form of performance share units (the &#x201c;Units&#x201d;).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; No shares will be issued under the Fiscal 2018 Performance Plan. Awards may be settled only with cash and will be paid subsequent to award vesting. The fair value of share-based compensation awards, that include performance shares, are accounted for as liabilities. Vesting for the Units is subject to achievement of both service-based and performance-based vesting requirements. Performance-based vesting occurs in three installments if the Company meets certain performance criteria generally set for each year of a three-year performance period. The service-based vesting criteria occurs in a single installment at the end of the third fiscal year after the awards are granted if the participant has continuously remained in service from the date of award through the end of the third fiscal year. The fair value of these awards is based on the trading price of the Company's common stock and is remeasured at each reporting period date until settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;General.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  The Company's 2019 Employee Stock Purchase Plan ("ESPP") was adopted by the board of directors in September 2018 and the Company's stockholders approved it in November 2018. The ESPP is intended to qualify under Section 423 of the Internal Revenue Code.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Reserve.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  The Company has reserved 0.4 million shares of its common stock for issuance under the ESPP. As of March&#160;31, 2022, 0.2 million shares were available for issuance. The number of shares reserved under the ESPP will automatically be adjusted in the event of a stock split, stock dividend or a reverse stock split (including an adjustment to the per-purchase period share limit).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Purchase Price.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  Employees may purchase each share of common stock under the ESPP at a price equal to 85% of the lower of the fair market values of the stock as of the beginning or the end of the six-month offering periods. An employee's contributions to the ESPP are limited to 15% of their regular hourly or salary compensation, and up to a maximum of 3,000 shares may be purchased during any offering period. A participant shall not be granted an option under the ESPP if such option would permit the participant's rights to purchase stock to accrue at a rate exceeding $25,000 grant date fair market value of stock for each calendar year in which such option is outstanding at any time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Offering Periods.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  Unless otherwise determined by the compensation committee, the ESPP will be operated through a series of successive six-month offering periods, which will begin each year on March 1 and September 1.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Duri&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ng the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three and nine months ended&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March&#160;31, 2022,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; approximately 41,000 and 0.1 million shares of common stock were issued under the ESPP, respectively. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Duri&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ng the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three and nine months ended&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March&#160;31, 2021,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; approximately 36,000 and 0.1 million shares of common stock were issued under the ESPP. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:24.75pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with accounting guidance for stock-based compensation, payments in equity instruments for goods or services are accounted for by the fair value method. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March 31, 2022, a decrease to additional paid-in capital of $38,000, all of which was employee related, was recognized due to changes in estimates in performance stock unit performance measures and reductions in headcount. For the nine months ended March 31, 2022, compensation of $1.4 million was reflected as an increase to additional&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; paid-in capital, all of which was employee related. Fo&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;r the three and nine months ended March&#160;31, 2021, stock-based compensation of $0.7 million and $2.2 million, respectively, was reflected as an increase to additional paid-in capital and a decrease of 17,000 and $0.1 million, respectively, was included in other accrued expenses, all of which was employee related.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="icfb9d06f4ea24bfb9da6d26bba64f59e_I20061121"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMzA1_374b0b16-749d-4f4a-a9fb-975bd517f1d7"
      unitRef="shares">1400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i82db2efb56364be499fa24d948efc805_I20100927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfODI1_795ef928-78c2-46cf-adbe-3bb6420bec4c"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i643716d34b6a4245a763bf8bf4629aa8_D20100927-20100927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMTE2NA_f283de0b-ea45-4870-b20c-d95290ae690d"
      unitRef="usdPerShare">9.31</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i38dcb43eafd747fbbc7861d7bb8a2b03_D20100927-20100927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMTE3MQ_3a7f441c-ae1b-47d2-bc11-c2180d3b3e11"
      unitRef="usdPerShare">19.74</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i38dcb43eafd747fbbc7861d7bb8a2b03_D20100927-20100927"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNzA5Mw_bdd7a417-ebff-42f4-b023-6eba7bf1f582">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm
      contextRef="ia4fb358160af4b1582deaf09e2b4bd56_D20100927-20100927"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMTQ2OQ_c74b9bcd-9b5b-4178-adab-12d1c396507a">P10Y</lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ie1f4201b19a74fef8349a17facf7daa8_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMTc0NQ_82f1ffa1-c373-40f6-9ac0-c5dc9e33031c"
      unitRef="shares">20000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i6e2b576ca32a4d868584d602195e7c37_D20180202-20180202"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMjEyNA_2d1faa40-e35c-444b-a025-2c12c75d55f0"
      unitRef="shares">425000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="ic3eb364b1b32431298d5283303fb50c1_D20181115-20181115"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMjEzNQ_3567219f-d12f-441a-93b7-9b553a9f4e7a"
      unitRef="shares">715000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i82320565cb5746a9a4deead3ae0f001d_D20201112-20201112"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMjE0OQ_be500fd9-2fee-498a-871d-ece789bef755"
      unitRef="shares">650000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i2cc2bb8a2f46410091908db5becaed25_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMjMwMQ_a48be340-81f0-4736-b39b-f662e5d3c057"
      unitRef="shares">2900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i45d0f653093a43c1aa4ad8a6f44b65f5_I20180202"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMjQ1Mg_2a3a0d56-376e-40be-81b4-81ab04df0e41"
      unitRef="shares">2440000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ica0b13add21047009a5fb1a118222ecf_I20180202"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMjQ3Nw_69c42bed-16bc-4b2b-a151-4e8b53f6b39b"
      unitRef="shares">475000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i2cc2bb8a2f46410091908db5becaed25_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMjc0Ng_21f30f6f-deeb-4bad-af4e-1c55c85c6b12"
      unitRef="usdPerShare">4.44</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ib1c7eca313734a9780d2949151a11055_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNzA4OA_3e3e5146-aeed-4e69-8286-d74ee9b64aac">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i2cc2bb8a2f46410091908db5becaed25_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMzE4Ng_856b949c-5973-40d9-897d-00f6c0021e52"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ia7df9f17944846a0ac9250ae7774a182_D20210701-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMzgwOQ_18b86544-7aa8-48e9-9614-ad1f188ff24b"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <lfvn:SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofVestingInstallments
      contextRef="ie920895e4f5f48ef81ce22593768c0b3_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNDIyNQ_22a81a28-c01d-487c-aabc-851b32ed8939"
      unitRef="installment">3</lfvn:SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofVestingInstallments>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ia7df9f17944846a0ac9250ae7774a182_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNzA5NA_072801cf-7357-451c-8f15-7fde55820f1a">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ibbe9559ba77040d5b39ea3519ff4b9b9_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNTA5NQ_e69d4247-17d0-49e7-bc90-362407ef51da"
      unitRef="shares">400000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="ibbe9559ba77040d5b39ea3519ff4b9b9_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNTE2NA_2403c139-3ee0-44ea-aabf-aa8b87952ce9"
      unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="ice3288151d3641c6b51df76356f2297c_D20210701-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNTUxOA_30ae0feb-eb66-468d-90ca-847666900c9b"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
      contextRef="ibbe9559ba77040d5b39ea3519ff4b9b9_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNTY5NA_91e69813-2337-4781-a45d-93052203796f"
      unitRef="number">0.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
      contextRef="ice3288151d3641c6b51df76356f2297c_D20210701-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNTc2OA_4d9c629a-08f5-40cf-aa55-932adaaf577f"
      unitRef="shares">3000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee>
    <lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted
      contextRef="ibbe9559ba77040d5b39ea3519ff4b9b9_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNTk4NA_28400f44-bc76-4eb4-aac3-11d19d88c8ca"
      unitRef="usd">25000</lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted>
    <lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod
      contextRef="ice3288151d3641c6b51df76356f2297c_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNzA4OQ_f4842eb2-9525-4feb-830e-20b2fa8c5a9a">P6M</lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMTA5OTUxMTYzNDkyMg_1b6eae56-6cb0-4140-9f72-c64629b393d9"
      unitRef="shares">41000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMTA5OTUxMTYzNDg4NQ_cc989e93-399a-4f2a-a496-0e04fea15626"
      unitRef="shares">100000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMTA5OTUxMTYzNDkzMA_233b33f3-6d31-44ea-8792-b64da50c9ea6"
      unitRef="shares">36000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMTA5OTUxMTYzNDkxNQ_50604929-061f-4b1e-b0aa-e5a5ad4e7c46"
      unitRef="shares">100000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="ia7987d4236804621a4361835b057e0ce_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfMTA5OTUxMTYzNTE2Mg_0024e0c8-0e43-484f-ac4b-5ae6c26c732f"
      unitRef="usd">-38000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNjcyOA_24041aac-46c8-4b6f-97f1-b8c30f50ff07"
      unitRef="usd">1400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNjg4NA_6c2d701a-d793-4f0e-aaaa-9292b581d85d"
      unitRef="usd">700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNjg5MQ_3ccb9228-182e-4bdd-be10-7cc435579d70"
      unitRef="usd">2200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <lfvn:SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNjk4Ng_069bf980-264d-4a1a-9510-10f9164a9efb"
      unitRef="usd">-17000</lfvn:SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities>
    <lfvn:SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF81OC9mcmFnOjY0MGU5ODYwOTc5OTQxYzA4M2Y3YWUxNmIzOWZjNzIxL3RleHRyZWdpb246NjQwZTk4NjA5Nzk5NDFjMDgzZjdhZTE2YjM5ZmM3MjFfNjk5Mw_dd57f65a-20a9-41da-8024-2fb6626dd671"
      unitRef="usd">-100000</lfvn:SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities>
    <us-gaap:LossContingencyDisclosures
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF82MS9mcmFnOmQzNTY0YTg1Yzk5NTQyNTc5OWUxNWZmNDdmMzFlMWQxL3RleHRyZWdpb246ZDM1NjRhODVjOTk1NDI1Nzk5ZTE1ZmY0N2YzMWUxZDFfODQxOA_7d7362c1-92ff-4934-af0f-c0c0dd8fb953">Commitments and Contingencies&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company accounts for contingent liabilities in accordance with ASC 450, Contingencies. This guidance requires management to assess potential contingent liabilities that may exist as of the date of the financial statements to determine the probability and amount of loss that may have occurred, which inherently involves an exercise of judgment. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company&#x2019;s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. For loss contingencies considered remote, no accrual or disclosures are generally made. Management has assessed potential contingent liabilities as of  March&#160;31, 2022, and based on the assessment, there are no probable loss contingencies requiring accrual or disclosures within its financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Legal Accruals&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to commitments and obligations in the ordinary course of business, from time to time, the Company is subject to various claims, pending and potential legal actions, investigations relating to governmental laws and regulations and other matters arising out of the normal conduct of its business. Management assesses contingencies to determine the degree of probability and range of possible loss for potential accrual in the consolidated financial statements. An estimated loss contingency is accrued in the consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because evaluating legal claims and litigation results are inherently unpredictable and unfavorable results could occur, assessing contingencies is highly subjective and requires judgments about future events. When evaluating contingencies, management may be unable to provide a meaningful estimate due to a number of factors, including the procedural status of the matter in question, the presence of complex or novel legal theories, and/or the ongoing discovery and development of information important to the matters. In addition, damage amounts claimed or asserted against the Company may be unsupported, exaggerated or unrelated to possible outcomes, and as such are not meaningful indicators of a potential liability. Management regularly reviews contingencies to determine the adequacy of financial statement accruals and related disclosures. The amount of ultimate loss may differ from these estimates. It is possible that cash flows or results of operations could be materially affected in any particular period by the unfavorable publicity or resolution of one or more of these contingencies. Whether any losses finally determined in any claim, action, investigation or proceeding or publicity related to such could reasonably have a material effect on the Company's business, financial condition, results of operations or cash flows will depend on a number of variables, including: the timing and amount of such losses; the structure and type of any remedies; the significance of the impact of any such losses, damages or remedies may have on the consolidated financial statements; and the unique facts and circumstances of the particular matter that may give rise to additional factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Class Action Lawsuit (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Smith v. LifeVantage Corp&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;.): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; On January 24, 2018, a purported class action was filed in the United States District Court for the District of Connecticut, entitled Smith v. LifeVantage Corp., Case No. 3:18-cv-a35 (D. Connecticut filed Jan. 24, 2018). In this action, Plaintiffs alleged that the Company, its Chief Executive Officer, Chief Sales Officer and Chief Marketing Officer operated a pyramid scheme in violation of a variety of federal and state statutes, including RICO and the Connecticut Unfair Trade Practices Act. On April 16, 2018, the Company filed motions with the court to dismiss the complaint against LifeVantage, dismiss the complaint against the Company's executives, transfer the venue of the case from the State of Connecticut to the State of Utah, and contest class certification. On July 23, 2018, the parties filed a stipulation with the Court agreeing to transfer the case to the Federal District Court for Utah. On September 20, 2018, Plaintiffs filed an amended complaint in Utah. As per the parties stipulated agreement, Plaintiffs' amended complaint dropped the RICO and Connecticut state law claims and removed the Company's Chief Sales Officer and Chief Marketing Officer as individual defendants (the former Chief Executive Officer remains a defendant in the case). The Plaintiffs' amended complaint added an antitrust claim, alleging that the Company fraudulently obtained patents for its products and is attempting to use those patents in an anti-competitive manner. The Company filed a Motion to Dismiss the amended complaint on November 5, 2018, Plaintiffs filed a response to the Company&#x2019;s Motion to Dismiss on December 17, 2018, and the Company filed a reply brief on January &lt;/span&gt;&lt;/div&gt;10, 2019. The Court ruled on the motion on December 5, 2019, dismissing three of the Plaintiff's four claims, including the antitrust claim, unjust enrichment claim, and the securities claim for the sale of unregistered securities. On December 19, 2019, Plaintiffs filed a second amended complaint which included three causes of action, including a 10(b)(5) securities fraud claim, and renewed claims relating to the sale of unregistered securities and unjust enrichment. LifeVantage filed a Motion to Dismiss the Second Amended Complaint on January 28, 2020, and with the Motion fully briefed by the parties as of March 17, 2020, the Court decided the matter on the parties&#x2019; briefs only on November 25, 2020. In its decision, the Court dismissed with prejudice the Plaintiffs&#x2019; Section 12(1) claim (sale of an unregistered security), because the Court concluded the claim is time barred. The Court also dismissed the Plaintiffs&#x2019; claim for unjust enrichment against LifeVantage without prejudice, and the Plaintiffs did not amend their complaint following the Court&#x2019;s order to re-plead unjust enrichment. The court found that the Plaintiffs had sufficiently pled their claim under Section 12(2) (offer to sell a security that misstates or omits a material fact by means of a prospectus or oral communication). LifeVantage filed its Answer to the Second Amended Complaint on December 23, 2020, responding to the Plaintiffs&#x2019; remaining securities claims. On February 2, 2021, the Court issued an amended scheduling order that reflects the parties&#x2019; agreement on a schedule for discovery and other litigation matters. On June 15, 2021, the plaintiffs filed their motion for class certification, and on July 13, 2021, the defendants, including LifeVantage Corporation, filed their opposition brief that opposed class certification. On July 27, 2021, the Plaintiffs filed their reply to LifeVantage&#x2019;s opposition brief. The court held a hearing for the motion for class certification on March 28, 2022. On April 19, 2022, the court issued an order denying the Plaintiff&#x2019;s motion for class certification. The Company has not established a loss contingency accrual for this lawsuit as it believes liability is not probable or estimable, and the Company plans to vigorously defend against this lawsuit. Nonetheless, an unfavorable resolution of this matter could have a material adverse effect on the Company's business, results of operations or financial condition.&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Matters.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;    &lt;/span&gt;In addition to the matters described above, the Company also may become involved in other litigation and regulatory matters incidental to its business and the matters disclosed in this quarterly report on Form 10-Q, including, but not limited to, product liability claims, regulatory actions, employment matters and commercial disputes. The Company intends to defend itself in any such matters and does not currently believe that the outcome of any such matters will have a material adverse effect on the Company's business, financial condition, results of operations and cash flows.</us-gaap:LossContingencyDisclosures>
    <us-gaap:LossContingencyClaimsDismissedNumber
      contextRef="i7b7712dd2ecf4cc990ccba081959ed4a_D20191205-20191205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF82MS9mcmFnOmQzNTY0YTg1Yzk5NTQyNTc5OWUxNWZmNDdmMzFlMWQxL3RleHRyZWdpb246ZDM1NjRhODVjOTk1NDI1Nzk5ZTE1ZmY0N2YzMWUxZDFfMzg0ODI5MDcwNTYzOA_4f4f2f9b-f6f7-4dc8-be89-b764d6240d50"
      unitRef="claim">3</us-gaap:LossContingencyClaimsDismissedNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ic9473e77deb447f2b4bcc4e5432b8e7b_I20191205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF82MS9mcmFnOmQzNTY0YTg1Yzk5NTQyNTc5OWUxNWZmNDdmMzFlMWQxL3RleHRyZWdpb246ZDM1NjRhODVjOTk1NDI1Nzk5ZTE1ZmY0N2YzMWUxZDFfMzg0ODI5MDcwNTYzOQ_d3493b3a-8c28-407e-bdaa-4ea0aa3daaf9"
      unitRef="claim">4</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF82NC9mcmFnOmE1ZmU3MWFlNmExMjQ4NGI4M2I3MDQ0MWQ2Zjk0OTJhL3RleHRyZWdpb246YTVmZTcxYWU2YTEyNDg0YjgzYjcwNDQxZDZmOTQ5MmFfNDk5_333a0167-cc36-482f-8ec5-59dfad2dc270">Related Party Transactions&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has entered into a series of agreements with GEG for outsourced software application development services. The Company and GEG have also entered into a common stock purchase agreement. For discussion related to the common stock purchase agreement, see Note 3. Two members of the Company's board of directors serve on the GEG board of directors.  No payments were made to GEG for software and application development service during the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three and nine months ended March&#160;31, 2022&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <lfvn:MembersOfBoardOfDirectorsServingOnRelatedPartyBoardOfDirectors
      contextRef="i40b4f0237f1545099548bf0d4db54998_D20210701-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF82NC9mcmFnOmE1ZmU3MWFlNmExMjQ4NGI4M2I3MDQ0MWQ2Zjk0OTJhL3RleHRyZWdpb246YTVmZTcxYWU2YTEyNDg0YjgzYjcwNDQxZDZmOTQ5MmFfMzEz_f086584c-2d00-43b3-904a-d9f156902bb5"
      unitRef="member">2</lfvn:MembersOfBoardOfDirectorsServingOnRelatedPartyBoardOfDirectors>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty
      contextRef="i8dd65cec87d94d2897061c2f0b29f444_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF82NC9mcmFnOmE1ZmU3MWFlNmExMjQ4NGI4M2I3MDQ0MWQ2Zjk0OTJhL3RleHRyZWdpb246YTVmZTcxYWU2YTEyNDg0YjgzYjcwNDQxZDZmOTQ5MmFfMzk4_3ec35094-856e-46c0-8499-90ffce56f060"
      unitRef="usd">0</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty
      contextRef="i74cd73657787445193edd1ca4da3a419_D20210701-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF82NC9mcmFnOmE1ZmU3MWFlNmExMjQ4NGI4M2I3MDQ0MWQ2Zjk0OTJhL3RleHRyZWdpb246YTVmZTcxYWU2YTEyNDg0YjgzYjcwNDQxZDZmOTQ5MmFfMzk4_515b9581-c2b1-4d88-800e-2a82060ad41f"
      unitRef="usd">0</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty
      contextRef="i632bfe9676454158bc03edbe6fd23491_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF82NC9mcmFnOmE1ZmU3MWFlNmExMjQ4NGI4M2I3MDQ0MWQ2Zjk0OTJhL3RleHRyZWdpb246YTVmZTcxYWU2YTEyNDg0YjgzYjcwNDQxZDZmOTQ5MmFfMzk4_85ff9ab9-b16b-4f5a-b787-f654bdb79415"
      unitRef="usd">0</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty
      contextRef="ic755febc552c421f91ad6b92bbb5e116_D20200701-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxZTc3NzI2ODY3ODQwZTM5NDk4ZDhmNWJiNTAzODQwL3NlYzo0MWU3NzcyNjg2Nzg0MGUzOTQ5OGQ4ZjViYjUwMzg0MF82NC9mcmFnOmE1ZmU3MWFlNmExMjQ4NGI4M2I3MDQ0MWQ2Zjk0OTJhL3RleHRyZWdpb246YTVmZTcxYWU2YTEyNDg0YjgzYjcwNDQxZDZmOTQ5MmFfMzk4_86580868-814e-4b5a-851d-9d7ec5aff3ff"
      unitRef="usd">0</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>43
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( +> HU0'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " "W@*-4TW&#V>T    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M2L0P$(9?17)O)TU9#Z';B^))07!!\1:2V=U@DX9DI-VW-XV[740?P&-F_GSS
M#4RG@]1CQ.<X!HQD,=W,;O!)ZK!E1Z(@ 9(^HE.IS@F?F_LQ.D7Y&0\0E/Y0
M!P3!^2TX)&44*5B 55B)K.^,ECJBHC&>\4:O^/ 9AP(S&G! AYX2-'4#K%\F
MAM,\=' %+##"Z-)W <U*+-4_L:4#[)R<DUU3TS354UMR>8<&WIX>7\JZE?6)
ME->8?R4KZ11PRRZ37]N[^]T#ZP47HN*;BK<[P27?R%:\+ZX__*[";C1V;_^Q
M\46P[^#77?1?4$L#!!0    ( +> HU297)PC$ 8  )PG   3    >&PO=&AE
M;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X?
MA1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@
MV2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?<D3$L/<@HL(2W@4R]9<
MX%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A T%116F]?(+3E'S/X%<M4C66C 1-7
M02:YB+3R^6S%_-K>/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1
MTDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP
M' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG J-6T_3:W?=
MTXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@ %AP
M=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9 %#@ WQ-%,
M4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']I
MJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88<G;CL3<CH<9T)\S_;VD:4E
M,L_O^0KK3CQG'U:6L%W/S^2>C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZ
MY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C?C8CWJV^:/5>A
M6$G:A/@01AKBG'/F<]%L^P>E1M'V5;S<HY=8%0&7&-\TJC4LQ=9XE<#QK9P\
M'1,2S90+!D&&ER0F$JDY?DU($_XKI=K^G-- \)0O)/I*D8]ILR.G=";-Z#,:
MP4:O&W6':-(\>OX%^9PU"AR1&QT"9QNS1B&$:;OP'J\DCIJMPA$K0CYB&38:
M<K46@;9QJ81@6A+&T7A.TK01_%FL-9,^8,CLS9%USM:1#A&27C="/F+.BY 1
MOQZ&.$J:[:)Q6 3]GE[#2<'H@LMF_;A^AM4S;"R.]T?4%TKD#R:G/^DR- >C
MFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1VC?"J_B"P#E_
M+GW/I>^Y]#VATK<W(WUGP=.+6]Y&;EO$^ZXQVM<T+BAC5W+-R,=4KY,IV#F?
MP.S]:#Z>\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE"<M4TV4WBA*>
M0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KT
ML<QP3A[+##MG/)(=MG>@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K3
M4I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.'
M>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)58#%;Q@,KD*)\
M3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^
M:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON<K2<15.+]%,[82EQB\X^;'
M<4Y3N!)VM@\",KF[.:EZ93%GIO+?+0P)+%N(61+B35WMU>>;G*YZ(G;ZEW?!
M8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4<!A87,N10[I*0
M!A,!S93)1/ "@F2F'("8^@N]\@RY*17.K3XY?T4L@X9.7M(E$A2*L P%(1=R
MX^_ODVIWC-?Z+(%MA%0R9-47RD.)P3TS<D/85"7SKMHF"X7;XE3-NQJ^)F!+
MPWING2TG_]M>U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83
M+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL'
M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MT3)J@+EXT.)AI'$&8G>&IB)*WC3]NOK#FZ&5P2:8Y[3I&VE<@OR:2YQBJYO
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M(X[0?HLGT[V#/+LG[_.LCDY [5+0E%5YGKWAZ$,BI/Q8[^2,(] -N.MJ9F)
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MH=Q!9/=8>AU+S\KRCZH4 FVJ\CD%A],S&G6QX^HL 13U&=5HFBA"/8\Y&D\
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M8LZY^O<DEP,,K088 H<[P#821[%%EJ(;]OAFQESMD]+!)LP(XSC2Q[KPCW7
MG\-11+$^UDV[:JSK_O, JB]DEB92E,5NRGKG:B]H\4&@Q0JTV U:<*[VLA;O
MQUKL9RU0$\A:P YD+:3,QEJB6$O"YY^KB0(J\3B=!P2)B FK.(ZU5O<8-64J
MHA&W$WE$H(B8SJ/L<Q8AM7BGFVU[1HN(R;$X-L*7;J.F0L4Z<C3K#HX9$8AP
M-H6*<.1H-W&ON!$Q_3X+=8D"('$#\'D"1\3D9 M;$$ 4)8F;DD\7."( VCC7
M_7"?5?.Q%-F(FVPG!(Z(B;06X;:&5D0C;J(=&#@B %BH&3CRFC53#XHLU.W%
M'1'(H*;;AJGF)@T\1DVU"D34#2+WLI>:5"$1TE=B/JNF- 4?ZH&/<W$LL;U;
MD8+K*PIEWI MOD(5BJ@'1<;BV">E0TWB$,9T[[5+_:DWH":Y. [UG$@?L).+
MX]#L5*8=HY8E**VEWUX@_T85Z.CY,G#4A!J/J-[J;J.F3,4^>O8L'#5!9INO
M%,;H61)Q%(A6ZLWD,FFJ4S2BSY>*HR:>L&6)3!6<Z--FX^C>Z3BF$,3^'])Q
M#$C'(<NH8 I([*72<<R,,[:D9ZJGVX$08MVJ^5@*9NRITG$=!J3CL+Z<Z8)6
MML@O4[1C9TW:,6#3!Y"T8P<E[9@"#WN)@",SW3%;-I35=HD\5]*.F;%)+/2%
M P.2=L*R%F(*8>SL23L&^&*4$FU=XK-JZE6L8Z>D[1@0*128ZGW78]64ID#'
M3DG;>4/!#(@FVD/!3.&-'9JV\X:"&1"P T+!S!]*!&H"0\& '1@*ANJSA8*Y
MHBT_8]H.?'D<2-L1'EI>'E<LY2>F[<#WQP%WCD=Z#JW+_6D[H":$XY!J7:$/
MV+5B3/2=!P.H/ELHF"LT\Q=(VW%%6.XF["'>"C>YR2G36]UMU)2IT,K=:#UF
MSR# 3=O.1<5-[N;FGNX*-WF'"-%;RFW45%C;7.F!XAE=%FYRD-JF!45![J;@
MJ2X+-PEH>ZT*?]R-O^=Q63@0H$2V]E2,Y&Y&/IW+P@&P2:SKW=ACU=R?J[@F
MW%P[(1 L ->0VG9="<4SX>;9@<Z( +!":*RO'KQF3;6**\+M\CW-#D(!Y-<L
M^Q"$8I!P,^A\SH@  I1")Y3'J/D0BE#"X_P=[HP(DU!RY&AR!SZKIEY%,G'*
MCA-ALHD08\.3SZHI32%,G+(OI;Z9 %S/"FA?"K;YS*)V9.#0?2D^*1T![$L1
M!.G1$^'?EP+4)!>S$3>F$VA?"F88Z[T*L",6CUPHCHH3]Z5XG1$!>9)69T0H
M2HHC]J5XG1%A>HF0,P*8&>\/<B8!9P2P YT1J#Z;,Q(IZ$8OL"\E4H2-CB:L
M+TH6@8%36TPO4AB-7@"CG0C(#EJU*HY&;HZZI_3(#(Y29IL5(\6]R..9[1TY
MPN !)6"S"6;"LJ:(%-XBCZ/FC!Q!4CH10#,:$FTD=R,SX*D/=J F1$*!]& >
M8->*.=(S@ /(CEG[B^)LY.;L0;L(P=DZ.@BUD4)MY$:M=Q<A.%M'^]$V\M,6
MJ FD+6 'TA:RL]$VJIT3C%Y@ME9(C3R.YP&AH\C$E6#ZPMQCU#RNJ)@6>W;$
MG#$@$IN>);=,5;&B7NRFWLDG*DWT6::&6&$O=F/O>0(B,9 UM+UO1<'8$]%\
MLGA(#.0-=3ST/$;-AU*4C=V4/2$:$@/^(V6V4\ *L+$;L =&0V( 803IIW'Z
M7K.F6H6Z^.RIPAA( B*A1;\&/JNF7@7 ^)1486SB1!?6=]LT92GBQ*>D">L[
MT<#E0@PX=SBR;2.,:T?2#TT3^J1T8NC$@8CTM4+L]^R FN1BCT5ZL 2P:\6,
MQ?KI,,@.(]N9T;!^2OX%G#L4UHZZA^<[=K"MJSD3:-YRSV>E2:T=7P^/=OL.
M7C1LOZL1-+4=NPYK!]K#H\.F>ZT;MO7OL7! 8>WD>NA&U7/=Q@!@S;)V0&'M
M,'OHV;WY=/<QA*;C:"X?ME9[K1]06#O@'KH)>$)L95MU4Y.Q!PPVLVU>0V'M
MN'OHIN&A=S>$IH<GH:SO >EO[9C53E-<.P4?'KUQ](2PT?9;&PE9/3[A,=(>
MJ7:"/CQZJ^FA]SR$ %5U#O:V5LQBI5VX4N.@Y[J88^YZ@"Y_P;%QVX//3--<
MOR7FE(,2"+C%!2&]9_2]9IJ\&BX]U[V<& 1$P)TOCB@@JM_ZXKGVY8@XX+;*
M1M0?" 1"=L9T#ME H4#($(P%@H9F,+!=NY6PNJ92/O7]1*Y5INF=+!:^J5)W
M^?KBQ_6',ENL+BK\FI5E-EO].$X3.;PK _GWNRPKMQ^JNP]W]V]>_0]02P,$
M%     @ MX"C5!??N54 !P  Y1L  !@   !X;"]W;W)K<VAE971S+W-H965T
M-BYX;6R566UOXC@0_BL6MSKM2<L2VX1 KZW$ M56:@LJ[>UG-S'@VR1FG4#+
M_?JS'9J$V#';?BAY&3O/C&?FF;$O7[GXF6THS<%;$J?956>3Y]N+7B\+-S0A
MV5>^I:E\L^(B(;F\%>M>MA641'I0$O>0YPUZ"6%IY_I2/UN(ZTN^RV.6TH4
MV2Y)B#A\HS%_O>K SON#1[;>Y.I![_IR2]9T2?/G[4+(NUXY2\02FF:,IT#0
MU55G#"\F>*0&:(E_&'W-:M= J?+"^4]U<QM==3R%B,8TS-441/[LZ83&L9I)
MXOAUG+13?E,-K%^_SWZCE9?*O)",3GC\@T7YYJHS[("(KL@NSA_YZW=Z5,A7
M\X4\SO1_\'J4]3H@W&4Y3XZ#)8*$I<4O>3L:HC9 SF,?@(X#4'- OV4 /@[
M6M$"F59K2G)R?2GX*Q!*6LZF+K1M]&BI#4O5,BYS(=\R.2Z_GLP?IK.'Y6P*
MY-5R?G<['3_)F^63_+F?/3PMP?P&3,;+[^#F;OYC"3X_IV07L9Q&?X$N>%Y.
MP>=/?X%/@*7@:<-W&4FC[+*72V1J_EYX1/&M0(%:4(S /4_S309F:42CT_$]
MJ5&I%GI7ZQMR3GA/Q%> X1> /(0L>":_/QPZX.#2REC/A]NL3+(-N)$ADX&5
MX F8;ZD@.4O78*S<F.6,9A>.[_3+[_3U=_HMWWF0<<_2D"?4M@;%V($>J\)[
M?]WW\>"RMZ\;QA0*1L.@%#J!Y9>P?*?ZX^A?Z<DR^/,,Y%Q&?\C3D,44I"5>
M]5S=A<I26\'W3#H">#D 7IJ*_):I!B6F@=-44RK37LA(D4S2")"$BYS]IQ_8
MK%=,Y]<,@_I]W+">16A0$SI!&I1( R?29<[#GUV5JR(@3243>-8*,C"^#_$
M-4":0@A"WPYR6((<.D&.:]8#? 6$2I]=ONKN,@I(EM'<FA:&)EZ$A@V\IA!"
M<&#'.RKQCLXL_XH*(2WZ[G[DS89O9+$G;, S97 ?VM%!KTK+GCMC;$BZIIG*
MJ[4(T';4WAHS\L+BL]$ :SP W0L8AGRG E1&!65[\A);<\AQEKJV?C,(+#+=
M@=^20R"J$"(GPMMRI<YA1*;#X'X3I"G4#6JA<@JR2O00GP&YEVF.B\,7E<ZL
MZ+#YX7Z_Z50VJ6#4YE85/T W02P$W1(6 ?JFT@@M?(GG&RJL4/LF")G/FO%I
M$_/AL 5K11K0=V*=*U@@YNFZFU.1.++(<:*3,#4M:@H%;?:L2 2Z6:2,FBTY
MM+JC20I=&'A->*84'."6+ <K[H!N\J@%C0NB20G=P&_RADVJC]H@5LP!W=11
MK#,)0[&CE6=:89I,T!T&1F1;I/H>\EIP5HP!W91Q1R4%UQ.O%:+)!MWAJ(G0
M(@1'@Q9O1!5I(.]#$7,&ZW&VDSSI-Z"Z94YQ5ER#W%RCRE1=$B]JA9ZM)K:B
MMC 0#)HFMD@%P]&H!7G%00A]J)!7Z3[[0"&/*B)!;B)9[$2X40XGBRE9#TOC
MY >=K>FO'=NJ6MIJ' MM0)FRF]:QB&'4ZH 5O:#S_8<VT7.F2RNK?:RX+11B
MPVT1<^"NJ :Y&Y3FLMZPE,@.Y?>7M2(,Y":,1[JM+:PJYTEZ )DJ\:UVL7#'
M$!LISRKF>2TI#U7L@<ZT'ALB9)$02F/06*XH5QM LFR67;JJG8GF/>6+2AG%
M,:\LWVQX'.EJU55:( N7(*_)V38IB$8MI06J* >Y*4?FG9#2Z+C:<A42V;7H
M10 LRQ0-[92*@";;F!\H/;XKEVX;$VO[A4SJP4&31BU",H&UJ%2Q$W*ST^R-
MBI 5;L6WJ@VS!YJMHVD6\#8AS^O;(>**GK";GHSL8 LS&VALDI!T;Z.$LHD%
M\J\%=T57V$U7-UQ0MD[!1+M^> "SU8J&TN=3K8X5L:4%DIUMT] VL7Z;G2N2
MPNY&:4I#H6L55@#4D:@O9I([]B16&S$75MB6ILC'0;/@MXEA.&S9Y\"U73(W
MY[6"!7_^,400_0U>Z)JEJ?(818M4,!Y9]3#Y#6%HI$V;&(*X);W@B@:QFP;/
MZT%5;G1J8#(=#()1<[?.)C8<^2T5&JX($;L)\>'HVS4"5_I\E!=QQ8O8S8NR
M3RE]UE[N%-L>S1J\R.#Q<6@HY=B^)8F8'&DD$%,$^VW;=[AB41PXC;E\7BSN
M]&[Z^ Y,;Y>3N_GR^7%VLK,.;A]NYH_WXZ?;^8/+H!7%83?%Z=73O?Y*LC9+
M94,@%])J&,LFG&$9BTQ;7JTH"[LIJPGQO5-M6;^1L3.-?-\(:5,*8]PL$'NU
M Y.$BK4^1Y)UCNKEBT.&\FEY5C76)S2-Y]_@Q:0X<:JF*0[ [HF0J2J3KKF2
M4WI? VD[49PI%3<YW^ICF1>>YSS1EQM*9-6A!.3[%>?Y^XWZ0'FR=_T_4$L#
M!!0    ( +> HU10^P8CM 8  $T0   8    >&PO=V]R:W-H965T<R]S:&5E
M=#<N>&ULK5A=4]PV%/TKFNU,^E##PD*;- %F@"0M29.0D*0S[?1!:UW;*K+D
M2#++]M?W7,GK74C(Q[0OK"U+]YY[[J<X6#A_&1JB**Y;8\/AI(FQ>SB=AK*A
M5H9MUY'%E\KY5D:\^GH:.D]2I4.MF<YV=GZ:ME+;R=%!6COW1P>NCT9;.O<B
M]&TK_?*$C%L<3G8GJX4WNFXB+TR/#CI9TP7%=]VYQ]MTE*)T2S9H9X6GZG!R
MO/OP9)_WIPWO-2W"QK-@2^;.7?++F3J<[# @,E1&EB#Q<T6G9 P+ HP/@\S)
MJ)(/;CZOI#]-ML.6N0QTZLSO6L7F</)@(A15LC?QC5O\2H,]/[*\TIF0_HK%
ML'=G(LH^1-<.AX&@U3;_RNN!AZ\Y,!L.S!+NK"BA?"RC/#KP;B$\[X8T?DBF
MIM, IRT[Y2)Z?-4X%X]>^5I:_8_,%%DE3F300;A*G'L*9&/Z<C"-T,4GIN4@
M]R3+G=TA]V?QPMG8!/'$*E(WST^!<00Z6P$]F7U6X OIM\7>;B%F.[/99^3M
MC8;O)7E[7V%X(4Z=#<YHM>9ATWRFXZFVTI9:&G&!14)<QB#^/)Z'Z!%9?WT&
MT?Z(:#\AVO_?7?%_R!6_Z8K>2[S5!#I\YWQ>QU8I2M=VTBY%Y1"3I 36;1^]
MKLFZ5I>A$+$A$6*OEBRX@>7I^ZC3RMA[:0P^EV7OO;9U$NIZJZ"@JI"EHNE;
M:05D4A#1H5!T0!%%[9P2#4D3FVWQMF%X&0V@(;AT"7\H/M"0Z5AP1ZXSA(QO
M-%T10]-^$%"(!2H %(0$JQJ]6CMIPDWQG7=76@'+AUX:'9>%"*4&7[J"2IBR
M=253R$ YMJJ^C EVSEKR68-&_*."*IP32B-:]+R/CC^&!(5_Y1H'"/*TD%X-
M!+4Z</W;XLJC(, S3T$:H'*)G=X"&:O5T'Z7LNT;WD5--"'M'V%KFQSX#L*@
M)D4X?/J"KG7I"O%,@H]"'/<<[$;+0OSJ .\Y_B!UI)4*2V\;J0TL+C8E/8<9
MRK5Y[27AK^<]D/T+H:9:</I6ZL4HG65?=.@EA3CSE,6A<]2ZAXR7J/%_P(MI
M]0*2)0B@(M',\L\;;72'"*!;CH1GW1U62\1I.R?/45LB& &!;GD1G0\1Y8.S
M"),2A:)ONUP5K%ENBS,(44KG.A(WM'Y:X6D#5V.?=WW=0'U^EQT'&P@KO0MA
M:^Z\ B;:X@@@7Y*8]T&GJ&V=(G/3/ (3-8U.U&H5HQD3)[GT)4)?(1N,Z[AV
M%6Q6VYMU5>"@8A:DND(H LIF@N?N*3F6($931 -/^6ER)2R$=2YZUZ5:@/%@
M*\F$45MS[6):7:0.B>9E@39C")<Z*T?L>%%*]N9<QD;<DVWW2,R=6@[NE;XF
M#B@$A:9J9/0&$?>^>S#;O?\H"*Z ;,J=Z?H)"\!>:7K.=O98960=&MVA1+H(
M +H5][[;O;__2%2RU285N16&XD9R#=M>M53+'_#V8/_![)$H6-")=AL+9Z?B
MQ"=&UFMLZF/)\G]?5:G5QT] AO&^IPLVLAP5HR9N!.'W&V1<<E8QT?^%XYQ+
MF-\N*>8"E\/\G&[25"0:<]O@".LP7ZZAC\&7ZS:V 9%PUZD!7W$C\6P[@D.Y
M&@0?7R?JLH&0.P8;8I]\O10*#>42\]$UEZW4OIME.'N]02T?"\ =/XY#$98!
M'3W;B01'_G"Q+<>9@#8;15BW_R%DN#EY MA& ON<R'(&=(AF)>;+37>,$;J9
M! L=&XS+0O:H(DB>WH<>P<3$\%'?<[%GFSS50\*F[LT?+YZ<I@K$S^###L/*
MEU3B>T"AL)$\7/8YV^!OM"CU-ZIA7H\-/ 73$CTH-6RDI1+NXNCD6HENQMG<
MW1J@4EJ-FCH7AN$@V?*""]0XWJU+.F1@O$Y;< _Q@_&LA;^BBA+E\8*#O,T3
M)_<_=4MBVH2'W;7H4H8&>>X6:WE?+84YS]RM #(CUL61"LYA=.-4A*]2_JUV
M#A3UX'6)NBSPFI9XNNHQ)!$W&^W4MX=C(L)%^C@P&=W@#RR"<D\?>CW$)]]N
MQ.[.UNO,C7+)$*B+Z,.B))]^M<TWP#02KL0/'>=VJ*5(_C+*%>V5#BC0F8U,
M^[,>CMC;*0:7?7M*/&56>\_SQB9R;H85E@8Y7\#'IPE;<XBF<7% ?#?4//+=
MI$=:BP$2JM,T"_Y6C#_GETJC[W(-&-%_ZBXQW;CB82*HTT4VY)$EW_;&U?&N
M?)ROB.OM^:*-F*XU^#)4X>C.]OT?)\+GRVM^B:Y+%\:YBQB!TB.&9Z0Z;\#W
M"M5W]<(*QO\@'/T+4$L#!!0    ( +> HU1LF-S\ !L   53   8    >&PO
M=V]R:W-H965T<R]S:&5E=#@N>&ULW3QI<QLWEG\%I75FXMJ6S%.'G:1*5CP;
M9S.)QW(R'[;V ]@-DHB;#4ZC6Q+SZ_==0*.;I"PG,S55^T7BT7AX>/<%?G7O
MZH]^;4RC'C9EY;\^63?-]N6+%SY?FXWV9VYK*OAFZ>J-;N!MO7KAM[71!2W:
ME"\FH]'YBXVVU<DW7]%G[^IOOG)M4]K*O*N5;S<;7>]>F]+=?WTR/@D?O+>K
M=8,?O/CFJZU>F5O3_+Q]5\.[%Q%*83>F\M95JC;+KT^NQR]?S_!Y>N 7:^Y]
M\EKA21;.?<0W;XNO3T:(D"E-WB $#?_NS(TI2P0$:/Q#8)[$+7%A^CI _PN=
M'<ZRT-[<N/+OMFC67Y]<GJC"+'5;-N_=_7=&SC-'>+DK/?U5]_SL;'JB\M8W
M;B.+ 8.-K?B_?A Z) LN1T<63&3!A/#FC0C+;W6CO_FJ=O>JQJ<!&KZ@H])J
M0,Y6R)3;IH9O+:QKOKEE9BBW5+=V5=FES775J.L\=VW5V&JEWKG2YM;XKUXT
ML!^N>I$+[-<,>W($]I7ZJZN:M5=OJL(4_?4O ,^(["0@^WKR*,"_ZOI,3<>9
MFHPFDT?@3>/AIP1O>@3>@5.J_[E>^*8&8?G?1S:8Q0UFM,'L7T+=1V&CMK[T
M6YV;KT] ';VI[\S)9VRH;ESEX76A23L^K(W*'?"I\J; 5_(=O%G:2E>YU:7R
M#7P &MEX9:N\; NC&EBG&;K'7?']C=ML=;53NBJ4A8_OUZXL=Z?NO@)HOEUX
M6UA= PYGZKH$J FBMFI,G8?U 2X" IY47I,JPP>U4::TH ^$H:T2C.&!,_6S
M-XC-&]]8T%PX[8<$+R#7%B!X0O9S#HUXU*:D!PKK\]+Y%N'P_F@A;;,#!6[6
M 7>D^+8&8MEM"0^N3&5J#<3 [\U6<$<T?JXLOKMM"%M _7IC:J")^O*_KJ_?
M/3]3;RO!&T'""CA@AUG6H[OU@.4_6EL#P,:I%AXUD1!X!NW!!F^9E,U:-THO
MEV E"0CLX6I$16\B4^%Y(\<OK5[8TC; /=ZTHP,^"63 ,P-.1Q8IS=L@E8.\
M'*7U,7QJ<V>JUM SYF&+[/.J: -I9 W1'HCH"I"SO&D!/C +K+4'--L260C'
MKA72I;;$E67M-@#!/4:Q,_43.)-*N6KE< OP"7;  , /O0<)?X23B<[ FDPM
MVD95KE$HPPVQ*9-]@WP!XVP%QVP<J/.=+EO64T3&+4!.C<]-E9M,>8V259NF
MK2O>Q&U +_6#H ZODO5B*1!A5"@\/\AGC@?9&,"@<*5;L>ING;=T8@ *Y[(U
M,J83!]AY#5ITBCX1E6>#?*!-,F:Z\[Z3AYS4'1PIN,E*W;1U#9_MU =$HF34
MKA5Q#5[U[<B?_N-R,KYXY8%H'FP@0(60I-8LOB[/VQK^M0U8%;.O2F>D^:7+
M@?MYV!7@&YVOC^V3FBA4IDYKD:'+MB(KE !D.W9,X$$S&CDFZ3MP]N>SVS,%
MI"YU31IA'O*U!C*IFB3./%A/XBO*LM E* @H/(5I!4O30248; ;K[RDN,<6I
MOH-#P!:#O7 Y1!GY1S#2A:F]4$&A 6G$EN2N+AC:&A!S:)?* 1RF,^L78KX4
M3D>:-PFG=?$K1#:BY[5)=H#WRJ.50_. ,N4J$;K'<*P>L^0]X@5MAFUZT.$-
MFM<U1IMW1I3HC,63G8Y:083KHV0+K<4-DAEW@$0=6)&IRC2?P"RQ=H!"(M2X
M":*WCQ H$$%LUK4Q:L/AE<'P2D%P!"(=HB." 2_&C,@>.^0,L.^ST=D8(LNR
M#.8%/IB&#U#,_-90Z%SNLCZW#IZYP[$"9?VGH3@;HCCY(RA^"P;_3N,*\*L0
M[K6=S_G.%"L4X&L$R!J<Q Y_'E@'@_$*ZW0O0*$8@&T,;7^_MO!ZHW=D]1?@
M_TSEDO"%O58X1F^//Q^P.#8H7/ XWIB/'GT&^/P6A)T\S\.6_3)\O"Q;](",
M'.P7B#TP!B!6KEVM"9V60Z@BDFJP9>%@ 9X&'_0M'*][-''I-J'O$B6CUN@"
M%;S$X[8E+]BV-6!+>SBU!AX 2M;#F<"J.@"$="*B4L# V)\&43GM4S,)(5.F
M]'TT<2[88P!XK^MBGRSHOS 9\,+!>UBC- :MIFE*M"X[@FK0+2]!KG*S60"_
M4:Q)G&@!4JDP&.=R; EGYR-V42+1%AZ5YX&/NK2_P<-L=F"%J /1\%/:_W1#
M,>YV2O1M<IZ-1J,T%@D4B@3YE]F"0_@<,%&S8_K_QY'N2;DMB'WH>11]T EY
M*MK@&X<LN-%^3=C2BS?@JR ,HX?3#= C6'1J$%!*A %T,@UF<:6%144(+$C\
MP?F">0*]@I@2 EZR3Q3&)&Q&8<$P"=Q<'G"@%Z;#X0SS/X@@&_8Y".,&U,$V
MZCVH79HPK@ %<J H>8?U6K(-/T@&TL0N3W<CE'/>#K4< *R 3X2TQ&2%6>&)
M$ J:%GP*I.G@[D27WEX)Y)"G1D)@4"VQ!X1M0Z[U;<1:@ZB-QV<74?@PTR-(
M,36%\*$:VCO;M#%8?W:>R*ZM^BM)^ ZN9>2^;P'V=)2):NSC=M'YP=^'V^AW
MXD:,.J## XSQHR0QXW2,$N^*[4!V, *G<TC@AHXL-P;U=0E_)1"O4,@*SI\0
MGX#Y>[# (..+TJ1:%@''$];=<_I)9V%%]0VF2QMPS.4N$>(<K4P'$A!Z35F1
MJPX>#R)QDE5BQ+9V.0H^JA<7_(#N"5P.2Y+ VU9<BR4NWFE;XI89&(0*PGO*
MT=9PI,* ?P.?B):04OP*_9:[CZI<N';1+-LR*=]4O?.$Q+++1S%S#ACRMT^D
MG>5(H3)X4K!L9^I'!_P%V3"+)EA?=:^39".1&C9N"/7);@3K)2%Y?JJL=NFV
ML-J03_^2PC/7>ECBG[], ,7U8)<LI!?@K!U*]S,UGF33V:6ZF)]=J2_X_60R
MQ_<7\/Z]OH]%!Z^FV=7D4DUF8":^H#<C?#.%-Q]<0^P.: &<\VQR<:[&HQ$H
M[A?\P7@VCQ^$0X>\$_@(KXN01P+[@7.4[H @@PQ@W,W^EC0!RP0@29AFKZ0R
M4_OFU(*/Y5>09DN9(). 2.PK)E04>C9B2OJU"W'CX\3<B!N?=Q\,;?$A'AUU
M]5P3:5A,/!ST=./N\!@1$7 ?VM;J%T0'L>F<29H"I*XY*@:JRY'LGFFE03_!
M,@'V9!6Z<DMC\G4%7AR>7 2+<+\V9%N1P+;:M@T%[ES].;@2.0GG,S7;*T"F
MK;KW9^JG[CN!5YLEMCU RNJ/7#'0 *'19 ZHR&5!>[:H0F NO&OK'$L*P%*
MD0(? FQZJ9" [Q7'/E!ILKF'$^VVS'>!L=80,X&!89:A= $_3DD\$O(ML$^$
M8,!F=)_&""-U@4 U,'#@ 7XS:<9R"'\JA'$I-/DR(0^H_S*UIO?HH8(-I8(&
M"@\A>Z;0D$_.7ZD?#,BA&I-=G[SZ6^OP9%A.DSC=(GG%9G<B9D,O2O;WKP8
M)T<!>CALJ>O'P67J'X]@<AR*+!=W(6D+@V9'OG&%*4\I  ;H451I,5L#O5?.
MC]1//V:>%PBGWA/O ^3!]7T2385$OW1(!+Q(O _J4403HR*@PP:RO4/H$HD>
MP[:O?F^X"N4AF96 ?&W*F!E&8P+K-D9SV ($[N0);8(&8E<U0JAC3?D5<R(4
MEX,!$L8\ FNO-HW59ESGV\6OI,4N79)6X]B<)5_*-DFD?4B]OBR9*\\SBD)-
MC:9&Y;;.VXUO.(K[TIRMSD2Q&LIU0</-'4IF3GK;%9F?GT$<Q]5-B.<<L()8
M&3Z3FB1\C&DB :0,SY4A>X"8:F-]=,C(4,"8M"%62)>FE@8)E>@DKJ$#8*Q$
MW0;F@!B_V"^B?$VD*ZTH/&SY*8<%'M0WJA!0(;^K*'#^CK9^#[<S=8M!5<:D
M/]4%Q<=4\6>'037]II<\EHP9IE=4#&F825(</@5"@%,F%]75LZA[]B"%2U(7
M>;R?^G+9NY$M-_I7B"L:\F^6/ (S(Y2,>*=&XD(X=*!H] GR1+]W^*Z&(*<J
M[ 84?'PQ>Z6PS4EU)\LYL&^WVS)TN7ZP2_,+Z"36L>7YGS:0._XGFH?9Y>25
MRA#B:^N2#][>J-<U%L&3SY"HWVH,XO]NRI*:"N'+@QM_J%MSFUL25=G8?\2X
M: TB"PJF@>9_TIOM*[5PQ4[Z+O7*H!F&*,6:)2!F^B?-U/4#(4KO*N= @K<V
M5TCVU0X-3O41'-P#2D3HAKU;[_S;OT5</9C(4.)/$P"_@^AU,R@1KNT6:PN^
M"2P,+"O L^9-N8NZ "+>8HS/_4[,:@S7/>$ #7?*T-)O]8YV0Y'NLU\JFIBG
M',R2MIBS!74F"60<'I&B@=:W6] ^/!)B$(-1S]9@"[82102M 2HA'P3+ ? )
M]:6X;<3U*0ND@N-A@<?BVOPC>ZQ%6Q6E&90-8UK%6H$4*72)#L6#($F[%X1$
M-['JA/)N*#PB2E%5N* &#WR'1B"REU.T/.I<4KT4L.0J*.RE,O&QW<GN0U9,
M!2P?DOHZ%ARE"$E]$*%\%[V+%.QM#N8)Z+TE8X(9*?RA+>N#9KG'H&CUL0)
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MT6N*'!KLCG0<[>;(_F(6=8O5*VZ"7D-H>+\/%V-%22!@S0]F;1DVOOM>5RD
MCKF1F"%CE<.$86#\*$%/MLCV%#Y&$(-#1VK P=![=5->0'/-9H8@\ 0.&V))
M,<->Y)86QE0R_A: 6VI3WV$IB+N0(>\<YIMILYRJM[^9VK$4-M2$#0HY0/X
M+3KN/C%4&H?0_;(7(%G?BP\DW<_",++D.P5:!T]C-7<=C<,P&;7=AW1,$HB
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M,5:*+\?.$,F"I(TV@KN381 X/ VTWX)" H')<(CZ110Y]A/V]?!D'/H<1:A
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M@(@_=CIHX:^07OO"IE??&OS!!&ZBB1A0HD:#FS35*,(<?<,[8.<M7O+&ZPP
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M,>)P"V(H$%CL]_ -EF-SA]R[2]!B**N: @'(_RHL+&"X*/DM=9_Q%=[ W6S
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MC]30.CA+PWPV.8=;?IJ(Z;U0';Z<$,K;)!Q/<GCI,8V.IE"-9N-GK07?^OU
M&G:'<7[53[%_U?O_ I3UC:0;5%B2:3RZ& =@^OG:+YQN_4Q;:4<3THL5_25!
MPPIT7FKM#@MV,/S)67X%4$L#!!0    ( +> HU2_7D:YO @  &,:   9
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MG02-!A=-H%:F#F#RPM<)44!6B&*F%MI:BE83CSDJ'K;E30!"L)/X1VU54UN
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MX<S9;8H^6QWQ_\<(F2 ^><[J1GS@0TV:/6&6Q[1)N:.N]+"?^B"?-G9&&>-
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M+818#ZJS!A&@JFE[WF,-M.&HF##/8Y0_,EOQ5,*#%-T_V!\V9=BP!:C'/J"
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MR\GQI%_X8%;KR OSJXM6K^B6XL?VO<?3?-!2FH9L,,XJ3]7EY/KX_-4IRXO
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MGC9\,?H6?Z A?4X:E<O9_;(Z>X+H"2^[,FH+,QE1MU4(X&?T2"ER@$I35<!
MYN\UA6W+YRSDPN_C(H5?Z+!6%2ZA@0/8%Q-TXX+K.[HM^G;==W!XK'%.$3/S
M<'9:[:,I.!S@?_0#R#^(S^-:;1/Z4,$<D\]R=1+@\'&66Y)JW#"*!-H-IQ2?
MD#Z?EP<-B2*;,\1Y,$A@->T:SEZ_X9.DC$BJBI\&RT8($IQDYT?\)J/P: XE
MB40_#G1H_3Z,N^F0:FY&714<#C5?-K89N3-U#=>XH;+^,3EPT^68CNGA7"Q
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M3J?;-J1W,B*][2?O0Y]IYZ,/XX#$2C[_RYAG8_Y&/JP.?V&XSA_6M^+YSQ,
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M9Z-@'PV^**S]T1I")$MK[\/FHYPD_2 (2\PI, A^;?$2RS(0L8P?+6?2N0S
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MN15&1K9";!E:>ONKB-QJS4Q<Q_D]5.R+A>)!4 ^XMT JSZ7>]GD3+H.)_;P
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M@\&SVJ'#<N8@@)RO@J:3S'VF:5G^!G@M!".K^ATFK/AYLN+GDU;\#@+.K40
M"W$=0$G7Q[R_JW*-O%T@OB7EC)GU_R/Y/#5^OV-7"B$!6\,  U"*8^L$U5M
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MFJ']#Q/2G6^Y6TW<P+U8\XN)QBGP?J4UO4S< >,;O/D'4$L#!!0    ( +>
MHU0?HEN'G04  +47   9    >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;+58
M;6_J-A3^*Q;:I%;J2F(@T"N*U,*E[;3>567=/DS[8!(#5IV8V0XMTW[\CI-
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MI?JFZ$EBVMA./U!*! _=!UXE9DT/3S=%U!)@8H.%*$A;<EI@(4PZ&]$""Y+
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MS"LSCT3@@"4/-);3KM6V(,8QF2?REBV_8V$HT'P12X3YA64>&_@61',A65J
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M,W4\\;R9RP>2S4RW\LBDZGW,XU0UP,AU@'H_9DRN!UJ@;*E[_P!02P,$%
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M&\S]I93X/K$MO3N1)W\!4$L#!!0    ( +> HU08[PF,A@0  ,D2   9
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MZQN-Z",.L:B#!.^%*6?@"T^IOB3H 2>YZB ?"1?]J'J,Q,4*4PD0[_>$\--
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M^75-";0800"_+].4;R_$6PB[UWG._P-02P,$%     @ MX"C5*]NJH?S 0
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M=/+!@UW?M7U MHV=LK7D^RY.&__0P84$O[^SEDY!:+[QUU'^!E!+ P04
M" "W@*-4R7U];*<"  !6"   &0   'AL+W=O<FMS:&5E=',O<VAE970S,2YX
M;6RU5MMNVS ,_17!V$,'#/4EUQ6.@2;.N@(K$+3K]C#L0;&96*AE>9*2-, ^
M?I3L>&GA>"VVO<06Q7-X2,EDPIV0#RH#T.21YX6:.)G6Y87KJB0#3M6Y**'
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M$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA]) 1-MC0[!:+#Y
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M\HE[A''U&>793)/R4"]&VF=E=K L..^[NJD<*YKO]P/W>YDW?P!02P,$%
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MZ&U0;_-.O9U_U-;-/<\UGO].JOWXK)V/GY;/S<5+F'#6\%/L^ M02P,$%
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M2P$"% ,4    " "W@*-4TW&#V>T    K @  $0              @ &O
M9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " "W@*-4F5R<(Q &  "<)P
M$P              @ '+ 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0
M   ( +> HU1-'EK-0@4  .L5   8              " @0P(  !X;"]W;W)K
M<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " "W@*-4R:]#8(@&  #$&0
M&               @(&$#0  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L!
M A0#%     @ MX"C5!6#RF_M @  RPD  !@              ("!0A0  'AL
M+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( +> HU3A-%[32 8
M , :   8              " @647  !X;"]W;W)K<VAE971S+W-H965T-"YX
M;6Q02P$"% ,4    " "W@*-4[K%-]!,,  "+4P  &               @('C
M'0  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ MX"C5!??
MN54 !P  Y1L  !@              ("!+"H  'AL+W=O<FMS:&5E=',O<VAE
M970V+GAM;%!+ 0(4 Q0    ( +> HU10^P8CM 8  $T0   8
M  " @6(Q  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " "W
M@*-4;)C<_  ;   %4P  &               @(%,.   >&PO=V]R:W-H965T
M<R]S:&5E=#@N>&UL4$L! A0#%     @ MX"C5,D/':S0!@  <Q   !@
M         ("!@E,  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0
M   ( +> HU3,7BA@X@,  / (   9              " @8A:  !X;"]W;W)K
M<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ MX"C5+]>1KF\"   8QH
M !D              ("!H5X  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q0
M2P$"% ,4    " "W@*-4SO I^7H%   5$   &0              @(&49P
M>&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( +> HU36F]]O
M-0L  %4B   9              " @45M  !X;"]W;W)K<VAE971S+W-H965T
M,3,N>&UL4$L! A0#%     @ MX"C5)>@(</C"0  @QD  !D
M ("!L7@  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " "W
M@*-4,U\L=+X"  !H!@  &0              @('+@@  >&PO=V]R:W-H965T
M<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( +> HU3]F3W"1A4   -"   9
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M970R,"YX;6Q02P$"% ,4    " "W@*-4#J$C3A $   M#P  &0
M    @($BK0  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    (
M +> HU0?SM%I^ ,  .T/   9              " @6FQ  !X;"]W;W)K<VAE
M971S+W-H965T,C(N>&UL4$L! A0#%     @ MX"C5)K)>V$4 P  %0D  !D
M             ("!F+4  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"
M% ,4    " "W@*-4!A 5RB(#  !>"P  &0              @('CN   >&PO
M=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( +> HU3U>NYIO0(
M +$'   9              " @3R\  !X;"]W;W)K<VAE971S+W-H965T,C4N
M>&UL4$L! A0#%     @ MX"C5*K2N/BX @  G0<  !D              ("!
M,+\  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " "W@*-4
M&.\)C(8$  #)$@  &0              @($?P@  >&PO=V]R:W-H965T<R]S
M:&5E=#(W+GAM;%!+ 0(4 Q0    ( +> HU0"8FN@S@,  +8-   9
M      " @=S&  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%
M  @ MX"C5.%>F#<.!P  VB,  !D              ("!X<H  'AL+W=O<FMS
M:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " "W@*-4KVZJA_,!  !&!
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M+G)E;'-02P$"% ,4    " "W@*-4V5Y4S$,#  !/%0  #P
M@ %MVP  >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ MX"C5(]ZM&%= 0
M)!,  !H              ( !W=X  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR
M96QS4$L! A0#%     @ MX"C5.];R@F& 0  U1,  !,              ( !
M<N   %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     "< )P"("@  *>(

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>147</ContextCount>
  <ElementCount>234</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>29</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="lfvn-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="lfvn-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="lfvn-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="lfvn-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="lfvn-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS??? EQUITY (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS??? EQUITY (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="lfvn-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="lfvn-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Organization and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/OrganizationandBasisofPresentation</Role>
      <ShortName>Organization and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="lfvn-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2102102 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="lfvn-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2109103 - Disclosure - Gig Economy Group Investment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/GigEconomyGroupInvestment</Role>
      <ShortName>Gig Economy Group Investment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="lfvn-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2111104 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="lfvn-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2116105 - Disclosure - Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/LongTermDebt</Role>
      <ShortName>Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="lfvn-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2118106 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="lfvn-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2120107 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="lfvn-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2122108 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="lfvn-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2124109 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="lfvn-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2203201 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="lfvn-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="lfvn-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2312302 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/Leases</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="lfvn-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2405401 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="lfvn-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Summary of Significant Accounting Policies - Components of Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Components of Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="lfvn-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Summary of Significant Accounting Policies - Summary of Computation of Net Income Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Summary of Computation of Net Income Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="lfvn-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - Summary of Significant Accounting Policies - Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="lfvn-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2410405 - Disclosure - Gig Economy Group Investment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails</Role>
      <ShortName>Gig Economy Group Investment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/GigEconomyGroupInvestment</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="lfvn-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2413406 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="lfvn-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2414407 - Disclosure - Leases - Schedule of Lease, Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails</Role>
      <ShortName>Leases - Schedule of Lease, Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="lfvn-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2415408 - Disclosure - Leases - Schedule of Maturity of Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Schedule of Maturity of Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="lfvn-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2417409 - Disclosure - Long-Term Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/LongTermDebtNarrativeDetails</Role>
      <ShortName>Long-Term Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="lfvn-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2419410 - Disclosure - Stockholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/StockholdersEquityDetails</Role>
      <ShortName>Stockholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/StockholdersEquity</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="lfvn-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2421411 - Disclosure - Stock-Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/StockBasedCompensationDetails</Role>
      <ShortName>Stock-Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/StockBasedCompensation</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="lfvn-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2423412 - Disclosure - Commitment and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CommitmentandContingenciesDetails</Role>
      <ShortName>Commitment and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="lfvn-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2425413 - Disclosure - Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/RelatedPartyTransactionsDetails</Role>
      <ShortName>Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/RelatedPartyTransactions</ParentRole>
      <Position>31</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="lfvn-20220331.htm">lfvn-20220331.htm</File>
    <File>lfvn-20220331.xsd</File>
    <File>lfvn-20220331_cal.xml</File>
    <File>lfvn-20220331_def.xml</File>
    <File>lfvn-20220331_lab.xml</File>
    <File>lfvn-20220331_pre.xml</File>
    <File>lfvn_033122xex311.htm</File>
    <File>lfvn_033122xex312.htm</File>
    <File>lfvn_033122xex321.htm</File>
    <File>lfvn_033122xex322.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="576">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>49
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "lfvn-20220331.htm": {
   "axisCustom": 0,
   "axisStandard": 13,
   "contextCount": 147,
   "dts": {
    "calculationLink": {
     "local": [
      "lfvn-20220331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "lfvn-20220331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "lfvn-20220331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lfvn-20220331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lfvn-20220331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "lfvn-20220331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 339,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 3,
    "http://xbrl.sec.gov/dei/2021q4": 5,
    "total": 8
   },
   "keyCustom": 26,
   "keyStandard": 208,
   "memberCustom": 12,
   "memberStandard": 15,
   "nsprefix": "lfvn",
   "nsuri": "http://www.lifevantage.com/20220331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i40b4f0237f1545099548bf0d4db54998_D20210701-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.lifevantage.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i40b4f0237f1545099548bf0d4db54998_D20210701-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i40b4f0237f1545099548bf0d4db54998_D20210701-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111104 - Disclosure - Leases",
     "role": "http://www.lifevantage.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i40b4f0237f1545099548bf0d4db54998_D20210701-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i40b4f0237f1545099548bf0d4db54998_D20210701-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116105 - Disclosure - Long-Term Debt",
     "role": "http://www.lifevantage.com/role/LongTermDebt",
     "shortName": "Long-Term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i40b4f0237f1545099548bf0d4db54998_D20210701-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i40b4f0237f1545099548bf0d4db54998_D20210701-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2118106 - Disclosure - Stockholders' Equity",
     "role": "http://www.lifevantage.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i40b4f0237f1545099548bf0d4db54998_D20210701-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i40b4f0237f1545099548bf0d4db54998_D20210701-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2120107 - Disclosure - Stock-Based Compensation",
     "role": "http://www.lifevantage.com/role/StockBasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i40b4f0237f1545099548bf0d4db54998_D20210701-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i40b4f0237f1545099548bf0d4db54998_D20210701-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2122108 - Disclosure - Commitments and Contingencies",
     "role": "http://www.lifevantage.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i40b4f0237f1545099548bf0d4db54998_D20210701-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i40b4f0237f1545099548bf0d4db54998_D20210701-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124109 - Disclosure - Related Party Transactions",
     "role": "http://www.lifevantage.com/role/RelatedPartyTransactions",
     "shortName": "Related Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i40b4f0237f1545099548bf0d4db54998_D20210701-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i40b4f0237f1545099548bf0d4db54998_D20210701-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2203201 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i40b4f0237f1545099548bf0d4db54998_D20210701-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i40b4f0237f1545099548bf0d4db54998_D20210701-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2304301 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i40b4f0237f1545099548bf0d4db54998_D20210701-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i40b4f0237f1545099548bf0d4db54998_D20210701-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2312302 - Disclosure - Leases (Tables)",
     "role": "http://www.lifevantage.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i40b4f0237f1545099548bf0d4db54998_D20210701-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "ia7987d4236804621a4361835b057e0ce_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossRealized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405401 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)",
     "role": "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "ia7987d4236804621a4361835b057e0ce_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossRealized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i48bc8c6f35e243a6b2a9a8d306274583_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
     "role": "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i48bc8c6f35e243a6b2a9a8d306274583_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i48bc8c6f35e243a6b2a9a8d306274583_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Summary of Significant Accounting Policies - Components of Inventory (Details)",
     "role": "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails",
     "shortName": "Summary of Significant Accounting Policies - Components of Inventory (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i48bc8c6f35e243a6b2a9a8d306274583_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "ia7987d4236804621a4361835b057e0ce_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Summary of Significant Accounting Policies - Summary of Computation of Net Income Per Share (Details)",
     "role": "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails",
     "shortName": "Summary of Significant Accounting Policies - Summary of Computation of Net Income Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "ia7987d4236804621a4361835b057e0ce_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "ia7987d4236804621a4361835b057e0ce_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408404 - Disclosure - Summary of Significant Accounting Policies - Segment Information (Details)",
     "role": "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails",
     "shortName": "Summary of Significant Accounting Policies - Segment Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "id2939647eeae400482eba40fd37747e0_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i48bc8c6f35e243a6b2a9a8d306274583_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410405 - Disclosure - Gig Economy Group Investment (Details)",
     "role": "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails",
     "shortName": "Gig Economy Group Investment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i48bc8c6f35e243a6b2a9a8d306274583_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i48bc8c6f35e243a6b2a9a8d306274583_I20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413406 - Disclosure - Leases - Narrative (Details)",
     "role": "http://www.lifevantage.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "ia7987d4236804621a4361835b057e0ce_D20220101-20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "ia7987d4236804621a4361835b057e0ce_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414407 - Disclosure - Leases - Schedule of Lease, Cost (Details)",
     "role": "http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails",
     "shortName": "Leases - Schedule of Lease, Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "ia7987d4236804621a4361835b057e0ce_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i48bc8c6f35e243a6b2a9a8d306274583_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415408 - Disclosure - Leases - Schedule of Maturity of Lease Liabilities (Details)",
     "role": "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails",
     "shortName": "Leases - Schedule of Maturity of Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i48bc8c6f35e243a6b2a9a8d306274583_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i44c9eefb9093469182cd44d1b4c1dd66_I20210401",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "lfvn:DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417409 - Disclosure - Long-Term Debt - Narrative (Details)",
     "role": "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails",
     "shortName": "Long-Term Debt - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i44c9eefb9093469182cd44d1b4c1dd66_I20210401",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "lfvn:DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i8365c04b98844bcea3d544bdda92cd4c_I20220217",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419410 - Disclosure - Stockholders' Equity (Details)",
     "role": "http://www.lifevantage.com/role/StockholdersEquityDetails",
     "shortName": "Stockholders' Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i8365c04b98844bcea3d544bdda92cd4c_I20220217",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "ia7987d4236804621a4361835b057e0ce_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421411 - Disclosure - Stock-Based Compensation (Details)",
     "role": "http://www.lifevantage.com/role/StockBasedCompensationDetails",
     "shortName": "Stock-Based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "ia7987d4236804621a4361835b057e0ce_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i48bc8c6f35e243a6b2a9a8d306274583_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
     "role": "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i48bc8c6f35e243a6b2a9a8d306274583_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i7b7712dd2ecf4cc990ccba081959ed4a_D20191205-20191205",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyClaimsDismissedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "claim",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423412 - Disclosure - Commitment and Contingencies (Details)",
     "role": "http://www.lifevantage.com/role/CommitmentandContingenciesDetails",
     "shortName": "Commitment and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i7b7712dd2ecf4cc990ccba081959ed4a_D20191205-20191205",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyClaimsDismissedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "claim",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i40b4f0237f1545099548bf0d4db54998_D20210701-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "lfvn:MembersOfBoardOfDirectorsServingOnRelatedPartyBoardOfDirectors",
      "reportCount": 1,
      "unique": true,
      "unitRef": "member",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425413 - Disclosure - Related Party Transactions (Details)",
     "role": "http://www.lifevantage.com/role/RelatedPartyTransactionsDetails",
     "shortName": "Related Party Transactions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i40b4f0237f1545099548bf0d4db54998_D20210701-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "lfvn:MembersOfBoardOfDirectorsServingOnRelatedPartyBoardOfDirectors",
      "reportCount": 1,
      "unique": true,
      "unitRef": "member",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "ia7987d4236804621a4361835b057e0ce_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Unaudited)",
     "role": "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "ia7987d4236804621a4361835b057e0ce_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i962d85b9976d4fa6b5d9584e36bb2ab1_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS\u2019 EQUITY (Unaudited)",
     "role": "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS\u2019 EQUITY (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i078343424c294ceca151c4f530b420fc_D20200701-20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i40b4f0237f1545099548bf0d4db54998_D20210701-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
     "role": "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i40b4f0237f1545099548bf0d4db54998_D20210701-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i40b4f0237f1545099548bf0d4db54998_D20210701-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Organization and Basis of Presentation",
     "role": "http://www.lifevantage.com/role/OrganizationandBasisofPresentation",
     "shortName": "Organization and Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i40b4f0237f1545099548bf0d4db54998_D20210701-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i40b4f0237f1545099548bf0d4db54998_D20210701-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2102102 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i40b4f0237f1545099548bf0d4db54998_D20210701-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i40b4f0237f1545099548bf0d4db54998_D20210701-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2109103 - Disclosure - Gig Economy Group Investment",
     "role": "http://www.lifevantage.com/role/GigEconomyGroupInvestment",
     "shortName": "Gig Economy Group Investment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220331.htm",
      "contextRef": "i40b4f0237f1545099548bf0d4db54998_D20210701-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 29,
   "tag": {
    "country_JP": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "JAPAN",
        "terseLabel": "Japan"
       }
      }
     },
     "localname": "JP",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "lfvn_AsiaPacificAndEuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asia Pacific And Europe [Member]",
        "label": "Asia Pacific And Europe [Member]",
        "terseLabel": "Asia/Pacific &amp; Europe"
       }
      }
     },
     "localname": "AsiaPacificAndEuropeMember",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Accounts Held Primarily At Financial Institution [Member]",
        "label": "Cash Accounts Held Primarily At Financial Institution [Member]",
        "terseLabel": "Cash accounts held primarily at One Financial Institution"
       }
      }
     },
     "localname": "CashAccountsHeldPrimarilyAtFinancialInstitutionMember",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Accounts Held At Other Financial Institutions [Member]",
        "label": "Cash Accounts Held at Other Financial Institutions [Member]",
        "terseLabel": "Cash held primarily at Other Financial Institutions"
       }
      }
     },
     "localname": "CashAccountsHeldatOtherFinancialInstitutionsMember",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lfvn_CommissionAndIncentives": {
     "auth_ref": [],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses related to commissions and other incentives earned by independent distributors. Commission and incentive expenses include sales commissions paid to our independent distributors, special incentives, costs for incentive trip and other rewards",
        "label": "Commission And Incentives",
        "terseLabel": "Commissions and incentives"
       }
      }
     },
     "localname": "CommissionAndIncentives",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Fixed Charge Coverage Ratio",
        "label": "Debt Instrument, Covenant, Fixed Charge Coverage Ratio",
        "terseLabel": "Debt instrument, covenant, fixed charge coverage ratio"
       }
      }
     },
     "localname": "DebtInstrumentCovenantFixedChargeCoverageRatio",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Required Minimum Working Capital",
        "label": "Debt Instrument, Covenant, Required Minimum Working Capital",
        "terseLabel": "Debt instrument, covenant, required minimum working capital"
       }
      }
     },
     "localname": "DebtInstrumentCovenantRequiredMinimumWorkingCapital",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Total Liabilities To Tangible Net Worth Ratio",
        "label": "Debt Instrument, Covenant, Total Liabilities To Tangible Net Worth Ratio",
        "terseLabel": "Debt instrument, covenant, total liabilities to tangible net worth ratio (not greater than)"
       }
      }
     },
     "localname": "DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "lfvn_DebtInstrumentFloorInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Floor Interest Rate",
        "label": "Debt Instrument, Floor Interest Rate",
        "terseLabel": "Floor interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentFloorInterestRate",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lfvn_DebtInstrumentTrailingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Trailing Period",
        "label": "Debt Instrument, Trailing Period",
        "terseLabel": "Trailing period"
       }
      }
     },
     "localname": "DebtInstrumentTrailingPeriod",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lfvn_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan",
        "label": "Employee Stock Purchase Plan [Member]",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lfvn_HandlingAndRestockingFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Handling and Restocking Fee, Percentage",
        "label": "Handling and Restocking Fee, Percentage",
        "terseLabel": "Handling and restocking fee, percentage (as a percent)"
       }
      }
     },
     "localname": "HandlingAndRestockingFeePercentage",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lfvn_IncreaseDecreaseInLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Lease Liabilities",
        "label": "Increase (Decrease) In Lease Liabilities",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInLeaseLiabilities",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lfvn_IncreaseDecreaseInPropertyAndEquipmentAndLeaseLiabilitiesFromLeaseIncentives": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Property, Equipment and Lease Liabilities From Lease Incentives",
        "label": "Increase (Decrease) in Property and Equipment and Lease Liabilities From Lease Incentives",
        "terseLabel": "Increase in property and equipment and lease liabilities from lease incentives"
       }
      }
     },
     "localname": "IncreaseDecreaseInPropertyAndEquipmentAndLeaseLiabilitiesFromLeaseIncentives",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lfvn_InventoryFinishedGoodsPercentOfTotalInventory": {
     "auth_ref": [],
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails": {
       "order": 1.0,
       "parentTag": "lfvn_InventoryPercentOfTotalInventory",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory, Finished Goods, Percent Of Total Inventory",
        "label": "Inventory, Finished Goods, Percent Of Total Inventory",
        "terseLabel": "Finished goods, percent of inventory (in percentage)"
       }
      }
     },
     "localname": "InventoryFinishedGoodsPercentOfTotalInventory",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lfvn_InventoryPercentOfTotalInventory": {
     "auth_ref": [],
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory, Percent Of Total Inventory",
        "label": "Inventory, Percent Of Total Inventory",
        "totalLabel": "Percent of total inventory (in percentage)"
       }
      }
     },
     "localname": "InventoryPercentOfTotalInventory",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, Payments Due, After Year Four",
        "label": "Lessee, Operating Lease, Liability, Payments Due, After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lfvn_March2016RevolvingLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2016 Revolving Loan [Member]",
        "label": "March 2016 Revolving Loan [Member]",
        "terseLabel": "March 2016 Revolving Loan"
       }
      }
     },
     "localname": "March2016RevolvingLoanMember",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lfvn_March2016TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2016 Term Loan [Member]",
        "label": "March 2016 Term Loan [Member]",
        "terseLabel": "March 2016 Term Loan"
       }
      }
     },
     "localname": "March2016TermLoanMember",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lfvn_MembersOfBoardOfDirectorsServingOnRelatedPartyBoardOfDirectors": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Members of Board of Directors Serving on Related Party Board of Directors",
        "label": "Members of Board of Directors Serving on Related Party Board of Directors",
        "terseLabel": "Members of company board of directors serving on GEG board of directors"
       }
      }
     },
     "localname": "MembersOfBoardOfDirectorsServingOnRelatedPartyBoardOfDirectors",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lfvn_MoneyBackGuaranteePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Money back guarantee period.",
        "label": "Money Back Guarantee Period",
        "terseLabel": "Money back guarantee period"
       }
      }
     },
     "localname": "MoneyBackGuaranteePeriod",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lfvn_NotesReceivableRelatedPartyMaximumCommitment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes Receivable, Related Party, Maximum Commitment",
        "label": "Notes Receivable, Related Party, Maximum Commitment",
        "terseLabel": "Notes receivable, related party, maximum commitment"
       }
      }
     },
     "localname": "NotesReceivableRelatedPartyMaximumCommitment",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lfvn_NumberOfGeographicSegments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of geographic segments.",
        "label": "Number Of Geographic Segments",
        "terseLabel": "Number of geographic segments"
       }
      }
     },
     "localname": "NumberOfGeographicSegments",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lfvn_OperatingLeaseRightOfUseAssetAbandonmentExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Right of Use Asset, Abandonment Expense",
        "label": "Operating Lease, Right of Use Asset, Abandonment Expense",
        "terseLabel": "Abandonment expense"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAbandonmentExpense",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lfvn_OperatingLeaseRightOfUseAssetSalvageValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Right of Use Asset, Salvage Value",
        "label": "Operating Lease, Right of Use Asset, Salvage Value",
        "terseLabel": "Salvage value"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetSalvageValue",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan": {
     "auth_ref": [],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan",
        "label": "Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan",
        "terseLabel": "Proceeds from common stock issued under employee stock purchase plan"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lfvn_RawMaterialsPercentOfTotalInventory": {
     "auth_ref": [],
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails": {
       "order": 2.0,
       "parentTag": "lfvn_InventoryPercentOfTotalInventory",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Raw Materials, Percent Of Total Inventory",
        "label": "Raw Materials, Percent Of Total Inventory",
        "terseLabel": "Raw materials, percent of inventory (in percentage)"
       }
      }
     },
     "localname": "RawMaterialsPercentOfTotalInventory",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lfvn_ReturnLiabilityReserve": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Return Liability Reserve",
        "label": "Return Liability Reserve",
        "terseLabel": "Return liability reserve"
       }
      }
     },
     "localname": "ReturnLiabilityReserve",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lfvn_SandyUTMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sandy, UT",
        "label": "Sandy, UT [Member]",
        "terseLabel": "Sandy, UT"
       }
      }
     },
     "localname": "SandyUTMember",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Amount In Excess Of Fair Market Value Of Stock For Option Not To Be Granted",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Amount In Excess Of Fair Market Value Of Stock For Option Not To Be Granted",
        "terseLabel": "Amount in excess of fair market value of stock for option not to be granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Period",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Period",
        "terseLabel": "Offering period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Contractual Term",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Contractual Term",
        "terseLabel": "Contractual term of stock options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Increase (Decrease) of Share-based Liabilities",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Increase (Decrease) of Share-based Liabilities",
        "negatedLabel": "Decrease in share-based compensation included in other accrued expenses"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lfvn_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofVestingInstallments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Vesting Installments",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Vesting Installments",
        "terseLabel": "Number of vesting installments"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofVestingInstallments",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lfvn_TwoThousandAndSevenLongTermIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand and seven long term incentive plan.",
        "label": "Two Thousand And Seven Long Term Incentive Plan [Member]",
        "terseLabel": "2007 Long-Term Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandAndSevenLongTermIncentivePlanMember",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lfvn_TwoThousandAndTenLongTermIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand and ten long term incentive plan.",
        "label": "Two Thousand And Ten Long Term Incentive Plan [Member]",
        "terseLabel": "2010 Long-Term Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandAndTenLongTermIncentivePlanMember",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lfvn_TwoThousandEighteenPerformancePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Eighteen Performance Plan",
        "label": "Two Thousand Eighteen Performance Plan [Member]",
        "terseLabel": "2018 Performance Plan"
       }
      }
     },
     "localname": "TwoThousandEighteenPerformancePlanMember",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Seventeen Long Term Incentive Plan, Excluding Two Thousand And Ten Long Term Incentive Plan [Member]",
        "label": "Two Thousand Seventeen Long Term Incentive Plan, Excluding Two Thousand And Ten Long Term Incentive Plan [Member]",
        "terseLabel": "2017 Long-Term Incentive Plan Excluding 2010 Long-Term Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lfvn_TwoThousandSeventeenLongTermIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Seventeen Long Term Incentive Plan [Member]",
        "label": "Two Thousand Seventeen Long Term Incentive Plan [Member]",
        "terseLabel": "2017 Long-Term Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandSeventeenLongTermIncentivePlanMember",
     "nsuri": "http://www.lifevantage.com/20220331",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AffiliatedEntityMember": {
     "auth_ref": [
      "r300",
      "r401",
      "r402",
      "r404",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Affiliated Entity [Member]",
        "terseLabel": "GEG"
       }
      }
     },
     "localname": "AffiliatedEntityMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails",
      "http://www.lifevantage.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AmericasMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Americas [Member]",
        "terseLabel": "Americas"
       }
      }
     },
     "localname": "AmericasMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r230",
      "r264",
      "r301",
      "r302",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r462",
      "r464",
      "r484",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails",
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r230",
      "r264",
      "r301",
      "r302",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r462",
      "r464",
      "r484",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails",
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r230",
      "r264",
      "r299",
      "r301",
      "r302",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r462",
      "r464",
      "r484",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails",
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r230",
      "r264",
      "r299",
      "r301",
      "r302",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r462",
      "r464",
      "r484",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails",
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r182",
      "r183",
      "r296",
      "r297",
      "r463",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r182",
      "r183",
      "r296",
      "r297",
      "r463",
      "r472",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r37",
      "r409"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r4",
      "r20",
      "r188",
      "r189"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalesCommissionCurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r40"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Sales Commission, Current",
        "terseLabel": "Commissions payable"
       }
      }
     },
     "localname": "AccruedSalesCommissionCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r23",
      "r55",
      "r56",
      "r57",
      "r451",
      "r469",
      "r470"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive (loss) income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r54",
      "r57",
      "r65",
      "r66",
      "r67",
      "r112",
      "r113",
      "r114",
      "r349",
      "r465",
      "r466",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive (Loss) Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r112",
      "r113",
      "r114",
      "r317",
      "r318",
      "r319",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedLabel": "Shares canceled or surrendered as payment of tax withholding and other"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition",
        "terseLabel": "Stock based compensation reflected in additional paid in capital"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r303",
      "r305",
      "r321",
      "r322"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from EPS calculation (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r106",
      "r164",
      "r173",
      "r179",
      "r198",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r345",
      "r350",
      "r370",
      "r407",
      "r409",
      "r433",
      "r449"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r52",
      "r106",
      "r198",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r345",
      "r350",
      "r370",
      "r407",
      "r409"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Noncurrent [Abstract]",
        "terseLabel": "Long-term assets"
       }
      }
     },
     "localname": "AssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r306",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r11",
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r85",
      "r92",
      "r97"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and Cash Equivalents \u2014 end of period",
        "periodStartLabel": "Cash and Cash Equivalents \u2014 beginning of period",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r85",
      "r373"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Decrease in Cash and Cash Equivalents:"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Non Cash Investing and Financing Activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r103",
      "r106",
      "r127",
      "r131",
      "r132",
      "r134",
      "r136",
      "r143",
      "r144",
      "r145",
      "r198",
      "r216",
      "r220",
      "r221",
      "r222",
      "r225",
      "r226",
      "r262",
      "r263",
      "r267",
      "r271",
      "r370",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r45",
      "r211",
      "r439",
      "r455"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies - Note 8"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Common Stock, capital shares reserved for future issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r112",
      "r113",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails",
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in USD per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r19",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "verboseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r19",
      "r409"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock \u2014 par value $0.0001 per share, 40,000 shares authorized and 12,577 and 13,609 issued and outstanding as of March\u00a031, 2022 and June\u00a030, 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r60",
      "r62",
      "r63",
      "r72",
      "r442",
      "r458"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r152",
      "r153",
      "r187",
      "r366",
      "r367",
      "r471",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r148",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure": {
     "auth_ref": [
      "r368"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum amount of loss due to credit risk that, based on the gross fair value of the financial instrument, the entity would incur if parties to the financial instruments that make up the concentration failed completely to perform according to the terms of the contracts and the collateral or other security, if any, for the amount due proved to be of no value to the entity.",
        "label": "Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure",
        "terseLabel": "Concentration of credit risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r151",
      "r152",
      "r153",
      "r154",
      "r366",
      "r369",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r152",
      "r153",
      "r187",
      "r366",
      "r367",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r99",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r76",
      "r419"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "auth_ref": [
      "r95",
      "r96"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Amount",
        "terseLabel": "Debt conversion, converted instrument, amount"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "auth_ref": [
      "r95",
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Shares Issued",
        "terseLabel": "Debt conversion, converted instrument, shares issued (in shares)"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_DebtConversionOriginalDebtInterestRateOfDebt": {
     "auth_ref": [
      "r95",
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The rate of interest that was being paid on the original debt issue that is being converted in the noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt Conversion, Original Debt, Interest Rate of Debt",
        "terseLabel": "Debt conversion, original debt, interest rate of debt (as a percent)"
       }
      }
     },
     "localname": "DebtConversionOriginalDebtInterestRateOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r102",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r244",
      "r251",
      "r252",
      "r253",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Long-Term Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r14",
      "r15",
      "r16",
      "r105",
      "r110",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r234",
      "r240",
      "r241",
      "r242",
      "r243",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r254",
      "r255",
      "r256",
      "r257",
      "r383",
      "r434",
      "r436",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r43",
      "r105",
      "r110",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r234",
      "r240",
      "r241",
      "r242",
      "r243",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r254",
      "r255",
      "r256",
      "r257",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r43"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments applied to principal.",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "terseLabel": "Quarterly installments"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r327",
      "r328"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income tax asset"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r90",
      "r107",
      "r333",
      "r338",
      "r339",
      "r340"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income tax"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r90",
      "r162"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "auth_ref": [
      "r357",
      "r358"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "negatedLabel": "Derivative instruments, realized loss"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r109",
      "r353",
      "r354",
      "r355",
      "r356",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Instruments and Hedging Activities"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income per share:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r73",
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r125",
      "r127",
      "r134",
      "r135",
      "r136",
      "r139",
      "r140",
      "r362",
      "r363",
      "r443",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net income per share, basic (in USD per share)",
        "verboseLabel": "Basic (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r73",
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r127",
      "r134",
      "r135",
      "r136",
      "r139",
      "r140",
      "r362",
      "r363",
      "r443",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net income per share, diluted (in USD per share)",
        "verboseLabel": "Diluted (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r137",
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Income Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r373"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Foreign Currency Effect on Cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r65",
      "r66",
      "r67",
      "r112",
      "r113",
      "r114",
      "r116",
      "r122",
      "r124",
      "r142",
      "r201",
      "r278",
      "r285",
      "r317",
      "r318",
      "r319",
      "r335",
      "r336",
      "r361",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r465",
      "r466",
      "r467",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityInterestIssuedOrIssuableByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of equity interests that are issued or issuable in a business combination.",
        "label": "Equity Interest Type [Axis]",
        "terseLabel": "Equity Interest Type [Axis]"
       }
      }
     },
     "localname": "EquityInterestIssuedOrIssuableByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityInterestIssuedOrIssuableTypeDomain": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of equity interest issued or issuable to acquire an entity in a business combination.",
        "label": "Equity Interest Issued or Issuable, Type [Domain]",
        "terseLabel": "Equity Interest Issued or Issuable, Type [Domain]"
       }
      }
     },
     "localname": "EquityInterestIssuedOrIssuableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r196"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Equity securities held without readily determinable value"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r364",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossRealized": {
     "auth_ref": [
      "r371",
      "r372"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), Realized",
        "negatedTerseLabel": "Foreign currency transaction loss, realized"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossRealized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r75",
      "r106",
      "r164",
      "r172",
      "r175",
      "r178",
      "r180",
      "r198",
      "r216",
      "r217",
      "r218",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r370"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r70",
      "r164",
      "r172",
      "r175",
      "r178",
      "r180",
      "r432",
      "r440",
      "r445",
      "r460"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r108",
      "r123",
      "r124",
      "r163",
      "r329",
      "r337",
      "r341",
      "r461"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax expense",
        "terseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r64",
      "r325",
      "r326",
      "r330",
      "r331",
      "r332",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r87",
      "r94"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Cash paid for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r49",
      "r438",
      "r456"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Income tax receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income tax payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Other accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInIncomeTaxesReceivable": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.",
        "label": "Increase (Decrease) in Income Taxes Receivable",
        "negatedTerseLabel": "Income tax receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInIncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventory, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other long-term assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Increase (Decrease) in Prepaid Expense",
        "negatedLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r128",
      "r129",
      "r130",
      "r136"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Stock awards and options (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r208",
      "r209"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r68",
      "r161",
      "r381",
      "r382",
      "r444"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r84",
      "r86",
      "r94"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r27",
      "r206"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r3",
      "r50",
      "r409"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory, net",
        "totalLabel": "Total inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r10",
      "r51",
      "r100",
      "r141",
      "r203",
      "r204",
      "r207",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": {
     "auth_ref": [
      "r28",
      "r29",
      "r206"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.",
        "label": "Inventory, Raw Materials and Supplies, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r50",
      "r205"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "terseLabel": "Inventory valuation reserves"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTextBlock": {
     "auth_ref": [
      "r195",
      "r197",
      "r199",
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investment.",
        "label": "Investment [Text Block]",
        "terseLabel": "Gig Economy Group Investment"
       }
      }
     },
     "localname": "InvestmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsAllOtherInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, All Other Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAllOtherInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Lease, Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Maturity of Lease Liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r396"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r396"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r396"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r396"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r396"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r396"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2022 (remaining three months ending June 30, 2022)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r396"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r39",
      "r106",
      "r174",
      "r198",
      "r216",
      "r217",
      "r218",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r346",
      "r350",
      "r351",
      "r370",
      "r407",
      "r408"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r26",
      "r106",
      "r198",
      "r370",
      "r409",
      "r437",
      "r453"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r41",
      "r106",
      "r198",
      "r216",
      "r217",
      "r218",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r346",
      "r350",
      "r351",
      "r370",
      "r407",
      "r408",
      "r409"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r38"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum capacity on draw"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r38",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.",
        "label": "Long-lived Assets by Geographic Areas [Table Text Block]",
        "terseLabel": "Schedule of Long-lived Assets by Geographic Areas"
       }
      }
     },
     "localname": "LongLivedAssetsByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermDebtPercentageBearingFixedInterestRate": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate.",
        "label": "Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate",
        "terseLabel": "Fixed rate interest on debt (as a percent)"
       }
      }
     },
     "localname": "LongTermDebtPercentageBearingFixedInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LongTermInvestments": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).",
        "label": "Long-term Investments",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "LongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r43",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyClaimsDismissedNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of claims dismissed.",
        "label": "Loss Contingency, Claims Dismissed, Number",
        "terseLabel": "Claims dismissed"
       }
      }
     },
     "localname": "LossContingencyClaimsDismissedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyDisclosures": {
     "auth_ref": [
      "r213",
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.",
        "label": "Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "LossContingencyDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Pending claims"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net Cash Used in Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash Flows from Financing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net Cash Used in Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash Flows from Investing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r85",
      "r88",
      "r91"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net Cash Provided by Operating Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash Flows from Operating Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r58",
      "r61",
      "r67",
      "r71",
      "r91",
      "r106",
      "r115",
      "r117",
      "r118",
      "r119",
      "r120",
      "r123",
      "r124",
      "r133",
      "r164",
      "r172",
      "r175",
      "r178",
      "r180",
      "r198",
      "r216",
      "r217",
      "r218",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r363",
      "r370",
      "r441",
      "r457"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncurrentAssets": {
     "auth_ref": [
      "r183"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.",
        "label": "Long-Lived Assets",
        "terseLabel": "Long-lived assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other expense"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other expense:"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r164",
      "r172",
      "r175",
      "r178",
      "r180"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r386"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r385"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r385"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r385"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r387",
      "r391"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash outflows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r384"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "terseLabel": "Amortization of right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r394",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate (as a percent)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r393",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r2",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Organization and Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/OrganizationandBasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r9",
      "r40"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued expenses"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r343",
      "r344",
      "r348"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r53"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "verboseLabel": "Currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive loss, net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r59",
      "r62",
      "r343",
      "r344",
      "r348"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Other comprehensive loss, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchase of company stock",
        "terseLabel": "Repurchase of company stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedLabel": "Shares canceled or surrendered as payment of tax withholding and other"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r306",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r18",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in USD per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r18",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r18",
      "r409"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock \u2014 par value $0.0001 per share, 5,000 shares authorized, no shares issued or outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r5",
      "r33",
      "r34"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r81",
      "r316"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Exercise of options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r12",
      "r13",
      "r210",
      "r409",
      "r446",
      "r454"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r74",
      "r202"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Bad debt expenses"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r190",
      "r192",
      "r193",
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r300",
      "r401",
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails",
      "http://www.lifevantage.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails",
      "http://www.lifevantage.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Purchases from Related Party",
        "terseLabel": "Related party purchase"
       }
      }
     },
     "localname": "RelatedPartyTransactionPurchasesFromRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r300",
      "r401",
      "r404",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails",
      "http://www.lifevantage.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r399",
      "r400",
      "r402",
      "r405",
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Party Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/RelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r83"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "terseLabel": "Repayment of term loan"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r324",
      "r418",
      "r486"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r22",
      "r285",
      "r320",
      "r409",
      "r452",
      "r468",
      "r470"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r112",
      "r113",
      "r114",
      "r116",
      "r122",
      "r124",
      "r201",
      "r317",
      "r318",
      "r319",
      "r335",
      "r336",
      "r361",
      "r465",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r159",
      "r160",
      "r171",
      "r176",
      "r177",
      "r181",
      "r182",
      "r187",
      "r295",
      "r296",
      "r419"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue, net"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r101",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition And Shipping and Handling"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Schedule of Revenue Disaggregated by Geographic Regions"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r392",
      "r397"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for lease obligations"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Computation of Net Income Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r10",
      "r30",
      "r31",
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Components of Inventory"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r403",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails",
      "http://www.lifevantage.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r69",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r306",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r46",
      "r103",
      "r143",
      "r144",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r267",
      "r271",
      "r276",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Secured Debt"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Share based payment award, vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Shares issued (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate",
        "terseLabel": "Maximum employee subscription rate (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest quantity of shares an employee can purchase under the plan per period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee",
        "terseLabel": "Maximum number of shares per employee (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Number of additional shares authorized (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "verboseLabel": "Number of shares authorized (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available for issuance under the ESPP (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r311",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "terseLabel": "Options outstanding, net of awards expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r304",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r306",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "terseLabel": "Right to purchase common stock, minimum price (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of non-vested options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price",
        "terseLabel": "Right to purchase common stock, non-vested and outstanding, exercise price (in USD per share)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Purchase price of common stock (as a percent)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "negatedTerseLabel": "Shares canceled or surrendered as payment of tax withholding and other (in shares)",
        "terseLabel": "Shares canceled or surrendered as payment of tax withholding (in shares)"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r98",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r17",
      "r18",
      "r19",
      "r103",
      "r106",
      "r127",
      "r131",
      "r132",
      "r134",
      "r136",
      "r143",
      "r144",
      "r145",
      "r198",
      "r216",
      "r220",
      "r221",
      "r222",
      "r225",
      "r226",
      "r262",
      "r263",
      "r267",
      "r271",
      "r278",
      "r370",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r48",
      "r65",
      "r66",
      "r67",
      "r112",
      "r113",
      "r114",
      "r116",
      "r122",
      "r124",
      "r142",
      "r201",
      "r278",
      "r285",
      "r317",
      "r318",
      "r319",
      "r335",
      "r336",
      "r361",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r465",
      "r466",
      "r467",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r112",
      "r113",
      "r114",
      "r142",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r18",
      "r19",
      "r278",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Common stock issued under employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r18",
      "r19",
      "r278",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Common stock issued under equity award plans (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r18",
      "r19",
      "r278",
      "r285",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "verboseLabel": "Exercise of options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r18",
      "r19",
      "r278",
      "r285"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Common stock issued under employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r278",
      "r285"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Common stock issued under equity award plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r48",
      "r278",
      "r285"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Repurchase common stock amount authorized (up to)"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining authorized repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r18",
      "r19",
      "r278",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedTerseLabel": "Repurchase of company stock (in shares)",
        "terseLabel": "Stock repurchase program shares repurchased (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r18",
      "r19",
      "r278",
      "r285"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedLabel": "Repurchase of company stock"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r19",
      "r24",
      "r25",
      "r106",
      "r191",
      "r198",
      "r370",
      "r409"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r104",
      "r263",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r277",
      "r285",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxesPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r15",
      "r435",
      "r450"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.",
        "label": "Taxes Payable",
        "terseLabel": "Income tax payable"
       }
      }
     },
     "localname": "TaxesPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UsTreasuryUstInterestRateMember": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate on direct treasury obligation of U.S. government (UST).",
        "label": "US Treasury (UST) Interest Rate [Member]",
        "terseLabel": "US Treasury (UST) Interest Rate"
       }
      }
     },
     "localname": "UsTreasuryUstInterestRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r146",
      "r147",
      "r149",
      "r150",
      "r155",
      "r156",
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]",
        "terseLabel": "Effect of dilutive securities:"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r126",
      "r136"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted weighted-average common shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r125",
      "r136"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic weighted-average common shares outstanding (in shares)",
        "verboseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Basic [Abstract]",
        "terseLabel": "Weighted-average shares outstanding:",
        "verboseLabel": "Denominator:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 9
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "b",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "321",
   "URI": "http://asc.fasb.org/topic&trid=75115024"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "http://asc.fasb.org/topic&trid=2196965"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "325",
   "URI": "http://asc.fasb.org/topic&trid=2197064"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/subtopic&trid=2127163"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "http://asc.fasb.org/subtopic&trid=2127197"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r487": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r488": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r489": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r491": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r492": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r493": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>50
<FILENAME>0000849146-22-000027-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000849146-22-000027-xbrl.zip
M4$L#!!0    ( +> HU1.B%71^9\! (QD$@ 1    ;&9V;BTR,#(R,#,S,2YH
M=&WLO6E7&\F6+OS]_@J]=+_=56N1=LR#JXJ[*(-]J+:$#<)N^.(5(R36P-'
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M64M$F!E]W\/SN[ZB\),HC.Y1F"A8<"T!6Q'J,A8$S51:^,"(\LR0H*E;6?M
MITC?S0Z8C8O70.&>:6UU?#C_GW!1T?9;M,7W:(M-H%$0FC&7$+11*#.,@ A+
M)D0D"A,$ZAG!/XIIS,04:?QZV.O=4M&;';\!/D-%YF^1F=PC,S,VXLA$YD)
MH*2=!#++D*$@0:8C59&:E;4L0SJCZ!$:O^D9E^!G;=C)2PKWPV%2LBL3(+L/
M+F\#"/AK9:OQ9LP%(P_C%0S$AMYVW#X)/4# G</=\L6@S1-OP)5HQDQ1O]!M
MUW[3V3Y>9_O-QO'VQM%1_5,]O>=BO_WQZ.!XG6PGAMDX1 ?'FQ?;&^OH'=TY
MVF^?MV!L:+_Y#WS>0_N77R[KS9VCQB=@J$]OC@\V'-L__@<(O(_KQV]:XWO@
M7<,#LB<:&SM']?:;_*"Y<[S=K)\WWF[B@T];>/]3XTOC\BBOMP^^-([W+NJ?
M/L9Z7C!$P1CU2QC[V6?G#*62APR8@&<L<IR!N?:9C8QP2@U!3*RLX3%#C#G@
MJU(?).)@+ PWH#*\=]H&0['V1F-O,36?M^X*^YC,[T*_'\(5D=\%</R:H=?>
MCLF_2.^>,96W=\=4/J3UXX^M!OEP5F_".S8^L.V-O22V]*#]\?C@TQM0!R#>
MEW\? <5:X5\[%P>?_(DE3&QOP+O@G0<;Z^>-C;^_)+71:(+8;OCVP2<8TZ<M
M!.)-ZV_?Q'ISCWW6&'N-.,E >$!-,Q0SZX@"/Y4Q9:3$0>J5M?=X_WM4LV!4
M8N$ILP+4/>-&"FHCB"D31!M3R"A&2!.9C3_<I=;ND>F%OX%$_G6W?1(Z_<(W
M7>^!JWH8DG3^?7%]R7MSD;Y:/S,]7_SK8^@G&I?(#,^6KGC[]9BN^^DZ#N\X
MVVXZ#M>?[U^NLSK9I_N?]LX;[:W+[4\'QS".\[MT;1RG,7UAC>-UWKC\ F-[
M<US?.+P\ %-PT-PD^\=U?M"N ]\DNF[R[0^?E7+8@?;-N B JPCBF8XD9CY$
MD$2KL2;^8<J^O.W[]D(,8"I=Z#_@LJ<0RJM^$6$"VM>*N-2K 3CJH+_S]DDK
MQ5:*[XYZB35N>><OSOLP@C]?WGY&^?[KEX[&T.\.>\5?183IU8C?2LK^B$T8
M/R@46&_\5^[3WS$/O5HQH/!@[.3UUO_<1BUW;UX;?W7[Z2<%/X[_Z@],;Y @
MQUH9&9(@=./[KG^[&J8?7THR1#.*KU]1_C+^>_R2E[<6ZL%UPYA%X;E2(3B&
M05UC%(R+6$O)L)=BI$P9T7.P7&7D<#!: 981??6@T2]/6X&$+XKI]Y/^Z%_-
MK T&8=@+:R,"%#^.'S'^;?QW>L;#G*BL4TY$R@-AX+):8K11GB)!)..*WC!/
M\[:B-WGJ!U=T6,CS[24;!9%?[>UN?/=J6JJT(Y@+,.R,>Z:<-1(9+)236&-2
MK"9&@J+Y6DT09E$@W9]=33!@A96[FI[/3V%8-R\MM+89='L_N/#W[D]?;H1.
MMYUW'GKL4\7CUB->WA[]M^ANI%;2,T*% HA(L&%48$6Y15P&Y$*ASQ-RF%]]
M3E*D?]KZ7%!B8]!""L89YJ"+$ W>!A$]H3"UD1T<K1N>QW7#3U\W/+%U<Y+S
M&*SCG#B0F:BQ\<)J8JWE 6-1K!L:XX>Y7#?T=/PPN773T6FG8,&<5HR%8#T/
MP1O&O$%66CD]_3R:=>FXEW]Z>-GY22MW^: >DH=?\SG\6B:.K]R, 4P]W;/Y
M[V$*^8&OT>TDWW_]/ =H,+X,OF]W.[N#KOM2/NO/EP^^XFK5KD8R1<-QBS1!
M.J2P0QI% !Z<:$#&P0L7- .K&O72D&;=^SRYAJ;UWN1^J_/:G.0#TUH0,C%A
M(E=1"@QB(PC7CLH ^!$K(ZB)4T0XSTRFG3 P>2?X3=/K@&?>7Q#Z2&<]E1K
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M4 F*W;G(C4&,)5 ;/8H82T$5M88L'T&G'-">"56))(9&JQ$*@1&#+)94DNA
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M)EH3:CR>'LEFM0)6&<4#8EJ;U$ XJ, 44JG/&X/OB9I!-_YE,0)W-N'/X,B
M8)D1-G"-!&!LL!5">($$=B(QN/?+1]RI-E2=/D&9)B"LP4BO03ZQUR+H: A/
M1#;8QN4CZ/0;JDZ?JA8C9U60H'T=$UP8<()5I!C<8.:$6T8=/',?>":$UM%R
MBVR,7C+&'+'&QD1@S*DT48R[=BX^?:?84'5"VR(D>%0\&*4Q!3MIP/$U05A,
M$6'1VB4BS8P:JDZ(3")R"? %8#L5C!%B1*2(6BQPB-XKLS1DFG9#U0G1QQIE
M3.H$3JQ@(3*K :;(E(]$0C-GEX8^L_:!)T<RIH22Q'$<F&#(&\ <D8@HE99*
M63M%D9K5"B#BD=>*1LP%D]P;A3P8 J000\A)/-J0#RLP]QOR7W<[+J2#HI.*
MW\G[7_Z^:%Z<A))WT[FVKUZ;_A$P;W<(+/VOT/+O>WG;]/+6Q?K@3=XQ'9>;
MUA:L93X8IF<\_[[\FT2<TKY\)C!-1W5&AYG1TH"B"HKH@"10W[FEIK<9%/KJ
M(5I/H=O&](F-%9@B8PD#V,  >QM-K+8,D>!LH,B.G"M!43;^L#S$GJUPWSDN
MZQL^EIA,C;(TL/"2< X$9H%1I0@O#SJF@BB)EIK>,Q3N:1'[ZN3ASC -_)&3
ML4_@X_@!3S[)&10$MY09(A5GBG@M!+,26^_!*U0LC"L)T=R9@WYO< U<WX;N
M8<^<'.7.M&[PRJ[I^(N]YO-7=:*))-,81XY;'[F@X.@Y@T@TU )0"Y0(>6<_
MY%QZ%#,ERH]N%IE<L(L08E-# Q>181*<<_#0@W;<4Q%B:EXVM[U!YD6:)G/>
M?2\<PJSNZ<EB%N5OWZTH/=%4@ZL4@@G@(H&N#-8P%#V5$KY=A YFWZ!Q^GF]
M#0OLS%+VH#,>_'O$);C\EC%.%0TJ$"J-E9J9*Y0TSRF'^:'@;(Z#C]H&9ZQF
M:8=TU%K2(#2B7(? E;]S@FPE@]^BX%,-Y 0]T\!Y3#MGP2@RH:@A1F@7@A8R
M;89VBP]QIDC!F4 <KKF4 2-N09,:)"UV2A!N1+#:28\7WPX6*&&]GYOWQL$;
MW'K';PY[W9.E[-<93$K% F+EP3-J-4AA9,@@9"D"Y(H7WRC.BIPSL9!$:A,T
M#SQ@S@";&B=3;VQB;8#_&[KX%G*&Y)R^N71,F;33!WLD&2,1,([$3@MJ.:=!
MQ\4WE[,BYTQLI^)182.H3+U<N=/*4;"=,08I$>)H$7J;?X.<15BV=_%J;W>Y
MS&1JV^,BJ%/&8"T=TX$ZJ5+7%X[ 7/+%-Y-3H-Q,+*()REI&+/C^@@G+K!&1
M65"G(<3HEL$B3H=RTS=^*#+FE4HGJA'&M-+2<F&PI<PY9]02&+\I4&XF=BZ=
MTV$Y QD#T3-@]"B04-L [GZ41KKEL7/_O%\N.Y<.!)"1,FR49]ASHSE8.2*$
M!LB)\1+$2*= N=G8.2*XC^#Z&4D8]T+%H )5UG#DHT!J>>S<\U)N^G9.4]"/
M,74$T PT9E0@?9QBE<YL"Q0O0=IW"I2;B9W3TB$5P<*!B6,2&:TE#H92'0QV
M!,_Q41TS 2;/<K8#IY8B$[EC4C$6=6JC;:E@AOE4W^M&I;QS6/(T:QK@B37R
MECYM)6&(2P?+ ^0@W%,B,.>4,NO0PLO!9!77L\B!XSQX0 !21L/ =AA-/(]2
M2.YBQ($MO!P\&PU^2@ZN2DY&+W^XYF3TX_@93RXZ217;Z=1#"3".*2-LD7##
M'J7C;$#O):)BC0D6\T;4ZST]Q7Z1]V".+YH]T^D;5U1F_GUQ\Y<;J=,8\U:>
M?M@L)O*<Q498IY8"6$Q ^J*0(F*I$;>8T;3G41(<0/J<4M2B(HU6$BJK*/8S
M0.\NS;X"].Y>^C,%UIQA!]A.41F85E()$:G#S'K#HO-Z@<A;;O':@LGU0G^P
MU>\/@]_NI?\:VPHWJZV_?V-KQ6,_DXF7B&NI#3= =>^=MN!*8.V-QMYB.L?'
M,R8*[9C.8;@F6#WOY.UA>WY+16^;6:>H,ZEK./@0W!"C8I 1DRBLY C'Q5IZ
M<[Y 2Z^Q9#IXK;#CZ7 ,322U*=&=*A8D*7JX8P%+/W>P]4H]]H+/!V^, PTU
MUEE7&VN# YSG-X(=3$IUIF>E+2Z]81KGC21ZW?3<45JL9NBUWW7-,^QTN@&=
M1,$!DW >B0I>4L&=E(Y9XBVUBFLC"#  \D+,/P=\FR0[X;3;.LT[AT^@RT08
M[^J%MR]:$)80 <"SEL%C(AG#0# 2*?4($\:<QHN0L_T%M</L(^D2$Q<$0I0#
M3*<DZ! ]H<0K@4/ Y8$@6"&.6,4N,V>7&YI#98AGB$U"<X 'KI$B&O0'DUP"
MDDOM.13F44OLB_QER0%9Q0ISPPJWG*\[S/ UY^O.I3^3/66!80M^?4R!-N2L
MB29&@C78'/#]1>G@I[Z8V?A#Q3?/ 'Y^WG-'Y&EFY^ZE/U,T095D*&7:+6="
M>A7 7^=>V6BC$)*54=IYYID*P0X>8(F?L$,!.<XMT^#3*N:X,8%'AH,A+"B*
ME9U_EOC5U,BSL '1E$4B ]7:,HFMLMI'3UG@ 1F';656YAZ.S,:B  #QPDMD
M77'HI#5!@8$1G&OC4K>FRI&97_4Q.6_&,@80U"!CD6<Z".N08UH3IES DH[[
M.+%Q91B;7_7QT?3RE&#: 8FXS0U[_6:OR(=?[/4'X[Q4NFQ2O/&NVSF$I[83
MC]S/;KW+.V$[ENRZ5+CF;CB&/;T\CDU&BP6-4B[<8Z<,?$C;G83% (P(>.1*
MN05BWXJ'9L1#*> ;0CIH&Z"4T%@1YQGSV#*'_2@[4+'.'++.[0(K-AD\'4-
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M\V,<\UQE[K/G&,.BI5QA@4QD%G.P"L ]2 < ;]9S47',8M(UX,C@@1:#]\7
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M*+$J2#MNPS@7:W^WO^'U<OZ@_6@7\O/P>K9OB-QW+*CR7G 7G)(^E18J+9'
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M-DS?FW^76KY6-[TO85![]^[USV121U W!2B T6O];BOWM<2R?\R)##PM U?
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MEE;R"E&6?X[ XJ),^8EB^.Q6IEC2OX=]>'._?[M78\S/@\\&O>$BUX!,R:R
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MVDX8G'5[)?0/A=<58DR5C(\\+=USDX@W?^H<=M-_6\!:A\6OCSPCD;W7*:Z
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M8!4LP&)D$;A:%&"Q<SSC(/5,48V"^9KG/H4<7L5$<\]$U@B/==191 G](1J
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ME284(!H98@JV(%EUF=K 2M"*Y(4'QBJ25X3DR0B9XMD1]B")\-R6&B-)O*=
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MCI.MFX7(1K-.CGC00"03FC@$)%YF;>FYU=3RK6W1E8Y7_;@^B*[$NQ9B>M*
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MTQ-HQ@4$VZIF? )?9#)PQE 8RP40)JPGTEM+\O\-05 Z:.5=BJU3C1N?D_)
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MJ5)$*VE LPZ.2/0+BH*F*O6,!H'7_>6FRA?;J+9@_)3]E)?DYM=Y9U.5]=$
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M?R$ZP )_U9US?3'8^&66"8$#Y_9]?LNJC=G^;]/_97O9;-=P5]^\?O7RKQT
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M]_Y;61>CKHXJ@PFE%H[;$^^'\> :;"X_@N8>IINXCG=$?X65P"/FGA7CQD-
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MU<K!%ZPO,>C!7@^G:PO5!":-*DMF&6XJ<66:;V>CGY&Y&U\[#(C%*A8Y!Q>
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MT6+=O26M&G#/H#+O-Y%9RB7EE 3/&.'&.J*--B10;D4 #:&0O%(#%N_XM6K
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MSG[[<]1#+#H#N?45RI>X<75A]4EC-[![=53B:L08_);\_%'7TNRG:,8NI=D
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MI+GPJ?41<EA*9R#GJJH!5P)0J^8M5?..]OC!SJ<0"J&HM00 R1$><DIT4([
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M,I0'+84A,G>@/8%:0Y1G!=&<:<]E")HOA+*##"8PS=("Q+X Z] 'E=)"AB*
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M<,&'U2)BT=G%O.ONZ!2DS<'A.':5I<_.N?*2H7-%I3IE(CA"!3I7"AU]98$
MW!E:<&XXYQO;WWV_M^ L P1 *!W&[K3-N3C'JTM8?X)0C0'U@T !C8AR$U^L
MXWEJ<^-"7F2<,PM+##HS+G4^8X5PU_;%_IC1=B8+;%VS5_-;!O]_RJACTCA&
MM,7$RB)P8KPP\,,)9C*P"W*!OEEY22N::?=\.9AQM=0WG#;KTCB=.D7:H9J&
M"EB\$=6 :L6\546T&W 68\Q8@6VY4\U!8J0/SBN;.YAX"+G\839^X^:=9:IQ
MTN0L\X3RFW<$A>\YXU1V<+3S26=:&%U(P"E#"<]92F10C !V%1ZC/<! &]O=
M192:/Q2GTL4;_%D\C,=U^F?3T>\U$'!X DK^[V@-XKD+3!NUHH.H;.YTW>O&
MMGH+&O_S+;._OVL_@=SIW"A'E$SA#&.I =[P@FC)%??4VV#X(W3X'^(U$A(Y
M()EF@2=B@DT<]+6MC/=I<<65!\1.K1C-LZHJ9N/:&&>H-H7O*B6TC^I#/WJ]
MI[PHQVB\5EZ2Z;*=E3KBJU*B^ESWW7SDX(<3JVZ:P$CUQ9W:O0/ $GR)OA;0
MG\=V_EF\!8BN9']ZUNE=^/H2=ZQ/[Z;O,=:K6E)9SU<3'9]Q'9SFI-:?'M1V
M (PY*(>3D:IG5]>0XPBUCZ&J"5RO;/JV^/@>7'T-L]GP\13F_1R7/CI^K"'+
MQ7CM XRQ'L- T9\!(Z.G)M;2]U^Q4&%5U>Z'LZON8P,Q!J%\.I?9?^]HX+=#
M"Q8<!GC.QG>LD?]CW6C<UNBY0 ]8S7CCU@@3#H^,._:6Q6*+9_,7HR<N"I92
ME;QLF#/B3_*VN=Z(YTPE((WMIZ<OIL\^MWD*S%*'X.W0SU?G_:]:JIH*#JBJ
M)=4-R"A0D\X0F[66%YTCL0HEELON820 C_'-R8N=,H!MBZ4G2,#$RA+=^; [
ME6>U<E#6'P76P#*X;BXB%GVU4Q?C8O^+6$>BVN,&?Y;,8W9\G,HB <;"7IOC
MLW2.A*TOX%VVAO&VX-:.4:XJ#QS'G?HT[/T90 IL<(2^&D#&4ZR\JC7Y9N;Y
M5,1HEB=Q7X"JN/1JM?%<&,QL9(2Z3B^&V^H>'W4ID+"4>>NON,K]59\T$=%F
M/[W =\E%Z3OU@3,[S6F<6Y@RFB9-D8K:%7X=D'S )6Y6!TT8]6.5U^G*US%L
M$!/!)RUBZAE-S3TN]A2^A ?\&.E1@F(3T3%?UUO32[XB_YN+<8.=/53,R0O=
M[_2P5G]=7J"1MO_Q%]-@,Q[NJF_-U$B=B"K*W.8/(&J,.^.R3+;7K\*:/;QX
MX]'^**/O=Y$UK!Z<@#P,8^7=*5+7Q*_.Y<W%&AY3,>'-ZCR>+F4>00%/AE!5
MR^G[6',$:X4T&HO[&0X:1QQF^*BC!ZB+730?GG_:I3K8C$)8Q8["G#9S"?<W
M,2 L(UR%IZJ $&"CB0&U<1CHL@$P*F2P.,I)"=K)PAS1G87_-=6936-A8D<G
M/#F0#X?5[LY$:"JIJMP4*!=+5UDEP\ 8"YEH\S'UN^[."I/S1_I;FY9V<&0_
MV8(J5KA 4I<IPF5JB>$R)]2)7.7&93P7C]#JK*B<'&$U[B>@!M3+J8J++Q8X
MFFC!=<A[IM9"U>AV*]D=FUCZVV7MW.9R;9ICI ZYXQ<Q+0OT/Q];,^AA=26R
MPI\>G N@)O>K]XP?GONZRE$8=\L;# $KHB,=>_I6>4BG5?(<(O>WLL:92Z97
MG39PFDPR6^.L3)6V%BV#<?P)B[9552Z_3963ZU\06%;$V^OOR?BDJ8YC7,4H
M=@'&[U5:ZD0C[:'&6I?&T]_J=A>1@+7"?.%U?ZHO2E5J'K8%(Y#]BYE=K.K
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M#[R0U)%<TX)PI2U1SJ:DD+G-?:X+)2SV[TC5BB()UQ>)-2^ST8+;,P:W6_K
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M=\?TA4.VF[\@0>DL N\70I?F>//<E:X^\F*G6Z>Q P--."=3W U>H2;W=C?
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MUN(+\""&+10NM Q5&9(. 'F2*^U$\$R6R2C!K+-Z,;K\NGU4O(1;]$[.B]>
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M6NP!Y0F+<$PRQI)HI;#O"?<\>&L4I=CR1-]^ENX:\-: ][0![[8Y%&O ^_&
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M$9+81!/QU-, 1.6,$HOC.94!Y@G!,V.8#+#SDL,=F*.5Y9$:]ZR(@#*G&&X
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MWD@&X<1SXHHJADI=ROT?AS/^/D,':E- )6;<AH*+/B=31/I85<%9XQ1V3"T
M8JX;HP)%:FR-44X_&=<LM257<B,&\GZ,I3_ET7OA%$M;G;%R7&-XE7]8 =GD
M^YF'/_<WCT)01&A975B*L^:I;4),:0<4O(2-5V^%+K;*TI^Q1#R-X1;9C7Z4
MS [=2US[AG+6I;3]04J&O(@/*A]FE)Z!Z1?9=5!0!7N1*?R@--(P4%U)V;U
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MGKD[&H*<:+^8LCG/$P*[;,Y3-N<IFX@\/>#*)B)E<YZ2KDJZ*IOS/(#L_9N
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MMVYREN*1SA!&8,?@;#09PQ4[S/""6.E?^=/HGI@2NPPS;I(_:[!25MR3@H>
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M +"K]"9.7G?<46MX'P!Q2>N;^*&TG94)/X?'5TRM,)B'Q]M.8-M%OM')^49
M!0R94%S,SML3VY:"J6NW8A>W8D0P'F8K]GH%_"@P<6.^#CIOY'#(,"#@47XJ
MAKH;]5J#?&332%;Q&P7A'=QUE<(-8:>5/+MSR2?#GB25):MR8K,-Z5_=[2 4
M\4)>L##6! Y#:;6Z  !L*"?U51YNSJ*J8&D!/(@MP4\]+)13IW_^'_^GUVC4
MK]Z]>?^>_K2O7G"VDN)NN&4PG5U,)LX>_G:CGZU9=$Q$.TKN%KX?.K0!#BC$
M&'9(. L(<PBS=2E1%G8 )W#T9GP&K)%5JP&'VP,;'B/S2GAKUP!]^^W&\KT)
M<"?\]M13A[8TTY.Q2.C25^$[)G_ET:/,$;+.!#>RS31,.>D;OW3ART@BDB5R
M8GI* ,_A/)SH!7M (8CB+RJP5..52!Q7UCB<R5L9<6YOMF,'8#R0A51S'6X;
MA.%W\GS"LX47(98N))Y3OG 2.M^1'BEA%H'D@(A>W(@U&WN81!=)6M0#NDGP
M+8B?CHB3%5CDN?_US&O9LMOM-CJ]3K?7JLMFO]7ON;UA>S!HUYOPR;]ZC6?W
M=]0]/#HMC7,G=/K-^W?JN1@^1&C>B"E*>.N+C &0 ..]*>D@CEHF7Q=P+R*,
M>)4B?G.2:7;0<V8.F##'*BHHHX6;==3-1NIFX0_X.J**+B991'TO$#K+'#FW
MCGMCGFN P68@>,'I]V9RUBR,ON.'^AW/80N!XTTIQS3/[IK">\?H@7T!FDEJ
M[(D6@YVF$?D3X1LX_BU2+[[<E8.DHH@5EO53EUX+&GB:8(D&I>4/L,H->0+=
M.!V@4;<[U@T)+NN=<"A&OCJS\@E9-WFYE5L5@!-)W^,@/G"<,3"S<,;U9 K2
MR-3P7A!:.? %,GLOR?S7O"Q +L' /L(0X(0VB0L623"J@B4R(3 2@Z3,7KTH
ML\I(9G?#X$<OKQR!7(8_@E@XCUZX]E17<$U:T4KU&W%-W K/)RTEIQY4P'ZR
MNZ:6S<B86X58XI3]DFZ220[^0"J[%3Y2&>J#'@;80/^,F>SR=!=4[=N&=X*P
M -&XF(;F!>O71\$-R_PM#:0Z6UUGDYW!S;VY4TM?=:'H#" X3:/PUG-9KUA)
M273-9@+?@CFVVVIXG6:FV-TVQK8FV,7<6,JYP21 XI6W9><>.Q6&XI)B'5/2
M3(T5W!]8O1#'$@EQQZW9.V^MN>_6SN#>;TP0L4JQ *(=J8&-X)]ZQ4"$"5*\
MG5R(J4PV6%7)-Y)I8Z#D. ,\Y8)/Q7RBHI9H6V!)"F;0X=[2*?Q:WRY\CWP6
M52FL*HQ7U]X"4W"D=%5%.+_9BV.LRF&MA&PU'5Q61HK>,M7IB4PB<]4?:$8R
M<CP*/3\X5#G__R<S\V@35(_2?;=TU95M[_J0>N QX]D9\)_K9*TW?UDWJK!;
MCB('><$Z5>TJ/U6<#F+0!-&D(N9_E(2@&&2N<!P2O\DMW5OGEF:WZ%"ZE%I"
M_A\)L)Y@9H\7L^^2W38S(MN8>1ZH8+Z8:2;W1CIRPM7'=A=8'/N,A(4Y5!9@
M+2AG5(>O_87H;OV/47(%#_QLA3,T9K/H31A-E;^ TXEH.[*B/8^<=@W_'(("
M +MV*>"H?7!4=4YZ/Z6[3$42>>S.0GO.; V2X1$I"< "L- :N!)Q\;PP^_?:
MUQI"Y9QID<OCQ0K/@2[:8FT($"A(XZR2R_<XU1T ^((T;-"3VSF2F=KZXL+T
M=,.@#T"O58;2'YB#!C;YK<S=J^L-KLSK0"Y1>!2L[9!?N\Z:)\<LH$R<HLO1
MPV/!=C'C/A[.\]<5O#.(O+ 7'PQ%+LT/X'HMNZ$D/!,4M1= T:'8%YB:"7S@
M&,ER.L=.!N1:%1P%L )!=064Y!7#QIQQ!3.ZP@23_\EEI*E(482/S8',S-99
MF/HN/R?S,]#YD61BZH^ O^0TU!RRZF+I\0(P5:W#>CBBQRH(DP4X8B\#OHB!
M[XUT&"0R'!JT'\(_WC09\2@T(^'%"Z2('I)86_M8CH$O1'+/;'WD5#*:Q'PD
M:I/@.'*::(:0PL_Y\D"&<STKAU*LH?)(57)W.!9Q"R] LQ/ )/#F:5F=GLL>
MBKS8 W<LE_:K+ZG,WS7S=]MGDK_[5  C;Z'N&,0%_KEUA>HEJZFQ!!)69J^6
M:!0&I8X_MXB3VH_EHQT2U:SK#%]U>Y<EBD S9$)F2T5[6A031(X3^K=(IWX(
M4-&_0:1'O78TBK!K$05CV0.ME;IT2DD^[;QL@I@],P%J4)9S DD8J_N<Y+R#
MVSVP#YI819$U:ED3DS=;E5=EN</G$TDYA2#1KA5?8^D/X4 CE> ,%_HU@5M'
M^7L&6MBG0&45-%JDZ-1)  X]GW3FF X?F8>/]>&MYTB[SY;A\^P%"K]WJ+=_
MK3:YFP<^^O7M3:Z\ _[XI)'E$>IKH$S?:F;;(-F*<61,+T@IVA%BA%<3;->H
M*ULT]:>@J4L*<Z@/B&L9/(FS^Z-(J):188"=34!MXA(!&66-_XA_S'']@1?D
MY8^*T.';-/!TKS^,L5 X&O[+,GT%^G@QI8"1[P6>56P,3\B-3PRI[<L?GM%5
M!12(.,Z8B>;!R/YT.KZV6,B-",)8%I04%2.K(.=#%L:1^OS!HF9<61.%TWUE
M])L* 3_A /MG'8!<W:RM5T!!=U11@&JB '\ETAD'@.<C<HM'6>NMXV2)._*-
M53'&,^(7IG5D=]CNI;Q&99 +EL("I*[!+52.$,'F-_S^6G^?Y1>1K:RCS:2O
M&[%<I&*R&$ B!Y+%:\9?5JS*UA=KO;' A"Y V%6;59QAOF;#7_772_ME"VO5
MJQ?4$XJT$DSN5$C0(K7K1A7G$NR^X6+XOF><D'4/[0<-%ZRJ^H&.0TP9W/#:
M+]E+\-T5!0,V@$/?UVZ<A2O)-EO9>$TD(I;@S+\Q-[% 4_E%G %U?1NO1H=E
M6"H/V%Q;ZJBB O!(D/X[%1&@&V58 .GX/OL*EGIO_E0W2K.G/@@@D#!1*HT4
MY0$(KH#TW>Q.53Z8>HF*(2PZ3.P.D.D0"6T01A$8Z0O)%PN8E+]0.T'TT<RS
M@!4-"G@4:XKVT>GA"O)K2 $RKKBU<W"2$;N=,V1)0;-[:WGM)'0QS9*5#)$3
MD$IFFRB-8TW^2Y; >8T/$E5^#&N6G=/7PA?(<KQ8K3A!1Q&NXE(&*^I"RV*B
MCXQF5;2IV,:)D>R'B8:%O-B<D])[6K5^\V=<N5WK]'Y>WB99<'JOCHRH&YV*
MDI'&I#PJRE?F!=XDG:@-@%4;C20]0[WO2(.SGI/^"DMPQ&WAA2^(-/4+:8LB
M6Q8PU:ZUZ[A=NU97_VVT];\KU@1@D$:J>P?FV'C4 "^92?]65LFKI]O-"O;X
MH3=[#0$43K3H]YP5:F=IGZ8-3"IVS[2)R3>?$A*1-@T/O'W]_MN;:P46/C8U
MTG9S=L'Q$\,_R^F:*M,8X^:P,7AV.]#"05%@ 7*+A/@)8$$S R3\=P505D)C
MQ0X4Z-4Y)N&M!@LCY#+"G =_>2<'48HA+)N)=$_^,DPCL@ONYC//BK?:> :\
MY7<2#PM?T$XF FPC84A%(UI;T%:6F<@ZG8AQO;& ZP7_S\).GIJ)-.YF(CG3
MX/_:]4,QD;RE-0.VMP#8C@'8\R 9\E2P#,NR@'8BFB4B:#Y[L:V@)B?H%%$C
M3&/0B]3SBSC;W$4^:T&\4CZWN!D4'40M9\2(3 F=]9W"9\) H]KO@8<A6'*;
MQ=:WB+!S;GTA6XSU3M4W$G$0V?G/%>4+"19U #\,J2JAA4\MG[E IPDU#1N@
M*;<HA%[L+X6:+S)R9V.5PG'*L\4MPX@[4#M>7@]%ED=]\=%_ [MO&"++(%?.
MTMQ,CQ7E<S>/.*2>Y(H'&G4^>K5[\Z.FJN5!Z2@IO*:]0%1N%.OF,WEX*HS6
MLE]E@&! $> ^)+@O<\!S8!7?-I%P%L?(@WO4LY2R230<35>C& Z]:"*RKFMZ
M"L-"4+#HW<.!#B.:3; Z4NB0)I6)M&0^Y115WY.!SA8O-H='BI(N^NDJVHN+
MMPUB.<NN( N-,, %?I='/]@5.Q'?I?8]LBR/=8,Z[/ZL@M0JC*3)/U:_TQOE
M_$KZ<<5(F8QXX1F%/QVF3#" *=";#FAL ^=,X8=D#7,V0;C\0MJ(<G5. 'D\
M=%[&7%F6_08?9GZ/!C@.DN/(,A(U$%E$3U&F_%"=3>T&7<K&CBB;2Q]=IZ)N
MR$B?*4+D5HA3X&SH+F.>B3N<PD<.<>@@#*JYHL*\0_5T*J#.YNH($V//QM-R
M-VGJZ!_3IRXZ6Z'WZ7 \8QP'*S))H'$V1Q&YG-_"7!&]XKL83"HE8CU?!S3Z
MJNHO.:R*(@KXS*LR"<!TUG=.-0E #T.LXG#35\W. HU5[>8!B8Q\1YV5TQN>
M*%9=@ [^Y-DO'S19BGWTHC4>;)-MD)<B2\HR+;.[K:T[;#?+L-VN]N?")<[L
MBS,:8S:R\GU0YD[,*" 5VM2L$BC#FH(P)4(<@HDPF\!:^-U,S3T9RY+[L[&=
M^W,'SG(.IM>#Z,ZK%+U=].1B0AN<"<2*BG<F'GHST1]"FJ-"@" $ P_?ED9<
MJV2F!\LL.+9BYVM\U&;E#QAT*?Y]0HT4MRTB-.>SY0%)2R5OUU4?L*GPW JW
M2\<YE'FG"Z-,?$VT%2G=<<+(+4*<,WS-GVS"AX=*:CEP2<G&!$!L;9],LH[R
MG_)DZZ,LCCD74W88^GXX(W(@SA6G$VQ&]A<Z<U(> H8#N5(S?F+DP7,&AW%U
MB-3,-U>P4/[7<^)98 _#C^,7F3VIWJ]-0FPI@'?KBVDL7^D_KEPOGOIB_LH+
MZ#STHZLBR%<,W".0\]?*INKW:XU.'\TJ'*F>SXY7%E>-+*Z%N?+\7<NNM3J-
MM5]CE_K]OFLW.WO]<M-F^[5.>]_]E'LM]WJ(O;:V6O4ET2W3+G 'Y"'_]:SY
M+'>YD.K]JC']8=F:Z3(S0&U\:7 D\8:'YL.]N]APG>T4Y(J9/%$'WW"F.I[H
MV5:/7M3Q&_8VYV=_X6$@L-0OBR#P60<SL!D?%F-3J[\"1$X1VU<?]L;0*%8H
M>8^._L=W_=1B]F'/K]0GU#CA68L\3I8^R$D!YS<9Q\PAT&=!CF^;S+4M +85
M%"X*FG:UR<!$"&Y#<R4(%T'8K+9+$-Z3X6$^" 7"=I%QVO(+0O07;()4^>0Q
M/5E>ZUD^><>U+COH'$?*X?!J7S:V2H^%19[>=48L[%/6H,_G5HN&3VP;F; .
M.NODP8-!M6X=U$;8$KP_+<+PX<YOGCO"5Q[5P>U^I=%OKC:)'Y*RK!UA<12X
M?-&(?$I8W*PTVZT'1N(2@TL,?KI3MRKU;K?$X!*#3Q:#@0?;C1*#2PP^60SN
M5=KM^C%B<.G1.,LGRVL]RR<?*72:56,\N>N)2LOR"1&K7$\/NJ\.IJC=N;$5
M]3[(?JN4 ;X$11%+SOM[;K]8*&3914=027]W9P9LO\9:K>#X!*3=KS2[NTK(
M%<=];$VNO*7REH[]EK!8Q&Y<E==47E-Y3:=_3?M&)T\F +EMTMAC^554KGT3
M[L<-4\S<UV<N0Y$/!J#C)O)FK]+IW"]6^0! .@TW9$DN%T\NC4:EV[A?5+0D
MEY)<+H5<[A^!+:FEI)9+H9;[1WM+:BFIY5*HY?Z1Y0-2"[DV7E+A^R^/T+'G
M<//!GMLOK$W!K6S(?:$K@?G$-/*P>8$_MR@&Q6-R>-J-GIT53[$!4Q2/O6FQ
M<0%\I[M!4F,.[!,9)&$T7]%]PW/_ZYG7LF6WVVUT>IUNKU67S7ZKWW-[P_9@
MT*XWX9-_]=K/]KB@1P?^4DT.-R<>#JNO52>3KV,<>7B-,XZX[<S^T[B.I]G%
MYKX^+A I-DBB:9;88C,$>.C.+C'!0QCPV!\G>B>$$S<X\@K;XUP[#O:81!KZ
M#/S,\>XQG^UX,.(/')DBI]2&%F<S9TV0LDEEL1J0@J.$L<4KMWK*@:%ZR_NP
M)S5'"QO$TK3.O#=7L8DUX.#U1.(,56K3RI-1 0%Q%ZH+J.):1L]:'.4]P9]7
MK#]3=Z2:U_)PU3B=3)G[Z4;2>M@L+RGB,*#.*MQCFV:#X[8\.I5J+ZZ'CU+/
M]ECF+UQZB:"I:ZH%TC2,:$0R=R#-IW;1K\Q&I*J[&/405TV/5H);C_-9M;0>
M#&M.0#2[5''5/'4X1R%!;;181/#T>9R!BH,978]FP>D!#>9I>?):C(,:L>TI
M]MLR+EMA/L'5E;$3>0.^Y8\A'*M!8^;@YVD@4I>N'##'Q6VZQ:Y_JTY>LV[4
M73-X8%=W;6.Q9^QW24?S'#AK!5L$_\ECE6A:+'7]DC]R]*$FQ/FY_Y#YK$H1
MF._3#ZFQU([F"=[0 H&M2[/ERI^H+<;F'@O(-,#IGO!H@CV.%?["D<9 I4!)
M:: )0.$/3\E;\S*<*( S'Y@PGC?4WG2C<46-^7'T=-V,1.: LM]Q"A5>I(/M
MJPE'&*]HX![]1?!,N<L:XQ*J)#G%:#(TUF7$(]F2QCEGT*.*];JS_#'L:P]
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M20%*DNX>SG-4$QRPQ32) K&X4?K5/5C=T2F'[[5/V/J'\%/Z^I!BYDR$R"W
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MJE C[A<8DXZ=Z1QLG;]-VX\D?"UU8I=*["Z\6$0X23<WGSD/ GW(*G.2V:2
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M&=!B0M3U(J^V<R76-3*]@YJ<1D90S2Q)-6MA!UGA49[-QJHE^4*'GD]9=V
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MRPS_TQJ&?P;,8\&1FT7U_")(MD8"DXR)ZL,X]O*<.<QI36/5^,*;H!8K32Y
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M@]29-7M7^8_<[U4G02QLG_R!THA&,A_,.4=^*$I*JUBW0)0JC3W!]B@CPS7
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MBQ-&4VI8A^;9%]W3QGH7A9,"I!1Q+ CY#L%GC46]C3-@!Q!O8\2?PBL?FLW
MJP_E3*IM$YE_O%HT/GFFV:PX_G#X:,??-&/V/\5*14HR4[XZ^ :M<22'0,1)
M,GWU\N5L-JO!-FNC\/;E=>2,04>/7TIW)**7KDC$RUZK;[<Z+W&[_*?=P[_A
M(_FC:5>Q+9DWI%;^X=!3#*4V3H#)W>1?<=-8S6VH>9B(56.MK&O'&S 19NA%
M^HH#31)T!V'Y7D*_#U0Z"/5'LWO_^5(L:K&'P\%#4)\6\4"%N@':C9HA_Z78
MD*Z'_>ATFSF57=-D*-;NR>0?AZD^X:/GQ(T;)3>^1&[<Q[\[G9>^-Y2W(DC0
M7Z :+HG C62<,#>^5MWEL,W1%TG-65WK]1Q;3F7=Y9BY]DOFNA]SU3T\VQJ,
M)7,]$^9JE[KN27-7?W@;_*O>;-J-Q@]46^U%#56UO9Q&H,)Z4^%;,INK$:JY
M&M,TBG'4/'($;H2' T):S\6+ES0?!/^Z>,[)3H:Q<C*4'/",.&"I7YX3!VS<
MR0'SEM\E!RPY8,D!&S7[_RM9X/FPP,9]E4"[1\.>;VK !]MU[G3LAE.TJ\W'
MOO+ )*M?[V1-DT4T$(&,JY]^^'*N^R4WZO5&R3[3*/#B<<E"SY.%-DH6>DXL
M]+Y:9,E"2Q9:LM =[M:N'X,C\A G+S;PS]F*V;N?Q\GD7?FIP5OW:IM1<VOF
M,&<]^RU^BQHZ\9Y2!:W_]_K+;]9S@)@,8@]3#5^K@5G&R.O?1#!*Q4B^>&4]
M]UY8OV<#]&ZR 7HWY@"]U\*G819?QU+BN*QD<2,8P,$I8JIN0(T2NX+5MUG^
M:SZ5#_CEIVQL%RW+N<P(O$B.\4R@^6+8?B(S&/%P WPX0 ALF') #V5;VVEO
M'/</G>_CT <)%*M[U+.E]M]+ _=RNS.8;G"BV3N<:):]>X?3XU_/X:4X29&F
M(-WY]GR2;KZ/BI6(T8C[10]\@ T/. 'DNU"&<+>CY2SX?>M"K_>&!@1_QI;R
M-&Y:T$AAZXU(A(57;SW/.3*0A,F1D>#RD:/ KG4\]W*EYUW$LD,UXS*U%.I6
M6E1^\.S)D^_W'D'3K?5ZIS*!IM>OV;WM-G0^// 87 :'T7B]V'(*IC5\,)"D
M_V8V'F@-..E05>OR,"ISWNM&<QL8)3S)8U=9K48V@3H._&P:QCQO3)G?:OIP
M3YO@A7EOQE+PH@'5"NOD<BK^S2:FJF%UP5Q-7\WGW.$PT4C@Q+S96/)X1IJT
M)6%#$A/6J0**A[1C4BBRLW"(<VA'(G)]-6T>5Q[) "2&;VP"H><K53R;FLL;
MV$5UT.PJ",EKLP'-[O?D8S%E/NG15/"MK#0[FK(^>U6=W,YE?0W[V2]'4=:W
M7?WIDP)^=4W?U_>_?KS^]ON7MU^WKZ4]$(Y\-K@K,S$P4:/<<MQJ1"8^]"7C
M?M88U%DWQ0GF(D73T.3FS%MCN")..<31N@,Y%OY0#R0DGZUZ@,9GI\AN:;V\
M7<.!Y@0"VM;JC+J[:FFM6J>^GR:V<=5&S>[N-R1OX[+]6K_QH!/B'L=)>O0J
MT&_OW[W]Q_7';]>_OK5N/GWY_.G+];?WGSYNX<^VV\?AT-Y?#3^NFP"[6[[:
M01$_^@/A*+ F^^H>_E@'[?+T,GYI?4WDK0RL+S7KG3>4^SC'#E H>0K 70 L
MJEV?(QE[J&>3$70S]N00!+W.'/G$84]Z\OGG+"ZZ],"+DJF53*UD:IN8VHV(
M?.NZ9EVG4<G2'M#3;H(5V12SL#P(M8:%+3U _"___IJ[QZ&+9SV/V]['<7S>
MBZ-Q5#36.RI>#D)W#O\9)Q/_E_\?4$L#!!0    ( +> HU3##0/QI0L  $AI
M   1    ;&9V;BTR,#(R,#,S,2YX<V3M76V3VC@2_IY?H>.J[G)5ZP$#\WJ9
M;#$SD%#'#!PPF]U/*6'+H!HC$4EFAOOUUY)Y!QL;A@NWL)7:8%O]M-1/=ZLE
M+/+IU[>^CX9$2,K9;<8^RV4080YW*>O>9I[;%>LJ\^OG#Q\^_<6R?K]KUM #
M=X(^80K="X(5<=$K53WTS27R!7F"]]$W+E[H$%O69R-TSP<C0;L]A?*Y?'[Y
MJ;BY*%SA7.?:MHJ7%Q=6L5BXMJZO+W*6XU[FBH5B/F?;E[]T;XK0Y@+N6%>>
MF[>*Y\2UK@J=:\N[+-CG%^2<%#N. 7V3-]+ID3Y&,# F;][D;::GU. FFWU]
M?3U[+9QQT<WF<SD[^_MCK66:9L9M?<I>%EJ_=80_:5_(ZL<=+,FTN3=D"\U]
MZI$A9@IWR9G#^UD]XERA8$\$-!R-44"95)@Y4P6N$I8:#8A<+P./L_JQUI.S
M<K:5!TU8*4$[@2(5+OH/Q,.!KVXS ?L18.@>)2[PZQ/-X$*#N<<*BRY13[A/
MY  [)-D(/W] 2-N>]@=<*,16I#TL.Z;74B@M9NL.:].$;-6X@Y5Q0=U>@H 9
MYHI4EOA*ZBMKAG'V)MU,-GD/ FEU,1YLT8MYR; GXSOI>S/GC/;U]77V37O7
M^GZL]173WM(?+3N?3FV4TR77#5?61.X]^C"+K'1]F,CMV(>U@13E$9LDS;5,
MV T#)(ESUN7#K,,#IL3(>-<&CUPG,KDPOKB-?I=0 _2CF%#[3$!_M,*/BYHQ
M8UP9#'UG?&\PH,SCX0VXI5F\F5#9)-XD6ZZDXS7Q8OZZP<(1W-\07-F!X ,B
M%"5R/I4;@)X@WFU&)W1KDM*^^[AS!CV9-%E1L.B/^G$61(A?FXUD(JM=XC8C
M@0:?A+8YY($/!$D[<!"1,*48HO_OQ^]@/^WX0<0)_#_'\%WBI1T^B%!&MQB]
MEF[#<T3=V\P]ASJT :5%!NG[S\UJ;.UA-,]D)L 3Z%F?/N>@VH,_R)I5KQ8R
MDDB+?LHN"RQ!!9*X=?;9?%[V]+'PN$F,X)*+))9;M.U:L?'-B3'C3%Q_>B@_
MM<H/\*%5KU4?2NWRPUVI5GJZ+[>^ELOMUC/#@4N5+@23DY "-88FV]"4!VY:
M8%\RX6D"CN;1T1@>A?CHXU3#/TYTKC-\ PL89X\H"CW?#[>+*N*)UKEC5Z+1
MQP6-1T]\JPW_?RP_M5OU2KU1;I;:57A:>H)&CXUF^2L(5'\K5Y_@LOQN8;Z=
MTGCG*.1RQ63.,=..ZA4TTX^@ VBA!RCLPBE1K*&N7FFUZ_?_^EJO/92;K?*_
MGZOM/][?0>*UQ'M$,9<[3^D1VB'F%?[MKU=Y^_*?*%1\\H/U(7Q?:GVMU.K?
MWJ\.V( >S_MY+G>Q32;0BI#1=*1$UT47,_H?TPO,W#LLJ>1>8VY,*7A- !9#
M8][.V798?5/I^%P&@L#%/"@"5&1@$??0// 14=8*^GTL1MQKT2ZC'I0T3)4<
MLZE#6;?!?>K $BX%;0D!XZG3?Y:I&P-KKN:@T0P;3<!/]"U9>V\T)J(3%OCY
MU4A,3B=4W.-/QY1+DQ'0QAU_#[R.8>-8+>2*A=U8#96<.%TV_A,6 CHZ) ]$
M8>J_/[LK"N)X+N;.BSOQ;*&I/O1QK/%$^C(G][P_X Q&"35.E0WA Q>C?3E
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MW] 8&%]@[O(NM)ZL:J'$>$&39D][%R4'6^!--YLJL.25/>)^X=Q-O9F5$N7
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MWP+UH$5[L51^[A;%@6%6)LT5NFH>@3&+P#+:_J"YM<Q#B(8_@ =7W[*C6M]
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M-5PX>SOONQW#XYK,#]%,TZM8UPT8+7Y=OI1,V+_]Y?\#4$L#!!0    ( +>
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M/Y9T<:K-06C@C$+-]#[W6$>S2-X;P^N+?-*[0<,5I?/HON=RPBD71(0PB8F
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MW=@=[6G8W5N;L@=;M-:'.WI8\@<I5E-9>\VT>=\4I]QOJFO:0 4LX%C!#.-
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MJ:1ZDL,0!0@B%C%(XP3!C(@@2C*NLL3M]*!'8<=F,GPQ=17 <@Z>=(L/QE&
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MY)(F.E[([T1J_%V:6%<IKJL.WN5%F>745(R\E0MS-#H1! 4RP]H&S](8HCA
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M/<+J+LV@9UH7@[9_R'5Y@]UH]E8/GESHG4W%WW1QLRC=TZOPF.9F8"(%SK)
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MK'@CU7Q1%[6_H]]E\?[[<D%U'UJDQ4N9B-.DLM-O:LAT3_>-R\%$"JD7+QK
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M809#E<5Q3.(P#AR=:4]U-3:>-%E5\MH/W:Q?&ZESUQO(%GSM*,X/:CT3V0Y
M.]F&>_)T/8>)9Z_6D]T-[,%Z3NU#;]6S;W2CC:T9<CT3.\-_))5V(B,:RRR
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M%A%!S.%U2*P<.,]U-+9%H#YDK86]JO)5:DA!([#K"?4)?&W/IB]';9A3Z0Z
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M^?V?SSSA4T3FLKET.+,:;X8&9JN#R7FSA7RG9_)E/RF-/4EET)EGQYL>GTI
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M[&.\X(I^9]<O>?2[.6<PSMW!N7\XL%)\=9S<5%G<Y4'D.<]5F6<@5T0!S)@
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M9JDM-&W<-95#8+TUG>480>14L")0_M1XJ=$SW$'SQ9^J+!?0X%_JS+P+-)6
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MXE\Y[:L/EOX$L-X1HG99K&+#WS\\WB^?E:J>N35?V.]&DUOS[9L99X=*KA"
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MPLV=(> :Q4]#H>A1/24NFB.52KD85;^**.X8=98_<1AFO%HG[C8=%3;Q^%@
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M N3#;!KO220)H$PS@1A7FDAA G&,68(T,,VEL#;42=HV4=1"@-SCCL"!(F_
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M(.8@<3< EY.4NJH+/_GHQ^G=]+7_-L;8ZQ9;(QW0!7/M2!(>([XL$@F<9\+
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MYO33Y]/_^?N[\_]=\4[^TZ\[SB7\'5CNOZ?J$WV!#61-K0S$ZHAN.@9&G'!
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ML_G%2O'7PD5Q6FL\B:)L7U(>D"U16I@G[4.B(9I*@[*V(W#8ZP/5+&P-]32
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M<+-5C_V LI[R&L#HK;WK4W0M\ZF?7.U;+U[]_ O,OLS]MZ_(;^DS\6 YEGX
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MIF:J%(B+UA"?3,[ 6#G/?A$& Y_V>K98=I*[@6HIN.31:**=+">PY<A4:DW
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M(#M4&PW@ZVHL"-KG&[[.\JUL:(2QKQ$L.DQ\,%R0BAIB W.$6] Y,$'9_9%
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M.[= NB\Q/82Y$4LX >"2CZ22;N'3_$/#^L45D!= %=?%'=&-$C7DC]O2H;S
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MOX)+<5L+Q*])VN9E!;(DQ0IT3:_Q;K=/!\628V&*Y<E*T]RO/TJVV[1=BNV
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M;BTR,#(R,#,S,2YH=&U02P$"% ,4    " "W@*-4PPT#\:4+  !(:0  $0
M            @ $HH $ ;&9V;BTR,#(R,#,S,2YX<V102P$"% ,4    " "W
M@*-4DCVZ.I,7  "FV@  %0              @ '\JP$ ;&9V;BTR,#(R,#,S
M,5]C86PN>&UL4$L! A0#%     @ MX"C5%5N/VNV*   UI8! !4
M     ( !PL,! &QF=FXM,C R,C S,S%?9&5F+GAM;%!+ 0(4 Q0    ( +>
MHU3<3I8M79L  +AE!@ 5              "  :OL 0!L9G9N+3(P,C(P,S,Q
M7VQA8BYX;6Q02P$"% ,4    " "W@*-4C+?232=5  !BL@, %0
M    @ $[B ( ;&9V;BTR,#(R,#,S,5]P<F4N>&UL4$L! A0#%     @ MX"C
M5!](X3;3!P  CB4  !4              ( !E=T" &QF=FY?,#,S,3(R>&5X
M,S$Q+FAT;5!+ 0(4 Q0    ( +> HU1HL _MPP<  'HE   5
M  "  9OE @!L9G9N7S S,S$R,GAE>#,Q,BYH=&U02P$"% ,4    " "W@*-4
MCZ%Q"E4%   U$P  %0              @ &1[0( ;&9V;E\P,S,Q,C)X97@S
M,C$N:'1M4$L! A0#%     @ MX"C5)BG2X5+!0  (1,  !4
M ( !&?," &QF=FY?,#,S,3(R>&5X,S(R+FAT;5!+!08     "@ * )8"  "7
%^ (    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
